Psyllid ID: psy9855
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 470 | 2.2.26 [Sep-21-2011] | |||||||
| Q9UQ07 | 419 | MAPK/MAK/MRK overlapping | yes | N/A | 0.612 | 0.687 | 0.333 | 1e-51 | |
| Q9WVS4 | 420 | MAPK/MAK/MRK overlapping | yes | N/A | 0.531 | 0.595 | 0.379 | 3e-49 | |
| Q9UPZ9 | 632 | Serine/threonine-protein | no | N/A | 0.421 | 0.313 | 0.415 | 1e-39 | |
| Q04859 | 622 | Serine/threonine-protein | no | N/A | 0.417 | 0.315 | 0.408 | 7e-39 | |
| P20794 | 623 | Serine/threonine-protein | no | N/A | 0.417 | 0.314 | 0.408 | 8e-39 | |
| P20793 | 622 | Serine/threonine-protein | no | N/A | 0.417 | 0.315 | 0.408 | 9e-39 | |
| Q9JKV2 | 629 | Serine/threonine-protein | no | N/A | 0.378 | 0.282 | 0.434 | 2e-38 | |
| Q62726 | 629 | Serine/threonine-protein | no | N/A | 0.378 | 0.282 | 0.428 | 3e-38 | |
| Q55FJ6 | 507 | Probable serine/threonine | yes | N/A | 0.425 | 0.394 | 0.386 | 6e-37 | |
| Q38772 | 294 | Cell division control pro | N/A | N/A | 0.382 | 0.612 | 0.394 | 2e-34 |
| >sp|Q9UQ07|MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens GN=MOK PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 204 bits (519), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 121/363 (33%), Positives = 184/363 (50%), Gaps = 75/363 (20%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK +V NL+EI LR++ H N+L L E +R + + L+ LM++
Sbjct: 35 MKQRFESIEQVNNLREIQALRRLNPHPNILMLHEVVFDRKSGSLALICELMDM------- 87
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
NI E L+ G+ P
Sbjct: 88 ---NIYE--------------------------------LIRGRR-------------YP 99
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
K++ H +YQ+ L H+H +FHRD+KPENILI+ D++ +GD GS + + SK
Sbjct: 100 LSEKKIMH---YMYQLCKSLDHIHRNGIFHRDVKPENILIKQDVLKLGDFGSCRSVYSKQ 156
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+TEYI+TRWYR+PECLLT+G+Y++++D+W+AGCVFYE + PLFPG +E+DQ+ +IH
Sbjct: 157 PYTEYISTRWYRAPECLLTDGFYTYKMDLWSAGCVFYEIASLQPLFPGVNELDQISKIHD 216
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
V+GTP + L KF++ ++ NF + FK+ G GI +L + + L+ M+ YDP R
Sbjct: 217 VIGTPAQKILTKFKQSRAMNFDFPFKK--GSGIPLLTTNLSPQCLSLLHAMVAYDPDERI 274
Query: 301 TAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMD 360
A + L YF EQ++ K+ G +K P H +A S+
Sbjct: 275 AAHQALQHPYFQ---------EQRKTEKR------ALGSHRKAGFPEHPVAPEPLSNSCQ 319
Query: 361 MSK 363
+SK
Sbjct: 320 ISK 322
|
Able to phosphorylate several exogenous substrates and to undergo autophosphorylation. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q9WVS4|MOK_MOUSE MAPK/MAK/MRK overlapping kinase OS=Mus musculus GN=Mok PE=1 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 98/258 (37%), Positives = 158/258 (61%), Gaps = 8/258 (3%)
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFG-KSRNLGTLIV 113
++++ + + ++ R + L ++ A + V +D K L L+ N+ LI
Sbjct: 35 MKQHFESIEQVNSLREIQALRRLNPHPNILALHEVVFDRKSGSLALICELMDMNIYELIR 94
Query: 114 GLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSL 173
G L ++ LY +YQ+ L H+H +FHRD+KPENIL++ D++ +GD GS
Sbjct: 95 GRRHPLSEKKIMLY-----MYQLCKSLDHMHRNGIFHRDVKPENILVKQDVLKLGDFGSC 149
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
+ + SK +TEYI+TRWYR+PECLLT+G+Y++++D+W+AGCVFYE + PLFPG +E+D
Sbjct: 150 RSVYSKQPYTEYISTRWYRAPECLLTDGFYTYKMDLWSAGCVFYEIASLQPLFPGVNELD 209
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
Q+ +IH V+GTP +TL KF++ ++ +F + FK+ G GI +L + + L+ M+
Sbjct: 210 QISKIHDVIGTPCQKTLTKFKQSRAMSFDFPFKK--GSGIPLLTANLSPQCLSLLHAMVA 267
Query: 294 YDPKRRPTAQKILSCAYF 311
YDP R A + L YF
Sbjct: 268 YDPDERIAAHQALQHPYF 285
|
Able to phosphorylate several exogenous substrates and to undergo autophosphorylation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 86/207 (41%), Positives = 123/207 (59%), Gaps = 9/207 (4%)
Query: 107 NLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLV 165
NL LI P+ + R ++YQI+ GL +H + FHRD+KPEN+L G +LV
Sbjct: 85 NLYQLIKERNKLFPESAIR-----NIMYQILQGLAFIHKHGFFHRDLKPENLLCMGPELV 139
Query: 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL 225
+ D G + I+SK +T+Y++TRWYR+PE LL YS +D+WA GC+ E T PL
Sbjct: 140 KIADFGLAREIRSKPPYTDYVSTRWYRAPEVLLRSTNYSSPIDVWAVGCIMAEVYTLRPL 199
Query: 226 FPGDSEIDQLDRIHQVLGTPKAETLKKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKG 284
FPG SEID + +I QVLGTPK E Y+ SS +++ Q + L+P +
Sbjct: 200 FPGASEIDTIFKICQVLGTPKKTDWP--EGYQLSSAMNFRWPQCVPNNLKTLIPNASSEA 257
Query: 285 KKLMSEMLKYDPKRRPTAQKILSCAYF 311
+L+ +ML++DPK+RPTA + L YF
Sbjct: 258 VQLLRDMLQWDPKKRPTASQALRYPYF 284
|
May play a key role in the development of multiple organ systems and particularly in cardiac development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 162 bits (409), Expect = 7e-39, Method: Compositional matrix adjust.
Identities = 83/203 (40%), Positives = 124/203 (61%), Gaps = 7/203 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLGSLQFIKSKGLHTEYIATRW 190
++YQI+ GL +H + FHRD+KPEN+L G +LV + D G + ++S+ +T+Y++TRW
Sbjct: 105 IMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRW 164
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +D+WA G + E T PLFPG SE+D++ +I QVLGTPK
Sbjct: 165 YRAPEVLLRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDW 224
Query: 251 KKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
E Y+ +S+ ++F Q + L+P + +LM+EML +DPK+RPTA + L
Sbjct: 225 P--EGYQLASSMNFRFPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHP 282
Query: 310 YF---ADLTQLKQYLEQKQVMKK 329
YF L +L+ KQ + K
Sbjct: 283 YFQVGQVLGSSAHHLDTKQTLHK 305
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 162 bits (409), Expect = 8e-39, Method: Compositional matrix adjust.
Identities = 83/203 (40%), Positives = 123/203 (60%), Gaps = 7/203 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLGSLQFIKSKGLHTEYIATRW 190
++YQI+ GL +H + FHRD+KPEN+L G +LV + D G + ++S+ +T+Y++TRW
Sbjct: 105 IMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRW 164
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +D+WA G + E PLFPG SE+D++ +I QVLGTPK
Sbjct: 165 YRAPEVLLRSSVYSSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDW 224
Query: 251 KKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
E Y+ +S+ ++F Q + L+P + +LM+EML +DPK+RPTA + L
Sbjct: 225 P--EGYQLASSMNFRFPQCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHP 282
Query: 310 YF---ADLTQLKQYLEQKQVMKK 329
YF L +LE KQ + K
Sbjct: 283 YFQVGQVLGPSSNHLESKQSLNK 305
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 9e-39, Method: Compositional matrix adjust.
Identities = 83/203 (40%), Positives = 124/203 (61%), Gaps = 7/203 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLGSLQFIKSKGLHTEYIATRW 190
++YQI+ GL +H + FHRD+KPEN+L G +LV + D G + ++S+ +T+Y++TRW
Sbjct: 105 IMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRW 164
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +D+WA G + E T PLFPG SE+D++ +I QVLGTPK
Sbjct: 165 YRAPEVLLRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDW 224
Query: 251 KKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
E Y+ +S+ ++F Q + L+P + +LM+EML +DPK+RPTA + L
Sbjct: 225 P--EGYQLASSMNFRFPQCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHP 282
Query: 310 YF---ADLTQLKQYLEQKQVMKK 329
YF L +L+ KQ + K
Sbjct: 283 YFQVGQVLGPSAHHLDAKQTLHK 305
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2 | Back alignment and function description |
|---|
Score = 160 bits (406), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 79/182 (43%), Positives = 114/182 (62%), Gaps = 4/182 (2%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLGSLQFIKSKGLHTEYIATRW 190
++YQI+ GL +H + FHRD+KPEN+L G +LV + D G + I+S+ +T+Y++TRW
Sbjct: 105 IMYQILQGLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRW 164
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +DIWA GC+ E T PLFPG SEID + +I QVLGTPK
Sbjct: 165 YRAPEVLLRSTNYSSPIDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDW 224
Query: 251 KKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
E Y+ SS + + Q + L+P + +L+ ++L++DPK+RPTA + L
Sbjct: 225 P--EGYQLSSAMNFLWPQCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYP 282
Query: 310 YF 311
YF
Sbjct: 283 YF 284
|
May play a role in cardiac development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (404), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 78/182 (42%), Positives = 114/182 (62%), Gaps = 4/182 (2%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLGSLQFIKSKGLHTEYIATRW 190
++YQI+ GL +H + FHRD+KPEN+L G +LV + D G + I+S+ +T+Y++TRW
Sbjct: 105 IMYQILQGLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRW 164
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +D+WA GC+ E T PLFPG SEID + +I QVLGTPK
Sbjct: 165 YRAPEVLLRSTNYSSPIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDW 224
Query: 251 KKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
E Y+ SS + + Q + L+P + +L+ ++L++DPK+RPTA + L
Sbjct: 225 P--EGYQLSSAMNFIWPQCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYP 282
Query: 310 YF 311
YF
Sbjct: 283 YF 284
|
May play a role in cardiac development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 80/207 (38%), Positives = 123/207 (59%), Gaps = 7/207 (3%)
Query: 107 NLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV 166
NL I T LP+ + R ++YQI+ LH +H+ FHRD+KPENI++ G+ +
Sbjct: 85 NLYESIKDRTKLLPETTIR-----NIIYQILQALHFMHTNGFFHRDLKPENIMLVGERLK 139
Query: 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226
+ D G + I+SK T+YI+TRWYR+PE LL YY+ +DIWA G + E + P+F
Sbjct: 140 IADFGLAREIESKPPFTDYISTRWYRAPEVLLRCTYYNAPIDIWAVGAIMAELYSLKPMF 199
Query: 227 PGDSEIDQLDRIHQVLGTPKAET-LKKFEKYKSSNFTYQFKQYPG-GGIDVLVPQIHEKG 284
PG SEIDQL +I ++G+P + T + + S FT+ Q P + L+P ++
Sbjct: 200 PGSSEIDQLFKICTIMGSPTSATWIDGIKLANSMGFTFPNVQPPSINPLSTLLPNANQDA 259
Query: 285 KKLMSEMLKYDPKRRPTAQKILSCAYF 311
+L++++L+YDP +RPT + L YF
Sbjct: 260 IELITDLLQYDPLKRPTPLQALQHRYF 286
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q38772|CDC2A_ANTMA Cell division control protein 2 homolog A OS=Antirrhinum majus GN=CDC2A PE=2 SV=2 | Back alignment and function description |
|---|
Score = 147 bits (371), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 73/185 (39%), Positives = 110/185 (59%), Gaps = 5/185 (2%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATR 189
LYQI+ G+ + HS++V HRD+KP+N+LI R + + + D G + F T + T
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL 167
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
WYR+PE LL +YS +D+W+ GC+F E + + PLFPGDSEID+L +I +V+GTP ET
Sbjct: 168 WYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVMGTPNEET 227
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
+F F ++P + +VP + G L+ +ML+ DP +R TA+ L
Sbjct: 228 WPGVTSL--PDFKSAFPKWPAKELAAVVPNLDASGLDLLDKMLRLDPSKRITARNALQHE 285
Query: 310 YFADL 314
YF D+
Sbjct: 286 YFKDI 290
|
Plays a key role in the control of the eukaryotic cell cycle. Antirrhinum majus (taxid: 4151) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 470 | ||||||
| 72004410 | 440 | PREDICTED: MAPK/MAK/MRK overlapping kina | 0.568 | 0.606 | 0.358 | 9e-56 | |
| 405959664 | 475 | MAPK/MAK/MRK overlapping kinase [Crassos | 0.719 | 0.711 | 0.325 | 5e-54 | |
| 47230003 | 423 | unnamed protein product [Tetraodon nigro | 0.538 | 0.598 | 0.370 | 1e-53 | |
| 410898597 | 472 | PREDICTED: MAPK/MAK/MRK overlapping kina | 0.557 | 0.555 | 0.357 | 2e-53 | |
| 242014629 | 541 | mitogen-activated protein kinase ERK-A, | 0.412 | 0.358 | 0.494 | 2e-53 | |
| 118348276 | 567 | Protein kinase domain containing protein | 0.625 | 0.518 | 0.385 | 3e-53 | |
| 126290468 | 445 | PREDICTED: MAPK/MAK/MRK overlapping kina | 0.557 | 0.588 | 0.351 | 8e-53 | |
| 348544261 | 456 | PREDICTED: MAPK/MAK/MRK overlapping kina | 0.540 | 0.557 | 0.353 | 2e-52 | |
| 344273702 | 461 | PREDICTED: MAPK/MAK/MRK overlapping kina | 0.612 | 0.624 | 0.333 | 2e-52 | |
| 148223111 | 411 | MOK protein kinase [Xenopus laevis] gi|4 | 0.568 | 0.649 | 0.350 | 3e-52 |
| >gi|72004410|ref|XP_786078.1| PREDICTED: MAPK/MAK/MRK overlapping kinase-like [Strongylocentrotus purpuratus] | Back alignment and taxonomy information |
|---|
Score = 224 bits (570), Expect = 9e-56, Method: Compositional matrix adjust.
Identities = 118/329 (35%), Positives = 181/329 (55%), Gaps = 62/329 (18%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK +V NL+EI ++++ H N+L L E +R T ++LV LM++
Sbjct: 35 MKQNYQSLEQVNNLREIQAMKRLSPHANILELKEVIFDRKTGNLSLVCELMDM------- 87
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
N+ LI G +LP
Sbjct: 88 ----------------------------------------------NIYELIRGRRHYLP 101
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
Q+ + Y +YQ++ L H+H +FHRD+KPENILIR D + + D GS + + SK
Sbjct: 102 QEKVKNY-----IYQLIKALEHMHRNGIFHRDVKPENILIRDDHLKLADFGSCRSVYSKQ 156
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
TEYI+TRWYR+PECLLT+GYYS+++D+W+ GCVFYE L+ +PLFPG +E+DQ+ +IH
Sbjct: 157 PFTEYISTRWYRAPECLLTDGYYSYQMDMWSVGCVFYEILSLHPLFPGANEVDQIAKIHD 216
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
V+GTP A L KF + K+ Y F G GI+ L+P ++ ++M+++ YDP R
Sbjct: 217 VMGTPDATILNKF-RNKARGINYNFPSKKGSGIEKLLPNATKQTLEIMNKLCTYDPDERI 275
Query: 301 TAQKILSCAYFADL---TQLKQYLEQKQV 326
TA++++ A+F DL + KQ++E+K++
Sbjct: 276 TAKQVIRHAFFKDLRDADKRKQHVEKKKL 304
|
Source: Strongylocentrotus purpuratus Species: Strongylocentrotus purpuratus Genus: Strongylocentrotus Family: Strongylocentrotidae Order: Echinoida Class: Echinoidea Phylum: Echinodermata Superkingdom: Eukaryota |
| >gi|405959664|gb|EKC25676.1| MAPK/MAK/MRK overlapping kinase [Crassostrea gigas] | Back alignment and taxonomy information |
|---|
Score = 218 bits (555), Expect = 5e-54, Method: Compositional matrix adjust.
Identities = 134/412 (32%), Positives = 208/412 (50%), Gaps = 74/412 (17%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK T +V NL+EI +R++ H N+L L E ++ + + L+ LM++
Sbjct: 40 MKQTYDSLEQVNNLREIQAMRRLSPHANILELQEVIFDKKSGTLVLICELMDM------- 92
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
N+ LI G +LP
Sbjct: 93 ----------------------------------------------NIYELIRGKRHYLP 106
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
++ + Y +YQ++ + H+H +FHRD+KPENILIR D++ + D GS + + SK
Sbjct: 107 ERKVKHY-----MYQLLKSVEHMHRNGIFHRDVKPENILIREDVLKLADFGSCRSVYSKQ 161
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+TEYI+TRWYR+PECLLT+GYY++++DIW+ GCVF+E L+ +PLFPG +E+DQ+ +IH
Sbjct: 162 PYTEYISTRWYRAPECLLTDGYYTYKMDIWSVGCVFFEILSLHPLFPGSNEVDQIAKIHD 221
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
++GTP + L K +K + NF F Q G GI+ L+P ++ +L+ +M YDP R
Sbjct: 222 IMGTPDSSVLDKLKKSRGMNFN--FPQKKGTGIERLLPHCTQEAIELIYQMCTYDPDERI 279
Query: 301 TAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAG-GMQKT-----SHPTHLLANTK 354
TA++ + YF DL LK ++KLA+ Y G G + S P +K
Sbjct: 280 TAKQAIRHPYFKDLRTLKS-----SAVRKLAR--YTRGLGFESWLRLDFSQPVTERQASK 332
Query: 355 SSHQMDMSKFIQ-SDLNTHQTKKTKSDFFSQARTSKYRFDQSSSIVLHPKNP 405
+ + D+ K Q + +T + +RT K R + SI PK P
Sbjct: 333 AKEKDDLEKKEQVRPRDKDETATITTLEVDTSRTEKKRSETEVSIPSLPKAP 384
|
Source: Crassostrea gigas Species: Crassostrea gigas Genus: Crassostrea Family: Ostreidae Order: Ostreoida Class: Bivalvia Phylum: Mollusca Superkingdom: Eukaryota |
| >gi|47230003|emb|CAG10417.1| unnamed protein product [Tetraodon nigroviridis] | Back alignment and taxonomy information |
|---|
Score = 217 bits (552), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 116/313 (37%), Positives = 168/313 (53%), Gaps = 60/313 (19%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK T + NL+E+ ++++ H N+L L E +++ + V+L+ LME+
Sbjct: 32 MKQTINSLEQANNLREVQAMKRLSPHANILQLHELILDKESGTVSLICELMEM------- 84
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
N+ LI G T LP
Sbjct: 85 ----------------------------------------------NIYELIQGRRTPLP 98
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
+ + Y +YQ+ L H+HS +FHRD+KPENILI+ + + +GD GS + I SK
Sbjct: 99 DHTVKNY-----MYQLCKSLEHMHSCGIFHRDVKPENILIKQNCLKLGDFGSCRSIYSKP 153
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
HTEYI+TRWYR+PECLLT+GYYSF++D+W+AGCVF+E ++ NPLFPG +E+DQ +IH
Sbjct: 154 PHTEYISTRWYRAPECLLTDGYYSFKMDMWSAGCVFFEIMSLNPLFPGANEVDQASKIHD 213
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
VLGTP L+KF++ ++ F + K+ G GI LVP+ L+ +ML YDP R
Sbjct: 214 VLGTPDPSVLRKFKQSRAMQFNFPPKK--GTGISRLVPRCPAPALSLLYQMLAYDPDERI 271
Query: 301 TAQKILSCAYFAD 313
TA L YF +
Sbjct: 272 TADTALRHTYFRE 284
|
Source: Tetraodon nigroviridis Species: Tetraodon nigroviridis Genus: Tetraodon Family: Tetraodontidae Order: Tetraodontiformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|410898597|ref|XP_003962784.1| PREDICTED: MAPK/MAK/MRK overlapping kinase-like [Takifugu rubripes] | Back alignment and taxonomy information |
|---|
Score = 216 bits (550), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 115/322 (35%), Positives = 173/322 (53%), Gaps = 60/322 (18%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK T + NL+E+ ++++ H N++ L E +++ + V+L+ LME+
Sbjct: 77 MKQTINSLEQANNLREVQAMKRLSPHANIIQLHELILDKESGTVSLICELMEM------- 129
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
N+ LI G T LP
Sbjct: 130 ----------------------------------------------NIYELIQGRRTPLP 143
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
+ + Y +YQ+ L H+HS +FHRD+KPENILI+ + + +GD GS + I SK
Sbjct: 144 DHTVKNY-----MYQLCKSLEHMHSCGIFHRDVKPENILIKQNCLKLGDFGSCRSIYSKP 198
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
HTEYI+TRWYR+PECLLT+GYYSF++D+W+AGCVF+E ++ NPLFPG +E+DQ +IH
Sbjct: 199 PHTEYISTRWYRAPECLLTDGYYSFKMDMWSAGCVFFEIMSLNPLFPGANEVDQASKIHD 258
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
VLGTP L+KF++ ++ +F + K+ G GI L+P+ L+ +ML YDP R
Sbjct: 259 VLGTPDQSVLQKFKQSRAMHFNFPPKK--GTGISRLIPKCPAPALSLLYQMLAYDPDERI 316
Query: 301 TAQKILSCAYFADLTQLKQYLE 322
TA L YF ++ ++ E
Sbjct: 317 TADTALRHTYFREIRMAEKRAE 338
|
Source: Takifugu rubripes Species: Takifugu rubripes Genus: Takifugu Family: Tetraodontidae Order: Tetraodontiformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|242014629|ref|XP_002427989.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212512488|gb|EEB15251.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 216 bits (549), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 96/194 (49%), Positives = 135/194 (69%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTEYIATRWYR 192
LYQ++ GL HLH + +FHRDIKPENILI+ +++ + DLGS++ S+ +TEYI+TRWYR
Sbjct: 114 LYQLLKGLDHLHHHGIFHRDIKPENILIKNEIIKLADLGSIRGAYSRPPYTEYISTRWYR 173
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKK 252
SPECLLT GYY ++D+WA GCVFYE LT PLFPG +E+DQ+ +IH VLGTP L K
Sbjct: 174 SPECLLTTGYYGPKMDVWACGCVFYELLTTKPLFPGTNEVDQITKIHDVLGTPNTRLLAK 233
Query: 253 FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312
F ++KS N Y F+ G G+ L+ + + G+ ++ +ML YDP+ R +++L YF
Sbjct: 234 FYRHKSRNCEYFFQAKTGSGLSCLLTNLTDNGRDILKQMLTYDPEHRINVRRLLEHRYFN 293
Query: 313 DLTQLKQYLEQKQV 326
DL + + L +K V
Sbjct: 294 DLREQEPILLKKPV 307
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|118348276|ref|XP_001007613.1| Protein kinase domain containing protein [Tetrahymena thermophila] gi|89289380|gb|EAR87368.1| Protein kinase domain containing protein [Tetrahymena thermophila SB210] | Back alignment and taxonomy information |
|---|
Score = 215 bits (548), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 123/319 (38%), Positives = 177/319 (55%), Gaps = 25/319 (7%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK +V LKEI LRK+ H +++ L E + T ++ LVF LM+ NL E IR
Sbjct: 35 MKNHFNSIEQVQRLKEIQALRKVSPHPHIIKLIEVLYDEPTGRLALVFELMDQNLYEAIR 94
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
K+ L Q K R + L + N I +T +P
Sbjct: 95 G--------KKQYLNQQKLNKHIKGEKRPAYYLS--------QRINNQKFDIFKVT--IP 136
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
K F +YQ++ + H+H +FHRDIKPENIL+ GD V + D GS + I S+
Sbjct: 137 ISVK------FYMYQLLKAIDHMHKKGIFHRDIKPENILLLGDHVKLADFGSCKGIYSEH 190
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+TEYI+TRWYR+PECLLT+GYYS ++D+W GCV +E ++ PLFPG+ E+DQ +IH
Sbjct: 191 PYTEYISTRWYRAPECLLTDGYYSSKMDLWGVGCVMFEVMSLFPLFPGNDELDQAHKIHN 250
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
VLGTP + L++F+K+ +++ F G GI+ L P I + L+ ++L YDP+ R
Sbjct: 251 VLGTPNPKILEQFQKH-ATHMELNFPPKKGTGIEKLAPHIPKDCVDLIYKLLCYDPEERI 309
Query: 301 TAQKILSCAYFADLTQLKQ 319
A++ L YF DL Q+ Q
Sbjct: 310 NAEQALQHPYFRDLYQMDQ 328
|
Source: Tetrahymena thermophila Species: Tetrahymena thermophila Genus: Tetrahymena Family: Tetrahymenidae Order: Hymenostomatida Class: Oligohymenophorea Phylum: Superkingdom: Eukaryota |
| >gi|126290468|ref|XP_001373940.1| PREDICTED: MAPK/MAK/MRK overlapping kinase [Monodelphis domestica] | Back alignment and taxonomy information |
|---|
Score = 214 bits (545), Expect = 8e-53, Method: Compositional matrix adjust.
Identities = 115/327 (35%), Positives = 179/327 (54%), Gaps = 65/327 (19%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK +V NL+EI LR++ H N+L L E +R T + L+ LM++N+ E
Sbjct: 59 MKQHFESIEQVNNLREIQALRRLNPHPNILTLHEVVFDRKTGSLALICELMDMNIYE--- 115
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
L+ G+ R P
Sbjct: 116 ---------------------------------------LIRGRRR-------------P 123
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
K++ + +YQ+ L H+H +FHRD+KPENILI+ DL+ +GD GS + + SK
Sbjct: 124 LSEKKIMN---YMYQLCKSLDHMHRNGIFHRDVKPENILIKQDLLKLGDFGSCRSVYSKQ 180
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+TEYI+TRWYR+PECLLT+GYYS+++D+W+AGCVFYE ++ PLFPG +E+DQ+ +IH
Sbjct: 181 PYTEYISTRWYRAPECLLTDGYYSYKMDMWSAGCVFYEIMSLQPLFPGANELDQISKIHD 240
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
++GTP +TL KF++ ++ +F + FK+ G GI +L + + L+ M++YDP R
Sbjct: 241 IIGTPPQKTLTKFKQSRAMSFDFPFKK--GSGISLLTSTLSPQSLSLIYAMVEYDPDERI 298
Query: 301 TAQKILSCAYFADLTQLKQYLEQKQVM 327
+A + L +YF + Q + +KQ +
Sbjct: 299 SAHQALQHSYFRE-----QRVAEKQAL 320
|
Source: Monodelphis domestica Species: Monodelphis domestica Genus: Monodelphis Family: Didelphidae Order: Didelphimorphia Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|348544261|ref|XP_003459600.1| PREDICTED: MAPK/MAK/MRK overlapping kinase-like [Oreochromis niloticus] | Back alignment and taxonomy information |
|---|
Score = 213 bits (542), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 111/314 (35%), Positives = 171/314 (54%), Gaps = 60/314 (19%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK T + NL+E+ ++++ H N++ L E ++ T +V+L+ LME+
Sbjct: 94 MKQTINSLEQANNLREVQAMKRLSPHANIVQLHELIFDKETGRVSLICELMEM------- 146
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
N+ I G T LP
Sbjct: 147 ----------------------------------------------NIYEFIQGRKTPLP 160
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
+ + + Y +YQ+ L H+HS +FHRD+KPENILI+ +++ +GD GS + + SK
Sbjct: 161 EHTVKHY-----MYQLCKSLEHMHSCGIFHRDVKPENILIKQNILKLGDFGSCRSVYSKP 215
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
HTEYI+TRWYR+PECLLT+GYYS ++DIW+AGCVF+E ++ NPLFPG +E+DQ+ +IH
Sbjct: 216 PHTEYISTRWYRAPECLLTDGYYSLKMDIWSAGCVFFEIMSLNPLFPGTNELDQIAKIHD 275
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
+LGTP L+KF++ ++ +F + K+ G GI L+P+ L+ +ML YD R
Sbjct: 276 ILGTPDQSLLQKFKQSRAMHFNFPPKK--GTGISRLIPKCPAPALSLLYQMLAYDSDERI 333
Query: 301 TAQKILSCAYFADL 314
TA+ L YF ++
Sbjct: 334 TAETALRHTYFREI 347
|
Source: Oreochromis niloticus Species: Oreochromis niloticus Genus: Oreochromis Family: Cichlidae Order: Perciformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|344273702|ref|XP_003408658.1| PREDICTED: MAPK/MAK/MRK overlapping kinase [Loxodonta africana] | Back alignment and taxonomy information |
|---|
Score = 213 bits (542), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 121/363 (33%), Positives = 187/363 (51%), Gaps = 75/363 (20%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK +V NL+EI LR++ H N+L L E +R + + L+ LM++
Sbjct: 77 MKQHFESIEQVNNLREIQALRRLNPHPNILTLHEVIFDRKSGSLALICELMDM------- 129
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
N+ LI G L
Sbjct: 130 ----------------------------------------------NIYELIRGRRQPLS 143
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
+++ RLY +YQ+ L H+H +FHRD+KPENIL++ D++ +GD GS + + SK
Sbjct: 144 EKTIRLY-----MYQLCKSLDHMHRNGIFHRDVKPENILVKQDVLKLGDFGSCRSVYSKQ 198
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+TEYI+TRWYRSPECLLT+GYYS+++D+W+AGCVFYE + PLFPG +E+DQ+ +IH
Sbjct: 199 PYTEYISTRWYRSPECLLTDGYYSYKMDVWSAGCVFYEIASLEPLFPGANELDQISKIHD 258
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
++GTP +TL KF++ ++ +F + FK+ G GI +L + + L+ M+ YDP R
Sbjct: 259 IIGTPAQKTLTKFKQSRAMSFDFPFKK--GSGISLLTTHLSPQCHSLLCAMVAYDPDERI 316
Query: 301 TAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMD 360
+A + L YF ++++ +K A NY + T P HL A + +
Sbjct: 317 SAHQALQHPYF----------QEQRAAEKQASANY-----RHTHLPDHLAAPGPAGNNWH 361
Query: 361 MSK 363
+K
Sbjct: 362 TAK 364
|
Source: Loxodonta africana Species: Loxodonta africana Genus: Loxodonta Family: Elephantidae Order: Proboscidea Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|148223111|ref|NP_001084801.1| MOK protein kinase [Xenopus laevis] gi|47124901|gb|AAH70644.1| MGC81521 protein [Xenopus laevis] | Back alignment and taxonomy information |
|---|
Score = 212 bits (540), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 116/331 (35%), Positives = 179/331 (54%), Gaps = 64/331 (19%)
Query: 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKR 69
+V NL+E+ LR++ H N+L LCE +R + ++L+ LM++
Sbjct: 44 QVNNLREVQALRRLSPHPNILTLCEVVFDRKSGCLSLICELMDM---------------- 87
Query: 70 AKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHT 129
N+ LI G LP+ R Y
Sbjct: 88 -------------------------------------NIYELIRGRRHPLPENKLRHY-- 108
Query: 130 TFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTEYIATR 189
+YQ+ L H+H +FHRD+KPENILI+ D++ +GD GS + + SK +TEYI+TR
Sbjct: 109 ---MYQLCKSLEHIHKNGIFHRDVKPENILIKQDVLKLGDFGSCRSLFSKQPYTEYISTR 165
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
WYR+PECLLT+GYY++++DIW+AGCVF+E + +PLFPG +E+DQ+ +IH V+GTP
Sbjct: 166 WYRAPECLLTDGYYTYKMDIWSAGCVFFEIASLHPLFPGSNELDQISKIHDVIGTPDLAL 225
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
LKKF+ ++ +F + K+ G GI L+P + LM ML+YDP R A + L +
Sbjct: 226 LKKFKPSRAMSFDFPTKK--GTGITRLLPNMSPDCLSLMCAMLEYDPDERLNASQSLQHS 283
Query: 310 YFADLTQLKQYLEQKQVMKKLAKKNYMAGGM 340
YF + + LE++ ++ +K+ +G M
Sbjct: 284 YFTE----PRILERQHRKIRITEKSNTSGSM 310
|
Source: Xenopus laevis Species: Xenopus laevis Genus: Xenopus Family: Pipidae Order: Anura Class: Amphibia Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 470 | ||||||
| UNIPROTKB|E7ERR8 | 389 | MOK "MAPK/MAK/MRK overlapping | 0.402 | 0.485 | 0.448 | 1.1e-50 | |
| UNIPROTKB|E1BTD4 | 623 | ICK "Uncharacterized protein" | 0.570 | 0.430 | 0.373 | 1.4e-47 | |
| UNIPROTKB|E1BDQ8 | 433 | MOK "Uncharacterized protein" | 0.536 | 0.581 | 0.380 | 2e-47 | |
| UNIPROTKB|F1P4H8 | 420 | RAGE "Uncharacterized protein" | 0.523 | 0.585 | 0.416 | 2e-47 | |
| MGI|MGI:1336881 | 420 | Stk30 "serine/threonine kinase | 0.531 | 0.595 | 0.379 | 4.2e-47 | |
| UNIPROTKB|Q9UQ07 | 419 | MOK "MAPK/MAK/MRK overlapping | 0.536 | 0.601 | 0.376 | 5.4e-47 | |
| UNIPROTKB|F1SA05 | 424 | MOK "Uncharacterized protein" | 0.540 | 0.599 | 0.371 | 2.3e-46 | |
| UNIPROTKB|E7ER76 | 418 | MOK "MAPK/MAK/MRK overlapping | 0.534 | 0.600 | 0.376 | 3e-46 | |
| DICTYBASE|DDB_G0268078 | 507 | DDB_G0268078 "RCK family prote | 0.665 | 0.617 | 0.292 | 1.6e-45 | |
| UNIPROTKB|Q9UPZ9 | 632 | ICK "Serine/threonine-protein | 0.568 | 0.422 | 0.367 | 2.5e-45 |
| UNIPROTKB|E7ERR8 MOK "MAPK/MAK/MRK overlapping kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 1.1e-50, Sum P(2) = 1.1e-50
Identities = 87/194 (44%), Positives = 131/194 (67%)
Query: 120 PQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSK 179
P K++ H +YQ+ L H+H +FHRD+KPENILI+ D++ +GD GS + + SK
Sbjct: 69 PLSEKKIMH---YMYQLCKSLDHIHRNGIFHRDVKPENILIKQDVLKLGDFGSCRSVYSK 125
Query: 180 GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239
+TEYI+TRWYR+PECLLT+G+Y++++D+W+AGCVFYE + PLFPG +E+DQ+ +IH
Sbjct: 126 QPYTEYISTRWYRAPECLLTDGFYTYKMDLWSAGCVFYEIASLQPLFPGVNELDQISKIH 185
Query: 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
V+GTP + L KF++ ++ NF + FK+ G GI +L + + L+ M+ YDP R
Sbjct: 186 DVIGTPAQKILTKFKQSRAMNFDFPFKK--GSGIPLLTTNLSPQCLSLLHAMVAYDPDER 243
Query: 300 PTAQKILSCAYFAD 313
A + L YF +
Sbjct: 244 IAAHQALQHPYFQE 257
|
|
| UNIPROTKB|E1BTD4 ICK "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 1.4e-47, Sum P(2) = 1.4e-47
Identities = 106/284 (37%), Positives = 158/284 (55%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLGSLQFIKSKGLHTEYIATRW 190
++YQI+ GL +H + FHRD+KPEN+L G +LV + D G + I+S+ +T+Y++TRW
Sbjct: 105 IMYQILQGLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRW 164
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +DIWA GC+ E T PLFPG SEID + +I QVLGTPK
Sbjct: 165 YRAPEVLLRSTSYSSPIDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKNDW 224
Query: 251 KKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
E Y+ SS+ +++ Q + L+P + +LM +ML++DPK+RPTA + L
Sbjct: 225 P--EGYQLSSSMNFRWPQCVPNNLKTLIPNASSEAVQLMRDMLQWDPKKRPTASQALRYP 282
Query: 310 YFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMDMSKFIQSDL 369
YF L L++ K+L K+ + + P +KS ++ F QS
Sbjct: 283 YFQVGHALG--LQELTRQKELHDKSSLHIKPVPPAQPP-----SKSHTRISSRPFQQSQT 335
Query: 370 NTHQTKKTKSDFFSQARTSKY-RFDQSSSIVL---HPKNPPNKS 409
+ H K+D S SKY + D+S+ ++L H K P K+
Sbjct: 336 SQHLVYTCKTDN-SGTEHSKYLQEDKSNQVLLPAIHNKVPQQKA 378
|
|
| UNIPROTKB|E1BDQ8 MOK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 2.0e-47, P = 2.0e-47
Identities = 99/260 (38%), Positives = 157/260 (60%)
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFG-KSRNLGTLIV 113
+++ + + ++ R + L ++ ++V +D K L L+ N+ LI
Sbjct: 50 MKQRFESIEQVNNLREIQALRRLNPHPNILTLHQVVFDRKSGSLALICELMDMNIYELIR 109
Query: 114 GLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSL 173
G P K++ H +YQ+ L H+H +FHRD+KPENIL++ D++ +GD GS
Sbjct: 110 GRRH--PLSEKKVRH---YMYQLCKSLDHMHRNGIFHRDVKPENILVKRDVLKLGDFGSC 164
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
+ + SK +TEYI+TRWYR+PECLLT+G+Y F++D+W+AGCV YE + PLFPG +E+D
Sbjct: 165 RSVYSKQPYTEYISTRWYRAPECLLTDGFYGFKMDLWSAGCVLYEMASLQPLFPGANELD 224
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
Q+ RIH V+GTP +TL KF++ ++ +F + FK+ G GI +L + + L+ M+
Sbjct: 225 QISRIHDVMGTPAEKTLTKFKQSRAMSFDFPFKK--GSGIPLLTTSLSPQCLSLLHAMVA 282
Query: 294 YDPKRRPTAQKILSCAYFAD 313
YDP R TA + L YF +
Sbjct: 283 YDPDERITAHQALQHPYFQE 302
|
|
| UNIPROTKB|F1P4H8 RAGE "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 2.0e-47, P = 2.0e-47
Identities = 107/257 (41%), Positives = 153/257 (59%)
Query: 59 IRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFG-KSRNLGTLIVGLTT 117
I +N+SE +A L ++ + V +D K L L+ N+ LI G
Sbjct: 42 IEQVNNLSEIQA---LRRLSPHPNILMLHEVVFDKKAGCLSLICELMDMNIYELIKGRRK 98
Query: 118 FLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIK 177
LP++ + Y +YQ+ L H+H +FHRD+KPENILI+ + + + D GS + I
Sbjct: 99 PLPEKKIKNY-----MYQLCKSLDHIHRNGIFHRDVKPENILIKQNTLKLADFGSCRTIY 153
Query: 178 SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
SK +TEYI+TRWYR+PECLLT GYYS+++DIW+AGCVFYE + PLFPG +++DQ+ +
Sbjct: 154 SKQPYTEYISTRWYRAPECLLTNGYYSYKMDIWSAGCVFYEMTSFQPLFPGSNDLDQISK 213
Query: 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
IH V+GTP TL KF++ NF + F++ G GI V + KG L+ M+KYDP
Sbjct: 214 IHDVIGTPANRTLNKFKQSTILNFHFPFQK--GKGIPPSVHNVSAKGLTLLYAMIKYDPD 271
Query: 298 RRPTAQKILSCAYFADL 314
R A + L YF +L
Sbjct: 272 ERIAAHQALQHPYFQEL 288
|
|
| MGI|MGI:1336881 Stk30 "serine/threonine kinase 30" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 4.2e-47, P = 4.2e-47
Identities = 98/258 (37%), Positives = 158/258 (61%)
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFG-KSRNLGTLIV 113
++++ + + ++ R + L ++ A + V +D K L L+ N+ LI
Sbjct: 35 MKQHFESIEQVNSLREIQALRRLNPHPNILALHEVVFDRKSGSLALICELMDMNIYELIR 94
Query: 114 GLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSL 173
G L ++ LY +YQ+ L H+H +FHRD+KPENIL++ D++ +GD GS
Sbjct: 95 GRRHPLSEKKIMLY-----MYQLCKSLDHMHRNGIFHRDVKPENILVKQDVLKLGDFGSC 149
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
+ + SK +TEYI+TRWYR+PECLLT+G+Y++++D+W+AGCVFYE + PLFPG +E+D
Sbjct: 150 RSVYSKQPYTEYISTRWYRAPECLLTDGFYTYKMDLWSAGCVFYEIASLQPLFPGVNELD 209
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
Q+ +IH V+GTP +TL KF++ ++ +F + FK+ G GI +L + + L+ M+
Sbjct: 210 QISKIHDVIGTPCQKTLTKFKQSRAMSFDFPFKK--GSGIPLLTANLSPQCLSLLHAMVA 267
Query: 294 YDPKRRPTAQKILSCAYF 311
YDP R A + L YF
Sbjct: 268 YDPDERIAAHQALQHPYF 285
|
|
| UNIPROTKB|Q9UQ07 MOK "MAPK/MAK/MRK overlapping kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 5.4e-47, P = 5.4e-47
Identities = 98/260 (37%), Positives = 156/260 (60%)
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFG-KSRNLGTLIV 113
+++ + + ++ R + L ++ + V +D K L L+ N+ LI
Sbjct: 35 MKQRFESIEQVNNLREIQALRRLNPHPNILMLHEVVFDRKSGSLALICELMDMNIYELIR 94
Query: 114 GLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSL 173
G P K++ H +YQ+ L H+H +FHRD+KPENILI+ D++ +GD GS
Sbjct: 95 GRR--YPLSEKKIMH---YMYQLCKSLDHIHRNGIFHRDVKPENILIKQDVLKLGDFGSC 149
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
+ + SK +TEYI+TRWYR+PECLLT+G+Y++++D+W+AGCVFYE + PLFPG +E+D
Sbjct: 150 RSVYSKQPYTEYISTRWYRAPECLLTDGFYTYKMDLWSAGCVFYEIASLQPLFPGVNELD 209
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
Q+ +IH V+GTP + L KF++ ++ NF + FK+ G GI +L + + L+ M+
Sbjct: 210 QISKIHDVIGTPAQKILTKFKQSRAMNFDFPFKK--GSGIPLLTTNLSPQCLSLLHAMVA 267
Query: 294 YDPKRRPTAQKILSCAYFAD 313
YDP R A + L YF +
Sbjct: 268 YDPDERIAAHQALQHPYFQE 287
|
|
| UNIPROTKB|F1SA05 MOK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 2.3e-46, P = 2.3e-46
Identities = 97/261 (37%), Positives = 156/261 (59%)
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFG-KSRNLGTLIV 113
++++ + + ++ R + L ++ + V +D K L L+ N+ LI
Sbjct: 35 MKQHFESIEQVNSLREIQALRRLNPHPNILTLHEVLFDRKSGSLALICELMDMNIYELIR 94
Query: 114 GLT-TFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGS 172
T P K++ +YQ+ L H+H +FHRD+KPENILI+ D++ +GD GS
Sbjct: 95 DCTGRRQPLSEKKISR---YMYQLCKSLDHMHRNGIFHRDVKPENILIKQDVLKLGDFGS 151
Query: 173 LQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232
+ + SK HTEY++TRWYR+PECLLT+G+YS+++D+W+AGCV YE + PLFPG +E+
Sbjct: 152 CRSVCSKQPHTEYVSTRWYRAPECLLTDGFYSYKMDLWSAGCVLYEIASLQPLFPGANEL 211
Query: 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEML 292
DQ+ +IH ++GTP A+TL KF++ ++ +F + F + G GI V + + L+ M+
Sbjct: 212 DQISKIHDIMGTPAAKTLSKFQQSRAVSFDFPFTK--GSGIPVPTASLSPQCLSLLRAMV 269
Query: 293 KYDPKRRPTAQKILSCAYFAD 313
YDP R TA + L YF +
Sbjct: 270 AYDPDDRVTAHQALQHPYFRE 290
|
|
| UNIPROTKB|E7ER76 MOK "MAPK/MAK/MRK overlapping kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 3.0e-46, P = 3.0e-46
Identities = 98/260 (37%), Positives = 156/260 (60%)
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFG-KSRNLGTLIV 113
+++ + + ++ R + L ++ + V +D K L L+ N+ LI
Sbjct: 35 MKQRFESIEQVNNLREIQALRRLNPHPNILMLHEVVFDRKSGSLALICELMDMNIYELIR 94
Query: 114 GLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSL 173
G P K++ H +YQ+ L H+H +FHRD+KPENILI+ D++ +GD GS
Sbjct: 95 GRR--YPLSEKKIMH---YMYQLCKSLDHIHRNGIFHRDVKPENILIK-DVLKLGDFGSC 148
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
+ + SK +TEYI+TRWYR+PECLLT+G+Y++++D+W+AGCVFYE + PLFPG +E+D
Sbjct: 149 RSVYSKQPYTEYISTRWYRAPECLLTDGFYTYKMDLWSAGCVFYEIASLQPLFPGVNELD 208
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
Q+ +IH V+GTP + L KF++ ++ NF + FK+ G GI +L + + L+ M+
Sbjct: 209 QISKIHDVIGTPAQKILTKFKQSRAMNFDFPFKK--GSGIPLLTTNLSPQCLSLLHAMVA 266
Query: 294 YDPKRRPTAQKILSCAYFAD 313
YDP R A + L YF +
Sbjct: 267 YDPDERIAAHQALQHPYFQE 286
|
|
| DICTYBASE|DDB_G0268078 DDB_G0268078 "RCK family protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 403 (146.9 bits), Expect = 1.6e-45, Sum P(2) = 1.6e-45
Identities = 99/338 (29%), Positives = 183/338 (54%)
Query: 119 LPQQSKRLYHTTF--VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFI 176
+ ++K L TT ++YQI+ LH +H+ FHRD+KPENI++ G+ + + D G + I
Sbjct: 90 IKDRTKLLPETTIRNIIYQILQALHFMHTNGFFHRDLKPENIMLVGERLKIADFGLAREI 149
Query: 177 KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236
+SK T+YI+TRWYR+PE LL YY+ +DIWA G + E + P+FPG SEIDQL
Sbjct: 150 ESKPPFTDYISTRWYRAPEVLLRCTYYNAPIDIWAVGAIMAELYSLKPMFPGSSEIDQLF 209
Query: 237 RIHQVLGTPKAET-LKKFEKYKSSNFTYQFKQYPG-GGIDVLVPQIHEKGKKLMSEMLKY 294
+I ++G+P + T + + S FT+ Q P + L+P ++ +L++++L+Y
Sbjct: 210 KICTIMGSPTSATWIDGIKLANSMGFTFPNVQPPSINPLSTLLPNANQDAIELITDLLQY 269
Query: 295 DPKRRPTAQKILSCAYF-----ADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHL 349
DP +RPT + L YF + + ++E K L K Y+ + S+ ++
Sbjct: 270 DPLKRPTPLQALQHRYFKVSIPSSILLKPNFIELSN--KYLIKNGYINNNINNNSNYSNN 327
Query: 350 LANTK-SSHQMDMSKFIQSDLNTH-----QTKKTKSDFFSQARTSKYRFDQSSSIVLHPK 403
N +S+ +++ +++ H QT K K+ F R S+Y + + S+ +
Sbjct: 328 NNNNNLNSNSENLNNVNKNNQQPHSPQKIQTPKPKNSFL---RKSRYSYLNNVSL----E 380
Query: 404 NPPNKSKHRFDQSSSTVLHSKNPPNRSKLDRKIFLREK 441
N N + + ++ ++++ +++ + +L +I +++
Sbjct: 381 NV-NNNNNNYNSNTTSGYYNQKLDSTPRLSPRIVRQQQ 417
|
|
| UNIPROTKB|Q9UPZ9 ICK "Serine/threonine-protein kinase ICK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 415 (151.1 bits), Expect = 2.5e-45, Sum P(2) = 2.5e-45
Identities = 107/291 (36%), Positives = 157/291 (53%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLGSLQFIKSKGLHTEYIATRW 190
++YQI+ GL +H + FHRD+KPEN+L G +LV + D G + I+SK +T+Y++TRW
Sbjct: 105 IMYQILQGLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSKPPYTDYVSTRW 164
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +D+WA GC+ E T PLFPG SEID + +I QVLGTPK
Sbjct: 165 YRAPEVLLRSTNYSSPIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDW 224
Query: 251 KKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
E Y+ SS +++ Q + L+P + +L+ +ML++DPK+RPTA + L
Sbjct: 225 P--EGYQLSSAMNFRWPQCVPNNLKTLIPNASSEAVQLLRDMLQWDPKKRPTASQALRYP 282
Query: 310 YF------ADLTQLKQYLE--QKQVMKKLAKKNYMAGGMQKTSHPTHLLANTK-SSHQMD 360
YF TQ Q E QK +++K Y+ + P +T+ SS Q
Sbjct: 283 YFQVGHPLGSTTQNLQDSEKPQKGILEKAGPPPYIKP-VPPAQPPAK--PHTRISSRQHQ 339
Query: 361 MSKFIQSDLNTHQTKKTKSDFFSQARTSKYRFDQSSSIV---LHPKNPPNK 408
S Q L H T K++ S + D+ S ++ LH K+P +K
Sbjct: 340 AS---QPPL--HLTYPYKAEVSRTDHPSHLQEDKPSPLLFPSLHNKHPQSK 385
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9UQ07 | MOK_HUMAN | 2, ., 7, ., 1, 1, ., 2, 2 | 0.3333 | 0.6127 | 0.6873 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 470 | |||
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-90 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-60 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-59 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-55 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-54 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-47 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-45 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-45 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-43 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-42 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-42 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-42 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-42 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-42 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-41 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-41 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-41 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-40 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-40 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-40 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-40 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-39 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-38 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-38 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-36 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-34 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-34 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-33 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-33 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-33 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-32 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-31 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-31 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-31 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-31 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-31 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-31 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-31 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-30 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-30 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-30 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-28 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-28 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-27 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-27 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-26 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-25 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-25 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-24 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-24 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-20 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-11 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-11 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-10 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-07 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-06 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.002 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.003 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.003 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.004 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.004 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 276 bits (707), Expect = 3e-90
Identities = 122/311 (39%), Positives = 169/311 (54%), Gaps = 60/311 (19%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK +V NL+EI LR++ H N+L L E +R T ++ LVF LM++NL E
Sbjct: 32 MKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYE--- 88
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
LI G LP
Sbjct: 89 --------------------------------------------------LIKGRKRPLP 98
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
++ + Y +YQ++ L H+H +FHRDIKPENILI+ D++ + D GS + I SK
Sbjct: 99 EKRVKSY-----MYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKP 153
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+TEYI+TRWYR+PECLLT+GYY ++DIWA GCVF+E L+ PLFPG +E+DQ+ +IH
Sbjct: 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD 213
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
VLGTP AE LKKF K + N+ + K+ G G+ L+P +G L+ ++L YDP R
Sbjct: 214 VLGTPDAEVLKKFRKSRHMNYNFPSKK--GTGLRKLLPNASAEGLDLLKKLLAYDPDERI 271
Query: 301 TAQKILSCAYF 311
TA++ L YF
Sbjct: 272 TAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 9e-60
Identities = 79/186 (42%), Positives = 111/186 (59%), Gaps = 3/186 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSK-GLHTEY 185
LYQ++ GL HS+ + HRD+KPEN+LI + V+ + D G + S +T Y
Sbjct: 99 LIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ TRWYR+PE LL + YS +DIW+ GC+F E L+R PLFPG SEIDQL +I + LGTP
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP 218
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
E KF + N+ + F + G + L P + L+S+ML YDP +R TA++
Sbjct: 219 DPEVWPKF-TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277
Query: 306 LSCAYF 311
L+ YF
Sbjct: 278 LAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (502), Expect = 1e-59
Identities = 82/182 (45%), Positives = 116/182 (63%), Gaps = 4/182 (2%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATRW 190
++YQI+ GL H+H + FHRD+KPEN+L+ G VV + D G + I+S+ +T+Y++TRW
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW 163
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +DIWA GC+ E T PLFPG SEIDQL +I VLGTP +
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223
Query: 251 KKFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
E YK +S ++F Q+ + L+P + L+ +ML++DPK+RPTA + L
Sbjct: 224 P--EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 310 YF 311
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 73/181 (40%), Positives = 115/181 (63%), Gaps = 4/181 (2%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGL-HTEYIATRW 190
+YQ++ GL + HS+++ HRD+KP+NILI D V+ + D G + +T + T W
Sbjct: 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW 163
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL +YS +DIW+ GC+F E +T PLFPGDSEIDQL +I Q+LGTP E+
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
K ++ F ++P ++ ++P++ +G L+S+ML+Y+P +R +A++ L Y
Sbjct: 224 PGVTKLP--DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
Query: 311 F 311
F
Sbjct: 282 F 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 82/192 (42%), Positives = 112/192 (58%), Gaps = 5/192 (2%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFI----KSKGLH 182
H + LYQI+ GL +LHS V HRD+KP NIL+ + + + D G + + KG
Sbjct: 104 HIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 183 TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
TEY+ TRWYR+PE LL+ Y+ +DIW+ GC+F E LTR PLFPG IDQL+ I +VL
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
GTP E LK K+ N+ + P + L P + L+ +ML +DPK+R TA
Sbjct: 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 303 QKILSCAYFADL 314
+ L+ Y A L
Sbjct: 284 DEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 86/301 (28%), Positives = 133/301 (44%), Gaps = 66/301 (21%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
L+EI +L+++ H N++ L + + ++S + LVF ME +LE+ I+ K I
Sbjct: 50 LREIKLLQEL-KHPNIIGLLDVFGHKSN--INLVFEFMETDLEKVIK---------DKSI 97
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
+ T A KS +
Sbjct: 98 VL-------TPADI----------------KS--------------------------YM 108
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRWY 191
+ GL +LHS + HRD+KP N+LI D V+ + D G + F T + TRWY
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
R+PE L +Y +D+W+ GC+F E L R P PGDS+IDQL +I + LGTP E
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311
+FK +P + + P + L+ +L +P +R TA++ L YF
Sbjct: 229 GVTSLPDYV---EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
Query: 312 A 312
+
Sbjct: 286 S 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 66/182 (36%), Positives = 101/182 (55%), Gaps = 6/182 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATR 189
++ Q++ G+ LHS+++ HRD+KP+NIL+ D V + D G + + T + T
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL 170
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
WYR+PE LL + Y+ +D+W+ GC+F E R PLF G SE DQLD+I V+G P E
Sbjct: 171 WYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
+ S+ F Y VP+I E+G L+ +ML ++P +R +A + L
Sbjct: 230 WPRNVSLPRSS----FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285
Query: 310 YF 311
YF
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 8e-45
Identities = 76/188 (40%), Positives = 110/188 (58%), Gaps = 18/188 (9%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGL----HTEYI 186
LYQ++ G+ + HS++V HRD+KP+N+LI G L + D G ++ G+ +T +
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKL-ADFG---LARAFGVPVRTYTHEV 160
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T WYR+PE LL YS +DIW+ GC+F E + R PLFPGDSEIDQL RI + LGTP
Sbjct: 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD 220
Query: 247 AET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
+ + YK + F ++ + +VP + E G L+S+ML YDP +R +A+
Sbjct: 221 EDVWPGVTSLPDYKPT-----FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK 275
Query: 304 KILSCAYF 311
L YF
Sbjct: 276 AALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 68/191 (35%), Positives = 105/191 (54%), Gaps = 6/191 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-----SLQFIKSKGL 181
H + LYQ++ GL ++HS V HRD+KP N+L+ D + +GD G S + K
Sbjct: 108 HIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 182 HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
TEY+ATRWYR+PE LL+ Y+ +D+W+ GC+F E L R LFPG + + QL I V
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
LG+P E L + + + + + P+ + L+S+ML++DP+ R T
Sbjct: 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT 287
Query: 302 AQKILSCAYFA 312
++ L + A
Sbjct: 288 VEQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 64/183 (34%), Positives = 99/183 (54%), Gaps = 26/183 (14%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIAT 188
+ QI+ GL +LHS + HRD+KPENIL+ + VV + D G + + +KS T ++ T
Sbjct: 102 KIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGT 161
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
WY +PE LL Y ++D+W+ G + YE LT P F G++ +DQL I ++LG P
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPP--- 218
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308
+F++ K S+ E+ K L+ + L DP +RPTA++IL
Sbjct: 219 --LEFDEPKWSS-------------------GSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
Query: 309 AYF 311
+F
Sbjct: 258 PWF 260
|
Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG--SLQF 175
LP+ + Y + ++ G+ ++H+ + HRD+KP N+LI D V+ + D G L
Sbjct: 96 LPEAQVKSY-----MRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS 150
Query: 176 IKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
+ L++ +ATRWYR+PE L Y +D+WA GC+F E L +PLFPG+++I+QL
Sbjct: 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210
Query: 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYD 295
+ + LGTP ET N F + ++ + P + L+ +L YD
Sbjct: 211 AIVFRTLGTPNEETWPGLTSLPDYNKIT-FPESKPIPLEEIFPDASPEALDLLKGLLVYD 269
Query: 296 PKRRPTAQKILSCAYF 311
P +R +A + L YF
Sbjct: 270 PSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 2e-42
Identities = 80/312 (25%), Positives = 120/312 (38%), Gaps = 84/312 (26%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
++EI +L+K+ H N++ L E ++ + +VF M+
Sbjct: 46 IREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVFEYMD--------------------- 83
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
H DL G L F Q K
Sbjct: 84 ------------H-----DLT--------------GLLDSPEVKFTESQIKCYMK----- 107
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH--TEYIATRW 190
Q++ GL +LHS + HRDIK NILI D V+ + D G + + T + T W
Sbjct: 108 -QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE-- 248
YR PE LL Y E+D+W+ GC+ E P+F G +E++QL++I ++ G+P E
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226
Query: 249 ----TLKKFEKYKS-----SNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
L FE K FK L+ ++L DPK+R
Sbjct: 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLID-----------PSALDLLDKLLTLDPKKR 275
Query: 300 PTAQKILSCAYF 311
+A + L YF
Sbjct: 276 ISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 67/184 (36%), Positives = 106/184 (57%), Gaps = 7/184 (3%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATR 189
+ Q+++G+ HLH + HRD+K N+L+ RG L + D G + ++ +T+ + T
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKI-CDFGLAREYGSPLKPYTQLVVTL 170
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
WYR+PE LL YS +D+W+ GC+F E LT+ PLFPG SEIDQL++I ++LGTP +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIH--EKGKKLMSEMLKYDPKRRPTAQKILS 307
F + + F +YP + P + + G L++ +L YDP +R +A+ L
Sbjct: 231 WPGFSELPGAK-KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289
Query: 308 CAYF 311
YF
Sbjct: 290 HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 6e-42
Identities = 75/187 (40%), Positives = 110/187 (58%), Gaps = 16/187 (8%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGL----HTEYIA 187
L+Q++ GL HS++V HRD+KP+N+LI + + + D G ++ G+ +T +
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---LARAFGVPVRTYTHEVV 162
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T WYR+PE LL YYS +DIW+ GC+F E +TR LFPGDSEIDQL RI + LGTP
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 222
Query: 248 ET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
+ YK S F ++ +VP + E G+ L+S+ML YDP +R +A+
Sbjct: 223 VVWPGVTSLPDYKPS-----FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277
Query: 305 ILSCAYF 311
L+ +F
Sbjct: 278 ALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 6e-42
Identities = 80/201 (39%), Positives = 117/201 (58%), Gaps = 11/201 (5%)
Query: 120 PQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFI 176
P +K LYQI+ G+ + HS++V HRD+KP+N+LI R + + + D G + F
Sbjct: 95 PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
Query: 177 KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236
T + T WYR+PE LL +YS +DIW+ GC+F E + + PLFPGDSEID+L
Sbjct: 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
Query: 237 RIHQVLGTPKAET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
+I ++LGTP ET + YKS+ F ++P + +VP + G L+S+ML+
Sbjct: 215 KIFRILGTPNEETWPGVTSLPDYKSA-----FPKWPPKDLATVVPTLEPAGVDLLSKMLR 269
Query: 294 YDPKRRPTAQKILSCAYFADL 314
DP +R TA+ L YF DL
Sbjct: 270 LDPSKRITARAALEHEYFKDL 290
|
Length = 294 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 8e-42
Identities = 73/184 (39%), Positives = 106/184 (57%), Gaps = 10/184 (5%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEYIATRW 190
LYQI+ G+ HS +V HRD+KP+N+LI ++ + D G + F ++T + T W
Sbjct: 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW 166
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL YS +DIW+ G +F E T+ PLF GDSEIDQL RI ++LGTP +
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226
Query: 251 KKFEK---YKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
YK++ F ++ G + V + E G L+ +ML YDP +R +A+K L+
Sbjct: 227 PGVTSLPDYKNT-----FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281
Query: 308 CAYF 311
YF
Sbjct: 282 HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 66/193 (34%), Positives = 109/193 (56%), Gaps = 7/193 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG------SLQFIKSKG 180
H +++YQ++ L ++HS V HRD+KP NIL+ D V + D G L+
Sbjct: 108 HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+ T+Y+ATRWYR+PE LL Y+ +D+W+ GC+ E L PLFPG S ++QL++I +
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
V+G P AE ++ + ++ P +D L+P+ + L+ ++L ++P +R
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287
Query: 301 TAQKILSCAYFAD 313
TA++ L Y A
Sbjct: 288 TAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIK 177
LP + R Y ++Q++ + + HS+ + HRDIKPENIL+ V+ + D G + ++
Sbjct: 97 LPPDAVRSY-----IWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALR 151
Query: 178 SKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
++ T+Y+ATRWYR+PE L+ + Y +D+WA GC+ E L PLFPGDS+IDQL
Sbjct: 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211
Query: 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHE-KGKKLMSEMLKY 294
I + LG + F + ++ P + L+
Sbjct: 212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRM 271
Query: 295 DPKRRPTAQKILSCAYF 311
DPK R T ++L YF
Sbjct: 272 DPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 69/182 (37%), Positives = 106/182 (58%), Gaps = 6/182 (3%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATR 189
+YQ++ G+ H H + V HRD+KP+N+L+ + L+ + DLG F +T I T
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL 175
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
WYR+PE LL +YS +DIW+ GC+F E + PLFPGDSE+ QL I ++LGTP +
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
K + ++F Q+ + VP + +G L+ +ML+YDP +R +A+ L+
Sbjct: 236 WPGVSKLRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 310 YF 311
YF
Sbjct: 293 YF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 69/191 (36%), Positives = 107/191 (56%), Gaps = 6/191 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-----SLQFIKSKGL 181
H +YQI+ GL ++HS V HRD+KP N+L+ D + + D G S ++ G
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 182 HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
TEY+ATRWYR+PE +L+ Y+ +D+W+ GC+ E L R P+F G +DQL++I QV
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
LGTP ETL + K+ N+ P + + P + L+ ++L +DP +R +
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285
Query: 302 AQKILSCAYFA 312
++ L Y A
Sbjct: 286 VEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 73/192 (38%), Positives = 103/192 (53%), Gaps = 15/192 (7%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGL--HTE- 184
H F++YQI+ GL ++HS + HRD+KP NI + D +L L F GL HT+
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDF----GLARHTDD 170
Query: 185 ----YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
Y+ATRWYR+PE +L +Y+ +DIW+ GC+ E LT LFPG IDQL RI
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
++GTP E L+K + N+ Q P + + L+ +ML DP +R
Sbjct: 231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI 290
Query: 301 TAQKILSCAYFA 312
TA + L+ Y A
Sbjct: 291 TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 59/181 (32%), Positives = 86/181 (47%), Gaps = 29/181 (16%)
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEY 185
F L QI++ L +LHS + HRD+KPENIL+ D V + D G + + T +
Sbjct: 97 DEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF 156
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ T Y +PE LL +G Y +DIW+ G + YE LT P FPGD DQL + + +G P
Sbjct: 157 VGTPEYMAPEVLLGKG-YGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKP 212
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
K I + K L+ ++L DP++R TA++
Sbjct: 213 KPPFPPPEWD------------------------ISPEAKDLIRKLLVKDPEKRLTAEEA 248
Query: 306 L 306
L
Sbjct: 249 L 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 77/206 (37%), Positives = 113/206 (54%), Gaps = 30/206 (14%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGD-----LVVVGDLGSLQFIKS--KGLHTE- 184
L+QI+NG+H+LHS V HRD+KP NIL+ G+ +V +GDLG + + K L
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 185 -YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE---------IDQ 234
+ T WYR+PE LL +Y+ +DIWA GC+F E LT P+F G DQ
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233
Query: 235 LDRIHQVLGTPKAE---TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK----- 286
L+RI +VLGTP + +KK +Y + ++ K YP + L + + K
Sbjct: 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS---NSLAKWMEKHKKPDSQGF 290
Query: 287 -LMSEMLKYDPKRRPTAQKILSCAYF 311
L+ ++L+YDP +R TA++ L YF
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 69/189 (36%), Positives = 102/189 (53%), Gaps = 2/189 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKG-LHTEY 185
H + LYQ++ GL ++HS V HRD+KP N+L+ + + + D G + KG TEY
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ TRWYR+PE LL Y+ +D+W+ GC+F E L R PLFPG + QL I ++LG+P
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
E L K+ + P L P + L+ +ML +DP +R T ++
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288
Query: 306 LSCAYFADL 314
L+ Y A L
Sbjct: 289 LAHPYLASL 297
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 73/199 (36%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG--DLVVVGDLG----SLQFIKSKGL 181
H + LYQI+ GL ++HS V HRD+KP N+L+ DL + D G + G
Sbjct: 107 HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKIC-DFGLARIADPEHDHTGF 165
Query: 182 HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
TEY+ATRWYR+PE +L Y+ +DIW+ GC+ E L+ PLFPG + QL+ I V
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
LGTP E L ++ N+ P + L P K L+ +ML ++P +R T
Sbjct: 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT 285
Query: 302 AQKILSCAYFADLTQLKQY 320
++ L+ Y L+QY
Sbjct: 286 VEEALAHPY------LEQY 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 6e-38
Identities = 72/193 (37%), Positives = 106/193 (54%), Gaps = 6/193 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG--SLQFIKSKG--LH 182
H F LYQ++ L ++H+ VFHRD+KP+NIL D + + D G + F +
Sbjct: 104 HHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163
Query: 183 TEYIATRWYRSPE-CLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
T+Y+ATRWYR+PE C Y+ +DIW+ GC+F E LT PLFPG + + QLD I +
Sbjct: 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
LGTP ET+ + K+ + ++ P +L+ +L +DPK RPT
Sbjct: 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
Query: 302 AQKILSCAYFADL 314
A++ L+ YF L
Sbjct: 284 AEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 8e-38
Identities = 73/189 (38%), Positives = 107/189 (56%), Gaps = 16/189 (8%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHT--EYIAT 188
L+Q++ GL + H +V HRD+KP+N+LI RG+L + D G L KS T + T
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKL-ADFG-LARAKSVPSKTYSNEVVT 166
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-DQLDRIHQVLGTPKA 247
WYR P+ LL YS LD+W GC+FYE T PLFPG +++ DQL +I +VLGTP
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE 226
Query: 248 ET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI--HEKGKKLMSEMLKYDPKRRPTA 302
ET + ++K Y F YP + P++ G++L + L+Y+PK+R +A
Sbjct: 227 ETWPGVSSNPEFK----PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA 282
Query: 303 QKILSCAYF 311
+ + YF
Sbjct: 283 AEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 69/188 (36%), Positives = 109/188 (57%), Gaps = 14/188 (7%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKG-LHTEYIATR 189
L+QI+ G+ HS+ + HRDIKPENIL+ + +V + D G + + + G ++T+Y+ATR
Sbjct: 105 YLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT--PKA 247
WYR+PE L+ + Y +DIWA GC+ E LT PLFPGDS+IDQL I + LG P+
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGG----GIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
+ + F+K N + + P ++ P++ L + L+ DP RP++
Sbjct: 225 QEI--FQK----NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278
Query: 304 KILSCAYF 311
++L +F
Sbjct: 279 QLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 7e-34
Identities = 70/186 (37%), Positives = 103/186 (55%), Gaps = 3/186 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL-VVVGDLGSLQFIKSKGLHTEYI 186
H F++YQI+ GL ++HS + HRD+KP N+ + D + + D G + + T Y+
Sbjct: 121 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYV 178
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
ATRWYR+PE +L +Y+ +DIW+ GC+ E LT LFPG IDQL I +++GTP
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
AE LKK + N+ Q P + + L+ +ML D +R TA + L
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 307 SCAYFA 312
+ AYFA
Sbjct: 299 AHAYFA 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 62/181 (34%), Positives = 100/181 (55%), Gaps = 6/181 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATRW 190
++ Q + GL LH+ + HRD+KPENIL+ G V + D G + + T + T W
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW 172
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL + Y+ +D+W+ GC+F E R PLF G+SE DQL +I ++G P +
Sbjct: 173 YRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
+ F+ + + + +VP+I E G +L+ EML ++P +R +A + L +
Sbjct: 232 PRDVTLPRGAFSPRGPR----PVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
Query: 311 F 311
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 67/184 (36%), Positives = 98/184 (53%), Gaps = 5/184 (2%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRG--DLVVVGDLGSLQFIKSKGLHTEYIAT 188
+ LYQI+ GL ++HS V HRD+KP NILI DL + D G L I+ + T Y++T
Sbjct: 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC-DFG-LARIQDPQM-TGYVST 168
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
R+YR+PE +LT Y E+DIW+AGC+F E L PLFPG ++Q I +LGTP +
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308
+ + F + L+ +ML +DP++R +A + L+
Sbjct: 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288
Query: 309 AYFA 312
Y A
Sbjct: 289 PYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 63/181 (34%), Positives = 98/181 (54%), Gaps = 6/181 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATRW 190
+++Q++ GL LHS++V HRD+KP+NIL+ + + D G + + T + T W
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 174
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE LL + Y+ +D+W+ GC+F E R PLF G S++DQL +I V+G P E
Sbjct: 175 YRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
+ F + I+ V I E GK L+ + L ++P +R +A LS Y
Sbjct: 234 PRDVALPRQAFHSK----SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
Query: 311 F 311
F
Sbjct: 290 F 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 60/186 (32%), Positives = 101/186 (54%), Gaps = 10/186 (5%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGL-HTEYIATR 189
+++Q + ++ H + HRD+KPENILI + + + D G + + G +T+Y+ATR
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
WYR+PE L+ + Y +D+WA GCVF E LT PL+PG S++DQL I + LG +
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DL 220
Query: 250 LKKFEKYKSSNFTYQFKQYPGGG----IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
+ + ++ S+N ++ P ++ P I + L+ DP R + +++
Sbjct: 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
Query: 306 LSCAYF 311
L YF
Sbjct: 281 LEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 37/205 (18%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----------------GDLVVVGDLGSLQF 175
+L QI+NGL+ LH + HRD+ P NI I G L +
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 176 IKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
++ + T + T WYR+PE L+ Y F +D+W+ GC+F E LT PLFPG++EIDQL
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 236 DRIHQVLGT------PKAETLK---KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK 286
RI ++LGT P+A+ L +F K + F ID
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAID------------ 291
Query: 287 LMSEMLKYDPKRRPTAQKILSCAYF 311
L+ +LK +P R +A++ L YF
Sbjct: 292 LLQSLLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 66/194 (34%), Positives = 101/194 (52%), Gaps = 29/194 (14%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTEY------- 185
++Q++ GL HS+ V HRD+KP+N+LI + G+L F GL +
Sbjct: 105 MFQLLKGLAFCHSHNVLHRDLKPQNLLINKN----GELKLADF----GLARAFGIPVRCY 156
Query: 186 ---IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQV 241
+ T WYR P+ L YS +D+W+AGC+F E PLFPG+ DQL RI ++
Sbjct: 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216
Query: 242 LGTPKAET---LKKFEKYKSSNFTYQFKQYPGGGIDV-LVPQIHEKGKKLMSEMLKYDPK 297
LGTP E+ + K YK + YP V +VP+++ G+ L+ +L +P
Sbjct: 217 LGTPTEESWPGVSKLPDYKP------YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPV 270
Query: 298 RRPTAQKILSCAYF 311
+R +A++ L YF
Sbjct: 271 QRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 63/187 (33%), Positives = 101/187 (54%), Gaps = 18/187 (9%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGL----HTEYIA 187
YQ++ G+ H +V HRD+KP+N+LI RG+L + D G ++ G+ + +
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKL-ADFG---LARAFGIPVNTFSNEVV 162
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T WYR+P+ LL YS +DIW+ GC+ E +T PLFPG + DQL +I +++GTP
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE 222
Query: 248 ET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
T + + +YK + F +YP + L P G L+ +L+ +P+ R +A
Sbjct: 223 STWPGISQLPEYKPT-----FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277
Query: 305 ILSCAYF 311
L +F
Sbjct: 278 ALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 68/197 (34%), Positives = 115/197 (58%), Gaps = 11/197 (5%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVG-DLGSLQFIKSKGLH 182
+++ L+Q++ GL++ H KV HRD+KP+N+LI RG+L + L + I +K
Sbjct: 103 MHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162
Query: 183 TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
E + T WYR P+ LL YS ++D+W GC+FYE T PLFPG + +QL I ++L
Sbjct: 163 NE-VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221
Query: 243 GTPKAET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
GTP ET + E++KS Y + +Y + P++ G +L+S++L+++ ++R
Sbjct: 222 GTPTEETWPGILSNEEFKS----YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKR 277
Query: 300 PTAQKILSCAYFADLTQ 316
+A++ + YF L +
Sbjct: 278 ISAEEAMKHPYFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 66/192 (34%), Positives = 96/192 (50%), Gaps = 14/192 (7%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG----------SLQFIKSKGL 181
+ Q++ G+++LH + HRDIK NILI ++ + D G + + G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 182 H--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239
T + TRWYR PE LL E Y+ +DIW GCVF E TR P+ G S+IDQL I
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
Query: 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
++ GTP ET + + F YP ++ ++ +G L+S++L DP +R
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSLDPYKR 299
Query: 300 PTAQKILSCAYF 311
TA L YF
Sbjct: 300 LTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 61/187 (32%), Positives = 103/187 (55%), Gaps = 7/187 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTE---YIA 187
F++YQ++ GL ++H+ + HRD+KP N+ + D +L L F ++ +E Y+
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC----ELKILDFGLARQTDSEMTGYVV 177
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
TRWYR+PE +L +Y+ +DIW+ GC+ E LT PLF G +DQL I +V GTP
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
E ++K + + N+ + ++ L+P + ++ +ML D + R TA + L+
Sbjct: 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
Query: 308 CAYFADL 314
YF +
Sbjct: 298 HPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 64/186 (34%), Positives = 102/186 (54%), Gaps = 3/186 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYI 186
H F++YQ++ GL ++HS + HRD+KP N+ + D + + D G + ++ T Y+
Sbjct: 119 HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYV 176
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
ATRWYR+PE +L +Y+ +DIW+ GC+ E L LFPG+ IDQL RI +V+GTP
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
E LKK + + P + + + L+ +ML D +R +A + L
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296
Query: 307 SCAYFA 312
+ YF+
Sbjct: 297 AHPYFS 302
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-31
Identities = 68/195 (34%), Positives = 114/195 (58%), Gaps = 11/195 (5%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVG-DLGSLQFIKSKGLH 182
+++ LYQI+ GL + H KV HRD+KP+N+LI RG+L + L + + +K
Sbjct: 103 MHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162
Query: 183 TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
E + T WYR P+ LL YS ++D+W GC+F+E + PLFPG + D+L I ++L
Sbjct: 163 NE-VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221
Query: 243 GTPKAET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
GTP ET + +++K+ Y F +Y + P++ +G +L+++ L+Y+ K+R
Sbjct: 222 GTPTEETWPGISSNDEFKN----YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKR 277
Query: 300 PTAQKILSCAYFADL 314
+A++ + AYF L
Sbjct: 278 ISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 62/185 (33%), Positives = 101/185 (54%), Gaps = 16/185 (8%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA 187
+++LYQ++ G+ HLHS + HRD+KP NI+++ D + + D G + + + T Y+
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 179
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
TR+YR+PE +L GY +DIW+ GC+ E + LFPG IDQ ++I + LGTP
Sbjct: 180 TRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI--------HEK-----GKKLMSEMLKY 294
E + + + N+ +Y G + L P + H K + L+S+ML
Sbjct: 239 EFMSRLQ-PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 295 DPKRR 299
DP++R
Sbjct: 298 DPEKR 302
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 15/196 (7%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV--VGDLGSLQFIKS----KGL 181
H +YQ++ GL ++HS V HRD+KP N+ I + +V +GD G + + KG
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 182 HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ----LDR 237
+E + T+WYRSP LL+ Y+ +D+WAAGC+F E LT PLF G E++Q L+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
Query: 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
+ V + E L + ++ P + L+P ++ + + ++L ++P
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGG-----EPRRPLRDLLPGVNPEALDFLEQILTFNPM 289
Query: 298 RRPTAQKILSCAYFAD 313
R TA++ L Y +
Sbjct: 290 DRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 63/181 (34%), Positives = 95/181 (52%), Gaps = 3/181 (1%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRWYR 192
Q++ GL +LH + HRD+K N+L+ + + D G + + T + T WYR
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKK 252
+PE LL Y+ +D+WA GC+ E L PL PG SEI+QLD I Q+LGTP
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 253 FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312
F + + P + P + E G +L++ +L YDPK+R TA++ L +YF
Sbjct: 236 FSDLPLVG-KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
Query: 313 D 313
+
Sbjct: 295 E 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 64/195 (32%), Positives = 106/195 (54%), Gaps = 17/195 (8%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHT 183
+++ ++Q++ GL + H K+ HRD+KP+N+LI +G+L L ++K + T
Sbjct: 102 MHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGEL----KLADFGLARAKSVPT 157
Query: 184 EY----IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239
+ + T WYR P+ LL YS +D+W GC+ YE T P+FPG + ++L I
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217
Query: 240 QVLGTPKAET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDP 296
++LGTP ET + E+++S Y F QY + P++ G L+S +L Y+
Sbjct: 218 RLLGTPTEETWPGITSNEEFRS----YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYET 273
Query: 297 KRRPTAQKILSCAYF 311
K R +A+ L +YF
Sbjct: 274 KSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTE---YIA 187
+++YQ++ GL ++HS + HRD+KP N+ + D +L L F ++ E Y+
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC----ELKILDFGLARHADAEMTGYVV 176
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
TRWYR+PE +L +Y+ +DIW+ GC+ E LT LF G +DQL +I +V G P
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
E ++K E + ++ +YP L P+ + L+ +ML+ D +R TA + L
Sbjct: 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296
Query: 308 CAYFADLTQLKQYLEQK 324
YF + EQ+
Sbjct: 297 HPYFDSFRDADEETEQQ 313
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 15/194 (7%)
Query: 130 TFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT 188
+++LYQ++ G+ HLHS + HRD+KP NI+++ D + + D G + + + T Y+ T
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVT 185
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
R+YR+PE +L GY +DIW+ GC+ E + + +F G IDQ +++ + LGTP AE
Sbjct: 186 RYYRAPEVILGMGYKE-NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI-------HEK-----GKKLMSEMLKYDP 296
+ + + N+ QYPG + L P +K + L+S+ML DP
Sbjct: 245 FMNRLQP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP 303
Query: 297 KRRPTAQKILSCAY 310
+R + + L Y
Sbjct: 304 DKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 68/199 (34%), Positives = 99/199 (49%), Gaps = 28/199 (14%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG---SLQFIKSKGLHT 183
H LYQI+ GL +LHS + HRDIKP N+L+ + V+ + D G + +SK + T
Sbjct: 104 HVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM-T 162
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243
+ + T++YR+PE L+ +Y+ +DIW+ GC+F E L R LF S I QLD I +LG
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222
Query: 244 TP------------KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEM 291
TP +A L+ K S Y + HE L+ M
Sbjct: 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYT----------LSSQATHE-AVHLLCRM 271
Query: 292 LKYDPKRRPTAQKILSCAY 310
L +DP +R +A L+ Y
Sbjct: 272 LVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 67/197 (34%), Positives = 101/197 (51%), Gaps = 20/197 (10%)
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR--GDLVVVGDLGSLQFIKSKGL--- 181
Y+ ++Q++ GL ++H + HRD+KP+N+LI G+L L ++K +
Sbjct: 103 YNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGEL----KLADFGLARAKSIPSQ 158
Query: 182 -HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-DQLDRIH 239
++ + T WYR P+ LL YS LDIW AGC+F E L P FPG S++ +QL++I
Sbjct: 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
Query: 240 QVLGTPKAET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHE--KGKKLMSEMLKY 294
VLG P +T + K YK F + V+ ++ K + L S+ML
Sbjct: 219 TVLGVPTEDTWPGVSKLPNYKPE----WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMM 274
Query: 295 DPKRRPTAQKILSCAYF 311
PK R +AQ L YF
Sbjct: 275 FPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 65/193 (33%), Positives = 104/193 (53%), Gaps = 13/193 (6%)
Query: 130 TFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT 188
+++LYQ++ G+ HLHS + HRD+KP NI+++ D + + D G + + + T Y+ T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
R+YR+PE +L GY +DIW+ GC+ E + LFPG IDQ +++ + LGTP E
Sbjct: 182 RYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 249 TLKKFE----KYKSSNFTYQFKQYPGGGIDVLVPQIHE-------KGKKLMSEMLKYDPK 297
+KK + Y + Y +P D L P E + + L+S+ML DP
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 298 RRPTAQKILSCAY 310
+R + + L Y
Sbjct: 301 KRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 81/227 (35%), Positives = 116/227 (51%), Gaps = 27/227 (11%)
Query: 98 LLLVFGK-SRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPE 156
L LVF +N+ L+ + +P + R Y +YQ++ +H H + HRDIKPE
Sbjct: 75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSY-----IYQLIKAIHWCHKNDIVHRDIKPE 129
Query: 157 NILIRG-DLVVVGDLGSLQFIK--SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAG 213
N+LI D++ + D G + + S +TEY+ATRWYRSPE LL Y +D+W+ G
Sbjct: 130 NLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDMWSVG 188
Query: 214 CVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGI 273
C+ E PLFPG+SEIDQL I +VLG AE +K F SN + ++P
Sbjct: 189 CILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF----YSNPRFHGLRFPA--- 241
Query: 274 DVLVPQIHEKGKK---------LMSEMLKYDPKRRPTAQKILSCAYF 311
V PQ E+ LM +LK +P R ++ L+ F
Sbjct: 242 -VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 65/198 (32%), Positives = 109/198 (55%), Gaps = 23/198 (11%)
Query: 130 TFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT 188
+++LYQ++ G+ HLHS + HRD+KP NI+++ D + + D G + + + T Y+ T
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
R+YR+PE +L GY +DIW+ GC+ E + LFPG IDQ +++ + LGTP E
Sbjct: 189 RYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247
Query: 249 TLKKFE---------KYKSSNFTYQFKQYPGGGIDVLVPQIHE-------KGKKLMSEML 292
+KK + + K + ++++ K +P DVL P E + + L+S+ML
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFE-KLFP----DVLFPADSEHNKLKASQARDLLSKML 302
Query: 293 KYDPKRRPTAQKILSCAY 310
D +R + + L Y
Sbjct: 303 VIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTEYIATRWY 191
YQ+ L ++HS + HRD+KP+N+LI + + D GS + + + YI +R+Y
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFY 236
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
R+PE +L Y+ +D+W+ GC+ E + P+F G S +DQL RI QVLGTP + LK
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296
Query: 252 ---------KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
KF K + K +P G + +S+ LKY+P +R
Sbjct: 297 EMNPNYADIKFPDVKPKDLK---KVFPKG--------TPDDAINFISQFLKYEPLKRLNP 345
Query: 303 QKILSCAYFADL----TQLKQYLEQ 323
+ L+ +F DL +L +Y+++
Sbjct: 346 IEALADPFFDDLRDPCIKLPKYIDK 370
|
Length = 440 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY 146
Y V D +L++ + + +L L+ L + +L QI+ GL +LHS
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL-----RILLQILEGLEYLHSN 111
Query: 147 KVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWYRSPECLLTEGYY 203
+ HRD+KPENIL+ V + D G S K L + T Y +PE LL +GYY
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 204 SFELDIWAAGCVFYE 218
S + DIW+ G + YE
Sbjct: 172 SEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 15/191 (7%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-----SLQFIKSKGLHTEY 185
V+ ++NGL+++H K+ HRD+K NILI D ++ + D G SL +T
Sbjct: 124 VMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ T WYR PE LL E Y +D+W AGC+ E TR+P+ G++E QL I Q+ G+
Sbjct: 184 VVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK-----LMSEMLKYDPKRRP 300
E +K + ++ + P G + ++ K L+ ++L DP +R
Sbjct: 244 TPEVWPGVDKLE----LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299
Query: 301 TAQKILSCAYF 311
A L+ +F
Sbjct: 300 DADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 72/190 (37%), Positives = 101/190 (53%), Gaps = 12/190 (6%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIR--GDLVVVGDLGSLQFIKSKGLHT--EYIAT 188
L+Q++ GL ++H + HRD+KP+N+LI G+L + D G L KS HT + T
Sbjct: 109 LFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKL-ADFG-LARAKSVPSHTYSNEVVT 166
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-DQLDRIHQVLGTPKA 247
WYR P+ LL YS LD+W GC+F E + FPG +I DQL+RI VLGTP
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE 226
Query: 248 ET---LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
+T + +K FT + + L H + L S++L+ PK R +AQ
Sbjct: 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH--AEDLASKLLQCFPKNRLSAQA 284
Query: 305 ILSCAYFADL 314
LS YF+DL
Sbjct: 285 ALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 81/312 (25%), Positives = 124/312 (39%), Gaps = 79/312 (25%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
++EI ILR++ +H N++ L E ++ D + K+ K
Sbjct: 54 IREIKILRQL-NHRNIVNLKEIVTDKQ----------------------DALDFKKDKGA 90
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
Y V E H DL +G L GL F K +
Sbjct: 91 FYLV---FEYMDH-----DL--------------MGLLESGLVHFSEDHIKSF------M 122
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKS--KGLHTEYIATR 189
Q++ GL++ H HRDIK NIL+ +G + + D G + S +T + T
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL-ADFGLARLYNSEESRPYTNKVITL 181
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
WYR PE LL E Y +D+W+ GC+ E T+ P+F + E+ QL+ I ++ G+P
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241
Query: 250 LKKFEKYKSSNFTYQFKQY-----------PGGGIDVLVPQIHEKGKKLMSEMLKYDPKR 298
K N KQY P +D L+ ML DP +
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALD------------LLDHMLTLDPSK 289
Query: 299 RPTAQKILSCAY 310
R TA++ L+ +
Sbjct: 290 RCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 91/322 (28%), Positives = 148/322 (45%), Gaps = 76/322 (23%)
Query: 15 KEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEIL 74
+EI++LR++ H NV+ L + +++ S R+V L+F E +L I+
Sbjct: 47 REIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIK-------------F 92
Query: 75 YQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLY 134
++ AN+ ++LP ++ KS +LY
Sbjct: 93 HRASKANKKP--------MQLPRSMV---KS--------------------------LLY 115
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGD-----LVVVGDLGSLQFIKS--KGLHT--EY 185
QI++G+H+LH+ V HRD+KP NIL+ G+ V + D+G + S K L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI---------DQLD 236
+ T WYR+PE LL +Y+ +DIWA GC+F E LT P+F E DQLD
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235
Query: 237 RIHQVLGTPKA---ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK----LMS 289
RI V+G P E ++K +Y + ++ Y + + + K L+
Sbjct: 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295
Query: 290 EMLKYDPKRRPTAQKILSCAYF 311
++L DP +R T+++ L YF
Sbjct: 296 KLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 27/206 (13%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-----LVVVGDLGSLQFIKS--KGLHT- 183
+LYQI++G+H+LH+ V HRD+KP NIL+ G+ V + D+G + S K L
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 184 -EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI---------D 233
+ T WYR+PE LL +Y+ +DIWA GC+F E LT P+F E D
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
Query: 234 QLDRIHQVLGTPKA---ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHE-----KGK 285
QLDRI V+G P E +KK ++ + ++ Y + + + H+ K
Sbjct: 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL-IKYMEKHKVKPDSKAF 291
Query: 286 KLMSEMLKYDPKRRPTAQKILSCAYF 311
L+ ++L DP +R T+++ + YF
Sbjct: 292 HLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 1e-20
Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 33/179 (18%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEYIAT 188
Q+ L +LHS K+ HRDIKP+NI + LV +GD G S + L + T
Sbjct: 107 DWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT 166
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
+Y SPE + Y+++ DIW+ GCV YE T F G++ ++ +I
Sbjct: 167 PYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI---------- 215
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+Y Y + + L+S +L+ DP+ RP+ +IL
Sbjct: 216 ---LKGQYPPIPSQYS-----------------SELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 66/225 (29%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 115 LTTFLPQQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLG 171
L T+L ++S+ L + QI+ GL +LH+ ++ HRD+K ENI I D V +GDLG
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG 202
Query: 172 SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-------RNP 224
+ QF T +PE L + Y S + DIW+AG V +E L P
Sbjct: 203 AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNS-KADIWSAGIVLFEMLAYPSTIFEDPP 261
Query: 225 LFPGDSEID---QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-- 279
P + L +I L E F + S F +Y L Q
Sbjct: 262 STPEEYVKSCHSHLLKIISTLKVHPEE----FPRDPGSRLVRGFIEYAS-----LERQPY 312
Query: 280 ----------IHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314
+ G+ L+ +ML +D RP+A++IL+ FA L
Sbjct: 313 TRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 91.0 bits (224), Expect = 7e-20
Identities = 81/397 (20%), Positives = 138/397 (34%), Gaps = 43/397 (10%)
Query: 34 ETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDL 93
E Y+ R + V L L + ++ + R +IL + Y D
Sbjct: 15 EVYLARDRKLVALKV----LAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE 70
Query: 94 KLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDI 153
+L++ + +L L+ + P +L QI++ L +LHS + HRDI
Sbjct: 71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF---ILAQILSALEYLHSKGIIHRDI 127
Query: 154 KPENILIR--GDLVVVGDLGSLQFIKSKG-------LHTEYIATRWYRSPECLL--TEGY 202
KPENIL+ G +V + D G + + G L + + T Y +PE LL + Y
Sbjct: 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY 187
Query: 203 YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFT 262
S DIW+ G YE LT P F G+ +TLK + + +
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QTLKIILELPTPSLA 236
Query: 263 YQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQYLE 322
I L+ ++L DPK R ++ LS A L + L
Sbjct: 237 SPLSPSNPELISKAA-------SDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
Query: 323 QKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMDMSKFIQSDLNTHQTKKTKSDFF 382
K + ++ + P+ + + ++ D + + +
Sbjct: 290 DL-------LKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVS 342
Query: 383 SQARTSKYRFDQSSSIVLHPKNPPNKSKHRFDQSSST 419
S S ++S + SSS+
Sbjct: 343 SSPHNSSSLLLSTASSKRSSLPKISARSSPSSLSSSS 379
|
Length = 384 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 37/179 (20%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENI-LIRGDLVVVGDLGSLQFIKSKGLHTE-YIATR 189
L+QIV+ + ++H + HRDIK NI L + L+ +GD G + + S+ E + T
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTP 165
Query: 190 WYRSPECLLTEGY-YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
+Y SPE L +G Y+F+ DIWA GCV YE LT F + ++ + +I Q TP
Sbjct: 166 YYMSPE--LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--- 220
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKG-KKLMSEMLKYDPKRRPTAQKIL 306
V ++ L+ +L+ DP++RPTA ++L
Sbjct: 221 ----------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 51/177 (28%), Positives = 76/177 (42%), Gaps = 35/177 (19%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSK----GLHTEYIATR 189
QI+ GL +LHS + HRDIK NIL+ D VV + D G + + G + T
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTP 167
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
++ +PE + E Y DIW+ GC E T P + SE+ L
Sbjct: 168 YWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPW---SELGNP---MAAL------- 213
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
YK + G + + E+ K + + L+ DPK+RPTA ++L
Sbjct: 214 ------YKIGS---------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 53/190 (27%), Positives = 80/190 (42%), Gaps = 36/190 (18%)
Query: 121 QQSKRLYHTTFV---LYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFI 176
++ ++L + Q++ GL LH K+ HRD+K NIL+ DLV +GDLG + +
Sbjct: 94 KKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL 153
Query: 177 KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236
K T+ I T Y +PE + YS++ DIW+ GC+ YE T P F S D
Sbjct: 154 KKNMAKTQ-IGTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211
Query: 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDP 296
++ G + P + + + ML+ P
Sbjct: 212 KVQ------------------------------RGKYPPIPPIYSQDLQNFIRSMLQVKP 241
Query: 297 KRRPTAQKIL 306
K RP KIL
Sbjct: 242 KLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHT-EYIATRWY 191
Q+ + L H+HS ++ HRDIKP N+ I VV +GDLG +F SK + T +Y
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229
SPE + G Y+F+ DIW+ GC+ YE F GD
Sbjct: 173 MSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 40/189 (21%)
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVG--DLGSLQFIKSKG 180
+ +IV L +LHS + HRD+KP+NILI + L G +G ++ +
Sbjct: 93 DVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152
Query: 181 LHT----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236
+ T Y +PE +L +G +S +D W+ GC+ YE L P F G++
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP----- 206
Query: 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDP 296
E + K ++ + ++ ++ L+S++L DP
Sbjct: 207 ----------EEIFQNILNGK-----IEWPED---------VEVSDEAIDLISKLLVPDP 242
Query: 297 KRRPTAQKI 305
++R A+ I
Sbjct: 243 EKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 49/197 (24%), Positives = 72/197 (36%), Gaps = 54/197 (27%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL-VVVGDLGSLQFIKSKGLHTE--- 184
T F +I+ L +LHS + HRD+KPENIL+ D+ + + D G+ + +
Sbjct: 104 TRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 185 ------------------YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226
++ T Y SPE LL E D+WA GC+ Y+ LT P F
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 227 PGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK 286
G +E +I Y F P K
Sbjct: 223 RGSNEYLTFQKI--------------------LKLEYSFP-----------PNFPPDAKD 251
Query: 287 LMSEMLKYDPKRRPTAQ 303
L+ ++L DP+ R
Sbjct: 252 LIEKLLVLDPQDRLGVN 268
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 32/179 (17%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIAT 188
+V +++ GL +LHS + HRDIK NIL+ D V + D G S Q +K +T + T
Sbjct: 102 YVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT-MVGT 160
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
++ +PE ++ Y ++ DIW+ G E P + + L +I G P
Sbjct: 161 PYWMAPE-VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-- 216
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
L+ EK+ S F K + + L+ +P++RPTA+++L
Sbjct: 217 -LRNPEKW-SDEF-----------------------KDFLKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 50/188 (26%)
Query: 132 VLYQIVNGLHHLH-----SYKVFHRDIKPENILIRGDLVV-VGDLG-------SLQFIKS 178
+L Q++ L+ H V HRD+KP NI + + V +GD G F K+
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169
Query: 179 KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
Y+ T +Y SPE L Y + DIW+ GC+ YE +P F R
Sbjct: 170 ------YVGTPYYMSPE-QLNHMSYDEKSDIWSLGCLIYELCALSPPFTA--------RN 214
Query: 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR 298
L K K G + + + +++ ML DP +
Sbjct: 215 QLQLA----------SKIKE------------GKFRRIPYRYSSELNEVIKSMLNVDPDK 252
Query: 299 RPTAQKIL 306
RP+ +++L
Sbjct: 253 RPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 32/179 (17%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
Q++ G+H++H ++ HRD+K +NI ++ +L+ +GD G S + S L T + T +Y
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYY 171
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
SPE L +GY S + DIW+ GC+ YE F G + + VL + T
Sbjct: 172 MSPEALKHQGYDS-KSDIWSLGCILYEMCCLAHAFEGQ------NFLSVVLRIVEGPTPS 224
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
E Y +M ML DP RP+A +IL +
Sbjct: 225 LPETYSRQL------------------------NSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 34/182 (18%)
Query: 131 FVLYQIVNGLHHLHSY-KVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYI 186
++ QI+ GL +LH+ + HRDIKP N+LI +G+ V + D G S + ++
Sbjct: 103 YIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE-VKIADFGISKVLENTLDQCNTFV 161
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTP 245
T Y SPE + E YS+ DIW+ G E + P P + + + P
Sbjct: 162 GTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGP 219
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
+ F+ +F+ + +S L+ DPK+RP+A ++
Sbjct: 220 PPSL-------PAEEFSPEFRDF-------------------ISACLQKDPKKRPSAAEL 253
Query: 306 LS 307
L
Sbjct: 254 LQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 36/168 (21%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
+IV L +LHS + +RD+KPENIL+ G + + D G + + + T Y
Sbjct: 101 EIVLALEYLHSLGIIYRDLKPENILLDADGHIKLT-DFGLAKELSSEGSRTNTFCGTPEY 159
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
+PE +L Y +D W+ G + YE LT P F + + ++I + L
Sbjct: 160 LAPE-VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI-------LKDPL- 210
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
+F ++ S + L+S +L+ DP +R
Sbjct: 211 RFPEFLSPEA-----------------------RDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 39/97 (40%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENIL--IRGDLVVVGDLGS---LQFIKSKGLHTE-YIA 187
QI+ G+ +LHS + HRDIK NIL G+ V +GD G+ LQ I S G +
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
T ++ SPE + EG Y + D+W+ GC E LT P
Sbjct: 170 TPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 41/97 (42%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTE-YIATRWYR 192
Q+ + L H+HS +V HRDIKP N+ I VV +GDLG +F SK + T +Y
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229
SPE + G Y+F+ DIW+ GC+ YE F GD
Sbjct: 174 SPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 48/183 (26%), Positives = 75/183 (40%), Gaps = 41/183 (22%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKG--LHTE---YIAT 188
Q++ GL +LHS+ + HRDIKP NI + ++ +GD G +K+ + E T
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 189 RWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
Y +PE + + DIW+ GCV E T + +LD Q++
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS------ELDNEFQIM---- 216
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEK---GKKLMSEMLKYDPKRRPTAQ 303
F P +P + GK + L+ DPK+RPTA
Sbjct: 217 --------------FHVGAGHKP------PIPDSLQLSPEGKDFLDRCLESDPKKRPTAS 256
Query: 304 KIL 306
++L
Sbjct: 257 ELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 43/245 (17%)
Query: 63 DNISEKRAKEILYQVKAANETAAH------YRVGWDLKLPFLLLVFGKSRNLGTLIVGLT 116
+I E +E ++ K E H YR D K ++L+ + L T++
Sbjct: 29 RHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG 88
Query: 117 TFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQ 174
F + Y F + +V +LH+ + +RD+KPEN+L+ G V + D G +
Sbjct: 89 LF----DE--YTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAK 141
Query: 175 FIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ 234
+KS + T Y +PE +L +G Y F +D W+ G + YE LT P F D E
Sbjct: 142 KLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
Query: 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKY 294
I+ + LK K + N+ I + K L+ ++L+
Sbjct: 201 --EIYNDI-------LKGNGKLEFPNY------------------IDKAAKDLIKQLLRR 233
Query: 295 DPKRR 299
+P+ R
Sbjct: 234 NPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 41/98 (41%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSK--GLHTEYIATRWY 191
Q+ + + H+HS +V HRDIKP N+ I VV +GDLG +F SK H+ + T +Y
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYY 172
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229
SPE + G Y+F+ DIW+ GC+ YE F GD
Sbjct: 173 MSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 38/199 (19%)
Query: 115 LTTFLPQQSKRLYHTTFVLY---QIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGD 169
L ++ ++ L +L+ QI+ LHH+H+ + HRD+K +NIL+ +V +GD
Sbjct: 86 LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGD 145
Query: 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGY-YSFELDIWAAGCVFYETLTRNPLFPG 228
G + + SK + T Y SPE L EG Y+ + DIWA GCV YE
Sbjct: 146 FGISKILSSKSKAYTVVGTPCYISPE--LCEGKPYNQKSDIWALGCVLYELA-------- 195
Query: 229 DSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLM 288
L R + P A LK P D P + ++L+
Sbjct: 196 -----SLKRAFEAANLP-ALVLK----------IMSGTFAPIS--DRYSPDL----RQLI 233
Query: 289 SEMLKYDPKRRPTAQKILS 307
ML DP +RP +I++
Sbjct: 234 LSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYI-ATRWYR 192
QI+ GL HLHS K+ HRDIK N+ + D V +GDLG + + I T +Y
Sbjct: 109 QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYL 168
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE 231
SPE L + Y+ + D+WA G V YE T F +++
Sbjct: 169 SPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 60/194 (30%), Positives = 84/194 (43%), Gaps = 35/194 (18%)
Query: 140 LHHLHSYKVFHRDIKPENI-LIRGDLVVVGDLGSLQFIKSKGLHTE------YIATRWYR 192
L +LH + HRD+K ENI L + V+GD G+ H + + T
Sbjct: 198 LAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGA---ACKLDAHPDTPQCYGWSGTLETN 254
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLF----PGDSEIDQLDRIHQVLGTPKA 247
SPE LL Y + DIW+AG V +E +N LF S QL I + +
Sbjct: 255 SPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS--QLRSIIRCMQVHPL 311
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDV----LVPQIHEKGKKLM------SEMLKYDPK 297
E F + S+N FKQY I + +P + K M ++ML +D +
Sbjct: 312 E----FPQNGSTNLCKHFKQY---AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQE 364
Query: 298 RRPTAQKILSCAYF 311
RP+AQ ILS F
Sbjct: 365 FRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 58/184 (31%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 42 RQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLV 101
R + + +LNL R +E+ A ++L Q+K N A YR W+ + L +V
Sbjct: 22 RTDGKQYVIKKLNLRNASRRERKAAEQEA-QLLSQLKHPNIVA--YRESWEGEDGLLYIV 78
Query: 102 FGKSRNLGTLIVGLTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENI- 158
G G L L Q+ K L V QI L +LH + HRD+K +N+
Sbjct: 79 MGFCEG-GDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134
Query: 159 LIRGDLVVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFY 217
L R +++ VGDLG + ++++ + + I T +Y SPE L + Y+++ D+WA GC Y
Sbjct: 135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPYNYKSDVWALGCCVY 193
Query: 218 ETLT 221
E T
Sbjct: 194 EMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 46/190 (24%), Positives = 72/190 (37%), Gaps = 42/190 (22%)
Query: 131 FVLYQIVNGLHHLHS-YKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYI 186
+ ++ GL +LH +K+ HRD+KP NIL+ RG + + D G S Q + S ++
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ-IKLCDFGVSGQLVNSLAK--TFV 160
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-----NPLFPGDSEIDQLDRIHQV 241
T Y +PE + YS + DIW+ G E T P D + L I V
Sbjct: 161 GTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--V 217
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
P KF ++ L DP+ RP+
Sbjct: 218 NEPPPRLPSGKFSPDFQD---------------------------FVNLCLIKDPRERPS 250
Query: 302 AQKILSCAYF 311
+++L +
Sbjct: 251 YKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 16/119 (13%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG 171
L +L + ++ +L+ QI G+ +L S + HRD+ NIL+ + LV + D G
Sbjct: 95 LRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG 154
Query: 172 SLQFIKSKGLHTEY--------IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
+ + +Y WY +PEC L +S D+W+ G YE T
Sbjct: 155 LAKVLPED---KDYYYVKEPGESPIFWY-APEC-LRTSKFSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 36/117 (30%), Positives = 57/117 (48%), Gaps = 3/117 (2%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATR 189
F QI+ GL HLH ++ +RD+KPEN+L+ V + DLG +K T
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTP 245
Y +PE +L Y F +D +A GC YE + R+P ++++ + + L
Sbjct: 159 GYMAPE-VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 36/194 (18%)
Query: 119 LPQQSKRLYHTTFVL---YQIVNGLHHLHSYKVFHRDIKPENI-LIRGDLVVVGDLGSLQ 174
+ Q +L+ +L Q+ G+ H+H +V HRDIK +NI L + V +GD GS +
Sbjct: 89 IKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
Query: 175 FIKSKGLHT-EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
+ S G + Y+ T +Y PE + Y+ + DIW+ GC+ YE T F +S +
Sbjct: 149 LLTSPGAYACTYVGTPYYVPPE-IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
+ ++ Q P S+++Y+ + L+ +M K
Sbjct: 208 LILKVCQGSYKP-----------LPSHYSYELRS-------------------LIKQMFK 237
Query: 294 YDPKRRPTAQKILS 307
+P+ RP+A ILS
Sbjct: 238 RNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 5e-12
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 3/94 (3%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRW 190
+YQ++ GL +LH V HRDIK NIL D VV + D G + + + T +
Sbjct: 105 VYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPY 164
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
+ +PE + G S DIW+ GC E LT NP
Sbjct: 165 WMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTEYIAT 188
F + +IV L +LHS + HRDIKP+NIL+ +G V + D + L T T
Sbjct: 104 FWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGT 162
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
Y +PE L +G YS +D W+ G YE L + G S
Sbjct: 163 PGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 38/177 (21%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATRWYRS 193
QI+ GL +LH HRDIK NIL+ + VV + D G + + + + ++ +
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMA 169
Query: 194 PECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKF 253
PE + +G Y DIW+ GC E T P + S+++ + + ++ G K
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKI-GRSKE------ 219
Query: 254 EKYKSSNFTYQFKQYPGGGIDVLVPQIHE----KGKKLMSEMLKYDPKRRPTAQKIL 306
+P I + + K + + L+ DP RPTA ++L
Sbjct: 220 -----------------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 36/89 (40%), Positives = 48/89 (53%), Gaps = 3/89 (3%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENI-LIRGDLVVVGDLGSLQFIKSK-GLHTEYIATRWYR 192
QI L H+H K+ HRDIK +NI L + + +GD G + + S L I T +Y
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT 221
SPE + Y+ + DIWA GCV YE T
Sbjct: 169 SPE-ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 38/197 (19%)
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENI-LIRGDLVVVGDLG-SLQFIKSKGLH-- 182
Y + YQIV L +HS K+ HRD+K NI L+ ++ +GD G S Q+ S L
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 183 TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
+ + T +Y +PE L YS + D+W+ G + YE LT + F G S Q + + QVL
Sbjct: 229 SSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVL 284
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
+ KY +P + K L+ +L +P RPT
Sbjct: 285 ----------YGKYDP---------FPCPVSSGM--------KALLDPLLSKNPALRPTT 317
Query: 303 QKILSC---AYFADLTQ 316
Q++L Y A+L Q
Sbjct: 318 QQLLHTEFLKYVANLFQ 334
|
Length = 478 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 52/192 (27%), Positives = 79/192 (41%), Gaps = 41/192 (21%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFI------KSKGLHT 183
VL +++ GL +LHS HRDIK NIL+ D V + D G + K T
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP----LFPGDSEIDQLDRIH 239
++ T + +PE + Y F+ DIW+ G E T P + L
Sbjct: 166 -FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-- 222
Query: 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
P ET ++KY S +F +K++S L+ DP +R
Sbjct: 223 ---DPPSLETGADYKKY-SKSF-----------------------RKMISLCLQKDPSKR 255
Query: 300 PTAQKILSCAYF 311
PTA+++L +F
Sbjct: 256 PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 54/175 (30%), Positives = 79/175 (45%), Gaps = 26/175 (14%)
Query: 136 IVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWYRS 193
++ GL +LHS K+ HRDIKP NIL+ R V + D G S + + S L + T +Y +
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LAGTFTGTSFYMA 171
Query: 194 PECLLTEGYYSFELDIWAAGCVFYE-TLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKK 252
PE + YS D+W+ G E R P FP + G P ++
Sbjct: 172 PE-RIQGKPYSITSDVWSLGLTLLEVAQNRFP-FPPE-------------GEPPLGPIEL 216
Query: 253 FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
Y + + K PG GI + E+ K + + L+ DP RRPT +L
Sbjct: 217 LS-YIVNMPNPELKDEPGNGI-----KWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIAT 188
+LYQ + GL +LHS K HRDIK NIL+ + + D G S Q + I T
Sbjct: 103 AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162
Query: 189 RWYRSPECLLTEGYYSFELDIWAAG 213
++ +PE + GY + + DIW+ G
Sbjct: 163 PFWMAPEVIQEIGYNN-KADIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG------SLQFIKSKGLHTEYI 186
QI G+ +L S HRD+ N L+ +LVV + D G + K KG +
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG---GKL 166
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
RW +PE L EG ++ + D+W+ G + +E T
Sbjct: 167 PIRWM-APES-LKEGKFTSKSDVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 31/201 (15%)
Query: 136 IVNGLHHLHSYKVFHRDIKPENILIR--GDLVVVGDLGSLQFIKSKGLHTEY-----IAT 188
++ + +LH ++ HRDIK ENI I GD V +GD G+ F + Y IAT
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGD-VCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFP-----GDSEID-QLDRIHQV 241
+PE LL Y +DIW+AG V +E T + LF GD + D Q+ I +
Sbjct: 250 ---NAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305
Query: 242 LGTPKAETLKKFEKYKSSNFTYQF-----KQYPGGGIDVLVPQIHE---KGKKLMSEMLK 293
GT E F +N + K G L ++E + L+ +ML
Sbjct: 306 SGTHPNE----FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361
Query: 294 YDPKRRPTAQKILSCAYFADL 314
+D RP+A+ +L A F D+
Sbjct: 362 FDAHHRPSAEALLDFAAFQDI 382
|
Length = 391 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 44/135 (32%), Positives = 69/135 (51%), Gaps = 13/135 (9%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTEYIATRWYR 192
QI G+ HLHS + +RD+KPEN+L+ +G+ + DLG +K T+ T Y
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGN-CRLSDLGLAVELKDGKTITQRAGTNGYM 161
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
+PE +L E YS+ +D +A GC YE + R P ++ + + K TL+
Sbjct: 162 APE-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--------KRRTLE 212
Query: 252 KFEKYKSSNFTYQFK 266
K++ NFT + K
Sbjct: 213 DEVKFEHQNFTEESK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSK 179
+ L T ++ Q++ + ++H K+ HRDIK ENI + D +V+GD G+ + +
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 180 GLHTEY--IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID---Q 234
+Y + T SPE L +GY DIW+ G + + L+ + GD Q
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379
Query: 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTY-QFKQYPGGGIDV--LVPQIHEKG--KKLMS 289
L +I L E F F Y + G V L+ + + +
Sbjct: 380 LLKIIDSLSVCDEE----FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLV 435
Query: 290 EMLKYDPKRRPTAQKILSCAYFA 312
+ML +D RP A ++L+ F+
Sbjct: 436 KMLTFDWHLRPGAAELLALPLFS 458
|
Length = 501 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 40/178 (22%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
QI GL H+H K+ HRDIK +NI + G + +GD G + Q S L + T +Y
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
SPE + Y+ + DIW+ GCV YE T F G++ +HQ++ LK
Sbjct: 169 LSPE-ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLV-------LK 213
Query: 252 KFEKY---KSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+ Y S NF+ + L+S++ K P+ RP+ IL
Sbjct: 214 ICQGYFAPISPNFSRDLRS-------------------LISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 97 FLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPE 156
+L++ + + +LI L LP+ + Y + ++V G+ LH + HRDIKPE
Sbjct: 73 YLVMEYLNGGDCASLIKTLG-GLPEDWAKQY-----IAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 157 NILI--RGDLVVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAG 213
N+LI G L + D G + GL + +++ T Y +PE +L G D W+ G
Sbjct: 127 NLLIDQTGHLKLT-DFG----LSRNGLENKKFVGTPDYLAPETILGVGDDK-MSDWWSLG 180
Query: 214 CVFYETLTRNPLFPGDSEIDQLDRI-HQVLGTPK 246
CV +E L P F ++ D I + + P+
Sbjct: 181 CVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 9e-11
Identities = 33/116 (28%), Positives = 56/116 (48%), Gaps = 18/116 (15%)
Query: 118 FLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQ 174
+L + +L + + + QI G+ +L S HRD+ N L+ +LVV + D G L
Sbjct: 91 YLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG-L- 148
Query: 175 FIKSKGLH-TEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
S+ L+ +Y RW +PE L EG ++ + D+W+ G + +E T
Sbjct: 149 ---SRDLYDDDYYRKRGGKLPIRWM-APES-LKEGKFTSKSDVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 41/179 (22%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIK------SKGLHTEYIA 187
Q++ +HH+HS + HRDIK NIL+ + LV +GD G F K S + +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG---FSKMYAATVSDDVGRTFCG 207
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y +PE + YS + D+++ G + YE LT F G++ + +V+
Sbjct: 208 TPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVM----H 255
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+TL G D L P I + +++++ +L DPKRRP++ K+L
Sbjct: 256 KTL-------------------AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 33/183 (18%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTE 184
+V +++ GL +LHS V HRDIK +NIL+ G V + D G + Q K K
Sbjct: 117 QIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNS 175
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
+ T ++ +PE ++ Y ++DIW+ G + E P + + + L I G
Sbjct: 176 VVGTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGI 233
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
P + +K+ S F K +++ L DP++RP+A++
Sbjct: 234 PPLKNPEKW----SPEF-----------------------KDFLNKCLVKDPEKRPSAEE 266
Query: 305 ILS 307
+L
Sbjct: 267 LLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 39/217 (17%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHT 183
L F +++ L +LH + V +RD+KPENIL+ +G + + D G + T
Sbjct: 92 LSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALC-DFGLCKLNMKDDDKT 150
Query: 184 E-YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
+ T Y +PE LL GY +D W G + YE LT P F D ++++ R ++L
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFY-DENVNEMYR--KIL 206
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR--- 299
P ++P G K L+ +L DP RR
Sbjct: 207 QEP--------------------LRFPDG--------FDRDAKDLLIGLLSRDPTRRLGY 238
Query: 300 PTAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYM 336
AQ+I + +F+ L+ K ++ Q K A + +
Sbjct: 239 NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAI 275
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 3e-10
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG------SLQFIKSKGLHTEYI 186
QI G+ +L S K HRD+ N L+ DLVV + D G + + K I
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
RW +PE L G ++ + D+W+ G + +E T
Sbjct: 172 --RWM-APESLKD-GIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 115 LTTFLPQQSKRLYH--TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLG 171
L T+L + + L T V Q+++ + ++H + HRDIK EN+L+ G + + +GD G
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305
Query: 172 SLQFIK---SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLF- 226
+ F + S H T +PE L + Y +DIW+AG V +E LF
Sbjct: 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTP-SVDIWSAGLVIFEAAVHTASLFS 364
Query: 227 --------PGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP 278
P D++I ++ R QV + +F ++ S Q++ P
Sbjct: 365 ASRGDERRPYDAQILRIIRQAQV-------HVDEFPQHAGSRLVSQYRHRAARNRR---P 414
Query: 279 -----------QIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311
++ + L+ L +D RRP+A ++L F
Sbjct: 415 AYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458
|
Length = 461 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 38/117 (32%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL 173
L +LP+ L QI G+ +LHS HRD+ N+L+ D LV +GD G
Sbjct: 95 LRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
Query: 174 QFIKSKGLHTEYIATR--------WYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
+ + EY R WY + EC L E +S+ D+W+ G YE LT
Sbjct: 155 KAVPEG---HEYYRVREDGDSPVFWY-AVEC-LKENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 4/131 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTEYIAT 188
F +I GL LH ++ +RD+KPENIL+ G + + DLG I + T
Sbjct: 106 FYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGT 164
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
Y +PE + E Y+F D W GC+ YE + F E + + + + + + E
Sbjct: 165 VGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE 223
Query: 249 TLKKFEKYKSS 259
+KF + S
Sbjct: 224 YSEKFSEAARS 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (146), Expect = 4e-10
Identities = 46/203 (22%), Positives = 81/203 (39%), Gaps = 42/203 (20%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L FL + ++L + QI G+ +L S HRD+ N L+ +LVV + D G
Sbjct: 88 LLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFG 147
Query: 172 SLQFIKSKGLHT----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPL 225
+ I + + +W +PE L +G ++ + D+W+ G + +E T P
Sbjct: 148 LSRDIYEDDYYRKRGGGKLPIKWM-APESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQP- 204
Query: 226 FPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGK 285
+PG S E L+ E Y+ + ++
Sbjct: 205 YPGMS---------------NEEVLELLED------GYRLPRPENCPDEL---------Y 234
Query: 286 KLMSEMLKYDPKRRPTAQKILSC 308
+LM + YDP+ RPT +++
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 32/98 (32%), Positives = 46/98 (46%), Gaps = 8/98 (8%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG--DLVVVGDLGSLQFIKSKGLHTEYI 186
++ Q+V L+ LH + + H DIK EN+L D + + D G + I + +
Sbjct: 111 VKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--- 167
Query: 187 ATRWYRSPECLLTEGY-YSFELDIWAAGCVFYETLTRN 223
T Y SPE + Y SF D WA G + YE LT
Sbjct: 168 GTLDYFSPEKIKGHNYDVSF--DWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDL--VVVGDLGS---LQFIKSKGLHTEYI-AT 188
QI+ G+ +LHS + HRDIK NIL R + V +GD G+ LQ I G + + T
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANIL-RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
++ SPE + EG Y + DIW+ GC E LT P
Sbjct: 173 PYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 4/131 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTE-YIAT 188
F QI++GL HLH ++ +RD+KPEN+L+ D V + DLG +K T+ Y T
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETL-TRNPLFPGDSEIDQLDRIHQVLGTPKA 247
+ +PE L E Y F +D +A G YE + R P +++ + ++L
Sbjct: 161 PGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT 219
Query: 248 ETLKKFEKYKS 258
K KS
Sbjct: 220 YPDKFSPASKS 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGL--HTEY 185
F ++V L +HS HRD+KP+N+L+ + + + D G+ + + G+
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 186 IATRWYRSPECLLTE---GYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+ T Y SPE L ++ GYY E D W+ G YE L + F DS
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 3/94 (3%)
Query: 135 QIVNGLHHLHSYK-VFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATRWYR 192
Q+V L +LH K + HRD+ P NI++ D V + D G + + + T + T Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226
PE + E Y + D+WA GC+ Y+ T P F
Sbjct: 181 CPEIVKNEPYGE-KADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKG-----LHTEY 185
Q++ GL +LH ++ HRD+K N+LI G + + D G+ + +KG +
Sbjct: 109 TEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
+ T + +PE L E Y D+W+ GCV E T P
Sbjct: 169 LGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRW 190
+ + + GL +LHS++ HRDIK NIL+ V + D GS + ++ T +
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPY 176
Query: 191 YRSPECLLT--EGYYSFELDIWAAGCVFYETLTRN-PLF 226
+ +PE +L EG Y ++D+W+ G E R PLF
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 8/106 (7%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHT---E 184
H F + ++ + LH HRD+KPEN LI G + F SKG+ T
Sbjct: 102 HARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS----GHIKLTDFGLSKGIVTYANS 157
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+ + Y +PE L +GY F +D W+ GC+ YE L P F G +
Sbjct: 158 VVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 7/119 (5%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQ---FIKSKGL 181
LY TF +IV GL LHS + +RD+K +N+++ D + + D G + F ++
Sbjct: 95 LYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA- 153
Query: 182 HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+ + T Y +PE L Y+F +D W+ G + YE L F GD E + + I
Sbjct: 154 -STFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 40/130 (30%), Positives = 60/130 (46%), Gaps = 3/130 (2%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATR 189
F +I+ GL LH +RD+KPENIL+ + + DLG I + T
Sbjct: 106 FYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTV 165
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ-VLGTPKAE 248
Y +PE L + Y+ D W GC+ YE + F G E + + + + VL T +
Sbjct: 166 GYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY 224
Query: 249 TLKKFEKYKS 258
+ K E+ KS
Sbjct: 225 SAKFSEEAKS 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 2/99 (2%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEY 185
+ + ++ +++ L ++H V HRDIK NIL+ V + D G + ++ + +
Sbjct: 102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF 161
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
+ T ++ +PE + YY + DIW+ G YE T NP
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 47 VFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSR 106
VF + LN E ++ + + +++L T HY + L +L++ +
Sbjct: 28 VFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNL-YLVMDYYVGG 86
Query: 107 NLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165
+L TL+ LP+ R Y V+ ++ +H LH HRDIKP+NIL+ + +
Sbjct: 87 DLLTLLSKFEDRLPEDMARFYLAEMVI--AIDSVHQLH---YVHRDIKPDNILMDMNGHI 141
Query: 166 VVGDLGSLQFIKSKGLHTEYIA--TRWYRSPECLLT----EGYYSFELDIWAAGCVFYET 219
+ D GS + G +A T Y SPE L +G Y E D W+ G YE
Sbjct: 142 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201
Query: 220 LTRNPLFPGDSEIDQLDRI 238
L F +S ++ +I
Sbjct: 202 LYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 38/184 (20%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG---SLQFIKSKGLH 182
+ F+L +++ GL +LH HRDIK NIL+ GD V + D G L SK +
Sbjct: 99 YIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD-VKLADFGVSGQLTSTMSK-RN 156
Query: 183 TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
T ++ T ++ +PE ++ + Y + DIW+ G E P S++ + R+ ++
Sbjct: 157 T-FVGTPFWMAPE-VIKQSGYDEKADIWSLGITAIELAKGEPPL---SDLHPM-RVLFLI 210
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
PK + + F+ FK + +S L DPK RP+A
Sbjct: 211 --PKNNP----PSLEGNKFSKPFKDF-------------------VSLCLNKDPKERPSA 245
Query: 303 QKIL 306
+++L
Sbjct: 246 KELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 43/187 (22%), Positives = 73/187 (39%), Gaps = 36/187 (19%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA 187
F Q++ GL +LHS + HRD+K +N+L+ D + + D G + KS ++
Sbjct: 110 VRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQN 167
Query: 188 TR-----WYRSPECLLTEGY-YSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240
++ +PE + + YS ++DIW+ GCV E R P D E
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIA------ 219
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300
F+ + P DV + ++ +P RP
Sbjct: 220 ----------AMFKLGNK-------RSAPPIPPDV-SMNLSPVALDFLNACFTINPDNRP 261
Query: 301 TAQKILS 307
TA+++L
Sbjct: 262 TARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGS---LQFIKSKGLHTEYI-ATR 189
QI+ G+ +LHS + HRDIK NIL V +GD G+ LQ I G + T
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
++ SPE + EG Y + D+W+ GC E LT P
Sbjct: 174 YWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 42/120 (35%), Positives = 63/120 (52%), Gaps = 9/120 (7%)
Query: 136 IVNGLHHL-HSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
++ GL +L +K+ HRD+KP NIL+ RG++ + D G S Q I S + ++ TR Y
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC-DFGVSGQLIDS--MANSFVGTRSY 168
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYE-TLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
SPE L +YS + DIW+ G E + R P+ P D++ +L V G P
Sbjct: 169 MSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 8e-09
Identities = 51/183 (27%), Positives = 74/183 (40%), Gaps = 34/183 (18%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
+V + + GL +LH HRDIK NIL+ GD V + D G S Q + +I
Sbjct: 105 YVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRKSFIG 163
Query: 188 TRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV-LGT 244
T ++ +PE E G Y + DIWA G E L P ++ + + +
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE---LQPPMFDLHPMRALFLISKSN 220
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
LK EK+ P H+ + + L DPK+RPTA K
Sbjct: 221 FPPPKLKDKEKWS--------------------PVFHD----FIKKCLTKDPKKRPTATK 256
Query: 305 ILS 307
+L
Sbjct: 257 LLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 29/170 (17%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATR 189
F +I GL LH ++ +RD+KPENIL+ + + DLG + + T
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 165
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
Y +PE + E Y+F D WA GC+ YE + G S Q + K E
Sbjct: 166 GYMAPEVVKNE-RYTFSPDWWALGCLLYE------MIAGQSPFQQRKK------KIKREE 212
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
+++ K ++ +F + L +L DPK R
Sbjct: 213 VERLVKEVQEEYSEKFS---------------PDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIAT 188
+V Q++ L+ LHS+KV HRD+K NIL+ D V + D G S + + +I T
Sbjct: 107 YVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGT 166
Query: 189 RWYRSPECLLTEGY----YSFELDIWAAGCVFYETLTRNP 224
++ +PE + E + Y ++ DIW+ G E P
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 33/86 (38%), Positives = 47/86 (54%), Gaps = 7/86 (8%)
Query: 136 IVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWYR 192
+V GL +L S K+ HRD+KP N+L+ RG V + D G S Q + S + Y+ T Y
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNS--IAKTYVGTNAYM 160
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYE 218
+PE + E Y D+W+ G F E
Sbjct: 161 APERISGE-QYGIHSDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIAT 188
F + ++V L HLH Y + +RD+KPENIL+ + + D G S + + T
Sbjct: 100 FYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYE 218
Y +PE LL E Y+ +D W+ G + +E
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL-VVVGDLG-SLQFIKSKGLHTEYIAT 188
++ +I+ GL HLH +KV HRDIK +N+L+ + V + D G S Q ++ G +I T
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174
Query: 189 RWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNP 224
++ +PE + + Y F+ D+W+ G E P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 40/118 (33%), Positives = 57/118 (48%), Gaps = 16/118 (13%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG 171
L +L + +RL H +LY QI G+ +L S + HRD+ NIL+ + V +GD G
Sbjct: 94 LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153
Query: 172 SLQFIKSKGLHTEYIATR--------WYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ + EY R WY +PE L TE +S D+W+ G V YE T
Sbjct: 154 LTKVLP---QDKEYYKVREPGESPIFWY-APESL-TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 49/181 (27%), Positives = 71/181 (39%), Gaps = 36/181 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKG--LHTEYIA 187
F L ++V +H +H HRDIKPEN+LI R + + D GS + + +
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVG 165
Query: 188 TRWYRSPECLLT-----EGYYSFELDIWAAGCVFYETL-TRNPL---------------- 225
T Y +PE L T +G Y E D W+ G + YE + R+P
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225
Query: 226 ----FPGDSEI--DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ 279
FP D ++ D LD I +L K +E F F + I +P
Sbjct: 226 RFLKFPEDPKVSSDFLDLIQSLLCGQKERL--GYEGLCCHPF---FSKIDWNNIRNSLPP 280
Query: 280 I 280
Sbjct: 281 F 281
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 11/126 (8%)
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIK 177
+P++ R Y VL L +HS HRD+KP+N+L+ + + + D G+ +
Sbjct: 139 VPEKWARFYTAEVVL-----ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193
Query: 178 SKGL--HTEYIATRWYRSPECLLTEG---YYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232
+G+ + T Y SPE L ++G YY E D W+ G YE L + F DS +
Sbjct: 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
Query: 233 DQLDRI 238
+I
Sbjct: 254 GTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 36/178 (20%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIR--GDLVVVGDLGSLQFIKSKGLHTE-YIATRWY 191
QI+ GL +LH ++ HRDIK +N+L+ +V + D G+ + + TE + T Y
Sbjct: 116 QILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQY 175
Query: 192 RSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
+PE ++ +G Y DIW+ GC E T P F + LG P+A
Sbjct: 176 MAPE-VIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------------IE-LGEPQAAM 221
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKIL 306
K FK +P +P+ + + K + + DP +R +A +L
Sbjct: 222 FK----------VGMFKIHPE------IPESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 42/144 (29%), Positives = 63/144 (43%), Gaps = 12/144 (8%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIK 177
Q+S R F +IV GL LH + +RD+K +N+L+ + + + D G +
Sbjct: 88 QRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147
Query: 178 SKGLHTE-YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236
G+ T + T Y +PE +L+ Y +D WA G + YE L F GD E +
Sbjct: 148 LGGVTTSTFCGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206
Query: 237 RI--HQV-----LGTPKAETLKKF 253
I +V L LK F
Sbjct: 207 SILEDEVRYPRWLSKEAKSILKSF 230
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 21/139 (15%)
Query: 128 HTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIR-GDLVV----------------VGD 169
H +++Q L + H+ + H D+KPENIL+ D VV + D
Sbjct: 232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229
LG + T ++TR YRSPE +L G+ + D+W+ GC+ YE T L+
Sbjct: 292 LGGC--CDERHSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTH 348
Query: 230 SEIDQLDRIHQVLGTPKAE 248
++ L + + LG +E
Sbjct: 349 DNLEHLHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 40/122 (32%), Positives = 62/122 (50%), Gaps = 11/122 (9%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENIL--IRGDLVVVGDLGS---LQFIKSKGLHTEYI-AT 188
QI+ G+ +LHS + HRDIK NIL G+ V +GD G+ +Q I G + + T
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
++ SPE + EG Y + D+W+ C E LT P + +E + + I ++ P
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKP 228
Query: 249 TL 250
L
Sbjct: 229 ML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 11/191 (5%)
Query: 59 IRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTF 118
++ D + K ++IL +V HY + KL +L+L F + +L T + F
Sbjct: 37 LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMF 95
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFI 176
+ K F L ++ L HLHS + +RD+KPENIL+ + + + D G S + I
Sbjct: 96 TEEDVK------FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149
Query: 177 KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236
+ + T Y +PE + G ++ D W+ G + +E LT + F G + +
Sbjct: 150 DHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208
Query: 237 RIHQV-LGTPK 246
I + LG P+
Sbjct: 209 MILKAKLGMPQ 219
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 37/104 (35%), Positives = 57/104 (54%), Gaps = 9/104 (8%)
Query: 132 VLYQIVNGLHHLHS-YKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
+ ++ GL +L +K+ HRD+KP NIL+ RG++ + D G S Q I S + ++
Sbjct: 104 ISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC-DFGVSGQLIDS--MANSFVG 160
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDS 230
TR Y SPE L +Y+ + DIW+ G E R P+ P D+
Sbjct: 161 TRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 40/121 (33%), Positives = 59/121 (48%), Gaps = 18/121 (14%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIK--SKGLH 182
F Q+V L +LHS + +RD+KPEN+L+ D + + D G F K +
Sbjct: 100 EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFG---FAKRVKGRTY 156
Query: 183 T-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
T EY+A PE +L++G Y +D WA G + YE L P F D+ I ++
Sbjct: 157 TLCGTPEYLA------PEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK 209
Query: 238 I 238
I
Sbjct: 210 I 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 6/89 (6%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL-VVVGDLG-SLQFIKSKGLHTEYIAT 188
++ +I+ GL HLH++KV HRDIK +N+L+ + V + D G S Q ++ G +I T
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184
Query: 189 RWYRSPECLLTE----GYYSFELDIWAAG 213
++ +PE + + Y + DIW+ G
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 47 VFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSR 106
++ + LN E ++ + + + +L T HY + L +L++ +
Sbjct: 28 IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYL-YLVMDYYVGG 86
Query: 107 NLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165
+L TL+ LP+ R Y + ++V +H +H HRDIKP+N+L+ + +
Sbjct: 87 DLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHI 141
Query: 166 VVGDLGSLQFIKSKGLHTEYIA--TRWYRSPECLLT----EGYYSFELDIWAAGCVFYET 219
+ D GS + G +A T Y SPE L G Y E D W+ G YE
Sbjct: 142 RLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201
Query: 220 LTRNPLFPGDSEIDQLDRI 238
L F +S ++ +I
Sbjct: 202 LYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 37/113 (32%), Positives = 57/113 (50%), Gaps = 5/113 (4%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKG--LHTEY 185
F L +I L HLH + +RD+KPENIL+ V + D G + +G HT +
Sbjct: 102 ACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-F 160
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
T Y +PE L+ G + +D W+ G + Y+ LT P F ++ +D+I
Sbjct: 161 CGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 137 VNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATRWYRSPE 195
+ GL +LHS+ + HRD+K NIL+ LV +GD GS + ++ T ++ +PE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPE 181
Query: 196 CLLT--EGYYSFELDIWAAGCVFYETLTRNP 224
+L EG Y ++D+W+ G E R P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 6e-08
Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 4/79 (5%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
MK + E NL+E+ LRK+ +H N++ L E V R ++ VF ME NL + ++
Sbjct: 32 MKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE--VFRENDELYFVFEYMEGNLYQLMK 89
Query: 61 TTDN--ISEKRAKEILYQV 77
SE + I+YQ+
Sbjct: 90 DRKGKPFSESVIRSIIYQI 108
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 6/114 (5%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGL-HTEY-IA 187
F ++V L +HS + HRD+KP+N+L+ + + + D G+ + G+ + +
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 188 TRWYRSPECLLTE---GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
T Y SPE L ++ GYY E D W+ G +E L + F DS + +I
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 41/133 (30%), Positives = 58/133 (43%), Gaps = 31/133 (23%)
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKS 178
LP R+Y VL L +LH+Y + HRD+KP+N+LI +G + F S
Sbjct: 98 LPVDMARMYFAETVL-----ALEYLHNYGIVHRDLKPDNLLITS----MGHIKLTDFGLS 148
Query: 179 K--------GLHTEYIA-------------TRWYRSPECLLTEGYYSFELDIWAAGCVFY 217
K L+ +I T Y +PE +L +GY +D WA G + Y
Sbjct: 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK-PVDWWAMGIILY 207
Query: 218 ETLTRNPLFPGDS 230
E L F GD+
Sbjct: 208 EFLVGCVPFFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 35/119 (29%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 121 QQSKR--LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFI 176
Q S R F +I+ GL LH + +RD+K +N+L+ D + + D G + +
Sbjct: 88 QSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147
Query: 177 KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
+G + + T Y +PE L + Y+ +D W+ G + YE L F G+ E D+L
Sbjct: 148 NGEGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 4/127 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTEYIAT 188
F ++ GL L ++ +RD+KPENIL+ RG + + DLG I + T
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGT 164
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
Y +PE + E Y+F D W GC+ YE + F E + + + + + + E
Sbjct: 165 VGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE 223
Query: 249 TLKKFEK 255
+KF +
Sbjct: 224 YSEKFSE 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 39/115 (33%), Positives = 62/115 (53%), Gaps = 14/115 (12%)
Query: 136 IVNGLHHL-HSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
++ GL +L +++ HRD+KP NIL+ RG++ + D G S Q I S + ++ TR Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLC-DFGVSGQLIDS--MANSFVGTRSY 168
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYE-TLTRNPLFPGDSEIDQLDRIHQVLGTP 245
SPE L +YS + DIW+ G E + R P+ P D++ + + G P
Sbjct: 169 MSPE-RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 34/121 (28%), Positives = 56/121 (46%), Gaps = 6/121 (4%)
Query: 122 QSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSK- 179
Q + + Q+ G+ +L HRD+ NIL+ DLV V D G + IK
Sbjct: 99 QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158
Query: 180 -GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDR 237
+ I +W +PE + G +S + D+W+ G + YE T + +PG + + D+
Sbjct: 159 YLSSDKKIPYKW-TAPEA-ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ 216
Query: 238 I 238
I
Sbjct: 217 I 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/140 (30%), Positives = 64/140 (45%), Gaps = 15/140 (10%)
Query: 109 GTLIVGLTTF---LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDL 164
G L+ L+ F LP+ R Y VL ++ +H L HRDIKP+N+L+ +
Sbjct: 86 GDLLTLLSKFEDRLPEDMARFYLAEMVL--AIDSVHQLG---YVHRDIKPDNVLLDKNGH 140
Query: 165 VVVGDLGSLQFIKSKGLHTEYIA--TRWYRSPECLLT----EGYYSFELDIWAAGCVFYE 218
+ + D GS + + G +A T Y SPE L +G Y E D W+ G YE
Sbjct: 141 IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200
Query: 219 TLTRNPLFPGDSEIDQLDRI 238
L F +S ++ +I
Sbjct: 201 MLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 36/193 (18%)
Query: 122 QSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKS 178
+ + ++L + + GL +LH KV HRDIK +NIL+ ++ +V D G S Q +
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV-DFGVSAQLDST 166
Query: 179 KGLHTEYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ 234
G +I T ++ +PE + + Y D+W+ G E P ++
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHP 223
Query: 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKY 294
+ + ++ P TLK E + S F F +SE L
Sbjct: 224 MRALFKIPRNP-PPTLKSPENW-SKKF-NDF----------------------ISECLIK 258
Query: 295 DPKRRPTAQKILS 307
+ ++RP +++L
Sbjct: 259 NYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 36/116 (31%), Positives = 63/116 (54%), Gaps = 14/116 (12%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTEYIATR--- 189
QI+ GL++LH+ + HRDIK NIL+ +G + + D G + +++ L T+ R
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKGG-IKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 190 ----WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
++ +PE ++ + Y+ + DIW+ GC+ E LT FP + QL I ++
Sbjct: 173 QGSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 35/195 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIAT 188
+L +I+ GL +LHS + HRDIK N+L+ +GD V + D G + Q ++ ++ T
Sbjct: 106 ILREILKGLDYLHSERKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
++ +PE ++ + Y F+ DIW+ G +T L G+ L + + PK
Sbjct: 165 PFWMAPE-VIKQSAYDFKADIWSLG------ITAIELAKGEPPNSDLHPMRVLFLIPK-N 216
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308
+ E S F K+ + L DP+ RPTA+++L
Sbjct: 217 SPPTLEGQYSKPF-----------------------KEFVEACLNKDPRFRPTAKELLKH 253
Query: 309 AYFADLTQLKQYLEQ 323
+ T+ +L +
Sbjct: 254 KFITRYTKKTSFLTE 268
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 115 LTTFLPQQSKRLYHTTFVL---YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDL 170
L FL + + L +L + G+ +L S K+ HRD+ NIL+ D V V D
Sbjct: 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDF 144
Query: 171 GSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNP 224
G L + S G+ + +W +PE L +S + D+W+ G + +E + R P
Sbjct: 145 G-LARVGSMGVDNSKLPVKW-TAPEA-LKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATR 189
V ++ L +LHS V HRDIK ++IL+ D V + D G Q K + T
Sbjct: 122 VCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 181
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
++ +PE +++ Y E+DIW+ G + E + P + DS + + R+ +P
Sbjct: 182 YWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPP-K 236
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
LK K VL + + ML +P+ R TAQ++L
Sbjct: 237 LKNAHKISP----------------VL--------RDFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG---SLQFIKSKGLHTEYI---- 186
QI++G+ +LH+ V HRDIK N+++ + ++ + D G L ++ G H+ +
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
T ++ +PE ++ E Y + DIW+ GC +E T P
Sbjct: 170 GTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 137 VNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATRWYRSPE 195
+ GL +LHS+ + HRDIK NIL+ V + D GS ++ T ++ +PE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---NSFVGTPYWMAPE 187
Query: 196 CLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKF 253
+L EG Y ++D+W+ G E R P + + L I Q + TL
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTL--- 240
Query: 254 EKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+S+ +T F+ + +D + +I ++ + +E+L++D RR ++L
Sbjct: 241 ---QSNEWTDSFRGF----VDYCLQKIPQE-RPASAELLRHDFVRRDRPARVL 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 3/110 (2%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL-QFIKSKGLHTEYIAT 188
F ++ L LH + V +RD+K +NIL+ + + D G + I + T + T
Sbjct: 100 FYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
Y +PE +L E Y +D WA G + YE + P F D+E D + I
Sbjct: 160 PDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIR--GDLVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
Q++ L +LHS K+ HRD+K N+L+ GD + + D G S + +K+ +I T ++
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGD-IKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 192 RSPECLLTEGY----YSFELDIWAAGCVFYETLTRNP 224
+PE ++ E Y ++ DIW+ G E P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 27/139 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHT-EYIA 187
+ +IV L HLH + +RDIK ENIL+ + VV+ D G S +F+ + +
Sbjct: 109 VYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 188 TRWYRSPECLLT-EGYYSFELDIWAAGCVFYETLT-----------------------RN 223
T Y +PE + G + +D W+ G + +E LT
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK 228
Query: 224 PLFPGDSEIDQLDRIHQVL 242
P FP + D I ++L
Sbjct: 229 PPFPKTMSAEARDFIQKLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 5e-07
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 137 VNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATRWYRSPE 195
+ GL +LHS+ + HRDIK NIL+ V + D GS ++ T ++ +PE
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPE 191
Query: 196 CLLT--EGYYSFELDIWAAGCVFYETLTRNP 224
+L EG Y ++D+W+ G E R P
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 3/110 (2%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIAT 188
F +I + L +LHS + +RD+KPENIL+ +V+ D G + I+ G + + T
Sbjct: 100 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
Y +PE L + Y +D W G V YE L P F + + D I
Sbjct: 160 PEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 6e-07
Identities = 36/124 (29%), Positives = 62/124 (50%), Gaps = 4/124 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATR 189
V + + L LHS +V HRDIK +NIL+ D V + D G Q + + + T
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
++ +PE ++T Y ++DIW+ G + E + P + ++ + L I GTP+ +
Sbjct: 181 YWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQN 238
Query: 250 LKKF 253
+K
Sbjct: 239 PEKL 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 16/118 (13%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +LP+ ++ + Y QI G+ +L S + HRD+ N+L+ + V +GD G
Sbjct: 95 LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 154
Query: 172 SLQFIKSKGLHTEYIATR--------WYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ I++ EY + WY +PECL+ +Y D+W+ G YE LT
Sbjct: 155 LTKAIET---DKEYYTVKDDLDSPVFWY-APECLIQSKFY-IASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 52/184 (28%), Positives = 79/184 (42%), Gaps = 48/184 (26%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFI--------KSKGLHTEY 185
+I +G+ +L + K HRD+ N ++ DL V +GD G + I KGL
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL---- 182
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPGDSEIDQLDRIHQVLG 243
+ RW +PE L +G ++ + D+W+ G V +E TL P + G S +VL
Sbjct: 183 LPVRWM-APES-LKDGVFTTKSDVWSFGVVLWEMATLAEQP-YQGLSN-------EEVL- 231
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
KF GG L +K +LM +Y+PK RPT
Sbjct: 232 --------KFVI--------------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFL 269
Query: 304 KILS 307
+I+S
Sbjct: 270 EIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 38/120 (31%), Positives = 55/120 (45%), Gaps = 9/120 (7%)
Query: 132 VLYQIVNGLHHL-HSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEYIAT 188
+ V L++L K+ HRD+KP NIL+ R + + D G S Q + S T
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-KTRDAGC 170
Query: 189 RWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPG-DSEIDQLDRIHQVLGTP 245
R Y +PE + Y D+W+ G YE T +P +S DQL ++ V G P
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV--VKGDP 228
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 34/134 (25%), Positives = 48/134 (35%), Gaps = 32/134 (23%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--------------------LVVV 167
F + ++V L +H HRDIKP+NILI D +
Sbjct: 102 TARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161
Query: 168 GDLGSLQFIKSKGLHTEY-----------IATRWYRSPECLLTEGYYSFELDIWAAGCVF 216
D +L F + + + T Y +PE L Y E D W+ G +
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVIL 220
Query: 217 YETLTRNPLFPGDS 230
YE L P F D+
Sbjct: 221 YEMLYGFPPFYSDT 234
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 10/122 (8%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKS----KGLHTEYI 186
+ QI G+ +L S+ HRD+ N L+ L V + D G + I S + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR--NPLFP-GDSEIDQLDRIHQVLG 243
RW PE +L G ++ E DIW+ G V +E + P + + E+ ++ R Q+L
Sbjct: 189 PVRWM-PPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 244 TP 245
P
Sbjct: 247 CP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 39/187 (20%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-----SLQFIKSKGLHTEY 185
V ++ L LH+ V HRDIK ++IL+ D V + D G S + + K L
Sbjct: 120 VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---- 175
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ T ++ +PE + Y + E+DIW+ G + E + P + + + + RI P
Sbjct: 176 VGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-NLPP 233
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
K + L K + + + + ML DP +R TA ++
Sbjct: 234 KLKNLHK---------------------------VSPRLRSFLDRMLVRDPAQRATAAEL 266
Query: 306 LSCAYFA 312
L+ + A
Sbjct: 267 LNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 47/159 (29%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLY---HT 129
+L VK HY KL F+L + G F Q +R +
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVL----------DFVNGGELFFHLQRERSFPEPRA 98
Query: 130 TFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLG-SLQFIKSKGLHTEYIA 187
F +I + L +LHS + +RD+KPENIL+ VV+ D G + I T +
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226
T Y +PE + + Y + +D W G V YE L P F
Sbjct: 159 TPEYLAPEVIRKQPYDN-TVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 9e-07
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 39/202 (19%)
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHT 183
+ +L +I+ GL +LHS K HRDIK N+L+ +GD V + D G + Q ++
Sbjct: 101 FQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRN 159
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243
++ T ++ +PE + Y S + DIW+ G +T L G+ + + +
Sbjct: 160 TFVGTPFWMAPEVIQQSAYDS-KADIWSLG------ITAIELAKGEPPNSDMHPMRVLFL 212
Query: 244 TPK--AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
PK TL + F+ FK++ + L DP RPT
Sbjct: 213 IPKNNPPTL-------TGEFSKPFKEF-------------------IDACLNKDPSFRPT 246
Query: 302 AQKILSCAYFADLTQLKQYLEQ 323
A+++L + + YL +
Sbjct: 247 AKELLKHKFIVKNAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 7/138 (5%)
Query: 118 FLPQQSKRLY---HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-S 172
F Q +R + F ++ + + +LHS + +RD+KPENIL+ VV+ D G
Sbjct: 84 FFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC 143
Query: 173 LQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232
+ ++ + + + T Y +PE L E Y +D W G V YE L P F
Sbjct: 144 KEGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVS 202
Query: 233 DQLDRI-HQVLGTPKAET 249
D I H+ L P +T
Sbjct: 203 QMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 7/101 (6%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEYIATR 189
V QI++G+ +LH + HRDIKP N+LI V + D G S ++ + T
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232
Query: 190 WYRSPECL---LTEGYYS-FELDIWAAGCVFYE-TLTRNPL 225
Y SPE + L G Y + DIW+ G E L R P
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 3/112 (2%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTE-YI 186
F +V GL +LH K+ +RD+K +N+L+ + V + D G + G T +
Sbjct: 103 AVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
T + +PE +LTE Y+ +D W G + YE L FPGD E + D I
Sbjct: 163 GTPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 3/98 (3%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIAT 188
F +I + L +LHS + +RD+KPENIL+ VV+ D G + I+ + + T
Sbjct: 100 FYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226
Y +PE L + Y +D W G V YE L P F
Sbjct: 160 PEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKS----KGLHTEYIATR 189
Q+ G+ +L K HRD+ N L+ ++VV + D G + I S K + I R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYE 218
W PE + Y+ E D+WA G V +E
Sbjct: 198 WM-PPESIFY-NRYTTESDVWAYGVVLWE 224
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 77/374 (20%), Positives = 138/374 (36%), Gaps = 90/374 (24%)
Query: 135 QIVNGLHHLHSYK-------VFHRDIKPENILIRGD------------------LVVVGD 169
Q+++ L + H+ K V HRD+KP+NI + + +GD
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPG 228
G + I + + + T +Y SPE LL E Y + D+WA GC+ YE + F
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF-- 243
Query: 229 DSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK-- 286
+K++NF+ + G P + KGK
Sbjct: 244 ---------------------------HKANNFSQLISELKRG------PDLPIKGKSKE 270
Query: 287 ---LMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKT 343
L+ +L K RP+A L C + + + + +A G +
Sbjct: 271 LNILIKNLLNLSAKERPSA---LQCLGYQIIKNVGPPVGAAGGGAGVAA---APGAVVAR 324
Query: 344 SHPT------HLLANTKSSHQMDMSKFIQSDLNTHQTKKTKSDFFSQARTSKYRFDQSSS 397
+P+ L A K+ H + I + +Q + + S + S+ + ++
Sbjct: 325 RNPSKEHPGLQLAAMEKAKHAEAANYGISPNTLINQRNEEQHGRRSSSCASRQSANNVTN 384
Query: 398 I-----------VLHPKNPPNKSKHRFDQSSSTVLHSKNPPNRSKLDRKIFLREKIADEE 446
I V + P+K ++ Q +T H+ N ++D+ R +I E
Sbjct: 385 ITSITSVTSVASVASVASVPSKDDRKYPQDGATHCHAVNGHYGGRVDKDHAERARIEKEN 444
Query: 447 SRRK-IHNEFLERK 459
+ RK + + LE+K
Sbjct: 445 AHRKALEMKILEKK 458
|
Length = 1021 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHT-EYIATRWY 191
+I+ L HLH + +RDIK ENIL+ + VV+ D G S +F+ + T + T Y
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+PE + +G + +D W+ G + +E LT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 39/178 (21%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATRWYR 192
+ G+ +L HRD+ N+L+ DLV V D G L S+G + + +W
Sbjct: 109 LDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFG-LAKEASQGQDSGKLPVKW-T 166
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
+PE L E +S + D+W+ G + +E + R P +P RI P + +
Sbjct: 167 APEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP-YP---------RI------PLKDVV 209
Query: 251 KKFEK-YKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
EK Y+ + P G P+++ K+M + + DP +RPT +++
Sbjct: 210 PHVEKGYR--------MEAPEG----CPPEVY----KVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 130 TFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYI 186
+++LY + GL HLH+ ++ HRD+K NIL+ G + +V D G S Q ++ +
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV-DFGVSAQLTSTRLRRNTSV 189
Query: 187 ATRWYRSPECLLTEGYYSFEL----DIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
T ++ +PE + E Y + D+W+ G +T L GD + + + +
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLG------ITAIELGDGDPPLFDMHPVKTLF 243
Query: 243 GTPK--AETLKKFEKY 256
P+ TL EK+
Sbjct: 244 KIPRNPPPTLLHPEKW 259
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL-QFIKSKGLHT 183
L TF +I+ GL LHS + +RD+K +NIL+ D + + D G + +
Sbjct: 95 LPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE 231
+ T Y +PE LL + Y+ +D W+ G + YE L F G E
Sbjct: 155 TFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 21/118 (17%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGD--------------LVVVGDLGS 172
T ++ Q+++ L H+ + HRD+KP+NI++ G L V D
Sbjct: 81 TGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 173 LQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
++ TE + T Y +PE L E D++A G +F E LT + G S
Sbjct: 141 ATLTRT----TEVLGTPTYCAPEQLRGEPVTP-NSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 38/121 (31%), Positives = 61/121 (50%), Gaps = 10/121 (8%)
Query: 123 SKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKG 180
S R ++T + Y +IV L +LHS ++ +RD+KPENIL+ + G + F +K
Sbjct: 95 SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE----GHIKLTDFGFAKK 150
Query: 181 LHTE---YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
L T Y +PE + ++G+ +D WA G + YE L P F D+ ++
Sbjct: 151 LRDRTWTLCGTPEYLAPEVIQSKGHNK-AVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209
Query: 238 I 238
I
Sbjct: 210 I 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 12/123 (9%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL-VVVGDLGSLQFIKS----KGLHTEYI 186
++ QI G+ L S+ V H+D+ N+L+ L V + DLG + + + K + +
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFP----GDSEIDQLDRIHQVL 242
RW SPE + G +S + DIW+ G V +E + L P + ++ ++ R QVL
Sbjct: 189 PIRWM-SPEA-IMYGKFSIDSDIWSYGVVLWEVFSYG-LQPYCGYSNQDVIEMIRNRQVL 245
Query: 243 GTP 245
P
Sbjct: 246 PCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 39/116 (33%), Positives = 53/116 (45%), Gaps = 9/116 (7%)
Query: 136 IVNGLHHLHS-YKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWYR 192
IV L +LHS V HRD+KP N+LI R V + D G S + S T + Y
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-KTIDAGCKPYM 170
Query: 193 SPECLLTEG---YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+PE + E Y + D+W+ G E T FP DS ++ QV+ P
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEP 224
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 33/123 (26%), Positives = 59/123 (47%), Gaps = 4/123 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATR 189
V ++ L +LH+ V HRDIK ++IL+ D + + D G Q K + T
Sbjct: 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTP 182
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
++ +PE +++ Y E+DIW+ G + E + P + + + + RI L P+ +
Sbjct: 183 YWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKD 240
Query: 250 LKK 252
K
Sbjct: 241 SHK 243
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 18/65 (27%), Positives = 35/65 (53%), Gaps = 4/65 (6%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKE 72
L+EI IL+K+ H N++ L + + + ++ LV E +L + ++ +SE A+
Sbjct: 45 LREIKILKKL-KHPNIVRLYDVFEDED--KLYLVMEYCEGGDLFDLLKKRGRLSEDEARF 101
Query: 73 ILYQV 77
L Q+
Sbjct: 102 YLRQI 106
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 2/107 (1%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATR 189
F +I+ GL H+H+ V +RD+KP NIL+ V + DLG K H + T
Sbjct: 101 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTH 159
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236
Y +PE L Y D ++ GC+ ++ L + F D+ +
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 31/183 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATR 189
V ++ L LH+ V HRDIK ++IL+ D V + D G Q K + T
Sbjct: 121 VCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
++ +PE L++ Y E+DIW+ G + E + P + + + + I L PK +
Sbjct: 181 YWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKN 238
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
L K + P + K + +L DP +R TA ++L
Sbjct: 239 LHK-----------------------VSPSL----KGFLDRLLVRDPAQRATAAELLKHP 271
Query: 310 YFA 312
+ A
Sbjct: 272 FLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 4/124 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATR 189
V + + L LHS +V HRDIK +NIL+ D V + D G Q + + + T
Sbjct: 120 VCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
++ +PE ++T Y ++DIW+ G + E + P + ++ + L I GTP+ +
Sbjct: 180 YWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQN 237
Query: 250 LKKF 253
++
Sbjct: 238 PERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 54/198 (27%), Positives = 79/198 (39%), Gaps = 47/198 (23%)
Query: 126 LYHTT---------FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQ 174
+YH T +V + + GL++LHS HRDIK NIL+ + V + D G S Q
Sbjct: 96 IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQ 155
Query: 175 FIKSKGLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNP----LFPG 228
+ +I T ++ +PE E G Y+ DIWA G E P L P
Sbjct: 156 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215
Query: 229 DSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLM 288
R ++ + K +K K SN + F +
Sbjct: 216 --------RALFLMTKSNFQPPKLKDKMKWSNSFHHF----------------------V 245
Query: 289 SEMLKYDPKRRPTAQKIL 306
L +PK+RPTA+K+L
Sbjct: 246 KMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 46/198 (23%)
Query: 136 IVNGLHHLHS-YKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
+V GL +L++ +++ HRDIKP NIL+ RG + + D G S + I S + ++ T Y
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLC-DFGVSGELINS--IADTFVGTSTY 168
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFP-GDSEIDQ---------LDRIHQV 241
SPE + Y+ + D+W+ G E FP S ID LD + Q+
Sbjct: 169 MSPERIQGGK-YTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQI 225
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
+ P + SS+F P+ + L DP RPT
Sbjct: 226 VQEPPP-------RLPSSDF----------------PEDLR---DFVDACLLKDPTERPT 259
Query: 302 AQKILSCAYFADLTQLKQ 319
Q++ + F +
Sbjct: 260 PQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 47/152 (30%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLY--QIVNGLHHL 143
HY D KL +L N G L L+ Q +R +Y +IV L HL
Sbjct: 71 HYAFQTDTKLHLIL----DYINGGELFTHLS-----QRERFKEQEVQIYSGEIVLALEHL 121
Query: 144 HSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHT-EYIATRWYRSPECLL-T 199
H + +RDIK ENIL+ + VV+ D G S +F + + + T Y +P+ +
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 200 EGYYSFELDIWAAGCVFYETLTRNPLFPGDSE 231
+G + +D W+ G + YE LT F D E
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYI 186
T F +IV+ L +LHS K+ +RD+K EN+++ D + + D G + I +
Sbjct: 97 TRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSE 231
T Y +PE +L + Y +D W G V YE + R P + D E
Sbjct: 157 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIK------SKGLHTEYI 186
YQ+ G+ L S HRD+ N+L+ G +V + D G + I KG +
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG--NARL 205
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
+W +PE + Y+FE D+W+ G + +E +L NP +PG
Sbjct: 206 PVKWM-APESIF-NCVYTFESDVWSYGILLWEIFSLGSNP-YPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 2/91 (2%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATR 189
F +I+ GL H+H+ V +RD+KP NIL+ V + DLG K H + T
Sbjct: 101 FYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTH 159
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETL 220
Y +PE L Y D ++ GC+ ++ L
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 4/110 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTE-Y 185
H F +I GL LHS + +RD+K +N+++ + + + D G + G+ T+ +
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
T Y +PE + + Y +D WA G + YE L F G+ E D+L
Sbjct: 162 CGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQAPFEGEDE-DEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENIL--IRGDLVVVGDLG-SLQFIKSKGLHTEYIAT 188
V Q + L++LH K+ HRD+K NIL + GD + + D G S + ++ +I T
Sbjct: 108 VCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGT 166
Query: 189 RWYRSPECLLTEGY----YSFELDIWAAGCVFYETLTRNP 224
++ +PE ++ E Y ++ D+W+ G E P
Sbjct: 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 15/139 (10%)
Query: 120 PQQSKR---LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQF 175
P+Q+K L + QI +G+ +L S HRD+ N L+ +L+V +GD G +
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 172
Query: 176 IKSK-----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFP- 227
+ S G HT + RW PE ++ ++ E D+W+ G + +E T + P F
Sbjct: 173 VYSTDYYRVGGHT-MLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQL 229
Query: 228 GDSEIDQLDRIHQVLGTPK 246
++E+ + +VL P+
Sbjct: 230 SNTEVIECITQGRVLERPR 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 4/100 (4%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATRWYR 192
+IV+ L +LHS V +RDIK EN+++ D + + D G + I + T Y
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSE 231
+PE +L + Y +D W G V YE + R P + D E
Sbjct: 163 APE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 33/122 (27%), Positives = 55/122 (45%), Gaps = 12/122 (9%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEYIAT 188
++L++ + GL HLH K HRD+K NIL+ V + D G S Q ++ + T
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT 187
Query: 189 RWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
++ +PE + E Y D+W+ G +T L GD + L + +
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLG------ITAIELGDGDPPLADLHPMRALFKI 241
Query: 245 PK 246
P+
Sbjct: 242 PR 243
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 6/112 (5%)
Query: 118 FLPQQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL- 173
F Q+ ++L H F +I L+ LH + +RD+K +N+L+ + + + D G
Sbjct: 85 FHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNP 224
+ I+ + + T Y +PE L E Y F +D WA G + +E + R+P
Sbjct: 145 EGIRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 51/203 (25%), Positives = 80/203 (39%), Gaps = 55/203 (27%)
Query: 126 LYHTT---------FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SL 173
+YH T +V + + GL +LHS HRDIK NIL+ GD V + D G +
Sbjct: 96 IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD-VKLADFGVAA 154
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLT-RNPLFPGDS 230
+ + +I T ++ +PE E G Y+ DIWA G E + P+F
Sbjct: 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF---- 210
Query: 231 EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGK----- 285
++ SNF P++ +K K
Sbjct: 211 ---------------DLHPMRALFLMSKSNFQ--------------PPKLKDKTKWSSTF 241
Query: 286 -KLMSEMLKYDPKRRPTAQKILS 307
+ L +PK+RPTA+++L+
Sbjct: 242 HNFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 3e-05
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 13/100 (13%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR-------GDLVVVGDLGSLQFIKSKGLHTE 184
+L +I+ GL +LHS K HRDIK N+L+ D V G L Q ++
Sbjct: 106 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-----T 160
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
++ T ++ +PE ++ + Y + DIW+ G E P
Sbjct: 161 FVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 26/137 (18%), Positives = 58/137 (42%), Gaps = 17/137 (12%)
Query: 115 LTTFLPQQSKRLYHTTF--VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L ++ +L + + + +L S HRD+ N L+ D VV V D G
Sbjct: 86 LLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFG 145
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
+++ L +Y ++ +W +P + +S + D+W+ G + +E +
Sbjct: 146 LARYV----LDDQYTSSQGTKFPVKW--APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
Query: 225 L-FPGDSEIDQLDRIHQ 240
+ + S + ++ +
Sbjct: 200 MPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 15/105 (14%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTE 184
L + QI +G+ +L S HRD+ N L+ LVV +GD G + I S T+
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TD 176
Query: 185 Y--------IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
Y + RW PE +L + + E DIW+ G V +E T
Sbjct: 177 YYRVGGRTMLPIRWM-PPESILYRKFTT-ESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 4e-05
Identities = 19/64 (29%), Positives = 37/64 (57%), Gaps = 4/64 (6%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKE 72
L+EIS+L+++ H N++ L + R++ LVF +++L++Y+ +S K
Sbjct: 46 LREISLLKEL-KHPNIVKLLDVIHTE--RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKS 102
Query: 73 ILYQ 76
I+YQ
Sbjct: 103 IMYQ 106
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 30/116 (25%), Positives = 54/116 (46%), Gaps = 8/116 (6%)
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIK 177
LP++ YQ+ G+ +L S K HRD+ N+L+ D V+ + D G + +
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 178 S----KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPG 228
+ K + +W +PE L + Y+ + D+W+ G + +E T +PG
Sbjct: 186 NIDYYKKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATR 189
V + + L LHS +V HRDIK +NIL+ D V + D G Q + + + T
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYET-------LTRNPL 225
++ +PE ++T Y ++DIW+ G + E L NPL
Sbjct: 180 YWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 13/101 (12%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG------SLQFIKSKGLHTEYIA 187
QI +G+ +L S HRD+ N L+ DLVV +GD G + + + G +
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG--HTMLP 187
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLF 226
RW PE ++ ++ E D+W+ G V +E T + P +
Sbjct: 188 IRWM-PPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 36/121 (29%), Positives = 55/121 (45%), Gaps = 11/121 (9%)
Query: 120 PQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKS 178
P + YH VL +LHS + +RD+KPEN+L+ V V D G F K
Sbjct: 116 PNDVAKFYHAELVL-----AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFG---FAKK 167
Query: 179 KGLHTEYI-ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
T + T Y +PE + ++G + +D W G + YE + P F D+ ++
Sbjct: 168 VPDRTFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK 226
Query: 238 I 238
I
Sbjct: 227 I 227
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 35/119 (29%), Positives = 57/119 (47%), Gaps = 6/119 (5%)
Query: 121 QQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIK 177
QQ + V Y +I GL LH + +RD+K +N+++ + + + D G +
Sbjct: 93 QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152
Query: 178 SKGLHTE-YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
G+ T + T Y +PE + + Y +D WA G + YE L P F G+ E D+L
Sbjct: 153 VDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDE-DEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 39/126 (30%), Positives = 58/126 (46%), Gaps = 15/126 (11%)
Query: 131 FVLYQIVNGLHHL-HSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIA 187
+ Y +V GL L + + HRD+KP N+L+ G+ V + D G S + S L I
Sbjct: 106 RITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIG 163
Query: 188 TRWYRSPECLLTEG-----YYSFELDIWAAGCVFYE-TLTRNPLFP--GDSEIDQLDRIH 239
+ Y +PE + + G Y+ + D+W+ G E L R P P + QL I
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI- 222
Query: 240 QVLGTP 245
V G P
Sbjct: 223 -VDGDP 227
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIATRWYR- 192
QI NG+ +L S + HRD+ NIL+ D V +GD G +++ + ++ +
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFG---LMRALPQNEDHYVMEEHLK 161
Query: 193 ------SPECLLTEGYYSFELDIWAAGCVFYETLT 221
+PE L T +S D+W G +E T
Sbjct: 162 VPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 34/124 (27%), Positives = 62/124 (50%), Gaps = 4/124 (3%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATR 189
V + + L LH+ +V HRDIK +N+L+ D V + D G Q + + + T
Sbjct: 120 VCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
++ +PE ++T Y ++DIW+ G + E + P + ++ + L I GTP+ +
Sbjct: 180 YWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQN 237
Query: 250 LKKF 253
+K
Sbjct: 238 PEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 46/204 (22%), Positives = 77/204 (37%), Gaps = 51/204 (25%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLG 171
L ++L L + +LY Q+ L +L S + HRDI N+L+ D V +GD G
Sbjct: 93 LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG 152
Query: 172 SLQFIKSKGLHTEYIATR------WYRSPECLLTEGYYSFEL--DIWAAGCVFYETLTR- 222
++++ + Y A++ W +PE + + F D+W G +E L
Sbjct: 153 LSRYLED---ESYYKASKGKLPIKWM-APESI---NFRRFTSASDVWMFGVCMWEILMLG 205
Query: 223 -NPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIH 281
P F G D + RI E L + ++
Sbjct: 206 VKP-FQGVKNNDVIGRIEN------GERLPMPPNCPPTLYS------------------- 239
Query: 282 EKGKKLMSEMLKYDPKRRPTAQKI 305
LM++ YDP +RP ++
Sbjct: 240 -----LMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTE-YI 186
F +IV+ L +LHS V +RD+K EN+++ D + + D G + S G + +
Sbjct: 97 ARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSE 231
T Y +PE +L + Y +D W G V YE + R P + D E
Sbjct: 157 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 27/111 (24%), Positives = 49/111 (44%), Gaps = 13/111 (11%)
Query: 136 IVNGLHHLHSYKVFHRDIKPENILI------RGDLVVVGDLGSLQFIKSKGLHTE----Y 185
+ G +L HRD+ N L+ +V +GD G + I + +
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQL 235
+ RW +PE LL +G ++ + D+W+ G + +E LT +P + + L
Sbjct: 175 LPVRWM-APESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 35/123 (28%), Positives = 57/123 (46%), Gaps = 4/123 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTE-Y 185
H F +I GL LHS + +RD+K +N+++ + + + D G + G T +
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF 161
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI-HQVLGT 244
T Y +PE + + Y +D WA G + YE L P F G+ E + I +
Sbjct: 162 CGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY 220
Query: 245 PKA 247
PK+
Sbjct: 221 PKS 223
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 35/125 (28%), Positives = 59/125 (47%), Gaps = 5/125 (4%)
Query: 118 FLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL- 173
F Q+S+R Y +I + L LH + +RD+K +N+L+ + + D G
Sbjct: 85 FHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
+ I + + + T Y +PE +L E Y +D WA G + YE L + F ++E D
Sbjct: 145 EGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
Query: 234 QLDRI 238
+ I
Sbjct: 204 LFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 31/124 (25%), Positives = 58/124 (46%), Gaps = 15/124 (12%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA------ 187
QI G+ ++ HRD++ N+L+ L+ + D G + I+ EY A
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED----NEYTAREGAKF 166
Query: 188 -TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQVLGTP 245
+W +PE + G ++ + D+W+ G + YE +T + +PG S D + + + P
Sbjct: 167 PIKW-TAPEA-INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
Query: 246 KAET 249
+ E
Sbjct: 225 RMEN 228
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEY------- 185
YQ+ G+ +L S K HRD+ N+L+ D V+ + D G + I H +Y
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDYYKKTTNG 202
Query: 186 -IATRWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
+ +W +PE L + Y+ + D+W+ G + +E TL +P +PG
Sbjct: 203 RLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIK------SKGLHTEYI 186
YQ+ NG+ L S HRD+ N+LI G LV + D G + I SKG + ++
Sbjct: 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFL 303
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+W +PE + Y + D+W+ G + +E T
Sbjct: 304 PLKWM-APESIFNNLYTTLS-DVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 18/45 (40%), Positives = 27/45 (60%)
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163
+PQ + + V+ Q++ GL LH + HRDIKPEN+L+ D
Sbjct: 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD 345
|
Length = 507 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 10/120 (8%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDL-VVVGDLGSLQFIKSKGLH----TEYIATR 189
QI G+ +L S+ H+D+ NILI L V + DLG + I S + + R
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFP-GDSEIDQLDRIHQVLGTPK 246
W PE ++ G +S + DIW+ G V +E + P + + E+ ++ R Q+L +
Sbjct: 192 WM-PPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSE 249
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 20/116 (17%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA------ 187
QI G+ +L S HRD+ NIL+ +LV + D G + I+ EY A
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD----EYTAREGAKF 166
Query: 188 -TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSE---IDQLDR 237
+W +PE G ++ + D+W+ G + E +T R P +PG + ++Q++R
Sbjct: 167 PIKW-TAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVP-YPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 10/115 (8%)
Query: 134 YQIVNGLHHL-HSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATR 189
IV LH+L + V HRD+KP NIL+ G+ V + D G S + + SK T
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGN-VKLCDFGISGRLVDSKA-KTRSAGCA 178
Query: 190 WYRSPECLLTE---GYYSFELDIWAAGCVFYETLTRNPLFPG-DSEIDQLDRIHQ 240
Y +PE + Y D+W+ G E T + +E + L +I Q
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 51/189 (26%), Positives = 79/189 (41%), Gaps = 42/189 (22%)
Query: 135 QIVNGLHHLHSYK-VFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
+IV+ L +LHS K V +RD+K EN+++ D + + D G + IK + T Y
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
+PE +L + Y +D W G V YE + R P + D E
Sbjct: 163 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------------------- 202
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR-----PTAQKI 305
K FE + P + K L+S +LK DPK+R A++I
Sbjct: 203 KLFELILMEEIRFPRTLSP-------------EAKSLLSGLLKKDPKQRLGGGPDDAKEI 249
Query: 306 LSCAYFADL 314
+ +FA +
Sbjct: 250 MQHKFFAGI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 32/115 (27%), Positives = 57/115 (49%), Gaps = 15/115 (13%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA------ 187
QI +G+ ++ HRD++ NIL+ +LV V D G + I+ EY A
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKF 165
Query: 188 -TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQ 240
+W +PE L G ++ + D+W+ G + E T+ + +PG + LD++ +
Sbjct: 166 PIKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 24/115 (20%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR--GDLVVVG------------DLGSLQFIK 177
+ ++I + ++HS V HRD+KP+NIL+ G++V++ DL + +
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 178 SKGLHTEY------IATRWYRSPECLL-TEGYYSFELDIWAAGCVFYETLT-RNP 224
++ + T Y +PE LL S DI+A G + Y+ LT P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPA--SESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 7/113 (6%)
Query: 117 TFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL 173
TFL +++KR + Y QIV +L S + +RD+KPEN+L+ D + + D G
Sbjct: 120 TFL-RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226
+ + ++ T Y +PE LL G+ D W G YE L P F
Sbjct: 179 KVVDTRTY--TLCGTPEYIAPEILLNVGHGK-AADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 47/183 (25%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA------ 187
QI +G+ ++ HRD++ NIL+ +LV + D G + I+ EY A
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED----NEYTARQGAKF 165
Query: 188 -TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQVLGTP 245
+W +PE L G ++ + D+W+ G + E +T+ + +PG ++R
Sbjct: 166 PIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPG-----MVNR-------- 210
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQK 304
E L++ E+ G + PQ E +LM K DP RPT +
Sbjct: 211 --EVLEQVER----------------GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEY 252
Query: 305 ILS 307
I S
Sbjct: 253 IQS 255
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 14/112 (12%)
Query: 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEK 68
L+EI +L+++ +H N++ L + V R + LVF M+ +L + I+ + E
Sbjct: 42 PKTALREIKLLKEL-NHPNIIKLLD--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPES 98
Query: 69 RAKEILYQV-KAANETAAHYRVGWDLKLPFLLLV---------FGKSRNLGT 110
K LYQ+ + +H + DLK LL+ FG +R+ G+
Sbjct: 99 LIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGS 150
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 42/177 (23%), Positives = 73/177 (41%), Gaps = 47/177 (26%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYIAT----- 188
Q+ +G+ +L + HRD+ N+L+ ++ V D G + IK Y A
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKF 166
Query: 189 --RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQVLGT 244
+W +PE L +S + D+W+ G + E +T R P +P G
Sbjct: 167 PIKW-TAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMP-YP---------------GM 208
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
AE L++ ++ Y+ PG ++++ +M + K DP RPT
Sbjct: 209 TNAEVLQQVDQ------GYRMPCPPG-----CPKELYD----IMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 24/94 (25%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRG-DLVVVGDLGSLQFIKSKGLHTEYIAT----- 188
QI G+ +L ++ HRD+ N+L++ V + D G + + EY A
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD--EKEYHAEGGKVP 174
Query: 189 -RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+W + E +L Y+ + D+W+ G +E +T
Sbjct: 175 IKWM-ALESIL-HRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 10/102 (9%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKS----KGLHTEYIAT 188
YQ+ G+ +L S K HRD+ N+L+ +++ + D G + + + K +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
+W +PE L + Y+ + D+W+ G + +E TL +P +PG
Sbjct: 204 KWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 50/184 (27%), Positives = 78/184 (42%), Gaps = 50/184 (27%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKS--------KGLHTEY 185
+I +G+ +L++ K HRD+ N ++ D V +GD G + I KGL
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL---- 182
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPGDSEIDQLDRIHQVLG 243
+ RW +PE L +G ++ D+W+ G V +E +L P + G S QVL
Sbjct: 183 LPVRWM-APESL-KDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-------EQVL- 231
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTA 302
KF GG +D P E+ LM +++PK RPT
Sbjct: 232 --------KF-------------VMDGGYLD--QPDNCPERVTDLMRMCWQFNPKMRPTF 268
Query: 303 QKIL 306
+I+
Sbjct: 269 LEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 14/104 (13%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKS------KGLHTEYI 186
YQ+ G+ L S HRD+ NIL+ G + + D G + I++ KG +
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG--NARL 278
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
+W +PE + Y+FE D+W+ G + +E +L +P +PG
Sbjct: 279 PVKWM-APESIF-NCVYTFESDVWSYGILLWEIFSLGSSP-YPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 20/107 (18%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH-TEY------ 185
YQ+ G+ +L S + HRD+ N+L+ D V+ + D G ++G+H +Y
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL-----ARGVHDIDYYKKTSN 195
Query: 186 --IATRWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
+ +W +PE L + Y+ + D+W+ G + +E TL +P +PG
Sbjct: 196 GRLPVKWM-APEALF-DRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 30/110 (27%), Positives = 54/110 (49%), Gaps = 9/110 (8%)
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL-QFI 176
LP++ R Y L L++LH + +RD+K +N+L+ + + + D G + +
Sbjct: 93 LPEEHARFYSAEISL-----ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147
Query: 177 KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPL 225
+ + + T Y +PE L E Y F +D WA G + +E + R+P
Sbjct: 148 RPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 66/263 (25%), Positives = 105/263 (39%), Gaps = 55/263 (20%)
Query: 96 PFLLLVFGKSRNLGTLIVGLTTFLPQ-QSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIK 154
PF+ +G + +L L T+ P+ S+ L +L+ + GL++LH HR+IK
Sbjct: 79 PFM--AYGSANSL------LKTYFPEGMSEALIGN--ILFGALRGLNYLHQNGYIHRNIK 128
Query: 155 PENILIRGD-LVVVGDLGSLQFIKSKGLHTEYI--------ATRWYRSPECLLTEGY-YS 204
+ILI GD LV + L L + G + + + + SPE L + Y Y+
Sbjct: 129 ASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYN 188
Query: 205 FELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET-----LKKFEKYKSS 259
+ DI++ G +T L G + R +L K + F +S
Sbjct: 189 VKSDIYSVG------ITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242
Query: 260 NFTYQFKQYPGGGIDVLVP---------QIHEKGKKLMSE--------MLKYDPKRRPTA 302
Q G G V+ ++ K S L+ DP++RP+A
Sbjct: 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA 302
Query: 303 QKILSCAYFADLTQLKQYLEQKQ 325
+LS A+F KQ EQ Q
Sbjct: 303 SSLLSHAFF------KQVKEQTQ 319
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 11/129 (8%)
Query: 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL-QFI 176
LP++ R Y +I L+ LH + +RD+K +N+L+ D + + D G + +
Sbjct: 93 LPEEHARFYAA-----EICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147
Query: 177 KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNP--LFPGDSEID 233
+ + T Y +PE L E Y F +D WA G + +E + R+P + + +++
Sbjct: 148 GPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
Query: 234 QLDRIHQVL 242
D + QV+
Sbjct: 207 TEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 13/115 (11%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTEY------ 185
+ QI G+ HL + + HRD+ N L+ V + L K ++EY
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV--KVSLLSLSKDV-YNSEYYKLRNA 178
Query: 186 -IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRI 238
I RW +PE + E +S + D+W+ G + +E T+ L F G S+ + L+R+
Sbjct: 179 LIPLRWL-APEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 86 HYRVGWDLKLPFLLLVFGKSRNLGTLI----VGLTTF-LPQQSKRLYHTTFVLYQIVNGL 140
R L +P ++L F K +L T + +G F LP Q+ + + I +G+
Sbjct: 72 RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-----MIDIASGM 126
Query: 141 HHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATR----WYRSPE 195
+L S HRD+ N ++ ++ V V D G + I S + + A++ W
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 196 CLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPG--DSEI 232
L + Y+ D+WA G +E +TR + G +SEI
Sbjct: 187 --LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 13/106 (12%)
Query: 122 QSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSK- 179
QS+ L+ + QI G+ +L S HRD+ N L+ +L+V +GD G + + S
Sbjct: 119 QSQMLH----IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174
Query: 180 ----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
G HT + RW PE ++ + + E D+W+ G V +E T
Sbjct: 175 YYRVGGHT-MLPIRWM-PPESIMYRKFTT-ESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 33/117 (28%), Positives = 51/117 (43%), Gaps = 12/117 (10%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +FL Q + V L I G+ +L HRD+ NIL+ +LV V D G
Sbjct: 92 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 172 SLQFIKSKGLHTEY-------IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+F++ Y I RW +PE + + S D+W+ G V +E ++
Sbjct: 152 LSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEAIAYRKFTSAS-DVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 30/117 (25%), Positives = 52/117 (44%), Gaps = 16/117 (13%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L + KR + + + G+ +L S + HRD+ N L+ V V D G
Sbjct: 86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG 145
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+++ L EY ++ RW SP +L +S + D+WA G + +E +
Sbjct: 146 LSRYV----LDDEYTSSVGSKFPVRW--SPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 35/144 (24%), Positives = 50/144 (34%), Gaps = 45/144 (31%)
Query: 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG--------------- 171
T F + + + + +H HRDIKP+N+L+ +G + + D G
Sbjct: 103 TRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYR 161
Query: 172 ---------SLQFIKSKGLHTEYIATRW----------------YRSPECLLTEGYYSFE 206
L FI T W Y +PE L GY E
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAET-WKRNRRALAYSTVGTPDYIAPEVFLQTGYNK-E 219
Query: 207 LDIWAAGCVFYETLTRNPLFPGDS 230
D W+ G + YE L P F D+
Sbjct: 220 CDWWSLGVIMYEMLVGYPPFCSDN 243
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 45/182 (24%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA------ 187
Q+ G+ ++ HRD++ NIL+ LV + D G + I+ EY A
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED----NEYTARQGAKF 165
Query: 188 -TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQVLGTP 245
+W +PE L G ++ + D+W+ G + E +T+ + +PG + + L+++ + P
Sbjct: 166 PIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
P +HE LM + K DP+ RPT + +
Sbjct: 224 ----------------------CPQD----CPISLHE----LMLQCWKKDPEERPTFEYL 253
Query: 306 LS 307
S
Sbjct: 254 QS 255
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 33/125 (26%), Positives = 57/125 (45%), Gaps = 17/125 (13%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA------ 187
QI G+ + HRD++ NIL+ LV + D G + I+ EY A
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKF 165
Query: 188 -TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQVLGT 244
+W +PE + G ++ + D+W+ G + E +T R P +PG S + + + +
Sbjct: 166 PIKW-TAPEA-INFGSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALERGYRM 222
Query: 245 PKAET 249
P+ E
Sbjct: 223 PRPEN 227
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 31/236 (13%)
Query: 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTT-DNISEKRA 70
A + E+ IL I +HLNV+ L + + +V NL ++R + S R
Sbjct: 56 ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115
Query: 71 K--EILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYH 128
K + + +A E + R + L F S +T PQ++ L+
Sbjct: 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST-------SGSTNPPQETDDLWK 168
Query: 129 TTFVL-------YQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKS-- 178
+ + +Q+ G+ L S K HRD+ NIL+ ++V + D G + I
Sbjct: 169 SPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 228
Query: 179 ----KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
KG + + +W +PE + + Y+ + D+W+ G + +E +L +P +PG
Sbjct: 229 DYVRKG--SARLPLKWM-APESIF-DKVYTTQSDVWSFGVLLWEIFSLGASP-YPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 54/219 (24%), Positives = 79/219 (36%), Gaps = 65/219 (29%)
Query: 66 SEKRAKEILYQVKAANETAAHYRVGWDLKL---------PFLLLVFGKSRNLGTLIVGLT 116
SE K+ L VKA + A W + L +L++ F +L T+++
Sbjct: 37 SEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD 96
Query: 117 TFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQ 174
TF S+ + T F + + V + +H HRDIKP+NILI RG + + D G S
Sbjct: 97 TF----SEDV--TRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150
Query: 175 FIKS------KGLHTEYIATR-------------------------W------------- 190
F K + L W
Sbjct: 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVG 210
Query: 191 ---YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226
Y +PE L +G Y E D W+ G + +E L P F
Sbjct: 211 TPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 19/56 (33%), Positives = 32/56 (57%), Gaps = 5/56 (8%)
Query: 107 NLGTLIVGLTTFLPQQSKR---LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159
N+ ++G LP+ +R + T ++ QI+ L LHS + HRD+KP+NI+
Sbjct: 234 NVEPYLLGKVQDLPKGLERENKIIQT--IMRQILFALDGLHSTGIVHRDVKPQNII 287
|
Length = 566 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 44/195 (22%)
Query: 117 TFLPQQSKRLYHTTF--VLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSL 173
TFL + RL ++ G+ +L S HRD+ N L+ +++ + D G
Sbjct: 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS 141
Query: 174 Q------FIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFP 227
+ + + G+ + I +W +PE L G YS E D+W+ G + +E +
Sbjct: 142 REEEDGVYASTGGM--KQIPVKW-TAPEAL-NYGRYSSESDVWSFGILLWEAFS------ 191
Query: 228 GDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP-QIHEKGKK 286
LG L SN Q ++ G+ + P + +
Sbjct: 192 --------------LGAVPYANL--------SN--QQTREAIEQGVRLPCPELCPDAVYR 227
Query: 287 LMSEMLKYDPKRRPT 301
LM +YDP +RP+
Sbjct: 228 LMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 36/118 (30%), Positives = 56/118 (47%), Gaps = 17/118 (14%)
Query: 115 LTTFLPQQSKRLYHTTFVLYQIV----NGLHHLHSYKVFHRDIKPENILIRGDLVV-VGD 169
L TFL ++ RL T L Q+ G+ +L S HRD+ N L+ + V+ + D
Sbjct: 79 LLTFLRKKKNRL--TVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISD 136
Query: 170 LG------SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
G + S GL + I +W +PE L G Y+ E D+W+ G + +ET +
Sbjct: 137 FGMSREEEGGIYTVSDGL--KQIPIKW-TAPEALNY-GRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 28/103 (27%), Positives = 50/103 (48%), Gaps = 12/103 (11%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIK------SKGLHTEYI 186
YQ+ G+ L S HRD+ N+L+ +G +V + D G + I SKG + ++
Sbjct: 244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFL 301
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPG 228
+W +PE + Y + D+W+ G + +E + +PG
Sbjct: 302 PVKWM-APESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 26/105 (24%), Positives = 41/105 (39%), Gaps = 33/105 (31%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV------------------VGDLGSLQFI 176
QI G+ +LH V H+DI N +I +L V +GD
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD------- 177
Query: 177 KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
E +W + E L+ + YS D+W+ G + +E +T
Sbjct: 178 ------NENRPVKWM-ALESLVNK-EYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 12/33 (36%), Positives = 20/33 (60%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163
F +++ L +LH + +RD+KPENIL+
Sbjct: 107 FYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 23/91 (25%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFI---KSKGLHTEYIATRW 190
QI G+++L +++ HR++ NIL++ D +V + D G + K ++E+
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ + E +L G Y+ + D+W+ G +E ++
Sbjct: 177 WMALESILF-GRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 25/189 (13%)
Query: 96 PFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDI 153
P ++L F K +L + + L + L ++L T + + I G+ +L + HRD+
Sbjct: 82 PMVILPFMKHGDLHSFL--LYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDL 139
Query: 154 KPENILIRGDL-VVVGDLGSLQFIKSKGLHTE--YIATRWYRSP------ECLLTEGYYS 204
N ++R D+ V V D G SK +++ Y R + P E L + Y+
Sbjct: 140 AARNCMLREDMTVCVADFGL-----SKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYT 193
Query: 205 FELDIWAAGCVFYETLTR--NPLFPG--DSEIDQLDRIHQVLGTPKAETLKKFEKYKSSN 260
+ D+WA G +E TR P +PG + EI R L P + L + S
Sbjct: 194 SKSDVWAFGVTMWEIATRGQTP-YPGVENHEIYDYLRHGNRLKQP-EDCLDELYDLMYSC 251
Query: 261 FTYQFKQYP 269
+ K P
Sbjct: 252 WRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 18/106 (16%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFI--------KSKGLHTE 184
+QI G+ +L K+ HRD+ N+L+ G + + D G + + +SKG
Sbjct: 134 WQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG---- 189
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
I +W + E L + Y+ + D+W+ G + +E TL NP +PG
Sbjct: 190 RIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 470 | |||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| KOG0983|consensus | 391 | 100.0 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1027|consensus | 903 | 100.0 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1290|consensus | 590 | 100.0 | ||
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0608|consensus | 1034 | 99.98 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| KOG4250|consensus | 732 | 99.98 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG4278|consensus | 1157 | 99.97 | ||
| KOG0196|consensus | 996 | 99.97 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696|consensus | 683 | 99.97 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG1151|consensus | 775 | 99.97 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG0587|consensus | 953 | 99.97 | ||
| KOG1167|consensus | 418 | 99.97 | ||
| KOG1006|consensus | 361 | 99.97 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG1094|consensus | 807 | 99.97 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0199|consensus | 1039 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1035|consensus | 1351 | 99.97 | ||
| KOG0200|consensus | 609 | 99.96 | ||
| KOG0695|consensus | 593 | 99.96 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0984|consensus | 282 | 99.96 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG3653|consensus | 534 | 99.94 | ||
| KOG1152|consensus | 772 | 99.94 | ||
| KOG1025|consensus | 1177 | 99.93 | ||
| KOG1024|consensus | 563 | 99.93 | ||
| KOG0576|consensus | 829 | 99.93 | ||
| KOG2052|consensus | 513 | 99.93 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0590|consensus | 601 | 99.92 | ||
| KOG1345|consensus | 378 | 99.91 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG4158|consensus | 598 | 99.86 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0603|consensus | 612 | 99.84 | ||
| KOG1240|consensus | 1431 | 99.81 | ||
| KOG0195|consensus | 448 | 99.8 | ||
| KOG0606|consensus | 1205 | 99.78 | ||
| KOG1033|consensus | 516 | 99.78 | ||
| KOG1164|consensus | 322 | 99.76 | ||
| KOG1023|consensus | 484 | 99.75 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG1163|consensus | 341 | 99.71 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1165|consensus | 449 | 99.69 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.6 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.6 | |
| KOG0590|consensus | 601 | 99.59 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.54 | |
| KOG1166|consensus | 974 | 99.49 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.41 | |
| KOG0601|consensus | 524 | 99.4 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.39 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.37 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.36 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.34 | |
| KOG0606|consensus | 1205 | 99.34 | ||
| KOG1266|consensus | 458 | 99.33 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.2 | |
| KOG1243|consensus | 690 | 99.1 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.09 | |
| KOG0601|consensus | 524 | 99.04 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG2137|consensus | 700 | 99.02 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.86 | |
| KOG3741|consensus | 655 | 98.82 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| KOG3087|consensus | 229 | 98.69 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.62 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.23 | |
| KOG1035|consensus | 1351 | 98.21 | ||
| KOG0576|consensus | 829 | 98.12 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.93 | |
| KOG1093|consensus | 725 | 97.66 | ||
| KOG1826|consensus | 2724 | 97.53 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.16 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.06 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.94 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.74 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.74 | |
| KOG1235|consensus | 538 | 96.73 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.68 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.44 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.14 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.49 | |
| KOG2268|consensus | 465 | 95.41 | ||
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 94.89 | |
| PLN02236 | 344 | choline kinase | 94.57 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 94.41 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.22 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 93.91 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.25 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.21 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.0 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.97 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.83 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.34 | |
| KOG2270|consensus | 520 | 91.4 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 90.79 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 90.68 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.14 | |
| KOG0595|consensus | 429 | 89.85 | ||
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 89.58 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 89.35 | |
| KOG0610|consensus | 459 | 88.02 | ||
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 87.54 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 87.5 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 86.29 |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-55 Score=427.72 Aligned_cols=254 Identities=38% Similarity=0.700 Sum_probs=237.0
Q ss_pred CCCCCCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHh
Q psy9855 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKA 79 (470)
Q Consensus 1 ~k~~~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~ 79 (470)
||.++..+++...+||++.|++|..|||||+|.+++.+.+. .+|+|||||+++|++++++++. +++..++.
T Consensus 43 MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~fVfE~Md~NLYqLmK~R~r~fse~~irn------- 114 (538)
T KOG0661|consen 43 MKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYFVFEFMDCNLYQLMKDRNRLFSESDIRN------- 114 (538)
T ss_pred HHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHH-------
Confidence 79999999999999999999999999999999999976433 8999999999999999998866 99998888
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
|++||++||+|+|.+|+.|||+||+|||
T Consensus 115 ----------------------------------------------------im~QilqGL~hiHk~GfFHRDlKPENiL 142 (538)
T KOG0661|consen 115 ----------------------------------------------------IMYQILQGLAHIHKHGFFHRDLKPENIL 142 (538)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhcCcccccCChhheE
Confidence 9999999999999999999999999999
Q ss_pred EeC-CeEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy9855 160 IRG-DLVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238 (470)
Q Consensus 160 l~~-~~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i 238 (470)
+.+ +.+||+|||+|+.+......+.++.|+||+|||+++..+.|+.++|||++|||++|+++-++.|+|.++.+++.+|
T Consensus 143 i~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI 222 (538)
T KOG0661|consen 143 ISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI 222 (538)
T ss_pred ecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH
Confidence 994 5999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+.++|+|....|..-.. .+...++.+++.++..+..+.+..+.++.+||.+||.+||.+||||.|+|+||||+...
T Consensus 223 c~VLGtP~~~~~~eg~~-La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 223 CEVLGTPDKDSWPEGYN-LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHhCCCccccchhHHH-HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 99999999988876422 35566788888889999999999999999999999999999999999999999998654
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=386.13 Aligned_cols=246 Identities=37% Similarity=0.689 Sum_probs=226.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeec---CCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVN---RSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~---~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+||+++|+.++ |+||+.+.+++.. ...+.+|+|+|+|+.||.++|+..+.+++..++-
T Consensus 65 akRtlRElklLr~~~-HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~-------------- 129 (359)
T KOG0660|consen 65 AKRTLRELKLLRHLR-HENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQY-------------- 129 (359)
T ss_pred HHHHHHHHHHHHHhc-CCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHH--------------
Confidence 456799999999999 9999999999875 2456799999999999999999877677766665
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
+++||++||+|+|+.||+||||||.|+|++.+ .+
T Consensus 130 ---------------------------------------------f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 130 ---------------------------------------------FLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred ---------------------------------------------HHHHHHHhcchhhcccccccccchhheeeccCCCE
Confidence 99999999999999999999999999999999 89
Q ss_pred EEEecCCcccccC---CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKS---KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
||||||+|+.... ....+.++.|.||+|||++.....|+.++||||+|||+.||++|++.|+|.+..+++..|...+
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 9999999998863 5556888999999999999888889999999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
|+|..+.+..........+...+++.+...+..+++..++.+.||+.+||..||.+|+|++|+|+||||....
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 9999999998887777778888899999999999999999999999999999999999999999999998764
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=363.43 Aligned_cols=243 Identities=35% Similarity=0.640 Sum_probs=216.6
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~ 85 (470)
+.-...++|||++|+.++ |+||+.++++| +..+.+.||+||++.||...|++... ++..+++.
T Consensus 42 dGi~~talREIK~Lqel~-h~nIi~LiD~F--~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~------------- 105 (318)
T KOG0659|consen 42 DGINRTALREIKLLQELK-HPNIIELIDVF--PHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKS------------- 105 (318)
T ss_pred cCccHHHHHHHHHHHHcc-Ccchhhhhhhc--cCCCceEEEEEeccccHHHHhcccccccCHHHHHH-------------
Confidence 444678899999999999 99999999999 44778999999999999999998876 88888887
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.++++||+|||.+.|+||||||.|+|++.+ .
T Consensus 106 ----------------------------------------------y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~ 139 (318)
T KOG0659|consen 106 ----------------------------------------------YMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ 139 (318)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc
Confidence 99999999999999999999999999999988 9
Q ss_pred EEEEecCCcccccCCCcc-ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 165 VVVGDLGSLQFIKSKGLH-TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
+||+|||+|+.+...... ...+.|+||+|||++.|.+.|+..+||||+|||+.||+.|.+.|+|.++.+++..|.+.+|
T Consensus 140 lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 140 LKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred EEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 999999999988754433 3348999999999999999999999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+|.++.|+.+.....-.- +.+.|......+++..++++.||+.+||.+||.+|+|+.|+|+|+||+..
T Consensus 220 TP~~~~WP~~~~lpdY~~---~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 220 TPTPDQWPEMTSLPDYVK---IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCcccCccccccccHHH---HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 999999998876443222 22445555666888999999999999999999999999999999999864
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=369.87 Aligned_cols=242 Identities=34% Similarity=0.590 Sum_probs=209.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.-++|||++|++|+ |||+|.|+++| +..+.++||+|||+.++.+-+..... +++..++.
T Consensus 46 KIAlREIrmLKqLk-H~NLVnLiEVF--rrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~----------------- 105 (396)
T KOG0593|consen 46 KIALREIRMLKQLK-HENLVNLIEVF--RRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKK----------------- 105 (396)
T ss_pred HHHHHHHHHHHhcc-cchHHHHHHHH--HhcceeEEEeeecchHHHHHHHhccCCCCHHHHHH-----------------
Confidence 34799999999999 99999999999 55888999999999888888877766 88888887
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|++|++.|+.|||+++++||||||+|||++.+ .+|||
T Consensus 106 ------------------------------------------~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 106 ------------------------------------------YLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred ------------------------------------------HHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEec
Confidence 99999999999999999999999999999988 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||+|+.+. .+...+.++.|+||+|||++.|...|+..+||||+||++.||++|.+.|+|.++.+++..|...+|...+
T Consensus 144 DFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 144 DFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred cchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 999999887 6677788999999999999999888999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhhhccCcc-ccccccC-CCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNF-TYQFKQY-PGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
....-+... ..| ...++.. -...++...+.++..+.||+.+||..||.+|++.+|+|.||||++..+
T Consensus 224 rhq~iF~~N--~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 224 RHQSIFSSN--PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred HHHHHhccC--CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 776665441 111 1122221 122344455778889999999999999999999999999999976543
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=388.22 Aligned_cols=217 Identities=29% Similarity=0.498 Sum_probs=186.0
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccccc
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGW 91 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (470)
+.+|++||++|+ |||||+++++|.. ....|+||||++ |+|.+.+..+..+.+...+.
T Consensus 223 v~~EieILkkL~-HP~IV~~~d~f~~--~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~------------------- 280 (475)
T KOG0615|consen 223 VQNEIEILKKLS-HPNIVRIKDFFEV--PDSSYMVLEYVEGGELFDKVVANKYLREDLGKL------------------- 280 (475)
T ss_pred hHHHHHHHHhcC-CCCEEEEeeeeec--CCceEEEEEEecCccHHHHHHhccccccchhHH-------------------
Confidence 579999999999 9999999999965 566899999999 69999999988888877777
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----eEEE
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVV 167 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ikL 167 (470)
+++|++.||.|||++||+||||||+|||+..+ .+||
T Consensus 281 ----------------------------------------~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 281 ----------------------------------------LFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ----------------------------------------HHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 99999999999999999999999999999876 6899
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEG--YYSFELDIWAAGCVFYETLTRNPLFPGDSEID-QLDRIHQVLGT 244 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~g~ 244 (470)
+|||+|+..++...+.+.||||.|.|||++.+.+ .+..++||||+||+||-+++|.+||.+..... ..++|.+
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---- 396 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---- 396 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----
Confidence 9999999999888999999999999999998765 24558999999999999999999997765433 3444432
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
+.+.+. ...+..+++++.+||.+||.+||++|||++|+|+||||+....+.
T Consensus 397 --------------G~y~f~---------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 397 --------------GRYAFG---------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred --------------Cccccc---------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 111111 122357899999999999999999999999999999999876543
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=389.56 Aligned_cols=241 Identities=29% Similarity=0.548 Sum_probs=210.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.|||.||++|. ||||++|.+..+.+..+.+|||+|||+.||..++..... +++.+++.
T Consensus 160 ~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc---------------- 222 (560)
T KOG0600|consen 160 PITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKC---------------- 222 (560)
T ss_pred hHHHHHHHHHHHhcC-CCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHH----------------
Confidence 456789999999999 999999999998876789999999999999999988665 99999888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|++||+.||+|||++||+|||||.+||||+.+ .+||
T Consensus 223 -------------------------------------------~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 223 -------------------------------------------YMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred -------------------------------------------HHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEe
Confidence 99999999999999999999999999999998 9999
Q ss_pred EecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|||+|++..... ..+..+.|.||+|||+++|...|+.++|+||+||||.||+.|++.|+|.++.+++..|.+++|.|
T Consensus 260 aDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred ccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 9999999776433 56788999999999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
....|. ..+............++ ..+......++..+.+|+..||..||.+|.||.++|+|+||.
T Consensus 340 ~e~~W~-~~kLP~~~~~kp~~~y~-r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 340 TEDYWP-VSKLPHATIFKPQQPYK-RRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred Chhccc-cccCCcccccCCCCccc-chHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 999988 33322111111112222 223333667899999999999999999999999999999994
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=365.86 Aligned_cols=244 Identities=33% Similarity=0.603 Sum_probs=213.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
.-..+|||.+|.+++ |||||.+-++..+.+.+.+|+|||||+.||..+|..... +.+.+++.
T Consensus 119 PItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~---------------- 181 (419)
T KOG0663|consen 119 PITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKT---------------- 181 (419)
T ss_pred cchhHHHHHHHHhcC-CCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHH----------------
Confidence 345699999999999 999999999999888888999999999999999988774 88888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|+++||+|||.+.|+||||||+|+|++.. .+||
T Consensus 182 -------------------------------------------L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKi 218 (419)
T KOG0663|consen 182 -------------------------------------------LMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKI 218 (419)
T ss_pred -------------------------------------------HHHHHHHHHHHHhhceeEecccchhheeeccCCcEEe
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||+|+.+++. ...+..+.|.||+|||++.|...|+.++|+||+|||+.||+++++.|+|.++.+++.+|.+.+|+|.
T Consensus 219 aDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 219 ADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred cccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 999999988754 4457789999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhccCccccccccCCCCCccccccc--ccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ--IHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
...|+.+....... ...+...+-..+...++. +++...+|+..+|.+||.+|.||+|+|+|+||.+.
T Consensus 299 e~iwpg~~~lp~~k-~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 299 EAIWPGYSELPAVK-KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cccCCCccccchhh-ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 99999887754332 122333333333333333 56999999999999999999999999999999974
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=371.15 Aligned_cols=240 Identities=33% Similarity=0.588 Sum_probs=208.9
Q ss_pred hHHHHHHhcCCCCCCeeeeceeeecCCCC---eEEEEeeccccCHHHHHHhc----ccccHHHHHHHHHHHHhhhccccc
Q psy9855 14 LKEISILRKIPDHLNVLCLCETYVNRSTR---QVTLVFPLMELNLEEYIRTT----DNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 14 ~rEi~iL~~L~~HpnIv~l~~~~~~~~~~---~~~lV~E~~~gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
-+|+++|+.+. |||||+|..+|....+. ...+||||++.+|.++++.. ..++.-.
T Consensus 65 nrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~----------------- 126 (364)
T KOG0658|consen 65 NRELQIMRKLD-HPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLE----------------- 126 (364)
T ss_pred cHHHHHHHhcC-CcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceee-----------------
Confidence 49999999999 99999999998754443 56799999999999999852 3344443
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--e
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--L 164 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ 164 (470)
++.+++||++||+|||+.||+||||||.|||+|.+ .
T Consensus 127 ------------------------------------------iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~ 164 (364)
T KOG0658|consen 127 ------------------------------------------IKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGV 164 (364)
T ss_pred ------------------------------------------eHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCe
Confidence 34499999999999999999999999999999988 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+||||||.|+.+..+.....+..|+.|+|||++.|...|+.+.||||.||++.||+-|++.|+|++..+++..|.+++|+
T Consensus 165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 99999999999998888888899999999999999999999999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCccc-ccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDV-LVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
|..+.+..+.... ....+++.....+.. +....++++.+|+.++|.++|.+|.++.|+|.||||++++.
T Consensus 245 Pt~e~I~~mn~~y---~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 245 PTREDIKSMNPNY---TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred CCHHHHhhcCccc---ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 9999988765422 133444444444433 56788999999999999999999999999999999998764
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=385.11 Aligned_cols=213 Identities=28% Similarity=0.496 Sum_probs=193.3
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
.-....+.+||+|.++|+ |||||+++++|.+ ...+|||+|+|. ++|..+++....++|.+++.
T Consensus 59 ~~~reKv~~EIeIHr~L~-HpnIV~f~~~FED--s~nVYivLELC~~~sL~el~Krrk~ltEpEary------------- 122 (592)
T KOG0575|consen 59 PKQREKVLNEIEIHRSLK-HPNIVQFYHFFED--SNNVYIVLELCHRGSLMELLKRRKPLTEPEARY------------- 122 (592)
T ss_pred cchHHHHHHHHHHHHhcC-CCcEEeeeeEeec--CCceEEEEEecCCccHHHHHHhcCCCCcHHHHH-------------
Confidence 344567899999999999 9999999999955 788999999999 89999999888899999988
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
|++||+.||.|||++||+|||||..|+|++++ .
T Consensus 123 ----------------------------------------------~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~ 156 (592)
T KOG0575|consen 123 ----------------------------------------------FLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN 156 (592)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhcCceecccchhheeecCcCc
Confidence 99999999999999999999999999999999 9
Q ss_pred EEEEecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 165 VVVGDLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 165 ikL~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
|||+|||+|..+.. +....+.||||.|.|||++...+ .+..+||||+|||||.||.|+|||...+..+.+..|..
T Consensus 157 VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--- 232 (592)
T KOG0575|consen 157 VKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--- 232 (592)
T ss_pred EEecccceeeeecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh---
Confidence 99999999998874 46678899999999999998766 79999999999999999999999999988888888754
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.-..++..++.++++||.+||..||.+|||+++||.|+||..
T Consensus 233 ----------------------------~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 233 ----------------------------NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ----------------------------cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 223345679999999999999999999999999999999953
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=361.51 Aligned_cols=218 Identities=23% Similarity=0.440 Sum_probs=186.7
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.-..+++||+++|+.++ |||||.+||.|..... .++|+||||+ |+|.++++..+.++|..+..
T Consensus 119 ~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~-------------- 182 (364)
T KOG0581|consen 119 ALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGE-EISICMEYMDGGSLDDILKRVGRIPEPVLGK-------------- 182 (364)
T ss_pred HHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCc-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHH--------------
Confidence 33567899999999998 9999999999987433 6999999999 69999999888899998888
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-e
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ 164 (470)
|+.+|++||.|||+ ++||||||||+|||++.. .
T Consensus 183 ---------------------------------------------ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe 217 (364)
T KOG0581|consen 183 ---------------------------------------------IARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE 217 (364)
T ss_pred ---------------------------------------------HHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC
Confidence 99999999999995 999999999999999987 9
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHh
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD--SEIDQLDRIHQVL 242 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~--~~~~~~~~i~~~~ 242 (470)
|||||||.+..+... ...+++||..|||||.+.+.. |+.++||||||+.++|+++|+.||... .....+..+..++
T Consensus 218 VKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 218 VKICDFGVSGILVNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV 295 (364)
T ss_pred EEeccccccHHhhhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence 999999999888766 668899999999999999876 999999999999999999999999764 2223333333333
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccc-cccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP-QIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..|+ ..++. .+|+++++||..||.+||.+|||++|+++|||+....
T Consensus 296 ~~pp---------------------------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 296 DEPP---------------------------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred cCCC---------------------------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 2221 22333 3899999999999999999999999999999998654
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=356.45 Aligned_cols=246 Identities=34% Similarity=0.668 Sum_probs=212.1
Q ss_pred hhhhhhHHHHHHhcCCCCCC-eeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcc----cccHHHHHHHHHHHHh
Q psy9855 9 AEVANLKEISILRKIPDHLN-VLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTD----NISEKRAKEILYQVKA 79 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~Hpn-Iv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~----~l~~~~~~~~~~~~~~ 79 (470)
....++||+.+|+.|+ |+| |+.|++++...+ .+.+++|+||++.||..++.... .++...++.
T Consensus 53 ~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~------- 124 (323)
T KOG0594|consen 53 VPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKS------- 124 (323)
T ss_pred CCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHH-------
Confidence 4667899999999999 999 999999987532 24799999999999999998766 244444444
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
+++||+.||+|||++||+||||||+|||
T Consensus 125 ----------------------------------------------------~m~Qll~gl~~~H~~~IlHRDLKPQNlL 152 (323)
T KOG0594|consen 125 ----------------------------------------------------FMRQLLRGLAFLHSHGILHRDLKPQNLL 152 (323)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhCCeecccCCcceEE
Confidence 9999999999999999999999999999
Q ss_pred EeCC-eEEEEecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 160 IRGD-LVVVGDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 160 l~~~-~ikL~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
++.+ .+||+|||+|+... .....+..++|.+|+|||++.+...|+..+||||+|||++||+++++.|+|.++.+++..
T Consensus 153 i~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 153 ISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR 232 (323)
T ss_pred ECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 9988 89999999999776 444567789999999999999998899999999999999999999999999999999999
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCC-CCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYP-GGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
|.+.+|+|..+.|+.......... .++.+. ...+....+..++...+++.+||.++|.+|.|++.+|.||||.++..
T Consensus 233 If~~lGtP~e~~Wp~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 233 IFRLLGTPNEKDWPGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred HHHHcCCCCccCCCCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 999999999999988776544333 444443 33444445666688999999999999999999999999999998753
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=330.21 Aligned_cols=234 Identities=27% Similarity=0.389 Sum_probs=196.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
.-+.+.||+.|.+.|+ ||||++|++.+. +.+..|+|+|+++| +|..-|..+..++|..+..
T Consensus 53 ~~e~l~rEarIC~~Lq-HP~IvrL~~ti~--~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH--------------- 114 (355)
T KOG0033|consen 53 DFQKLEREARICRKLQ-HPNIVRLHDSIQ--EESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------------- 114 (355)
T ss_pred cHHHHHHHHHHHHhcC-CCcEeehhhhhc--ccceeEEEEecccchHHHHHHHHHHHHHHHHHHH---------------
Confidence 3456789999999999 999999999874 47889999999995 8887776555566666665
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---- 163 (470)
+++||++||.|||.+||||||+||+|+|+...
T Consensus 115 --------------------------------------------~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 115 --------------------------------------------CIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhcCceeccCChhheeeeeccCCC
Confidence 99999999999999999999999999999654
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
-+||+|||+|..+..+......+|||.|||||++...+ |+..+|||+.|||||-|+.|.+||.+.+..+..++|.+.
T Consensus 151 ~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-- 227 (355)
T KOG0033|consen 151 AVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-- 227 (355)
T ss_pred ceeecccceEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--
Confidence 69999999999988766777889999999999998766 899999999999999999999999998888888888652
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHHHHHHH
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQYLEQ 323 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~~~~~~ 323 (470)
.+.+..+ ..+.+++++++|+++||..||.+|+|+.|+|+|||+.+..........
T Consensus 228 ----------------~yd~~~~---------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~ 282 (355)
T KOG0033|consen 228 ----------------AYDYPSP---------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHR 282 (355)
T ss_pred ----------------ccCCCCc---------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhh
Confidence 2222222 235789999999999999999999999999999999987766555555
Q ss_pred HHHHHHHHh
Q psy9855 324 KQVMKKLAK 332 (470)
Q Consensus 324 ~~~~~~~~~ 332 (470)
......+++
T Consensus 283 ~dtvd~lrk 291 (355)
T KOG0033|consen 283 QDTVDCLKK 291 (355)
T ss_pred HHHHHHHHH
Confidence 555544443
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=339.93 Aligned_cols=218 Identities=31% Similarity=0.505 Sum_probs=190.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
++..+|+.||+++.|||||+++.++|. +...+++|+|.|+ |.|.+++.+.-.+++...+.
T Consensus 67 EaT~~Ev~ILRqv~GHP~II~l~D~ye--s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~----------------- 127 (411)
T KOG0599|consen 67 EATRQEISILRQVMGHPYIIDLQDVYE--SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRR----------------- 127 (411)
T ss_pred HHHHHHHHHHHHhcCCCcEEEeeeecc--CcchhhhhhhhcccchHHHHhhhheeecHHHHHH-----------------
Confidence 456899999999999999999999984 4778999999999 89999998877788888877
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|++|+++|+.|||.++||||||||+|||++++ .++|+
T Consensus 128 ------------------------------------------iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 128 ------------------------------------------IMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEe
Confidence 99999999999999999999999999999999 99999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhcc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLT-----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
|||++..+..+......||||+|.|||.+.. .+.|+..+|+|++|||+|.|+.|++||......-.+..|+.
T Consensus 166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime--- 242 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME--- 242 (411)
T ss_pred ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh---
Confidence 9999999999998999999999999998753 23489999999999999999999999976655555555543
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
+.+.+..++| .+++..++|||.+||++||.+|+|++|+|+||||.++.+
T Consensus 243 ---------------GkyqF~speW---------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 243 ---------------GKYQFRSPEW---------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred ---------------cccccCCcch---------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 3344443433 468899999999999999999999999999999976543
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.33 Aligned_cols=214 Identities=26% Similarity=0.424 Sum_probs=190.3
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|-.+|.+|.+||.|++|+..|++ ...+|+|+||++ |+|.++|...+.+++.-.+.
T Consensus 119 YV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~------------------ 178 (604)
T KOG0592|consen 119 YVTREKEALTQLSGHPGIVKLYFTFQD--EESLYFVLEYAPNGDLLDLIKKYGSFDETCARF------------------ 178 (604)
T ss_pred hhhHHHHHHHHhhCCCCeEEEEEEeec--ccceEEEEEecCCCcHHHHHHHhCcchHHHHHH------------------
Confidence 456889999999779999999998865 778999999999 89999999998888877776
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
|+.||+.||+|||++|||||||||+|||++.+ +++|+|
T Consensus 179 -----------------------------------------YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITD 217 (604)
T KOG0592|consen 179 -----------------------------------------YAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITD 217 (604)
T ss_pred -----------------------------------------HHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEee
Confidence 99999999999999999999999999999999 999999
Q ss_pred cCCcccccCCCc--------------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy9855 170 LGSLQFIKSKGL--------------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235 (470)
Q Consensus 170 FG~a~~~~~~~~--------------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 235 (470)
||.|+.+..... ...++||..|++||++.... .+..+|||+||||+|.|+.|.+||.+.++.-.+
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 999987753211 14589999999999887654 899999999999999999999999999999999
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
++|+.+- ..+++.+++.+.|||.++|..||.+|+|++||.+||||.+++
T Consensus 297 qkI~~l~-------------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 297 QKIQALD-------------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred HHHHHhc-------------------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 9998742 224467889999999999999999999999999999999998
Q ss_pred HHH
Q psy9855 316 QLK 318 (470)
Q Consensus 316 ~~~ 318 (470)
...
T Consensus 346 w~n 348 (604)
T KOG0592|consen 346 WEN 348 (604)
T ss_pred hhh
Confidence 644
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=364.63 Aligned_cols=220 Identities=25% Similarity=0.425 Sum_probs=200.1
Q ss_pred CCCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhc
Q psy9855 4 TCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANE 82 (470)
Q Consensus 4 ~~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~ 82 (470)
.+.+.....+.|||-||+-|. ||||++++++|. ++.++|+|+||++ |.|.+++...+.+++.++..
T Consensus 50 ~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe--~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~---------- 116 (786)
T KOG0588|consen 50 ELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWE--NKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAH---------- 116 (786)
T ss_pred ccccccccchhhhhHHHHHhc-CCCeeeeeeeec--cCceEEEEEEecCCchhHHHHHhhCCCCCHHHHH----------
Confidence 345555677899999999999 999999999985 4889999999999 69999999999999998888
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.||+.||.|||..+|+||||||+|+|++.
T Consensus 117 -------------------------------------------------ff~QIi~gv~yCH~~~icHRDLKpENlLLd~ 147 (786)
T KOG0588|consen 117 -------------------------------------------------FFRQILDGVSYCHAFNICHRDLKPENLLLDV 147 (786)
T ss_pred -------------------------------------------------HHHHHHHHHHHHhhhcceeccCCchhhhhhc
Confidence 9999999999999999999999999999998
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
. .|||+|||.|.....+....+.||+|.|+|||++.|.++-+.++||||+|||||.||+|+.||.+++....+.++.+
T Consensus 148 ~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~- 226 (786)
T KOG0588|consen 148 KNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR- 226 (786)
T ss_pred ccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-
Confidence 7 89999999999988888999999999999999999999889999999999999999999999998887777776643
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
+...++..++.++.+||.+||.+||++|+|.+||++|||+.+...
T Consensus 227 ------------------------------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 227 ------------------------------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ------------------------------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 334456789999999999999999999999999999999987543
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=344.54 Aligned_cols=216 Identities=25% Similarity=0.481 Sum_probs=190.4
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.++.||+||+.|+ |||||.|++.+.. .+.+|||||||. |||.+||...+.+++..++.
T Consensus 52 ~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~--~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~--------------- 113 (429)
T KOG0595|consen 52 LVELLLSEIKILKELK-HPNIVRLLDCIED--DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARH--------------- 113 (429)
T ss_pred HHHHHHHHHHHHHhcC-CcceeeEEEEEec--CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHH---------------
Confidence 3556789999999999 9999999998855 678999999999 79999999999999998888
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---- 163 (470)
++.||+.||++||+++||||||||+|||++..
T Consensus 114 --------------------------------------------Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~ 149 (429)
T KOG0595|consen 114 --------------------------------------------FMQQLASALQFLHENNIIHRDLKPQNILLSTTARND 149 (429)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCC
Confidence 99999999999999999999999999999763
Q ss_pred ---eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 164 ---LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 164 ---~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
.+||+|||+|+.+..+....+.||++.|||||++.... |+.|+|+||+|+|+|++++|++||...+..+.+..+.+
T Consensus 150 ~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k 228 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK 228 (429)
T ss_pred CCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 58999999999999888888999999999999998755 99999999999999999999999999998888776544
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
. ..........++....+|+...|..+|.+|.+..+-+.|+++....
T Consensus 229 ~----------------------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 229 G----------------------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred c----------------------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 2 1122223345667778999999999999999999999999998643
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=338.82 Aligned_cols=215 Identities=28% Similarity=0.405 Sum_probs=190.7
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
+......|..||..++ ||.||+++..|++ .+.+|||+||+. |.|.-.|.+.+.+++..++.
T Consensus 68 e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt--~~kLylVld~~~GGeLf~hL~~eg~F~E~~arf--------------- 129 (357)
T KOG0598|consen 68 EVRHTKAERNILSKIK-HPFIVKLIYSFQT--EEKLYLVLDYLNGGELFYHLQREGRFSEDRARF--------------- 129 (357)
T ss_pred hHHHHHHHHHHHHhCC-CCcEeeeEEeccc--CCeEEEEEeccCCccHHHHHHhcCCcchhHHHH---------------
Confidence 4567889999999999 9999999998865 788999999999 59999999988899988887
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
|+..|+.||.|||++|||||||||+|||++.+ +++
T Consensus 130 --------------------------------------------YlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~ 165 (357)
T KOG0598|consen 130 --------------------------------------------YLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIK 165 (357)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEE
Confidence 99999999999999999999999999999988 999
Q ss_pred EEecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||+++... .+....++|||+.|||||++.+.+ |+.++|.|||||++|||++|.+||.+.+.......|.+.
T Consensus 166 LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~---- 240 (357)
T KOG0598|consen 166 LTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG---- 240 (357)
T ss_pred EeccccchhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC----
Confidence 99999998544 445566789999999999999877 899999999999999999999999999888887777541
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc----CHHHHHhcccCCChhH
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp----t~~elL~hp~f~~~~~ 316 (470)
.....+..++.++++||.++|..||++|. .+.++-+||||.+++.
T Consensus 241 --------------------------k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 241 --------------------------KLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred --------------------------cCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 11222234899999999999999999996 6899999999999875
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=351.64 Aligned_cols=212 Identities=27% Similarity=0.469 Sum_probs=187.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.||+.+++.+..||||+++++++.. ...+|+|||||. |+|.+++...+.+.|..++.
T Consensus 63 ~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~---------------- 124 (370)
T KOG0583|consen 63 DELIKREISILRRLRSHPNIIRLLEVFAT--PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARK---------------- 124 (370)
T ss_pred chhhHHHHHHHHHhccCCCEeEEEEEEec--CCeEEEEEEecCCccHHHHHHHcCCCChHHHHH----------------
Confidence 34556899999999989999999999965 555999999999 59999999977799988877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ik 166 (470)
+++||+.||+|||++||+||||||+|||++.+ .+|
T Consensus 125 -------------------------------------------~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 125 -------------------------------------------YFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEE
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCcccc-cCCCccccccccCcccCchhhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 167 VGDLGSLQFI-KSKGLHTEYIATRWYRSPECLLTEG-YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 167 L~DFG~a~~~-~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|+|||++... .......+.|||+.|+|||++.+.. +-+.++||||+||+||.|++|..||.+.+.......|.+
T Consensus 162 l~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~---- 237 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK---- 237 (370)
T ss_pred EeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc----
Confidence 9999999988 5677788899999999999999877 557999999999999999999999998777766666533
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccc-cHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI-HEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
....++..+ +.++.+|+.+||..||.+|+|+.+++.||||+.
T Consensus 238 ---------------------------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ---------------------------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------------------------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 112233445 999999999999999999999999999999985
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=335.51 Aligned_cols=239 Identities=31% Similarity=0.607 Sum_probs=195.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.++ ||||+++++++.. .+..++||||++|+|.+++..... +++..+..
T Consensus 47 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~---------------- 107 (288)
T cd07871 47 PCTAIREVSLLKNLK-HANIVTLHDIIHT--ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI---------------- 107 (288)
T ss_pred chhHHHHHHHHHhCC-CCCEeeEEEEEcC--CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHH----------------
Confidence 345679999999999 9999999998854 567999999999999999876544 56666665
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 108 -------------------------------------------~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl 144 (288)
T cd07871 108 -------------------------------------------FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKL 144 (288)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++...... .......|++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.|.
T Consensus 145 ~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07871 145 ADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPT 224 (288)
T ss_pred CcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998765422 2234457899999999987755689999999999999999999999999999999999999999999
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.+.|........- ....++...........+.++.++++||.+||.+||.+|||++|+|+||||
T Consensus 225 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 225 EETWPGITSNEEF-RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hHHhhccccchhh-hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 8887764331100 011122221222223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.40 Aligned_cols=214 Identities=25% Similarity=0.426 Sum_probs=186.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
.+-++.|+.+|+.++ |+|||.+++.|.. .+.+|+||||++ |+|.+++.... ++|.++..
T Consensus 314 keLilnEi~Vm~~~~-H~NiVnfl~Sylv--~deLWVVMEym~ggsLTDvVt~~~-~~E~qIA~---------------- 373 (550)
T KOG0578|consen 314 KELLLNEILVMRDLH-HPNIVNFLDSYLV--GDELWVVMEYMEGGSLTDVVTKTR-MTEGQIAA---------------- 373 (550)
T ss_pred hhhhHHHHHHHHhcc-chHHHHHHHHhcc--cceeEEEEeecCCCchhhhhhccc-ccHHHHHH----------------
Confidence 345789999999999 9999999999976 578999999999 59999987654 88888888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+++++.||+|||.+||+|||||.+|||++.+ .+||
T Consensus 374 -------------------------------------------Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKl 410 (550)
T KOG0578|consen 374 -------------------------------------------ICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKL 410 (550)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++..+.... ...+.+|||+|||||++.... |++++||||||++++||+-|.+||-.++....+..|... |+|.
T Consensus 411 tDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~ 488 (550)
T KOG0578|consen 411 TDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK 488 (550)
T ss_pred eeeeeeeccccccCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC
Confidence 9999988776544 557789999999999987655 999999999999999999999999988888777777542 2221
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...+..+|.++++||.+||+.|+.+|++|.|+|+||||+...
T Consensus 489 ---------------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 489 ---------------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred ---------------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 112357899999999999999999999999999999996543
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.65 Aligned_cols=216 Identities=25% Similarity=0.404 Sum_probs=176.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.+|.+|+ |||||+++|.........++++|||++ |+|.+++...+ .+++..++.
T Consensus 59 ~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~---------------- 121 (313)
T KOG0198|consen 59 ESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRR---------------- 121 (313)
T ss_pred HHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHH----------------
Confidence 34789999999999 999999999754322236999999999 69999999887 589988888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-C-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-D-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~-~ik 166 (470)
+.+||++||+|||++|||||||||+|||++. + .+|
T Consensus 122 -------------------------------------------ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~K 158 (313)
T KOG0198|consen 122 -------------------------------------------YTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVK 158 (313)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEE
Confidence 9999999999999999999999999999999 4 999
Q ss_pred EEecCCcccccC----CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKS----KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD-SEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~ 241 (470)
|+|||++..... ........||+.|||||++........++|||||||++.||+||++||... ...+.+..+..
T Consensus 159 laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~- 237 (313)
T KOG0198|consen 159 LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR- 237 (313)
T ss_pred eccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc-
Confidence 999999887663 122345789999999999985322345999999999999999999999763 22222222211
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
......++..+++++++||.+||..||++||||+++|+|||.....
T Consensus 238 ----------------------------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 238 ----------------------------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ----------------------------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 1122345567999999999999999999999999999999998644
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=344.38 Aligned_cols=219 Identities=22% Similarity=0.376 Sum_probs=190.8
Q ss_pred CCCCCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhh
Q psy9855 2 KATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 2 k~~~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~ 81 (470)
|...++-+-.++.+|++|++.|+ |||||.++++| ++..++|+|+|||.|+|..+|...+.++|+.++.
T Consensus 37 K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esf--Et~~~~~vVte~a~g~L~~il~~d~~lpEe~v~~--------- 104 (808)
T KOG0597|consen 37 KSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESF--ETSAHLWVVTEYAVGDLFTILEQDGKLPEEQVRA--------- 104 (808)
T ss_pred hcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhh--cccceEEEEehhhhhhHHHHHHhccCCCHHHHHH---------
Confidence 33344444567899999999999 99999999999 4588999999999999999999999999999998
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
|++|++.||.|||+++|+|||+||.|||++
T Consensus 105 --------------------------------------------------~a~~LVsaL~yLhs~rilhrd~kPqniLl~ 134 (808)
T KOG0597|consen 105 --------------------------------------------------IAYDLVSALYYLHSNRILHRDMKPQNILLE 134 (808)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhcCcccccCCcceeeec
Confidence 999999999999999999999999999999
Q ss_pred CC-eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
.+ .+|+||||+|+....+. ..+...|||.|||||++.+.. |+..+|+||+|||+||++.|++||...+-......|.
T Consensus 135 ~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~ 213 (808)
T KOG0597|consen 135 KGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL 213 (808)
T ss_pred CCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh
Confidence 88 99999999999887554 345678999999999988755 9999999999999999999999998877666665554
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.- ....+...+..+.+|++.+|..||.+|.|+.+++.|||+++.
T Consensus 214 ~d-------------------------------~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 214 KD-------------------------------PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred cC-------------------------------CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 31 011224688999999999999999999999999999999864
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=347.98 Aligned_cols=240 Identities=30% Similarity=0.507 Sum_probs=196.2
Q ss_pred hhhHHHHHHhcCCC-----CCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhccc
Q psy9855 12 ANLKEISILRKIPD-----HLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 12 ~~~rEi~iL~~L~~-----HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~ 84 (470)
+..-|+.+|..|+. --|||+++++|.. .+|+|||+|.++.+|+++|+.+.. ++...++.
T Consensus 228 Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~------------ 293 (586)
T KOG0667|consen 228 QAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRK------------ 293 (586)
T ss_pred HHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHH------------
Confidence 45789999999973 3589999999976 789999999999999999998775 66666655
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
|+.||+.||.+||+.||||+||||+|||+..-
T Consensus 294 -----------------------------------------------~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 294 -----------------------------------------------FAQQILTALLFLHELGIIHCDLKPENILLKDPK 326 (586)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCeeeccCChhheeeccCC
Confidence 99999999999999999999999999999764
Q ss_pred --eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 --LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 --~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.|||+|||+++.....-. +++.++.|+|||+++|.+ |+.+.||||||||++||++|.+.|+|.++.+++..|.++
T Consensus 327 r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred cCceeEEecccccccCCcce--eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 899999999988765443 789999999999999977 999999999999999999999999999999999999999
Q ss_pred hCCCchHHHHHHhhhc---cC-ccccc-----------------------ccc--CC--CCCcccccc-cccHHHHHHHH
Q psy9855 242 LGTPKAETLKKFEKYK---SS-NFTYQ-----------------------FKQ--YP--GGGIDVLVP-QIHEKGKKLMS 289 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~---~~-~~~~~-----------------------~~~--~~--~~~~~~~~~-~~s~~~~~Li~ 289 (470)
+|.|+...+....+.. .. ..... ... .| ...+..... .....+.|||.
T Consensus 404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk 483 (586)
T KOG0667|consen 404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK 483 (586)
T ss_pred hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence 9999998876544321 11 00000 000 00 011111112 23456799999
Q ss_pred HhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 290 EMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 290 ~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+||++||.+|+|+.|+|+||||.+..
T Consensus 484 ~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 484 RCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred HHhccCchhcCCHHHHhcCccccccc
Confidence 99999999999999999999999643
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=320.39 Aligned_cols=203 Identities=31% Similarity=0.528 Sum_probs=175.4
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc----ccHHHHHHHHHHHHhhhcc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN----ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~----l~~~~~~~~~~~~~~~~~~ 83 (470)
+......|+.+|++|+ |||||+++++-..+++..++||||+|+ |||.+.|+.... ++|..++.
T Consensus 61 ~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk----------- 128 (375)
T KOG0591|consen 61 ARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWK----------- 128 (375)
T ss_pred HHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHH-----------
Confidence 4566789999999999 999999999555556667999999999 899999976543 88988888
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh--CC--CeecCCCCCcEE
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS--YK--VFHRDIKPENIL 159 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~--~g--IvHrDLKp~NIL 159 (470)
++.|++.||..||. .. |+||||||.||+
T Consensus 129 ------------------------------------------------~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIF 160 (375)
T KOG0591|consen 129 ------------------------------------------------YFVQLCRALYHCHSKIPRGTVMHRDIKPANIF 160 (375)
T ss_pred ------------------------------------------------HHHHHHHHHHHHhccccccceeeccCcchheE
Confidence 99999999999999 45 999999999999
Q ss_pred EeCC-eEEEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 160 IRGD-LVVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 160 l~~~-~ikL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
++.+ .+||+|||+++.+..... ....+|||+||+||.+.+.+ |+.++||||+||++|||+.-++||.|++-.....+
T Consensus 161 l~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~K 239 (375)
T KOG0591|consen 161 LTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKK 239 (375)
T ss_pred EcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHH
Confidence 9988 899999999998875543 45689999999999998877 99999999999999999999999999977777666
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCccccc-ccccHHHHHHHHHhcccCCCCCcCH
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLV-PQIHEKGKKLMSEMLKYDPKRRPTA 302 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Li~~~L~~dP~~Rpt~ 302 (470)
|.+. ....++ ..+|.++..||..|+.+||+.||+.
T Consensus 240 I~qg------------------------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 240 IEQG------------------------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHcC------------------------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 6541 222233 4578999999999999999999986
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.51 Aligned_cols=245 Identities=34% Similarity=0.630 Sum_probs=197.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC---CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS---TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~---~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+++|+.+|+.|+ ||||+++++++...+ ...+|+|||||+++|.+++.....+++..+..
T Consensus 44 ~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~--------------- 107 (338)
T cd07859 44 TRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF--------------- 107 (338)
T ss_pred HHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHH---------------
Confidence 45789999999999 999999999886432 24589999999999999998777788877777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 108 --------------------------------------------i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~k 143 (338)
T cd07859 108 --------------------------------------------FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLK 143 (338)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCC----ccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 144 L~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~ 223 (338)
T cd07859 144 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223 (338)
T ss_pred EccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence 99999987543221 12345799999999988652 34889999999999999999999999999988888889999
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.|.|....+..+.......+................+.+++.+.++|.+||..||++|||++++|+||||++..
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 99988877665543222211111111111222223356788899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.94 Aligned_cols=211 Identities=25% Similarity=0.403 Sum_probs=189.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
.+...+|..+|+.+. ||.++++++.|.+ .+.+|+||||.+ |.|..++++.+.+++..++.
T Consensus 88 veH~~nEk~vL~~v~-~PFlv~l~~t~~d--~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arF---------------- 148 (355)
T KOG0616|consen 88 VEHTHNEKRVLKAVS-HPFLVKLYGTFKD--NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARF---------------- 148 (355)
T ss_pred HHHHhhHHHHHhhcc-CceeEEEEEeecc--CCeEEEEEeccCCccHHHHHHhcCCCCchhHHH----------------
Confidence 345689999999999 9999999998855 888999999999 59999999999999988887
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||+++|++|||||+|||++.+ .+||
T Consensus 149 -------------------------------------------YAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 149 -------------------------------------------YAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEE
Confidence 99999999999999999999999999999998 9999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
+|||+|+..... ..+.||||.|+|||++...+ |+.++|.|||||++|||+.|.+||.+.+.....++|...
T Consensus 186 tDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------ 256 (355)
T KOG0616|consen 186 TDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------ 256 (355)
T ss_pred EeccceEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC------
Confidence 999999987654 56789999999999998877 899999999999999999999999999998888888652
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCC-----cCHHHHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR-----PTAQKILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R-----pt~~elL~hp~f~~~~~ 316 (470)
--.+++.++.++++||.++|+.|-.+| ....+|..||||+++..
T Consensus 257 -------------------------~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 257 -------------------------KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred -------------------------cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 122446789999999999999999999 35778999999998864
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.69 Aligned_cols=244 Identities=34% Similarity=0.601 Sum_probs=198.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-----ccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-----ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-----l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.||+.+++.|+ ||||+.|..+|... ...+++++||.+.||.++|+-++. ++...
T Consensus 71 S~SAcREiaL~REl~-h~nvi~Lv~Vfl~~-d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~m--------------- 133 (438)
T KOG0666|consen 71 SMSACREIALLRELK-HPNVISLVKVFLSH-DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSM--------------- 133 (438)
T ss_pred CHHHHHHHHHHHHhc-CCcchhHHHHHhcc-CceEEEEehhhhhhHHHHHHHhccchhccCCHHH---------------
Confidence 456799999999999 99999999999754 678999999999999999976543 44444
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.|+.||+.|+.|||++-|+||||||.|||+..+
T Consensus 134 --------------------------------------------vKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 134 --------------------------------------------VKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG 169 (438)
T ss_pred --------------------------------------------HHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC
Confidence 44499999999999999999999999999999765
Q ss_pred ----eEEEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----
Q psy9855 164 ----LVVVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS----- 230 (470)
Q Consensus 164 ----~ikL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~----- 230 (470)
.|||+|||+++.+...- .....+.|.||+|||++.|...|+.++|||++|||+.||++-.+.|.+..
T Consensus 170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~ 249 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT 249 (438)
T ss_pred CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence 79999999999876432 22456889999999999999999999999999999999999999997743
Q ss_pred ----hHHHHHHHHHHhCCCchHHHHHHhhhccCcc-ccccc--cCCCCCccc---ccccccHHHHHHHHHhcccCCCCCc
Q psy9855 231 ----EIDQLDRIHQVLGTPKAETLKKFEKYKSSNF-TYQFK--QYPGGGIDV---LVPQIHEKGKKLMSEMLKYDPKRRP 300 (470)
Q Consensus 231 ----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~---~~~~~s~~~~~Li~~~L~~dP~~Rp 300 (470)
..+++.+|.+++|+|....|+.+.++..-.. ...+. .+....+.. ....-++.+.+|+.+||.+||.+|+
T Consensus 250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI 329 (438)
T KOG0666|consen 250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI 329 (438)
T ss_pred CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence 3688999999999999999998887653311 11111 111111110 1112345589999999999999999
Q ss_pred CHHHHHhcccCCCh
Q psy9855 301 TAQKILSCAYFADL 314 (470)
Q Consensus 301 t~~elL~hp~f~~~ 314 (470)
|++++|+|+||.+.
T Consensus 330 ta~qAleh~yF~~d 343 (438)
T KOG0666|consen 330 TAEQALEHPYFTED 343 (438)
T ss_pred cHHHHhcccccccC
Confidence 99999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.45 Aligned_cols=240 Identities=28% Similarity=0.540 Sum_probs=191.7
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecC------CCCeEEEEeeccccCHHHHHHhc----ccccHHHHHHHHHHHHhhhc
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNR------STRQVTLVFPLMELNLEEYIRTT----DNISEKRAKEILYQVKAANE 82 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~------~~~~~~lV~E~~~gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~ 82 (470)
..+|+.+|+.++ ||||++++++|... ....+++||||++++|.+++... ..+++..++.
T Consensus 106 ~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~---------- 174 (440)
T PTZ00036 106 KNRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL---------- 174 (440)
T ss_pred HHHHHHHHHhcC-CCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHH----------
Confidence 458999999999 99999999987532 12357899999999998887532 2255555555
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.||+.||+|||++||+||||||+|||++.
T Consensus 175 -------------------------------------------------~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~ 205 (440)
T PTZ00036 175 -------------------------------------------------YSYQLCRALAYIHSKFICHRDLKPQNLLIDP 205 (440)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHCCEecCCcCHHHEEEcC
Confidence 9999999999999999999999999999986
Q ss_pred C--eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 163 D--LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 163 ~--~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+ .+||+|||+++...........+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+..+..
T Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred CCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 5 69999999998776555555678899999999987766689999999999999999999999999999999999999
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCc-ccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGI-DVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+|.|..+.+...... .....++......+ ..++...++++.+||.+||.+||.+|||+.|+|+||||.++.
T Consensus 286 ~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPN---YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HhCCCCHHHHHHhchh---hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 9999988766543211 00111111111111 123345788999999999999999999999999999998654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=323.17 Aligned_cols=237 Identities=32% Similarity=0.643 Sum_probs=191.8
Q ss_pred hhhhHHHHHHhcCC--CCCCeeeeceeeec---CCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhcc
Q psy9855 11 VANLKEISILRKIP--DHLNVLCLCETYVN---RSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 11 ~~~~rEi~iL~~L~--~HpnIv~l~~~~~~---~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~ 83 (470)
..+.+|+.++..+. .||||+++++++.. .....+++||||++++|.+++..... +++..+..
T Consensus 46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~----------- 114 (290)
T cd07862 46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD----------- 114 (290)
T ss_pred HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHH-----------
Confidence 35678888887763 39999999998853 23456999999999999999875432 66666665
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 115 ------------------------------------------------i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~ 146 (290)
T cd07862 115 ------------------------------------------------MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 146 (290)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC
Confidence 99999999999999999999999999999877
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+....
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 147 GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred CCEEEccccceEeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 89999999998765544445668999999999987654 8999999999999999999999999999999999999988
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
+.|.++.+.......... +...+........+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 226 GLPGEEDWPRDVALPRQA----FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CCCChhhchhhhcccchh----ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 888777665433221111 11112223333445788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.03 Aligned_cols=250 Identities=32% Similarity=0.540 Sum_probs=186.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
..+.+|+.+|++++ ||||+++++++.......+|+||||++++|.+++........
T Consensus 43 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~----------------------- 98 (317)
T cd07868 43 MSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKA----------------------- 98 (317)
T ss_pred HHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccc-----------------------
Confidence 45689999999999 999999999997766778999999999999998864321000
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC----C-eE
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG----D-LV 165 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~----~-~i 165 (470)
......+....++.++.||+.||+|||++||+||||||+|||+.. + .+
T Consensus 99 ---------------------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~ 151 (317)
T cd07868 99 ---------------------------NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 151 (317)
T ss_pred ---------------------------cCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcE
Confidence 000011233444559999999999999999999999999999942 2 79
Q ss_pred EEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh---------H
Q psy9855 166 VVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE---------I 232 (470)
Q Consensus 166 kL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~---------~ 232 (470)
||+|||++....... .....+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+... .
T Consensus 152 kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~ 231 (317)
T cd07868 152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 231 (317)
T ss_pred EEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccH
Confidence 999999998664321 223468899999999998766689999999999999999999999975432 4
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCcccc-cccc--CCCCC----cccccccccHHHHHHHHHhcccCCCCCcCHHHH
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTY-QFKQ--YPGGG----IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~----~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~el 305 (470)
+++..+...+|.|....|............. .+.. ..... ........+..+.+||.+||.+||.+|||++|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~ 311 (317)
T cd07868 232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 311 (317)
T ss_pred HHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHH
Confidence 6677888899999888877654432111100 0000 00000 001112345678999999999999999999999
Q ss_pred HhcccC
Q psy9855 306 LSCAYF 311 (470)
Q Consensus 306 L~hp~f 311 (470)
|+||||
T Consensus 312 l~hp~f 317 (317)
T cd07868 312 MQDPYF 317 (317)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=292.78 Aligned_cols=240 Identities=31% Similarity=0.634 Sum_probs=208.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...++|||-+|+.|+ |.|||+++++. .+...+.+|+|||..+|..+...... ++.+.++.
T Consensus 45 pssalreicllkelk-hknivrl~dvl--hsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rs---------------- 105 (292)
T KOG0662|consen 45 PSSALREICLLKELK-HKNIVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRS---------------- 105 (292)
T ss_pred cHHHHHHHHHHHHhh-hcceeehhhhh--ccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHH----------------
Confidence 567899999999999 99999999977 55788999999999999999987655 77766666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|+++||.|+|++++.||||||.|+|++.+ .+||
T Consensus 106 -------------------------------------------fmlqllrgl~fchshnvlhrdlkpqnllin~ngelkl 142 (292)
T KOG0662|consen 106 -------------------------------------------FMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_pred -------------------------------------------HHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEe
Confidence 99999999999999999999999999999988 9999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|||+++.++-.- .....+.|.+|++|.++.|..-|+...|+||.|||+.|+.. |++.|+|.+..+++.+|.+.+|+|
T Consensus 143 adfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p 222 (292)
T KOG0662|consen 143 ADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_pred cccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC
Confidence 9999999877443 45667889999999999999889999999999999999997 999999999999999999999999
Q ss_pred chHHHHHHhhhccCccccccccCC-CCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYP-GGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
..+.|+.+.+...-.. ++.++ ...+..+.|.+...-+||++++|..+|.+|++++++++||||.+.
T Consensus 223 ~ed~wps~t~lpdyk~---yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 223 TEDQWPSMTKLPDYKP---YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccccCCccccCCCCcc---cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 9999988766432221 11111 224455667777888999999999999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=326.49 Aligned_cols=242 Identities=31% Similarity=0.530 Sum_probs=187.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.. ....|+||||++++|.+++..... +++..++.
T Consensus 48 ~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~----------------- 107 (303)
T cd07869 48 FTAIREASLLKGLK-HANIVLLHDIIHT--KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL----------------- 107 (303)
T ss_pred hhHHHHHHHHhhCC-CCCcCeEEEEEec--CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHH-----------------
Confidence 35689999999999 9999999999865 668999999999999998876543 66666666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 108 ------------------------------------------~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 108 ------------------------------------------FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEC
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS-EIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~g~p~ 246 (470)
|||++...... ......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+.+..+....+.+.
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (303)
T cd07869 146 DFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225 (303)
T ss_pred CCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence 99998754322 223446789999999998776668899999999999999999999998754 4466777777778877
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccc--cccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVL--VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...|.......... ...+........... ...++..+.+||.+||+.||.+|||+.|+|+||||+++.
T Consensus 226 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 226 EDTWPGVHSLPHFK-PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hhhccchhhccccc-cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 66655433211100 000000000000000 013467889999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=323.49 Aligned_cols=223 Identities=25% Similarity=0.357 Sum_probs=181.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|++.+..++ ||||++++..|+. ...+|+||+||. |++.++|+..-. +.|..+..
T Consensus 69 d~l~kE~~~msl~~-HPNIv~~~~sFvv--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~--------------- 130 (516)
T KOG0582|consen 69 DALRKEVQTMSLID-HPNIVTYHCSFVV--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIAT--------------- 130 (516)
T ss_pred HHHHHHHHHhhhcC-CCCcceEEEEEEe--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHH---------------
Confidence 46789999999999 9999999999986 678999999999 799999987654 77777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
|++++++||.|||.+|.||||||+.||||+.+ .|+
T Consensus 131 --------------------------------------------iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~Vk 166 (516)
T KOG0582|consen 131 --------------------------------------------ILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVK 166 (516)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhcCceecccccccEEEcCCCcEE
Confidence 99999999999999999999999999999998 999
Q ss_pred EEecCCcccccCCCc-----cccccccCcccCchhhcc-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLT-EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 167 L~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~-~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
|+|||.+..+...+. ..+++||++|||||++.. ...|+.|+||||||++..||.+|..||....++..+. ..
T Consensus 167 LadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~t 244 (516)
T KOG0582|consen 167 LADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LT 244 (516)
T ss_pred EcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HH
Confidence 999997766554331 156799999999999543 3359999999999999999999999998887777663 33
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
+-|.|+...... .-..-...++..++.+|..||+.||.+||||+++|+|+||+....
T Consensus 245 Lqn~pp~~~t~~-------------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 245 LQNDPPTLLTSG-------------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hcCCCCCccccc-------------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 334443211100 001111345668899999999999999999999999999997543
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.60 Aligned_cols=221 Identities=25% Similarity=0.421 Sum_probs=200.3
Q ss_pred CCCCCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHh
Q psy9855 2 KATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKA 79 (470)
Q Consensus 2 k~~~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~ 79 (470)
|-++.+.....+++|+..|+-++ |||||+||++. .....+|||+|+-+ |||++||-.+.. +.|..++.
T Consensus 53 KTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEVi--DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~k------- 122 (864)
T KOG4717|consen 53 KTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVI--DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKK------- 122 (864)
T ss_pred ccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehh--cccceEEEEEEecCCchHHHHHHhhhccccHHHHHH-------
Confidence 44567777888999999999999 99999999977 45788999999999 699999987776 88888877
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
|+.||+.|+.|||+..+|||||||+||.
T Consensus 123 ----------------------------------------------------YF~QI~~AI~YCHqLHVVHRDLKPENVV 150 (864)
T KOG4717|consen 123 ----------------------------------------------------YFAQIVHAISYCHQLHVVHRDLKPENVV 150 (864)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHhhhhhhcccCCcceeE
Confidence 9999999999999999999999999999
Q ss_pred EeCC--eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 160 IRGD--LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 160 l~~~--~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
+-.. .+||+|||++..+..+...++.||+..|-|||+++|..+--+++||||||||||-|++|++||...++.+.+..
T Consensus 151 FFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm 230 (864)
T KOG4717|consen 151 FFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM 230 (864)
T ss_pred EeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh
Confidence 9776 89999999999999988899999999999999999988667899999999999999999999999999999888
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
|++. -..++..++.++++||..||+.||.+|.+.++|..|+|++.++
T Consensus 231 ImDC-------------------------------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 231 IMDC-------------------------------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred hhcc-------------------------------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 8652 2345567899999999999999999999999999999999764
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=328.75 Aligned_cols=215 Identities=30% Similarity=0.423 Sum_probs=178.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
+...+||.||++|. |||||+|+++..++....+|||+|||. |.+...=.....+++.+++.
T Consensus 153 ekv~~EIailKkl~-H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~----------------- 214 (576)
T KOG0585|consen 153 EKVRREIAILKKLH-HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARK----------------- 214 (576)
T ss_pred HHHHHHHHHHHhcC-CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHH-----------------
Confidence 36789999999999 999999999998888999999999999 66543322222255555555
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|+++++.||+|||.+|||||||||+|+|++++ ++||+
T Consensus 215 ------------------------------------------ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 215 ------------------------------------------YLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99999999999999999999999999999988 99999
Q ss_pred ecCCccccc------CCCccccccccCcccCchhhccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 169 DLGSLQFIK------SKGLHTEYIATRWYRSPECLLTE---GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 169 DFG~a~~~~------~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
|||.+.... ........+|||.|+|||.+.+. ...+.+.||||+||+||.|+.|+.||.+....+...+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 999887662 22233446999999999998763 335788999999999999999999999999988888886
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.. ...++ ..+.+.+.++|||.+||.+||++|++..++..|||...-
T Consensus 333 n~--------------------pL~fP---------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 333 ND--------------------PLEFP---------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cC--------------------cccCC---------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 51 01111 123578999999999999999999999999999999853
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=327.23 Aligned_cols=207 Identities=23% Similarity=0.307 Sum_probs=174.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHh--cccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRT--TDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~--~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|.+|+ |||||+++|++..+. ..+++||||++ |+|.+++.. ...++...+..
T Consensus 83 ~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~-~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~-------------- 146 (362)
T KOG0192|consen 83 RKAFRREASLLSRLR-HPNIVQFYGACTSPP-GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLR-------------- 146 (362)
T ss_pred HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCC-CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHH--------------
Confidence 458899999999999 999999999987532 26999999999 799999987 34466666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC-CeecCCCCCcEEEeCC--
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK-VFHRDIKPENILIRGD-- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g-IvHrDLKp~NILl~~~-- 163 (470)
++.||+.||.|||+++ ||||||||+|||++.+
T Consensus 147 ---------------------------------------------~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~ 181 (362)
T KOG0192|consen 147 ---------------------------------------------IALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGK 181 (362)
T ss_pred ---------------------------------------------HHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCC
Confidence 9999999999999999 9999999999999988
Q ss_pred eEEEEecCCcccccCC-CccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.+||+|||+++..... ...+...||+.|||||++.+. ..|+.++||||||+++|||++|..||.+.........+..
T Consensus 182 ~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~- 260 (362)
T KOG0192|consen 182 TLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV- 260 (362)
T ss_pred EEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-
Confidence 8999999999877654 334457999999999999852 4599999999999999999999999999887555544433
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
......++..+++.+..||..||..||.+||++.+++
T Consensus 261 ----------------------------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 261 ----------------------------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred ----------------------------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 1122233345889999999999999999999999988
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=324.69 Aligned_cols=243 Identities=32% Similarity=0.625 Sum_probs=196.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++++++ ||||+++++++.. .+..++||||++++|.+++..... ++...+..
T Consensus 48 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~---------------- 108 (309)
T cd07872 48 PCTAIREVSLLKDLK-HANIVTLHDIVHT--DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKI---------------- 108 (309)
T ss_pred chhHHHHHHHHHhCC-CCCcceEEEEEee--CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHH----------------
Confidence 345779999999999 9999999999865 667999999999999998876544 56666655
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 109 -------------------------------------------~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl 145 (309)
T cd07872 109 -------------------------------------------FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKL 145 (309)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.+|.+.
T Consensus 146 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 225 (309)
T cd07872 146 ADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225 (309)
T ss_pred CccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998765422 2223457899999999987666689999999999999999999999999999999999999999998
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...|..+...... ....++...........+.++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 226 EETWPGISSNDEF-KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHHHhhhcchhhh-hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 8877665332110 1111222212222223356889999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=327.43 Aligned_cols=217 Identities=24% Similarity=0.402 Sum_probs=185.3
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
+...++.|-.+|.... +|+||+|+..|++ ...+||||||.+ ||+..+|...+.+++..++.
T Consensus 184 Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD--~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arf--------------- 245 (550)
T KOG0605|consen 184 QVEHVRAERDILAEVD-SPWVVKLYYSFQD--KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARF--------------- 245 (550)
T ss_pred hHHHHHHHHHHhhhcC-CCcEEEEEEEecC--CCeeEEEEEecCCccHHHHHHhcCcCchHHHHH---------------
Confidence 3456788999999977 9999999999965 778999999999 69999999988888887777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
|+.+++.|++.||+.|+|||||||+|+||+.. ++|
T Consensus 246 --------------------------------------------YiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiK 281 (550)
T KOG0605|consen 246 --------------------------------------------YIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIK 281 (550)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHcCcccccCChhheeecCCCCEe
Confidence 99999999999999999999999999999988 999
Q ss_pred EEecCCcccccCC----------------------C-c-------------------------cccccccCcccCchhhc
Q psy9855 167 VGDLGSLQFIKSK----------------------G-L-------------------------HTEYIATRWYRSPECLL 198 (470)
Q Consensus 167 L~DFG~a~~~~~~----------------------~-~-------------------------~~~~~gt~~Y~APE~l~ 198 (470)
|+|||++..+... . . ....+|||-|+|||++.
T Consensus 282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll 361 (550)
T KOG0605|consen 282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL 361 (550)
T ss_pred eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence 9999998543210 0 0 11248999999999999
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccc
Q psy9855 199 TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP 278 (470)
Q Consensus 199 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (470)
+.+ |+..+|.||||||+||||.|.+||.+.++.+...+|..+-.+ +.++ ...
T Consensus 362 ~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~------------------l~fP---------~~~ 413 (550)
T KOG0605|consen 362 GKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET------------------LKFP---------EEV 413 (550)
T ss_pred cCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh------------------ccCC---------CcC
Confidence 988 999999999999999999999999999999999998874211 1111 113
Q ss_pred cccHHHHHHHHHhcccCCCCCcC---HHHHHhcccCCChhH
Q psy9855 279 QIHEKGKKLMSEMLKYDPKRRPT---AQKILSCAYFADLTQ 316 (470)
Q Consensus 279 ~~s~~~~~Li~~~L~~dP~~Rpt---~~elL~hp~f~~~~~ 316 (470)
.++++++|||.+||. ||++|.. ++||-+||||+++..
T Consensus 414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 414 DLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred cccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 567999999999999 9999986 999999999999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.34 Aligned_cols=239 Identities=32% Similarity=0.559 Sum_probs=186.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHh-cccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRT-TDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. .+.+|+||||+++++.+.+.. ...+++..++.
T Consensus 44 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~---------------- 104 (287)
T cd07848 44 KETTLRELKMLRTLK-QENIVELKEAFRR--RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRS---------------- 104 (287)
T ss_pred hhhHHHHHHHHHhCC-CccccchhhhEec--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHH----------------
Confidence 345689999999999 9999999998854 678999999999765555543 33477766666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||+.||+||||||+||+++.+ .++|
T Consensus 105 -------------------------------------------~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl 141 (287)
T cd07848 105 -------------------------------------------YIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKL 141 (287)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+....|..
T Consensus 142 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07848 142 CDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPL 220 (287)
T ss_pred eeccCcccccccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 9999988764322 223457899999999997765 8999999999999999999999999998888888888888877
Q ss_pred chHHHHHHhhhccC-ccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSS-NFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
+...+..+...... .........+..........++.++.+||.+||+.||++|||++++|+||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 221 PAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 76665543221100 0000000000111111223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=310.74 Aligned_cols=224 Identities=22% Similarity=0.389 Sum_probs=185.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC--CCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR--STRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~--~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.||+++.-...+|||||+++++|.+. +...+.+|||.|+ |.|...|.+++. ++|.++..
T Consensus 98 s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~e------------ 165 (400)
T KOG0604|consen 98 SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASE------------ 165 (400)
T ss_pred CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHH------------
Confidence 356789999998888899999999999743 3456889999999 599999998887 99988888
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
|+.||..|+.|||+.+|.||||||+|+|+...
T Consensus 166 -----------------------------------------------I~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~ 198 (400)
T KOG0604|consen 166 -----------------------------------------------IMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS 198 (400)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhcchhhccCChhheeeecCC
Confidence 99999999999999999999999999999765
Q ss_pred ---eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 164 ---LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 164 ---~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
.+||+|||+|+.........+.|.||+|.|||++...+ |+..+|+||+|||+|-|++|.+||........--.+.
T Consensus 199 ~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk- 276 (400)
T KOG0604|consen 199 PNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK- 276 (400)
T ss_pred CCcceEecccccccccCCCccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH-
Confidence 79999999999888777778889999999999886655 9999999999999999999999997764321111110
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.++..+.|.+..+. +..+|+.++|+|+.+|..+|.+|.|+++++.|||+.+...
T Consensus 277 -------------~rI~~gqy~FP~pE---------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 277 -------------RRIRTGQYEFPEPE---------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred -------------hHhhccCccCCChh---------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 01112222222111 2468999999999999999999999999999999997543
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.21 Aligned_cols=215 Identities=29% Similarity=0.492 Sum_probs=187.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++||++|.+|||||.++++|.. ...+++|||+|. |.|.+.|... .+++..+..
T Consensus 79 ~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~---------------- 139 (382)
T KOG0032|consen 79 REDVRREVAILQQLSGHPNIVQLKDAFED--PDSVYLVMELCEGGELFDRIVKK-HYSERDAAG---------------- 139 (382)
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeEEEEEEecCCchHHHHHHHc-cCCHHHHHH----------------
Confidence 45778999999999989999999999965 668999999999 6999999876 477777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.|++|||+.|||||||||+|+|+...
T Consensus 140 -------------------------------------------~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 140 -------------------------------------------IIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCC
Confidence 99999999999999999999999999999643
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++++|||++............+||+.|+|||++...+ |+..+||||+||++|.|++|.+||.+.+.......|...
T Consensus 177 ~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-- 253 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-- 253 (382)
T ss_pred cEEEeeCCCceEccCCceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--
Confidence 69999999999988866778899999999999987655 899999999999999999999999999987777766441
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+.+ ....++.++..+++||.+||..||.+|+|+.++|+|||+++.
T Consensus 254 ----------------~~~f---------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 254 ----------------DFDF---------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ----------------CCCC---------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 1111 122345789999999999999999999999999999999875
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=315.24 Aligned_cols=208 Identities=25% Similarity=0.436 Sum_probs=189.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.|||+|+..|+ ||||++++++|. +.+.+.|||||.. |.|++||..++.+++.+++.
T Consensus 98 vhIRREIeIMSsLN-HPhII~IyEVFE--NkdKIvivMEYaS~GeLYDYiSer~~LsErEaRh----------------- 157 (668)
T KOG0611|consen 98 VHIRREIEIMSSLN-HPHIIQIYEVFE--NKDKIVIVMEYASGGELYDYISERGSLSEREARH----------------- 157 (668)
T ss_pred HHHHHHHHHHhhcC-CCceeehhhhhc--CCceEEEEEEecCCccHHHHHHHhccccHHHHHH-----------------
Confidence 45789999999999 999999999994 4788999999999 79999999999999999888
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|++||+.|+.|||.+++||||||.+|||++.+ ++||+
T Consensus 158 ------------------------------------------fFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 158 ------------------------------------------FFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred ------------------------------------------HHHHHHHHHHHHhhccceecccchhheeecCCCCeeee
Confidence 99999999999999999999999999999998 99999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++..+.......++||++.|.+||++.|.++-++.+|.|||||+||.|+.|..||.|.+....+.+|....
T Consensus 196 DFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga------ 269 (668)
T KOG0611|consen 196 DFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA------ 269 (668)
T ss_pred ccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc------
Confidence 99999999999999999999999999999998888899999999999999999999999998877777765421
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
+ ..|.-+..+..||+.||-+||++|.|++++..|=|.+
T Consensus 270 ------------Y--------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 ------------Y--------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------------c--------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0 1134556778999999999999999999999998876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.57 Aligned_cols=211 Identities=25% Similarity=0.332 Sum_probs=178.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+++|+.+|.+++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 40 ~~~~~e~~~l~~l~-hp~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 99 (323)
T cd05571 40 AHTLTESRVLQNTR-HPFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARF----------------- 99 (323)
T ss_pred HHHHHHHHHHHhCC-CCCCCCEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 45679999999999 9999999998864 678999999999 59999998777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 100 ------------------------------------------~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~ 137 (323)
T cd05571 100 ------------------------------------------YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKIT 137 (323)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+...
T Consensus 138 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------ 210 (323)
T cd05571 138 DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------ 210 (323)
T ss_pred eCCCCcccccCCCcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------
Confidence 999987543 222334568999999999987755 899999999999999999999999877655544433210
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
...++..+++++.+||.+||..||++|| ++.++++||||.++.
T Consensus 211 -------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 211 -------------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0112346789999999999999999999 899999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=316.99 Aligned_cols=243 Identities=31% Similarity=0.614 Sum_probs=195.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.|+ ||||+++++++.. .+..++||||++++|.+++..... +++..+..
T Consensus 48 ~~~~~~E~~~l~~l~-h~nI~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~---------------- 108 (301)
T cd07873 48 PCTAIREVSLLKDLK-HANIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL---------------- 108 (301)
T ss_pred hhHHHHHHHHHHhcC-CCCcceEEEEEec--CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHH----------------
Confidence 345679999999999 9999999999864 668999999999999999876443 66666666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 109 -------------------------------------------~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl 145 (301)
T cd07873 109 -------------------------------------------FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKL 145 (301)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+...++.+.
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 225 (301)
T cd07873 146 ADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225 (301)
T ss_pred CcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999887644222 223456789999999987766688999999999999999999999999998888889999999888
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...|..+.... .......+...........+.+++.+.+||.+||..||.+|||++++|+||||..+.
T Consensus 226 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 226 EETWPGILSNE-EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhhchhhhccc-cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 87776542211 001111222222222233456788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=327.96 Aligned_cols=245 Identities=30% Similarity=0.486 Sum_probs=196.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC---CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS---TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~---~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|+.++ ||||+++++++.... ...+|+||||+.++|.+++.....+++..++.
T Consensus 43 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~-------------- 107 (372)
T cd07853 43 CKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-------------- 107 (372)
T ss_pred HHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCCCCCHHHHHH--------------
Confidence 346789999999999 999999999986532 12689999999999999997776677777777
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 108 ---------------------------------------------~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~ 142 (372)
T cd07853 108 ---------------------------------------------FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVL 142 (372)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCC--CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 166 VVGDLGSLQFIKSK--GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 166 kL~DFG~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|+|||++...... .......+|+.|+|||++.+...++.++||||+||++|||++|++||.+.+..+++..+...+|
T Consensus 143 kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g 222 (372)
T cd07853 143 KICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222 (372)
T ss_pred EeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999998765422 2233457899999999998766689999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhhhccCccccccccCCC--CCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPG--GGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+..+.+........ .........+. ..........++++.+||.+||..||.+|||+.++|+||||.+..
T Consensus 223 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 223 TPSLEAMRSACEGAR-AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CCCHHHHHHhhHHHH-HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 998876544322100 00000000000 011123345688999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.48 Aligned_cols=241 Identities=29% Similarity=0.544 Sum_probs=189.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+++.++ ||||+++++++.... ...+|+||||++++|.+.+.. .+++..+..
T Consensus 64 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~------------- 127 (359)
T cd07876 64 AKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSY------------- 127 (359)
T ss_pred HHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--cCCHHHHHH-------------
Confidence 446789999999999 999999999986432 245899999999998887743 255655555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 128 ----------------------------------------------~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 128 ----------------------------------------------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC
Confidence 99999999999999999999999999999887 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...+|.
T Consensus 162 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 240 (359)
T cd07876 162 LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240 (359)
T ss_pred EEEecCCCccccccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999997665444445668999999999987755 899999999999999999999999999888888889998998
Q ss_pred CchHHHHHHhhhc----cCc-------cccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYK----SSN-------FTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~----~~~-------~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
|..+.+....... ... +...++.+............++++.+||.+||..||++|||+.|+|+||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 8876554432211 000 00000111000111112235678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=312.53 Aligned_cols=236 Identities=32% Similarity=0.636 Sum_probs=189.7
Q ss_pred hhhHHHHHHhcCC--CCCCeeeeceeeecC---CCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhccc
Q psy9855 12 ANLKEISILRKIP--DHLNVLCLCETYVNR---STRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 12 ~~~rEi~iL~~L~--~HpnIv~l~~~~~~~---~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~ 84 (470)
.+.+|+.+++.|. +||||+++++++... ....+++||||+.++|.+++..... +++..+..
T Consensus 45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~------------ 112 (288)
T cd07863 45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD------------ 112 (288)
T ss_pred HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHH------------
Confidence 4567888887763 399999999987642 2456899999999999999876432 66766666
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 113 -----------------------------------------------~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~ 145 (288)
T cd07863 113 -----------------------------------------------LMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 145 (288)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999999999999877
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++|+|||++.............||..|+|||++.+.. ++.++||||+||++|+|++|.+||.+....+.+..+....+
T Consensus 146 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 146 QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred CEEECccCccccccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 89999999998765444445567899999999987755 89999999999999999999999999988888888988888
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.+....|..........+ ............+.++..+.+||.+||..||.+|||+.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAF----SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCChhhCccccccccccc----CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 877665543222111111 1111222333446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=323.70 Aligned_cols=242 Identities=31% Similarity=0.586 Sum_probs=194.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+.+|+.++ ||||+++++++... .....|+++++++++|.+++.. ..+++..+..
T Consensus 59 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~-------------- 122 (343)
T cd07878 59 RRTYRELRLLKHMK-HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQF-------------- 122 (343)
T ss_pred HHHHHHHHHHHhcC-CCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHH--------------
Confidence 45679999999999 99999999988632 1245799999999999988754 3477777766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 123 ---------------------------------------------i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 123 ---------------------------------------------LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeecccCChhhEEECCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||++...... ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+....|.+
T Consensus 158 kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 158 RILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred EEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999998865432 3456899999999998775568999999999999999999999999988888888898888888
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..+............+....+..+...........++.+.+||.+||..||.+|||+.|+|+||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 7766554433222222222222222223333345678889999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=317.18 Aligned_cols=250 Identities=32% Similarity=0.528 Sum_probs=184.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
..+.+|+++|+.++ ||||+++++++.......+++||||++++|.+++........
T Consensus 43 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~----------------------- 98 (317)
T cd07867 43 MSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKA----------------------- 98 (317)
T ss_pred HHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhcccc-----------------------
Confidence 35679999999999 999999999987666778999999999999998854321000
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC----C-eE
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG----D-LV 165 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~----~-~i 165 (470)
......+....+..++.||+.||.|||++||+||||||+|||+.. + .+
T Consensus 99 ---------------------------~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 151 (317)
T cd07867 99 ---------------------------NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 151 (317)
T ss_pred ---------------------------CCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcE
Confidence 000011223344459999999999999999999999999999942 2 79
Q ss_pred EEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh---------H
Q psy9855 166 VVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE---------I 232 (470)
Q Consensus 166 kL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~---------~ 232 (470)
+|+|||+++...... .....+||+.|+|||++.+...++.++|||||||++|||++|.+||.+... .
T Consensus 152 kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~ 231 (317)
T cd07867 152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH 231 (317)
T ss_pred EEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccH
Confidence 999999998664322 123457899999999987766689999999999999999999999975432 3
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCc---cccccccCCCCC----cccccccccHHHHHHHHHhcccCCCCCcCHHHH
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSN---FTYQFKQYPGGG----IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~el 305 (470)
..+..+...+|.+....|.......... ............ ........+..+.+||.+||..||.+|||+.|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~ 311 (317)
T cd07867 232 DQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQA 311 (317)
T ss_pred HHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHH
Confidence 5667788888888887776654421100 000000000000 011112346778999999999999999999999
Q ss_pred HhcccC
Q psy9855 306 LSCAYF 311 (470)
Q Consensus 306 L~hp~f 311 (470)
|+||||
T Consensus 312 l~hp~f 317 (317)
T cd07867 312 LQDPYF 317 (317)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.38 Aligned_cols=241 Identities=29% Similarity=0.546 Sum_probs=190.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+++.++ ||||+++++++... ....+|+||||++++|.+++.. .+++..+..
T Consensus 67 ~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~------------- 130 (364)
T cd07875 67 AKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSY------------- 130 (364)
T ss_pred HHHHHHHHHHHHhcC-CCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh--cCCHHHHHH-------------
Confidence 346789999999998 99999999988642 2346899999999999888753 255555555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 131 ----------------------------------------------~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 131 ----------------------------------------------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred ----------------------------------------------HHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc
Confidence 99999999999999999999999999999887 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.
T Consensus 165 ~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 165 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999998766554455678999999999997755 899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhccC----c--c-ccc----cccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYKSS----N--F-TYQ----FKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~~~----~--~-~~~----~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
|.++.+..+...... . + ... +...............+..+++||.+||..||.+|||++++|+||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 887766554332100 0 0 000 0000000001111224578899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=313.65 Aligned_cols=216 Identities=25% Similarity=0.380 Sum_probs=175.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+++|+.+|..++ |+||+++++++.. .+.+++|||||+ |+|.+++.... .+++..+..
T Consensus 45 ~~~~~E~~il~~l~-~~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~--------------- 106 (285)
T cd05631 45 AMALNEKRILEKVN-SRFVVSLAYAYET--KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF--------------- 106 (285)
T ss_pred HHHHHHHHHHHhcC-CCcEEEEEEEEcc--CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHH---------------
Confidence 35679999999998 9999999998854 668999999999 69988875433 266666655
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 107 --------------------------------------------~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~k 142 (285)
T cd05631 107 --------------------------------------------YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIR 142 (285)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||++............+||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--- 218 (285)
T cd05631 143 ISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK--- 218 (285)
T ss_pred EeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh---
Confidence 99999998765444445568999999999998755 89999999999999999999999987654333222222110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
.........++.++.+||.+||..||.+||| ++++++||||.++..
T Consensus 219 ------------------------~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 219 ------------------------EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred ------------------------cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 0111233467899999999999999999997 899999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=318.17 Aligned_cols=212 Identities=25% Similarity=0.397 Sum_probs=177.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|.+++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 37 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~---------------- 97 (312)
T cd05585 37 VTHTLAERTVLAQVN-CPFIVPLKFSFQS--PEKLYLVLAFINGGELFHHLQREGRFDLSRARF---------------- 97 (312)
T ss_pred HHHHHHHHHHHHhCC-CCcEeceeeEEec--CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 345679999999998 9999999998854 678999999999 69999998776677777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 98 -------------------------------------------~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl 134 (312)
T cd05585 98 -------------------------------------------YTAELLCALENLHKFNVIYRDLKPENILLDYQGHIAL 134 (312)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 135 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~----- 208 (312)
T cd05585 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE----- 208 (312)
T ss_pred EECcccccCccCCCccccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----
Confidence 99999875432 22334568999999999987755 899999999999999999999999887665544443220
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc---CHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP---TAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp---t~~elL~hp~f~~~~ 315 (470)
...++..+++++.+||.+||..||.+|| ++.+++.||||.+..
T Consensus 209 --------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 209 --------------------------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred --------------------------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 0112346789999999999999999997 589999999999763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=328.79 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=182.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
..+.+|+++|++|+ ||||++++++|.. ....++|+|++.++|..++.....+++..+..
T Consensus 128 ~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~------------------ 186 (391)
T PHA03212 128 GGTATEAHILRAIN-HPSIIQLKGTFTY--NKFTCLILPRYKTDLYCYLAAKRNIAICDILA------------------ 186 (391)
T ss_pred hhhHHHHHHHHhCC-CCCCCCEeEEEEE--CCeeEEEEecCCCCHHHHHHhcCCCCHHHHHH------------------
Confidence 45689999999999 9999999999865 66799999999999999998776677777766
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||++|||||||||+|||++.+ .++|+|
T Consensus 187 -----------------------------------------i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~D 225 (391)
T PHA03212 187 -----------------------------------------IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGD 225 (391)
T ss_pred -----------------------------------------HHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEe
Confidence 99999999999999999999999999999877 899999
Q ss_pred cCCcccccCC--CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHH
Q psy9855 170 LGSLQFIKSK--GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD-------SEIDQLDRIHQ 240 (470)
Q Consensus 170 FG~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~-------~~~~~~~~i~~ 240 (470)
||++...... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+. ....++..+..
T Consensus 226 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred CCcccccccccccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 9998754321 2234568999999999987755 899999999999999999999876443 23456677777
Q ss_pred HhCCCchHHHHHHhhhccCcc---ccccccCCC-CCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNF---TYQFKQYPG-GGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..|.++.+............+ .......+. .........++.++.+||.+||.+||.+|||++|+|+||||+++.
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 777655432110000000000 000000000 000011124577899999999999999999999999999998753
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=307.94 Aligned_cols=244 Identities=49% Similarity=0.884 Sum_probs=196.9
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
+.+.....+|+.++.++.+|+||+++++++.+...+.+++||||++++|.+++.... .+++..+..
T Consensus 38 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~------------- 104 (282)
T cd07831 38 SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKS------------- 104 (282)
T ss_pred CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHH-------------
Confidence 334445578999999997799999999998765447899999999999999887643 367776666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeE
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLV 165 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~i 165 (470)
++.||+.||+|||+.|++||||+|+||+++.+.+
T Consensus 105 ----------------------------------------------~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~ 138 (282)
T cd07831 105 ----------------------------------------------YMYQLLKSLDHMHRNGIFHRDIKPENILIKDDIL 138 (282)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCceecccCHHHEEEcCCCe
Confidence 9999999999999999999999999999999889
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||.+.............++..|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....|.+
T Consensus 139 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~ 218 (282)
T cd07831 139 KLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP 218 (282)
T ss_pred EEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCC
Confidence 99999999876655444556789999999987665557899999999999999999999999999988888898888887
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
............. ....++...........+.++..+.+||.+||..||++|||++++++||||
T Consensus 219 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 219 DAEVLKKFRKSRH--MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CHHHHHhhccccc--ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 7765433322111 111222222222233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=315.54 Aligned_cols=210 Identities=24% Similarity=0.346 Sum_probs=178.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|+.++ ||||+++++++.+ ...+|+||||++ |+|.+++.....+++..+..
T Consensus 46 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~----------------- 105 (291)
T cd05612 46 QHVHNEKRVLKEVS-HPFIIRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF----------------- 105 (291)
T ss_pred HHHHHHHHHHHhCC-CCcHhhhHhhhcc--CCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 45678999999999 9999999998754 678999999998 69999998877788877776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~ 143 (291)
T cd05612 106 ------------------------------------------YASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLT 143 (291)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEE
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 144 Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------- 213 (291)
T cd05612 144 DFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------- 213 (291)
T ss_pred ecCcchhccCC--cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Confidence 99998766432 23457999999999987755 799999999999999999999999888766655554321
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
...++..++..+.+||.+||+.||.+|++ ++++++||||..+..
T Consensus 214 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 214 ------------------------KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred ------------------------CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 01122356788999999999999999995 999999999987653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=321.44 Aligned_cols=209 Identities=22% Similarity=0.331 Sum_probs=177.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||+++++++.. .+.+|+||||+. |+|.+++.....+++..+..
T Consensus 63 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 122 (329)
T PTZ00263 63 QHVAQEKSILMELS-HPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF----------------- 122 (329)
T ss_pred HHHHHHHHHHHhCC-CCCCCcEEEEEEc--CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHH-----------------
Confidence 35789999999998 9999999999865 678999999998 59999998877777777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 123 ------------------------------------------~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~ 160 (329)
T PTZ00263 123 ------------------------------------------YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVT 160 (329)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++....... ...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------- 230 (329)
T PTZ00263 161 DFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------- 230 (329)
T ss_pred eccCceEcCCCc--ceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------
Confidence 999988664332 3458999999999998765 799999999999999999999999887766555444320
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLT 315 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~ 315 (470)
...++..++..+.+||.+||..||.+|++ +++++.||||.+..
T Consensus 231 ------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 231 ------------------------RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred ------------------------CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 01122347788999999999999999997 79999999999754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=322.51 Aligned_cols=210 Identities=24% Similarity=0.334 Sum_probs=179.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 76 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~~--~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~----------------- 135 (340)
T PTZ00426 76 DHVFSERKILNYIN-HPFCVNLYGSFKD--ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF----------------- 135 (340)
T ss_pred HHHHHHHHHHHhCC-CCCCcceEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 35678999999999 9999999999865 678999999998 69999998877788877776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 136 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 136 ------------------------------------------YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+.......+...
T Consensus 174 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~------- 243 (340)
T PTZ00426 174 DFGFAKVVDTR--TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG------- 243 (340)
T ss_pred cCCCCeecCCC--cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC-------
Confidence 99998765432 24568999999999997755 789999999999999999999999887765555544321
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
...++..+++.+.++|.+||..||.+|+ |++++++||||.++..
T Consensus 244 ------------------------~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 244 ------------------------IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred ------------------------CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 1112345788999999999999999995 8999999999998663
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.76 Aligned_cols=242 Identities=31% Similarity=0.573 Sum_probs=190.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+++.++ ||||+++++++.... ....|+||||++++|.+.+.. .+++..+..
T Consensus 60 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~------------- 123 (355)
T cd07874 60 AKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSY------------- 123 (355)
T ss_pred HHHHHHHHHHHHHhC-CCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh--cCCHHHHHH-------------
Confidence 346779999999999 999999999886432 245899999999998888753 255555555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 124 ----------------------------------------------~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~ 157 (355)
T cd07874 124 ----------------------------------------------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC
Confidence 99999999999999999999999999999887 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...++.
T Consensus 158 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred EEEeeCcccccCCCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999998766554455678999999999987755 899999999999999999999999999988888888888888
Q ss_pred CchHHHHHHhhhcc----Ccccc---cccc-CCCC---CcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYKS----SNFTY---QFKQ-YPGG---GIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~~----~~~~~---~~~~-~~~~---~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
+.++.+..+..... ..... .++. .+.. .........+.++.+||.+||..||++|||+.|+|+||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 88776654432110 00000 0000 0000 001112234678899999999999999999999999999974
Q ss_pred h
Q psy9855 314 L 314 (470)
Q Consensus 314 ~ 314 (470)
.
T Consensus 317 ~ 317 (355)
T cd07874 317 W 317 (355)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.14 Aligned_cols=238 Identities=31% Similarity=0.564 Sum_probs=197.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.||+.++..+. |+||++++.+|+... ...+|+|||+|.++|.+.+. -.++...++.
T Consensus 60 kra~rel~l~~~v~-~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~-------------- 122 (369)
T KOG0665|consen 60 KRAYRELKLMKCVN-HKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL--MELDHETISY-------------- 122 (369)
T ss_pred hhhhhhhhhhhhhc-ccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHH--------------
Confidence 45789999999999 999999999998532 35589999999999999986 2244444444
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|++|+++|++|||+.||+||||||+||++..+ .+
T Consensus 123 ---------------------------------------------i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 123 ---------------------------------------------ILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhcceeecccCcccceecchhhe
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
||.|||+|+.....-..+.++.|+.|+|||++.+.+ |...+||||+|||+.||++|+..|+|.+..+++.++.+.+|+|
T Consensus 158 Ki~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 158 KILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred eeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 999999998877665667889999999999999988 8999999999999999999999999999999999999999999
Q ss_pred chHHHHHHhhhccCccccccccC---------CCCCcccc---cccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQY---------PGGGIDVL---VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
.+..+..+......-.. ..+++ |...+... .+.-+..+.+|+.+||..||++|.+++++|+||||+
T Consensus 237 d~~F~~qL~~~~r~yv~-~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVE-NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred CHHHHHHhhHHHHHHhh-cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 99988776554321111 11111 11111111 122356789999999999999999999999999997
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.87 Aligned_cols=213 Identities=25% Similarity=0.393 Sum_probs=180.3
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
.+.-|-+||..+. ||.+..||+.|. .....|+|||||+ |+|..+.++... +++..++.
T Consensus 123 Ra~tE~eIL~~lD-HPFlPTLYa~fe--t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRF---------------- 183 (459)
T KOG0610|consen 123 RAQTEREILSLLD-HPFLPTLYASFE--TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARF---------------- 183 (459)
T ss_pred HHHHHHHHHHhcC-CCccchhhheee--ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHH----------------
Confidence 4567889999999 999999999995 4788999999999 599999877665 77777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+..|+.||+|||..|||+|||||+|||+.++ +|.|
T Consensus 184 -------------------------------------------YaAEvl~ALEYLHmlGivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 184 -------------------------------------------YAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEe
Confidence 99999999999999999999999999999888 9999
Q ss_pred EecCCcccccC-----------------------------------C----------------------CccccccccCc
Q psy9855 168 GDLGSLQFIKS-----------------------------------K----------------------GLHTEYIATRW 190 (470)
Q Consensus 168 ~DFG~a~~~~~-----------------------------------~----------------------~~~~~~~gt~~ 190 (470)
+||.++..... . .....++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99997643210 0 00123589999
Q ss_pred ccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCC
Q psy9855 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPG 270 (470)
Q Consensus 191 Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (470)
|+|||++.|.+ .+.++|.|+|||++|||+.|..||.|.+..+.+.+|.. .+ ..++
T Consensus 301 YlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---~~-----------------l~Fp---- 355 (459)
T KOG0610|consen 301 YLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---QP-----------------LKFP---- 355 (459)
T ss_pred cccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---CC-----------------CcCC----
Confidence 99999999988 69999999999999999999999999999888887753 11 0111
Q ss_pred CCcccccccccHHHHHHHHHhcccCCCCCcC----HHHHHhcccCCChhH
Q psy9855 271 GGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT----AQKILSCAYFADLTQ 316 (470)
Q Consensus 271 ~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt----~~elL~hp~f~~~~~ 316 (470)
-.+.++..++|||+++|++||.+|.. |.||-+||||+++..
T Consensus 356 -----~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 356 -----EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred -----CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 11367899999999999999999999 999999999999874
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=293.47 Aligned_cols=244 Identities=30% Similarity=0.503 Sum_probs=198.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeec------CCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVN------RSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANE 82 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~------~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~ 82 (470)
....+||+++|..|+ |+||+.+++++.. .....+|+||.+|+.||..++..... ++...++.
T Consensus 60 pitalreikiL~~lk-Henv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk---------- 128 (376)
T KOG0669|consen 60 PITALREIKILQLLK-HENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKK---------- 128 (376)
T ss_pred cHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHH----------
Confidence 346799999999999 9999999998752 22345999999999999999976533 66666666
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.+++.||.|+|.+.|+|||+||+|+||+.
T Consensus 129 -------------------------------------------------~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~ 159 (376)
T KOG0669|consen 129 -------------------------------------------------VMKGLMNGLYYIHRNKILHRDMKAANVLITK 159 (376)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHhhHHhhcccHhhEEEcC
Confidence 9999999999999999999999999999999
Q ss_pred C-eEEEEecCCcccccC-----CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKS-----KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
+ .++|+|||+++.+.. ....+..+.|.+|++||.+.|.+.|+++.|||..|||+.||++|.+.|.+.++..++.
T Consensus 160 dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~ 239 (376)
T KOG0669|consen 160 DGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH 239 (376)
T ss_pred CceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH
Confidence 7 899999999976542 2234566889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccc-----cccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVL-----VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.|..++|....+.|+....+..-.-. .....+.+....+ +-.-.+++.|||.+||.+||.+|++++++|.|.||
T Consensus 240 ~Is~LcGs~tkevWP~~d~lpL~~si-e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 240 LISQLCGSITKEVWPNVDNLPLYQSI-ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred HHHHHhccCCcccCCCcccchHHHhc-cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 99999999999998876554311100 0010111111111 01125688999999999999999999999999999
Q ss_pred CCh
Q psy9855 312 ADL 314 (470)
Q Consensus 312 ~~~ 314 (470)
..-
T Consensus 319 ~kd 321 (376)
T KOG0669|consen 319 WKD 321 (376)
T ss_pred hcC
Confidence 853
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.29 Aligned_cols=211 Identities=23% Similarity=0.327 Sum_probs=177.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+++|+.+|+.++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 40 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~----------------- 99 (328)
T cd05593 40 AHTLTESRVLKNTR-HPFLTSLKYSFQT--KDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF----------------- 99 (328)
T ss_pred HHHHHHHHHHHhCC-CCCCcceEEEEEc--CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHH-----------------
Confidence 45689999999999 9999999998864 678999999999 69999988777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 100 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~ 137 (328)
T cd05593 100 ------------------------------------------YGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKIT 137 (328)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 138 DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------- 209 (328)
T cd05593 138 DFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------- 209 (328)
T ss_pred cCcCCccCCCcccccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-------
Confidence 9999875432 22334568999999999987755 89999999999999999999999987765544433311
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
....++..++.++.+||.+||..||.+|+ ++.++++||||.+..
T Consensus 210 ------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 210 ------------------------EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred ------------------------CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 00112346789999999999999999997 899999999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.14 Aligned_cols=206 Identities=24% Similarity=0.377 Sum_probs=175.5
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~ 84 (470)
.....+++|+++|++|+ |+|||+++|++.. .+.+|||||||. |+|.++|+... .+...+...
T Consensus 243 m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~--~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~------------ 307 (468)
T KOG0197|consen 243 MSPEAFLREAQIMKKLR-HEKLVKLYGVCTK--QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLD------------ 307 (468)
T ss_pred cChhHHHHHHHHHHhCc-ccCeEEEEEEEec--CCceEEEEEecccCcHHHHhhhcCCCccchHHHHH------------
Confidence 34567899999999999 9999999999865 457999999999 99999999732 266666666
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.|||+|++||+++++|||||-..|||++++
T Consensus 308 -----------------------------------------------~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~ 340 (468)
T KOG0197|consen 308 -----------------------------------------------FAAQIAEGMAYLESKNYIHRDLAARNILVDEDL 340 (468)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCccchhhhhhheeeccCc
Confidence 99999999999999999999999999999999
Q ss_pred eEEEEecCCcccccCCCccccc--cccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEY--IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~--~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
.+||+|||+|+...++...... --...|.|||.+.... ++.++|||||||+||||+| |+.||++.+..+.+..+.+
T Consensus 341 ~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~ 419 (468)
T KOG0197|consen 341 VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER 419 (468)
T ss_pred eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence 8999999999965544432221 2245699999998766 8999999999999999998 9999999999999998876
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
....| .++.+|+++.++|..||..+|++|||++.+.
T Consensus 420 GyRlp------------------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 420 GYRLP------------------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred cCcCC------------------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 44333 2357899999999999999999999999654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=307.78 Aligned_cols=237 Identities=35% Similarity=0.680 Sum_probs=189.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc---cccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD---NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~---~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+++.++ ||||+++++++.. ...+|+||||++++|.+++.... .+++..+..
T Consensus 44 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~--------------- 105 (285)
T cd07861 44 STAIREISLLKELQ-HPNIVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS--------------- 105 (285)
T ss_pred HHHHHHHHHHHhcC-CCCEeeeEEEEee--CCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHH---------------
Confidence 45789999999999 9999999999865 67899999999999999986533 266666665
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+||+++.+ .++
T Consensus 106 --------------------------------------------~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~ 141 (285)
T cd07861 106 --------------------------------------------YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIK 141 (285)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||++...... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+....+....+.+
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~ 221 (285)
T cd07861 142 LADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP 221 (285)
T ss_pred ECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999988755422 122334678999999998766557899999999999999999999999988888888888877777
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
....|........ +....+.+...........+++++.+||.+||..||.+|||+.+++.||||
T Consensus 222 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 222 TEDVWPGVTSLPD--YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ChhhhhcchhhHH--HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 7666654333211 111122222222233345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.87 Aligned_cols=212 Identities=22% Similarity=0.317 Sum_probs=178.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+..||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 40 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~----------------- 100 (320)
T cd05590 40 ECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF----------------- 100 (320)
T ss_pred HHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHH-----------------
Confidence 4567899999887569999999998854 678999999999 59999998877788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~ 138 (320)
T cd05590 101 ------------------------------------------YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLA 138 (320)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 139 DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------ 211 (320)
T cd05590 139 DFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------ 211 (320)
T ss_pred eCCCCeecCcCCCcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------
Confidence 999887543 222334568999999999987654 899999999999999999999999888776665554321
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH------HHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA------QKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~------~elL~hp~f~~~~ 315 (470)
....+..++.++.+||.+||+.||.+||++ +++++||||..+.
T Consensus 212 -------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 212 -------------------------EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 011223578899999999999999999998 9999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.17 Aligned_cols=211 Identities=24% Similarity=0.324 Sum_probs=177.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++..++ ||||++++++|.. .+.+|+||||++ |+|..++.....+++..++.
T Consensus 40 ~~~~~E~~~l~~l~-hp~i~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~----------------- 99 (323)
T cd05595 40 AHTVTESRVLQNTR-HPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARF----------------- 99 (323)
T ss_pred HHHHHHHHHHHhCC-CCCCcceeeEEec--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 35678999999999 9999999998865 678999999999 69999998777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 100 ------------------------------------------~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 137 (323)
T cd05595 100 ------------------------------------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKIT 137 (323)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEec
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 138 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------ 210 (323)
T cd05595 138 DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------ 210 (323)
T ss_pred ccHHhccccCCCCccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------
Confidence 9998875322 22234567999999999987655 899999999999999999999999877665554443210
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
...++..+++++.+||.+||..||.+|+ ++.++++||||.+..
T Consensus 211 -------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 211 -------------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 0112346789999999999999999998 999999999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=327.29 Aligned_cols=218 Identities=22% Similarity=0.335 Sum_probs=189.2
Q ss_pred CCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcc
Q psy9855 5 CPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 5 ~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~ 83 (470)
+.+.+.+..+.|-.|+.....||.+++++..|+. ..++|+||||+.| |+.. +...+.+++..+..
T Consensus 407 l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarf----------- 472 (694)
T KOG0694|consen 407 LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARF----------- 472 (694)
T ss_pred eccccHHHHHHHHHHHHHhccCCeEeeccccccc--CCeEEEEEEecCCCcEEE-EEecccccHHHHHH-----------
Confidence 4455667789999999999889999999999954 7899999999995 7333 33344588877776
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
|+..|+.||+|||++||||||||.+|||+|.+
T Consensus 473 ------------------------------------------------yaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e 504 (694)
T KOG0694|consen 473 ------------------------------------------------YAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE 504 (694)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHhcCceeeecchhheEEccc
Confidence 99999999999999999999999999999988
Q ss_pred -eEEEEecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 -LVVVGDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 -~ikL~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.+||+|||+++..- .+....++||||.|||||++.+.. |+.++|.|||||+||||+.|..||+|+++.+....|...
T Consensus 505 Gh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d 583 (694)
T KOG0694|consen 505 GHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND 583 (694)
T ss_pred CcEEecccccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 99999999998654 566778899999999999998866 999999999999999999999999999999999888641
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-----HHHHhcccCCChhH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-----QKILSCAYFADLTQ 316 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-----~elL~hp~f~~~~~ 316 (470)
...++-.++.++.++|+++|..||++|..+ ++|..||||+.++.
T Consensus 584 -------------------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 584 -------------------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred -------------------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 122345789999999999999999999975 78999999999874
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=307.21 Aligned_cols=236 Identities=31% Similarity=0.605 Sum_probs=190.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhc-ccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.+ .+.+++|+||++++|.+++... ..+++..+..
T Consensus 44 ~~~~~ei~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~----------------- 103 (284)
T cd07839 44 SSALREICLLKELK-HKNIVRLYDVLHS--DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS----------------- 103 (284)
T ss_pred cchhHHHHHHHhcC-CCCeeeHHHHhcc--CCceEEEEecCCCCHHHHHHhcCCCCCHHHHHH-----------------
Confidence 45678999999998 9999999999864 6689999999999999988654 3377777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||++||+||||||+||+++.+ .++|+
T Consensus 104 ------------------------------------------~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~ 141 (284)
T cd07839 104 ------------------------------------------FMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLA 141 (284)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEEC
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++...... .......++..|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+.
T Consensus 142 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
T cd07839 142 DFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221 (284)
T ss_pred ccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 99998765432 2223456789999999987766678999999999999999998766 567777788888888888888
Q ss_pred hHHHHHHhhhccCccccccccC-CCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQY-PGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
...+........... .... ....+....+.+++++.+||.+||..||.+|||+++++.||||
T Consensus 222 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 222 EESWPGVSKLPDYKP---YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hHHhHHhhhcccccc---cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 777765544322111 1111 1112233446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=292.36 Aligned_cols=209 Identities=25% Similarity=0.370 Sum_probs=184.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHh--cccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRT--TDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~--~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
+.++.||++|-..|+ ||||++++++|.+ ...+||++||.. |.|...|.. ...+++.....
T Consensus 66 ~~qlrREiEIqs~L~-hpnilrlY~~fhd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~-------------- 128 (281)
T KOG0580|consen 66 EHQLRREIEIQSHLR-HPNILRLYGYFHD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAAT-------------- 128 (281)
T ss_pred hhhhhheeEeecccC-CccHHhhhhheec--cceeEEEEEecCCchHHHHHHhcccccccccchhH--------------
Confidence 557889999999999 9999999999965 778999999999 899999984 44477777766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|++|++.||.|||.++|+||||||+|+|++.. .+
T Consensus 129 ---------------------------------------------Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 129 ---------------------------------------------YIKQLANALLYCHLKRVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred ---------------------------------------------HHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCe
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
||+|||.+.... .+...+.|||..|.+||...+.. ++..+|+|++|++.||++.|.+||...+..+...+|.++-
T Consensus 164 kiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~--- 238 (281)
T KOG0580|consen 164 KIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD--- 238 (281)
T ss_pred eccCCCceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc---
Confidence 999999887655 44557789999999999998876 8999999999999999999999999998888888886631
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
..+++.++.++.|||.+||..+|.+|.+..|++.|||+..
T Consensus 239 ----------------------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 239 ----------------------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ----------------------------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 1123678999999999999999999999999999999864
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.23 Aligned_cols=216 Identities=25% Similarity=0.451 Sum_probs=191.9
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~ 84 (470)
-+...+++|+.++.++. |||||.+.+.|.. ++..+||||+||+ |+|.+.|..... ++++.+..
T Consensus 45 ~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~-~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~------------ 110 (426)
T KOG0589|consen 45 PERRSAIQEMDLLSKLL-HPNIVEYKDSFEE-DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILK------------ 110 (426)
T ss_pred hhhHHHHHHHHHHHhcc-CCCeeeeccchhc-CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHH------------
Confidence 34557899999999999 9999999999975 3344999999999 599999988774 88888887
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||.|||+++|+|||||+.||+++.+
T Consensus 111 -----------------------------------------------~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~ 143 (426)
T KOG0589|consen 111 -----------------------------------------------WFVQILLAVNYLHENRVLHRDLKCANIFLTKDK 143 (426)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhhhhhcccchhhhhhccccC
Confidence 99999999999999999999999999999988
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.|+|+|||+|+...... ...+.+||+.||+||++.+.+ |+.++|||||||++|||++-+++|.+.+......+|.+..
T Consensus 144 ~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 144 KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL 222 (426)
T ss_pred ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc
Confidence 78999999999988766 677889999999999998866 9999999999999999999999999999888888887643
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...++..++.+++.||..||..+|..||++.++|.+|......
T Consensus 223 ------------------------------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 223 ------------------------------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred ------------------------------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 3445567899999999999999999999999999998877543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=313.69 Aligned_cols=210 Identities=25% Similarity=0.381 Sum_probs=176.9
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+.+|+.++ ||||++++++|.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 46 ~~~~E~~il~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~------------------ 104 (323)
T cd05584 46 HTKAERNILEAVK-HPFIVDLIYAFQT--GGKLYLILEYLSGGELFMHLEREGIFMEDTACF------------------ 104 (323)
T ss_pred HHHHHHHHHHhCC-CCchhceeeEEec--CCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHH------------------
Confidence 4578999999999 9999999999865 678999999999 59999998777677777666
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+|
T Consensus 105 -----------------------------------------~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 105 -----------------------------------------YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEee
Confidence 89999999999999999999999999999877 899999
Q ss_pred cCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 170 LGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 170 FG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
||++..... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+...
T Consensus 144 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~------- 215 (323)
T cd05584 144 FGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG------- 215 (323)
T ss_pred CcCCeecccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------
Confidence 999875432 22334567999999999987755 789999999999999999999999887765555444321
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
...+++.+++.+.+||.+||..||++|| +++++++||||....
T Consensus 216 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 216 ------------------------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred ------------------------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 1123356788999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=315.67 Aligned_cols=217 Identities=23% Similarity=0.326 Sum_probs=175.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..+++||||+++++++.. .+.+++||||++ |+|.+++.....+++..++.
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~----------------- 109 (332)
T cd05614 49 EHTRTERNVLEHVRQSPFLVTLHYAFQT--EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF----------------- 109 (332)
T ss_pred HHHHHHHHHHHhccCCCCcccEEEEEec--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 3467899999999779999999998854 677999999999 59999998777788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 110 ------------------------------------------~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~ 147 (332)
T cd05614 110 ------------------------------------------YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147 (332)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++....... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+....
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---- 223 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI---- 223 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH----
Confidence 999987653222 22346899999999998776557899999999999999999999996543221111111100
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
. .....++..++..+.+||.+||..||++|| +++++++||||++..
T Consensus 224 -------~----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 224 -------L----------------KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred -------h----------------cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0 000112345788999999999999999999 899999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=312.92 Aligned_cols=212 Identities=21% Similarity=0.312 Sum_probs=178.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+..|++++..+.+||||+++++++.. .+.+|+||||++ |+|..++.....+++..+..
T Consensus 40 ~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~----------------- 100 (321)
T cd05591 40 DCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF----------------- 100 (321)
T ss_pred HHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 4567899999887569999999999865 678999999999 59999998777777777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~ 138 (321)
T cd05591 101 ------------------------------------------YAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLA 138 (321)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 139 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------ 211 (321)
T cd05591 139 DFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------ 211 (321)
T ss_pred ecccceecccCCccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------
Confidence 999887543 222334567999999999987655 899999999999999999999999988877666555331
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-------CHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-------TAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-------t~~elL~hp~f~~~~ 315 (470)
....+..++.++.+||.+||..||++|+ +++++++||||....
T Consensus 212 -------------------------~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 212 -------------------------DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 0112234688999999999999999999 999999999998765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=304.36 Aligned_cols=239 Identities=33% Similarity=0.641 Sum_probs=194.5
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+.++.+++ ||||+++++++.+......|+||||++++|.+++..... +++..+..
T Consensus 50 ~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~------------------ 110 (293)
T cd07843 50 TSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC------------------ 110 (293)
T ss_pred hHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHH------------------
Confidence 4578999999999 999999999987655588999999999999999876544 67777666
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||++|++||||||+||+++.+ .++|+|
T Consensus 111 -----------------------------------------i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 111 -----------------------------------------LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEee
Confidence 99999999999999999999999999999987 899999
Q ss_pred cCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 170 LGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 170 FG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
||.+...... .......+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+....+....+...++.|...
T Consensus 150 ~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 150 FGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred cCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9988876543 233445678899999998766557899999999999999999999999999999999999999999888
Q ss_pred HHHHHhhhccCccccccccCCCCCccccccc--ccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ--IHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.|..+.......- ...............+. +++.+.+||.+||..||++|||+.|+|+||||
T Consensus 230 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 230 IWPGFSELPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHhhccchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 8876654322111 00000001111111222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=300.20 Aligned_cols=245 Identities=27% Similarity=0.481 Sum_probs=200.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCC---CeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRST---RQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~---~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.||+++|..++ |.||+..+++.+.+.- ..+|+|+|+|..||..+|...+.++.+.++-
T Consensus 96 ~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKV-------------- 160 (449)
T KOG0664|consen 96 CKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKV-------------- 160 (449)
T ss_pred HHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhh--------------
Confidence 456899999999999 9999999998765432 3479999999999999997766666555554
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
+++||++||+|||+.||+||||||.|+|++.+ .+
T Consensus 161 ---------------------------------------------FlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvL 195 (449)
T KOG0664|consen 161 ---------------------------------------------FVYQILRGLKYLHTANILHRDIKPGNLLVNSNCIL 195 (449)
T ss_pred ---------------------------------------------hHHHHHhhhHHHhhcchhhccCCCccEEeccCceE
Confidence 99999999999999999999999999999999 88
Q ss_pred EEEecCCcccccCC--CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 166 VVGDLGSLQFIKSK--GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 166 kL~DFG~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
||||||+++..... ...+..+.|.+|+|||+++|.+.|+.++||||+|||+.||+..+..|...++.++++.|.+++|
T Consensus 196 KICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG 275 (449)
T KOG0664|consen 196 KICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG 275 (449)
T ss_pred EecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence 99999999876533 2345678899999999999999999999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhhhccCccccccccCCC--CCcccccc--cccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPG--GGIDVLVP--QIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+|..+.++....-. .....+....+. ..+..+.. .-..+..+++.+||..||.+|.+.++++.|+|..+.+
T Consensus 276 TPs~EaMr~ACEGA-k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 276 TPSQEAMKYACEGA-KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred CCcHHHHHHHhhhh-HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 99999887654421 111111111110 11111211 2345778999999999999999999999999998765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=313.60 Aligned_cols=217 Identities=22% Similarity=0.360 Sum_probs=180.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 46 ~~~~~e~~~l~~~~-h~~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~----------------- 105 (333)
T cd05600 46 RHVLTERDILTTTK-SEWLVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF----------------- 105 (333)
T ss_pred HHHHHHHHHHHhCC-CCCCccEEEEEEc--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 45779999999999 9999999998864 678999999998 59999998777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~ 143 (333)
T cd05600 106 ------------------------------------------YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLT 143 (333)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+.......
T Consensus 144 Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--- 217 (333)
T cd05600 144 DFGLSKGIVT--YANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL--- 217 (333)
T ss_pred eCcCCccccc--ccCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc---
Confidence 9999876543 334568999999999988764 8999999999999999999999998887766665554321100
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..+ ........+++++.+||.+||..+|.+||+++++++||||.+..
T Consensus 218 ---------------~~~-----~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 218 ---------------QRP-----VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred ---------------cCC-----CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 000 00001135789999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.28 Aligned_cols=242 Identities=33% Similarity=0.574 Sum_probs=194.5
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
...+|+.++++++ |+||+++++++.+...+.+++||||++++|.+++.... .+++..+..
T Consensus 52 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~------------------ 112 (309)
T cd07845 52 SSLREITLLLNLR-HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC------------------ 112 (309)
T ss_pred hhhHHHHHHHhCC-CCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHH------------------
Confidence 4568999999999 99999999999765556799999999999999987643 366666666
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||+.|++||||||+||+++.+ .++|+|
T Consensus 113 -----------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 113 -----------------------------------------LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred -----------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 99999999999999999999999999999887 899999
Q ss_pred cCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 170 LGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 170 FG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
||.+...... .......++..|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+...++.+...
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 152 FGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred cceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 9998876533 222334568889999998776668899999999999999999999999999999999999999988877
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.|..+....... .......+...........++.+.+||.+||..||++|||++++++||||.+.
T Consensus 232 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 232 IWPGFSDLPLVG-KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hchhhhcccccc-cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 766554422110 01111111111222234468899999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=314.55 Aligned_cols=211 Identities=25% Similarity=0.330 Sum_probs=176.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++..++ ||||+++++++.. .+.+|+||||++ |+|..++.....+++..+..
T Consensus 40 ~~~~~e~~~l~~~~-hp~i~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~----------------- 99 (325)
T cd05594 40 AHTLTENRVLQNSR-HPFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARF----------------- 99 (325)
T ss_pred HHHHHHHHHHHhCC-CCCCCceEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45678999999999 9999999998865 678999999999 59999988777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||+ +||+||||||+|||++.+ .++|
T Consensus 100 ------------------------------------------~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL 137 (325)
T cd05594 100 ------------------------------------------YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKI 137 (325)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEE
Confidence 99999999999997 799999999999999887 8999
Q ss_pred EecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 138 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~----- 211 (325)
T cd05594 138 TDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----- 211 (325)
T ss_pred ecCCCCeecCCCCcccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----
Confidence 9999987543 222334567999999999987755 899999999999999999999999877655444433210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
...++..+++++.+||.+||+.||.+|+ ++.++++||||.+..
T Consensus 212 --------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 212 --------------------------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred --------------------------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 0112345788999999999999999997 999999999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=311.12 Aligned_cols=212 Identities=23% Similarity=0.353 Sum_probs=175.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.....|..++..+.+||||+++++++.. .+.+|+||||+. |+|..++.....+++..+..
T Consensus 40 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~----------------- 100 (316)
T cd05620 40 ECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF----------------- 100 (316)
T ss_pred HHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 4567888888876459999999999865 678999999999 59999998776677777766
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~ 138 (316)
T cd05620 101 ------------------------------------------YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIA 138 (316)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeC
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 139 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------ 211 (316)
T cd05620 139 DFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------ 211 (316)
T ss_pred ccCCCeecccCCCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------
Confidence 999886432 222334568999999999987755 899999999999999999999999887765555444220
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-HHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-QKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-~elL~hp~f~~~~ 315 (470)
...++..++.++.+||.+||..||.+|+++ +++++||||+.+.
T Consensus 212 -------------------------~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 212 -------------------------TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 011223578899999999999999999998 5889999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.98 Aligned_cols=214 Identities=22% Similarity=0.354 Sum_probs=174.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++.+.+ ...+|+|||||+ |+|.+++.....+++..++.
T Consensus 46 ~~~~~E~~il~~~~-~~~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~----------------- 105 (363)
T cd05628 46 GHIRAERDILVEAD-SLWVVKMFYSFQD--KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF----------------- 105 (363)
T ss_pred HHHHHHHHHHHhCC-CCCcceEEEEEec--CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 35678999999998 9999999998864 678999999998 59999998877788888777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~ 143 (363)
T cd05628 106 ------------------------------------------YIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLS 143 (363)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCC------------------------------------ccccccccCcccCchhhccCCCCCCcccHHHH
Q psy9855 169 DLGSLQFIKSKG------------------------------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAA 212 (470)
Q Consensus 169 DFG~a~~~~~~~------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSl 212 (470)
|||++....... .....+||+.|+|||++.+.. ++.++|||||
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSl 222 (363)
T cd05628 144 DFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSL 222 (363)
T ss_pred eccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhh
Confidence 999987543210 012458999999999998765 8999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhc
Q psy9855 213 GCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEML 292 (470)
Q Consensus 213 G~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L 292 (470)
||++|||++|..||.+.+..+....+...... ..++ -...+++++++||.+|+
T Consensus 223 Gvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------------~~~p---------~~~~~s~~~~~li~~l~ 275 (363)
T cd05628 223 GVIMYEMLIGYPPFCSETPQETYKKVMNWKET------------------LIFP---------PEVPISEKAKDLILRFC 275 (363)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCc------------------ccCC---------CcCCCCHHHHHHHHHHc
Confidence 99999999999999988777666655431110 0000 01246889999999977
Q ss_pred ccCCC---CCcCHHHHHhcccCCChh
Q psy9855 293 KYDPK---RRPTAQKILSCAYFADLT 315 (470)
Q Consensus 293 ~~dP~---~Rpt~~elL~hp~f~~~~ 315 (470)
. +|. .||+++|+++||||+++.
T Consensus 276 ~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 276 C-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred C-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 5 444 468999999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=301.74 Aligned_cols=240 Identities=30% Similarity=0.582 Sum_probs=195.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++++++ ||||+++++++.. ...+++|+||++++|.+++..... +++..+..
T Consensus 43 ~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~---------------- 103 (286)
T cd07832 43 PNQALREIKALQACQ-HPYVVKLLDVFPH--GSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKS---------------- 103 (286)
T ss_pred hHHHHHHHHHHHhCC-CCCCcceeeEEec--CCeeEEEecccCCCHHHHHHhcCCCCCHHHHHH----------------
Confidence 456789999999999 9999999999865 678999999997799999865433 67777666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||+.|++|+||||+||+++.+ .++|
T Consensus 104 -------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l 140 (286)
T cd07832 104 -------------------------------------------YMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140 (286)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|||.+....... ......|+..|+|||++.+...++.++||||+||++|+|++|.++|.+.+....+..+...++.+
T Consensus 141 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07832 141 ADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220 (286)
T ss_pred eeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCC
Confidence 9999887665433 23445789999999998766667899999999999999999999999999888999999989988
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
....|..+...... ....+.......+....+..+..+.+||.+||..||.+|||++++|+||||.
T Consensus 221 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 221 NEETWPGLTSLPDY-NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ChHHHhhccCcchh-hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 88777664432211 0111111112223334456789999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.88 Aligned_cols=211 Identities=22% Similarity=0.341 Sum_probs=178.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|.+++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 43 ~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~----------------- 102 (318)
T cd05582 43 VRTKMERDILAEVN-HPFIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF----------------- 102 (318)
T ss_pred HHHHHHHHHHHhCC-CCCcccEEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 34678999999999 9999999998865 678999999998 69999998776688877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 103 ------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~ 140 (318)
T cd05582 103 ------------------------------------------YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLT 140 (318)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 141 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~------ 213 (318)
T cd05582 141 DFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA------ 213 (318)
T ss_pred eccCCcccCCCCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC------
Confidence 99998765433 2334568999999999987755 789999999999999999999999887766555544321
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~ 315 (470)
...++..+++.+.+||.+||+.||.+||| +.+++.||||..+.
T Consensus 214 -------------------------~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 214 -------------------------KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 01123457889999999999999999999 78899999999865
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.71 Aligned_cols=237 Identities=35% Similarity=0.663 Sum_probs=191.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|++++++++ ||||+++++++.+ .+..++||||+.++|.+++.... .+++..+..
T Consensus 44 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~---------------- 104 (284)
T cd07860 44 STAIREISLLKELN-HPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS---------------- 104 (284)
T ss_pred hHHHHHHHHHHhcC-CCCCcchhhhccc--CCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHH----------------
Confidence 45789999999999 9999999998854 67899999999989999986543 256666665
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||+.|++||||+|+||+++.+ .++|
T Consensus 105 -------------------------------------------~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l 141 (284)
T cd07860 105 -------------------------------------------YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKL 141 (284)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+....+.+.
T Consensus 142 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 221 (284)
T cd07860 142 ADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 221 (284)
T ss_pred eeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999887654322 223346788999999887766578899999999999999999999999988888888888888887
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
...+........ +...+..+.........+.++.++.++|.+||..||.+|||+.++++||||
T Consensus 222 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 222 EVVWPGVTSLPD--YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhhhhhhhHHHH--HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 766554433211 111222222333333445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.84 Aligned_cols=218 Identities=21% Similarity=0.347 Sum_probs=180.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
-..++-||+||..+. ||+||+|++.|.. .+.+|++.|||+| -...++-.-+. +++.++.-
T Consensus 73 LEDylVEIeILa~Cd-HP~ivkLl~ayy~--enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqv--------------- 134 (1187)
T KOG0579|consen 73 LEDYLVEIEILAECD-HPVIVKLLSAYYF--ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQV--------------- 134 (1187)
T ss_pred HhhhhhhhhhhhcCC-ChHHHHHHHHHhc--cCceEEEEeecCCchHhHHHHHhccccchHHHHH---------------
Confidence 356789999999999 9999999999876 5679999999995 67666654443 66666665
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
+++|++.||.|||+++|||||||..|||++-+ .++
T Consensus 135 --------------------------------------------vc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdir 170 (1187)
T KOG0579|consen 135 --------------------------------------------VCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIR 170 (1187)
T ss_pred --------------------------------------------HHHHHHHHHHHHhhcchhhhhccccceEEEecCcEe
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCccccc-CCCccccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIK-SKGLHTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||.+.... .......++|||+|||||++.. ...|++++||||||++|.||..+.+|...-+.+..+-.|.+.
T Consensus 171 LADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS 250 (1187)
T KOG0579|consen 171 LADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 250 (1187)
T ss_pred eecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc
Confidence 99999765443 2333457899999999999864 345999999999999999999999999888888888777652
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~ 317 (470)
- .+.-.-+...+..+.||+.+||..||..||++.++|+||||.++...
T Consensus 251 e----------------------------PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 251 E----------------------------PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred C----------------------------CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 1 01111234677889999999999999999999999999999977643
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.16 Aligned_cols=212 Identities=24% Similarity=0.367 Sum_probs=176.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
...++|..++..+.+||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 40 ~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~----------------- 100 (316)
T cd05592 40 ECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF----------------- 100 (316)
T ss_pred HHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 3456788888776559999999998854 678999999998 69999998777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~ 138 (316)
T cd05592 101 ------------------------------------------YAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIA 138 (316)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 139 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------ 211 (316)
T cd05592 139 DFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND------ 211 (316)
T ss_pred cCcCCeECCCCCCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------
Confidence 9999875432 22334568999999999987755 899999999999999999999999888766555444220
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-HHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-QKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-~elL~hp~f~~~~ 315 (470)
...++..++.++.+||.+||..||.+||++ .++++||||..+.
T Consensus 212 -------------------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 212 -------------------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 111234578899999999999999999986 4888999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.15 Aligned_cols=212 Identities=23% Similarity=0.344 Sum_probs=177.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+.+||||+++++++.. .+.+|+||||++ |+|..++.....+++..+..
T Consensus 40 ~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~----------------- 100 (318)
T cd05570 40 ECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF----------------- 100 (318)
T ss_pred HHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 3567899999988669999999998864 678999999998 69999998777788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~ 138 (318)
T cd05570 101 ------------------------------------------YAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIA 138 (318)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEec
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 139 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------ 211 (318)
T cd05570 139 DFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------ 211 (318)
T ss_pred ccCCCeecCcCCCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------
Confidence 999886532 222334457999999999987755 899999999999999999999999887765544443210
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-----HHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-----QKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-----~elL~hp~f~~~~ 315 (470)
....+..++..+.+||.+||..||.+|||+ .++++||||....
T Consensus 212 -------------------------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 212 -------------------------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred -------------------------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 011223578899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.85 Aligned_cols=214 Identities=23% Similarity=0.373 Sum_probs=175.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||++++++|.. ...+|+|||||+ |+|.+++.....+++..+..
T Consensus 46 ~~~~~E~~il~~l~-h~~iv~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~----------------- 105 (364)
T cd05599 46 AHVRAERDILAEAD-NPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRF----------------- 105 (364)
T ss_pred HHHHHHHHHHHhCC-CCCCcceEEEEEc--CCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHH-----------------
Confidence 34678999999999 9999999999865 678999999998 69999998877788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 143 (364)
T cd05599 106 ------------------------------------------YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLS 143 (364)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCC---------------------------------------ccccccccCcccCchhhccCCCCCCcccH
Q psy9855 169 DLGSLQFIKSKG---------------------------------------LHTEYIATRWYRSPECLLTEGYYSFELDI 209 (470)
Q Consensus 169 DFG~a~~~~~~~---------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DI 209 (470)
|||++....... .....+||+.|+|||++.+.. ++.++||
T Consensus 144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di 222 (364)
T cd05599 144 DFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDW 222 (364)
T ss_pred ecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeee
Confidence 999886543211 011347999999999987755 8999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHH
Q psy9855 210 WAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMS 289 (470)
Q Consensus 210 wSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~ 289 (470)
|||||++|||++|.+||.+.+..+....+..... ...++ ....+++++.+||.
T Consensus 223 wSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~------------------~~~~~---------~~~~~s~~~~~li~ 275 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE------------------TLQFP---------DEVPLSPEAKDLIK 275 (364)
T ss_pred ecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------------------ccCCC---------CCCCCCHHHHHHHH
Confidence 9999999999999999988876665544432100 00000 01246889999999
Q ss_pred HhcccCCCCCcC---HHHHHhcccCCChh
Q psy9855 290 EMLKYDPKRRPT---AQKILSCAYFADLT 315 (470)
Q Consensus 290 ~~L~~dP~~Rpt---~~elL~hp~f~~~~ 315 (470)
+||. +|.+|++ +.++++||||+...
T Consensus 276 ~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 276 RLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred HHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9997 9999998 99999999999865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=281.88 Aligned_cols=248 Identities=23% Similarity=0.459 Sum_probs=199.5
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
.+....+.||++||+.|.|||||++|+++..++......||+||.+. |...+..
T Consensus 73 PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~------------------------- 127 (338)
T KOG0668|consen 73 PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP------------------------- 127 (338)
T ss_pred hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-------------------------
Confidence 34456788999999999999999999999998888889999999995 7666642
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-- 163 (470)
+++...++.+++|++.||.|||++||+|||+||.|++++..
T Consensus 128 -------------------------------------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r 170 (338)
T KOG0668|consen 128 -------------------------------------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR 170 (338)
T ss_pred -------------------------------------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc
Confidence 12334455599999999999999999999999999999987
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~ 242 (470)
.++|+|+|+|.+...+...+-.+.+++|--||++.....|+.+-|+|||||++..|+..+.| |.|.+..+++.+|.+++
T Consensus 171 kLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 171 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 79999999999988887778889999999999998888899999999999999999998766 57899999999999999
Q ss_pred CCCchHH-HHHHhhhccCccccccccCCCCCccccc-----ccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 243 GTPKAET-LKKFEKYKSSNFTYQFKQYPGGGIDVLV-----PQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 243 g~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
|+..... ..+..-.....+.....+..+..+..+. .-+++++.||+.++|.+|..+|+||.|++.||||..+.+
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 9854432 2222222223333322233333333222 235799999999999999999999999999999986653
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=310.30 Aligned_cols=216 Identities=21% Similarity=0.297 Sum_probs=172.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+.+||||++++++|.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 40 ~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~----------------- 100 (329)
T cd05588 40 DWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF----------------- 100 (329)
T ss_pred HHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 3467899999999669999999998864 678999999999 59999998777788888777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~ 138 (329)
T cd05588 101 ------------------------------------------YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLT 138 (329)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEC
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHh
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID-----QLDRIHQVL 242 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~-----~~~~i~~~~ 242 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+ ....+.+.
T Consensus 139 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~- 216 (329)
T cd05588 139 DYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV- 216 (329)
T ss_pred cCccccccccCCCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-
Confidence 999887532 233344568999999999998755 8999999999999999999999996321100 00000000
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC------HHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT------AQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt------~~elL~hp~f~~~~ 315 (470)
. ......++..++..+.+||.+||+.||.+|+| ++++++||||..+.
T Consensus 217 ----------~----------------~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 217 ----------I----------------LEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred ----------H----------------HcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 0 00011133467889999999999999999997 78999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.95 Aligned_cols=215 Identities=21% Similarity=0.323 Sum_probs=174.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||+++++.|.+ .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 46 ~~~~~E~~il~~~~-h~~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~----------------- 105 (382)
T cd05625 46 AHVKAERDILAEAD-NEWVVRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARF----------------- 105 (382)
T ss_pred HHHHHHHHHHHhCC-CCcCCeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45778999999998 9999999999865 678999999998 69999998776677777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 106 ------------------------------------------YIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC------------------------------------------------CccccccccCcccCchhhccC
Q psy9855 169 DLGSLQFIKSK------------------------------------------------GLHTEYIATRWYRSPECLLTE 200 (470)
Q Consensus 169 DFG~a~~~~~~------------------------------------------------~~~~~~~gt~~Y~APE~l~~~ 200 (470)
|||++...... ......+||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 99987532100 001234799999999998876
Q ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccc
Q psy9855 201 GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI 280 (470)
Q Consensus 201 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (470)
. ++.++|||||||++|||++|.+||.+.+..+....+...... ........+
T Consensus 224 ~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~p~~~~~ 275 (382)
T cd05625 224 G-YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------------------LHIPPQAKL 275 (382)
T ss_pred C-CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------------------cCCCCcccC
Confidence 5 899999999999999999999999888766555444321100 000112357
Q ss_pred cHHHHHHHHHhcccCCCCCcC---HHHHHhcccCCChhH
Q psy9855 281 HEKGKKLMSEMLKYDPKRRPT---AQKILSCAYFADLTQ 316 (470)
Q Consensus 281 s~~~~~Li~~~L~~dP~~Rpt---~~elL~hp~f~~~~~ 316 (470)
++++.+||.+|+ .+|.+|++ ++++++||||+.+..
T Consensus 276 s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 276 SPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred CHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 899999999986 59999997 999999999998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.09 Aligned_cols=217 Identities=24% Similarity=0.453 Sum_probs=175.7
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhcc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~ 83 (470)
....+.+|+.+|..|+ |||||+++++|.......+|||||||+ |+|.++|... ..+++..++.
T Consensus 55 ~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~----------- 122 (1021)
T PTZ00266 55 EKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD----------- 122 (1021)
T ss_pred HHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHH-----------
Confidence 3556889999999999 999999999998766778999999999 6999998753 2366666666
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-------CCeecCCCCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-------KVFHRDIKPE 156 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-------gIvHrDLKp~ 156 (470)
|+.||+.||+|||+. +||||||||+
T Consensus 123 ------------------------------------------------Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPe 154 (1021)
T PTZ00266 123 ------------------------------------------------ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQ 154 (1021)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHhcccccccCCceeccCcHH
Confidence 999999999999984 4999999999
Q ss_pred cEEEeCC------------------eEEEEecCCcccccCCCccccccccCcccCchhhccC-CCCCCcccHHHHHHHHH
Q psy9855 157 NILIRGD------------------LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFY 217 (470)
Q Consensus 157 NILl~~~------------------~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~ 217 (470)
|||++.+ .++|+|||++............+||+.|+|||++.+. ..++.++||||||||||
T Consensus 155 NILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 155 NIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred HeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 9999642 4899999999876655445566899999999998653 34789999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCC
Q psy9855 218 ETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297 (470)
Q Consensus 218 elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~ 297 (470)
+|++|..||........+...... . ........+.++.+||..||..+|.
T Consensus 235 ELLTGk~PF~~~~~~~qli~~lk~--~----------------------------p~lpi~~~S~eL~dLI~~~L~~dPe 284 (1021)
T PTZ00266 235 ELCSGKTPFHKANNFSQLISELKR--G----------------------------PDLPIKGKSKELNILIKNLLNLSAK 284 (1021)
T ss_pred HHHHCCCCCCcCCcHHHHHHHHhc--C----------------------------CCCCcCCCCHHHHHHHHHHhcCChh
Confidence 999999999766554433222110 0 0011134678899999999999999
Q ss_pred CCcCHHHHHhcccCCChh
Q psy9855 298 RRPTAQKILSCAYFADLT 315 (470)
Q Consensus 298 ~Rpt~~elL~hp~f~~~~ 315 (470)
+|||+.|+|.||||..+.
T Consensus 285 eRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 285 ERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HCcCHHHHhccHHHhhcC
Confidence 999999999999998654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=307.42 Aligned_cols=212 Identities=23% Similarity=0.346 Sum_probs=175.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
....+|..++..+.+||||+++++++.. .+.+++||||++ |+|.+++.....+++..+..
T Consensus 40 ~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~----------------- 100 (316)
T cd05619 40 ECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF----------------- 100 (316)
T ss_pred HHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 4467888888876449999999999865 668999999998 69999998766677777666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~ 138 (316)
T cd05619 101 ------------------------------------------YAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIA 138 (316)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++..... .......+||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 139 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------ 211 (316)
T cd05619 139 DFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------ 211 (316)
T ss_pred cCCcceECCCCCCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------
Confidence 9998875322 22234567999999999987755 899999999999999999999999887765554443210
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHH-HHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ-KILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~-elL~hp~f~~~~ 315 (470)
....+..++.++.+||.+||..||.+||++. ++++||||..+.
T Consensus 212 -------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 212 -------------------------NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------------------------CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 0112235778899999999999999999996 899999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=307.46 Aligned_cols=214 Identities=20% Similarity=0.294 Sum_probs=178.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+++|+.++..+.+|++|+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~---------------- 105 (324)
T cd05587 44 VECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF---------------- 105 (324)
T ss_pred HHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 34578999999999855678999988864 668999999998 69999998777777777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 106 -------------------------------------------~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 106 -------------------------------------------YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.... ........+||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~----- 216 (324)
T cd05587 143 ADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH----- 216 (324)
T ss_pred eecCcceecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----
Confidence 9999886432 222334568999999999998755 799999999999999999999999888766665554321
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-----HHHHhcccCCChhH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-----QKILSCAYFADLTQ 316 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-----~elL~hp~f~~~~~ 316 (470)
...++..++.++.++|.+||..||.+|+++ +++++||||..++.
T Consensus 217 --------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 217 --------------------------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred --------------------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 011234578899999999999999999986 89999999998653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.36 Aligned_cols=215 Identities=25% Similarity=0.351 Sum_probs=178.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..++ ||||+++++++.+ .+.+|+||||++ ++|.+++.....+++..++.
T Consensus 45 ~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~---------------- 105 (350)
T cd05573 45 IAHVRAERDILADAD-SPWIVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF---------------- 105 (350)
T ss_pred HHHHHHHHHHHHhcC-CCCccchhhheec--CCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHH----------------
Confidence 345778999999999 9999999998864 678999999998 69999998876688877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 106 -------------------------------------------i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 106 -------------------------------------------YIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEe
Confidence 99999999999999999999999999999888 8999
Q ss_pred EecCCcccccCCC------------------------------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHH
Q psy9855 168 GDLGSLQFIKSKG------------------------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFY 217 (470)
Q Consensus 168 ~DFG~a~~~~~~~------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ 217 (470)
+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ 221 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILY 221 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhh
Confidence 9999987665432 223457999999999998764 899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCC
Q psy9855 218 ETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297 (470)
Q Consensus 218 elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~ 297 (470)
+|++|+.||.+.+.......+...... ........+++++.+||.+||. ||.
T Consensus 222 ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~p~~~~~~~~~~~li~~ll~-dp~ 273 (350)
T cd05573 222 EMLYGFPPFYSDTLQETYNKIINWKES---------------------------LRFPPDPPVSPEAIDLICRLLC-DPE 273 (350)
T ss_pred hhccCCCCCCCCCHHHHHHHHhccCCc---------------------------ccCCCCCCCCHHHHHHHHHHcc-Chh
Confidence 999999999888766555554431100 0000112368999999999997 999
Q ss_pred CCcC-HHHHHhcccCCChh
Q psy9855 298 RRPT-AQKILSCAYFADLT 315 (470)
Q Consensus 298 ~Rpt-~~elL~hp~f~~~~ 315 (470)
+|++ ++++++||||.++.
T Consensus 274 ~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 274 DRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred hcCCCHHHHhcCCCcCCCC
Confidence 9999 99999999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=314.27 Aligned_cols=216 Identities=20% Similarity=0.291 Sum_probs=173.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|+.++ ||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 46 ~~~~~E~~il~~l~-h~~iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~----------------- 105 (381)
T cd05626 46 AHVKAERDILAEAD-NEWVVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF----------------- 105 (381)
T ss_pred HHHHHHHHHHHhcC-CCCeeeeEEEEec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45678999999999 9999999999865 678999999998 69999998877788777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 106 ------------------------------------------YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCC------------------------------------------------CccccccccCcccCchhhccC
Q psy9855 169 DLGSLQFIKSK------------------------------------------------GLHTEYIATRWYRSPECLLTE 200 (470)
Q Consensus 169 DFG~a~~~~~~------------------------------------------------~~~~~~~gt~~Y~APE~l~~~ 200 (470)
|||++...... ......+||+.|+|||++.+.
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 99987532100 001235799999999998775
Q ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccc
Q psy9855 201 GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI 280 (470)
Q Consensus 201 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (470)
. ++.++|||||||++|||++|..||.+.+..+....+....+. ........+
T Consensus 224 ~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~ 275 (381)
T cd05626 224 G-YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------------------LHIPPQVKL 275 (381)
T ss_pred C-CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------------------cCCCCCCCC
Confidence 5 899999999999999999999999887765554444321100 000011257
Q ss_pred cHHHHHHHHHhcc--cCCCCCcCHHHHHhcccCCChhH
Q psy9855 281 HEKGKKLMSEMLK--YDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 281 s~~~~~Li~~~L~--~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
++++.+||.+|+. .+|..|++++++++||||.++..
T Consensus 276 s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 276 SPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 8999999999654 45556999999999999998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.85 Aligned_cols=245 Identities=33% Similarity=0.614 Sum_probs=198.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecC--CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNR--STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~--~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.+|+.++ ||||+++++++... ....+++||||++|+|.+++.....+++..+..
T Consensus 49 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~---------------- 111 (334)
T cd07855 49 KRTLRELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY---------------- 111 (334)
T ss_pred HHHHHHHHHHHhcC-CCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhccCCCCCHHHHHH----------------
Confidence 45678999999999 99999999987642 345789999999999999997766688877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|
T Consensus 112 -------------------------------------------i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 112 -------------------------------------------FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEe
Confidence 99999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCc-----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++........ ....+|+..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHh
Confidence 99999876543221 1345789999999998665558999999999999999999999999998888899999999
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
|.|+...+..............+.......+..+.+.+++++.++|.+||..+|.+|||+.++++||||.+..
T Consensus 229 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 9988876654433221111112222222233334466789999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.09 Aligned_cols=239 Identities=23% Similarity=0.394 Sum_probs=180.7
Q ss_pred hhHHHHHHhcCC-----CCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 13 NLKEISILRKIP-----DHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 13 ~~rEi~iL~~L~-----~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+|++++..++ +|.+|++++++|.. ..+++|+|||+++++|.+++...+.+++..+..
T Consensus 172 ~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~--------------- 235 (467)
T PTZ00284 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQN-ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ--------------- 235 (467)
T ss_pred HHHHHHHHHHHhhcCcccCcceeeeEEEEEc-CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHH---------------
Confidence 456777777765 24568999998864 356799999999999999998777788877777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC---
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD--- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~--- 163 (470)
|+.||+.||+|||+ .|||||||||+|||++.+
T Consensus 236 --------------------------------------------i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 236 --------------------------------------------IIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc
Confidence 99999999999998 599999999999999754
Q ss_pred --------------eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy9855 164 --------------LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229 (470)
Q Consensus 164 --------------~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~ 229 (470)
.+||+|||.+..... .....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 389999998754322 234568999999999998765 899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCchHHHHHHhhhccCcccccc----ccCCCCCc------ccc-cccccHHHHHHHHHhcccCCCC
Q psy9855 230 SEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQF----KQYPGGGI------DVL-VPQIHEKGKKLMSEMLKYDPKR 298 (470)
Q Consensus 230 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~------~~~-~~~~s~~~~~Li~~~L~~dP~~ 298 (470)
+..+.+..+...+|.++..............+.... +......+ ... .....+.+.|||.+||.+||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 999999999999998876543321100000000000 00000000 000 0012466889999999999999
Q ss_pred CcCHHHHHhcccCCCh
Q psy9855 299 RPTAQKILSCAYFADL 314 (470)
Q Consensus 299 Rpt~~elL~hp~f~~~ 314 (470)
|||++|+|+||||...
T Consensus 429 R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 429 RLNARQMTTHPYVLKY 444 (467)
T ss_pred CCCHHHHhcCcccccc
Confidence 9999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=300.08 Aligned_cols=215 Identities=27% Similarity=0.389 Sum_probs=170.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHh----cccccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRT----TDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~----~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+.+|+.+|+.++ ||||+++.+++.. .+.+|+||||++ |+|.+++.. ...+++..+..
T Consensus 38 ~~~~~E~~il~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~------------- 101 (280)
T cd05608 38 EGAMVEKRILAKVH-SRFIVSLAYAFQT--KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF------------- 101 (280)
T ss_pred HHHHHHHHHHHhCC-CCcEeeeeEEEcC--CCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHH-------------
Confidence 34578999999998 9999999998854 677999999998 699888743 22366666655
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+||+++.+ .
T Consensus 102 ----------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 135 (280)
T cd05608 102 ----------------------------------------------YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN 135 (280)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 99999999999999999999999999999877 8
Q ss_pred EEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 165 VVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
++|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+....-
T Consensus 136 ~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 214 (280)
T cd05608 136 VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214 (280)
T ss_pred EEEeeCccceecCCCCccccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc
Confidence 9999999987654332 223457899999999998755 88999999999999999999999976543222111111000
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
......+..++..+.+|+.+||+.||++|| |++++++||||++..
T Consensus 215 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 215 ---------------------------NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred ---------------------------ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 001112346789999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.94 Aligned_cols=214 Identities=21% Similarity=0.311 Sum_probs=173.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||+++++.|.. .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 46 ~~~~~E~~il~~l~-h~~iv~~~~~~~~--~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~----------------- 105 (376)
T cd05598 46 AHVKAERDILAEAD-NEWVVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARF----------------- 105 (376)
T ss_pred HHHHHHHHHHHhCC-CCCcceEEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 44678999999999 9999999999865 678999999998 69999998877777777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~ 143 (376)
T cd05598 106 ------------------------------------------YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLT 143 (376)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCC--------------------------------------------CccccccccCcccCchhhccCCCCC
Q psy9855 169 DLGSLQFIKSK--------------------------------------------GLHTEYIATRWYRSPECLLTEGYYS 204 (470)
Q Consensus 169 DFG~a~~~~~~--------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~ 204 (470)
|||++..+... ......+||+.|+|||++.+.. ++
T Consensus 144 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~ 222 (376)
T cd05598 144 DFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YT 222 (376)
T ss_pred eCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CC
Confidence 99987432100 0012357999999999987755 89
Q ss_pred CcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHH
Q psy9855 205 FELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKG 284 (470)
Q Consensus 205 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 284 (470)
.++|||||||++|+|++|..||.+.+..+....+..... .........++.++
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~~~s~~~ 275 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET---------------------------TLHIPSQAKLSREA 275 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------------------cccCCCCCCCCHHH
Confidence 999999999999999999999988876655444432100 00001113578899
Q ss_pred HHHHHHhcccCCCCCc---CHHHHHhcccCCChh
Q psy9855 285 KKLMSEMLKYDPKRRP---TAQKILSCAYFADLT 315 (470)
Q Consensus 285 ~~Li~~~L~~dP~~Rp---t~~elL~hp~f~~~~ 315 (470)
.+||.+|+ .+|.+|+ |+.++++||||..+.
T Consensus 276 ~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 276 SDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred HHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99999977 5999999 999999999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=306.55 Aligned_cols=238 Identities=17% Similarity=0.308 Sum_probs=176.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|..++ ||||+++++++.. .+.+++||||++ |+|.+++.....+++..+..
T Consensus 47 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 107 (331)
T cd06649 47 RNQIIRELQVLHECN-SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---------------- 107 (331)
T ss_pred HHHHHHHHHHHHHCC-CCCCCeEEEEEEE--CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 456889999999999 9999999999865 668999999999 59999998777777777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||+. +|+||||||+|||++.+ .++
T Consensus 108 -------------------------------------------~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~k 144 (331)
T cd06649 108 -------------------------------------------VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIK 144 (331)
T ss_pred -------------------------------------------HHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEE
Confidence 999999999999986 69999999999999887 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+.... ++.+.
T Consensus 145 l~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~ 218 (331)
T cd06649 145 LCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPV 218 (331)
T ss_pred EccCccccccccc-ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccc
Confidence 9999998765432 234567999999999987755 89999999999999999999999977665443222 22211
Q ss_pred hHHHHH----HhhhccC---cc-ccccccCC------------CC-CcccccccccHHHHHHHHHhcccCCCCCcCHHHH
Q psy9855 247 AETLKK----FEKYKSS---NF-TYQFKQYP------------GG-GIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305 (470)
Q Consensus 247 ~~~~~~----~~~~~~~---~~-~~~~~~~~------------~~-~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~el 305 (470)
...... ....... .. .......+ .. ........+++++.+||.+||..||++|||+.++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el 298 (331)
T cd06649 219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 298 (331)
T ss_pred cccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH
Confidence 100000 0000000 00 00000000 00 0000112467899999999999999999999999
Q ss_pred HhcccCCChh
Q psy9855 306 LSCAYFADLT 315 (470)
Q Consensus 306 L~hp~f~~~~ 315 (470)
++||||+...
T Consensus 299 l~h~~~~~~~ 308 (331)
T cd06649 299 MNHTFIKRSE 308 (331)
T ss_pred hcChHHhhcc
Confidence 9999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.72 Aligned_cols=214 Identities=22% Similarity=0.351 Sum_probs=172.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++..++ ||||++++++|.+ ...+|+|||||+ |+|.+++.....+++..++.
T Consensus 46 ~~~~~E~~il~~l~-hp~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~----------------- 105 (377)
T cd05629 46 AHVKAERDVLAESD-SPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF----------------- 105 (377)
T ss_pred HHHHHHHHHHHhCC-CCCcceEEEEEEc--CCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 35678999999998 9999999999865 678999999998 69999998777788777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~ 143 (377)
T cd05629 106 ------------------------------------------YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLS 143 (377)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCC------------------------------------------------ccccccccCcccCchhhccC
Q psy9855 169 DLGSLQFIKSKG------------------------------------------------LHTEYIATRWYRSPECLLTE 200 (470)
Q Consensus 169 DFG~a~~~~~~~------------------------------------------------~~~~~~gt~~Y~APE~l~~~ 200 (470)
|||++....... .....+||+.|+|||++.+.
T Consensus 144 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 223 (377)
T cd05629 144 DFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223 (377)
T ss_pred ecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC
Confidence 999886321100 00124799999999998775
Q ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccc
Q psy9855 201 GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI 280 (470)
Q Consensus 201 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (470)
. ++.++|||||||++|||++|.+||.+.+..+....+...... ..++ -...+
T Consensus 224 ~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------~~~p---------~~~~~ 275 (377)
T cd05629 224 G-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET------------------LYFP---------DDIHL 275 (377)
T ss_pred C-CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc------------------cCCC---------CCCCC
Confidence 5 899999999999999999999999887776665554431100 0000 01246
Q ss_pred cHHHHHHHHHhcccCCCCC---cCHHHHHhcccCCChh
Q psy9855 281 HEKGKKLMSEMLKYDPKRR---PTAQKILSCAYFADLT 315 (470)
Q Consensus 281 s~~~~~Li~~~L~~dP~~R---pt~~elL~hp~f~~~~ 315 (470)
+.++.+||.+||. +|.+| +|+.++++||||.+..
T Consensus 276 s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 276 SVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred CHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 8899999999998 77765 5999999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=300.50 Aligned_cols=242 Identities=36% Similarity=0.663 Sum_probs=192.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|++++++++ ||||+++++++.. ....|+||||++++|.+++..... +++..+..
T Consensus 46 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~---------------- 106 (294)
T PLN00009 46 STAIREISLLKEMQ-HGNIVRLQDVVHS--EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT---------------- 106 (294)
T ss_pred HHHHHHHHHHHhcc-CCCEeeEEEEEec--CCeEEEEEecccccHHHHHHhCCCCCcCHHHHHH----------------
Confidence 45679999999998 9999999999864 678999999999999988865443 34455544
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ik 166 (470)
++.||+.||+|||++|++||||+|+||+++.+ .++
T Consensus 107 -------------------------------------------~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~k 143 (294)
T PLN00009 107 -------------------------------------------YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALK 143 (294)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEE
Confidence 99999999999999999999999999999853 789
Q ss_pred EEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||++...... .......+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.|
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 223 (294)
T PLN00009 144 LADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTP 223 (294)
T ss_pred EcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998765422 222345678999999998775568899999999999999999999999988888888888888888
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
....|..+..... +....+.+.........+.+++.+.++|.+||..+|++||++.++++||||.+.+.
T Consensus 224 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 224 NEETWPGVTSLPD--YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred Chhhccccccchh--hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 7776654332111 11111122222222334567899999999999999999999999999999997653
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=308.44 Aligned_cols=210 Identities=25% Similarity=0.374 Sum_probs=173.9
Q ss_pred hhhHHHH-HHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 12 ANLKEIS-ILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 12 ~~~rEi~-iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.+++|.. +++.++ ||||+++++++.. .+.+|+||||++ |+|..++.....+++..+..
T Consensus 41 ~~~~e~~~~~~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~----------------- 100 (323)
T cd05575 41 HIMAERNVLLKNVK-HPFLVGLHYSFQT--ADKLYFVLDYVNGGELFFHLQRERSFPEPRARF----------------- 100 (323)
T ss_pred HHHHHHHHHHhhCC-CCCCCCeeEEEEe--CCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHH-----------------
Confidence 4556655 457788 9999999998864 678999999999 59999998777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~ 138 (323)
T cd05575 101 ------------------------------------------YAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLT 138 (323)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 139 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------ 211 (323)
T cd05575 139 DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK------ 211 (323)
T ss_pred ccCCCcccccCCCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------
Confidence 999887543 222334567999999999987755 899999999999999999999999887765555444320
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH----HHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA----QKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~----~elL~hp~f~~~~ 315 (470)
...+.+.++..+.+||.+||+.||.+||++ .++++||||....
T Consensus 212 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 212 -------------------------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 011234678999999999999999999997 6999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.33 Aligned_cols=216 Identities=22% Similarity=0.357 Sum_probs=171.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+..|+..|.+|++|.+||+|++|-.. .+.+|+|||+-+.||..+|+.... ++...++.
T Consensus 404 ~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~----------------- 464 (677)
T KOG0596|consen 404 DGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKF----------------- 464 (677)
T ss_pred HHHHHHHHHHHHhcCCceEEEEeeeecc--CceEEEEeecccccHHHHHHhccCCCchHHHHH-----------------
Confidence 4578999999999999999999998765 788999999999999999987765 22233333
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEEe
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGD 169 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~D 169 (470)
|.+|++.|+.++|.+||||.||||.|+|+-.+.+||+|
T Consensus 465 ------------------------------------------ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLID 502 (677)
T KOG0596|consen 465 ------------------------------------------YWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLID 502 (677)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeee
Confidence 99999999999999999999999999999999999999
Q ss_pred cCCcccccCCCc---cccccccCcccCchhhccCC----------CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 170 LGSLQFIKSKGL---HTEYIATRWYRSPECLLTEG----------YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 170 FG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~----------~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
||.|..+..... ....+||+.||+||.+.... ..+.++||||||||||+|+.|++||... ...+.
T Consensus 503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~a 580 (677)
T KOG0596|consen 503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIA 580 (677)
T ss_pred echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHH
Confidence 999988775442 34569999999999985321 1567899999999999999999999543 22333
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
++..+. ..+....|+..+ -..++.++|+.||..||.+|||+.++|+|||++..
T Consensus 581 Kl~aI~---------------~P~~~Iefp~~~----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 581 KLHAIT---------------DPNHEIEFPDIP----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred HHHhhc---------------CCCccccccCCC----------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 333322 111111222111 11338999999999999999999999999999873
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=308.88 Aligned_cols=244 Identities=34% Similarity=0.648 Sum_probs=195.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC---CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS---TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~---~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+|+.++ ||||+++++++.... ...+|+|+||++++|.+++.....+++..+..
T Consensus 49 ~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~--------------- 112 (337)
T cd07858 49 KRTLREIKLLRHLD-HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQY--------------- 112 (337)
T ss_pred HHHHHHHHHHHhcC-CCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHH---------------
Confidence 45678999999998 999999999876422 24589999999999999998777788888777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||++|++||||||+||+++.+ .++
T Consensus 113 --------------------------------------------i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 113 --------------------------------------------FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||++...... .......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....|.+
T Consensus 149 L~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 149 ICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998766433 233455789999999988764458899999999999999999999999988888888888888888
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
..+.+..........+.......+........+.+++.+.+||.+||..||++|||+.++++||||..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 776653322211111111111111222223345788999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.68 Aligned_cols=232 Identities=26% Similarity=0.408 Sum_probs=182.5
Q ss_pred CchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 6 PDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 6 ~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
+.-....++||++++.++++|+||++|+++|.+ ...+|||||-|. |.|...|..+..+++.++..
T Consensus 115 ~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~------------ 180 (463)
T KOG0607|consen 115 PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASR------------ 180 (463)
T ss_pred CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEecccCchHHHHHHHhhhccHHHHHH------------
Confidence 344467889999999999999999999999955 678999999999 69999999888899999888
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.+|+.||.|||.+||.||||||+|||....
T Consensus 181 -----------------------------------------------vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn 213 (463)
T KOG0607|consen 181 -----------------------------------------------VVKDIASALDFLHTKGIAHRDLKPENILCESPN 213 (463)
T ss_pred -----------------------------------------------HHHHHHHHHHHHhhcCcccccCCccceeecCCC
Confidence 99999999999999999999999999999654
Q ss_pred ---eEEEEecCCcccccCCC--------ccccccccCcccCchhhc----cCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy9855 164 ---LVVVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLL----TEGYYSFELDIWAAGCVFYETLTRNPLFPG 228 (470)
Q Consensus 164 ---~ikL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~----~~~~~~~~~DIwSlG~il~elltg~~pf~~ 228 (470)
-+|||||.++..+.... ...+.+|+..|||||+.. ....|+.++|.||||+|+|-|++|.+||.|
T Consensus 214 ~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 214 KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 58999999876543211 234568999999999863 234589999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCchHHH-----HHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHH
Q psy9855 229 DSEIDQLDRIHQVLGTPKAETL-----KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303 (470)
Q Consensus 229 ~~~~~~~~~i~~~~g~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~ 303 (470)
....+ +|...-+.. .-+..+..+.|.+.-. -+..+|.+++|||..+|..|+.+|.++.
T Consensus 294 ~Cg~d--------CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdk---------dWahIS~eakdlisnLlvrda~~rlsa~ 356 (463)
T KOG0607|consen 294 HCGAD--------CGWDRGEVCRVCQNKLFESIQEGKYEFPDK---------DWAHISSEAKDLISNLLVRDAKQRLSAA 356 (463)
T ss_pred ccCCc--------CCccCCCccHHHHHHHHHHHhccCCcCChh---------hhHHhhHHHHHHHHHHHhccHHhhhhhh
Confidence 64321 111111110 0112222222222111 1246899999999999999999999999
Q ss_pred HHHhcccCCChh
Q psy9855 304 KILSCAYFADLT 315 (470)
Q Consensus 304 elL~hp~f~~~~ 315 (470)
++++|||++...
T Consensus 357 ~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 357 QVLNHPWVQRCA 368 (463)
T ss_pred hccCCccccccc
Confidence 999999999765
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=313.54 Aligned_cols=205 Identities=23% Similarity=0.335 Sum_probs=174.7
Q ss_pred HHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccCC
Q psy9855 15 KEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDL 93 (470)
Q Consensus 15 rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (470)
.||+-|++|+ ||||+.|.|+++. ...+|||||||. |.|.++|+..+.+......+
T Consensus 161 TdIKHLRkLk-H~NII~FkGVCtq--sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~--------------------- 216 (904)
T KOG4721|consen 161 TDIKHLRKLK-HPNIITFKGVCTQ--SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVD--------------------- 216 (904)
T ss_pred hhHHHHHhcc-CcceeeEeeeecC--CceeEEeeeccccccHHHHHhccCccCHHHHHH---------------------
Confidence 4588899999 9999999999864 778999999999 89999999988887777777
Q ss_pred CccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCC
Q psy9855 94 KLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGS 172 (470)
Q Consensus 94 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~ 172 (470)
+..+|+.|+.|||.+.|||||||.-||||+.+ .|||+|||-
T Consensus 217 --------------------------------------Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 217 --------------------------------------WSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred --------------------------------------HHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999999999999999987 899999999
Q ss_pred cccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Q psy9855 173 LQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKK 252 (470)
Q Consensus 173 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 252 (470)
++...+......++||..|||||++...+ .+.|+|||||||+|||||||..||.+-+...++ -.+|.
T Consensus 259 S~e~~~~STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVGs-------- 325 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVGS-------- 325 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeE----EeccC--------
Confidence 98877766667789999999999998876 899999999999999999999999664332221 11111
Q ss_pred HhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 253 FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
...--.++..+++.++=||++||+-.|..||++.++|.|-=+
T Consensus 326 -----------------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 326 -----------------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred -----------------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 112223456788999999999999999999999999998433
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=299.71 Aligned_cols=215 Identities=26% Similarity=0.394 Sum_probs=175.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+++.++ ||||+++++.+.. ...+|+||||++ |+|.+++.... .+++..+..
T Consensus 45 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~--------------- 106 (285)
T cd05605 45 AMALNEKQILEKVN-SRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF--------------- 106 (285)
T ss_pred HHHHHHHHHHHhcC-CCCEeeeeeeecC--CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHH---------------
Confidence 45678999999998 9999999998854 568999999998 69998886532 366766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||+.||+||||||+||+++++ .++
T Consensus 107 --------------------------------------------~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 142 (285)
T cd05605 107 --------------------------------------------YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||++............+|+..|+|||++.+.. ++.++||||+||++|+|++|..||.+.........+.....
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--- 218 (285)
T cd05605 143 ISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK--- 218 (285)
T ss_pred EeeCCCceecCCCCccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh---
Confidence 99999988765444444568999999999987655 89999999999999999999999987665443333322110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
......+..++..+.+||.+||..||.+|| +++++++||||....
T Consensus 219 ------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 219 ------------------------EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred ------------------------hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 001112345788999999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=311.37 Aligned_cols=212 Identities=22% Similarity=0.335 Sum_probs=180.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|.+++ ++||.++|+.|.. +..++++||||. |++.++++....+.+..+..
T Consensus 56 ediqqei~~Ls~~~-~~~it~yygsyl~--g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~----------------- 115 (467)
T KOG0201|consen 56 EDIQQEISVLSQCD-SPNITEYYGSYLK--GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAV----------------- 115 (467)
T ss_pred HHHHHHHHHHHhcC-cchHHhhhhheee--cccHHHHHHHhcCcchhhhhccCCCCccceeee-----------------
Confidence 45679999999999 9999999999987 677999999999 69999998776666655554
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++++++.||.|||.++.+|||||+.|||+..+ .+||+
T Consensus 116 ------------------------------------------ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~ 153 (467)
T KOG0201|consen 116 ------------------------------------------ILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLA 153 (467)
T ss_pred ------------------------------------------ehHHHHHHhhhhhhcceecccccccceeEeccCcEEEE
Confidence 99999999999999999999999999999988 99999
Q ss_pred ecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||.+........ ..+++||+.|||||++.+.+ |+.++||||||++.+||++|.+|+....++..+..|-
T Consensus 154 DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------- 224 (467)
T KOG0201|consen 154 DFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------- 224 (467)
T ss_pred ecceeeeeechhhccccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc--------
Confidence 9999988775443 37889999999999999655 9999999999999999999999998776533332221
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
......+...+++.+++||..||+.||+.||+|.++|+|+|++...
T Consensus 225 ----------------------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 225 ----------------------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred ----------------------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 2222333347889999999999999999999999999999999754
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=311.44 Aligned_cols=234 Identities=29% Similarity=0.441 Sum_probs=171.8
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
....|+.+|.+++ ||||+++++++.. ....++|||++.++|.+++..... +++..+..
T Consensus 103 ~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~------------------ 161 (357)
T PHA03209 103 TTLIEAMLLQNVN-HPSVIRMKDTLVS--GAITCMVLPHYSSDLYTYLTKRSRPLPIDQALI------------------ 161 (357)
T ss_pred ccHHHHHHHHhCC-CCCCcChhheEEe--CCeeEEEEEccCCcHHHHHHhccCCCCHHHHHH------------------
Confidence 4568999999999 9999999999865 567899999999999999865433 66666666
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
|+.||+.||+|||++|||||||||+|||++.+ .++|+|
T Consensus 162 -----------------------------------------i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~D 200 (357)
T PHA03209 162 -----------------------------------------IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGD 200 (357)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEec
Confidence 99999999999999999999999999999887 899999
Q ss_pred cCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHH
Q psy9855 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSE---------IDQLDRIH 239 (470)
Q Consensus 170 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~-~pf~~~~~---------~~~~~~i~ 239 (470)
||++.............||+.|+|||++.+.. ++.++|||||||++|||+++. ++|.+... ...+..+.
T Consensus 201 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 201 LGAAQFPVVAPAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred CccccccccCcccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 99987654443444567999999999987755 899999999999999999854 44443211 12233333
Q ss_pred HHhCCCchHHH--------HHHhhhccCccccccccCCCCCcc-cccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 240 QVLGTPKAETL--------KKFEKYKSSNFTYQFKQYPGGGID-VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 240 ~~~g~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
..++..+.... ..+..+... ...+..... .....++.++.+||.+||..||.+|||+.|+|+|||
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASL------ERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhccc------CCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 43443222111 001000000 000000000 011246778889999999999999999999999999
Q ss_pred CCCh
Q psy9855 311 FADL 314 (470)
Q Consensus 311 f~~~ 314 (470)
|+++
T Consensus 354 f~~~ 357 (357)
T PHA03209 354 FAQL 357 (357)
T ss_pred hccC
Confidence 9863
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=300.00 Aligned_cols=241 Identities=33% Similarity=0.638 Sum_probs=196.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++++.++ |+||+++++++.. .+..++||||+.|+|.+++.... .+++..+..
T Consensus 46 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~---------------- 106 (298)
T cd07841 46 NFTALREIKLLQELK-HPNIIGLLDVFGH--KSNINLVFEFMETDLEKVIKDKSIVLTPADIKS---------------- 106 (298)
T ss_pred hHHHHHHHHHHhhcC-CCCChhhhheeec--CCEEEEEEcccCCCHHHHHhccCCCCCHHHHHH----------------
Confidence 345678999999999 9999999999865 67899999999889999998765 577777666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||+|+||+++.+ .++|
T Consensus 107 -------------------------------------------~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l 143 (298)
T cd07841 107 -------------------------------------------YMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKL 143 (298)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... ......+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.+..+.+..+...++.+.
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 223 (298)
T cd07841 144 ADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223 (298)
T ss_pred ccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCc
Confidence 9999987765432 223346788899999887655678999999999999999999999999888888888888888877
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...+......... ......+...........+..+.+||.+||..||.+|||+.+++.||||.+..
T Consensus 224 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 224 EENWPGVTSLPDY---VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred hhhhhhccccccc---ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 7666554332211 11111222233444566789999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.82 Aligned_cols=234 Identities=28% Similarity=0.402 Sum_probs=180.8
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGW 91 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (470)
...+|+++|+.|+ ||||++++++|.. ...+|+|||++.++|.+++.....+++..+..
T Consensus 132 ~~~~E~~il~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~------------------- 189 (392)
T PHA03207 132 TPGREIDILKTIS-HRAIINLIHAYRW--KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT------------------- 189 (392)
T ss_pred cHHHHHHHHHhcC-CCCccceeeeEee--CCEEEEEehhcCCCHHHHHHhcCCCCHHHHHH-------------------
Confidence 3468999999999 9999999998864 67899999999999999997666677777777
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEec
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDL 170 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DF 170 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+||
T Consensus 190 ----------------------------------------i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~Df 229 (392)
T PHA03207 190 ----------------------------------------IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229 (392)
T ss_pred ----------------------------------------HHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccC
Confidence 99999999999999999999999999999887 8999999
Q ss_pred CCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCC
Q psy9855 171 GSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS---EIDQLDRIHQVLGT 244 (470)
Q Consensus 171 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~g~ 244 (470)
|++........ ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.. ....+..+.+.++.
T Consensus 230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred ccccccCcccccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 99876553321 23457999999999987755 8999999999999999999999997653 34555666665554
Q ss_pred CchHHH--------HHHhhhccCccccccccCCCCCccc--ccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETL--------KKFEKYKSSNFTYQFKQYPGGGIDV--LVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+.+.. ..+..+. . ...+...... ....++.++.+||.+||..||++|||+.++|.||||...
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYA-----I--VLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CccccCCccchhHHHHHHhhc-----c--cccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 432211 1111100 0 0000000000 012456788999999999999999999999999999864
Q ss_pred h
Q psy9855 315 T 315 (470)
Q Consensus 315 ~ 315 (470)
.
T Consensus 382 ~ 382 (392)
T PHA03207 382 P 382 (392)
T ss_pred c
Confidence 3
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=297.30 Aligned_cols=238 Identities=30% Similarity=0.617 Sum_probs=193.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc---cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD---NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~---~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ ||||+++++++.. .+..++||||++++|.+++.... .+++..+..
T Consensus 42 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~-------------- 104 (284)
T cd07836 42 PSTAIREISLMKELK-HENIVRLHDVIHT--ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKS-------------- 104 (284)
T ss_pred hHHHHHHHHHHHhhc-CCCEeeeeeeEee--CCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHH--------------
Confidence 345678999999998 9999999999865 56789999999999999987644 256666655
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||+.|++||||||+||+++++ .+
T Consensus 105 ---------------------------------------------~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~ 139 (284)
T cd07836 105 ---------------------------------------------FTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL 139 (284)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|+|||.+...... .......++..|++||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.
T Consensus 140 ~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (284)
T cd07836 140 KLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT 219 (284)
T ss_pred EEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 99999988755432 12234567889999999877655789999999999999999999999999888888888888888
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
|....+..+... ..+....+.........+.+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus 220 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 220 PTESTWPGISQL--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CChhhHHHHhcC--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 888777766532 12222222222222233445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=300.60 Aligned_cols=242 Identities=29% Similarity=0.508 Sum_probs=189.3
Q ss_pred hhhhhHHHHHHhcCCCCC-----CeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhc
Q psy9855 10 EVANLKEISILRKIPDHL-----NVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANE 82 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~Hp-----nIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~ 82 (470)
.++++-|+++|.+|..+. -+|++.++|. -.++.|||+|.++.++.++|..+.. ++...++.
T Consensus 129 reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd--yrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~---------- 196 (415)
T KOG0671|consen 129 REAALIEIEVLQKINESDPNGKFRCVQMRDWFD--YRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRH---------- 196 (415)
T ss_pred hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh--ccCceEEEEeccChhHHHHhccCCccccchHHHHH----------
Confidence 457788999999995232 4788888884 4789999999999999999988664 55555555
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
+++||+++++|||+.+++|.||||+|||+.+
T Consensus 197 -------------------------------------------------m~~QL~~sv~fLh~~kl~HTDLKPENILfvs 227 (415)
T KOG0671|consen 197 -------------------------------------------------MGYQLLESVAFLHDLKLTHTDLKPENILFVS 227 (415)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHhcceeecCCChheEEEec
Confidence 9999999999999999999999999999832
Q ss_pred --------------------C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh
Q psy9855 163 --------------------D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221 (470)
Q Consensus 163 --------------------~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt 221 (470)
+ .|+|+|||.|....+. ....+.|..|+|||++++-+ ++..+||||+||||+|+++
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYT 304 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccC-cCCccCceeeeeEEEEeec
Confidence 1 5789999999876544 36779999999999999988 8999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCchHHHHHHh--hhc-cCccccccccCCC---------CCccccc---ccccHHHHH
Q psy9855 222 RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFE--KYK-SSNFTYQFKQYPG---------GGIDVLV---PQIHEKGKK 286 (470)
Q Consensus 222 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~--~~~-~~~~~~~~~~~~~---------~~~~~~~---~~~s~~~~~ 286 (470)
|...|++..+.+.++.+.+++|+.+...+.... ++. .+...+......+ ..+.... .....++.|
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 999999999999999999999977776665542 111 1111111111111 0000000 112346789
Q ss_pred HHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 287 LMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 287 Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
||++||.+||.+|+|+.|+|.||||+...
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 99999999999999999999999998653
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.04 Aligned_cols=238 Identities=33% Similarity=0.637 Sum_probs=185.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ ||||+++++++.. ....++||||++++|.+++..... +++..++.
T Consensus 48 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~----------------- 107 (291)
T cd07844 48 FTAIREASLLKDLK-HANIVTLHDIIHT--KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRL----------------- 107 (291)
T ss_pred hhHHHHHHHHhhCC-CcceeeEEEEEec--CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHH-----------------
Confidence 34678999999998 9999999999864 678999999999999999876543 66666666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||++||+||||||+||+++.+ .++|+
T Consensus 108 ------------------------------------------~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 108 ------------------------------------------FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEEC
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS-EIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~g~p~ 246 (470)
|||++...... .......++..|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+.+..+.+..+.+.
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (291)
T cd07844 146 DFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT 225 (291)
T ss_pred ccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence 99988654321 112234578889999998765557899999999999999999999997765 5667777788888887
Q ss_pred hHHHHHHhhhccCccccccccCCCCCccccccccc--HHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIH--EKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
...+.......... ................+.++ ..+.++|.+||..+|.+|||+.++++||||
T Consensus 226 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 226 EETWPGVSSNPEFK-PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhhhhhhccccc-cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 77766554321100 01111111111112223344 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=305.03 Aligned_cols=213 Identities=19% Similarity=0.274 Sum_probs=178.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.....|..++..+.+|++|+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~----------------- 105 (323)
T cd05616 45 ECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF----------------- 105 (323)
T ss_pred HHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 3467888999888769999999998854 678999999998 69999998777777777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~ 143 (323)
T cd05616 106 ------------------------------------------YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIA 143 (323)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEc
Confidence 99999999999999999999999999999888 89999
Q ss_pred ecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 144 DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----- 217 (323)
T cd05616 144 DFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----- 217 (323)
T ss_pred cCCCceecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----
Confidence 9999875432 22334568999999999987755 8999999999999999999999999887766665554310
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
..++..++.++.+|+.+||..||.+|++ ..++++||||..+..
T Consensus 218 --------------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 218 --------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred --------------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1123457889999999999999999998 489999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=306.91 Aligned_cols=216 Identities=20% Similarity=0.290 Sum_probs=171.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++.++.+||||+++++++.. .+.+|+||||++ |+|..++.....+++..+..
T Consensus 40 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~----------------- 100 (329)
T cd05618 40 DWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF----------------- 100 (329)
T ss_pred HHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 3467899999888559999999999865 678999999999 69999988777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~ 138 (329)
T cd05618 101 ------------------------------------------YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLT 138 (329)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHh
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE-----IDQLDRIHQVL 242 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~-----~~~~~~i~~~~ 242 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+....
T Consensus 139 DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i 217 (329)
T cd05618 139 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217 (329)
T ss_pred eCCccccccCCCCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH
Confidence 999987532 222334568999999999998755 89999999999999999999999953110 00000010000
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC------HHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT------AQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt------~~elL~hp~f~~~~ 315 (470)
......++..++..+.+||.+||..||.+||| +.++++||||.+..
T Consensus 218 ---------------------------~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 218 ---------------------------LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred ---------------------------hcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 00011233567889999999999999999998 58999999998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=297.05 Aligned_cols=216 Identities=25% Similarity=0.364 Sum_probs=170.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+..|+++|+.++ ||||+++++++.. ...+|+||||++ ++|.+++..... +++..+..
T Consensus 38 ~~~~~E~~il~~l~-hp~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~--------------- 99 (277)
T cd05607 38 KMALLEKEILEKVN-SPFIVNLAYAFES--KTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIH--------------- 99 (277)
T ss_pred HHHHHHHHHHHhcC-CCcEEEEEEEEec--CCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHH---------------
Confidence 34567999999998 9999999998854 678999999998 599988865432 55554444
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+.||+||||||+||+++.+ .++
T Consensus 100 --------------------------------------------~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~ 135 (277)
T cd05607 100 --------------------------------------------YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCR 135 (277)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEE
Confidence 89999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||++.............|+..|+|||++.+.. ++.++||||+||++|+|++|..||.+.........+....
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---- 210 (277)
T cd05607 136 LSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT---- 210 (277)
T ss_pred EeeceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh----
Confidence 99999988765544444567899999999987766 8999999999999999999999997643321111111100
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH----HHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA----QKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~----~elL~hp~f~~~~ 315 (470)
. ..........++.++.+||.+||+.||.+||++ ++++.||||+.+.
T Consensus 211 ------~----------------~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 211 ------L----------------EDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred ------h----------------ccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 0 000111123578899999999999999999999 7788999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=295.21 Aligned_cols=235 Identities=32% Similarity=0.601 Sum_probs=181.6
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+++++.++ ||||+++++++.. ....++||||+++ .|..++.....+++..+..
T Consensus 46 ~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~------------------ 104 (286)
T cd07847 46 IALREIRMLKQLK-HPNLVNLIEVFRR--KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK------------------ 104 (286)
T ss_pred HHHHHHHHHHhCC-CCCEeeeeeEEee--CCEEEEEEeccCccHHHHHHhCCCCCCHHHHHH------------------
Confidence 4678999999999 9999999999865 6789999999996 6666665555577777776
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||+.|++||||||+||+++.+ .++|+|
T Consensus 105 -----------------------------------------~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~d 143 (286)
T cd07847 105 -----------------------------------------IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCD 143 (286)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECc
Confidence 99999999999999999999999999999877 899999
Q ss_pred cCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 170 LGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 170 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
||++....... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+....+.....
T Consensus 144 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 144 FGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred cccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 99988765433 23345688999999998775568899999999999999999999999888777777776655543332
Q ss_pred HHHHHhhhccCccccc--ccc-CCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 249 TLKKFEKYKSSNFTYQ--FKQ-YPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
....+.. ..+... .+. ..........+.++..+.+||.+||..||++|||+.+++.||||
T Consensus 224 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 224 HQQIFST---NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred Hhhhccc---ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 2111110 000000 000 00111122234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.47 Aligned_cols=213 Identities=23% Similarity=0.404 Sum_probs=175.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+.+|+.+|..++ ||||+++++++.. .+.+|+||||++ |+|.+++... ..+++..+..
T Consensus 110 ~~~~~E~~~l~~l~-Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~------------- 173 (478)
T PTZ00267 110 AYARSELHCLAACD-HFGIVKHFDDFKS--DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL------------- 173 (478)
T ss_pred HHHHHHHHHHHhCC-CCCEeEEEEEEEE--CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHH-------------
Confidence 34678999999999 9999999999865 678999999998 6999887542 2255555554
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 174 ----------------------------------------------i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~ 207 (478)
T PTZ00267 174 ----------------------------------------------LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207 (478)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc
Confidence 99999999999999999999999999999977 8
Q ss_pred EEEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
++|+|||++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 208 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~ 286 (478)
T PTZ00267 208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286 (478)
T ss_pred EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 9999999998765332 234567999999999987755 899999999999999999999999887766555444321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.....+..++.++.+||.+||..||++|||+.+++.|||++....
T Consensus 287 ------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~~ 331 (478)
T PTZ00267 287 ------------------------------KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVAN 331 (478)
T ss_pred ------------------------------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHHHH
Confidence 111123457889999999999999999999999999999986543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=306.24 Aligned_cols=244 Identities=34% Similarity=0.616 Sum_probs=193.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecC---CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNR---STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~---~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+|+.++ ||||+++++++... .....|+|+||++++|.+++... .+++..++.
T Consensus 48 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~l~~~~~~~--------------- 110 (336)
T cd07849 48 QRTLREIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ-HLSNDHIQY--------------- 110 (336)
T ss_pred HHHHHHHHHHHhCC-CCCcCchhheeecccccccceEEEEehhcccCHHHHHhcC-CCCHHHHHH---------------
Confidence 45678999999999 99999999987542 23468999999999999888543 467766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+||+++.+ .++
T Consensus 111 --------------------------------------------i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 111 --------------------------------------------FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++....... .....+|+..|+|||++.+...++.++||||+||++|+|++|++||.+.........+...+
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~ 226 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL 226 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 99999987654322 12335789999999987665558899999999999999999999999988888888888889
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+.+..+.+..........+....+..+........+.+++++.+||.+||..||++|||+.++++||||....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 9887776654433222222111111111222223356788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=310.10 Aligned_cols=214 Identities=25% Similarity=0.384 Sum_probs=174.3
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+.++..++ ||||+++++++.. ...+|+|||||+ |+|.+++... .+++..+..
T Consensus 89 ~~~~e~~il~~~~-h~~iv~~~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~------------------ 146 (370)
T cd05596 89 FFWEERDIMAHAN-SEWIVQLHYAFQD--DKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARF------------------ 146 (370)
T ss_pred HHHHHHHHHHhCC-CCCcceEEEEEec--CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHH------------------
Confidence 4678999999999 9999999998854 678999999998 6999998654 366666655
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+|
T Consensus 147 -----------------------------------------~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 147 -----------------------------------------YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEe
Confidence 89999999999999999999999999999877 899999
Q ss_pred cCCcccccCCC--ccccccccCcccCchhhccCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 170 LGSLQFIKSKG--LHTEYIATRWYRSPECLLTEG---YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 170 FG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~---~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
||++....... .....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.+.+.......+.....
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~- 264 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN- 264 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-
Confidence 99987664332 223568999999999986532 378999999999999999999999998876665555532100
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC--CcCHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR--RPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--Rpt~~elL~hp~f~~~~ 315 (470)
...+ .....++.++.+||.+||..+|.+ |+|++++++||||++..
T Consensus 265 -----------------~~~~---------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 265 -----------------SLTF---------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred -----------------cCCC---------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 0000 011257899999999999999988 99999999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.01 Aligned_cols=240 Identities=30% Similarity=0.575 Sum_probs=189.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+.+++.++ ||||++++++|.... ....|+||||+.++|.+.+... +++..+..
T Consensus 60 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~-------------- 122 (353)
T cd07850 60 KRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSY-------------- 122 (353)
T ss_pred HHHHHHHHHHHhcC-CCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHH--------------
Confidence 35678999999998 999999999886432 2458999999999999988643 66666665
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+||+++.+ .+
T Consensus 123 ---------------------------------------------~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 123 ---------------------------------------------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999999888 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||++.............++..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+...+|.|
T Consensus 158 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (353)
T cd07850 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236 (353)
T ss_pred EEccCccceeCCCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999999998766544445567899999999987755 8999999999999999999999999998888899999999998
Q ss_pred chHHHHHHhhhccCccc----c---ccccC-CCCC----cccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 246 KAETLKKFEKYKSSNFT----Y---QFKQY-PGGG----IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~----~---~~~~~-~~~~----~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
..+.+..+......... . .+... +... ........+..+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 87665544321110000 0 00000 0000 00011235677899999999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=304.86 Aligned_cols=210 Identities=26% Similarity=0.370 Sum_probs=172.0
Q ss_pred hhhhHHHHHH---hcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISIL---RKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL---~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+.++ ..++ ||||+++++++.. .+.+|+||||++ |+|..++.. ..+++..+..
T Consensus 44 ~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~--~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~-------------- 105 (324)
T cd05589 44 ESLMCEKRIFETANSER-HPFLVNLFACFQT--EDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVF-------------- 105 (324)
T ss_pred HHHHHHHHHHHhccccC-CCChhceeeEEEc--CCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHH--------------
Confidence 3456676655 5666 9999999998864 678999999999 599888754 3477777666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 106 ---------------------------------------------~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 106 ---------------------------------------------YAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|+|||++.... ........+|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 141 kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--- 216 (324)
T cd05589 141 KIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--- 216 (324)
T ss_pred EeCcccCCccCCCCCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Confidence 999999886533 222334568999999999987755 899999999999999999999999888776665554321
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
....+..++..+.+||.+||..||.+|| ++.++++||||.++.
T Consensus 217 ----------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 217 ----------------------------EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred ----------------------------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 0112345788999999999999999999 799999999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=295.73 Aligned_cols=237 Identities=36% Similarity=0.680 Sum_probs=192.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+++++.++ ||||+++++++.. .+..|+||||++++|.+++.... .+++..+..
T Consensus 43 ~~~~~E~~~l~~l~-~~~iv~~~~~~~~--~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~---------------- 103 (283)
T cd07835 43 STAIREISLLKELN-HPNIVRLLDVVHS--ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS---------------- 103 (283)
T ss_pred hHHHHHHHHHHhcC-CCCccCHhheecc--CCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHH----------------
Confidence 45778999999999 9999999999864 67899999999999999987765 466766666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++|++||||+|+||+++.+ .++|
T Consensus 104 -------------------------------------------~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l 140 (283)
T cd07835 104 -------------------------------------------YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKL 140 (283)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||.+....... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.+..++|.
T Consensus 141 ~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd07835 141 ADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD 220 (283)
T ss_pred eecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999987554221 223346788999999887655578899999999999999999999999888888888888888888
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
...|....... .+...++...........+.++..+.++|.+||+.||.+|||++++++||||
T Consensus 221 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 221 EDVWPGVTSLP--DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hHHhhhhhhch--hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 77665443321 1111222222222333446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=297.11 Aligned_cols=240 Identities=33% Similarity=0.634 Sum_probs=187.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC---CCeEEEEeeccccCHHHHHHhcc-----cccHHHHHHHHHHHHhhhc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS---TRQVTLVFPLMELNLEEYIRTTD-----NISEKRAKEILYQVKAANE 82 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~---~~~~~lV~E~~~gsL~~~l~~~~-----~l~~~~~~~~~~~~~~~~~ 82 (470)
..+.+|+.++..+.+||||+++++++.... ....|+||||++++|.+++.... .+++..+..
T Consensus 45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~---------- 114 (295)
T cd07837 45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS---------- 114 (295)
T ss_pred hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHH----------
Confidence 457899999999976799999999886432 22389999999999999986532 145555554
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.||+.||+|||++||+||||||+||+++.
T Consensus 115 -------------------------------------------------~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~ 145 (295)
T cd07837 115 -------------------------------------------------FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK 145 (295)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHCCeeecCCChHHEEEec
Confidence 9999999999999999999999999999997
Q ss_pred -C-eEEEEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 163 -D-LVVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 163 -~-~ikL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
+ .++|+|||.+...... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+.
T Consensus 146 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 146 QKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred CCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 4 8999999988755322 222334678899999988765557899999999999999999999999998888888888
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
..++.+....+.......... ..+...........+.++.++.+||.+||..||.+|||+.+++.||||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWH---EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHhCCCChhhCcchhhccchh---hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 888877766554433321111 1111111222223356889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=306.37 Aligned_cols=246 Identities=39% Similarity=0.661 Sum_probs=202.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC---CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS---TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~---~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ ||||+++++++.... ...+|+||||++++|.+++.....+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~-------------- 107 (330)
T cd07834 43 AKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY-------------- 107 (330)
T ss_pred hhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCCCHHHHHH--------------
Confidence 456789999999999 999999999886532 24789999999999999998776778877777
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 108 ---------------------------------------------i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~ 142 (330)
T cd07834 108 ---------------------------------------------FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDL 142 (330)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+|+|||.+....... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 143 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (330)
T cd07834 143 KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222 (330)
T ss_pred EEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence 999999988765442 2345578999999999887645899999999999999999999999999999999999999
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.|.+....+..........+...........+....+.++..+.+||.+||..+|.+|||++++++||||++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 99888776654333222222222222223333444566889999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=308.49 Aligned_cols=213 Identities=24% Similarity=0.370 Sum_probs=174.6
Q ss_pred hhhHHHHHHhcCC--CCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 12 ANLKEISILRKIP--DHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 12 ~~~rEi~iL~~L~--~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..++|..++..+. +||||+++++++.. ...+|+||||++ |+|.+++.....+++..+..
T Consensus 39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~---------------- 100 (330)
T cd05586 39 HTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF---------------- 100 (330)
T ss_pred HHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHH----------------
Confidence 3456777777663 59999999998854 678999999998 69999998777788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 101 -------------------------------------------~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl 137 (330)
T cd05586 101 -------------------------------------------YIAELVLALEHLHKYDIVYRDLKPENILLDATGHIAL 137 (330)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.... ........+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 138 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----- 212 (330)
T cd05586 138 CDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----- 212 (330)
T ss_pred ecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----
Confidence 9999987543 2233445689999999999876655899999999999999999999999887665544443210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc----CHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP----TAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp----t~~elL~hp~f~~~~ 315 (470)
........+++++.+||.+||..||.+|| ++.++++||||.+..
T Consensus 213 -------------------------~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 213 -------------------------KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred -------------------------CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 00001124688999999999999999998 799999999998764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=310.69 Aligned_cols=215 Identities=23% Similarity=0.365 Sum_probs=175.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++.+.. .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 46 ~~~~~e~~~l~~l~-~~~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~----------------- 105 (360)
T cd05627 46 AHIRAERDILVEAD-GAWVVKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF----------------- 105 (360)
T ss_pred HHHHHHHHHHHhCC-CCCEeeEEEEEEc--CCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHH-----------------
Confidence 45678999999998 9999999998864 678999999998 59999998777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~ 143 (360)
T cd05627 106 ------------------------------------------YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLS 143 (360)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCC------------------------------------ccccccccCcccCchhhccCCCCCCcccHHHH
Q psy9855 169 DLGSLQFIKSKG------------------------------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAA 212 (470)
Q Consensus 169 DFG~a~~~~~~~------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSl 212 (470)
|||++....... .....+||+.|+|||++.+.. ++.++|||||
T Consensus 144 DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSl 222 (360)
T cd05627 144 DFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSL 222 (360)
T ss_pred eccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccc
Confidence 999886543110 012357999999999988765 8999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhc
Q psy9855 213 GCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEML 292 (470)
Q Consensus 213 G~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L 292 (470)
||++|||++|.+||.+.+.......+...... ..++ ....+++++.+||.+|+
T Consensus 223 Gvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~------------------~~~p---------~~~~~s~~~~~li~~l~ 275 (360)
T cd05627 223 GVIMYEMLIGYPPFCSETPQETYRKVMNWKET------------------LVFP---------PEVPISEKAKDLILRFC 275 (360)
T ss_pred cceeeecccCCCCCCCCCHHHHHHHHHcCCCc------------------eecC---------CCCCCCHHHHHHHHHhc
Confidence 99999999999999888776665554321000 0000 01236889999999987
Q ss_pred ccCCCCCc---CHHHHHhcccCCChhH
Q psy9855 293 KYDPKRRP---TAQKILSCAYFADLTQ 316 (470)
Q Consensus 293 ~~dP~~Rp---t~~elL~hp~f~~~~~ 316 (470)
. ||.+|+ +++++++||||+++..
T Consensus 276 ~-~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 276 T-DSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred c-ChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 4 999998 5899999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.26 Aligned_cols=213 Identities=21% Similarity=0.290 Sum_probs=173.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++.++.+||||+++++++.. .+.+|+||||++ |+|..++.....+++..+..
T Consensus 40 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~----------------- 100 (327)
T cd05617 40 DWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF----------------- 100 (327)
T ss_pred HHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 3467999999999669999999998865 678999999998 69999988777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~ 138 (327)
T cd05617 101 ------------------------------------------YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLT 138 (327)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHH
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE------IDQLDRIHQV 241 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~------~~~~~~i~~~ 241 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .+.......
T Consensus 139 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~- 216 (327)
T cd05617 139 DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL- 216 (327)
T ss_pred ccccceeccCCCCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-
Confidence 999887532 233344568999999999987755 89999999999999999999999964221 111111110
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC------HHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT------AQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt------~~elL~hp~f~~~~ 315 (470)
.....++..++..+.++|.+||..||.+|++ ++++++||||..+.
T Consensus 217 -----------------------------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 217 -----------------------------EKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred -----------------------------hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 0011133457889999999999999999998 57999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=307.60 Aligned_cols=215 Identities=23% Similarity=0.312 Sum_probs=176.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.++..++ ||||+++++++.. .+.+|+||||++ |+|.+++... ..+++..+..
T Consensus 46 ~~~~~e~~i~~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~---------------- 106 (330)
T cd05601 46 SFFEEERDILSISN-SPWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF---------------- 106 (330)
T ss_pred HHHHHHHHHHHhCC-CCCCcceeeEEec--CCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHH----------------
Confidence 45678999999998 9999999998864 678999999998 6999999876 4477777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 107 -------------------------------------------~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 107 -------------------------------------------YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEe
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc--cccccccCcccCchhhcc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 168 GDLGSLQFIKSKGL--HTEYIATRWYRSPECLLT-----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 168 ~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+|||++........ .....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 144 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 223 (330)
T cd05601 144 ADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223 (330)
T ss_pred ccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 99999987654332 233579999999999863 33478999999999999999999999988776665555433
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
... . ......+.++.++.+||.+||. +|.+|||++++++||||..+.
T Consensus 224 ~~~---------------------~------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 224 FQR---------------------F------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred CCC---------------------c------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 100 0 0001123578999999999998 999999999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.19 Aligned_cols=243 Identities=32% Similarity=0.627 Sum_probs=194.4
Q ss_pred hhhhHHHHHHhcC-CCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKI-PDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L-~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++.++ + ||||+++++++...+....|+||||++++|.+++... .+++..+..
T Consensus 51 ~~~~~E~~~l~~l~~-h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~----------------- 111 (337)
T cd07852 51 QRTFREIMFLQELGD-HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN-ILEDVHKRY----------------- 111 (337)
T ss_pred hhhhHHHHHHHHhcC-CCCccceeeeeccCCCceEEEEecccccCHHHHHhcC-CCCHHHHHH-----------------
Confidence 4567899999999 6 9999999999876556678999999999999998765 455555555
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|+
T Consensus 112 ------------------------------------------i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 112 ------------------------------------------IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEe
Confidence 99999999999999999999999999999988 89999
Q ss_pred ecCCcccccCCC------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 169 DLGSLQFIKSKG------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 169 DFG~a~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|||.+....... ......|+..|+|||++.+...++.++|||||||++|+|++|++||.+....+....+....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999887654322 22345789999999988765667899999999999999999999999998888888888888
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+.+..+.+..+.......+................+.++.++.++|.+||..||.+|||+.++++||||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 888776665543321111111111111222233345578999999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.04 Aligned_cols=246 Identities=33% Similarity=0.625 Sum_probs=197.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeec--CCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+++|+.++.++.+||||+++++.... .....+++++||++++|.+++.....+++..++.
T Consensus 46 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~---------------- 109 (332)
T cd07857 46 KRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQS---------------- 109 (332)
T ss_pred HHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHH----------------
Confidence 4578999999999669999999987542 2235689999999999999998776677777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 110 -------------------------------------------~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 110 -------------------------------------------FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEe
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKG-----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||.+....... ......||..|+|||++.+...++.++||||+||++|+|++|.+||.+.+....+..+...+
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 9999987654321 12345789999999988765558899999999999999999999999999899999999999
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
|.+..+.+..+.......+.......+........+.++..+.+||.+||..||.+|||+.+++.||||....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 9988776655543222222222222222233334456788999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=305.61 Aligned_cols=211 Identities=27% Similarity=0.368 Sum_probs=173.8
Q ss_pred hhhhHHHHH-HhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISI-LRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~i-L~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+++|..+ ++.++ ||||+++++++.. .+.+|+||||++ |+|..++.....+++..+..
T Consensus 40 ~~~~~e~~~~l~~~~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 100 (325)
T cd05604 40 KHIMAERNVLLKNVK-HPFLVGLHYSFQT--TEKLYFVLDFVNGGELFFHLQRERSFPEPRARF---------------- 100 (325)
T ss_pred HHHHHHHHHHHHhCC-CCCCccEEEEEec--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHH----------------
Confidence 345666654 66787 9999999998864 678999999999 59999988777788877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 101 -------------------------------------------~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL 137 (325)
T cd05604 101 -------------------------------------------YAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL 137 (325)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 138 ~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~----- 211 (325)
T cd05604 138 TDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK----- 211 (325)
T ss_pred eecCCcccCCCCCCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----
Confidence 9999987533 222334568999999999987755 789999999999999999999999887766555444320
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH----HHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA----QKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~----~elL~hp~f~~~~ 315 (470)
.....+.++..+.++|.+||..||.+||++ .++++||||....
T Consensus 212 --------------------------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 212 --------------------------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred --------------------------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 011234678899999999999999999976 5999999999765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.37 Aligned_cols=212 Identities=24% Similarity=0.323 Sum_probs=163.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.++ |+||+++++++.. .+.+++|||||+ |+|.+.. ...+..+..
T Consensus 116 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~---------------- 172 (353)
T PLN00034 116 RRQICREIEILRDVN-HPNVVKCHDMFDH--NGEIQVLLEFMDGGSLEGTH----IADEQFLAD---------------- 172 (353)
T ss_pred HHHHHHHHHHHHhCC-CCCcceeeeEecc--CCeEEEEEecCCCCcccccc----cCCHHHHHH----------------
Confidence 456789999999999 9999999998854 678999999999 5775432 233444444
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 173 -------------------------------------------i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL 209 (353)
T PLN00034 173 -------------------------------------------VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKI 209 (353)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++....... .....+||..|+|||++... ...+.++|||||||++|||++|+.||......+....+....
T Consensus 210 ~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 289 (353)
T PLN00034 210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC 289 (353)
T ss_pred cccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh
Confidence 9999988664322 23456899999999987432 234568999999999999999999997433222111111110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
..........++.++.+||.+||..||++|||+.|+|+||||...
T Consensus 290 ---------------------------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 290 ---------------------------MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ---------------------------ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 000111234678899999999999999999999999999999863
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.25 Aligned_cols=238 Identities=24% Similarity=0.370 Sum_probs=171.4
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
...+|+++|++|+ |||||++++++.. .+..++|||++.++|.+++..... +++..+..
T Consensus 206 ~~~~E~~iL~~L~-HpnIv~l~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~------------------ 264 (461)
T PHA03211 206 SSVHEARLLRRLS-HPAVLALLDVRVV--GGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTA------------------ 264 (461)
T ss_pred CHHHHHHHHHHCC-CCCCCcEEEEEEE--CCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHH------------------
Confidence 4568999999999 9999999998865 677899999999999999876433 66666666
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
|+.||+.||.|||++|||||||||+|||++.+ .++|+|
T Consensus 265 -----------------------------------------i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 265 -----------------------------------------VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcc
Confidence 99999999999999999999999999999887 899999
Q ss_pred cCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHH
Q psy9855 170 LGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS-------EIDQLDRIH 239 (470)
Q Consensus 170 FG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-------~~~~~~~i~ 239 (470)
||+++...... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..++.... ...++.++.
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i 382 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRII 382 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHH
Confidence 99987654321 123457999999999998765 8999999999999999999875542211 123344444
Q ss_pred HHhCCCchHH-----HHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 240 QVLGTPKAET-----LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 240 ~~~g~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...+....+. ......+.........+......+.. ...++..+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 383 RQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 4333211110 00000000000000011111111111 1245678899999999999999999999999999974
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.82 Aligned_cols=214 Identities=25% Similarity=0.384 Sum_probs=172.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. ...+|+|||||+ |+|.+++... .+++..+..
T Consensus 88 ~~~~~e~~i~~~~~-hp~iv~~~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~----------------- 146 (370)
T cd05621 88 AFFWEERDIMAFAN-SPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKF----------------- 146 (370)
T ss_pred HHHHHHHHHHHhCC-CCCEeeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHH-----------------
Confidence 34678999999999 9999999998864 678999999998 6999998654 366666666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 147 ------------------------------------------~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 147 ------------------------------------------YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCc--cccccccCcccCchhhccCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 169 DLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEG---YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 169 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~---~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
|||++........ ....+||+.|+|||++.+.. .++.++||||+||++|+|++|..||.+.+.......+.....
T Consensus 185 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05621 185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred ecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Confidence 9999987643322 23568999999999987542 378899999999999999999999988877666555543110
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC--CcCHHHHHhcccCCCh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR--RPTAQKILSCAYFADL 314 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--Rpt~~elL~hp~f~~~ 314 (470)
. ..+ .....++..++++|..||..++.+ |+|+.++++||||+..
T Consensus 265 ~------------------~~~---------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 265 S------------------LNF---------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred c------------------cCC---------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0 000 011246889999999999865543 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=298.92 Aligned_cols=241 Identities=37% Similarity=0.664 Sum_probs=183.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-----cccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-----NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-----~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+.+|+.++..++ ||||+++++++.......+++||||++++|.+++.... .+++..++.
T Consensus 47 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~------------- 112 (316)
T cd07842 47 QSACREIALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS------------- 112 (316)
T ss_pred HHHHHHHHHHHhcC-CCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHH-------------
Confidence 45688999999999 99999999999875557899999999999988875432 244544444
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG--- 162 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~--- 162 (470)
++.||+.||+|||++||+||||||+||+++.
T Consensus 113 ----------------------------------------------i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~ 146 (316)
T cd07842 113 ----------------------------------------------LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGP 146 (316)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCC
Confidence 9999999999999999999999999999987
Q ss_pred -C-eEEEEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh-----
Q psy9855 163 -D-LVVVGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE----- 231 (470)
Q Consensus 163 -~-~ikL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~----- 231 (470)
+ .++|+|||++........ .....++..|+|||++.+...++.++|||||||++|+|++|.+||.+...
T Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 147 ERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226 (316)
T ss_pred ccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence 4 899999999886543221 23457889999999987765688999999999999999999999976543
Q ss_pred ----HHHHHHHHHHhCCCchHHHHHHhhhccCccc---cccccCCCCCc-cccc--ccccHHHHHHHHHhcccCCCCCcC
Q psy9855 232 ----IDQLDRIHQVLGTPKAETLKKFEKYKSSNFT---YQFKQYPGGGI-DVLV--PQIHEKGKKLMSEMLKYDPKRRPT 301 (470)
Q Consensus 232 ----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~--~~~s~~~~~Li~~~L~~dP~~Rpt 301 (470)
...+..+...++.+....+............ ......+.... .... ...+..+.++|.+||..||++|||
T Consensus 227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 2356667777787777666554443211110 00000110000 0011 156778999999999999999999
Q ss_pred HHHHHhcccC
Q psy9855 302 AQKILSCAYF 311 (470)
Q Consensus 302 ~~elL~hp~f 311 (470)
+.|+++||||
T Consensus 307 ~~eil~~~~f 316 (316)
T cd07842 307 AEEALEHPYF 316 (316)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=294.39 Aligned_cols=206 Identities=18% Similarity=0.181 Sum_probs=168.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeec--CCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+|.+++ ||||++++|++.+ .....+++|||||+ |+|.+++.....++......
T Consensus 63 ~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~--------------- 126 (283)
T PHA02988 63 DITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLD--------------- 126 (283)
T ss_pred HHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHH---------------
Confidence 44669999999999 9999999999875 44567899999999 69999998766666666555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~i 165 (470)
++.|++.||.|||+ .+++||||||+|||++.+ .+
T Consensus 127 --------------------------------------------i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 127 --------------------------------------------MAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcE
Confidence 99999999999998 499999999999999988 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
||+|||++....... ....|+..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+.....
T Consensus 163 kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~- 239 (283)
T PHA02988 163 KIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN- 239 (283)
T ss_pred EEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-
Confidence 999999987654322 345789999999998652 3489999999999999999999999988776655544432110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..+++.+.+||.+||+.||++|||+.++++
T Consensus 240 ----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 240 ----------------------------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------------------------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01122357889999999999999999999999984
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=289.33 Aligned_cols=209 Identities=22% Similarity=0.401 Sum_probs=172.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++++++ ||||+++++++.. ...+++|+||++ ++|.+++.....+++..+..
T Consensus 49 ~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~----------------- 108 (263)
T cd06625 49 NALECEIQLLKNLQ-HERIVQYYGCLRD--DETLSIFMEYMPGGSVKDQLKAYGALTETVTRK----------------- 108 (263)
T ss_pred HHHHHHHHHHHhCC-CCCeeeeEEEEcc--CCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHH-----------------
Confidence 35678999999998 9999999999865 568999999998 59999998776677777666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||+.||+||||+|+||+++.+ .++|+
T Consensus 109 ------------------------------------------~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 109 ------------------------------------------YTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||.+......... ....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+...
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 222 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--- 222 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc---
Confidence 99998755422111 2356888999999988765 889999999999999999999999776544433332210
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.....++..++..+.++|.+||..+|.+|||+.++++||||
T Consensus 223 --------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 223 --------------------------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------------------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01122334678899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=301.77 Aligned_cols=242 Identities=19% Similarity=0.303 Sum_probs=174.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.++ ||||++++++|.. .+.+++||||+. |+|.+++.....+++..+..
T Consensus 47 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 107 (333)
T cd06650 47 RNQIIRELQVLHECN-SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---------------- 107 (333)
T ss_pred HHHHHHHHHHHHHCC-CCcccceeEEEEE--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 456889999999999 9999999999875 678999999998 59999998776677777666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||+. +|+||||||+|||++.+ .++
T Consensus 108 -------------------------------------------~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~k 144 (333)
T cd06650 108 -------------------------------------------VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 144 (333)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEE
Confidence 999999999999985 79999999999999877 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCC
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ-VLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~-~~g~p 245 (470)
|+|||++...... ......|+..|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+.. ..+.+
T Consensus 145 L~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (333)
T cd06650 145 LCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDP 222 (333)
T ss_pred EeeCCcchhhhhh-ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCc
Confidence 9999998755332 223457899999999987754 88999999999999999999999976654332211110 01111
Q ss_pred chHHHHHHhhhccCccc-cccccC------------CCCCcccc-cccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFT-YQFKQY------------PGGGIDVL-VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~------------~~~~~~~~-~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
................. +..... ........ ...++.++.+||.+||..||++|||+.|++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred cccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 10000000000000000 000000 00000000 12357889999999999999999999999999999
Q ss_pred CChh
Q psy9855 312 ADLT 315 (470)
Q Consensus 312 ~~~~ 315 (470)
+...
T Consensus 303 ~~~~ 306 (333)
T cd06650 303 KRSE 306 (333)
T ss_pred hcCc
Confidence 8653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=291.94 Aligned_cols=237 Identities=37% Similarity=0.708 Sum_probs=200.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhc-ccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ |+||+++++++.. .+..++|+||++++|.+++... ..+++..+..
T Consensus 43 ~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~----------------- 102 (282)
T cd07829 43 STALREISLLKELK-HPNIVKLLDVIHT--ERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKS----------------- 102 (282)
T ss_pred HHHHHHHHHHHhcC-CCCHHHHHhhhhc--CCceEEEecCcCcCHHHHHHhhccCCCHHHHHH-----------------
Confidence 45678999999999 9999999998864 5789999999999999999876 3477777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.|++.||+|||++||+||||+|+||+++.+ .++|+
T Consensus 103 ------------------------------------------~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~ 140 (282)
T cd07829 103 ------------------------------------------IMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLA 140 (282)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEe
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||.+....... ......++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+..
T Consensus 141 d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
T cd07829 141 DFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE 220 (282)
T ss_pred cCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcH
Confidence 999887665332 2334466788999999877645899999999999999999999999999999999999999999988
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
..|..+.... .+...++.+.........+.++..+.++|.+||..||++||++.+++.||||
T Consensus 221 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 221 ESWPGVTKLP--DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHhhcccc--cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 8887766543 2333444444444444456678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.65 Aligned_cols=211 Identities=24% Similarity=0.325 Sum_probs=172.1
Q ss_pred hhhhHHHH-HHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEIS-ILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~-iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+++|+. +++.++ ||||+++++++.. .+.+|+|||||+ |+|...+.....+++..+..
T Consensus 40 ~~~~~e~~~~l~~~~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 100 (321)
T cd05603 40 NHIMAERNVLLKNLK-HPFLVGLHYSFQT--AEKLYFVLDYVNGGELFFHLQRERCFLEPRARF---------------- 100 (321)
T ss_pred HHHHHHHHHHHHhCC-CCCccceeeEEEc--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHH----------------
Confidence 34556655 577888 9999999998854 678999999999 59999887766677777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 101 -------------------------------------------~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl 137 (321)
T cd05603 101 -------------------------------------------YAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVL 137 (321)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 138 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----- 211 (321)
T cd05603 138 TDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK----- 211 (321)
T ss_pred ccCCCCccCCCCCCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----
Confidence 9999887532 222334568999999999987655 899999999999999999999999887655544443210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH----HHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA----QKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~----~elL~hp~f~~~~ 315 (470)
...+++..+..+.++|.+||..||.+|+++ .++++||||..+.
T Consensus 212 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 212 --------------------------PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred --------------------------CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 011234567889999999999999999875 5999999998765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=305.66 Aligned_cols=209 Identities=24% Similarity=0.393 Sum_probs=181.8
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+++|+..|.+|+ |||+|.+-|.|.- ....|||||||-|+-.+++.-... +.+..+..
T Consensus 72 DIlKEVrFL~~l~-HPntieYkgCyLr--e~TaWLVMEYClGSAsDlleVhkKplqEvEIAA------------------ 130 (948)
T KOG0577|consen 72 DILKEVRFLRQLR-HPNTIEYKGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------------ 130 (948)
T ss_pred HHHHHHHHHHhcc-CCCcccccceeec--cchHHHHHHHHhccHHHHHHHHhccchHHHHHH------------------
Confidence 5789999999999 9999999999875 566899999999988888876655 77777777
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
|..+.+.||+|||+.+.||||||..|||+++. .|||+|
T Consensus 131 -----------------------------------------i~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaD 169 (948)
T KOG0577|consen 131 -----------------------------------------ITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLAD 169 (948)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeecc
Confidence 99999999999999999999999999999887 899999
Q ss_pred cCCcccccCCCccccccccCcccCchhhc--cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 170 LGSLQFIKSKGLHTEYIATRWYRSPECLL--TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 170 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
||.|..... .+.++|||+|||||+++ ..+.|+-++||||||++..||.-.+||+...+.+..+..|...-.
T Consensus 170 FGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes---- 242 (948)
T KOG0577|consen 170 FGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---- 242 (948)
T ss_pred ccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC----
Confidence 999877653 46789999999999985 446799999999999999999999999999998888888865211
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
...-.+..++.+..|+..||..-|.+|||.+++|.|+|...-
T Consensus 243 -------------------------PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 243 -------------------------PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -------------------------CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 011124678899999999999999999999999999999853
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=302.79 Aligned_cols=210 Identities=25% Similarity=0.389 Sum_probs=173.5
Q ss_pred hhhHHHH-HHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 12 ANLKEIS-ILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 12 ~~~rEi~-iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.+++|.. +++.++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 41 ~~~~e~~~~l~~~~-h~~Iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~----------------- 100 (325)
T cd05602 41 HIMSERNVLLKNVK-HPFLVGLHFSFQT--ADKLYFVLDYINGGELFYHLQRERCFLEPRARF----------------- 100 (325)
T ss_pred HHHHHHHHHHHhCC-CCCCCceeEEEEc--CCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 4455554 467787 9999999998864 678999999999 59999998776677777766
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 101 ------------------------------------------~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~ 138 (325)
T cd05602 101 ------------------------------------------YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 138 (325)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEc
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 139 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------ 211 (325)
T cd05602 139 DFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------ 211 (325)
T ss_pred cCCCCcccccCCCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC------
Confidence 999987543 223334568999999999987755 899999999999999999999999887766655544321
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHH----HHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ----KILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~----elL~hp~f~~~~ 315 (470)
.....+.++..+.++|.+||+.||.+|+++. ++++|+||....
T Consensus 212 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 212 -------------------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred -------------------------CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 0112346789999999999999999999876 899999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=299.90 Aligned_cols=212 Identities=19% Similarity=0.302 Sum_probs=177.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+.+|++|+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~----------------- 105 (323)
T cd05615 45 ECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF----------------- 105 (323)
T ss_pred HHHHHHHHHHHhccCCCchhheeeEEec--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 4567899999999867889999998865 567999999998 69999998777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 106 ------------------------------------------i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~ 143 (323)
T cd05615 106 ------------------------------------------YAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIA 143 (323)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEe
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++...... ......+||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 144 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----- 217 (323)
T cd05615 144 DFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----- 217 (323)
T ss_pred ccccccccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----
Confidence 99998754322 2234567999999999987755 8999999999999999999999998887666555543310
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~ 315 (470)
..++..++.++.+++.+||..||.+|++ .+++++||||..+.
T Consensus 218 --------------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 218 --------------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred --------------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 1122457889999999999999999997 57999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=300.53 Aligned_cols=238 Identities=33% Similarity=0.627 Sum_probs=191.9
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGW 91 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (470)
.+.+|++++..++ ||||+++++++.. .+..++||||++|+|.+++.....+++..+..
T Consensus 66 ~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~------------------- 123 (335)
T PTZ00024 66 TTLRELKIMNEIK-HENIMGLVDVYVE--GDFINLVMDIMASDLKKVVDRKIRLTESQVKC------------------- 123 (335)
T ss_pred hHHHHHHHHHhCC-CcceeeeeEEEec--CCcEEEEEeccccCHHHHHHhcCCCCHHHHHH-------------------
Confidence 4679999999999 9999999999864 67899999999999999998766677777666
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEec
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDL 170 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DF 170 (470)
++.||+.||+|||+.||+||||+|+||+++.+ .++|+||
T Consensus 124 ----------------------------------------~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 124 ----------------------------------------ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred ----------------------------------------HHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99999999999999999999999999999887 8999999
Q ss_pred CCcccccCC---------------CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy9855 171 GSLQFIKSK---------------GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235 (470)
Q Consensus 171 G~a~~~~~~---------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 235 (470)
|.+...... .......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 988765411 11123356888999999877655789999999999999999999999999998889
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
..+...++.|....|.......... .+............+..+.++.++|.+||..+|++|||++++|.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYT---EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhccccc---ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 8898888888776554432211100 000111112222334668899999999999999999999999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=295.52 Aligned_cols=240 Identities=35% Similarity=0.622 Sum_probs=189.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC------CCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS------TRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANET 83 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~------~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~ 83 (470)
..+.+|+++++.++ ||||+++++++.... ...+++|+||++++|.+.+.... .+++..++.
T Consensus 52 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~----------- 119 (311)
T cd07866 52 ITALREIKILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC----------- 119 (311)
T ss_pred hhHHHHHHHHHhcC-CCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHH-----------
Confidence 45679999999999 999999999876432 33589999999999988876543 377777776
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
++.||++||+|||++||+||||||+||+++.+
T Consensus 120 ------------------------------------------------i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~ 151 (311)
T cd07866 120 ------------------------------------------------YMLQLLEGINYLHENHILHRDIKAANILIDNQ 151 (311)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999987
Q ss_pred -eEEEEecCCcccccCCCc------------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy9855 164 -LVVVGDLGSLQFIKSKGL------------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~------------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~ 230 (470)
.++|+|||++........ .....|++.|+|||++.+...++.++|||||||++|+|++|++||.+.+
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 899999998876542211 1234678889999988765558899999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 231 EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 231 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
.......+....+.+.+..+..+...............+. ........+++.+.++|.+||..||.+|||+.+++.|||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR-TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCc-cHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 9888888888888887776665544322111111111111 111122345678899999999999999999999999999
Q ss_pred C
Q psy9855 311 F 311 (470)
Q Consensus 311 f 311 (470)
|
T Consensus 311 f 311 (311)
T cd07866 311 F 311 (311)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=299.13 Aligned_cols=263 Identities=21% Similarity=0.264 Sum_probs=170.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-c---cH---HHHHHHHHHHHhhh
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-I---SE---KRAKEILYQVKAAN 81 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l---~~---~~~~~~~~~~~~~~ 81 (470)
...+++|+.+|..+.+||||+++++++.. ..+.+++|||||+ |+|.+++..... . .+ ..... +.......
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 131 (338)
T cd05102 54 HKALMSELKILIHIGNHLNVVNLLGACTK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGR-FRAMVEQS 131 (338)
T ss_pred HHHHHHHHHHHHHhccCcceeeEEeEecC-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhh-hhhhhhhh
Confidence 35688999999999449999999998764 3456899999999 699999976532 0 00 00000 00000000
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
.+ ...........+.-.+.....................+....+..++.||+.||+|||++||+||||||+|||++
T Consensus 132 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~ 208 (338)
T cd05102 132 RV---DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS 208 (338)
T ss_pred cc---ccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc
Confidence 00 000000000001111111000000000001111234566777888999999999999999999999999999998
Q ss_pred CC-eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLD 236 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~ 236 (470)
.+ .++|+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+.
T Consensus 209 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~ 287 (338)
T cd05102 209 ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC 287 (338)
T ss_pred CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH
Confidence 77 899999999976543221 12334567899999987755 8999999999999999997 999998754333222
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
..... ......+..+++.+.+||.+||..||.+|||+.++++
T Consensus 288 ~~~~~-----------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 288 QRLKD-----------------------------GTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHhc-----------------------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 21110 0001122456788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=294.77 Aligned_cols=215 Identities=26% Similarity=0.398 Sum_probs=171.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+++|+.+|+.++ |+||+.+++.+.. .+..|+||||++ ++|.+++..... +++..+..
T Consensus 45 ~~~~~E~~il~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~--------------- 106 (285)
T cd05630 45 SMALNEKQILEKVN-SRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF--------------- 106 (285)
T ss_pred HHHHHHHHHHHhCC-CCCeeeeeEEEec--CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHH---------------
Confidence 45678999999998 9999999998854 668999999998 599998865432 66666655
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||.|||+.||+||||||+||+++.+ .++
T Consensus 107 --------------------------------------------~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~ 142 (285)
T cd05630 107 --------------------------------------------YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIR 142 (285)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||++.............|+..|+|||++.+.. ++.++||||+||++|+|++|..||.+...............
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~--- 218 (285)
T cd05630 143 ISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--- 218 (285)
T ss_pred EeeccceeecCCCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh---
Confidence 99999987665444444558999999999987755 89999999999999999999999976543211111111000
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~ 315 (470)
.........+++++.+||.+||+.||++||| ++++++||||.++.
T Consensus 219 ------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 219 ------------------------EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred ------------------------hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 0001122457788999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=292.08 Aligned_cols=239 Identities=39% Similarity=0.712 Sum_probs=194.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.++ ||||+++++++.. ....++|+||++++|.+++.... .+++..+..
T Consensus 42 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~---------------- 102 (283)
T cd05118 42 PKTALREIKLLKELN-HPNIIKLLDVFRH--KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKS---------------- 102 (283)
T ss_pred HHHHHHHHHHHHHhc-CCCcchHHHhhcc--CCCEEEEEeccCCCHHHHHHhhcccCCHHHHHH----------------
Confidence 346789999999999 9999999998854 67899999999999999887643 366666666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||.|||++||+|+||||+||+++.+ .++|
T Consensus 103 -------------------------------------------~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l 139 (283)
T cd05118 103 -------------------------------------------YLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKL 139 (283)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||.+....... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+.
T Consensus 140 ~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~ 219 (283)
T cd05118 140 ADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD 219 (283)
T ss_pred eeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc
Confidence 9999887665433 333456888999999987764589999999999999999999999999998888888888888887
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
...+..+.... ......++...........+.++.++.++|.+||..||.+||++.+++.||||
T Consensus 220 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 220 PEVWPKFTSLA-RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hHhcccchhhh-hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 77666554421 11111122211222233445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.12 Aligned_cols=241 Identities=41% Similarity=0.734 Sum_probs=196.1
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
+.....+|+..+.++.+||||+++++++.. .+..++||||++|+|.+++.... .+++..+..
T Consensus 40 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~-------------- 103 (283)
T cd07830 40 EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRS-------------- 103 (283)
T ss_pred hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEecCCCCHHHHHHhcccccCCHHHHHH--------------
Confidence 344557899999999889999999998865 77899999999989999987764 466666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||++|++|+||+|+||+++.+ .+
T Consensus 104 ---------------------------------------------~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~ 138 (283)
T cd07830 104 ---------------------------------------------IIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVV 138 (283)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCE
Confidence 99999999999999999999999999999987 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||.+.............++..|+|||++.+...++.++|+||||+++|+|++|.+||.+.+..+....+...++.+
T Consensus 139 ~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 218 (283)
T cd07830 139 KIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP 218 (283)
T ss_pred EEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCC
Confidence 99999999877655455556789999999988665557899999999999999999999999999999999999999988
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
....|........ ......+...........+..+..+.+||.+||..||++|||+.|++.||||
T Consensus 219 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 219 TKQDWPEGYKLAS-KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ChhhhhhHhhhhc-cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 8776654332211 1122222222222222333457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=300.83 Aligned_cols=242 Identities=31% Similarity=0.599 Sum_probs=192.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+.+++.++ ||||+++++++.... ...+++|+||+.++|..++. ..+++..+..
T Consensus 59 ~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~-------------- 121 (342)
T cd07879 59 KRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQY-------------- 121 (342)
T ss_pred hHHHHHHHHHHhcC-CCCccchhheecccccCCCCceEEEEecccccCHHHHHc--CCCCHHHHHH--------------
Confidence 45789999999998 999999999886432 24579999999988887753 2366666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+||+++.+ .+
T Consensus 122 ---------------------------------------------~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 122 ---------------------------------------------LVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||++...... .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....|.+
T Consensus 157 kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 157 KILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred EEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999998764322 2345788999999998765558899999999999999999999999988888888888888888
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.+..+..........+....+..+........+.++..+.+||.+||+.||.+|||+.+++.||||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 77766555442222222222222222233334567888999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=294.63 Aligned_cols=239 Identities=30% Similarity=0.489 Sum_probs=183.6
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCC------CCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRS------TRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~------~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~ 84 (470)
.+.+|++++++++ ||||+++++++.... ....++||||++++|.+++.... .+++..+..
T Consensus 57 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~------------ 123 (310)
T cd07865 57 TALREIKILQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK------------ 123 (310)
T ss_pred HHHHHHHHHHhCC-CCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHH------------
Confidence 4578999999998 999999999876432 24579999999999998886654 367776666
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++|++|+||||+||+++.+
T Consensus 124 -----------------------------------------------i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 124 -----------------------------------------------VMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156 (310)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC
Confidence 99999999999999999999999999999987
Q ss_pred eEEEEecCCcccccCCC-----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKG-----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i 238 (470)
.++|+|||++....... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 89999999987654321 1233467889999998877655788999999999999999999999998888888888
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCC-cccc-cccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGG-IDVL-VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
....|..+.+.+.......... ....+...... ...+ ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFK-KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHhCCCChhhcccccchhhhh-hccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 8888876666544332211100 00000000000 0001 11235778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=288.98 Aligned_cols=237 Identities=31% Similarity=0.538 Sum_probs=180.9
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+.+|+.++ |+||+++++++.. ....|+||||+.++|.+++.... .+++..+..
T Consensus 49 ~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~------------------ 107 (291)
T cd07870 49 TAIREASLLKGLK-HANIVLLHDIIHT--KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL------------------ 107 (291)
T ss_pred HHHHHHHHHHhcC-CCCEeEEEEEEec--CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHH------------------
Confidence 5679999999999 9999999998864 66899999999999888876543 255555555
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||+.||+|+||||+|||++.+ .++|+|
T Consensus 108 -----------------------------------------~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~D 146 (291)
T cd07870 108 -----------------------------------------FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLAD 146 (291)
T ss_pred -----------------------------------------HHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEec
Confidence 99999999999999999999999999999877 899999
Q ss_pred cCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCch
Q psy9855 170 LGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS-EIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 170 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~g~p~~ 247 (470)
||++....... ......++..|+|||++.+...++.++|||||||++|+|++|..||.+.. ..+.+..+....|.|..
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred cccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 99887543222 22344678999999998765557889999999999999999999997654 44666667777787777
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccc--cccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP--QIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
..+............. .............. ..+..+.+++.+||..||.+|||++|++.||||
T Consensus 227 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 227 DTWPGVSKLPNYKPEW-FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhhhhhcccccchh-ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 7665554322111110 00000111111111 136788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.40 Aligned_cols=242 Identities=33% Similarity=0.599 Sum_probs=194.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+.+++.++ ||||+++++++...+ ...+++|+||++++|.+++... .+++..+..
T Consensus 59 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~l~~~~~~~-------------- 122 (343)
T cd07851 59 KRTYRELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ-KLSDDHIQF-------------- 122 (343)
T ss_pred HHHHHHHHHHHhcc-CCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhcC-CCCHHHHHH--------------
Confidence 45678999999998 999999999876422 2358999999999999998753 477777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||+.||+||||||+||+++.+ .+
T Consensus 123 ---------------------------------------------~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 123 ---------------------------------------------LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||++...... .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+
T Consensus 158 kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 235 (343)
T cd07851 158 KILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235 (343)
T ss_pred EEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence 99999998765432 3445788999999998765457899999999999999999999999988888888888888888
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+..+..+.......+..................++..+.+||.+||..||.+|||+.++++||||.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 8776655543222222222222222222333345689999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=290.62 Aligned_cols=238 Identities=33% Similarity=0.610 Sum_probs=182.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++..++ ||||+++++++.. .+..++|+||+++ +|..++.....+++..+..
T Consensus 45 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~----------------- 104 (286)
T cd07846 45 KIAMREIRMLKQLR-HENLVNLIEVFRR--KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK----------------- 104 (286)
T ss_pred HHHHHHHHHHHhcC-CcchhhHHHhccc--CCeEEEEEecCCccHHHHHHhccCCCCHHHHHH-----------------
Confidence 45679999999998 9999999999854 6789999999995 6776665544466666666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.||+||||+|+||+++.+ .++|+
T Consensus 105 ------------------------------------------~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 105 ------------------------------------------YLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++...... .......++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+....+....
T Consensus 143 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07846 143 DFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222 (286)
T ss_pred eeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence 99988765432 22344578899999999876555788999999999999999999999988877777777776665433
Q ss_pred HHHHHHhhhccCccccccccCC-CCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYP-GGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.....+...... .....+... ........+.++..+.+|+.+||..+|++|||+.++++||||
T Consensus 223 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 223 RHQEIFQKNPLF-AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhHHHhccchHh-hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 221111110000 000000000 011112245678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.30 Aligned_cols=218 Identities=22% Similarity=0.317 Sum_probs=173.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++..++ |+||+++++++.. .+.+|+||||++ |+|.+++.... .+++..+..
T Consensus 45 ~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~--------------- 106 (331)
T cd05597 45 TACFREERDVLVNGD-RRWITNLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF--------------- 106 (331)
T ss_pred HHHHHHHHHHHHhCC-CCCCCceEEEEec--CCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHH---------------
Confidence 344678999999998 9999999998864 678999999998 69999997643 477777766
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 107 --------------------------------------------~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 107 --------------------------------------------YLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCCcc--ccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
|+|||++......... ...+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05597 143 LADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred EEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 9999998765433221 23479999999999863 23478899999999999999999999988776655544432
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC--CcCHHHHHhcccCCChh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR--RPTAQKILSCAYFADLT 315 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--Rpt~~elL~hp~f~~~~ 315 (470)
... ........+.+++.+.+||.+||..++.+ |++++++++||||.+.+
T Consensus 223 ~~~--------------------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 223 HKE--------------------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred CCC--------------------------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 100 00111112347899999999999764444 88999999999999865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=304.73 Aligned_cols=211 Identities=23% Similarity=0.392 Sum_probs=179.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+..|+.+|+.|+ ||||++++++|.+..+..+.+|+|++. |+|..|+++.+.++...++.
T Consensus 86 eR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~----------------- 147 (632)
T KOG0584|consen 86 ERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKS----------------- 147 (632)
T ss_pred HHHHHHHHHHccCC-CCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHH-----------------
Confidence 67889999999999 999999999999887888999999999 89999999999998888888
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC--CCeecCCCCCcEEEeCC--eE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY--KVFHRDIKPENILIRGD--LV 165 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~--gIvHrDLKp~NILl~~~--~i 165 (470)
|++||++||.|||++ .|+|||||.+||+|+++ .|
T Consensus 148 ------------------------------------------W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V 185 (632)
T KOG0584|consen 148 ------------------------------------------WCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV 185 (632)
T ss_pred ------------------------------------------HHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence 999999999999987 59999999999999998 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD-RIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~-~i~~~~g~ 244 (470)
||+|+|+|........ ...+|||.|||||++. ..|+..+||||||+++.||+|+..||.......++. ++.. |.
T Consensus 186 KIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--Gi 260 (632)
T KOG0584|consen 186 KIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GI 260 (632)
T ss_pred eecchhHHHHhhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CC
Confidence 9999999987764433 3479999999999876 349999999999999999999999997655444443 3322 21
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+ ... ..--.+++++||.+||.. ..+|+|+.|+|.||||+..
T Consensus 261 KP-~sl--------------------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 261 KP-AAL--------------------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CH-HHh--------------------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11 111 111257889999999999 8999999999999999974
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=290.33 Aligned_cols=240 Identities=30% Similarity=0.549 Sum_probs=189.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhc-ccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.....+..++|+||++++|.+++... ..+++..+..
T Consensus 43 ~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~----------------- 104 (287)
T cd07840 43 ITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC----------------- 104 (287)
T ss_pred HHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHH-----------------
Confidence 45779999999999 9999999999875434789999999999999998765 3477766666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.|++|+||+|+||+++.+ .++|+
T Consensus 105 ------------------------------------------i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~ 142 (287)
T cd07840 105 ------------------------------------------YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLA 142 (287)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEc
Confidence 99999999999999999999999999999988 89999
Q ss_pred ecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||.+....... ......++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+....+..+....+.+.
T Consensus 143 d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07840 143 DFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT 222 (287)
T ss_pred cccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 999988665433 233456788899999887655578999999999999999999999999988888888888888887
Q ss_pred hHHHHHHhhhccCccccccccCCCCCccccccc-ccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
...|..+............... .......... ++..+.++|.+||..+|.+|||+.++++||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 223 DENWPGVSKLPWFENLKPKKPY-KRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhhhhccccccc-hhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 7666544332100000000000 0011111122 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.87 Aligned_cols=242 Identities=20% Similarity=0.226 Sum_probs=171.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ ||||+++++++.. .+..|+||||++ |+|.+++.... .+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~-------------- 105 (327)
T cd08227 43 VTFLQGELHVSKLFN-HPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-------------- 105 (327)
T ss_pred HHHHHHHHHHHHhcC-CCCeeeEEEEEEE--CCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHH--------------
Confidence 345678999999998 9999999999865 567999999999 69999986532 366666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 106 ---------------------------------------------i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~ 140 (327)
T cd08227 106 ---------------------------------------------ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 140 (327)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcE
Confidence 99999999999999999999999999999887 88
Q ss_pred EEEecCCcccccCCC--------ccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 166 kL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
+++|||.+....... ......++..|+|||++.+. ..++.++|||||||++|+|++|..||..........
T Consensus 141 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred EEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 999998654332111 11223567789999998753 348899999999999999999999997655443322
Q ss_pred HHHHHhCCCc---------hHHHHH-Hhhhc-cCcccc------ccccCCCCCcccccccccHHHHHHHHHhcccCCCCC
Q psy9855 237 RIHQVLGTPK---------AETLKK-FEKYK-SSNFTY------QFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299 (470)
Q Consensus 237 ~i~~~~g~p~---------~~~~~~-~~~~~-~~~~~~------~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R 299 (470)
... .+..+ .+.... ..... ...... ................+++++.+||.+||+.||++|
T Consensus 221 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 298 (327)
T cd08227 221 EKL--NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDAR 298 (327)
T ss_pred HHh--cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhc
Confidence 221 11111 000000 00000 000000 000000111112233567899999999999999999
Q ss_pred cCHHHHHhcccCCChh
Q psy9855 300 PTAQKILSCAYFADLT 315 (470)
Q Consensus 300 pt~~elL~hp~f~~~~ 315 (470)
||++++++||||+++.
T Consensus 299 pt~~ell~~p~f~~~~ 314 (327)
T cd08227 299 PSASTLLNHSFFKQIK 314 (327)
T ss_pred CCHHHHhcChhhhhcc
Confidence 9999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.27 Aligned_cols=215 Identities=25% Similarity=0.366 Sum_probs=172.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. .+.+|+|||||+ |+|.+++... .+++..+..
T Consensus 88 ~~~~~e~~i~~~~~-hp~iv~~~~~~~~--~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~----------------- 146 (371)
T cd05622 88 AFFWEERDIMAFAN-SPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARF----------------- 146 (371)
T ss_pred HHHHHHHHHHHhCC-CCCCCeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHH-----------------
Confidence 34678999999998 9999999998864 678999999998 6999998654 366666655
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 147 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 147 ------------------------------------------YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCc--cccccccCcccCchhhccCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 169 DLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEG---YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 169 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~---~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
|||++........ ....+||+.|+|||++.+.. .++.++|||||||++|||++|..||.+.+.......+.....
T Consensus 185 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (371)
T cd05622 185 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264 (371)
T ss_pred eCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999987653322 23568999999999986532 378999999999999999999999998877665555543110
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC--CcCHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR--RPTAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--Rpt~~elL~hp~f~~~~ 315 (470)
. .. ......++..+.+||.+||..++.+ |++++++++||||++..
T Consensus 265 ~------------------~~---------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 265 S------------------LT---------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred c------------------cc---------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 0 00 0112367899999999999844433 78999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=288.50 Aligned_cols=218 Identities=22% Similarity=0.336 Sum_probs=182.2
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~ 84 (470)
+.+-..+++||.|+.++. .|+||++||.|.. ...+|+|||||+ |++.++++.+.. +++.++..
T Consensus 69 ~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK--~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~------------ 133 (502)
T KOG0574|consen 69 DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFK--HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISA------------ 133 (502)
T ss_pred cchHHHHHHHHHHHHHcC-Cchhhhhhhhhcc--CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHH------------
Confidence 344456899999999999 9999999999865 566999999999 899999988776 88888887
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
+++.-++||+|||...-+|||||..|||++.+
T Consensus 134 -----------------------------------------------iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G 166 (502)
T KOG0574|consen 134 -----------------------------------------------VLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG 166 (502)
T ss_pred -----------------------------------------------HHHHHHhHHHHHHHHHHHHhhcccccEEEcccc
Confidence 99999999999999999999999999999887
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
..||+|||.|..+.+.- ..++..||+.|||||++..-+ |+.++||||||++..||..|++||.+-.++..+..|
T Consensus 167 ~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---- 241 (502)
T KOG0574|consen 167 IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---- 241 (502)
T ss_pred hhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEec----
Confidence 89999999998776432 346789999999999998777 899999999999999999999999776554332221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+..|.. ....+...+.++.||+++||..+|++|-|+.++++|||+++..
T Consensus 242 -----------------------PT~PPP-TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 242 -----------------------PTKPPP-TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred -----------------------cCCCCC-CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 111111 1112235688999999999999999999999999999999754
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.05 Aligned_cols=214 Identities=21% Similarity=0.352 Sum_probs=172.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-c--cHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-I--SEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l--~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.-+..||.+.++|+ |.|||+++|.+ ..++++-|.||-.+ |+|.++++..-. + .|..+..
T Consensus 617 QPLhEEIaLH~~Lr-HkNIVrYLGs~--senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~f-------------- 679 (1226)
T KOG4279|consen 617 QPLHEEIALHSTLR-HKNIVRYLGSV--SENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNF-------------- 679 (1226)
T ss_pred ccHHHHHHHHHHHh-hHhHHHHhhcc--CCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHH--------------
Confidence 44678999999999 99999999987 45788999999999 699999986543 3 4444443
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--e
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--L 164 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ 164 (470)
+.+||++||.|||++.|||||||-+|||++.- .
T Consensus 680 ---------------------------------------------YtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGv 714 (1226)
T KOG4279|consen 680 ---------------------------------------------YTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGV 714 (1226)
T ss_pred ---------------------------------------------HHHHHHHHhhhhhhcceeeccccCCcEEEeeccce
Confidence 99999999999999999999999999999865 8
Q ss_pred EEEEecCCccccc-CCCccccccccCcccCchhhcc-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 165 VVVGDLGSLQFIK-SKGLHTEYIATRWYRSPECLLT-EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 165 ikL~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
+||+|||-++.+. -.....++.||..|||||++.. .+.|+.++|||||||++.||.||++||........ .+.++
T Consensus 715 lKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkV- 791 (1226)
T KOG4279|consen 715 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKV- 791 (1226)
T ss_pred EEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhh-
Confidence 9999999887665 3445567899999999999864 34599999999999999999999999965322111 11110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
|. + ..-..++..++.+++.||.+|+.+||.+||+|.++|++||++..
T Consensus 792 Gm--------------------y-----KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 792 GM--------------------Y-----KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cc--------------------e-----ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 10 0 11233456788999999999999999999999999999999854
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=285.68 Aligned_cols=214 Identities=23% Similarity=0.407 Sum_probs=169.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANE 82 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~ 82 (470)
...+.+|+.++..+.+||||+++++++.... ...+|+||||++ ++|.+++.... .+++..+..
T Consensus 46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~---------- 115 (272)
T cd06637 46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY---------- 115 (272)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHH----------
Confidence 4467899999999955999999999987532 346899999999 59999987643 266666655
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.||+.||+|||++||+||||||+||+++.
T Consensus 116 -------------------------------------------------~~~qi~~~l~~LH~~~ivh~dl~~~nili~~ 146 (272)
T cd06637 116 -------------------------------------------------ICREILRGLSHLHQHKVIHRDIKGQNVLLTE 146 (272)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHCCCccCCCCHHHEEECC
Confidence 9999999999999999999999999999998
Q ss_pred C-eEEEEecCCcccccCC-CccccccccCcccCchhhccC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
+ .++|+|||++...... .......|+..|+|||++.+. ..++.++||||+||++|+|++|..||..........
T Consensus 147 ~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~ 226 (272)
T cd06637 147 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226 (272)
T ss_pred CCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 8 8999999998765432 223446789999999988632 247889999999999999999999996654433222
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.+.. ..........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 227 ~~~~-----------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 227 LIPR-----------------------------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHhc-----------------------------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 2111 000111123567889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.02 Aligned_cols=215 Identities=27% Similarity=0.404 Sum_probs=175.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+++|+.++ |+||+.+++.+.. .+..|+||||+. ++|.+++.... .+++..+..
T Consensus 45 ~~~~~E~~il~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~--------------- 106 (285)
T cd05632 45 SMALNEKQILEKVN-SQFVVNLAYAYET--KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF--------------- 106 (285)
T ss_pred HHHHHHHHHHHHcC-CcCceeEEEEEec--CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHH---------------
Confidence 34678999999998 9999999998854 678999999999 59998886533 366766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||.|||++||+||||||+||+++.+ .++
T Consensus 107 --------------------------------------------~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~k 142 (285)
T cd05632 107 --------------------------------------------YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||++.............|+..|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+......
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~-- 219 (285)
T cd05632 143 ISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE-- 219 (285)
T ss_pred EecCCcceecCCCCcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc--
Confidence 99999887655444444568999999999987755 899999999999999999999999876654443333221100
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~ 315 (470)
........++.++.+|+.+||..||++||| +.+++.|+||....
T Consensus 220 -------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 220 -------------------------TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred -------------------------cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 011123467888999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.17 Aligned_cols=216 Identities=23% Similarity=0.332 Sum_probs=173.0
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.+.+|+.++..++ |+||+++++.+.. .+.+|+||||+. |+|.+++... ..+++..++.
T Consensus 47 ~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~----------------- 106 (332)
T cd05623 47 CFREERDVLVNGD-NQWITTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF----------------- 106 (332)
T ss_pred HHHHHHHHHhhCC-CCCEeeEEEEEec--CCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHH-----------------
Confidence 4678999999998 9999999998864 678999999998 6999999764 3467766666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 107 ------------------------------------------~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~ 144 (332)
T cd05623 107 ------------------------------------------YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLA 144 (332)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCc--cccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 169 DLGSLQFIKSKGL--HTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 169 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|||++........ ....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 145 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~ 224 (332)
T cd05623 145 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224 (332)
T ss_pred ecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence 9999876543222 234579999999999863 3347899999999999999999999998887666655543210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC--CcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR--RPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--Rpt~~elL~hp~f~~~~ 315 (470)
. ..........++.++.+||.+||..++.. |++++++++||||.++.
T Consensus 225 ~--------------------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 225 E--------------------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred c--------------------------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 0 00011112357899999999999765544 78999999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=287.89 Aligned_cols=239 Identities=31% Similarity=0.561 Sum_probs=185.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCH-HHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNL-EEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL-~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++++.+. |+||+++++++.. .+..++||||+++++ ..++.....+++..+..
T Consensus 44 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~---------------- 104 (288)
T cd07833 44 KKTALREVKVLRQLR-HENIVNLKEAFRR--KGRLYLVFEYVERTLLELLEASPGGLPPDAVRS---------------- 104 (288)
T ss_pred hhHHHHHHHHHHhcC-CCCeeehhheEEE--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHH----------------
Confidence 356789999999999 9999999999865 678999999999754 44444444477777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++|++||||+|+||+++.+ .++|
T Consensus 105 -------------------------------------------~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl 141 (288)
T cd07833 105 -------------------------------------------YIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKL 141 (288)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|||.+....... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+....+..
T Consensus 142 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 221 (288)
T cd07833 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221 (288)
T ss_pred EeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999988765443 33456788999999999876458999999999999999999999999888888888887777766
Q ss_pred chHHHHHHhhhccCccccccccCC-CCC-cccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYP-GGG-IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.......+....... ...+.... ... .......++.++.+||.+||..+|++|||++++++||||
T Consensus 222 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 222 PPSHQELFSSNPRFA-GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CHHHhhhcccCcccc-ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 654443332111000 00000000 000 011223458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=284.74 Aligned_cols=214 Identities=25% Similarity=0.399 Sum_probs=176.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++++.++ ||||+++++.+.. ...+++|+||++ ++|.+++.....+++..+..
T Consensus 37 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~---------------- 97 (262)
T cd05572 37 QEHIFSEKEILEECN-HPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARF---------------- 97 (262)
T ss_pred HHHHHHHHHHHHhCC-CCCEeeeeeeEEc--CCccEEEEecCCCCcHHHHHhhcCCCCHHHHHH----------------
Confidence 456889999999998 9999999998854 677999999998 69999998776677777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++|++|+||+|+||+++.+ .++|
T Consensus 98 -------------------------------------------~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l 134 (262)
T cd05572 98 -------------------------------------------YIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKL 134 (262)
T ss_pred -------------------------------------------HHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS--EIDQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~--~~~~~~~i~~~~g~p 245 (470)
+|||++.............|+..|+|||.+.+.. ++.++|+||+||++|+|++|..||.... ..+....+...
T Consensus 135 ~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 209 (262)
T cd05572 135 VDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG---- 209 (262)
T ss_pred eeCCcccccCcccccccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc----
Confidence 9999988776544344567899999999887655 7899999999999999999999997765 33333222210
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~ 315 (470)
......+...++++.++|.+||..||.+||| +.|+++||||++..
T Consensus 210 -------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 210 -------------------------NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred -------------------------CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 0011122345788999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.48 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=173.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
..+.+|+.+|.+|+ ||||+++++++.. .+..|+|++++.++|.+++..... ...
T Consensus 208 ~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~-~~~---------------------- 261 (501)
T PHA03210 208 IQLENEILALGRLN-HENILKIEEILRS--EANTYMITQKYDFDLYSFMYDEAF-DWK---------------------- 261 (501)
T ss_pred HHHHHHHHHHHhCC-CCCcCcEeEEEEE--CCeeEEEEeccccCHHHHHhhccc-ccc----------------------
Confidence 45679999999999 9999999999865 567899999999999988754321 000
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
.......++.|+.||+.||+|||++|||||||||+|||++.+ .++|+|
T Consensus 262 -------------------------------~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~D 310 (501)
T PHA03210 262 -------------------------------DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGD 310 (501)
T ss_pred -------------------------------ccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEe
Confidence 000112344499999999999999999999999999999887 899999
Q ss_pred cCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCC-CCC--CChHHHHHHHHHHhCC
Q psy9855 170 LGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPG--DSEIDQLDRIHQVLGT 244 (470)
Q Consensus 170 FG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~p-f~~--~~~~~~~~~i~~~~g~ 244 (470)
||++..+.... .....+||..|+|||++.+.. ++.++|||||||++|||++|..+ |.+ ......+..+...++.
T Consensus 311 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~ 389 (501)
T PHA03210 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSV 389 (501)
T ss_pred CCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhccc
Confidence 99998765332 223468999999999998765 89999999999999999998754 432 2344555555555543
Q ss_pred CchHHH----HHHhhhccCccccccccCCCCCcccc--cccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 245 PKAETL----KKFEKYKSSNFTYQFKQYPGGGIDVL--VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...+.. ..+..+....+ ...+ .....+ ...++..+.++|.+||.+||.+|||+.|+|+||||....
T Consensus 390 ~~~~~p~~~~~~~~~i~~~~~----~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 390 CDEEFPDPPCKLFDYIDSAEI----DHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred ChhhcCCcHHHHHHHhhhhhc----ccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 322211 00110000000 0000 000000 123567889999999999999999999999999998754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=280.74 Aligned_cols=211 Identities=24% Similarity=0.418 Sum_probs=173.5
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc--ccccHHHHHHHHHHHHhhhccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT--DNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~--~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
.....+.+|+++++.++ ||||+++++++.. .+..++||||++ ++|.+++... ..+++..+..
T Consensus 41 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------------ 105 (256)
T cd08529 41 REREEAIDEARVLAKLD-SSYIIRYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR------------ 105 (256)
T ss_pred HHHHHHHHHHHHHHhcC-CCCeehheeeecc--CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHH------------
Confidence 44567789999999999 9999999998865 578999999998 5999999765 2366666655
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||.|||+.|++||||||+||+++.+
T Consensus 106 -----------------------------------------------i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~ 138 (256)
T cd08529 106 -----------------------------------------------FFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD 138 (256)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC
Confidence 99999999999999999999999999999987
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++....... ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+..
T Consensus 139 ~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-- 215 (256)
T cd08529 139 NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-- 215 (256)
T ss_pred CEEEcccccceeccCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--
Confidence 89999999887665432 223457889999999987755 78999999999999999999999987765444433321
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.........++..+.++|.+||+.+|++||++.++++|||+
T Consensus 216 ----------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ----------------------------GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ----------------------------CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 11111223567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=288.99 Aligned_cols=240 Identities=30% Similarity=0.508 Sum_probs=187.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC--------CCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhh
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS--------TRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAAN 81 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~--------~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~ 81 (470)
..+.+|+++++.++ ||||+++++++.... .+.+++|+||++++|.+++.... .+++..+..
T Consensus 51 ~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~--------- 120 (302)
T cd07864 51 ITAIREIKILRQLN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS--------- 120 (302)
T ss_pred HHHHHHHHHHHhCC-CCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHH---------
Confidence 45678999999998 999999999886532 34799999999999888887543 366666666
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||+|||+.||+||||||+||+++
T Consensus 121 --------------------------------------------------i~~qi~~aL~~LH~~~i~H~dl~p~nili~ 150 (302)
T cd07864 121 --------------------------------------------------FMKQLLEGLNYCHKKNFLHRDIKCSNILLN 150 (302)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999999999999
Q ss_pred CC-eEEEEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i 238 (470)
.+ .++|+|||.+....... ......++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 88 89999999887664332 2223456788999998876555789999999999999999999999988888888889
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
....+.+....++.+............... ..........++..+.++|.+||..||.+|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQY-RRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHhCCCChhhccccccccccccccccccc-ccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 888888877666544332110000000000 011112223568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=283.70 Aligned_cols=208 Identities=21% Similarity=0.435 Sum_probs=171.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 51 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~----------------- 110 (267)
T cd06628 51 DALAREIALLKELQ-HENIVQYLGSSLD--ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----------------- 110 (267)
T ss_pred HHHHHHHHHHHhcC-CCCeeeEEEEEEe--CCccEEEEEecCCCCHHHHHHhccCccHHHHHH-----------------
Confidence 35779999999998 9999999998865 668899999998 59999998776677777666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.|++.||+|||++|++||||+|+||+++.+ .++|+
T Consensus 111 ------------------------------------------~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 111 ------------------------------------------FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEec
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCC-------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 169 DLGSLQFIKSKG-------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 169 DFG~a~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|||.+....... ......|+..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~- 226 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE- 226 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-
Confidence 999887665221 112346888999999887654 78899999999999999999999987654433332211
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
......+..++..+.++|.+||+.||.+||++.++++||||
T Consensus 227 -----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 -----------------------------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------------------------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 01112234578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=284.14 Aligned_cols=211 Identities=24% Similarity=0.415 Sum_probs=169.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.......+++++||++ ++|.+++.....+++..+..
T Consensus 49 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~----------------- 110 (266)
T cd06651 49 SALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK----------------- 110 (266)
T ss_pred HHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 35678999999998 999999999887655677899999998 59999998766677766666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.||+||||+|+||+++.+ .++|+
T Consensus 111 ------------------------------------------~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 111 ------------------------------------------YTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSK----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||++...... .......++..|+|||++.+.. ++.++||||+||++|+|++|..||...........+.. .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~ 224 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---Q 224 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---C
Confidence 99988754321 1112346888999999987754 78999999999999999999999976544333322211 0
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
.....++..+++.+.++| +||..+|++|||++++++||||+
T Consensus 225 --------------------------~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 225 --------------------------PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------------------CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 001122345678888998 68888999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=308.95 Aligned_cols=214 Identities=26% Similarity=0.454 Sum_probs=173.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCC------CeEEEEeeccc-cCHHHHHHhcc----cccHHHHHHHHHHHH
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRST------RQVTLVFPLME-LNLEEYIRTTD----NISEKRAKEILYQVK 78 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~------~~~~lV~E~~~-gsL~~~l~~~~----~l~~~~~~~~~~~~~ 78 (470)
...+.+|+.+|..+. |+||+++++.+..... ..+++||||++ |+|.++|.... .+++..+..
T Consensus 75 ~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~------ 147 (496)
T PTZ00283 75 KNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL------ 147 (496)
T ss_pred HHHHHHHHHHHhcCC-CCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHH------
Confidence 445789999999999 9999999987753221 24789999999 69999986532 255555555
Q ss_pred hhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENI 158 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NI 158 (470)
++.||+.||+|||++||+||||||+||
T Consensus 148 -----------------------------------------------------i~~qll~aL~~lH~~~IiHrDLKP~NI 174 (496)
T PTZ00283 148 -----------------------------------------------------LFIQVLLAVHHVHSKHMIHRDIKSANI 174 (496)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 999999999999999999999999999
Q ss_pred EEeCC-eEEEEecCCcccccCC---CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy9855 159 LIRGD-LVVVGDLGSLQFIKSK---GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ 234 (470)
Q Consensus 159 Ll~~~-~ikL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~ 234 (470)
|++.+ .++|+|||+++..... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.
T Consensus 175 Ll~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~ 253 (496)
T PTZ00283 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253 (496)
T ss_pred EEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99887 8999999998765422 2234568999999999987755 89999999999999999999999988776555
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+..+.. .....+++.+++++.+||.+||..||.+||++.++++|||++..
T Consensus 254 ~~~~~~------------------------------~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 254 MHKTLA------------------------------GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHHhc------------------------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 444322 11122345688999999999999999999999999999998753
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=285.09 Aligned_cols=216 Identities=25% Similarity=0.367 Sum_probs=174.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|++++++++ ||||+++++++.. ....|+||||++ ++|.+++.... .+++..+..
T Consensus 46 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~--------------- 107 (280)
T cd06611 46 LEDFMVEIDILSECK-HPNIVGLYEAYFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRY--------------- 107 (280)
T ss_pred HHHHHHHHHHHHhCC-CCceeEEEEEEec--CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHH---------------
Confidence 346789999999999 9999999999864 678999999999 59999987654 377777776
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||.|||++||+|+||||+||+++.+ .++
T Consensus 108 --------------------------------------------~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~ 143 (280)
T cd06611 108 --------------------------------------------VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVK 143 (280)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCC-ccccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||.+....... ......|+..|+|||++.. ...++.++|||||||++|+|++|.+||.+.........+...
T Consensus 144 l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (280)
T cd06611 144 LADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS 223 (280)
T ss_pred EccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC
Confidence 99999876554322 2234578999999998753 223678999999999999999999999877654444333210
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
. ......+..++.++.++|.+||..+|.+||++.++++||||.+..
T Consensus 224 --~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 224 --E--------------------------PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred --C--------------------------CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 0 000111235778899999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=304.64 Aligned_cols=213 Identities=23% Similarity=0.378 Sum_probs=186.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.||++++..|. |||||+++.+.. ....+|+||||+. |.+.+++..++.+.+..++.
T Consensus 100 ~k~~rev~imk~l~-HPnIvkl~~v~~--t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~----------------- 159 (596)
T KOG0586|consen 100 QKLGREVDIMKSLN-HPNIVKLFSVIE--TEATLYLVMEYASGGELFDYLVKHGRMKEKEARA----------------- 159 (596)
T ss_pred HHHHHHHHHHHhcC-Ccceeeeeeeee--ecceeEEEEEeccCchhHHHHHhcccchhhhhhh-----------------
Confidence 44789999999999 999999999874 4678999999998 69999999999888877766
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.|++.|++|||+++|||||||.+|||++.+ .+||+
T Consensus 160 ------------------------------------------~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIa 197 (596)
T KOG0586|consen 160 ------------------------------------------KFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIA 197 (596)
T ss_pred ------------------------------------------hhHHHHHHHHHHhhcceeccccchhhcccccccceeee
Confidence 99999999999999999999999999999999 69999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++..+..+....+.||++.|+|||++.+..+.++.+|+||+|+++|-|+.|..||.|.+..+.-.+...
T Consensus 198 DfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-------- 269 (596)
T KOG0586|consen 198 DFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-------- 269 (596)
T ss_pred ccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee--------
Confidence 999999999888889999999999999999998889999999999999999999999998764443322211
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
....++-.++.++.+||+++|..+|.+|++++++..|.|......
T Consensus 270 -----------------------gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 270 -----------------------GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred -----------------------eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 111122357888999999999999999999999999999986543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=281.91 Aligned_cols=211 Identities=23% Similarity=0.362 Sum_probs=171.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++++.++ ||||+++++.+.. ....|+++||++ ++|.+++.... .+++..+..
T Consensus 42 ~~~~~~e~~~~~~l~-~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~--------------- 103 (256)
T cd06612 42 LQEIIKEISILKQCD-SPYIVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA--------------- 103 (256)
T ss_pred HHHHHHHHHHHHhCC-CCcEeeeeeeeec--CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHH---------------
Confidence 456889999999998 9999999999865 578999999999 59999987543 366766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||+.|++||||+|+||+++.+ .++
T Consensus 104 --------------------------------------------~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~ 139 (256)
T cd06612 104 --------------------------------------------ILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAK 139 (256)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||++....... ......|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+...
T Consensus 140 l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---- 214 (256)
T cd06612 140 LADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---- 214 (256)
T ss_pred EcccccchhcccCccccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----
Confidence 99999988765433 223456888999999987755 799999999999999999999999765543322221100
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
..........++..+.++|.+||..||.+|||+.++|+||||
T Consensus 215 ------------------------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 ------------------------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------------------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000011123567889999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=285.06 Aligned_cols=215 Identities=19% Similarity=0.292 Sum_probs=172.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+++++.++ ||||+++++++.. .+..++|+||++ ++|..++... ..+++..+..
T Consensus 47 ~~~~~e~~~l~~l~-h~~ii~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~---------------- 107 (282)
T cd06643 47 EDYMVEIDILASCD-HPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV---------------- 107 (282)
T ss_pred HHHHHHHHHHHHCC-CCCeeeEEEEEee--CCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHH----------------
Confidence 45788999999998 9999999998865 568999999999 5888887653 3367766666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||+.||+||||||+|||++.+ .++|
T Consensus 108 -------------------------------------------~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl 144 (282)
T cd06643 108 -------------------------------------------VCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKL 144 (282)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++...... .......++..|+|||++.. ...++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~ 224 (282)
T cd06643 145 ADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE 224 (282)
T ss_pred ccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC
Confidence 999988755432 22234578999999998742 2336789999999999999999999998776555444433210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
. .....+..++.++.+||.+||..||.+|||+.++++||||....
T Consensus 225 ~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 225 P----------------------------PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred C----------------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 0 00112235678999999999999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=282.30 Aligned_cols=210 Identities=20% Similarity=0.376 Sum_probs=172.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|+.++ |+||+++++++.. .+..++|+||++ ++|.+++.+...+++..+..
T Consensus 47 ~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 106 (265)
T cd06631 47 EKLQEEVDLLKSLK-HVNIVQYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCK----------------- 106 (265)
T ss_pred HHHHHHHHHHHhcC-CCCEeeEeeEeec--CCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45788999999998 9999999999865 578999999998 59999998776677777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.||+|+||+|+||+++.+ .++|+
T Consensus 107 ------------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 107 ------------------------------------------YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEec
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccC-------CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 169 DLGSLQFIKS-------KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 169 DFG~a~~~~~-------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|||.+..... ........|+..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+...
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc
Confidence 9998876532 11223456899999999987655 789999999999999999999999776544333222211
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
. .........++.++.++|.+||..+|.+|||+.++++||||
T Consensus 224 ~----------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 224 R----------------------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred c----------------------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 11122334678899999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=279.08 Aligned_cols=210 Identities=25% Similarity=0.462 Sum_probs=171.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|++++++++ |+||+++++.+.. ....+|+||||++ ++|.+++.... .+++.++..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~-------------- 106 (257)
T cd08223 43 RKAAEQEAQLLSQLK-HPNIVAYRESWEG-EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE-------------- 106 (257)
T ss_pred HHHHHHHHHHHHhCC-CCCeeeeeeeecC-CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHH--------------
Confidence 345788999999998 9999999997743 3456899999998 59999987632 266666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+||+++.+ .+
T Consensus 107 ---------------------------------------------~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~ 141 (257)
T cd08223 107 ---------------------------------------------WFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNII 141 (257)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|+|||++...... .......+++.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--- 217 (257)
T cd08223 142 KVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--- 217 (257)
T ss_pred EEecccceEEecccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---
Confidence 99999998766432 2234457899999999887754 789999999999999999999999876654443333220
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
........+++++.++|.+||..||++|||+.+++.||||
T Consensus 218 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 218 ---------------------------KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ---------------------------CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0111234578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=284.65 Aligned_cols=213 Identities=31% Similarity=0.540 Sum_probs=173.7
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccccc
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGW 91 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (470)
..+|+.++++++ ||||+++++++.. ....++|||++++ +|.+++.....+++..+..
T Consensus 45 ~~~e~~~~~~l~-~~~i~~~~~~~~~--~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~------------------- 102 (260)
T PF00069_consen 45 NIREIKILRRLR-HPNIVQILDVFQD--DNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILK------------------- 102 (260)
T ss_dssp HHHHHHHHHHHT-BTTBCHEEEEEEE--SSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHH-------------------
T ss_pred hhhhhhcccccc-ccccccccccccc--ccccccccccccccccccccccccccccccccc-------------------
Confidence 356999999997 9999999999876 7789999999996 9999998666688888777
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEec
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDL 170 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DF 170 (470)
++.||+.||++||+.||+|+||||+||+++.+ .++|+||
T Consensus 103 ----------------------------------------~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 103 ----------------------------------------IAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp ----------------------------------------HHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSG
T ss_pred ----------------------------------------cccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999976 8999999
Q ss_pred CCcccc-cCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Q psy9855 171 GSLQFI-KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249 (470)
Q Consensus 171 G~a~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~ 249 (470)
|.+... ..........++..|+|||++.....++.++||||+|+++|+|++|..||......+....+.+.........
T Consensus 143 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T PF00069_consen 143 GSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS 222 (260)
T ss_dssp TTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence 998753 2333445668899999999987334489999999999999999999999988755555555444332111110
Q ss_pred HHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.. .....+..+.++|.+||..||++|||+.++++||||
T Consensus 223 ~~------------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 SQ------------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TT------------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cc------------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00 001123788999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=286.56 Aligned_cols=210 Identities=28% Similarity=0.425 Sum_probs=177.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|++++ ||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 46 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~----------------- 105 (290)
T cd05580 46 EHVLNEKRILQSIR-HPFLVNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF----------------- 105 (290)
T ss_pred HHHHHHHHHHHhCC-CCCccceeeEEEc--CCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 45778999999999 9999999998865 678999999996 79999998877788777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||+|+|||++.+ .++|+
T Consensus 106 ------------------------------------------~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~ 143 (290)
T cd05580 106 ------------------------------------------YAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKIT 143 (290)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++...... ....+|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.. +
T Consensus 144 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~----- 213 (290)
T cd05580 144 DFGFAKRVKGR--TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--G----- 213 (290)
T ss_pred eCCCccccCCC--CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C-----
Confidence 99998876544 34457899999999887654 78899999999999999999999987764444433321 0
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
...++..++..+.++|.+||..||.+|+ +++++++||||..+..
T Consensus 214 ------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 214 ------------------------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred ------------------------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 0112345678999999999999999999 9999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=289.42 Aligned_cols=241 Identities=17% Similarity=0.295 Sum_probs=173.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++.+++ ||||+++++.+.. .+.+++||||++ ++|.+++.....+++..+..
T Consensus 43 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~---------------- 103 (308)
T cd06615 43 RNQIIRELKVLHECN-SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGK---------------- 103 (308)
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEee--CCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 345789999999998 9999999999865 678999999998 59999998776677777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||+ .|++||||||+|||++.+ .++
T Consensus 104 -------------------------------------------~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~ 140 (308)
T cd06615 104 -------------------------------------------ISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIK 140 (308)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEE
Confidence 99999999999997 599999999999999887 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||++...... .....+|+..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+........
T Consensus 141 l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (308)
T cd06615 141 LCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGE 218 (308)
T ss_pred EccCCCccccccc-ccccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccc
Confidence 9999988755332 224567899999999887654 78999999999999999999999976653332221111000000
Q ss_pred hHHHH-HHhhhccC--c---cccccccCCCCCcccc-cccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLK-KFEKYKSS--N---FTYQFKQYPGGGIDVL-VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~-~~~~~~~~--~---~~~~~~~~~~~~~~~~-~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
..... ........ . ................ ...++.++.+||.+||..||++|||+.++++||||...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000 00000000 0 0000000000000001 11367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=287.05 Aligned_cols=216 Identities=22% Similarity=0.362 Sum_probs=173.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++.+.. ....|+||||++ ++|.+++... .+++.++..
T Consensus 62 ~~~~~e~~~l~~~~-h~~v~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~----------------- 120 (296)
T cd06654 62 ELIINEILVMRENK-NPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAA----------------- 120 (296)
T ss_pred HHHHHHHHHHHhCC-CCCEeeEEEEEEe--CCEEEEeecccCCCCHHHHHHhc-CCCHHHHHH-----------------
Confidence 45789999999998 9999999998865 668999999998 5999998643 356655555
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.||+||||||+||+++.+ .++|+
T Consensus 121 ------------------------------------------i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~ 158 (296)
T cd06654 121 ------------------------------------------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158 (296)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEC
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||.+....... ......|++.|+|||.+.+.. ++.++|||||||++|+|++|..||........+..+... +.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~--- 233 (296)
T cd06654 159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT--- 233 (296)
T ss_pred ccccchhccccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC---
Confidence 999887654322 223457899999999887654 789999999999999999999999876654433222110 00
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
........++..+.+||.+||..||++|||+.++++||||.......
T Consensus 234 ------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~ 280 (296)
T cd06654 234 ------------------------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280 (296)
T ss_pred ------------------------CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCcc
Confidence 00011235778899999999999999999999999999998765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=285.09 Aligned_cols=215 Identities=23% Similarity=0.376 Sum_probs=168.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhh
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAAN 81 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~ 81 (470)
....+.+|+.++.++.+||||+++++++... ....+|+||||++ |+|.+++..... +++..+..
T Consensus 55 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~--------- 125 (282)
T cd06636 55 EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--------- 125 (282)
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHH---------
Confidence 3456788999999996699999999998642 3467899999998 599999875432 55555544
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||+|||+.||+||||+|+||+++
T Consensus 126 --------------------------------------------------~~~qi~~al~~LH~~~ivH~dl~~~nili~ 155 (282)
T cd06636 126 --------------------------------------------------ICREILRGLAHLHAHKVIHRDIKGQNVLLT 155 (282)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 999999999999999999999999999999
Q ss_pred CC-eEEEEecCCcccccCC-CccccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 235 (470)
.+ .++|+|||++...... .......|+..|+|||++.. ...++.++|||||||++|+|++|..||.........
T Consensus 156 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 156 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred CCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 87 8999999988765422 22344678999999998753 233788999999999999999999999765543333
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
..+.. ..........++.++.+||.+||..||.+|||+.++|+||||
T Consensus 236 ~~~~~-----------------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 236 FLIPR-----------------------------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hhHhh-----------------------------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 22211 000111123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=279.03 Aligned_cols=210 Identities=27% Similarity=0.461 Sum_probs=173.4
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+.+|+++|+.++ ||||+++++.+.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 42 ~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~------------- 105 (256)
T cd08220 42 ERLAAQNECQVLKLLS-HPNIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILH------------- 105 (256)
T ss_pred HHHHHHHHHHHHhhCC-CCchhheeeeEec--CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHH-------------
Confidence 3456789999999999 9999999998854 678999999998 599999976432 66666666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-- 163 (470)
++.|++.||+|||++||+||||+|+||+++.+
T Consensus 106 ----------------------------------------------~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~ 139 (256)
T cd08220 106 ----------------------------------------------FFVQILLALHHVHTKLILHRDLKTQNILLDKHKM 139 (256)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 99999999999999999999999999999865
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++|+|||.+.............|+..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 140 ~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-- 216 (256)
T cd08220 140 VVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-- 216 (256)
T ss_pred EEEEccCCCceecCCCccccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc--
Confidence 68999999998776554444567899999999987654 789999999999999999999999876654444333220
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
........++.++.+++.+||..||.+|||+.++++||||
T Consensus 217 ----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 217 ----------------------------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------------------------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 1111223578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=294.42 Aligned_cols=243 Identities=33% Similarity=0.578 Sum_probs=190.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.++.+++ ||||+++++++... .....|+++++++++|.+++... .+++..+..
T Consensus 60 ~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~------------- 124 (345)
T cd07877 60 AKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF------------- 124 (345)
T ss_pred HHHHHHHHHHHHHcC-CCcccceeeeeeecccccccccEEEEehhcccCHHHHHhcC-CCCHHHHHH-------------
Confidence 345779999999999 99999999988632 22458999999988999887643 367766666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+||+++.+ .
T Consensus 125 ----------------------------------------------i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 125 ----------------------------------------------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC
Confidence 99999999999999999999999999999887 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++...... .....++..|+|||++.+...++.++|||||||++|+|++|.+||.+......+..+....+.
T Consensus 159 ~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 159 LKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999998765332 234578999999998876555889999999999999999999999988888888888888888
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+.......+.......+.......+...........++++.+||.+||..||.+|||+.++++||||.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 77766554433221111111112222222222234678899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=288.73 Aligned_cols=243 Identities=22% Similarity=0.294 Sum_probs=173.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+++++.++ ||||+++++++.. .+..+++|||++ |+|.+++.... .+++..+..
T Consensus 43 ~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~-------------- 105 (314)
T cd08216 43 LKLLQQEIITSRQLQ-HPNILPYVTSFIV--DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-------------- 105 (314)
T ss_pred HHHHHHHHHHHHhcC-Ccchhhhhheeec--CCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHH--------------
Confidence 356789999999999 9999999999865 667999999999 69999987642 256655555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+||+++.+ .+
T Consensus 106 ---------------------------------------------~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~ 140 (314)
T cd08216 106 ---------------------------------------------ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140 (314)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeecCCCCcceEEEecCCce
Confidence 99999999999999999999999999999986 89
Q ss_pred EEEecCCcccccCCC--------ccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 166 kL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
+|+|||.+....... ......++..|+|||++.+. ..++.++||||+||++|+|++|..||..........
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~ 220 (314)
T cd08216 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (314)
T ss_pred EEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999876543221 12334577889999998653 247899999999999999999999998765443322
Q ss_pred HHHHHhCCCchHH----HHHHhh-hccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 237 RIHQVLGTPKAET----LKKFEK-YKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 237 ~i~~~~g~p~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
. ...|...... ...... ........................++.++.+||.+||..||++|||++++|+||||
T Consensus 221 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 221 E--KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred H--HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 2 1222111100 000000 00000000000000011111223457789999999999999999999999999999
Q ss_pred CChhH
Q psy9855 312 ADLTQ 316 (470)
Q Consensus 312 ~~~~~ 316 (470)
+.+..
T Consensus 299 ~~~~~ 303 (314)
T cd08216 299 KQCKR 303 (314)
T ss_pred hhhcc
Confidence 87753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.39 Aligned_cols=242 Identities=29% Similarity=0.566 Sum_probs=190.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
...+.+|++++..++ ||||++++++|.. .....|+|+||++++|.+++... .+++..+..
T Consensus 53 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~----------------- 112 (328)
T cd07856 53 AKRTYRELKLLKHLR-HENIISLSDIFIS-PLEDIYFVTELLGTDLHRLLTSR-PLEKQFIQY----------------- 112 (328)
T ss_pred hHHHHHHHHHHHhcC-CCCeeeEeeeEec-CCCcEEEEeehhccCHHHHHhcC-CCCHHHHHH-----------------
Confidence 346779999999999 9999999998864 24568999999999999888643 355555555
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||+|+||+++.+ .++|+
T Consensus 113 ------------------------------------------~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 113 ------------------------------------------FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeC
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||.+...... .....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.........+.+.+|.++.+
T Consensus 151 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 151 DFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228 (328)
T ss_pred ccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99988754322 2345778899999987664558999999999999999999999999988888888888888988876
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
............+................+.+++.+.++|.+||..+|++|||+++++.||||....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 6554332221111111111111122233356789999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=293.54 Aligned_cols=242 Identities=31% Similarity=0.598 Sum_probs=191.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCC----CeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRST----RQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~----~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+.+|+.++ ||||+++++++..... ..+++||||++++|.+++.. ..+++..+..
T Consensus 59 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~-------------- 122 (343)
T cd07880 59 KRAYRELRLLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQF-------------- 122 (343)
T ss_pred HHHHHHHHHHHhcC-CCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHH--------------
Confidence 45779999999998 9999999998864321 34699999998899988864 3477777666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||+.||+||||||+||+++.+ .+
T Consensus 123 ---------------------------------------------i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 123 ---------------------------------------------LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||++...... .....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+.......+....+.+
T Consensus 158 kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 158 KILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred EEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999998765432 2345678999999998764457899999999999999999999999888888888888877777
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+.+....+.......+....+...........+.++..+.++|.+||..||.+|||+.+++.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 6655544433222222222222222222334457888999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.97 Aligned_cols=212 Identities=21% Similarity=0.328 Sum_probs=175.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ ||||+++++++.+ ....|+|+||++ ++|.+++... .+++..+..
T Consensus 44 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~----------------- 102 (274)
T cd06609 44 EDIQQEIQFLSQCR-SPYITKYYGSFLK--GSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAF----------------- 102 (274)
T ss_pred HHHHHHHHHHHHcC-CCCeeeeeEEEEE--CCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHH-----------------
Confidence 45789999999999 9999999998865 578999999998 5999998765 567777666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||++|++||||+|+||+++.+ .++|+
T Consensus 103 ------------------------------------------~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~ 140 (274)
T cd06609 103 ------------------------------------------ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLA 140 (274)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++...... .......|+..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 141 d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~------ 213 (274)
T cd06609 141 DFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN------ 213 (274)
T ss_pred ccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc------
Confidence 99998876543 2234557889999999987765 899999999999999999999999776544333322211
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccc-cccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP-QIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
....+.. .++..+.++|.+||..||++|||++++++||||.....
T Consensus 214 ------------------------~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 214 ------------------------NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred ------------------------CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 0011111 26788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=283.99 Aligned_cols=216 Identities=28% Similarity=0.397 Sum_probs=174.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|+++|+.++ ||||+++++++.. .+.+|+||||++ ++|.+++.... .+++..+..
T Consensus 37 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~-------------- 99 (277)
T cd05577 37 EQMALNEKKILEKVS-SRFIVSLAYAFET--KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF-------------- 99 (277)
T ss_pred hHHHHHHHHHHHhCC-CCCEeeeeeEEec--CCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHH--------------
Confidence 345678999999999 9999999998854 678999999999 59999997655 467766666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||+.|++||||+|+||+++.+ .+
T Consensus 100 ---------------------------------------------~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~ 134 (277)
T cd05577 100 ---------------------------------------------YAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV 134 (277)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||.+.............++..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+....
T Consensus 135 ~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 210 (277)
T cd05577 135 RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--- 210 (277)
T ss_pred EEccCcchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc---
Confidence 999999887665443344557888999999987755 8899999999999999999999997654321111111100
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
.......+..+++.+.++|.+||..||.+|| ++.++++||||.+++
T Consensus 211 ------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 211 ------------------------LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ------------------------ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 0001112345688999999999999999999 999999999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=277.67 Aligned_cols=212 Identities=26% Similarity=0.503 Sum_probs=174.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhcc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~ 83 (470)
....+.+|+++++.++ ||||+++++.+........+++|||++ ++|.+++... ..+++..+..
T Consensus 42 ~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~----------- 109 (265)
T cd08217 42 EKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----------- 109 (265)
T ss_pred HHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHH-----------
Confidence 3456788999999999 999999999887666678899999998 5999998753 2356655555
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH-----hCCCeecCCCCCcE
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH-----SYKVFHRDIKPENI 158 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH-----~~gIvHrDLKp~NI 158 (470)
++.||+.||+||| +.+++|+||+|+||
T Consensus 110 ------------------------------------------------~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 110 ------------------------------------------------ILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred ------------------------------------------------HHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 9999999999999 99999999999999
Q ss_pred EEeCC-eEEEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 159 LIRGD-LVVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 159 Ll~~~-~ikL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
+++.+ .++|+|||++........ .....|++.|+|||++.+.. ++.++|+||||+++|+|++|..||.+.+......
T Consensus 142 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 220 (265)
T cd08217 142 FLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS 220 (265)
T ss_pred EEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHH
Confidence 99987 899999999887764443 34567899999999987655 7899999999999999999999998776443333
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.+.. .....+...++..+.+++.+||..+|.+|||+.++++|||+
T Consensus 221 ~~~~------------------------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 221 KIKE------------------------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHhc------------------------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 2211 11122334678899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=284.05 Aligned_cols=217 Identities=20% Similarity=0.328 Sum_probs=171.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+++.++ ||||+++++.+.. .+.+|+||||++ ++|..++.... .+++..+..
T Consensus 53 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~--------------- 114 (292)
T cd06644 53 LEDYMVEIEILATCN-HPYIVKLLGAFYW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--------------- 114 (292)
T ss_pred HHHHHHHHHHHHhCC-CCcEeeeEEEEEe--CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHH---------------
Confidence 345778999999999 9999999998865 568999999999 58888775533 366766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+||+++.+ .++
T Consensus 115 --------------------------------------------~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k 150 (292)
T cd06644 115 --------------------------------------------ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIK 150 (292)
T ss_pred --------------------------------------------HHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEE
Confidence 99999999999999999999999999999866 899
Q ss_pred EEecCCcccccCC-CccccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||.+...... .......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+.......+...
T Consensus 151 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 230 (292)
T cd06644 151 LADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 230 (292)
T ss_pred EccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC
Confidence 9999987654322 22234578899999998853 233688999999999999999999999776544433332110
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
. .........++.++.++|.+||..||++||+++++++||||..+..
T Consensus 231 ---~-------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 231 ---E-------------------------PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred ---C-------------------------CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 0 0011122356788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=280.51 Aligned_cols=213 Identities=22% Similarity=0.398 Sum_probs=172.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|+.++ |+||+++++++.. .+..++|+||+. ++|.+++.....+++..+..
T Consensus 48 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 107 (268)
T cd06630 48 EALRKEIRLMARLN-HPHIIRMLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----------------- 107 (268)
T ss_pred HHHHHHHHHHHHcC-CCceehhhceecc--CCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHH-----------------
Confidence 56789999999999 9999999999854 678999999999 59999998776677777766
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVVV 167 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ikL 167 (470)
++.||+.||+|||++|++|+||+|+||+++.+ .++|
T Consensus 108 ------------------------------------------~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 108 ------------------------------------------YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999999999999999999765 6999
Q ss_pred EecCCcccccCCC-----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKG-----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||.+....... ......|+..|+|||.+.+.. ++.++||||+||++|+|++|..||...........+....
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 224 (268)
T cd06630 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA 224 (268)
T ss_pred cccccccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh
Confidence 9999987664321 122346888999999987654 7899999999999999999999996544332222222110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
. .......+..++.++.+++.+||..+|.+|||+.++++||||.
T Consensus 225 ~--------------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 S--------------------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred c--------------------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 0111223346788999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=296.80 Aligned_cols=222 Identities=26% Similarity=0.448 Sum_probs=186.2
Q ss_pred CCCCCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHh
Q psy9855 2 KATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKA 79 (470)
Q Consensus 2 k~~~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~ 79 (470)
|.+|+.-.+..+..|+.||.++. ||.||.+-..| +..+.+++|||-+.||..+.|-.... +++..-+.
T Consensus 599 KlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~--ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkF------- 668 (888)
T KOG4236|consen 599 KLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMF--ETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKF------- 668 (888)
T ss_pred cccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEee--cCCceEEEEehhhcchHHHHHHHhhcccchHHHHHH-------
Confidence 55677777888999999999999 99999998777 55778999999999999988855443 65554444
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
++.||+.||.|||.++|||+||||+|||
T Consensus 669 ----------------------------------------------------lvtQIL~ALr~LH~knIvHCDLKPENVL 696 (888)
T KOG4236|consen 669 ----------------------------------------------------LVTQILVALRYLHFKNIVHCDLKPENVL 696 (888)
T ss_pred ----------------------------------------------------HHHHHHHHHHHhhhcceeeccCCchhee
Confidence 8999999999999999999999999999
Q ss_pred EeCC----eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy9855 160 IRGD----LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235 (470)
Q Consensus 160 l~~~----~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 235 (470)
+.+. ++||||||+|+.+++.......+|||.|.|||++...+ |...-|+||+|||+|.-++|..||..+.+. -
T Consensus 697 Las~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--n 773 (888)
T KOG4236|consen 697 LASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--N 773 (888)
T ss_pred eccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccch--h
Confidence 9765 89999999999999988889999999999999999877 899999999999999999999999654332 2
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+|.. ..|. ++ ... +..+++++.|||..+|++.-.+|.|.++.|.|||+++..
T Consensus 774 dQIQN------------------AaFM--yP---p~P----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 774 DQIQN------------------AAFM--YP---PNP----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHhhc------------------cccc--cC---CCc----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 22221 1111 11 111 246889999999999999999999999999999999754
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=283.58 Aligned_cols=216 Identities=21% Similarity=0.402 Sum_probs=172.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcc---cccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTD---NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~---~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+|.+++ ||||+++++.+.. .+.+++||||++| +|..++.... .+++..+..
T Consensus 43 ~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~------------- 106 (286)
T cd06622 43 FNQIIMELDILHKAV-SPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR------------- 106 (286)
T ss_pred HHHHHHHHHHHHhcC-CCcHHhhhhheec--CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHH-------------
Confidence 356889999999998 9999999998865 6789999999994 9999887642 366666666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||.|||+ .||+||||||+||+++.+
T Consensus 107 ----------------------------------------------~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~ 140 (286)
T cd06622 107 ----------------------------------------------ITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG 140 (286)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC
Confidence 99999999999997 599999999999999887
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEG-----YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~-----~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i 238 (470)
.++|+|||.+...... ......+++.|+|||++.+.. .++.++|||||||++|+|++|..||...........+
T Consensus 141 ~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 219 (286)
T cd06622 141 QVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL 219 (286)
T ss_pred CEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH
Confidence 8999999988765432 223456888999999885432 2578999999999999999999999765544333333
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..... .....+++.++.++.+||.+||..+|.+||++.++++||||....
T Consensus 220 ~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 220 SAIVD---------------------------GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHhh---------------------------cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 22211 111223346789999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.21 Aligned_cols=211 Identities=25% Similarity=0.357 Sum_probs=168.2
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+.+++.++ ||||+++++++.. .+.+++||||++ ++|.+++...+.+++..+..
T Consensus 52 ~~~~e~~~~~~l~-h~~ii~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~------------------ 110 (267)
T cd06645 52 VVQQEIIMMKDCK-HSNIVAYFGSYLR--RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY------------------ 110 (267)
T ss_pred HHHHHHHHHHhCC-CCCeeeEEEEEEe--CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHH------------------
Confidence 4678999999998 9999999998865 678999999999 59999998777788887777
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||+.||+|+||||+||+++.+ .++|+|
T Consensus 111 -----------------------------------------~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~d 149 (267)
T cd06645 111 -----------------------------------------VSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLAD 149 (267)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECc
Confidence 99999999999999999999999999999877 899999
Q ss_pred cCCcccccCCC-ccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 170 LGSLQFIKSKG-LHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 170 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
||++....... ......|+..|+|||++.. ...++.++|||||||++|+|++|..||...........+...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~----- 224 (267)
T cd06645 150 FGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS----- 224 (267)
T ss_pred ceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-----
Confidence 99887654321 2234578999999998742 234788999999999999999999998665433322221110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
.+. ..... ....++..+.++|.+||..||++|||++++++|||
T Consensus 225 -------------~~~-------~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 -------------NFQ-------PPKLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -------------CCC-------CCccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000 00000 01246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.08 Aligned_cols=204 Identities=27% Similarity=0.420 Sum_probs=166.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
....+|+.++....+||||+++++++. +..+.|+|||++.| -|.+.+.....+. ..+..
T Consensus 360 ~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~----------------- 419 (612)
T KOG0603|consen 360 DDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQ----------------- 419 (612)
T ss_pred cccccccchhhhhcCCCcceeecceec--CCceeeeeehhccccHHHHHHHhcchhH-HHHHH-----------------
Confidence 345688888888888999999999884 48889999999995 5555555444333 34434
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe-CC-eEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR-GD-LVVV 167 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~-~~-~ikL 167 (470)
|+.||+.||.|||.+|||||||||+|||++ +. +++|
T Consensus 420 ------------------------------------------w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 420 ------------------------------------------WAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEE
Confidence 999999999999999999999999999995 44 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
+|||.+...... ..+.+-|..|.|||++...+ |+.++||||||++||+|++|+.||...... ..+...++.+.
T Consensus 458 tyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~- 530 (612)
T KOG0603|consen 458 TYFGFWSELERS--CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK- 530 (612)
T ss_pred EEechhhhCchh--hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-
Confidence 999999877654 44567899999999998655 999999999999999999999999765544 12222222111
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
....+|+++++||++||++||.+|+++.+++.||||
T Consensus 531 ----------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ----------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----------------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 114789999999999999999999999999999999
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.06 Aligned_cols=216 Identities=24% Similarity=0.363 Sum_probs=169.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccc-cCHHHHHHhcc----cccHHHHHHHHHHHHh
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLME-LNLEEYIRTTD----NISEKRAKEILYQVKA 79 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~-gsL~~~l~~~~----~l~~~~~~~~~~~~~~ 79 (470)
....+.+|+.+++++..|+||+++++++.... ...+++||||++ ++|.+++.... .+++..+..
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~------- 117 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY------- 117 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHH-------
Confidence 34567899999999955999999999987532 456899999999 59999986532 356655555
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
++.|++.||+|||+.|++||||+|+||+
T Consensus 118 ----------------------------------------------------~~~ql~~al~~lH~~~i~H~~l~p~ni~ 145 (275)
T cd06608 118 ----------------------------------------------------ILRETLRGLAYLHENKVIHRDIKGQNIL 145 (275)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHhcCCcccCCCCHHHEE
Confidence 9999999999999999999999999999
Q ss_pred EeCC-eEEEEecCCcccccCCC-ccccccccCcccCchhhccC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy9855 160 IRGD-LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233 (470)
Q Consensus 160 l~~~-~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~ 233 (470)
++.+ .++|+|||.+....... ......|+..|+|||++... ..++.++|||||||++|+|++|.+||.......
T Consensus 146 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 225 (275)
T cd06608 146 LTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225 (275)
T ss_pred EccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH
Confidence 9877 89999999887654322 22345789999999987542 236789999999999999999999997655444
Q ss_pred HHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 234 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
....+... +. . .......++..+.+||.+||..||++|||+.++++|||+
T Consensus 226 ~~~~~~~~---~~-----------------------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 226 ALFKIPRN---PP-----------------------P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHhhcc---CC-----------------------C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 43333210 00 0 000112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=280.94 Aligned_cols=237 Identities=34% Similarity=0.667 Sum_probs=183.7
Q ss_pred hhhhHHHHHHhcCC--CCCCeeeeceeeecCCC---CeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhcc
Q psy9855 11 VANLKEISILRKIP--DHLNVLCLCETYVNRST---RQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 11 ~~~~rEi~iL~~L~--~HpnIv~l~~~~~~~~~---~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~ 83 (470)
..+.+|+.++.++. .||||+++++++..... ..++++|||+.++|.+++..... +++..+..
T Consensus 43 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~----------- 111 (287)
T cd07838 43 LSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD----------- 111 (287)
T ss_pred hhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHH-----------
Confidence 34667888877663 39999999999875322 24899999999999999876443 66666666
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
++.||+.||+|||+.|++|+||+|+||+++.+
T Consensus 112 ------------------------------------------------~~~~i~~al~~LH~~~i~h~~l~~~nili~~~ 143 (287)
T cd07838 112 ------------------------------------------------LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD 143 (287)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHCCeeeccCChhhEEEccC
Confidence 99999999999999999999999999999988
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||.+.............++..|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 144 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 144 GQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred CCEEEeccCcceeccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 89999999988765544444556888999999987755 7899999999999999999999999998888888887766
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
+.+....+......... .+............+.++..+.++|.+||..||.+||++.++++||||
T Consensus 223 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 223 GLPSEEEWPRNVSLPRS----SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCCChHhcCCCcccchh----hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 65543332211100000 011111112233334667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.93 Aligned_cols=242 Identities=30% Similarity=0.547 Sum_probs=181.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC------------CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHH
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS------------TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVK 78 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~------------~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~ 78 (470)
..+.+|+++|+.++ ||||+++++++.... ....|+||||++++|.+++... .+++..++.
T Consensus 47 ~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~l~~~~~~~------ 118 (342)
T cd07854 47 KHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG-PLSEEHARL------ 118 (342)
T ss_pred HHHHHHHHHHHhcC-CCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHcC-CCCHHHHHH------
Confidence 45779999999998 999999998775422 1357999999999999888643 367766666
Q ss_pred hhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENI 158 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NI 158 (470)
++.||+.||.|||+.||+||||||+||
T Consensus 119 -----------------------------------------------------~~~qi~~aL~~LH~~givH~dikp~Ni 145 (342)
T cd07854 119 -----------------------------------------------------FMYQLLRGLKYIHSANVLHRDLKPANV 145 (342)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 999999999999999999999999999
Q ss_pred EEeCC--eEEEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy9855 159 LIRGD--LVVVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232 (470)
Q Consensus 159 Ll~~~--~ikL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~ 232 (470)
+++.+ .++|+|||.+....... ......|+..|+|||++.+...++.++|||||||++|+|++|..||.+.+..
T Consensus 146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 225 (342)
T cd07854 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225 (342)
T ss_pred EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99754 78999999887653221 1223467889999998766555889999999999999999999999988877
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
+....+......+.......+......... ..............+.++.++.+||.+||..||.+|||+.+++.||||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 226 EQMQLILESVPVVREEDRNELLNVIPSFVR-NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhh-hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 776666655444433332222110000000 0000111122223456889999999999999999999999999999998
Q ss_pred Ch
Q psy9855 313 DL 314 (470)
Q Consensus 313 ~~ 314 (470)
..
T Consensus 305 ~~ 306 (342)
T cd07854 305 CY 306 (342)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=280.66 Aligned_cols=222 Identities=21% Similarity=0.306 Sum_probs=168.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++..++ ||||+++++++.. .+..|++|||++ ++|.+++.......+.....
T Consensus 52 ~~~~~~ei~~l~~l~-h~~i~~~~~~~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 112 (283)
T cd05048 52 QQEFRQEAELMSDLQ-HPNIVCLLGVCTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES---------------- 112 (283)
T ss_pred HHHHHHHHHHHHhcC-CcccceEEEEEcC--CCceEEEEecCCCCcHHHHHHhcCCCccccccc----------------
Confidence 345789999999999 9999999998854 567899999998 69999997653211100000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
........+....+..++.||+.||+|||++|++||||||+||+++.+ .++|
T Consensus 113 ---------------------------~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 113 ---------------------------GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred ---------------------------ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEE
Confidence 000001123344555699999999999999999999999999999888 8999
Q ss_pred EecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~-- 242 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR-- 242 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Confidence 9999987654322 223446788899999887655 8999999999999999998 99999887765554443220
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..++.++.+|+.+||..||.+|||+.+++++
T Consensus 243 ----------------------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 243 ----------------------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred ----------------------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=291.47 Aligned_cols=217 Identities=22% Similarity=0.330 Sum_probs=173.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.++..++ |+||+++++++.. .+..|+||||+. |+|.+++... ..+++..+..
T Consensus 46 ~~~~~e~~~l~~~~-~~~i~~l~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~---------------- 106 (331)
T cd05624 46 ACFREERNVLVNGD-CQWITTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF---------------- 106 (331)
T ss_pred HHHHHHHHHHHhCC-CCCEeeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHH----------------
Confidence 34678899999998 9999999998864 678999999998 6999999874 3477766666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 107 -------------------------------------------~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 107 -------------------------------------------YIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCcc--ccccccCcccCchhhccC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 168 GDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+|||++......... ...+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 144 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 144 ADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred EeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence 999998766543322 235799999999988652 34788999999999999999999999887766555544321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC--CcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR--RPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--Rpt~~elL~hp~f~~~~ 315 (470)
.. ..........+++++.+||.+||..++.+ |++++++++||||....
T Consensus 224 ~~--------------------------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 224 EE--------------------------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred CC--------------------------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 00 00011112357899999999999976654 57999999999999765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=280.20 Aligned_cols=216 Identities=22% Similarity=0.376 Sum_probs=166.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|.+++ ||||+++++.+.. .+..++||||+++ +|..+. .+++..+..
T Consensus 43 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~---------------- 99 (279)
T cd06619 43 QKQIMSELEILYKCD-SPYIIGFYGAFFV--ENRISICTEFMDGGSLDVYR----KIPEHVLGR---------------- 99 (279)
T ss_pred HHHHHHHHHHHHhCC-CCCeeeEEEEEEE--CCEEEEEEecCCCCChHHhh----cCCHHHHHH----------------
Confidence 346789999999998 9999999999865 5678999999995 775542 255555555
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||+.||+|+||||+|||++.+ .++|
T Consensus 100 -------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l 136 (279)
T cd06619 100 -------------------------------------------IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKL 136 (279)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999888 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCC
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL---DRIHQVLGT 244 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~---~~i~~~~g~ 244 (470)
+|||++...... .....+||..|+|||++.+.. ++.++|||||||++|+|++|..||......... ........
T Consensus 137 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 213 (279)
T cd06619 137 CDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV- 213 (279)
T ss_pred eeCCcceecccc-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-
Confidence 999998765432 234468999999999987755 899999999999999999999999653211100 00000000
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
. ...........++++.++|.+||..||++||+++++++||||.......
T Consensus 214 ----------~--------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~ 263 (279)
T cd06619 214 ----------D--------------EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263 (279)
T ss_pred ----------c--------------cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence 0 0000011234678899999999999999999999999999998765433
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=274.81 Aligned_cols=209 Identities=28% Similarity=0.475 Sum_probs=173.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|++++ |+||+++++++.. .+.+++|||||+ ++|.+++.... .+++..+..
T Consensus 43 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 105 (256)
T cd08221 43 RRDALNEIVILSLLQ-HPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-------------- 105 (256)
T ss_pred HHHHHHHHHHHHhCC-CCCeeEEEeEEec--CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHH--------------
Confidence 446789999999998 9999999999865 678999999998 59999997652 266666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.|++.||+|||+.|++||||+|+||+++.+ .+
T Consensus 106 ---------------------------------------------~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~ 140 (256)
T cd08221 106 ---------------------------------------------YLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLI 140 (256)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|+|||++....... ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+.. +
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~- 216 (256)
T cd08221 141 KLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--G- 216 (256)
T ss_pred EECcCcceEEcccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--C-
Confidence 999999987664433 234567899999999887755 78899999999999999999999987766555544432 1
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
........++.++.++|.+||..+|.+||++.++++|||+
T Consensus 217 ---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 217 ---------------------------NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ---------------------------CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0111124578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=278.41 Aligned_cols=211 Identities=25% Similarity=0.430 Sum_probs=169.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++.+.......+++||||++ ++|.+++.....+++..+..
T Consensus 49 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 110 (265)
T cd06652 49 NALECEIQLLKNLL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK----------------- 110 (265)
T ss_pred HHHHHHHHHHHhcC-CCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 35678999999998 999999999886554567899999998 59999998766677766666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+|+||||+||+++.+ .++|+
T Consensus 111 ------------------------------------------~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 111 ------------------------------------------YTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEEC
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSK----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||.+...... .......|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+. ..
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~ 224 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQ 224 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cC
Confidence 99988754321 1123356889999999987755 7899999999999999999999997654433332221 11
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
+ .....+..++..+.++|.+||. +|.+|||++++++|||+.
T Consensus 225 ~--------------------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 225 P--------------------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred C--------------------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 0111234677889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=284.34 Aligned_cols=213 Identities=20% Similarity=0.364 Sum_probs=173.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.. ...+++|+||+. ++|..++... .+++..+..
T Consensus 61 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~----------------- 119 (296)
T cd06655 61 ELIINEILVMKELK-NPNIVNFLDSFLV--GDELFVVMEYLAGGSLTDVVTET-CMDEAQIAA----------------- 119 (296)
T ss_pred HHHHHHHHHHHhcC-CCceeeeeeeEec--CceEEEEEEecCCCcHHHHHHhc-CCCHHHHHH-----------------
Confidence 45678999999999 9999999999865 678999999998 5999988653 366666666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.|++.||+|||++|++||||||+||+++.+ .++|+
T Consensus 120 ------------------------------------------i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~ 157 (296)
T cd06655 120 ------------------------------------------VCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLT 157 (296)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++........ .....|+..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+... +.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~--- 232 (296)
T cd06655 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT--- 232 (296)
T ss_pred cCccchhcccccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC---
Confidence 9998876543322 23457889999999887655 789999999999999999999999887665544333210 00
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.....+..+++.+.+||.+||..||.+|||+.++++||||....
T Consensus 233 ------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 233 ------------------------PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ------------------------cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 00111235778899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=276.06 Aligned_cols=210 Identities=23% Similarity=0.413 Sum_probs=173.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ |+||+++++++.. ...+++|+||++ ++|.+++.....+++..+..
T Consensus 47 ~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~----------------- 106 (258)
T cd06632 47 KQLEQEIALLSKLQ-HPNIVQYLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL----------------- 106 (258)
T ss_pred HHHHHHHHHHHhcC-CCCchheeeeEec--CCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45789999999998 9999999998754 678999999998 59999998776677776666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.||+|+||+|+||+++.+ .++|+
T Consensus 107 ------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~ 144 (258)
T cd06632 107 ------------------------------------------YTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLA 144 (258)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||.+.............|+..|+|||.+.....++.++|+|||||++|+|++|..||...........+...
T Consensus 145 d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------- 217 (258)
T cd06632 145 DFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------- 217 (258)
T ss_pred cCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------
Confidence 9998877654443455678999999998865444789999999999999999999999766543333222110
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.....+++.+++.+.+++.+||..+|.+|||+.+++.|||+
T Consensus 218 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 ----------------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 11122334678899999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=280.50 Aligned_cols=215 Identities=21% Similarity=0.395 Sum_probs=171.8
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+++++.+. ||||+++++.+.. .+.+++|+||++ ++|.+++... ..+++..+..
T Consensus 42 ~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~-------------- 104 (265)
T cd06605 42 IQKQILRELDILHKCN-SPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGK-------------- 104 (265)
T ss_pred HHHHHHHHHHHHHHCC-CCchhhhheeeec--CCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHH--------------
Confidence 3456889999999999 9999999998865 578999999999 6999999876 4477777666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-e
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||+ .|++|+||||+||+++.+ .
T Consensus 105 ---------------------------------------------~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~ 139 (265)
T cd06605 105 ---------------------------------------------IAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ 139 (265)
T ss_pred ---------------------------------------------HHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC
Confidence 99999999999999 999999999999999987 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE--IDQLDRIHQVL 242 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~~~ 242 (470)
++|+|||.+......... ...++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... ......+....
T Consensus 140 ~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (265)
T cd06605 140 IKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217 (265)
T ss_pred EEEeecccchhhHHHHhh-cccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh
Confidence 999999988765432222 267889999999987754 89999999999999999999999965421 11111111111
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCccccccc-ccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.. ....+... ++.++.++|.+||..||.+|||+.+++.||||+..
T Consensus 218 ~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 218 NE---------------------------PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cC---------------------------CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 10 00111122 78889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=282.68 Aligned_cols=211 Identities=22% Similarity=0.373 Sum_probs=170.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ ||||+++++++.. .+..++|+||+.|+|.+++.... .+++..+..
T Consensus 60 ~~~~~Ei~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~----------------- 119 (307)
T cd06607 60 QDIIKEVRFLQQLR-HPNTIEYKGCYLR--EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA----------------- 119 (307)
T ss_pred HHHHHHHHHHHhCC-CCCEEEEEEEEEe--CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHH-----------------
Confidence 35789999999999 9999999999865 56789999999999988876533 366666655
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||+.||+||||+|+||+++.+ .++|+
T Consensus 120 ------------------------------------------~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~ 157 (307)
T cd06607 120 ------------------------------------------ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLA 157 (307)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++...... ....++..|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 158 dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~----- 229 (307)
T cd06607 158 DFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----- 229 (307)
T ss_pred ecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-----
Confidence 99988755432 34578889999998753 344788999999999999999999999876654443332210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.........++..+.++|.+||..||++||++.+++.||||....
T Consensus 230 ------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 230 ------------------------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred ------------------------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 000011123678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=306.50 Aligned_cols=219 Identities=23% Similarity=0.351 Sum_probs=181.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
+...|.||+++|..|+ |||||+|+|++.. ++.+|+|+|||. |||.+||+.+..-....+
T Consensus 532 ~~~dF~REaeLla~l~-H~nIVrLlGVC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~----------------- 591 (774)
T KOG1026|consen 532 ARQDFRREAELLAELQ-HPNIVRLLGVCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLA----------------- 591 (774)
T ss_pred HHHHHHHHHHHHHhcc-CCCeEEEEEEEcc--CCeeEEEEEecccccHHHHHHhhCCcccccc-----------------
Confidence 4667999999999999 9999999999854 788999999999 999999987654211110
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
.|.+ ....+...+.+.|+.||+.|++||-++.+|||||-..|+||.++ .||
T Consensus 592 ----------------~g~~------------~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 592 ----------------SGQD------------TPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred ----------------CCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 0000 02335556677799999999999999999999999999999999 899
Q ss_pred EEecCCcccccCCCcccc---ccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLHTE---YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~---~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||+++.+-..+.+.. ..-...|||||.++..+ |+.++||||+||+|||+++ |+.||.+.++.+.++.|.+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-- 720 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-- 720 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc--
Confidence 999999998765554432 23356799999998866 8999999999999999998 9999999999999988865
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
+..-..+.+++.++.+||..||+.+|.+||++.||-
T Consensus 721 ----------------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 ----------------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ----------------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 122334568999999999999999999999999985
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=281.29 Aligned_cols=222 Identities=19% Similarity=0.300 Sum_probs=171.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHh-----cccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRT-----TDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~-----~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+.++.++.+||||+++++++.. .+..+++|||++++|.++... ...+++..+..
T Consensus 46 ~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~------------ 111 (288)
T cd06616 46 QKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------------ 111 (288)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHH------------
Confidence 45678999999999779999999998865 567899999999877665432 12355555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIRGD 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~ 163 (470)
++.|++.||+|||+. ||+||||||+||+++.+
T Consensus 112 -----------------------------------------------i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~ 144 (288)
T cd06616 112 -----------------------------------------------IAVATVKALNYLKEELKIIHRDVKPSNILLDRN 144 (288)
T ss_pred -----------------------------------------------HHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC
Confidence 999999999999974 99999999999999877
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
.++|+|||++.............|+..|+|||++.+. ..++.++||||+||++|+|++|..||.... .....+.+
T Consensus 145 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~ 222 (288)
T cd06616 145 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQ 222 (288)
T ss_pred CcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhh
Confidence 8999999998766544444455789999999998765 358899999999999999999999997654 12222222
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHH
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~ 317 (470)
...... ..........++.++.+||.+||..||++|||+++++.||||......
T Consensus 223 ~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 223 VVKGDP-----------------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred hcCCCC-----------------------CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 111000 000011113578899999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.51 Aligned_cols=213 Identities=22% Similarity=0.339 Sum_probs=172.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+++|..++ ||||+++++.+.. ....|+||||+. ++|.+++.... .+++..+..
T Consensus 46 ~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~--------------- 107 (316)
T cd05574 46 KRVLTEQEILATLD-HPFLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF--------------- 107 (316)
T ss_pred HHHHHHHHHHHhCC-CCCchhheeeeec--CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHH---------------
Confidence 45789999999999 9999999998854 678999999998 59999987542 366666665
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+.|++||||||+||+++.+ .++
T Consensus 108 --------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 143 (316)
T cd05574 108 --------------------------------------------YAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIM 143 (316)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCC------------------------------ccccccccCcccCchhhccCCCCCCcccHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKG------------------------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVF 216 (470)
Q Consensus 167 L~DFG~a~~~~~~~------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il 216 (470)
|+|||++....... ......||..|+|||++.+.. ++.++|||||||++
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll 222 (316)
T cd05574 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILL 222 (316)
T ss_pred EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHH
Confidence 99999876543211 112346889999999987755 78999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCC
Q psy9855 217 YETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDP 296 (470)
Q Consensus 217 ~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP 296 (470)
|+|++|..||.+.+....+..+... .........++..+.++|.+||..||
T Consensus 223 ~~l~~g~~pf~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 223 YEMLYGTTPFKGSNRDETFSNILKK-----------------------------EVTFPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred HHHhhCCCCCCCCchHHHHHHHhcC-----------------------------CccCCCccccCHHHHHHHHHHccCCH
Confidence 9999999999887765554443210 00000112368899999999999999
Q ss_pred CCCcC----HHHHHhcccCCChh
Q psy9855 297 KRRPT----AQKILSCAYFADLT 315 (470)
Q Consensus 297 ~~Rpt----~~elL~hp~f~~~~ 315 (470)
++||| ++++|+||||++..
T Consensus 274 ~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 274 SKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred hHCCCchhhHHHHHcCchhhcCC
Confidence 99999 99999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=281.75 Aligned_cols=213 Identities=24% Similarity=0.348 Sum_probs=167.1
Q ss_pred hhHHHHHHhcC--CCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 13 NLKEISILRKI--PDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 13 ~~rEi~iL~~L--~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+|..++..+ .+||||+.+++++.. .+..++||||++ |+|.+++.....+++..+..
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~----------------- 101 (279)
T cd05633 41 ALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF----------------- 101 (279)
T ss_pred HHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHH-----------------
Confidence 45555444443 139999999998864 567999999999 69999998777788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 102 ------------------------------------------i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~ 139 (279)
T cd05633 102 ------------------------------------------YATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 139 (279)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++....... .....|+..|+|||.+.+...++.++||||+||++|+|++|..||.+....... .+....
T Consensus 140 dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~------ 211 (279)
T cd05633 140 DLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT------ 211 (279)
T ss_pred cCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh------
Confidence 999887554332 234578999999998865445789999999999999999999999754321111 111100
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
......+++.++.++.++|.+||..||.+|+ |+.++++||||+++.
T Consensus 212 ---------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 212 ---------------------LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ---------------------hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0001123346789999999999999999999 699999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=286.30 Aligned_cols=217 Identities=29% Similarity=0.425 Sum_probs=184.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
+..++.|-.||.++. .+.||.+-.+| ++.+.+|||+..|. |||.=.|...+ .+++..+..
T Consensus 229 e~maLnEk~iL~kV~-s~FiVslaYAf--eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~F-------------- 291 (591)
T KOG0986|consen 229 ETMALNEKQILEKVS-SPFIVSLAYAF--ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARF-------------- 291 (591)
T ss_pred hHHhhHHHHHHHHhc-cCcEEEEeeee--cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHH--------------
Confidence 456799999999999 99999997666 56888999999999 59987776666 477777766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+.+|+.||++||..+||+|||||+|||+|+. ++
T Consensus 292 ---------------------------------------------YAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Ghv 326 (591)
T KOG0986|consen 292 ---------------------------------------------YAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHV 326 (591)
T ss_pred ---------------------------------------------HHHHHHhhHHHHHhcceeeccCChhheeeccCCCe
Confidence 99999999999999999999999999999988 99
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|+|+|..+..+......+||.+|||||++.+.. |+..+|.|||||++|||+.|+.||....+....+.+.+..
T Consensus 327 RISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--- 402 (591)
T KOG0986|consen 327 RISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--- 402 (591)
T ss_pred EeeccceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH---
Confidence 999999999999988888889999999999998877 9999999999999999999999997655443333332211
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
......++..+|+++++|.+.+|..||.+|.. ++++-+||||++++.
T Consensus 403 ------------------------~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 403 ------------------------LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred ------------------------hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 11122344678999999999999999999975 679999999999764
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=280.54 Aligned_cols=216 Identities=23% Similarity=0.360 Sum_probs=167.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC---CCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhh
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS---TRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~---~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~ 81 (470)
...+.+|+.++.++.+||||+++++++...+ .+..++||||++ ++|.+++... ..+++..+..
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~--------- 132 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY--------- 132 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHH---------
Confidence 3456789999999955999999999986432 356899999998 5999988632 2255555554
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||+|||+.||+||||||+||+++
T Consensus 133 --------------------------------------------------~~~qi~~al~~lH~~~ivH~dlkp~nili~ 162 (291)
T cd06639 133 --------------------------------------------------ILYGALLGLQHLHNNRIIHRDVKGNNILLT 162 (291)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhCCeeccCCCHHHEEEc
Confidence 999999999999999999999999999998
Q ss_pred CC-eEEEEecCCcccccCCC-ccccccccCcccCchhhccCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEG----YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~----~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 235 (470)
.+ .++|+|||++....... ......|+..|+|||++.... .++.++|||||||++|+|++|++||........+
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 87 79999999887654332 223457889999999875432 2578999999999999999999999876554444
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
..+... +. ........++..+.+||.+||..+|++||++.++++||||+
T Consensus 243 ~~~~~~---~~-------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 243 FKIPRN---PP-------------------------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHhcC---CC-------------------------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 333210 00 00001124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=276.04 Aligned_cols=213 Identities=26% Similarity=0.333 Sum_probs=171.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++++.++ ||||+++++++.. .+.+|++|||++ ++|.+++... ..+++..+..
T Consensus 44 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~--------------- 105 (262)
T cd06613 44 FEIIQQEISMLKECR-HPNIVAYFGSYLR--RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY--------------- 105 (262)
T ss_pred HHHHHHHHHHHHhCC-CCChhceEEEEEe--CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHH---------------
Confidence 346789999999999 9999999998865 678999999999 5999998776 4577777766
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||+|||++||+|+||+|+||+++.+ .++
T Consensus 106 --------------------------------------------~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~ 141 (262)
T cd06613 106 --------------------------------------------VCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVK 141 (262)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEE
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCcccccCCC-ccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||.+....... ......++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 142 l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~- 220 (262)
T cd06613 142 LADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN- 220 (262)
T ss_pred ECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Confidence 99999887655332 23445788999999988664 247889999999999999999999998776554443332210
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
+. . ........++.++.+||.+||..+|.+|||+.+++.|+|
T Consensus 221 -----------------~~-------~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 221 -----------------FP-------P-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -----------------CC-------C-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 0 000112345678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=280.53 Aligned_cols=216 Identities=21% Similarity=0.322 Sum_probs=167.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc----cccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD----NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~----~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
+..+.+|+.++.+..+||||+++++++.. .+..|+||||++|+|.+++.... .+++..+..
T Consensus 43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~------------- 107 (283)
T cd06617 43 QKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK------------- 107 (283)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHH-------------
Confidence 44567788765454449999999998864 56799999999999998886521 256666665
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC-
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIRGD- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++ +++||||||+||+++.+
T Consensus 108 ----------------------------------------------~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~ 141 (283)
T cd06617 108 ----------------------------------------------IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG 141 (283)
T ss_pred ----------------------------------------------HHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC
Confidence 999999999999998 99999999999999887
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE---GYYSFELDIWAAGCVFYETLTRNPLFPGD-SEIDQLDRIH 239 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~-~~~~~~~~i~ 239 (470)
.++|+|||.+.............|+..|+|||++.+. ..++.++|+|||||++|+|++|..||... ...+.+..+.
T Consensus 142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (283)
T cd06617 142 QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221 (283)
T ss_pred CEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH
Confidence 8999999998876544333445788999999988642 23688999999999999999999999643 2222222221
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
. +. ........++.++.++|.+||..+|.+|||+.++++||||....
T Consensus 222 ~--~~---------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 222 E--EP---------------------------SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred h--cC---------------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 1 00 00001124688999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=284.19 Aligned_cols=214 Identities=23% Similarity=0.396 Sum_probs=172.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++.+.. .+..++||||++ ++|.+++... .+++..+..
T Consensus 63 ~~~~~~e~~~l~~l~-h~~ii~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~---------------- 122 (292)
T cd06658 63 RELLFNEVVIMRDYH-HENVVDMYNSYLV--GDELWVVMEFLEGGALTDIVTHT-RMNEEQIAT---------------- 122 (292)
T ss_pred HHHHHHHHHHHHhCC-CCcHHHHHHheec--CCeEEEEEeCCCCCcHHHHHhcC-CCCHHHHHH----------------
Confidence 345789999999998 9999999998865 678999999998 5898887543 366666665
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|
T Consensus 123 -------------------------------------------~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL 159 (292)
T cd06658 123 -------------------------------------------VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKL 159 (292)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... ......|+..|+|||++.+.. ++.++|||||||++|||++|..||.+.........+......
T Consensus 160 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-- 236 (292)
T cd06658 160 SDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-- 236 (292)
T ss_pred ccCcchhhcccccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--
Confidence 9999887553222 223457899999999886654 789999999999999999999999877655544333221100
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.......++..+.++|.+||..||.+|||++++++||||....
T Consensus 237 --------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 237 --------------------------RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred --------------------------ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 0001124678899999999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=282.07 Aligned_cols=214 Identities=23% Similarity=0.334 Sum_probs=172.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ ||||+++++.+.. .+.+++||||++ ++|.+++.....+++..+..
T Consensus 46 ~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~----------------- 105 (305)
T cd05609 46 QQVFVERDILTFAE-NPFVVSMFCSFET--KRHLCMVMEYVEGGDCATLLKNIGALPVDMARM----------------- 105 (305)
T ss_pred HHHHHHHHHHHhCC-CCCeeeeEEEEec--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 35678999999998 9999999998854 678999999999 59999998776677777766
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.|++.||+|||++|++||||||+||+++.+ .++|+
T Consensus 106 ------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~ 143 (305)
T cd05609 106 ------------------------------------------YFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLT 143 (305)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEe
Confidence 89999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC----------------CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy9855 169 DLGSLQFIKSK----------------GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232 (470)
Q Consensus 169 DFG~a~~~~~~----------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~ 232 (470)
|||.++..... .......|+..|+|||.+.+.. ++.++|||||||++|+|++|..||.+....
T Consensus 144 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 144 DFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred eCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99987632100 0011246788999999987655 799999999999999999999999877665
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC---HHHHHhcc
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT---AQKILSCA 309 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt---~~elL~hp 309 (470)
+....+.... .........++.++.++|.+||..||++||+ +.++|+||
T Consensus 223 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 223 ELFGQVISDD----------------------------IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHHHHhcc----------------------------cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 5444433210 0001111257888999999999999999998 79999999
Q ss_pred cCCChh
Q psy9855 310 YFADLT 315 (470)
Q Consensus 310 ~f~~~~ 315 (470)
||...+
T Consensus 275 ~~~~~~ 280 (305)
T cd05609 275 FFLGLD 280 (305)
T ss_pred cccCCC
Confidence 998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=291.10 Aligned_cols=261 Identities=18% Similarity=0.249 Sum_probs=180.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-c------cHHHH---HHHHHHHH
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-I------SEKRA---KEILYQVK 78 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l------~~~~~---~~~~~~~~ 78 (470)
...+.+|+.+|..+..||||+++++++.. .+..++|||||+ |+|.+++..... . ..... ..+.....
T Consensus 82 ~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (375)
T cd05104 82 REALMSELKVLSYLGNHINIVNLLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQRE 159 (375)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhc
Confidence 45678999999999449999999998854 667999999999 699999976432 0 00000 00000000
Q ss_pred hhh-----------ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC
Q psy9855 79 AAN-----------ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK 147 (470)
Q Consensus 79 ~~~-----------~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g 147 (470)
... ...................+|.....+...+.... ..+....+..++.||+.||+|||++|
T Consensus 160 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~ 234 (375)
T cd05104 160 MSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDE-----LALDTEDLLSFSYQVAKGMSFLASKN 234 (375)
T ss_pred ccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 000 00001111122223345567776666666654432 34556778889999999999999999
Q ss_pred CeecCCCCCcEEEeCC-eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-C
Q psy9855 148 VFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-R 222 (470)
Q Consensus 148 IvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g 222 (470)
|+||||||+|||++.+ .++|+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |
T Consensus 235 ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g 313 (375)
T cd05104 235 CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLG 313 (375)
T ss_pred eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcC
Confidence 9999999999999987 799999999876543321 11234566799999987755 8999999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH
Q psy9855 223 NPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302 (470)
Q Consensus 223 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~ 302 (470)
..||.+............. ......+...+.++.+||.+||..||++|||+
T Consensus 314 ~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 314 SSPYPGMPVDSKFYKMIKE-----------------------------GYRMLSPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred CCCCCCCCchHHHHHHHHh-----------------------------CccCCCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999776543333222110 00001122457889999999999999999999
Q ss_pred HHHHh
Q psy9855 303 QKILS 307 (470)
Q Consensus 303 ~elL~ 307 (470)
.++++
T Consensus 365 ~eil~ 369 (375)
T cd05104 365 KQIVQ 369 (375)
T ss_pred HHHHH
Confidence 99985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=276.45 Aligned_cols=205 Identities=18% Similarity=0.259 Sum_probs=165.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+++|+.+|..++ ||||+++++++.. .+..++||||++ |+|.+++.... .+++..+..
T Consensus 50 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~--------------- 111 (266)
T cd05064 50 RRGFLAEALTLGQFD-HSNIVRLEGVITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG--------------- 111 (266)
T ss_pred HHHHHHHHHHHhcCC-CCCcCeEEEEEec--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHH---------------
Confidence 456789999999998 9999999998864 678999999999 59999987643 367766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++|++||||||+|||++.+ .++
T Consensus 112 --------------------------------------------~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~ 147 (266)
T cd05064 112 --------------------------------------------MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCK 147 (266)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEE
Confidence 99999999999999999999999999999888 899
Q ss_pred EEecCCcccccCCCccc--cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKGLHT--EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
++|||.+.......... ...++..|+|||++.+.. ++.++|||||||++||+++ |..||.+.+..+....+....
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~- 225 (266)
T cd05064 148 ISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF- 225 (266)
T ss_pred ECCCcccccccccchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-
Confidence 99999776543222111 234567899999987755 8999999999999999775 999998877666555443211
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..++..+.+++.+||..+|.+|||++++++
T Consensus 226 -----------------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 -----------------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 01123457888999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=274.19 Aligned_cols=209 Identities=27% Similarity=0.457 Sum_probs=171.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ ||||+++++++.. .+..++|+||+. ++|.+++.... .+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~-------------- 105 (256)
T cd08218 43 REESRKEVAVLSNMK-HPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD-------------- 105 (256)
T ss_pred HHHHHHHHHHHHhCC-CCCeeeeEeeecC--CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHH--------------
Confidence 446789999999999 9999999998854 678999999998 59999987643 256666665
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++|++|+||+|+||+++.+ .+
T Consensus 106 ---------------------------------------------~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~ 140 (256)
T cd08218 106 ---------------------------------------------WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTI 140 (256)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|+|||.+........ .....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||......+....+.. +
T Consensus 141 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~- 216 (256)
T cd08218 141 KLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--G- 216 (256)
T ss_pred EEeeccceeecCcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--C-
Confidence 9999998876543322 22346888999999987755 78899999999999999999999987665554444322 1
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
........++.++.++|.+||..+|.+||++.++++||||
T Consensus 217 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 217 ---------------------------SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ---------------------------CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 1111234578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=275.15 Aligned_cols=215 Identities=26% Similarity=0.381 Sum_probs=172.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc---cccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD---NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~---~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+++|+.++ |+||+++++.+.. ....++|||+++ ++|.+++.... .+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~------------- 106 (267)
T cd06610 43 VDELRKEVQAMSQCN-HPNVVKYYTSFVV--GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT------------- 106 (267)
T ss_pred HHHHHHHHHHHHhcC-CCCEEEEEEEEee--CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHH-------------
Confidence 456789999999998 9999999998865 678999999998 59999997642 366666666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||+.||+||||+|+||+++++ .
T Consensus 107 ----------------------------------------------~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~ 140 (267)
T cd06610 107 ----------------------------------------------VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS 140 (267)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC
Confidence 99999999999999999999999999999987 8
Q ss_pred EEEEecCCcccccCCCc-----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
++|+|||++........ ....+|+..|+|||++.....++.++|+|||||++|+|++|..||...+.......+.
T Consensus 141 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 220 (267)
T cd06610 141 VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220 (267)
T ss_pred EEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh
Confidence 99999998876653322 2345789999999998776458999999999999999999999997765544333322
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.. .+ +..........++..+.+++.+||..||++|||+.++++||||
T Consensus 221 ~~---~~----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 221 QN---DP----------------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cC---CC----------------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 10 00 0000011123678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=291.62 Aligned_cols=266 Identities=15% Similarity=0.159 Sum_probs=178.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHH--HH-------HHHHHH
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRA--KE-------ILYQVK 78 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~--~~-------~~~~~~ 78 (470)
...+.+|+.+|+.+..|+||+++++++.. .+.+++|||||. |+|.+++..... +..... .. ......
T Consensus 85 ~~~~~~E~~il~~l~~h~nIv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (374)
T cd05106 85 REALMSELKILSHLGQHKNIVNLLGACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITL 162 (374)
T ss_pred HHHHHHHHHHHHhhccCCceeeEeeEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccch
Confidence 34678999999999449999999998854 668999999999 699999975432 000000 00 000000
Q ss_pred hhhccccccccccCCCccceeeeccCCCCchhhhhcc-cccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGL-TTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPEN 157 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~N 157 (470)
........-+........++.|+...+.......... ........+....+..++.||+.||+|||++||+||||||+|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~N 242 (374)
T cd05106 163 EKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARN 242 (374)
T ss_pred hcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchhe
Confidence 0000000011112223345566655555443332111 122233456778888899999999999999999999999999
Q ss_pred EEEeCC-eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChH
Q psy9855 158 ILIRGD-LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEI 232 (470)
Q Consensus 158 ILl~~~-~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~ 232 (470)
||++.+ .++|+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||......
T Consensus 243 il~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 243 VLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred EEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 999987 899999999876543221 11233566799999987654 8999999999999999997 99999775443
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+... ......+..++.++.++|.+||..||.+|||+.++++
T Consensus 322 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 322 SKFYKMVKR-----------------------------GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHc-----------------------------ccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 332222210 0000112345789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=279.15 Aligned_cols=214 Identities=23% Similarity=0.423 Sum_probs=173.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.. .+..++|+||++ ++|.+++.. ..+++..+..
T Consensus 61 ~~~~~e~~~l~~~~-h~~vv~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~----------------- 119 (285)
T cd06648 61 ELLFNEVVIMRDYQ-HPNIVEMYSSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAT----------------- 119 (285)
T ss_pred HHHHHHHHHHHHcC-CCChheEEEEEEc--CCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHH-----------------
Confidence 45789999999998 9999999998864 677999999998 599999876 4466666666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||+|+||+++.+ .++|+
T Consensus 120 ------------------------------------------~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~ 157 (285)
T cd06648 120 ------------------------------------------VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLS 157 (285)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEc
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||.+....... ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.... .
T Consensus 158 d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~--- 232 (285)
T cd06648 158 DFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-P--- 232 (285)
T ss_pred ccccchhhccCCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-C---
Confidence 999876554322 223356899999999987655 8999999999999999999999998766555444332210 0
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
........++..+.++|.+||..+|++|||+.++++||||.....
T Consensus 233 ------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 233 ------------------------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ------------------------CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 000011246788999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=280.45 Aligned_cols=231 Identities=17% Similarity=0.262 Sum_probs=166.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|.+++ ||||+++++++.. .+..++||||++ |+|.+++.............
T Consensus 63 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 123 (304)
T cd05096 63 RNDFLKEVKILSRLK-DPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGN---------------- 123 (304)
T ss_pred HHHHHHHHHHHhhcC-CCCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccc----------------
Confidence 346789999999998 9999999999865 567999999998 69999986543110000000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
...........+....+..++.||+.||.|||+.||+||||||+|||++.+ .++|
T Consensus 124 ------------------------~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 179 (304)
T cd05096 124 ------------------------DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKI 179 (304)
T ss_pred ------------------------cccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEE
Confidence 000001112234445566699999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 180 ~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~ 258 (304)
T cd05096 180 ADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFF 258 (304)
T ss_pred CCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHh
Confidence 99999876543321 12345678899999987655 8999999999999999986 567887766555444433211
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
... ........++.++..+.+||.+||..||.+|||+.++.+
T Consensus 259 ~~~-----------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 259 RDQ-----------------------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred hhc-----------------------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 000 000011123457789999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=275.23 Aligned_cols=212 Identities=21% Similarity=0.293 Sum_probs=164.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cc--cHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NI--SEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l--~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+++.++ |+||+++++++.. .+..++|+||++ ++|.+++.... .+ ++..+..
T Consensus 49 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~------------- 112 (268)
T cd06624 49 VQPLHEEIALHSYLK-HRNIVQYLGSDSE--NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF------------- 112 (268)
T ss_pred HHHHHHHHHHHHhcC-CCCeeeeeeeecc--CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHH-------------
Confidence 346789999999999 9999999998854 678999999998 59999987542 23 4444444
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-- 163 (470)
++.||+.||+|||++||+||||||+||+++.+
T Consensus 113 ----------------------------------------------~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~ 146 (268)
T cd06624 113 ----------------------------------------------YTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG 146 (268)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC
Confidence 89999999999999999999999999999763
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEG-YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.++|+|||.+....... ......|++.|+|||++.+.. .++.++|||||||++|+|++|..||...............
T Consensus 147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~ 226 (268)
T cd06624 147 VVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM 226 (268)
T ss_pred eEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh
Confidence 89999999887654322 223346889999999886532 3788999999999999999999999653321111000000
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
......++..+++++.+|+.+||..+|.+|||+.+++.||||
T Consensus 227 ----------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 227 ----------------------------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ----------------------------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 001112334678899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=283.13 Aligned_cols=217 Identities=23% Similarity=0.363 Sum_probs=172.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. .+..|+||||++ ++|.+++... .+++..+..
T Consensus 60 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~---------------- 119 (297)
T cd06656 60 KELIINEILVMRENK-NPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAA---------------- 119 (297)
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEec--CCEEEEeecccCCCCHHHHHHhC-CCCHHHHHH----------------
Confidence 345789999999998 9999999999865 678999999998 5999998643 356666655
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|++.||.|||+.||+||||||+|||++.+ .++|
T Consensus 120 -------------------------------------------~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l 156 (297)
T cd06656 120 -------------------------------------------VCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKL 156 (297)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||.+........ .....+++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+.. .+.
T Consensus 157 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~-- 232 (297)
T cd06656 157 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT-- 232 (297)
T ss_pred CcCccceEccCCccCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCC--
Confidence 99998876543322 23457889999999887654 78999999999999999999999976544322211110 000
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
.....+..++..+.+||.+||..||++|||+.++++||||.......
T Consensus 233 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 233 -------------------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred -------------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 00111235678899999999999999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=276.75 Aligned_cols=214 Identities=22% Similarity=0.342 Sum_probs=174.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++..+. ||||+++++.+.. ....++||||++ ++|.+++... .+++..+..
T Consensus 46 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~-~l~~~~~~~---------------- 105 (277)
T cd06640 46 IEDIQQEITVLSQCD-SPYVTKYYGSYLK--GTKLWIIMEYLGGGSALDLLRAG-PFDEFQIAT---------------- 105 (277)
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEEE--CCEEEEEEecCCCCcHHHHHhcC-CCCHHHHHH----------------
Confidence 346789999999998 9999999998865 678999999998 5999998653 466666666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|++.||+|||+.|++|+||+|+||+++.+ .++|
T Consensus 106 -------------------------------------------~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l 142 (277)
T cd06640 106 -------------------------------------------MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKL 142 (277)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++........ .....++..|+|||++.+.. ++.++|+|||||++|+|++|..||.+.........+..
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------ 215 (277)
T cd06640 143 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK------ 215 (277)
T ss_pred cccccceeccCCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc------
Confidence 99999876654332 23346888999999987655 78999999999999999999999977654433322211
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~ 317 (470)
.....+...++..+.++|.+||..+|++||++.++++||||......
T Consensus 216 ------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 216 ------------------------NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred ------------------------CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 01112234567889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=281.84 Aligned_cols=214 Identities=24% Similarity=0.419 Sum_probs=173.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++..++ ||||+++++.+.. .+..++|+||++ ++|.+++.. ..+++..+..
T Consensus 62 ~~~~~~e~~~l~~l~-hp~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~---------------- 121 (297)
T cd06659 62 RELLFNEVVIMRDYQ-HQNVVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQ-TRLNEEQIAT---------------- 121 (297)
T ss_pred HHHHHHHHHHHHhCC-CCchhhhhhheee--CCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHH----------------
Confidence 345789999999998 9999999998865 678999999999 599887754 3366666666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++|++||||||+||+++.+ .++|
T Consensus 122 -------------------------------------------~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL 158 (297)
T cd06659 122 -------------------------------------------VCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKL 158 (297)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... .....+|+..|+|||++.+.. ++.++|||||||++|+|++|..||......+....+.. .+
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~- 233 (297)
T cd06659 159 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SP- 233 (297)
T ss_pred eechhHhhcccccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cC-
Confidence 9999887554322 223457899999999987655 79999999999999999999999987665554433321 00
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.........++..+.++|.+||..+|.+||++.++++||||.+..
T Consensus 234 ------------------------~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 234 ------------------------PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred ------------------------CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 001111235678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=273.07 Aligned_cols=210 Identities=28% Similarity=0.488 Sum_probs=170.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
+...+.+|+.+++.++ |+||+++++.+.. ....++|+||++ ++|.+++..... +++..+..
T Consensus 42 ~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~------------- 105 (257)
T cd08225 42 EKEASKKEVILLAKMK-HPNIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS------------- 105 (257)
T ss_pred hhHHHHHHHHHHHhCC-CCChhhhhheecc--CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHH-------------
Confidence 3456789999999999 9999999998854 678999999998 599999876443 56666555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-- 163 (470)
++.||+.||+|||+.|++|+||||+||+++.+
T Consensus 106 ----------------------------------------------~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~ 139 (257)
T cd08225 106 ----------------------------------------------WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM 139 (257)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC
Confidence 99999999999999999999999999999877
Q ss_pred eEEEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||.+........ .....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+..
T Consensus 140 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-- 216 (257)
T cd08225 140 VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-- 216 (257)
T ss_pred eEEecccccchhccCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--
Confidence 579999998876654322 23346889999999887654 78999999999999999999999977655444332211
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.......+.++.++.++|.+||..+|++|||+.++++||||
T Consensus 217 ----------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 ----------------------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------------------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 11112234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=275.44 Aligned_cols=205 Identities=24% Similarity=0.380 Sum_probs=162.9
Q ss_pred HHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccCCC
Q psy9855 16 EISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLK 94 (470)
Q Consensus 16 Ei~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 94 (470)
|+.....+.+||||+++++.|.. .+.+|+||||++ ++|.+++.....+++..+..
T Consensus 58 e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~---------------------- 113 (267)
T PHA03390 58 EPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKK---------------------- 113 (267)
T ss_pred hHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHH----------------------
Confidence 44444334459999999999865 568999999998 69999998776778877777
Q ss_pred ccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eEEEEecCC
Q psy9855 95 LPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVVVGDLGS 172 (470)
Q Consensus 95 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ikL~DFG~ 172 (470)
++.||+.||.|||+.|++||||||+||+++.+ .++|+|||.
T Consensus 114 -------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 114 -------------------------------------IIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred -------------------------------------HHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999999999999999877 699999998
Q ss_pred cccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHH
Q psy9855 173 LQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ-LDRIHQVLGTPKAETLK 251 (470)
Q Consensus 173 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~ 251 (470)
+...... ....|+..|+|||++.+.. ++.++||||+||++|+|++|..||........ ...+....
T Consensus 157 ~~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 223 (267)
T PHA03390 157 CKIIGTP---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--------- 223 (267)
T ss_pred ceecCCC---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---------
Confidence 8765432 2346889999999987755 78999999999999999999999975543221 11111100
Q ss_pred HHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-HHHHHhcccCCC
Q psy9855 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-AQKILSCAYFAD 313 (470)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-~~elL~hp~f~~ 313 (470)
.......+.+++.+.+||.+||+.||.+||+ ++++|+||||..
T Consensus 224 -------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 224 -------------------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -------------------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0011122468899999999999999999996 699999999963
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=275.89 Aligned_cols=209 Identities=27% Similarity=0.393 Sum_probs=173.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++++++ ||||+++++.+. +....++|+||+. ++|.+++.....+++..+..
T Consensus 44 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~---------------- 104 (258)
T cd05578 44 VRNVLNERRILQELN-HPFLVNLWYSFQ--DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF---------------- 104 (258)
T ss_pred HHHHHHHHHHHHhCC-CCChHHHHHhhc--CCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHH----------------
Confidence 456789999999998 999999999885 4678999999998 59999998776677777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||.|||++|++|+||+|+||+++.+ .++|
T Consensus 105 -------------------------------------------~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 105 -------------------------------------------WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI--DQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~--~~~~~i~~~~g~p 245 (470)
+|||.+.............|+..|+|||++.+.. ++.++|+|||||++|+|++|..||...+.. +.+.....
T Consensus 142 ~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----- 215 (258)
T cd05578 142 TDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----- 215 (258)
T ss_pred eecccccccCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-----
Confidence 9999888765544445567889999999987755 799999999999999999999999876532 11111110
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH--HHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA--QKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~--~elL~hp~f 311 (470)
......+..++..+.++|.+||..||.+||++ +++++||||
T Consensus 216 -------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 216 -------------------------TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------------------------cccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 01112334567899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=278.12 Aligned_cols=214 Identities=22% Similarity=0.367 Sum_probs=171.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++.+.. ....|+||||++ ++|.+++.. ..+++..+..
T Consensus 47 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~----------------- 105 (277)
T cd06642 47 EDIQQEITVLSQCD-SPYITRYYGSYLK--GTKLWIIMEYLGGGSALDLLKP-GPLEETYIAT----------------- 105 (277)
T ss_pred HHHHHHHHHHHcCC-CCccHhhhccccc--CCceEEEEEccCCCcHHHHhhc-CCCCHHHHHH-----------------
Confidence 45789999999998 9999999998864 667999999999 599998854 3366666665
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||++|++|+||+|+||+++.+ .++|+
T Consensus 106 ------------------------------------------~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~ 143 (277)
T cd06642 106 ------------------------------------------ILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLA 143 (277)
T ss_pred ------------------------------------------HHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++........ .....|+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+..
T Consensus 144 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------- 215 (277)
T cd06642 144 DFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK------- 215 (277)
T ss_pred cccccccccCcchhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-------
Confidence 9999876553322 23346888999999987754 78999999999999999999999976544332221110
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
.........++..+.++|.+||..+|++|||+.++++||||.......
T Consensus 216 -----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 263 (277)
T cd06642 216 -----------------------NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKT 263 (277)
T ss_pred -----------------------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence 011112235678899999999999999999999999999997655433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=278.17 Aligned_cols=212 Identities=22% Similarity=0.349 Sum_probs=171.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ ||||+++++++.. ....|+||||+.|+|.+++.... .+++..+..
T Consensus 66 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~----------------- 125 (313)
T cd06633 66 QDIIKEVKFLQQLK-HPNTIEYKGCYLK--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------------- 125 (313)
T ss_pred HHHHHHHHHHHhCC-CCCCccEEEEEEe--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHH-----------------
Confidence 35789999999998 9999999999865 56799999999999988886543 366666655
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||++|++||||+|+||+++.+ .++|+
T Consensus 126 ------------------------------------------~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~ 163 (313)
T cd06633 126 ------------------------------------------ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLA 163 (313)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++..... .....|+..|+|||++.. ...++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 164 dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---- 236 (313)
T cd06633 164 DFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---- 236 (313)
T ss_pred ecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----
Confidence 9998764322 234578999999998753 2447889999999999999999999998776555554432210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
........++..+.+||.+||..+|.+||++.+++.||||.....
T Consensus 237 -------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 237 -------------------------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred -------------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 001112346678899999999999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=273.68 Aligned_cols=211 Identities=25% Similarity=0.361 Sum_probs=169.2
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccccc
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGW 91 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (470)
...|..++....+|+||+++++++.. .+.+|+|+||++ ++|.+++.....+++..+..
T Consensus 43 ~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~------------------- 101 (260)
T cd05611 43 VKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ------------------- 101 (260)
T ss_pred HHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHH-------------------
Confidence 45566555544349999999998854 678999999998 59999998777777777777
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEec
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDL 170 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DF 170 (470)
++.||+.||.|||+.|++||||+|+||+++.+ .++|+||
T Consensus 102 ----------------------------------------i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 141 (260)
T cd05611 102 ----------------------------------------YIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDF 141 (260)
T ss_pred ----------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeec
Confidence 99999999999999999999999999999887 8999999
Q ss_pred CCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Q psy9855 171 GSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250 (470)
Q Consensus 171 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 250 (470)
|++..... .....|+..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+.......+....
T Consensus 142 g~~~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 209 (260)
T cd05611 142 GLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-------- 209 (260)
T ss_pred ccceeccc---cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc--------
Confidence 98875443 23456888999999987765 7999999999999999999999998776655444332210
Q ss_pred HHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC---HHHHHhcccCCChh
Q psy9855 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT---AQKILSCAYFADLT 315 (470)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt---~~elL~hp~f~~~~ 315 (470)
. .........++..+.++|.+||..||++||| ++|++.||||.++.
T Consensus 210 ----------~---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 210 ----------I---------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ----------c---------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 0 0001122357889999999999999999995 57999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=276.35 Aligned_cols=211 Identities=25% Similarity=0.349 Sum_probs=166.6
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+.++..++ ||||+++++++.. .+.+++||||++ ++|.+++.....+++..+..
T Consensus 52 ~~~~e~~~l~~~~-h~~ii~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~------------------ 110 (267)
T cd06646 52 LIQQEIFMVKECK-HCNIVAYFGSYLS--REKLWICMEYCGGGSLQDIYHVTGPLSELQIAY------------------ 110 (267)
T ss_pred HHHHHHHHHHhcC-CCCeeeeeEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH------------------
Confidence 4678999999999 9999999999865 568999999999 59999997766677777766
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.|++.||+|||+.||+||||||+||+++.+ .++|+|
T Consensus 111 -----------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~d 149 (267)
T cd06646 111 -----------------------------------------VCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLAD 149 (267)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECc
Confidence 99999999999999999999999999999877 799999
Q ss_pred cCCcccccCCC-ccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 170 LGSLQFIKSKG-LHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 170 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
||++....... ......|+..|+|||.+.+ ...++.++||||+||++|+|++|..||......+....+..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------ 223 (267)
T cd06646 150 FGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------ 223 (267)
T ss_pred CccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec------
Confidence 99987654322 2234578899999998753 23367899999999999999999999865433222111100
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
.. ...+ .. .....++..+.+||.+||..+|++|||++++|+|+|
T Consensus 224 ------------~~--~~~~-----~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 ------------SN--FQPP-----KL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ------------CC--CCCC-----CC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00 0000 00 011346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.82 Aligned_cols=213 Identities=20% Similarity=0.352 Sum_probs=169.5
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+.++..++ ||||+++++++.. .+..++||||+. ++|.+++.....+++..+..
T Consensus 54 ~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~------------------ 112 (272)
T cd06629 54 ALRSEIETLKDLD-HLNIVQYLGFETT--EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF------------------ 112 (272)
T ss_pred HHHHHHHHHHhcC-CCCcceEEEEecc--CCceEEEEecCCCCcHHHHHhhccCCCHHHHHH------------------
Confidence 4678999999998 9999999998754 678999999998 59999998776677766666
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||.|||++|++||||+|+||+++.+ .++|+|
T Consensus 113 -----------------------------------------~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d 151 (272)
T cd06629 113 -----------------------------------------FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISD 151 (272)
T ss_pred -----------------------------------------HHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEee
Confidence 99999999999999999999999999999877 899999
Q ss_pred cCCcccccCCC---ccccccccCcccCchhhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 170 LGSLQFIKSKG---LHTEYIATRWYRSPECLLTEG-YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 170 FG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
||++....... ......|+..|+|||++.... .++.++|+|||||++|++++|..||...........+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--- 228 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--- 228 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc---
Confidence 99887543211 123456889999999887643 37889999999999999999999996654433322211100
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.. ........+.++..+.++|.+||..+|.+|||++++|+||||
T Consensus 229 ------------------~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 ------------------SA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ------------------cC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00 001112234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.48 Aligned_cols=212 Identities=25% Similarity=0.330 Sum_probs=173.0
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+-+|+.+|..|+ |||||+++|+-.. ...++|.||||+ |+|.+++...+..++...+.
T Consensus 1280 ~i~eEm~vlE~ln-HpNlV~YyGVEvH--Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~v------------------ 1338 (1509)
T KOG4645|consen 1280 LIAEEMKVLEGLN-HPNLVRYYGVEVH--REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRV------------------ 1338 (1509)
T ss_pred chHHHHHHHHhcc-CccccccCceeec--HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHH------------------
Confidence 3568999999999 9999999998765 566899999999 79999998877666655554
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
+..|++.||+|||++|||||||||.||+++.+ .+|++|
T Consensus 1339 -----------------------------------------yt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1339 -----------------------------------------YTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred -----------------------------------------HHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeec
Confidence 99999999999999999999999999999987 899999
Q ss_pred cCCcccccCCC-----ccccccccCcccCchhhccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 170 LGSLQFIKSKG-----LHTEYIATRWYRSPECLLTEG--YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 170 FG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
||.|..+.... ......||+.|||||++.+.. ...-+.|||||||++.||+||+.||...+..-++...+.
T Consensus 1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-- 1455 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-- 1455 (1509)
T ss_pred ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh--
Confidence 99998876442 234578999999999997643 245689999999999999999999976544333222211
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+....++..++.+.+|||.+||+.||.+|+++.|+|+|.|-+..
T Consensus 1456 ---------------------------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1456 ---------------------------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ---------------------------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 112223445689999999999999999999999999999887643
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=289.20 Aligned_cols=217 Identities=21% Similarity=0.321 Sum_probs=195.8
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
-.++.+..|-.||..++ .|.||++|-.| ++...+|+.||.|- |.|...+++++.+.+...+.
T Consensus 462 kQqeHv~sEr~Im~~~~-s~fIvrLYrTf--rd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF-------------- 524 (732)
T KOG0614|consen 462 KQQEHVFSERNIMMECR-SDFIVRLYRTF--RDSKYVYMLMEACLGGELWTILRDRGSFDDYTARF-------------- 524 (732)
T ss_pred hHHHHHHhHHHHHHhcC-chHHHHHHHHh--ccchhhhhhHHhhcCchhhhhhhhcCCcccchhhh--------------
Confidence 34667889999999999 99999999988 45888999999997 69999999998888877766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+..+++|++|||++|||+|||||+|.+++.+ .+
T Consensus 525 ---------------------------------------------~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~ 559 (732)
T KOG0614|consen 525 ---------------------------------------------YVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYL 559 (732)
T ss_pred ---------------------------------------------hHHHHHHHHHHHHhcCceeccCChhheeeccCCce
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
||.|||+|+.+..+....++||||.|.|||+++..+ .+.++|.||||+++|||++|.+||.+.+++.....|.+.+.
T Consensus 560 KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-- 636 (732)
T KOG0614|consen 560 KLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-- 636 (732)
T ss_pred EEeehhhHHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--
Confidence 999999999999999999999999999999999987 69999999999999999999999999999999888877431
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
...++..++..+.+||+++...+|.+|.. +.+|-.|-||.+.+.
T Consensus 637 ---------------------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 637 ---------------------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ---------------------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 22234578889999999999999999987 889999999998764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=275.48 Aligned_cols=214 Identities=21% Similarity=0.386 Sum_probs=171.5
Q ss_pred hhhhhHHHHHHhcCC--CCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIP--DHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~--~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ .||||+++++++.. ....|+||||++ ++|.+++... .+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~-------------- 105 (277)
T cd06917 43 VSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISV-------------- 105 (277)
T ss_pred HHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEEEEecCCCCcHHHHHHcc-CCCHHHHHH--------------
Confidence 345778999999996 49999999998864 678999999998 5999998654 466666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||+.||+||||+|+||+++.+ .+
T Consensus 106 ---------------------------------------------i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~ 140 (277)
T cd06917 106 ---------------------------------------------IIREVLVALKYIHKVGVIHRDIKAANILVTNTGNV 140 (277)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCE
Confidence 99999999999999999999999999999977 89
Q ss_pred EEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|+|||.+....... ......|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.........+..
T Consensus 141 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---- 216 (277)
T cd06917 141 KLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---- 216 (277)
T ss_pred EEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc----
Confidence 999999887665432 223457899999999887655578999999999999999999999976544332211100
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCccccc-ccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLV-PQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.....+. ..++.++.++|.+||..||.+|||+.+++.||||++..
T Consensus 217 --------------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 217 --------------------------SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred --------------------------CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 0000111 12678899999999999999999999999999998755
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=274.00 Aligned_cols=214 Identities=27% Similarity=0.454 Sum_probs=174.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++.+++ ||||+++++.+.. ....|+|+||+. ++|.+++.....+++..+..
T Consensus 37 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 97 (265)
T cd05579 37 VDQVLTERDILSQAQ-SPYVVKLYYSFQG--KKNLYLVMEYLPGGDLASLLENVGSLDEDVARI---------------- 97 (265)
T ss_pred HHHHHHHHHHHHhCC-CcchhHHHHheec--CcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 346789999999999 9999999998854 678999999998 59999998766677777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||+.|++||||+|+||+++.+ .++|
T Consensus 98 -------------------------------------------i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l 134 (265)
T cd05579 98 -------------------------------------------YIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKL 134 (265)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEE
Confidence 99999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCC---------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy9855 168 GDLGSLQFIKSKG---------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238 (470)
Q Consensus 168 ~DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i 238 (470)
+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||......+....+
T Consensus 135 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 213 (265)
T cd05579 135 TDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI 213 (265)
T ss_pred EecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999887544321 123356788999999987755 788999999999999999999999877655544443
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH---HHHHhcccCCChh
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA---QKILSCAYFADLT 315 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~---~elL~hp~f~~~~ 315 (470)
.. +. . . ++ ....++..+.++|.+||..+|.+|||+ .++|+||||+++.
T Consensus 214 ~~--~~----------------~--~---~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 214 LN--GK----------------I--E---WP------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred hc--CC----------------c--C---CC------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 22 00 0 0 00 001247899999999999999999999 9999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=275.00 Aligned_cols=220 Identities=25% Similarity=0.400 Sum_probs=168.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|++++..++ ||||++++++|.....+.+|+||||++ ++|.+++... ..+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~------------ 109 (287)
T cd06621 43 QKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK------------ 109 (287)
T ss_pred HHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHH------------
Confidence 456789999999998 999999999987666678999999998 5999887532 1244444444
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||+.|++|+||+|+||+++.+
T Consensus 110 -----------------------------------------------i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~ 142 (287)
T cd06621 110 -----------------------------------------------IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG 142 (287)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC
Confidence 99999999999999999999999999999887
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE-----IDQLDRI 238 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~-----~~~~~~i 238 (470)
.++|+|||++........ ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... .+....+
T Consensus 143 ~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 220 (287)
T cd06621 143 QVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220 (287)
T ss_pred eEEEeecccccccccccc-ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH
Confidence 899999998875543222 2446788999999887654 88999999999999999999999976521 1111111
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.. .... ... .. .......++.+.+||.+||..||.+|||+.|++.||||....
T Consensus 221 ~~---~~~~----------------~~~---~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 221 VN---MPNP----------------ELK---DE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred hc---CCch----------------hhc---cC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 10 0000 000 00 000013467889999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=275.07 Aligned_cols=207 Identities=23% Similarity=0.337 Sum_probs=165.0
Q ss_pred HHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccCCCcc
Q psy9855 18 SILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLP 96 (470)
Q Consensus 18 ~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (470)
+++.... ||||+++++++.. .+..|+||||+. |+|.+++.....+++..+..
T Consensus 49 ~~~~~~~-~~~i~~~~~~~~~--~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~------------------------ 101 (278)
T cd05606 49 SLVSTGD-CPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF------------------------ 101 (278)
T ss_pred HHHHhCC-CCcEeeeeeeeec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHH------------------------
Confidence 3444455 9999999998864 668999999998 59999987766688887777
Q ss_pred ceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCccc
Q psy9855 97 FLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQF 175 (470)
Q Consensus 97 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~ 175 (470)
++.|++.||+|||++||+||||||+||+++.+ .++|+|||++..
T Consensus 102 -----------------------------------~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 102 -----------------------------------YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred -----------------------------------HHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999999999999999999999887 899999998875
Q ss_pred ccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhh
Q psy9855 176 IKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEK 255 (470)
Q Consensus 176 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 255 (470)
..... ....+|+..|+|||++.+...++.++||||+||++|+|++|..||.+..............
T Consensus 147 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 212 (278)
T cd05606 147 FSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------------- 212 (278)
T ss_pred cCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-------------
Confidence 54322 2345799999999998765458899999999999999999999997653221111100000
Q ss_pred hccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 256 YKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
.....++..++.++.+++.+||..+|.+|| ++.++++||||.+..
T Consensus 213 ---------------~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 213 ---------------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred ---------------ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 001112335688999999999999999999 999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=284.05 Aligned_cols=244 Identities=22% Similarity=0.258 Sum_probs=169.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+++.++ ||||++++++|.. .+..++|+||+. ++|.+++..... +++..+..
T Consensus 44 ~~~~~e~~~~~~l~-h~niv~~~~~~~~--~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~--------------- 105 (328)
T cd08226 44 KALQNEVVLSHFFR-HPNIMTSWTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN--------------- 105 (328)
T ss_pred HHHHHHHHHHHhCC-CCCcceEeeeEec--CCceEEEEecccCCCHHHHHHhhcccCCCHHHHHH---------------
Confidence 56789999999999 9999999999965 667999999999 599999876432 66666555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 106 --------------------------------------------~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~ 141 (328)
T cd08226 106 --------------------------------------------ILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVS 141 (328)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEE
Confidence 99999999999999999999999999999977 899
Q ss_pred EEecCCcccccCCCcc--------ccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGLH--------TEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~--------~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
++|||.+......... ....++..|+|||++.+. ..++.++||||+||++|+|++|.+||.+.........
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 221 (328)
T cd08226 142 LSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221 (328)
T ss_pred EechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence 9999854332211110 112345679999998764 2378999999999999999999999987665444333
Q ss_pred HHHHhCCCchHH--HH-HHhhhccCccccc-------cc-----cCC-CCCcccccccccHHHHHHHHHhcccCCCCCcC
Q psy9855 238 IHQVLGTPKAET--LK-KFEKYKSSNFTYQ-------FK-----QYP-GGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301 (470)
Q Consensus 238 i~~~~g~p~~~~--~~-~~~~~~~~~~~~~-------~~-----~~~-~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt 301 (470)
........+... .. ............. .. ... ..........++..+.+||.+||..||++|||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 301 (328)
T cd08226 222 KLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301 (328)
T ss_pred HhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC
Confidence 322111000000 00 0000000000000 00 000 00000112346788999999999999999999
Q ss_pred HHHHHhcccCCChhH
Q psy9855 302 AQKILSCAYFADLTQ 316 (470)
Q Consensus 302 ~~elL~hp~f~~~~~ 316 (470)
++++|+||||..+.+
T Consensus 302 a~e~l~~~~~~~~~~ 316 (328)
T cd08226 302 ASSLLSHAFFKQVKE 316 (328)
T ss_pred HHHHhhCHHHHHHHH
Confidence 999999999986654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=276.45 Aligned_cols=215 Identities=23% Similarity=0.336 Sum_probs=166.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeec---CCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhh
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVN---RSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~---~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~ 81 (470)
...+.+|+.++..+.+||||+++++++.. ...+.+++||||++ ++|.+++... ..+++..+..
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~--------- 128 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY--------- 128 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHH---------
Confidence 34567899999999459999999998753 23467999999998 5999987532 2255555555
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||.|||+.+|+||||||+||+++
T Consensus 129 --------------------------------------------------~~~~i~~~l~~lH~~~i~H~dlkp~nili~ 158 (286)
T cd06638 129 --------------------------------------------------ILHEALMGLQHLHVNKTIHRDVKGNNILLT 158 (286)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhCCccccCCCHHhEEEC
Confidence 999999999999999999999999999999
Q ss_pred CC-eEEEEecCCcccccCCC-ccccccccCcccCchhhccC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 235 (470)
.+ .++|+|||++....... ......|++.|+|||++... ..++.++||||+||++|+|++|..||........+
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~ 238 (286)
T cd06638 159 TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238 (286)
T ss_pred CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence 87 79999999987654332 22345789999999987532 33788999999999999999999999766543332
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
..+... .......+..++..+.+||.+||..||++|||+.++++|+||
T Consensus 239 ~~~~~~----------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 239 FKIPRN----------------------------PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred hhcccc----------------------------CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 221110 000001112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=273.37 Aligned_cols=219 Identities=21% Similarity=0.286 Sum_probs=168.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.++ ||||+++++++.. ....++||||++ ++|.+++...+.-.....
T Consensus 52 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~------------------ 110 (280)
T cd05049 52 RKDFEREAELLTNFQ-HENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLK------------------ 110 (280)
T ss_pred HHHHHHHHHHHHhcC-CCCchheeeEEec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhc------------------
Confidence 457889999999999 9999999999865 578999999999 699999976532000000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
........+....+..++.||+.||+|||++|++||||||+||+++.+ .++|
T Consensus 111 ---------------------------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 111 ---------------------------SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred ---------------------------ccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 001122233445556699999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~-- 240 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG-- 240 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--
Confidence 99999876533221 22335678899999987755 8999999999999999998 99999877665544443210
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..++..+.++|.+||..||.+|||+.|+++
T Consensus 241 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 ----------------------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111122357889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=277.82 Aligned_cols=222 Identities=16% Similarity=0.197 Sum_probs=164.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++.++.+||||+++++++.. .+.+++|+||++ ++|.+++.............
T Consensus 46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 107 (297)
T cd05089 46 HRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA---------------- 107 (297)
T ss_pred HHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcceEEEEecCCCcHHHHHHhccccccccccc----------------
Confidence 34678999999999559999999998854 567999999998 69999997644211110000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
........+....+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 108 ---------------------------~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 108 ---------------------------KEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ---------------------------cccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 000011234445566699999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++..............+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~---- 235 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---- 235 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC----
Confidence 9999886432211111223355799999887655 8999999999999999997 999998877655444332110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..++..+.+||.+||..+|.+|||++++++
T Consensus 236 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 236 --------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred --------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01122357889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.44 Aligned_cols=205 Identities=26% Similarity=0.446 Sum_probs=161.8
Q ss_pred hhhHHHHHHhcCCCCCCeeeecee-eecC---C-CCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCET-YVNR---S-TRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~-~~~~---~-~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~ 83 (470)
.+.+||++|+.|.||+|||.++|. ...+ . .-.++|.||||. |.|.++++.+-. |++.++..
T Consensus 80 ~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLk----------- 148 (738)
T KOG1989|consen 80 AVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLK----------- 148 (738)
T ss_pred HHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHH-----------
Confidence 457999999999999999999994 3322 1 245889999999 699999985443 78888877
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEe
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILIR 161 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~ 161 (470)
|++|+++||++||... |||||||-+||||+
T Consensus 149 ------------------------------------------------If~dv~~AVa~mH~~~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 149 ------------------------------------------------IFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS 180 (738)
T ss_pred ------------------------------------------------HHHHHHHHHHHHhcCCCccchhhhhhhheEEc
Confidence 9999999999999987 99999999999999
Q ss_pred CC-eEEEEecCCcccccCCCcc----------ccccccCcccCchhhc--cCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy9855 162 GD-LVVVGDLGSLQFIKSKGLH----------TEYIATRWYRSPECLL--TEGYYSFELDIWAAGCVFYETLTRNPLFPG 228 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~~~----------~~~~gt~~Y~APE~l~--~~~~~~~~~DIwSlG~il~elltg~~pf~~ 228 (470)
.+ .+||||||.|......... -...-|+.|+|||++. .....+.|+|||+|||+||.|+....||.+
T Consensus 181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 181 ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 88 8999999988643322111 1124689999999874 223489999999999999999999999976
Q ss_pred CChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 229 DSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 229 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....++ . ..+.++. .+.++..+++||..||+.||.+||++-|++.+
T Consensus 261 sg~laIl----------------------n--g~Y~~P~---------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 261 SGKLAIL----------------------N--GNYSFPP---------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CcceeEE----------------------e--ccccCCC---------CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 5322111 0 1122221 25789999999999999999999999999854
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=265.50 Aligned_cols=221 Identities=20% Similarity=0.312 Sum_probs=181.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
+-..+++.+.++....++|+||+.+|+|.. +..+++.||.|...+..+++.... ++|..+-.
T Consensus 133 e~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk--------------- 195 (391)
T KOG0983|consen 133 ENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVFICMELMSTCAEKLLKRIKGPIPERILGK--------------- 195 (391)
T ss_pred HHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHHHHHHHHHHHHHHHHHHhcCCchHHhhhh---------------
Confidence 345677888888777779999999999976 566899999999777777766554 77766555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~i 165 (470)
+...++.||.||-. +||+|||+||+|||++.. .+
T Consensus 196 --------------------------------------------~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gni 231 (391)
T KOG0983|consen 196 --------------------------------------------MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNI 231 (391)
T ss_pred --------------------------------------------hHHHHHHHHHHHHHhcceeecccCccceEEccCCCE
Confidence 88999999999975 599999999999999987 99
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPG-DSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~ 242 (470)
||||||.+..+.+....+...|-+.|||||.+.-. ..|+..+||||||+.++||+||+.||.+ .++.+.+..+.+.
T Consensus 232 KlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~- 310 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE- 310 (391)
T ss_pred EeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-
Confidence 99999999988888777888999999999988533 4589999999999999999999999987 4566666666541
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
.|+ .-.....+|+.+.+|+..||..|+.+||...++|+|||+.......
T Consensus 311 -ePP--------------------------~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 311 -EPP--------------------------LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred -CCC--------------------------CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence 110 0001124789999999999999999999999999999999766443
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=272.59 Aligned_cols=214 Identities=20% Similarity=0.295 Sum_probs=163.3
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.+++.++ |+||+++++++.. ....++||||++ ++|.+++........
T Consensus 52 ~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~-------------------- 108 (277)
T cd05036 52 DESDFLMEALIMSKFN-HQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPE-------------------- 108 (277)
T ss_pred HHHHHHHHHHHHHhCC-CCCEeeEEEEEcc--CCCcEEEEecCCCCCHHHHHHHhCCCCC--------------------
Confidence 3456899999999999 9999999998854 556899999998 699999876532000
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---- 163 (470)
....+.+..+..++.||+.||+|||++|++||||||+||+++.+
T Consensus 109 --------------------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 109 --------------------------------RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCc
Confidence 00112233344499999999999999999999999999999854
Q ss_pred eEEEEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 239 (470)
.++|+|||++......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 5899999998866432211 1223356799999987655 8999999999999999996 999998876655443322
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.. .....+..++..+.+++.+||..+|++|||+.++++|
T Consensus 236 ~~------------------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GG------------------------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cC------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 0011234578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=274.58 Aligned_cols=218 Identities=20% Similarity=0.271 Sum_probs=165.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++.+++ ||||+++++++.. .+..++||||++ ++|.+++.........
T Consensus 51 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~-------------------- 107 (288)
T cd05093 51 RKDFHREAELLTNLQ-HEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVL-------------------- 107 (288)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEec--CCccEEEEEcCCCCCHHHHHHHcCCcccc--------------------
Confidence 346789999999999 9999999998864 678999999999 6999999754320000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
+ ........+....+..++.||+.||+|||++|++||||||+|||++.+ .++|
T Consensus 108 -----------------------~---~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 108 -----------------------M---AEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred -----------------------c---cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 0 000001123334445599999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||.+........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~-- 238 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG-- 238 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--
Confidence 99999876543221 12334577899999887654 8999999999999999998 99999877665555444321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........++.++.+|+.+||..||.+|||+.+++.
T Consensus 239 ----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 ----------------------------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001112346788999999999999999999999963
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=271.14 Aligned_cols=212 Identities=25% Similarity=0.432 Sum_probs=175.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++..++ |+||+++++.+.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~---------------- 103 (264)
T cd06623 43 RKQLLRELKTLRSCE-SPYVVKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---------------- 103 (264)
T ss_pred HHHHHHHHHHHHhcC-CCCeeeEEEEEcc--CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 456889999999999 9999999998865 578999999999 69999998776688877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+ .|++||||+|+||+++.+ .++
T Consensus 104 -------------------------------------------~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~ 140 (264)
T cd06623 104 -------------------------------------------IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVK 140 (264)
T ss_pred -------------------------------------------HHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEE
Confidence 99999999999999 999999999999999887 899
Q ss_pred EEecCCcccccCCCcc-ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLH-TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE---IDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~---~~~~~~i~~~~ 242 (470)
|+|||.+......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+....+..
T Consensus 141 l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-- 217 (264)
T cd06623 141 IADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-- 217 (264)
T ss_pred EccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc--
Confidence 9999988876543332 245788999999988765 488999999999999999999999977642 222222111
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCccccccc-ccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
......... ++..+.++|.+||..+|++|||+.++++||||+..
T Consensus 218 ----------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 218 ----------------------------GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ----------------------------CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 011112233 78899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=275.91 Aligned_cols=212 Identities=25% Similarity=0.392 Sum_probs=170.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ |+||+++++++.. ....++||||+.|+|.+++..... +++..+..
T Consensus 60 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~----------------- 119 (308)
T cd06634 60 QDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------------- 119 (308)
T ss_pred HHHHHHHHHHHhCC-CCCcccEEEEEEc--CCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHH-----------------
Confidence 35678999999998 9999999998865 567899999999999888754333 66666655
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.|++.||.|||+.|++||||+|+||+++.+ .++|+
T Consensus 120 ------------------------------------------~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~ 157 (308)
T cd06634 120 ------------------------------------------VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 157 (308)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEEC
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++...... ....|+..|+|||++.+ ...++.++|||||||++|+|++|..||......+....+....
T Consensus 158 dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---- 230 (308)
T cd06634 158 DFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---- 230 (308)
T ss_pred CcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC----
Confidence 99988765432 34578899999998753 2347889999999999999999999997765444443332210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
........++..+.+||.+||..+|.+||++++++.|||+.....
T Consensus 231 -------------------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 231 -------------------------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred -------------------------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 001112356788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=274.55 Aligned_cols=220 Identities=19% Similarity=0.296 Sum_probs=166.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++.+++ ||||+++++++.. ....++||||++ ++|.+++.....-..
T Consensus 52 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~---------------------- 106 (291)
T cd05094 52 KDFQREAELLTNLQ-HEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAM---------------------- 106 (291)
T ss_pred HHHHHHHHHHhcCC-CCCcceEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCcccc----------------------
Confidence 45789999999999 9999999998854 667999999998 699999976432000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
+ +...........+....+..++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 107 --------------------~-~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 107 --------------------I-LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred --------------------c-ccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEEC
Confidence 0 0000001111223445566699999999999999999999999999999988 89999
Q ss_pred ecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---- 240 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ---- 240 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC----
Confidence 9999876543221 23345678899999887755 8899999999999999998 9999977766554433321
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.........++..+.+++.+||..||.+|||+.++++
T Consensus 241 --------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 241 --------------------------GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred --------------------------CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 0111122346788999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=268.39 Aligned_cols=206 Identities=20% Similarity=0.317 Sum_probs=165.9
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+.+|+.++ ||||+++++++.. ....++||||++ |+|.+++.... .+++..+..
T Consensus 42 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~-------------- 104 (256)
T cd05114 42 SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQ--QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS-------------- 104 (256)
T ss_pred cHHHHHHHHHHHHHCC-CCCceeEEEEEcc--CCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHH--------------
Confidence 3457889999999999 9999999998854 567999999998 69999987543 366666655
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+||+++.+ .+
T Consensus 105 ---------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~ 139 (256)
T cd05114 105 ---------------------------------------------MCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV 139 (256)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCccccccCcceEEEcCCCeE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||.+......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 140 kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 218 (256)
T cd05114 140 KVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218 (256)
T ss_pred EECCCCCccccCCCceeccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 99999988765432222 1224556799999987654 8899999999999999999 999998877666655553310
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. ...+...+..+.+++.+||..+|.+|||+.++++
T Consensus 219 ~------------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 219 R------------------------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred C------------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 0111235678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=268.81 Aligned_cols=204 Identities=18% Similarity=0.269 Sum_probs=165.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++..++ ||||+++++++. ....++||||++ |+|.+++.....+++..+..
T Consensus 40 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 99 (257)
T cd05116 40 KDELLREANVMQQLD-NPYIVRMIGICE---AESWMLVMELAELGPLNKFLQKNKHVTEKNITE---------------- 99 (257)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEc---CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 345789999999998 999999999874 345799999999 69999998766677777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||.||+++.+ .++|
T Consensus 100 -------------------------------------------i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl 136 (257)
T cd05116 100 -------------------------------------------LVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKI 136 (257)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEE
Confidence 99999999999999999999999999999988 7999
Q ss_pred EecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++......... ....++..|+|||.+.... ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 137 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~- 214 (257)
T cd05116 137 SDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG- 214 (257)
T ss_pred CCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-
Confidence 999998766533221 1223457899999886544 7889999999999999997 99999877665554444221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++++.++|.+||..||++||++.+|..
T Consensus 215 -----------------------------~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 215 -----------------------------ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=271.33 Aligned_cols=222 Identities=17% Similarity=0.206 Sum_probs=163.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++.++.+||||+++++++.. .+..++||||++ |+|.+++.............
T Consensus 39 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~---------------- 100 (270)
T cd05047 39 HRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA---------------- 100 (270)
T ss_pred HHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeCCCCcHHHHHHhccccccccccc----------------
Confidence 34677999999999559999999998864 567899999998 69999997654211110000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
........+....+..++.||+.||+|||++|++||||||+|||++.+ .++|
T Consensus 101 ---------------------------~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 101 ---------------------------IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred ---------------------------cccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence 000111233445556699999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++..............+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~----- 227 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 227 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----
Confidence 9999885332211111223456799999886654 8999999999999999997 99999776654444333110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........++.++.+|+.+||..||.+|||+.++++
T Consensus 228 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 -------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000112346788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=269.86 Aligned_cols=210 Identities=23% Similarity=0.402 Sum_probs=171.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++++++ ||||+++++.+.....+.+++|+||++ ++|.+++.....+++..+..
T Consensus 49 ~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~----------------- 110 (264)
T cd06653 49 NALECEIQLLKNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR----------------- 110 (264)
T ss_pred HHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 46778999999999 999999999887655677899999998 59999998766677777766
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||+.|++|+||||+||+++.+ .++|+
T Consensus 111 ------------------------------------------~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 111 ------------------------------------------YTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEC
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSK----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||++...... .......|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+. ..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~ 224 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQ 224 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cC
Confidence 99988765321 1123456899999999987755 7899999999999999999999997665444333221 11
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.....++..+++.+.++|.+||. +|..|||+.+++.|||.
T Consensus 225 --------------------------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 225 --------------------------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------------------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 11122345688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=277.84 Aligned_cols=223 Identities=17% Similarity=0.205 Sum_probs=163.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|.++.+||||+++++++.. .+.+|+||||++ ++|.+++.....+.......
T Consensus 51 ~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 112 (303)
T cd05088 51 HRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA---------------- 112 (303)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCceEEEEeCCCCcHHHHHHhccccccccccc----------------
Confidence 34577899999999449999999998854 667999999998 69999997654221100000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
........++...+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 113 ---------------------------~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 113 ---------------------------IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred ---------------------------ccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 000011123445555699999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.............++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----- 239 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 239 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-----
Confidence 9999886432111112223466799999886654 7899999999999999998 99999876654443332110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
........++.++.+||.+||..+|++||++++++++
T Consensus 240 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 -------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000112467889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=272.45 Aligned_cols=222 Identities=22% Similarity=0.328 Sum_probs=168.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.. ....++||||++ |+|.+++.......+.
T Consensus 54 ~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--------------------- 109 (288)
T cd05061 54 IEFLNEASVMKGFT-CHHVVRLLGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAEN--------------------- 109 (288)
T ss_pred HHHHHHHHHHHhCC-CCCeeeEEEEEcC--CCCcEEEEeCCCCCCHHHHHHHhcccccc---------------------
Confidence 45678999999998 9999999998854 567899999998 6999999753311000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
...........+..++.||+.||.|||++||+||||||+|||++.+ .++|+
T Consensus 110 ----------------------------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 110 ----------------------------NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 0001112233445599999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||+++........ ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--- 237 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--- 237 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---
Confidence 99998765432211 2234567899999887654 7999999999999999998 78999876655444333210
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh------cccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS------CAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~------hp~f~~~~ 315 (470)
........+++.+.+++.+||+.||.+|||+.++++ ||||.+++
T Consensus 238 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 238 ---------------------------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred ---------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 001112345788999999999999999999999987 99998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=267.20 Aligned_cols=205 Identities=20% Similarity=0.317 Sum_probs=161.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|+.++ ||||+++++++.. ....++||||++ ++|.+++..... +++..+..
T Consensus 37 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 98 (252)
T cd05084 37 KAKFLQEARILKQYS-HPNIVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ--------------- 98 (252)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEcC--CCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHH---------------
Confidence 456889999999998 9999999998854 567999999998 599999876443 66666666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+||+++.+ .++
T Consensus 99 --------------------------------------------~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~k 134 (252)
T cd05084 99 --------------------------------------------MVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLK 134 (252)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCccccccchheEEEcCCCcEE
Confidence 99999999999999999999999999999887 799
Q ss_pred EEecCCcccccCCCccc---cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLHT---EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||.+.......... ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........+....
T Consensus 135 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~ 213 (252)
T cd05084 135 ISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213 (252)
T ss_pred ECccccCcccccccccccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 99999987544321111 112245699999887655 7899999999999999997 889997665544333222100
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..++..+.+|+.+||..+|++|||+.++++
T Consensus 214 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 214 ------------------------------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------------------------------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01122356788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=273.67 Aligned_cols=218 Identities=21% Similarity=0.346 Sum_probs=169.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++++.++ ||||+++++.+.. .+.+++||||++ ++|.+++...+.+++..+..
T Consensus 47 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~---------------- 107 (284)
T cd06620 47 RKQILRELQIMHECR-SPYIVSFYGAFLN--ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK---------------- 107 (284)
T ss_pred HHHHHHHHHHHHHcC-CCCcceEeeeEec--CCEEEEEEecCCCCCHHHHHHhccCCCHHHHHH----------------
Confidence 346789999999998 9999999999865 578999999999 59999987766677777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||.|||+ .|++||||+|+||+++.+ .++
T Consensus 108 -------------------------------------------~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~ 144 (284)
T cd06620 108 -------------------------------------------IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIK 144 (284)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEE
Confidence 99999999999997 699999999999999887 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ----LDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~----~~~i~~~~ 242 (470)
|+|||++...... .....+|+..|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+...
T Consensus 145 l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~- 221 (284)
T cd06620 145 LCDFGVSGELINS-IADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL- 221 (284)
T ss_pred EccCCcccchhhh-ccCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-
Confidence 9999987654322 223457899999999987654 78999999999999999999999976543211 0000000
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCccccc-ccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLV-PQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
...... .....+. ..++..+.+||.+||..||.+|||+.++++|+||.+.
T Consensus 222 -------~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 222 -------LQQIVQ---------------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred -------HHHHhh---------------ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000000 0000011 1367789999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=269.14 Aligned_cols=205 Identities=21% Similarity=0.315 Sum_probs=164.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+++|+.++ ||||+++++++.. ...+++||||++ ++|.+++..... +++..+..
T Consensus 46 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~-------------- 108 (263)
T cd05052 46 VEEFLKEAAVMKEIK-HPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-------------- 108 (263)
T ss_pred HHHHHHHHHHHHhCC-CCChhheEEEEcC--CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHH--------------
Confidence 346789999999999 9999999998854 567899999998 699999875432 55555555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.|++.||+|||++|++||||||+||+++.+ .+
T Consensus 109 ---------------------------------------------~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~ 143 (263)
T cd05052 109 ---------------------------------------------MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 143 (263)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCccc--cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLHT--EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||.+.......... ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 144 kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 222 (263)
T cd05052 144 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY 222 (263)
T ss_pred EeCCCccccccccceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 999999987665432211 123456799999887655 7899999999999999998 999998876554443332100
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..++.++.++|.+||..||++|||+.++++
T Consensus 223 ------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 ------------------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ------------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01122457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=276.12 Aligned_cols=211 Identities=23% Similarity=0.373 Sum_probs=170.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ ||||+++++++.. ....++||||+.|+|.+++.... .+++..+..
T Consensus 70 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~----------------- 129 (317)
T cd06635 70 QDIIKEVKFLQRIK-HPNSIEYKGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------------- 129 (317)
T ss_pred HHHHHHHHHHHhCC-CCCEEEEEEEEee--CCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHH-----------------
Confidence 35789999999998 9999999998865 56789999999999988876433 366666655
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||++||+||||+|+||+++.+ .++|+
T Consensus 130 ------------------------------------------i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 130 ------------------------------------------ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++..... .....|+..|+|||++.+ ...++.++|||||||++|+|++|..||.+.........+.....
T Consensus 168 dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--- 241 (317)
T cd06635 168 DFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--- 241 (317)
T ss_pred cCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC---
Confidence 9998765432 234578899999998742 23478899999999999999999999977665554444432100
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.......++..+.++|.+||..+|.+|||+.++++|+|+....
T Consensus 242 --------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 242 --------------------------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --------------------------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0111234678899999999999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=266.61 Aligned_cols=206 Identities=25% Similarity=0.350 Sum_probs=171.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc---------ccccHHHHHHHHHHHHh
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT---------DNISEKRAKEILYQVKA 79 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~---------~~l~~~~~~~~~~~~~~ 79 (470)
...+.+|++++..++ |+||+++++++.. ...+++||||++ ++|.+++... ..+++..+..
T Consensus 40 ~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~------- 109 (262)
T cd00192 40 RKDFLKEARVMKKLG-HPNVVRLLGVCTE--EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS------- 109 (262)
T ss_pred HHHHHHHHHHHhhcC-CCChheeeeeecC--CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHH-------
Confidence 456789999999999 9999999998865 678999999997 7999999876 4477777766
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
++.||+.||+|||++|++||||||+||+
T Consensus 110 ----------------------------------------------------~~~~l~~al~~lH~~~i~H~di~p~nil 137 (262)
T cd00192 110 ----------------------------------------------------FAIQIAKGMEYLASKKFVHRDLAARNCL 137 (262)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHcCCcccCccCcceEE
Confidence 9999999999999999999999999999
Q ss_pred EeCC-eEEEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy9855 160 IRGD-LVVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQ 234 (470)
Q Consensus 160 l~~~-~ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~ 234 (470)
++.+ .++|+|||.+....... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.
T Consensus 138 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 216 (262)
T cd00192 138 VGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216 (262)
T ss_pred ECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9997 89999999998765432 223456788999999887754 8999999999999999998 6999988766555
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
...+... .....+..++.++.+++.+||..||.+|||+.+++++
T Consensus 217 ~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 217 LEYLRKG------------------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHcC------------------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4444320 0111234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=270.24 Aligned_cols=209 Identities=27% Similarity=0.522 Sum_probs=168.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+.+++.++ ||||+++++++.. ....++|+||++ ++|.+++... ..+++..++.
T Consensus 46 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~------------ 110 (260)
T cd08222 46 TVQANQEAQLLSKLD-HPAIVKFHASFLE--RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE------------ 110 (260)
T ss_pred HHHHHHHHHHHHhCC-CCcHHHHHHHHhc--CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHH------------
Confidence 345678999999999 9999999998854 567999999999 5999888642 2255555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCe
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL 164 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ 164 (470)
++.|++.||.|||++|++|+||+|+||+++.+.
T Consensus 111 -----------------------------------------------~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~ 143 (260)
T cd08222 111 -----------------------------------------------WFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL 143 (260)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHcCccccCCChhheEeecCC
Confidence 999999999999999999999999999999889
Q ss_pred EEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 165 VVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
++|+|||.+....... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.........+..
T Consensus 144 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--- 219 (260)
T cd08222 144 LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--- 219 (260)
T ss_pred EeecccCceeecCCCcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---
Confidence 9999999887654322 233456888999999886654 78899999999999999999999976654443333221
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
......+..++.++.++|.+||..||++||++.++++||||
T Consensus 220 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 ---------------------------GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------------------------CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 01111234577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=271.12 Aligned_cols=222 Identities=22% Similarity=0.299 Sum_probs=165.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.. ....|+||||++ ++|.+++..........
T Consensus 52 ~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-------------------- 108 (283)
T cd05090 52 GEFQQEASLMAELH-HPNIVCLLGVVTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVG-------------------- 108 (283)
T ss_pred HHHHHHHHHHhhCC-CCCeeeEEEEEec--CCceEEEEEcCCCCcHHHHHHhcCCCCccc--------------------
Confidence 45779999999998 9999999998854 567999999999 69999986432100000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
... .........+....+..++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 109 ----------------~~~------~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (283)
T cd05090 109 ----------------CSS------DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKIS 166 (283)
T ss_pred ----------------ccc------ccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEec
Confidence 000 0000011223444556699999999999999999999999999999988 79999
Q ss_pred ecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||++....... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 242 (283)
T cd05090 167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR--- 242 (283)
T ss_pred cccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence 999987654322 123345677899999887654 7999999999999999998 99999877654444433220
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 243 ---------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 243 ---------------------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred ---------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0111224577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=266.15 Aligned_cols=213 Identities=25% Similarity=0.429 Sum_probs=174.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++++++ ||||+++++.+........++|+||++ ++|.+++.....+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~---------------- 105 (260)
T cd06606 43 LEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK---------------- 105 (260)
T ss_pred HHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 456789999999999 999999999886533378999999997 69999998776677777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|++.||+|||+.|++|+||+|+||+++.+ .++|
T Consensus 106 -------------------------------------------~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l 142 (260)
T cd06606 106 -------------------------------------------YTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKL 142 (260)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|||.+........ .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... ....+.....
T Consensus 143 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~- 218 (260)
T cd06606 143 ADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS- 218 (260)
T ss_pred cccccEEecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc-
Confidence 99999887765543 34567889999999887655 78999999999999999999999977651 1111111100
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
......++..++..+.++|.+||..||.+||++.++++||||
T Consensus 219 -------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 -------------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------------------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 111222334568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=285.30 Aligned_cols=262 Identities=17% Similarity=0.280 Sum_probs=173.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-c----cHHHHHHH-HHHHHhhhc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-I----SEKRAKEI-LYQVKAANE 82 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l----~~~~~~~~-~~~~~~~~~ 82 (470)
...+++|+++|.+|..||||+++++++.. .+.+|+|||||+ |+|.++|..... + ++...... ...+..+..
T Consensus 84 ~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (400)
T cd05105 84 KQALMSELKIMTHLGPHLNIVNLLGACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE 161 (400)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence 45688999999999669999999999854 677999999999 699999976432 0 00000000 000000000
Q ss_pred ccccccc------------ccCCCc--------------------cceeee---ccCCCCchhhhhcccccCcccchhhh
Q psy9855 83 TAAHYRV------------GWDLKL--------------------PFLLLV---FGKSRNLGTLIVGLTTFLPQQSKRLY 127 (470)
Q Consensus 83 ~~~~~~~------------~~~~~~--------------------~~~~~e---~~~~~~l~~~l~~~~~~~~~~~~~~~ 127 (470)
....|.. ...+.. .+.-.. -..++.+.+++.. .....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----~~~~~l~~~ 237 (400)
T cd05105 162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSD----DGSEGLTTL 237 (400)
T ss_pred cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHh----cccCCCCHH
Confidence 0000000 000000 000001 1122333444332 223356677
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCC
Q psy9855 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYY 203 (470)
Q Consensus 128 ~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~ 203 (470)
.+..++.||+.||+|||++||+||||||+|||++.+ .++|+|||++........ .....++..|+|||++.+.. +
T Consensus 238 ~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~ 316 (400)
T cd05105 238 DLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-Y 316 (400)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-C
Confidence 888899999999999999999999999999999988 899999999876543221 12345678899999987755 8
Q ss_pred CCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccH
Q psy9855 204 SFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHE 282 (470)
Q Consensus 204 ~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 282 (470)
+.++|||||||++|+|++ |..||.+............. .........++.
T Consensus 317 ~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 367 (400)
T cd05105 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-----------------------------GYRMAKPDHATQ 367 (400)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc-----------------------------CCCCCCCccCCH
Confidence 999999999999999997 99999775433332221110 000112235788
Q ss_pred HHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 283 KGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 283 ~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+.++|.+||..||++|||+.++.+
T Consensus 368 ~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 368 EVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHHHCccCHhHCcCHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=266.92 Aligned_cols=203 Identities=16% Similarity=0.257 Sum_probs=162.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.++++++ ||||+++++++. ....++||||++ ++|.+++.... .+++..+..
T Consensus 40 ~~~~~E~~~l~~l~-h~~ii~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------- 99 (257)
T cd05115 40 DEMMREAEIMHQLD-NPYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVE---------------- 99 (257)
T ss_pred HHHHHHHHHHHhcC-CCCeEEEEEEEc---CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHH----------------
Confidence 45789999999998 999999999874 346899999998 69999987543 377777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++|++||||||+|||++.+ .++|
T Consensus 100 -------------------------------------------~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl 136 (257)
T cd05115 100 -------------------------------------------LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKI 136 (257)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEe
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++......... ....++..|+|||++.+.. ++.++|||||||++|++++ |..||.+....+....+...
T Consensus 137 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 214 (257)
T cd05115 137 SDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG- 214 (257)
T ss_pred ccCCccccccCCccceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-
Confidence 999998755432211 1122356899999887655 7899999999999999996 99999877665544333221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....++..++++.++|.+||..||++||++.++.+
T Consensus 215 -----------------------------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 215 -----------------------------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011123457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=268.49 Aligned_cols=205 Identities=29% Similarity=0.498 Sum_probs=167.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ ||||+++++.+.. .+.+|+||||++ ++|.+++.... .+++..+..
T Consensus 42 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~-------------- 104 (255)
T cd08219 42 VEDSRKEAVLLAKMK-HPNIVAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ-------------- 104 (255)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEEE--CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHH--------------
Confidence 456778999999999 9999999998864 678999999998 69999886532 256666555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||++||+|+||||+||+++.+ .+
T Consensus 105 ---------------------------------------------~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~ 139 (255)
T cd08219 105 ---------------------------------------------WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKV 139 (255)
T ss_pred ---------------------------------------------HHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|+|||.+....... ......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+..
T Consensus 140 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---- 214 (255)
T cd08219 140 KLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ---- 214 (255)
T ss_pred EEcccCcceeecccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc----
Confidence 999999987665332 233457899999999987755 78999999999999999999999987765444433321
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....++..++..+.+||.+||..||++|||+.+++.
T Consensus 215 --------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 215 --------------------------GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred --------------------------CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 1111223457788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=279.15 Aligned_cols=261 Identities=19% Similarity=0.233 Sum_probs=170.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-c-cHHHHHHHHH------HHHhhh
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-I-SEKRAKEILY------QVKAAN 81 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l-~~~~~~~~~~------~~~~~~ 81 (470)
..+.+|+.++.++.+|+||+++++++.. ....++++|||++ ++|.+++..... . .......... ......
T Consensus 55 ~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (337)
T cd05054 55 KALMTELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133 (337)
T ss_pred HHHHHHHHHHHhhccCcchhheeeeEec-CCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence 4578999999999559999999998764 3567899999999 599999965432 0 0000000000 000000
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
.....+.. ........++.... .-............+....+..++.||+.||+|||++||+||||||+|||++
T Consensus 134 ~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~ 207 (337)
T cd05054 134 DSVSSSQS---SASSGFIEDKSLSD---VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS 207 (337)
T ss_pred ccCCcccc---ccccccccCcchhh---cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe
Confidence 00000000 00000111111000 0000011112233567788888999999999999999999999999999999
Q ss_pred CC-eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLD 236 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~ 236 (470)
.+ .++|+|||++..+..... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+.
T Consensus 208 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~ 286 (337)
T cd05054 208 ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286 (337)
T ss_pred CCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH
Confidence 77 899999999986543221 12335567899999987755 8999999999999999997 999997754333222
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
..... ......+...++++.+++.+||+.+|++||++.++++|
T Consensus 287 ~~~~~-----------------------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 287 RRLKE-----------------------------GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHhc-----------------------------cCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22110 00011123467889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=269.43 Aligned_cols=218 Identities=24% Similarity=0.304 Sum_probs=187.1
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.+....+.|-.+|...+ ||.+..|-..|+. ++.+|+||||.. |.|.-.|.+...+++...+.
T Consensus 210 dEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt--~drlCFVMeyanGGeLf~HLsrer~FsE~RtRF-------------- 272 (516)
T KOG0690|consen 210 DEVAHTLTENRVLQNCR-HPFLTSLKYSFQT--QDRLCFVMEYANGGELFFHLSRERVFSEDRTRF-------------- 272 (516)
T ss_pred HHhhhhhhHHHHHHhcc-CcHHHHhhhhhcc--CceEEEEEEEccCceEeeehhhhhcccchhhhh--------------
Confidence 34556789999999999 9999999888854 788999999999 59988887777788877766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
+...|+.||.|||+++||.||||.+|+|++.+ ++
T Consensus 273 ---------------------------------------------YGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 273 ---------------------------------------------YGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred ---------------------------------------------hhHHHHHHhhhhhhCCeeeeechhhhheeccCCce
Confidence 99999999999999999999999999999998 99
Q ss_pred EEEecCCcccc-cCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFI-KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
||+|||+++.. ..+....++||||.|.|||++.... |+.++|.|.+||++|||++|+.||...+....+..|...
T Consensus 308 KitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--- 383 (516)
T KOG0690|consen 308 KITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--- 383 (516)
T ss_pred EeeecccchhcccccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh---
Confidence 99999998754 3555678899999999999997655 999999999999999999999999988877766666431
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhHHHH
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQLKQ 319 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~~~~ 319 (470)
.-.++..++++++.|+..+|..||.+|.. +.|+.+|+||..+.....
T Consensus 384 ----------------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 384 ----------------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred ----------------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 01133578999999999999999999974 899999999999886443
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=272.16 Aligned_cols=205 Identities=26% Similarity=0.409 Sum_probs=163.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc--ccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT--DNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~--~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|++++.+++ ||||++++|++.. .+..++|+|||+ |+|.++|... ..++...+..
T Consensus 45 ~~~~~~e~~~l~~l~-h~ni~~~~g~~~~--~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~-------------- 107 (259)
T PF07714_consen 45 EEEFLNEIQILRKLR-HPNIVKLYGFCIE--NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLS-------------- 107 (259)
T ss_dssp HHHHHHHHHHHHTHS-BTTBE-EEEEEES--SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHH--------------
T ss_pred ceeeeeccccccccc-ccccccccccccc--ccccccccccccccccccccccccccccccccccc--------------
Confidence 567899999999997 9999999999973 556999999999 7999999987 4477777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||+++++|+||+++|||++.+ .+
T Consensus 108 ---------------------------------------------i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~ 142 (259)
T PF07714_consen 108 ---------------------------------------------IAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQV 142 (259)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEE
T ss_pred ---------------------------------------------ccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999977 99
Q ss_pred EEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
||+|||++........ .....+...|+|||.+.+.. ++.++||||||+++|||++ |+.||.+.+..+....+.+.
T Consensus 143 Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~ 221 (259)
T PF07714_consen 143 KLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG 221 (259)
T ss_dssp EEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence 9999999887632221 12345677899999987755 7999999999999999999 78999888776666555321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..++..+.++|..||..||.+|||+.++++
T Consensus 222 ------------------------------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 222 ------------------------------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ------------------------------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ------------------------------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111123457899999999999999999999999984
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=270.10 Aligned_cols=214 Identities=23% Similarity=0.332 Sum_probs=163.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.+++.++ ||||+++++++.. ....++||||++ |+|.+++..... +...
T Consensus 54 ~~~~~e~~~l~~l~-~~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~-------------------- 110 (277)
T cd05062 54 IEFLNEASVMKEFN-CHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENN-------------------- 110 (277)
T ss_pred HHHHHHHHHHHhCC-CCCeeeEEEEEcC--CCCeEEEEecCCCCCHHHHHHHcCcccccc--------------------
Confidence 45789999999998 9999999998853 667999999999 699999865331 0000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
..........+..++.|++.||+|||+.|++||||||+||+++.+ .++|
T Consensus 111 ------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 111 ------------------------------PVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred ------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 000112233445599999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++......... ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-- 237 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-- 237 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Confidence 999998755432211 1234577899999987654 8999999999999999998 78999877665544433220
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
........++..+.+++.+||..||++|||+.+++++
T Consensus 238 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 ----------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0111223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=267.39 Aligned_cols=206 Identities=22% Similarity=0.322 Sum_probs=165.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++.+++ ||||+++++++.. ...+++||||+. |+|.+++.... .+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~--------------- 104 (256)
T cd05113 43 EDEFIEEAKVMMKLS-HEKLVQLYGVCTK--QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE--------------- 104 (256)
T ss_pred HHHHHHHHHHHhcCC-CCCeeeEEEEEcc--CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHH---------------
Confidence 456889999999999 9999999998854 567899999998 69999997654 367766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+.|++|+||||+||+++.+ .++
T Consensus 105 --------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~k 140 (256)
T cd05113 105 --------------------------------------------MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVK 140 (256)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||.+......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 141 l~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~- 218 (256)
T cd05113 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL- 218 (256)
T ss_pred ECCCccceecCCCceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-
Confidence 9999988765433221 1223456799999987655 8899999999999999998 999997766555444443211
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
........+..+.+++.+||..||.+|||+.+++.+
T Consensus 219 -----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 219 -----------------------------RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 001112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=266.15 Aligned_cols=209 Identities=30% Similarity=0.545 Sum_probs=173.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+++++.++ ||||+++++.+.. ....++|+||++ ++|.+++... ..+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~~~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~------------ 107 (258)
T cd08215 43 REDALNEVKILKKLN-HPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD------------ 107 (258)
T ss_pred HHHHHHHHHHHHhcC-CCChhheEEEEec--CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHH------------
Confidence 456789999999999 9999999998865 578999999999 5999999764 3366666666
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||.|||+.|++|+||+|+||+++.+
T Consensus 108 -----------------------------------------------i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~ 140 (258)
T cd08215 108 -----------------------------------------------WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG 140 (258)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCEecccCChHHeEEcCCC
Confidence 99999999999999999999999999999986
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||.+....... ......|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...........+..
T Consensus 141 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-- 217 (258)
T cd08215 141 LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-- 217 (258)
T ss_pred cEEECCccceeecccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc--
Confidence 89999999887665443 334457899999999887655 78999999999999999999999977664443333221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.....++..++..+.+++.+||..+|++|||+.++|+||||
T Consensus 218 ----------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 ----------------------------GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ----------------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 11122334678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=303.78 Aligned_cols=217 Identities=26% Similarity=0.362 Sum_probs=184.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..-|..|-.||..-. .+-|++++.+|++ ..++|+|||||+ |||..++.....+++.-++.
T Consensus 119 tA~F~EERDimv~~n-s~Wiv~LhyAFQD--~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArF---------------- 179 (1317)
T KOG0612|consen 119 TACFREERDIMVFGN-SEWIVQLHYAFQD--ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARF---------------- 179 (1317)
T ss_pred HHHHHHHhHHHHcCC-cHHHHHHHHHhcC--ccceEEEEecccCchHHHHHhhcCCChHHHHHH----------------
Confidence 345667788888877 9999999999965 788999999999 69999999888888888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+..|+.||.-||+.|+|||||||+|||++.. ++||
T Consensus 180 -------------------------------------------Y~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikL 216 (1317)
T KOG0612|consen 180 -------------------------------------------YTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKL 216 (1317)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhccceeccCCcceeEecccCcEee
Confidence 99999999999999999999999999999987 9999
Q ss_pred EecCCcccccCCCc--cccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 168 GDLGSLQFIKSKGL--HTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 168 ~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+|||.+..+...+. ....+|||-|++||++.. .+.|+..+|.||+||++|||+.|..||..++..+.+.+|+..
T Consensus 217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 99998877764442 355799999999999852 245899999999999999999999999999999988888763
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC---HHHHHhcccCCChhH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT---AQKILSCAYFADLTQ 316 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt---~~elL~hp~f~~~~~ 316 (470)
-. .+.|| -...+|+++++||.+++. +|+.|.. ++++-.||||.++..
T Consensus 297 k~------------------~l~FP---------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 297 KE------------------SLSFP---------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hh------------------hcCCC---------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 10 11111 013589999999999887 7889988 999999999999875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=268.73 Aligned_cols=215 Identities=20% Similarity=0.269 Sum_probs=160.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+++|+.+++.++ ||||+++++.+.. ....++||||++ |+|.+++........
T Consensus 39 ~~~~~~e~~~~~~l~-h~nii~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------- 94 (269)
T cd05042 39 QLLFLQEVQPYRELN-HPNVLQCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVA--------------------- 94 (269)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEECC--CCceEEEEEeCCCCcHHHHHHhcccccc---------------------
Confidence 346789999999998 9999999998854 567999999999 699999976542100
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
.......+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 95 ---------------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl 141 (269)
T cd05042 95 ---------------------------------QMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKI 141 (269)
T ss_pred ---------------------------------ccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEE
Confidence 001112233399999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhcc------CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLT------EGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDR 237 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~------~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~ 237 (470)
+|||++........ .....++..|+|||++.. ...++.++|||||||++|||++ |..||......+.+..
T Consensus 142 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~ 221 (269)
T cd05042 142 GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ 221 (269)
T ss_pred eccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 99998865432221 122345677999998743 2236889999999999999998 8889987766555444
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+...... ..........++..+.+++..|| .||++|||++++++
T Consensus 222 ~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 222 VVREQDI-------------------------KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HhhccCc-------------------------cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 3321100 00011223457788899999998 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=271.67 Aligned_cols=215 Identities=24% Similarity=0.394 Sum_probs=174.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++++.++ |+||+++++.+.. ....|+|+||++ ++|.+++.... .++...+..
T Consensus 59 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~--------------- 120 (286)
T cd06614 59 KELIINEILIMKDCK-HPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY--------------- 120 (286)
T ss_pred HHHHHHHHHHHHHCC-CCCeeEEEEEEEE--CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHH---------------
Confidence 456789999999998 9999999999865 578999999999 69999998776 567766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+.||+|+||+|+||+++.+ .++
T Consensus 121 --------------------------------------------i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~ 156 (286)
T cd06614 121 --------------------------------------------VCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVK 156 (286)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEE
Confidence 99999999999999999999999999999977 899
Q ss_pred EEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||.+....... ......++..|+|||++.+.. ++.++|||||||++|+|++|..||...........+... +.
T Consensus 157 l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~- 233 (286)
T cd06614 157 LADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GI- 233 (286)
T ss_pred ECccchhhhhccchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC-
Confidence 99999876554321 123346788999999887654 799999999999999999999999876655443333210 00
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
........++..+.++|.+||..+|.+|||+.++++||||....
T Consensus 234 --------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 234 --------------------------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred --------------------------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 00001123678899999999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=270.39 Aligned_cols=220 Identities=21% Similarity=0.320 Sum_probs=163.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.++ ||||+++++++.......+++||||++ ++|.+++... .+++..+..
T Consensus 50 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~---------------- 111 (283)
T cd05080 50 TSGWKKEINILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLL---------------- 111 (283)
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHH----------------
Confidence 456789999999998 999999999887655667899999999 6999998654 377776666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|++.||+|||++||+||||||+|||++.+ .++|
T Consensus 112 -------------------------------------------i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l 148 (283)
T cd05080 112 -------------------------------------------FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKI 148 (283)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-h
Q psy9855 168 GDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV-L 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-~ 242 (470)
+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||...... ...+... .
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~ 225 (283)
T cd05080 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQ 225 (283)
T ss_pred eecccccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccc
Confidence 99999876653221 12234566799999887644 789999999999999999999998553211 1111100 0
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+......+..... ..........++.++.+++.+||..||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 226 GQMTVVRLIELLE--------------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cccchhhhhhhhh--------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000000000 00011123457889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=257.02 Aligned_cols=220 Identities=30% Similarity=0.372 Sum_probs=165.4
Q ss_pred CCCCCc-hhhhhhhHHHHHHhcCCCCCCeeeeceeeecC---CCCeEEEEeeccc-cCHHHHHHhccc----ccHHHHHH
Q psy9855 2 KATCPD-FAEVANLKEISILRKIPDHLNVLCLCETYVNR---STRQVTLVFPLME-LNLEEYIRTTDN----ISEKRAKE 72 (470)
Q Consensus 2 k~~~~~-~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~---~~~~~~lV~E~~~-gsL~~~l~~~~~----l~~~~~~~ 72 (470)
|+.|.. .+.+.+++|++..++++ ||||++++++.... .....||+++|+. |+|.+.|+.... +++.++..
T Consensus 53 kI~c~~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~ 131 (302)
T KOG2345|consen 53 KILCHSQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILW 131 (302)
T ss_pred eeeccchHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHH
Confidence 345666 34567899999999999 99999999986532 3456999999998 899999876442 77777777
Q ss_pred HHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--Cee
Q psy9855 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFH 150 (470)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvH 150 (470)
|+.+|++||++||+.. +.|
T Consensus 132 -----------------------------------------------------------if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 132 -----------------------------------------------------------IFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred -----------------------------------------------------------HHHHHHHHHHHHhccCCcccc
Confidence 9999999999999998 999
Q ss_pred cCCCCCcEEEeCC-eEEEEecCCcccccCCCc----------cccccccCcccCchhhccCC--CCCCcccHHHHHHHHH
Q psy9855 151 RDIKPENILIRGD-LVVVGDLGSLQFIKSKGL----------HTEYIATRWYRSPECLLTEG--YYSFELDIWAAGCVFY 217 (470)
Q Consensus 151 rDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~----------~~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlG~il~ 217 (470)
|||||.|||+++. .++|.|||.+....-.-. ......|..|+|||++.-.. ..+.++|||||||+||
T Consensus 153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 9999999999986 899999998876431110 11235688999999885432 2688999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCC
Q psy9855 218 ETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297 (470)
Q Consensus 218 elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~ 297 (470)
.|+.|..||.-. ... |. +-.......+. . ..-.+.+|+.+.+||+.||..||.
T Consensus 233 a~mf~~sPfe~~---------~~~-Gg-------------SlaLAv~n~q~---s-~P~~~~yse~l~~lik~mlqvdP~ 285 (302)
T KOG2345|consen 233 AMMFGESPFERI---------YQQ-GG-------------SLALAVQNAQI---S-IPNSSRYSEALHQLIKSMLQVDPN 285 (302)
T ss_pred HHHHcCCcchHH---------hhc-CC-------------eEEEeeecccc---c-cCCCCCccHHHHHHHHHHhcCCcc
Confidence 999999999421 110 00 00000000000 0 001134899999999999999999
Q ss_pred CCcCHHHHHhc
Q psy9855 298 RRPTAQKILSC 308 (470)
Q Consensus 298 ~Rpt~~elL~h 308 (470)
+||++.+++.+
T Consensus 286 qRP~i~~ll~~ 296 (302)
T KOG2345|consen 286 QRPTIPELLSK 296 (302)
T ss_pred cCCCHHHHHHH
Confidence 99999999864
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=267.09 Aligned_cols=213 Identities=25% Similarity=0.352 Sum_probs=168.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ |+||+++++.+.. .+.+++|+||++ ++|.+++.....+++..+..
T Consensus 43 ~~~~~~e~~~~~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~---------------- 103 (264)
T cd06626 43 IKEIADEMKVLELLK-HPNLVKYYGVEVH--REKVYIFMEYCSGGTLEELLEHGRILDEHVIRV---------------- 103 (264)
T ss_pred HHHHHHHHHHHHhCC-CCChhheeeeEec--CCEEEEEEecCCCCcHHHHHhhcCCCChHHHHH----------------
Confidence 456789999999998 9999999998754 678999999999 69999998766577776666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||.|||+.||+|+||+|+||+++.+ .++|
T Consensus 104 -------------------------------------------i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl 140 (264)
T cd06626 104 -------------------------------------------YTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKL 140 (264)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCcc-----ccccccCcccCchhhccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 168 GDLGSLQFIKSKGLH-----TEYIATRWYRSPECLLTEG--YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~-----~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+|||++......... ....++..|+|||++.+.. .++.++|||||||++|++++|..||.+............
T Consensus 141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~ 220 (264)
T cd06626 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG 220 (264)
T ss_pred cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh
Confidence 999988776533221 2356788999999886543 268899999999999999999999976532222111111
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
. +.. ........++..+.++|.+||..+|.+|||+.+++.|||+
T Consensus 221 ~-~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 A-GHK--------------------------PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred c-CCC--------------------------CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 000 0000112357888999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=266.60 Aligned_cols=205 Identities=19% Similarity=0.272 Sum_probs=164.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+.+|+.+++.++ |+||+++++++.. ..+..++||||++ ++|.+++..... +++..+..
T Consensus 42 ~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~------------- 106 (256)
T cd05082 42 TAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK------------- 106 (256)
T ss_pred hHHHHHHHHHHHHhCC-CCCeeeEEEEEEc-CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHH-------------
Confidence 3456789999999998 9999999997653 3567899999998 699999976543 55666555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+||+++.+ .
T Consensus 107 ----------------------------------------------~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~ 140 (256)
T cd05082 107 ----------------------------------------------FSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV 140 (256)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCEeccccchheEEEcCCCc
Confidence 99999999999999999999999999999887 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
++|+|||++....... ....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....+...
T Consensus 141 ~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-- 215 (256)
T cd05082 141 AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-- 215 (256)
T ss_pred EEecCCccceeccccC--CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--
Confidence 9999999887544322 2334567899999887654 7899999999999999997 99999776554444333210
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+.++..+.++|.+||..+|++|||+.++++
T Consensus 216 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 216 ----------------------------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ----------------------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001123467889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=263.28 Aligned_cols=210 Identities=24% Similarity=0.420 Sum_probs=171.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+++.++ ||||+++++.+.. ....++++||++ ++|.+++... ..+++..+..
T Consensus 41 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 102 (253)
T cd05122 41 KEKIINEIQILKKCK-HPNIVKYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY--------------- 102 (253)
T ss_pred HHHHHHHHHHHHhCC-CCCEeEEEEEEec--CCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHH---------------
Confidence 456789999999999 9999999998865 577999999999 6999998776 3467776666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||+|||++|++||||+|+||+++.+ .++
T Consensus 103 --------------------------------------------i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~ 138 (253)
T cd05122 103 --------------------------------------------VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVK 138 (253)
T ss_pred --------------------------------------------HHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEE
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||.+.............++..|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+... ..
T Consensus 139 l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~-- 214 (253)
T cd05122 139 LIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GP-- 214 (253)
T ss_pred EeeccccccccccccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CC--
Confidence 99999888766543234567889999999987655 789999999999999999999999776544443332210 00
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
........++..+.++|.+||..||++|||+.++++|||
T Consensus 215 -------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 215 -------------------------PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -------------------------CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000001124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=286.36 Aligned_cols=209 Identities=24% Similarity=0.384 Sum_probs=176.5
Q ss_pred CCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhc
Q psy9855 5 CPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANE 82 (470)
Q Consensus 5 ~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~ 82 (470)
|.....+.|+.|..++++++ |||||+|+|++.+ ...|||||+++ |.|..|+..+.. ++......
T Consensus 430 ~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e---~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~l---------- 495 (974)
T KOG4257|consen 430 CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE---QPMWIVMELAPLGELREYLQQNKDSLPLRTLTL---------- 495 (974)
T ss_pred CChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec---cceeEEEecccchhHHHHHHhccccchHHHHHH----------
Confidence 44445778999999999999 9999999999864 56899999999 999999987664 44433333
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
+++||+.||+|||+.++|||||-..|||+..
T Consensus 496 -------------------------------------------------y~~Qi~talaYLeSkrfVHRDIAaRNiLVsS 526 (974)
T KOG4257|consen 496 -------------------------------------------------YCYQICTALAYLESKRFVHRDIAARNILVSS 526 (974)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHhhchhhhhhhhhheeecC
Confidence 9999999999999999999999999999988
Q ss_pred C-eEEEEecCCcccccCCCccccccc--cCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIA--TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRI 238 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i 238 (470)
. .+||+|||+++.+.+........| ..-|||||.+.... ++.++|||-|||.+||++. |..||.|-.+.+.+..|
T Consensus 527 p~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i 605 (974)
T KOG4257|consen 527 PQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI 605 (974)
T ss_pred cceeeecccchhhhccccchhhccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe
Confidence 7 899999999999988776655555 34599999987765 8999999999999999987 99999887666555444
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+ +.....++.+++.+..|+.+||.+||.+||++.++..
T Consensus 606 En------------------------------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 606 EN------------------------------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred cC------------------------------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 32 3344566789999999999999999999999998763
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=273.27 Aligned_cols=206 Identities=20% Similarity=0.336 Sum_probs=163.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+++++.+||||+++++++.. .+..++||||+. |+|.+++..... +++.++..
T Consensus 83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~--------------- 145 (302)
T cd05055 83 EALMSELKIMSHLGNHENIVNLLGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS--------------- 145 (302)
T ss_pred HHHHHHHHHHHhccCCCCcceEEEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHH---------------
Confidence 4578999999999449999999998865 567999999998 699999976433 66666666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+|+||||+|||++.+ .++
T Consensus 146 --------------------------------------------i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 146 --------------------------------------------FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++........ .....++..|+|||.+.+.. ++.++||||+||++|+|++ |..||.+....+........
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~- 259 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE- 259 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-
Confidence 999999876543221 12234577899999887755 7899999999999999998 99999776544433222210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+ .........+.++.+|+.+||..+|++|||+.++++
T Consensus 260 ~----------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 G----------------------------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred C----------------------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 000112346788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=276.51 Aligned_cols=216 Identities=22% Similarity=0.364 Sum_probs=171.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. .+..|+|+||++ ++|.+++... .+++..+..
T Consensus 60 ~~~~~~e~~~l~~l~-hp~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~---------------- 119 (293)
T cd06647 60 KELIINEILVMRENK-HPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAA---------------- 119 (293)
T ss_pred HHHHHHHHHHHhhcC-CCCeeehhheeee--CCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHH----------------
Confidence 345789999999998 9999999999865 567999999998 5999998653 255555555
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||.|||++|++||||||+||+++.+ .++|
T Consensus 120 -------------------------------------------i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL 156 (293)
T cd06647 120 -------------------------------------------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL 156 (293)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... ......|++.|+|||.+.+.. ++.++|||||||++|++++|..||...+....+..+.. .+
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~--- 231 (293)
T cd06647 157 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG--- 231 (293)
T ss_pred ccCcceecccccccccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CC---
Confidence 9999877554332 223457889999999887644 78999999999999999999999977654433222111 00
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~ 317 (470)
.........++..+.++|.+||..+|++||++.+++.||||.....+
T Consensus 232 ------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 232 ------------------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred ------------------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 00011123467889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=273.14 Aligned_cols=217 Identities=23% Similarity=0.328 Sum_probs=172.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|..+.+|+||+++++.+.. ...+|+||||++ ++|.+++.....+++..+..
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~----------------- 109 (290)
T cd05613 49 EHTRTERQVLEHIRQSPFLVTLHYAFQT--DTKLHLILDYINGGELFTHLSQRERFKEQEVQI----------------- 109 (290)
T ss_pred HHHHHHHHHHHhcccCCChhceeeEeec--CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 4467899999999769999999998854 567999999999 59999998776677777666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||+.|++||||+|+|||++.+ .++|+
T Consensus 110 ------------------------------------------~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~ 147 (290)
T cd05613 110 ------------------------------------------YSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 147 (290)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEe
Confidence 89999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCC--ccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 169 DLGSLQFIKSKG--LHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 169 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|||++....... ......|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+....-
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-- 225 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-- 225 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh--
Confidence 999987654322 22345789999999988653 2367899999999999999999999964332222222211100
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
......+..++..+.+++.+||..||.+|| ++++++.||||....
T Consensus 226 -------------------------~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 226 -------------------------KSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred -------------------------ccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 000112245778899999999999999997 899999999999876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=268.85 Aligned_cols=201 Identities=19% Similarity=0.324 Sum_probs=157.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.++..++ ||||+++++++.. ....++||||++ |+|..++.... .+++..+..
T Consensus 49 ~~~~~~~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~---------------- 109 (262)
T cd05077 49 LAFFETASMMRQVS-HKHIVLLYGVCVR--DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK---------------- 109 (262)
T ss_pred HHHHHHHHHHHhCC-CCCEeeEEEEEec--CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHH----------------
Confidence 35678899999999 9999999998865 556899999999 58888876543 366666666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 110 -------------------------------------------i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~ 146 (262)
T cd05077 110 -------------------------------------------VAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGE 146 (262)
T ss_pred -------------------------------------------HHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCC
Confidence 99999999999999999999999999999754
Q ss_pred ---eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHH
Q psy9855 164 ---LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETL-TRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 164 ---~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ell-tg~~pf~~~~~~~~~~~i~ 239 (470)
.++++|||.+...... ....++..|+|||++.....++.++|||||||++|+|+ .|..||.+....+... +.
T Consensus 147 ~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~ 222 (262)
T cd05077 147 CGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FY 222 (262)
T ss_pred CCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HH
Confidence 2899999988654322 23467889999998875556899999999999999998 5888887654322211 10
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
. .. .......++++.+||.+||..||.+||++.+++++
T Consensus 223 ~------------------~~-------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 223 E------------------GQ-------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred h------------------cC-------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 00 00112345778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=271.85 Aligned_cols=222 Identities=20% Similarity=0.308 Sum_probs=166.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+.+||||+++++++.. .+.+++||||++ |+|.+++.......+...
T Consensus 60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~------------------- 118 (293)
T cd05053 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYAS------------------- 118 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeeEEEEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccc-------------------
Confidence 4578999999999449999999998854 667999999998 699999976432111000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
..........++...+..++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 119 ------------------------~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~ 174 (293)
T cd05053 119 ------------------------PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIA 174 (293)
T ss_pred ------------------------cccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeC
Confidence 00011122234456666699999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||.+........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 175 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 250 (293)
T cd05053 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG--- 250 (293)
T ss_pred ccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC---
Confidence 9999886653321 12223456799999887654 8999999999999999997 99999877655544333210
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..++..+.+|+.+||..||++|||+.+++++
T Consensus 251 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 251 ---------------------------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ---------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0011223567889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.15 Aligned_cols=245 Identities=27% Similarity=0.508 Sum_probs=190.8
Q ss_pred hhhhhhHHHHHHhcCCC-----CCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcc
Q psy9855 9 AEVANLKEISILRKIPD-----HLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~-----HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~ 83 (470)
-...-++|++||++|.. --|+++|+-.|.. .+++|||+|-+..+|.++|+..+.
T Consensus 471 M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h--knHLClVFE~LslNLRevLKKyG~------------------- 529 (752)
T KOG0670|consen 471 MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH--KNHLCLVFEPLSLNLREVLKKYGR------------------- 529 (752)
T ss_pred HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--cceeEEEehhhhchHHHHHHHhCc-------------------
Confidence 34566899999999972 3588999998855 789999999999999999987664
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
..++.+..++.|+.|+..||..|-..||+|.||||+|||++.+
T Consensus 530 -------------------------------------nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 530 -------------------------------------NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred -------------------------------------ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 1122333344499999999999999999999999999999987
Q ss_pred --eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 --LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 --~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.+||||||.|....+... +.+..+..|+|||+++|.. |+...|+||+||+||||+||+..|+|.+..+++...+.+
T Consensus 573 k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred cceeeeccCccccccccccc-cHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 799999999988776554 4567788999999999977 899999999999999999999999999999999999999
Q ss_pred hCCCchHHHHHHhhh---ccCccccccccC----------------CCCC----------cccccccccHHHHHHHHHhc
Q psy9855 242 LGTPKAETLKKFEKY---KSSNFTYQFKQY----------------PGGG----------IDVLVPQIHEKGKKLMSEML 292 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~---~~~~~~~~~~~~----------------~~~~----------~~~~~~~~s~~~~~Li~~~L 292 (470)
-|..+..++..-.-. -..++++..... |... +..-.+.+-.++.+||.+||
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 998777666542111 011111110000 0000 00001123357899999999
Q ss_pred ccCCCCCcCHHHHHhcccCCC
Q psy9855 293 KYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 293 ~~dP~~Rpt~~elL~hp~f~~ 313 (470)
..||++|.|+.|+|.||||..
T Consensus 731 ~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 731 ILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred ccChhhcCCHHHHhcCCcccC
Confidence 999999999999999999974
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=273.16 Aligned_cols=220 Identities=20% Similarity=0.272 Sum_probs=170.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+++|+.++..+.+||||+++++++.. ....|+||||++++|.+++..... +++..+..
T Consensus 57 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~---------------- 118 (296)
T cd06618 57 NKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFICMELMSTCLDKLLKRIQGPIPEDILGK---------------- 118 (296)
T ss_pred HHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHH----------------
Confidence 34567888878777679999999999865 667999999999988888766333 66665555
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+ .||+||||+|+||+++.+ .++
T Consensus 119 -------------------------------------------i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 119 -------------------------------------------MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEE
Confidence 99999999999997 599999999999999877 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE---GYYSFELDIWAAGCVFYETLTRNPLFPGDSE-IDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~ 242 (470)
|+|||.+.............++..|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 156 L~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-- 233 (296)
T cd06618 156 LCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-- 233 (296)
T ss_pred ECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc--
Confidence 9999998776544444445688899999998654 2378899999999999999999999965322 222222211
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
.. .. .......++.++.+||.+||..||.+|||++++++||||.......
T Consensus 234 -~~-------------------~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 283 (296)
T cd06618 234 -EE-------------------PP------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283 (296)
T ss_pred -CC-------------------CC------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence 00 00 0001114678899999999999999999999999999999765433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=272.94 Aligned_cols=214 Identities=23% Similarity=0.408 Sum_probs=172.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ |+||+++++.+.. .+..++||||++ ++|.+++... .+++..+..
T Consensus 61 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~---------------- 120 (292)
T cd06657 61 RELLFNEVVIMRDYQ-HENVVEMYNSYLV--GDELWVVMEFLEGGALTDIVTHT-RMNEEQIAA---------------- 120 (292)
T ss_pred HHHHHHHHHHHHhcC-CcchhheeeEEEe--CCEEEEEEecCCCCcHHHHHhcC-CCCHHHHHH----------------
Confidence 445789999999999 9999999999865 678999999999 5898887543 366666655
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|++.||+|||++|++||||+|+||+++.+ .++|
T Consensus 121 -------------------------------------------~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l 157 (292)
T cd06657 121 -------------------------------------------VCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKL 157 (292)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... ......|+..|+|||.+.+.. ++.++|+||+||++|+|++|..||.+.........+.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--- 233 (292)
T cd06657 158 SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--- 233 (292)
T ss_pred cccccceecccccccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC---
Confidence 9999877554322 223457899999999886544 78999999999999999999999987765554443322110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
... .....++..+.++|.+||..||.+||++.++++||||....
T Consensus 234 ------------------------~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 234 ------------------------PKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ------------------------ccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 000 01235678889999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.94 Aligned_cols=220 Identities=21% Similarity=0.324 Sum_probs=166.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. ....++++||+. ++|.+++........
T Consensus 53 ~~~~~e~~~~~~l~-h~~iv~~~~~~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~---------------------- 107 (283)
T cd05091 53 EEFKHEAMMRSRLQ-HPNIVCLLGVVTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSD---------------------- 107 (283)
T ss_pred HHHHHHHHHHhcCC-CCCcCeEEEEEcC--CCceEEEEEcCCCCcHHHHHHhcCCCcc----------------------
Confidence 45778999999999 9999999998854 567899999999 699999864321000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
+... .........+....+..++.|++.||+|||++||+||||||+|||++++ .++|+
T Consensus 108 ------------------~~~~---~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 108 ------------------VGST---DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred ------------------cccc---ccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEec
Confidence 0000 0000011223445566699999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||+++....... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~--- 242 (283)
T cd05091 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR--- 242 (283)
T ss_pred ccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence 9998876543221 22345678899999987655 7999999999999999998 88999887766555544321
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........++..+.+|+.+||+.+|.+||++.++++
T Consensus 243 ---------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 243 ---------------------------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred ---------------------------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 111223467888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.39 Aligned_cols=206 Identities=19% Similarity=0.288 Sum_probs=164.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++++.++ ||||+++++++.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 104 (256)
T cd05059 43 EDDFIEEAKVMMKLS-HPNLVQLYGVCTK--QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD--------------- 104 (256)
T ss_pred HHHHHHHHHHHHhCC-CCCEEEEEEEEcC--CCceEEEEecCCCCCHHHHHHhcccCCCHHHHHH---------------
Confidence 446789999999998 9999999998754 567999999998 599999976443 66666666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+||+++.+ .++
T Consensus 105 --------------------------------------------i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05059 105 --------------------------------------------MCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVK 140 (256)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||.++........ ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 219 (256)
T cd05059 141 VSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219 (256)
T ss_pred ECCcccceecccccccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999988765432221 1122345799999887655 8999999999999999998 8999987766554444322100
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
...+..++.++.+++.+||..+|++|||+.++++.
T Consensus 220 ------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 ------------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=262.99 Aligned_cols=209 Identities=27% Similarity=0.435 Sum_probs=174.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++.+++ ||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~---------------- 103 (254)
T cd06627 43 LKSIMQEIDLLKNLK-HPNIVKYIGSIET--SDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---------------- 103 (254)
T ss_pred HHHHHHHHHHHHhCC-CCCccEEEEEEEe--CCEEEEEEecCCCCcHHHHHHhccCCCHHHHHH----------------
Confidence 456789999999998 9999999998854 578999999999 49999998776688877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|++.||.|||+.||+||||+|+||+++.+ .++|
T Consensus 104 -------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l 140 (254)
T cd06627 104 -------------------------------------------YVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKL 140 (254)
T ss_pred -------------------------------------------HHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||.+........ .....++..|+|||.+.+.. ++.++||||+|+++|+|++|..||...........+..
T Consensus 141 ~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------ 213 (254)
T cd06627 141 ADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------ 213 (254)
T ss_pred eccccceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence 99999887654332 23457889999999887655 78999999999999999999999976654333322211
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
......+..++..+.+++.+||..+|++|||+.+++.||||
T Consensus 214 ------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 214 ------------------------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ------------------------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 11122334678899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=274.72 Aligned_cols=205 Identities=19% Similarity=0.282 Sum_probs=161.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+++.++ ||||++++|++.. ...++|+||+. |+|.+++..... ++...+..
T Consensus 53 ~~~~~~e~~~l~~l~-h~niv~~~g~~~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~--------------- 113 (316)
T cd05108 53 NKEILDEAYVMASVD-NPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN--------------- 113 (316)
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEcC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHH---------------
Confidence 456789999999998 9999999998864 34789999998 799999987543 55555555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 114 --------------------------------------------~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~k 149 (316)
T cd05108 114 --------------------------------------------WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVK 149 (316)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhcCeeccccchhheEecCCCcEE
Confidence 89999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++......... ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+..
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-- 226 (316)
T cd05108 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-- 226 (316)
T ss_pred EccccccccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC--
Confidence 9999999876533221 1223466799999987655 8999999999999999997 9999977654433221111
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
......++.++..+.+++.+||..||.+|||+.+++.+
T Consensus 227 ----------------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 ----------------------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ----------------------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00011123467788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=264.47 Aligned_cols=207 Identities=28% Similarity=0.440 Sum_probs=172.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ ||||+++++.+.. ....|+||||++ ++|.+++.....+++..+..
T Consensus 38 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~----------------- 97 (250)
T cd05123 38 EHTLTERNILSRIN-HPFIVKLHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARF----------------- 97 (250)
T ss_pred HHHHHHHHHHHHcC-CCcHHHHHHHeec--CCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 36789999999999 9999999998854 778999999996 79999998776677777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||+.|++|+||+|+||+++.+ .++|+
T Consensus 98 ------------------------------------------~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~ 135 (250)
T cd05123 98 ------------------------------------------YAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLT 135 (250)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999999999999888 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||.+...... .......++..|+|||.+.+.. .+.++|+|||||++|++++|..||...........+..
T Consensus 136 d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------- 207 (250)
T cd05123 136 DFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------- 207 (250)
T ss_pred ecCcceecccCCCcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-------
Confidence 99988766543 2334557888999999887655 78899999999999999999999977665333333221
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH---HHHHhcccC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA---QKILSCAYF 311 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~---~elL~hp~f 311 (470)
....++..++..+.++|.+||..||++|||+ +++++||||
T Consensus 208 ------------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 ------------------------DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------------------------CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0111233458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=270.07 Aligned_cols=223 Identities=19% Similarity=0.265 Sum_probs=165.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++.+++ ||||+++++++.. .+..++|||++. ++|.+++..........
T Consensus 63 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~------------------- 120 (296)
T cd05051 63 REDFLKEVKILSRLS-DPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGL------------------- 120 (296)
T ss_pred HHHHHHHHHHHHhcC-CCCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccc-------------------
Confidence 446789999999999 9999999998864 578999999998 69999987654100000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
......+....+..++.||+.||+|||++||+||||||+||+++.+ .++|
T Consensus 121 -----------------------------~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l 171 (296)
T cd05051 121 -----------------------------ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKI 171 (296)
T ss_pred -----------------------------cccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEE
Confidence 0011122334444499999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||.+....... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+.+..+....
T Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~ 250 (296)
T cd05051 172 ADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFF 250 (296)
T ss_pred ccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcc
Confidence 9999987654332 123345677899999887644 8999999999999999998 778887766555544443221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.... ........+.++.++.+++.+||..||.+|||+.++++
T Consensus 251 ~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 251 RDDG-----------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cccc-----------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 1000 00011122456789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=272.06 Aligned_cols=221 Identities=19% Similarity=0.326 Sum_probs=165.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.+.+||||+++++++.. .+.+++||||+. |+|.+++.............
T Consensus 62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~----------------- 122 (314)
T cd05099 62 ADLISEMELMKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD----------------- 122 (314)
T ss_pred HHHHHHHHHHHhccCCCCeeeEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCccccccc-----------------
Confidence 4577999999999559999999998854 567999999998 69999997643210000000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
........+.+..+..++.||+.||.|||++||+||||||+|||++.+ .++|+
T Consensus 123 --------------------------~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~ 176 (314)
T cd05099 123 --------------------------ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIA 176 (314)
T ss_pred --------------------------ccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEc
Confidence 001111234445566699999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||.++....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--- 252 (314)
T cd05099 177 DFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG--- 252 (314)
T ss_pred cccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---
Confidence 9999976543221 11223456799999987654 8999999999999999998 89999877665554443220
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..++.++.+++.+||..||.+|||+.++++
T Consensus 253 ---------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 253 ---------------------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ---------------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001122456788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=267.10 Aligned_cols=215 Identities=25% Similarity=0.346 Sum_probs=165.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..++ ||||+++++++.. ....++||||++ |+|.+++.......+.
T Consensus 53 ~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~-------------------- 109 (277)
T cd05032 53 RIEFLNEASVMKEFN-CHHVVRLLGVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAEN-------------------- 109 (277)
T ss_pred HHHHHHHHHHHHhCC-CCceeEEEEEEcC--CCCcEEEEecCCCCCHHHHHHhcccchhh--------------------
Confidence 346789999999998 9999999998864 577999999998 6999998653321000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
...........+..++.||+.||.|||+.||+||||||+|||++.+ .++|
T Consensus 110 -----------------------------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 110 -----------------------------NPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred -----------------------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 0001112334445599999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||+++....... .....++..|+|||.+.+.. ++.++|||||||++|++++ |..||.+.+..+....+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--- 236 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--- 236 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc---
Confidence 99999876543321 22345678899999887654 8999999999999999998 9999987766554443321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+..++.++.++|.+||..+|++|||+.++++
T Consensus 237 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 ---------------------------GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011122346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=265.25 Aligned_cols=207 Identities=21% Similarity=0.324 Sum_probs=165.9
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+.+|..++ ||||+++++.+.. .+..++||||++ ++|.+++..... ++...+..
T Consensus 48 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~-------------- 110 (266)
T cd05033 48 QRLDFLTEASIMGQFD-HPNIIRLEGVVTK--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVG-------------- 110 (266)
T ss_pred HHHHHHHHHHHHHhCC-CCCcceEeEEEec--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHH--------------
Confidence 3456789999999999 9999999998854 667999999998 599999976543 66666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.|++.||+|||++||+||||||+|||++.+ .+
T Consensus 111 ---------------------------------------------~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 111 ---------------------------------------------MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVC 145 (266)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccC-CCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKS-KGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~-~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
+|+|||++..... .... ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+...
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 224 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 9999999887642 1111 1224467899999887654 8999999999999999997 99999776655544443221
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.. ......+++.+.+|+.+||..+|++||++.+++++
T Consensus 225 ~~------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 225 YR------------------------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CC------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 01123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=263.83 Aligned_cols=209 Identities=30% Similarity=0.525 Sum_probs=170.8
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhcc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~ 83 (470)
+...+.+|+++++.++ |+||+++++++.. ....++|+||++ ++|.+++... ..+++..+..
T Consensus 42 ~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~----------- 107 (256)
T cd08530 42 EREDAVNEIRILASVN-HPNIISYKEAFLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----------- 107 (256)
T ss_pred HHHHHHHHHHHHHhCC-CCCchhhhhhhcc--CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHH-----------
Confidence 3456789999999999 9999999998865 578999999998 5999998662 2255555554
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
++.|++.||+|||+.|++|+||+|+||+++.+
T Consensus 108 ------------------------------------------------~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 108 ------------------------------------------------IFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred ------------------------------------------------HHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 99999999999999999999999999999988
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++...... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||...+..+....+..
T Consensus 140 ~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-- 215 (256)
T cd08530 140 DLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-- 215 (256)
T ss_pred CcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--
Confidence 8999999998776544 333457889999999987654 78899999999999999999999987765443333221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.........++.++.++|.+||..+|.+|||+.++++||++
T Consensus 216 ----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 ----------------------------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ----------------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 11112234577889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.36 Aligned_cols=211 Identities=21% Similarity=0.356 Sum_probs=171.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++.+++ ||||+++++.+.. ....++||||++ ++|.+++... .++...+..
T Consensus 47 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~i~~~-~~~~~~~~~----------------- 105 (277)
T cd06641 47 EDIQQEITVLSQCD-SPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLEPG-PLDETQIAT----------------- 105 (277)
T ss_pred HHHHHHHHHHHhcC-CCCEeEEEEEEEe--CCeEEEEEEeCCCCcHHHHHhcC-CCCHHHHHH-----------------
Confidence 45778999999999 9999999999865 678999999999 5999988643 366666665
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.|++.||.|||+.|++|+||+|+||+++.+ .++|+
T Consensus 106 ------------------------------------------~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~ 143 (277)
T cd06641 106 ------------------------------------------ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 143 (277)
T ss_pred ------------------------------------------HHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEe
Confidence 99999999999999999999999999999887 79999
Q ss_pred ecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++........ .....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+..
T Consensus 144 dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------- 215 (277)
T cd06641 144 DFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK------- 215 (277)
T ss_pred ecccceecccchhhhccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-------
Confidence 9998876543321 23356888999999887654 78899999999999999999999976554433332211
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.....+...++.++.+++.+||..+|.+||++.++++||||....
T Consensus 216 -----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 216 -----------------------NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred -----------------------CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 011122345788899999999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=268.50 Aligned_cols=220 Identities=20% Similarity=0.264 Sum_probs=166.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++..++ |+||+++++++.. .+..++||||++ ++|.+++......... ..
T Consensus 51 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~--~~---------------- 109 (280)
T cd05092 51 RQDFQREAELLTVLQ-HQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKI--LA---------------- 109 (280)
T ss_pred HHHHHHHHHHHhcCC-CCCCceEEEEEec--CCceEEEEecCCCCCHHHHHHhcCcchhh--hc----------------
Confidence 346789999999998 9999999998864 567899999998 6999999765421000 00
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
.........+....+..++.||+.||+|||++|++||||||+|||++++ .++|
T Consensus 110 --------------------------~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 110 --------------------------GGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred --------------------------ccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 0001111223445566699999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+....
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 241 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR- 241 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-
Confidence 99998875543221 12234567899999887755 8999999999999999998 999997766655444432210
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..+++.+.+||.+||..||.+||++.++++
T Consensus 242 -----------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 -----------------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -----------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01112357788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=286.74 Aligned_cols=209 Identities=23% Similarity=0.359 Sum_probs=165.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
-++|.+|+.+|++-+ |.||+-+.|++.. ..+.||+.+|+| +|+.+|..... +.....
T Consensus 432 lqaFKnEVa~lkkTR-H~NIlLFMG~~~~---p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~----------------- 490 (678)
T KOG0193|consen 432 LQAFKNEVAVLKKTR-HENILLFMGACMN---PPLAIITQWCEGSSLYTHLHVQETKFDMNTT----------------- 490 (678)
T ss_pred HHHHHHHHHHHhhcc-hhhheeeehhhcC---CceeeeehhccCchhhhhccchhhhhhHHHH-----------------
Confidence 456889999999999 9999999999964 335999999998 99999975442 433333
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
+.|++||++|+.|||.++|||||||..||++.++ .||
T Consensus 491 ------------------------------------------idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 491 ------------------------------------------IDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred ------------------------------------------HHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEE
Confidence 3399999999999999999999999999999996 999
Q ss_pred EEecCCccccc---CCCccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIK---SKGLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~---~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||++..-. .........|...|||||++... ..|+..+|||||||++|||++|..||........+..+-+.
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 99999886432 22233455788899999998643 24899999999999999999999999855544444444332
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+.|. ........+.++++|+..||.+++++||++.+||.
T Consensus 609 ~l~pd--------------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 609 YLMPD--------------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCcc--------------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 22221 11222467789999999999999999999999983
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=265.41 Aligned_cols=207 Identities=22% Similarity=0.302 Sum_probs=161.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccc-cCHHHHHHhcc------cccHHHHHHHHHHHHh
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLME-LNLEEYIRTTD------NISEKRAKEILYQVKA 79 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~-gsL~~~l~~~~------~l~~~~~~~~~~~~~~ 79 (470)
..+.+|+.+|+.++ ||||+++++++.... ....++|+||+. |+|.+++.... .+++..+
T Consensus 46 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~--------- 115 (273)
T cd05035 46 EEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL--------- 115 (273)
T ss_pred HHHHHHHHHHHhCC-CCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHH---------
Confidence 46789999999999 999999999875422 234799999999 69999985432 1344333
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
..++.||+.||+|||++||+||||||+||+
T Consensus 116 --------------------------------------------------~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil 145 (273)
T cd05035 116 --------------------------------------------------LKFMVDIALGMEYLSNRNFIHRDLAARNCM 145 (273)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHHhCCeeccccchheEE
Confidence 349999999999999999999999999999
Q ss_pred EeCC-eEEEEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy9855 160 IRGD-LVVVGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQ 234 (470)
Q Consensus 160 l~~~-~ikL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~ 234 (470)
++.+ .++|+|||+++........ ....++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+.
T Consensus 146 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05035 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224 (273)
T ss_pred ECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9888 8999999998865433221 1223567899999886644 8999999999999999999 8999987766554
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
...+... .....+..++..+.+++.+||..||.+|||+.+++.+
T Consensus 225 ~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 225 YDYLRHG------------------------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHcC------------------------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4433220 0111234578899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=266.22 Aligned_cols=208 Identities=20% Similarity=0.280 Sum_probs=160.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccc-cCHHHHHHhcc------cccHHHHHHHHHHHH
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLME-LNLEEYIRTTD------NISEKRAKEILYQVK 78 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~-gsL~~~l~~~~------~l~~~~~~~~~~~~~ 78 (470)
...+.+|+++++.++ ||||+++++++... .....++||||+. |+|.+++.... .+++..+.
T Consensus 44 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~------- 115 (272)
T cd05075 44 MEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLV------- 115 (272)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHH-------
Confidence 456789999999998 99999999976432 1235789999998 69998874321 13344333
Q ss_pred hhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENI 158 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NI 158 (470)
.++.||+.||+|||++||+||||||+||
T Consensus 116 ----------------------------------------------------~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 143 (272)
T cd05075 116 ----------------------------------------------------KFMTDIASGMEYLSSKSFIHRDLAARNC 143 (272)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHCCeeccccchhhe
Confidence 4999999999999999999999999999
Q ss_pred EEeCC-eEEEEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy9855 159 LIRGD-LVVVGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEID 233 (470)
Q Consensus 159 Ll~~~-~ikL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~ 233 (470)
|++.+ .++|+|||++......... ....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+
T Consensus 144 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 222 (272)
T cd05075 144 MLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222 (272)
T ss_pred EEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99877 8999999998876433221 2234567899999887654 8999999999999999999 899998766554
Q ss_pred HHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 234 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+... ......+.++..+.++|.+||..||++|||+.+++++
T Consensus 223 ~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 223 IYDYLRQG------------------------------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 44333220 0011224567889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.86 Aligned_cols=201 Identities=18% Similarity=0.294 Sum_probs=159.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+..|+.+++.+. ||||+++++++.. ....++||||++ |+|.+++..... +++..+..
T Consensus 44 ~~~~~e~~~l~~~~-h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~---------------- 104 (258)
T cd05078 44 ESFFEAASMMSQLS-HKHLVLNYGVCVC--GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE---------------- 104 (258)
T ss_pred HHHHHHHHHHHhCC-CCChhheeeEEEe--CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHH----------------
Confidence 45678999999998 9999999999865 566899999999 699999976553 66666655
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.||+|||++||+||||||+||+++.+
T Consensus 105 -------------------------------------------~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~ 141 (258)
T cd05078 105 -------------------------------------------VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKT 141 (258)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCccceEEEeccccccc
Confidence 99999999999999999999999999999765
Q ss_pred ----eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCC-CCCCCCChHHHHHHH
Q psy9855 164 ----LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSEIDQLDRI 238 (470)
Q Consensus 164 ----~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~-~pf~~~~~~~~~~~i 238 (470)
.++++|||.+...... ....++..|+|||++.+...++.++|||||||++|+|++|. +||............
T Consensus 142 ~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~ 218 (258)
T cd05078 142 GNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY 218 (258)
T ss_pred CCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH
Confidence 2789999988654332 23568889999999877555789999999999999999984 666554433222111
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.. ...++...+.++.+||.+||+.||++|||++++++.
T Consensus 219 ~~--------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 ED--------------------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred Hc--------------------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 011223455788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=264.47 Aligned_cols=206 Identities=17% Similarity=0.328 Sum_probs=164.7
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+.+|+.+++.++ |+||+++++.+.. .+..++||||++ ++|.+++.... .++...+..
T Consensus 44 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------------- 107 (261)
T cd05072 44 SVQAFLEEANLMKTLQ-HDKLVRLYAVVTK--EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID------------- 107 (261)
T ss_pred hHHHHHHHHHHHHhCC-CCCeeeEEEEEcC--CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHH-------------
Confidence 3457789999999999 9999999998754 667899999998 69999986542 255555544
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||+.|++||||||+||+++.+ .
T Consensus 108 ----------------------------------------------~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~ 141 (261)
T cd05072 108 ----------------------------------------------FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM 141 (261)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCeeccccchhhEEecCCCc
Confidence 99999999999999999999999999999988 8
Q ss_pred EEEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
++|+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05072 142 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220 (261)
T ss_pred EEECCCccceecCCCceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 99999999986653321 12234567899999887654 7889999999999999998 99999887665555444321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. .......++.++.+++.+||..+|++|||++++++
T Consensus 221 ~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 Y------------------------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred C------------------------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 00112356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=262.97 Aligned_cols=205 Identities=23% Similarity=0.301 Sum_probs=166.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.++.+++ ||||+++++++.. ...++||||++ ++|.+++.... .+++..+..
T Consensus 40 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~-------------- 101 (257)
T cd05040 40 MDDFLKEAAIMHSLD-HENLIRLYGVVLT---HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD-------------- 101 (257)
T ss_pred HHHHHHHHHHHhhcC-CCCccceeEEEcC---CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHH--------------
Confidence 346789999999999 9999999998864 67899999998 69999997764 356666555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++|++||||||+||+++.+ .+
T Consensus 102 ---------------------------------------------~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~ 136 (257)
T cd05040 102 ---------------------------------------------YAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136 (257)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCccccccCcccEEEecCCEE
Confidence 99999999999999999999999999999987 89
Q ss_pred EEEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
+|+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 137 KIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred EeccccccccccccccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999887653221 12245678899999887655 8999999999999999998 9999987766665544432
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. ........++..+.+++.+||..+|++|||+.++++
T Consensus 216 ~~-----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 216 EG-----------------------------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred cC-----------------------------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00 000112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=262.84 Aligned_cols=204 Identities=20% Similarity=0.283 Sum_probs=164.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++++.+. ||||+++++++. ....++||||++ |+|.+++.....+++..+..
T Consensus 40 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 99 (257)
T cd05060 40 KKEFLREASVMAQLD-HPCIVRLIGVCK---GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---------------- 99 (257)
T ss_pred HHHHHHHHHHHHhcC-CCCeeeEEEEEc---CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHH----------------
Confidence 456789999999998 999999999764 345899999998 69999998776677777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.|++.||+|||+.|++||||||+|||++.+ .++|
T Consensus 100 -------------------------------------------~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl 136 (257)
T cd05060 100 -------------------------------------------LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKI 136 (257)
T ss_pred -------------------------------------------HHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEe
Confidence 99999999999999999999999999999888 8999
Q ss_pred EecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||.+......... ....++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 137 ~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~- 214 (257)
T cd05060 137 SDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG- 214 (257)
T ss_pred ccccccceeecCCcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-
Confidence 999998866433221 1112345799999887655 8999999999999999997 99999776655444333210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..++..+.++|.+||..+|.+|||+.++++
T Consensus 215 -----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 -----------------------------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -----------------------------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001122456789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=270.51 Aligned_cols=222 Identities=18% Similarity=0.316 Sum_probs=167.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+.+||||+++++.+.. .+..++||||++ |+|.+++.............
T Consensus 65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 125 (304)
T cd05101 65 SDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYD----------------- 125 (304)
T ss_pred HHHHHHHHHHHhhccCCCchheeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccc-----------------
Confidence 4578999999999449999999998865 567899999998 69999997653211000000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
....+...+.+..+..++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 126 --------------------------~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~ 179 (304)
T cd05101 126 --------------------------IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179 (304)
T ss_pred --------------------------cccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEEC
Confidence 000112234455566699999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||.+........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 180 D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--- 255 (304)
T cd05101 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG--- 255 (304)
T ss_pred CCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---
Confidence 9999886643221 12234567899999987755 8999999999999999998 88999877655544433210
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..++.++.+||.+||..+|.+|||+.++++.
T Consensus 256 ---------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 256 ---------------------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ---------------------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 0011123578899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=300.97 Aligned_cols=210 Identities=22% Similarity=0.342 Sum_probs=175.0
Q ss_pred CCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-------ccHHHHHHHHHH
Q psy9855 5 CPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-------ISEKRAKEILYQ 76 (470)
Q Consensus 5 ~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-------l~~~~~~~~~~~ 76 (470)
+...+...|++|..+|..++ |||||+++|++.. .+..+|++|||+ |||..||++.+. ++..+...
T Consensus 734 ~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~---- 806 (1025)
T KOG1095|consen 734 SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLA---- 806 (1025)
T ss_pred CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHH----
Confidence 34455778999999999999 9999999999876 677899999999 699999998732 44444433
Q ss_pred HHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q psy9855 77 VKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPE 156 (470)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~ 156 (470)
++.||++|+.||+++++|||||...
T Consensus 807 -------------------------------------------------------~a~dvA~G~~YLe~~~fvHRDLAaR 831 (1025)
T KOG1095|consen 807 -------------------------------------------------------FALDVAKGMNYLESKHFVHRDLAAR 831 (1025)
T ss_pred -------------------------------------------------------HHHHHhhhhHHHHhCCCcCcchhhh
Confidence 9999999999999999999999999
Q ss_pred cEEEeCC-eEEEEecCCcccccCCCcccc--c-cccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCh
Q psy9855 157 NILIRGD-LVVVGDLGSLQFIKSKGLHTE--Y-IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSE 231 (470)
Q Consensus 157 NILl~~~-~ikL~DFG~a~~~~~~~~~~~--~-~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~ 231 (470)
|+|++.. .+||+|||+|+.+........ . .-...|||||.+... .++.++|||||||++||+++ |..||++.+.
T Consensus 832 NCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 832 NCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred heeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 9999998 899999999996654443321 1 223569999999874 49999999999999999998 9999999998
Q ss_pred HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 232 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+.+..+... +.-..++.+++.+.++|..||+.+|++||++..+++
T Consensus 911 ~~v~~~~~~g------------------------------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 911 FEVLLDVLEG------------------------------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHHHHhC------------------------------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 8877655441 122234678999999999999999999999999996
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=260.32 Aligned_cols=205 Identities=20% Similarity=0.328 Sum_probs=163.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++..++ ||||+++++++.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 36 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 97 (250)
T cd05085 36 KIKFLSEARILKQYD-HPNIVKLIGVCTQ--RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK--------------- 97 (250)
T ss_pred HHHHHHHHHHHHhCC-CCCcCeEEEEEec--CCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHH---------------
Confidence 346789999999998 9999999998864 567899999998 699999875433 56666555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||.|||++|++||||||+||+++.+ .++
T Consensus 98 --------------------------------------------~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~ 133 (250)
T cd05085 98 --------------------------------------------FALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLK 133 (250)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||++......... ....++..|+|||++.+.. ++.++|||||||++|++++ |..||.+.........+....
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~- 211 (250)
T cd05085 134 ISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY- 211 (250)
T ss_pred ECCCccceeccccccccCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999988754432221 1223456799999887654 7899999999999999998 999998776554443332110
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.......++..+.+++.+||..+|++|||+.++++
T Consensus 212 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 -----------------------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01122357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=270.73 Aligned_cols=221 Identities=20% Similarity=0.335 Sum_probs=163.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+.+||||+++++++.. .+..|+||||++ |+|.+++.........
T Consensus 68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~--------------------- 124 (307)
T cd05098 68 SDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGME--------------------- 124 (307)
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccc---------------------
Confidence 4578899999999559999999998864 567999999999 6999999764321000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.+ ........+.+..+..++.||+.||+|||++|++||||||+|||++.+ .++|+
T Consensus 125 ------------~~~~----------~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~ 182 (307)
T cd05098 125 ------------YCYN----------PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182 (307)
T ss_pred ------------cccc----------cccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEEC
Confidence 0000 000111234445566699999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||.+......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 183 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--- 258 (307)
T cd05098 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG--- 258 (307)
T ss_pred CCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC---
Confidence 99998765432211 1223456899999887755 7999999999999999998 88999776544433332210
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..++.++.+||.+||..+|.+|||+.++++
T Consensus 259 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 259 ---------------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred ---------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 011123456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=268.78 Aligned_cols=209 Identities=27% Similarity=0.462 Sum_probs=173.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++.++.+||||+++++++.. .+..++|||+++ ++|.+++.....+++..+..
T Consensus 45 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~---------------- 106 (280)
T cd05581 45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF---------------- 106 (280)
T ss_pred HHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 45678999999999779999999998854 678999999996 69999998877788877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||.|||+.|++|+||+|+||+++.+ .++|
T Consensus 107 -------------------------------------------i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l 143 (280)
T cd05581 107 -------------------------------------------YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKI 143 (280)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEe
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC---------------------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy9855 168 GDLGSLQFIKSKG---------------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226 (470)
Q Consensus 168 ~DFG~a~~~~~~~---------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf 226 (470)
+|||++....... ......++..|+|||++.+.. ++.++|||||||++|++++|..||
T Consensus 144 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred cCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999887654322 112346788999999887654 788999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH----
Q psy9855 227 PGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA---- 302 (470)
Q Consensus 227 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~---- 302 (470)
...+....+..+... ...++..+++.+.+||.+||..||.+|||+
T Consensus 223 ~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 271 (280)
T cd05581 223 RGSNEYLTFQKILKL-------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGY 271 (280)
T ss_pred CCccHHHHHHHHHhc-------------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCH
Confidence 877654444333211 111234568889999999999999999999
Q ss_pred HHHHhcccC
Q psy9855 303 QKILSCAYF 311 (470)
Q Consensus 303 ~elL~hp~f 311 (470)
+++++||||
T Consensus 272 ~~ll~~~~~ 280 (280)
T cd05581 272 DELKAHPFF 280 (280)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=267.20 Aligned_cols=229 Identities=18% Similarity=0.258 Sum_probs=166.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..++ ||||+++++.+.. .+..++|+||+. ++|.+++...........-
T Consensus 47 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~----------------- 106 (290)
T cd05045 47 LRDLLSEFNLLKQVN-HPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLG----------------- 106 (290)
T ss_pred HHHHHHHHHHHhhCC-CCCEeeEEEEEec--CCCcEEEEEecCCCCHHHHHHhcCCccccccc-----------------
Confidence 346789999999999 9999999998854 567899999999 6999998754321110000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
..+.. ............+....+..++.|++.||+|||++||+||||||+|||++++ .++|
T Consensus 107 ---------------~~~~~---~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl 168 (290)
T cd05045 107 ---------------SDGNR---NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKI 168 (290)
T ss_pred ---------------ccccc---ccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEe
Confidence 00000 0000011122345566677799999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.........+....
T Consensus 169 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~- 246 (290)
T cd05045 169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY- 246 (290)
T ss_pred ccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-
Confidence 99999876533221 12234567899999887655 8999999999999999998 999998776554433322100
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..++.++.+++.+||+.+|.+||++.++++
T Consensus 247 -----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 247 -----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01112356789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=266.07 Aligned_cols=201 Identities=19% Similarity=0.270 Sum_probs=157.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.++..++ ||||+++++++.. ....++||||++ |+|..++.... .+++..+..
T Consensus 61 ~~~~~~~~~~~~l~-h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~---------------- 121 (274)
T cd05076 61 LAFFETASLMSQVS-HIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT---------------- 121 (274)
T ss_pred HHHHHHHHHHhcCC-CCCeeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHH----------------
Confidence 35678999999999 9999999999865 567899999999 69999986533 366666655
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.||+|||++||+||||||+|||++..
T Consensus 122 -------------------------------------------i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 122 -------------------------------------------VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred -------------------------------------------HHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999999743
Q ss_pred ---eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHH
Q psy9855 164 ---LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETL-TRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 164 ---~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ell-tg~~pf~~~~~~~~~~~i~ 239 (470)
.++++|||.+...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||.+....+....+.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 235 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence 4799999987543322 23367888999998876555899999999999999995 6999997765433222111
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.. ...+...+..+.++|.+||..+|++|||+.++|++
T Consensus 236 ~~--------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 236 KK--------------------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hc--------------------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 00 00112345678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=263.51 Aligned_cols=215 Identities=19% Similarity=0.230 Sum_probs=157.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. ....++||||++ |+|.+++........
T Consensus 39 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------- 94 (269)
T cd05087 39 QMKFLEEAQPYRSLQ-HSNLLQCLGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAEL--------------------- 94 (269)
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEcC--CCCcEEEEECCCCCcHHHHHHHhhhccc---------------------
Confidence 346789999999999 9999999998854 567899999999 699999865321000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
.......++.++.|++.||+|||+.|++||||||+||+++.+ .++|
T Consensus 95 ---------------------------------~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL 141 (269)
T cd05087 95 ---------------------------------MTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKI 141 (269)
T ss_pred ---------------------------------ccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEE
Confidence 001112233389999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCC------CCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEG------YYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDR 237 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~------~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~ 237 (470)
+|||.+........ .....++..|+|||++.+.. .++.++|||||||++|||++ |..||......+....
T Consensus 142 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 221 (269)
T cd05087 142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY 221 (269)
T ss_pred CCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 99998875443221 12346778899999885421 25789999999999999996 9999977655444332
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
...... . ...........++.+.++|..|| .+|++|||+++++.
T Consensus 222 ~~~~~~-------------------~------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 222 TVREQQ-------------------L------KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred Hhhccc-------------------C------CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 211000 0 00001112246778899999999 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=262.57 Aligned_cols=205 Identities=22% Similarity=0.342 Sum_probs=164.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.++++++ ||||+++++++.. .+..++||||++ ++|.+++.... .++...+..
T Consensus 45 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 107 (261)
T cd05068 45 PKDFLAEAQIMKKLR-HPKLIQLYAVCTL--EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID-------------- 107 (261)
T ss_pred HHHHHHHHHHHHHCC-CCCccceeEEEec--CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHH--------------
Confidence 456889999999999 9999999998754 667899999996 69999997654 366666555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.|++.||.|||++||+||||||+||+++.+ .+
T Consensus 108 ---------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (261)
T cd05068 108 ---------------------------------------------MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNIC 142 (261)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCccc--cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLHT--EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||++.......... ...++..|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 221 (261)
T cd05068 143 KVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY 221 (261)
T ss_pred EECCcceEEEccCCcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999988765322211 112345799999887654 7999999999999999999 999998876655554442210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.......++..+.+++.+||..+|.+||++.++++
T Consensus 222 ------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 222 ------------------------------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------------------------------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 01122356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.07 Aligned_cols=223 Identities=29% Similarity=0.419 Sum_probs=170.2
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGW 91 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (470)
-+.|||..|+.-+.|||||++++ .+.+....||..|+|..+|.++++.... +...
T Consensus 548 ~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIalELC~~sL~dlie~~~~--d~~~--------------------- 602 (903)
T KOG1027|consen 548 FAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIALELCACSLQDLIESSGL--DVEM--------------------- 602 (903)
T ss_pred HHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEehHhhhhHHHHHhcccc--chhh---------------------
Confidence 45799999999999999999977 4466889999999999999999987411 0000
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---C---eE
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG---D---LV 165 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---~---~i 165 (470)
.+. .....++.|++.||++||+-+||||||||.||||+. + .+
T Consensus 603 -------------~~~-------------------i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra 650 (903)
T KOG1027|consen 603 -------------QSD-------------------IDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRA 650 (903)
T ss_pred -------------ccc-------------------ccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeE
Confidence 000 112238999999999999999999999999999976 2 68
Q ss_pred EEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~ 240 (470)
+|+|||+++.+..+. ...+..||-+|+|||++.... -+.++||||+||++|+.++| ..||.+.... -.+|..
T Consensus 651 ~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~ 727 (903)
T KOG1027|consen 651 KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILT 727 (903)
T ss_pred EecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhc
Confidence 899999998876433 234568999999999998766 57799999999999999985 8999554221 122221
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHHHH
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQY 320 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~~~ 320 (470)
| ......+.+....++.|||.+|++++|..||+|.++|.||+|..-....++
T Consensus 728 --~--------------------------~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~F 779 (903)
T KOG1027|consen 728 --G--------------------------NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSF 779 (903)
T ss_pred --C--------------------------ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHH
Confidence 0 111111222222388999999999999999999999999999987765555
Q ss_pred HH
Q psy9855 321 LE 322 (470)
Q Consensus 321 ~~ 322 (470)
+.
T Consensus 780 l~ 781 (903)
T KOG1027|consen 780 LR 781 (903)
T ss_pred HH
Confidence 43
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=268.98 Aligned_cols=217 Identities=21% Similarity=0.326 Sum_probs=169.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++.++.+||||+++++.+.. ....|+||||+. |+|.+++.....+++..+..
T Consensus 49 ~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~----------------- 109 (288)
T cd05583 49 EHTRTERQVLEAVRRCPFLVTLHYAFQT--DTKLHLILDYVNGGELFTHLYQREHFTESEVRV----------------- 109 (288)
T ss_pred HHHHHHHHHHHhccCCcchhhhheeeec--CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHH-----------------
Confidence 3467899999999769999999998854 677999999998 59999987666577766666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.|++.||+|||+.|++||||+|+||+++.+ .++|+
T Consensus 110 ------------------------------------------~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~ 147 (288)
T cd05583 110 ------------------------------------------YIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLT 147 (288)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEE
Confidence 89999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCc--cccccccCcccCchhhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 169 DLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEG-YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 169 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|||++........ .....|+..|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+.+..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--- 224 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--- 224 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH---
Confidence 9998876543321 22346889999999886543 36789999999999999999999996433221111111100
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC---HHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT---AQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt---~~elL~hp~f~~~~ 315 (470)
. ......+..++..+.++|.+||..||++||| +.++|+||||+.+.
T Consensus 225 --------~----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 225 --------L----------------KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred --------H----------------ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 0 0001123456788999999999999999998 56789999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=261.58 Aligned_cols=206 Identities=25% Similarity=0.319 Sum_probs=159.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+++.++ ||||+++++++.. .++..++||||+. |+|.+++..... .+...+..
T Consensus 40 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 102 (262)
T cd05058 40 VEQFLKEGIIMKDFS-HPNVLSLLGICLP-SEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG--------------- 102 (262)
T ss_pred HHHHHHHHHHHccCC-CCCcceEEEEeec-CCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHH---------------
Confidence 346789999999998 9999999997653 2456889999999 699999975433 34433333
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+.|++||||||+|||++.+ .++
T Consensus 103 --------------------------------------------~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~k 138 (262)
T cd05058 103 --------------------------------------------FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVK 138 (262)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEE
Confidence 88999999999999999999999999999988 899
Q ss_pred EEecCCcccccCCCc-----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 167 L~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
|+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+..+....+..
T Consensus 139 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 217 (262)
T cd05058 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217 (262)
T ss_pred ECCccccccccCCcceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 999999875543211 12334577899999887655 8899999999999999999 5677876655443333211
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. ........+++.+.+++.+||..+|++||++.++++
T Consensus 218 ~------------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 218 G------------------------------RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred C------------------------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 000111245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=262.02 Aligned_cols=205 Identities=22% Similarity=0.362 Sum_probs=165.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|+.++ ||||+++++++.. ....++||||++ ++|.+++..... ++...+..
T Consensus 46 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 108 (261)
T cd05148 46 QQDFQKEVQALKRLR-HKHLISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID-------------- 108 (261)
T ss_pred HHHHHHHHHHHhcCC-CcchhheeeeEec--CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHH--------------
Confidence 446789999999999 9999999998854 667999999999 599999976432 55555555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+||+++.+ .+
T Consensus 109 ---------------------------------------------~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~ 143 (261)
T cd05148 109 ---------------------------------------------MACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVC 143 (261)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeeccccCcceEEEcCCceE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCcc-ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 166 VVGDLGSLQFIKSKGLH-TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|+|||.+......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+..+.....
T Consensus 144 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 222 (261)
T cd05148 144 KVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR 222 (261)
T ss_pred EEccccchhhcCCccccccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc
Confidence 99999998766433221 2334567899999887654 8899999999999999998 8999988776555554432110
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+++.+.++|.+||..||.+|||+.++++
T Consensus 223 ------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 ------------------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1122467789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=260.77 Aligned_cols=203 Identities=19% Similarity=0.330 Sum_probs=162.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.++++++ |+||+++++++. ....++||||++ ++|.+++.... .+++..+..
T Consensus 45 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 106 (260)
T cd05070 45 PESFLEEAQIMKKLR-HDKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD-------------- 106 (260)
T ss_pred HHHHHHHHHHHHhcC-CCceEEEEeEEC---CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHH--------------
Confidence 456889999999998 999999999763 345799999998 59999987543 256655555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+||+++++ .+
T Consensus 107 ---------------------------------------------~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~ 141 (260)
T cd05070 107 ---------------------------------------------MAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVC 141 (260)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCcccCCCccceEEEeCCceE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||.+......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05070 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY 220 (260)
T ss_pred EeCCceeeeeccCcccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998765433211 1234566799999886654 7899999999999999999 899998876655554442210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
....+...+..+.+|+.+||..||.+|||+.+++
T Consensus 221 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 221 ------------------------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ------------------------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 0112235678899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=262.94 Aligned_cols=198 Identities=23% Similarity=0.290 Sum_probs=159.1
Q ss_pred hHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccC
Q psy9855 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWD 92 (470)
Q Consensus 14 ~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (470)
.+|...+.... ||||+++++++.. ....++||||++ |+|.+++.....+++..+..
T Consensus 33 ~~~~~~~~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~-------------------- 89 (237)
T cd05576 33 SRERLTIIPHC-VPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR-------------------- 89 (237)
T ss_pred hhHHHHHHhcC-CCceeehhhheec--CCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHH--------------------
Confidence 45666666666 9999999998864 678999999999 59999998766677777777
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecC
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG 171 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG 171 (470)
++.||+.||+|||++||+||||||+||+++.+ .++++|||
T Consensus 90 ---------------------------------------~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~ 130 (237)
T cd05576 90 ---------------------------------------WAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS 130 (237)
T ss_pred ---------------------------------------HHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeccc
Confidence 99999999999999999999999999999987 89999999
Q ss_pred CcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Q psy9855 172 SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251 (470)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 251 (470)
.+...... .....++..|+|||.+.+.. ++.++||||+||++|+|++|..||...... +.
T Consensus 131 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~------------ 190 (237)
T cd05576 131 RWSEVEDS--CDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSG-----IN------------ 190 (237)
T ss_pred chhccccc--cccCCcCccccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc------------
Confidence 87655432 23345677899999886544 788999999999999999999887432100 00
Q ss_pred HHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-----HHHHhcccC
Q psy9855 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-----QKILSCAYF 311 (470)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-----~elL~hp~f 311 (470)
......+++.+++.+.+||.+||+.||.+|||+ +++++||||
T Consensus 191 ------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 ------------------THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ------------------cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 000011234578899999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=260.86 Aligned_cols=203 Identities=20% Similarity=0.296 Sum_probs=164.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.++..++ |+||+++++++.. ....++||||++ ++|.+++.... .+++..+..
T Consensus 44 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 106 (256)
T cd05039 44 AQAFLAEASVMTTLR-HPNLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG-------------- 106 (256)
T ss_pred HHHHHHHHHHHHhcC-CcceeeeEEEEcC--CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHH--------------
Confidence 456889999999999 9999999998865 677999999999 69999997665 366666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.|++.||.|||++|++||||||+||+++.+ .+
T Consensus 107 ---------------------------------------------~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~ 141 (256)
T cd05039 107 ---------------------------------------------FALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA 141 (256)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCccchhcccceEEEeCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|+|||.+........ ...++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+...
T Consensus 142 ~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--- 215 (256)
T cd05039 142 KVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG--- 215 (256)
T ss_pred EEcccccccccccccc--cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---
Confidence 9999999887643222 234566799999887654 7889999999999999997 99999776654443332210
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++.+.++|.+||..+|++|||+.++++
T Consensus 216 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 ---------------------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------------------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001122356889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=263.62 Aligned_cols=205 Identities=30% Similarity=0.539 Sum_probs=161.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+.+|+.+|+.++ ||||+++++++.. .+..++|+||++ |+|.+++... ..+++..+..
T Consensus 47 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~------------- 110 (267)
T cd08228 47 QDCVKEIDLLKQLN-HPNVIKYLDSFIE--DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK------------- 110 (267)
T ss_pred HHHHHHHHHHHhCC-CcceeeeeeeEEE--CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHH-------------
Confidence 45789999999999 9999999998865 568999999999 5999988532 2255555555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++|++|+||||+||+++.+ .
T Consensus 111 ----------------------------------------------~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~ 144 (267)
T cd08228 111 ----------------------------------------------YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV 144 (267)
T ss_pred ----------------------------------------------HHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC
Confidence 99999999999999999999999999999887 8
Q ss_pred EEEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE--IDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~~ 241 (470)
++|+|||.+........ .....|+..|+|||.+.+.. ++.++||||+||++|+|++|..||..... ......+..
T Consensus 145 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~- 222 (267)
T cd08228 145 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ- 222 (267)
T ss_pred EEECccccceeccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-
Confidence 99999998876653322 23457888999999987755 78999999999999999999999865432 121111110
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+. .......++..+.++|.+||..+|++|||+.++++
T Consensus 223 ~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 223 CDY----------------------------PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred CCC----------------------------CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 000 00111246788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=263.94 Aligned_cols=204 Identities=19% Similarity=0.272 Sum_probs=162.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++..+. ||||+++++++.. ...++++||++ |+|.+++..... +++..+..
T Consensus 53 ~~~~~~e~~~l~~~~-~~~i~~~~~~~~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~--------------- 113 (279)
T cd05109 53 NKEILDEAYVMAGVG-SPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN--------------- 113 (279)
T ss_pred HHHHHHHHHHHHhcC-CCCCceEEEEEcC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHH---------------
Confidence 456789999999998 9999999998853 34789999999 799999976543 77777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 114 --------------------------------------------~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~k 149 (279)
T cd05109 114 --------------------------------------------WCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVK 149 (279)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEE
Confidence 99999999999999999999999999999876 899
Q ss_pred EEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++......... ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||...........+...
T Consensus 150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~- 227 (279)
T cd05109 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG- 227 (279)
T ss_pred ECCCCceeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-
Confidence 9999998866532221 1223467899999987655 8999999999999999998 99999766544333222110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........++.++.+++.+||..||++||++.+++.
T Consensus 228 -----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 228 -----------------------------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------------------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001112356788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=262.12 Aligned_cols=205 Identities=21% Similarity=0.320 Sum_probs=164.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|..++ ||||+++++++.. .+..|+||||++ ++|.+++..... ++...+..
T Consensus 49 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 110 (267)
T cd05066 49 RRDFLSEASIMGQFD-HPNIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG--------------- 110 (267)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEec--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHH---------------
Confidence 456789999999998 9999999998854 567999999998 599999976543 56665555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++|++||||||+|||++.+ .++
T Consensus 111 --------------------------------------------i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 111 --------------------------------------------MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||.+......... ....++..|+|||.+.+.. ++.++|+|||||++|++++ |..||.+....+....+...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~ 225 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC
Confidence 9999998866532211 1122356799999987655 7999999999999999886 99999877665554444321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. ......+++.+.+++.+||+.+|.+||++.++++
T Consensus 226 ~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 226 YR------------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred Cc------------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 10 0112356788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=271.44 Aligned_cols=222 Identities=20% Similarity=0.315 Sum_probs=166.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++.++.+||||+++++++.. .+.+++|+||++ |+|.+++............
T Consensus 62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------------------ 121 (334)
T cd05100 62 SDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSF------------------ 121 (334)
T ss_pred HHHHHHHHHHHhhcCCCCeeeeeEEEcc--CCceEEEEecCCCCcHHHHHHhcCCccccccc------------------
Confidence 4678999999999449999999998864 567999999998 6999998754321000000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
.....+...+.+..+..++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 122 -------------------------~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~ 176 (334)
T cd05100 122 -------------------------DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIA 176 (334)
T ss_pred -------------------------ccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEEC
Confidence 0001122334455666699999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||+++....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 252 (334)
T cd05100 177 DFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG--- 252 (334)
T ss_pred CcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---
Confidence 9999876543221 12233456799999987755 8899999999999999998 88999877655544433210
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 253 ---------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 253 ---------------------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ---------------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 0111223567889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=265.89 Aligned_cols=224 Identities=21% Similarity=0.265 Sum_probs=164.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|.+++ ||||+++++++.. ....++||||+. ++|.+++......+...
T Consensus 61 ~~~~~~ei~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~------------------- 118 (295)
T cd05097 61 RNDFLKEIKIMSRLK-NPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFT------------------- 118 (295)
T ss_pred HHHHHHHHHHHHhCC-CCCcCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhcccccccc-------------------
Confidence 345789999999999 9999999998854 667999999999 59999986532100000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
............+..++.||+.||+|||++|++||||||+||+++.+ .++|
T Consensus 119 ----------------------------~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl 170 (295)
T cd05097 119 ----------------------------HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKI 170 (295)
T ss_pred ----------------------------ccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEe
Confidence 00001122334455599999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+.+..+....
T Consensus 171 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~ 249 (295)
T cd05097 171 ADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFF 249 (295)
T ss_pred cccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhh
Confidence 99999876543221 12234567899999887655 8999999999999999988 667887766555444433211
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
... .........+.+++.+.+|+.+||..||++|||++++++
T Consensus 250 ~~~-----------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 250 RNQ-----------------------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hhc-----------------------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 000011123356789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=261.95 Aligned_cols=205 Identities=21% Similarity=0.308 Sum_probs=163.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|++++..++ ||||+++++++.. .+..++||||++ ++|.+++.... .+++..+..
T Consensus 50 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 111 (268)
T cd05063 50 RQDFLSEASIMGQFS-HHNIIRLEGVVTK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG--------------- 111 (268)
T ss_pred HHHHHHHHHHHhcCC-CCCeeEEEEEEcc--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHH---------------
Confidence 446789999999998 9999999998854 567899999999 59999987643 366666665
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||+|||+.|++||||||+||+++.+ .++
T Consensus 112 --------------------------------------------~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~k 147 (268)
T cd05063 112 --------------------------------------------MLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECK 147 (268)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEE
Confidence 99999999999999999999999999999888 899
Q ss_pred EEecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||++......... .....+..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~ 226 (268)
T cd05063 148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226 (268)
T ss_pred ECCCccceecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC
Confidence 9999988765432211 1112345799999887654 7899999999999999997 99999877665555444321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. ......++..+.+++.+||..+|.+||++.++++
T Consensus 227 ~~------------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 227 FR------------------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CC------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 10 0011246788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=260.47 Aligned_cols=204 Identities=22% Similarity=0.351 Sum_probs=162.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ ||||+++++++. .+..++||||++ ++|.+++..... ++...+..
T Consensus 45 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 106 (260)
T cd05069 45 PEAFLQEAQIMKKLR-HDKLVPLYAVVS---EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD-------------- 106 (260)
T ss_pred HHHHHHHHHHHHhCC-CCCeeeEEEEEc---CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHH--------------
Confidence 346789999999999 999999998763 345799999999 599999975432 45555544
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||+.|++|+||||+||+++++ .+
T Consensus 107 ---------------------------------------------~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~ 141 (260)
T cd05069 107 ---------------------------------------------MAAQIADGMAYIERMNYIHRDLRAANILVGDNLVC 141 (260)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||.+......... ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05069 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY 220 (260)
T ss_pred EECCCccceEccCCcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998765433211 2234567899999887654 7899999999999999999 999998876655544432210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..++..+.+++.+||..||.+||+++++++
T Consensus 221 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 221 ------------------------------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ------------------------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01122356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=261.32 Aligned_cols=211 Identities=18% Similarity=0.217 Sum_probs=159.7
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc----ccHHHHHHHHHHHHhhhcc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN----ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~----l~~~~~~~~~~~~~~~~~~ 83 (470)
....+++|+.++..++ ||||+++++.+.. ....|+||||++ |+|.+++..... .++..+..
T Consensus 38 ~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~----------- 103 (268)
T cd05086 38 EQNEFLQQGDPYRILQ-HPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR----------- 103 (268)
T ss_pred HHHHHHHHHHHHhccC-CcchhheEEEecC--CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHH-----------
Confidence 3457899999999998 9999999998864 567899999999 699999875421 23333333
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
++.||+.||+|||+.|++||||||+|||++.+
T Consensus 104 ------------------------------------------------~~~~i~~al~~lH~~~i~H~dikp~nil~~~~ 135 (268)
T cd05086 104 ------------------------------------------------MACEIAAGVTHMHKHNFLHSDLALRNCFLTSD 135 (268)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHCCeeccCCccceEEEcCC
Confidence 89999999999999999999999999999887
Q ss_pred -eEEEEecCCcccccCCC---ccccccccCcccCchhhccC------CCCCCcccHHHHHHHHHHHHh-CCCCCCCCChH
Q psy9855 164 -LVVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTE------GYYSFELDIWAAGCVFYETLT-RNPLFPGDSEI 232 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~------~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~ 232 (470)
.++|+|||++....... .....+++..|+|||++... ..++.++|||||||++|||++ |..||......
T Consensus 136 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 215 (268)
T cd05086 136 LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215 (268)
T ss_pred ccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 89999999875432211 12345788899999987431 125788999999999999997 67888777665
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+.+..+...... ......+...+++.+.+++..|| .+|++|||++++++
T Consensus 216 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 216 EVLNHVIKDQQV-------------------------KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHhhccc-------------------------ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 555544321000 00001122346788899999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=260.85 Aligned_cols=212 Identities=23% Similarity=0.337 Sum_probs=161.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.++ ||||+++++++.. ....++||||++ ++|.+++.......
T Consensus 43 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~---------------------- 97 (269)
T cd05044 43 KKEFLKEAHLMSNFN-HPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVER---------------------- 97 (269)
T ss_pred HHHHHHHHHHHHhcC-CCCeeeEeeeecC--CCCeEEEEeccCCCcHHHHHHHhhhcc----------------------
Confidence 446789999999999 9999999998864 567999999998 69999986532100
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
.....+.+..+..++.||+.||+|||+.|++|+||||+||+++.+
T Consensus 98 ------------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~ 147 (269)
T cd05044 98 ------------------------------FGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDAD 147 (269)
T ss_pred ------------------------------cCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCC
Confidence 000112223344499999999999999999999999999999864
Q ss_pred -eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy9855 164 -LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRI 238 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i 238 (470)
.++|+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+
T Consensus 148 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~ 226 (269)
T cd05044 148 RVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226 (269)
T ss_pred cceEECCcccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence 589999999876543221 12234567899999887655 7999999999999999998 99999877665544433
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
... ........++..+.++|.+||..+|.+||+++++++
T Consensus 227 ~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 227 TAG------------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred hcC------------------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 210 001122356788999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=264.43 Aligned_cols=220 Identities=21% Similarity=0.333 Sum_probs=160.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+++|..++ ||||+++++++...+...+++||||++ ++|.+++..... +++..+..
T Consensus 50 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~---------------- 112 (284)
T cd05081 50 RDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL---------------- 112 (284)
T ss_pred HHHHHHHHHHHhCC-CCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHH----------------
Confidence 35689999999999 999999999876555667999999998 699999976433 66666665
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|
T Consensus 113 -------------------------------------------~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l 149 (284)
T cd05081 113 -------------------------------------------YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKI 149 (284)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++......... ....++..|+|||++.+.. ++.++|||||||++|||++|..++..... ..... .+
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~----~~ 223 (284)
T cd05081 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRM----MG 223 (284)
T ss_pred CCCcccccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhh----cc
Confidence 999998866432211 1123345699999987654 78999999999999999998877644321 11111 11
Q ss_pred CCch--HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKA--ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.... .....+..... ..........++.++.+||.+||..+|++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 224 NDKQGQMIVYHLIELLK-----------NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cccccccchHHHHHHHh-----------cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1000 00000000000 00111123467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=264.18 Aligned_cols=221 Identities=23% Similarity=0.396 Sum_probs=162.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.+|+.++ ||||+++++++...+....++||||++ ++|.+++..... ++...+..
T Consensus 51 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~---------------- 113 (284)
T cd05079 51 ADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK---------------- 113 (284)
T ss_pred HHHHHHHHHHHhCC-CCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHH----------------
Confidence 46789999999998 999999999887654567899999998 599999865432 66666665
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|
T Consensus 114 -------------------------------------------i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l 150 (284)
T cd05079 114 -------------------------------------------YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKI 150 (284)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++++.|+..... . .....+
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~---~~~~~~ 224 (284)
T cd05079 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--L---FLKMIG 224 (284)
T ss_pred CCCccccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--h---hhhhcc
Confidence 99999886643221 12345677899999887654 78999999999999999998776533211 1 111111
Q ss_pred CCchHH-HHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAET-LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+. ......... ..........++..+.+||.+||+.||.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 225 PTHGQMTVTRLVRVLE-----------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cccccccHHHHHHHHH-----------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111110 000000000 000111234578899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=262.62 Aligned_cols=203 Identities=18% Similarity=0.259 Sum_probs=159.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+..|+.++.++. ||||+++++++. ....++|+||+. |+|.+++.... .+++..+..
T Consensus 54 ~~~~~~~~~l~~l~-h~~iv~~~~~~~---~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~---------------- 113 (279)
T cd05111 54 QEITDHMLAMGSLD-HAYIVRLLGICP---GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN---------------- 113 (279)
T ss_pred HHHHHHHHHHhcCC-CCCcceEEEEEC---CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHH----------------
Confidence 34567888999998 999999999864 345789999998 79999997644 366766666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++|++||||||+|||++.+ .++|
T Consensus 114 -------------------------------------------i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl 150 (279)
T cd05111 114 -------------------------------------------WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQI 150 (279)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEE
Confidence 99999999999999999999999999999888 8999
Q ss_pred EecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||.++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.........+...
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-- 227 (279)
T cd05111 151 ADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-- 227 (279)
T ss_pred cCCccceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--
Confidence 9999987654322 123345677899999887654 8999999999999999998 99999876554432222110
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........++..+.+++.+||..||++|||+.++++
T Consensus 228 ----------------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 228 ----------------------------ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000111235677899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=260.49 Aligned_cols=204 Identities=21% Similarity=0.344 Sum_probs=162.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+++++.++ ||||+++++.+. ....++||||++ |+|.+++.... .++...+..
T Consensus 45 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 106 (262)
T cd05071 45 PEAFLQEAQVMKKLR-HEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-------------- 106 (262)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEC---CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHH--------------
Confidence 346789999999998 999999998763 345799999999 59999997532 255555555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.|++.||+|||++||+||||||+||+++.+ .+
T Consensus 107 ---------------------------------------------~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~ 141 (262)
T cd05071 107 ---------------------------------------------MAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 141 (262)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCccccccCcccEEEcCCCcE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||.+......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+....
T Consensus 142 ~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~ 220 (262)
T cd05071 142 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 220 (262)
T ss_pred EeccCCceeeccccccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC
Confidence 99999998765433221 2234567899999887655 8999999999999999999 889998776555444332100
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.......++..+.++|.+||+.||++|||+.++++
T Consensus 221 ------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 221 ------------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------------------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00112457788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=264.12 Aligned_cols=227 Identities=19% Similarity=0.260 Sum_probs=166.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++..++ ||||+++++++.. ....++||||++ |+|.+++.............
T Consensus 52 ~~~~~~ei~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 112 (288)
T cd05050 52 QADFQREAALMAEFD-HPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH---------------- 112 (288)
T ss_pred HHHHHHHHHHHHhcC-CCchheEEEEEcC--CCccEEEEecCCCCCHHHHHHHcCccccccccc----------------
Confidence 345788999999998 9999999998854 567899999999 69999997644311111100
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++ ............+....+..++.||+.||+|||++|++||||||+||+++.+ .++|
T Consensus 113 -----------------~~----~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l 171 (288)
T cd05050 113 -----------------ST----SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 171 (288)
T ss_pred -----------------cc----cccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEE
Confidence 00 0000011111234455666799999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||.+........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~--- 247 (288)
T cd05050 172 ADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD--- 247 (288)
T ss_pred CccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---
Confidence 99998875543221 12234466799999887655 8999999999999999997 8889977765554433321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+..++.++.+||.+||..||.+|||+.|+++
T Consensus 248 ---------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 248 ---------------------------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ---------------------------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0011122356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=276.07 Aligned_cols=264 Identities=16% Similarity=0.164 Sum_probs=171.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHH---HHHhhh----c
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILY---QVKAAN----E 82 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~---~~~~~~----~ 82 (470)
..+++|+++|.++.+||||+++++++.. .+.+++|||||. |+|.+++................ .+.... .
T Consensus 85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (401)
T cd05107 85 QALMSELKIMSHLGPHLNIVNLLGACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLS 162 (401)
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEEEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccc
Confidence 4678999999999779999999998865 567999999999 69999997654210000000000 000000 0
Q ss_pred cccc---------------------------------cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHH
Q psy9855 83 TAAH---------------------------------YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHT 129 (470)
Q Consensus 83 ~~~~---------------------------------~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~ 129 (470)
.... +............+.+.....+...... ........+....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~ 241 (401)
T cd05107 163 QRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRD-TLINESPALSYMDL 241 (401)
T ss_pred ccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchh-hhhcCCCCCCHHHH
Confidence 0000 0000000000000111111111100000 01122234566777
Q ss_pred HHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCC
Q psy9855 130 TFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSF 205 (470)
Q Consensus 130 ~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~ 205 (470)
..|+.||+.||+|||+.||+||||||+|||++.+ .++|+|||++....... ......++..|+|||++.+.. ++.
T Consensus 242 ~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~ 320 (401)
T cd05107 242 VGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTT 320 (401)
T ss_pred HHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCc
Confidence 8899999999999999999999999999999987 89999999987653221 112345778899999987654 789
Q ss_pred cccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHH
Q psy9855 206 ELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKG 284 (470)
Q Consensus 206 ~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 284 (470)
++|||||||++|||++ |..||......+........ + .....+..++.++
T Consensus 321 ~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~-~----------------------------~~~~~p~~~~~~l 371 (401)
T cd05107 321 LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR-G----------------------------YRMAKPAHASDEI 371 (401)
T ss_pred HhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc-C----------------------------CCCCCCCCCCHHH
Confidence 9999999999999998 89999765544433322210 0 0011223568899
Q ss_pred HHHHHHhcccCCCCCcCHHHHHh
Q psy9855 285 KKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 285 ~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+||.+||..+|.+||++.++++
T Consensus 372 ~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 372 YEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=262.71 Aligned_cols=206 Identities=22% Similarity=0.338 Sum_probs=162.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc---------cccHHHHHHHHHHHHhh
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD---------NISEKRAKEILYQVKAA 80 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~---------~l~~~~~~~~~~~~~~~ 80 (470)
..+.+|+++|.+++ ||||+++++++.+ ....|+||||++ |+|.+++.... .+++..+..
T Consensus 53 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~-------- 121 (275)
T cd05046 53 SEFRRELDMFRKLS-HKNVVRLLGLCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA-------- 121 (275)
T ss_pred HHHHHHHHHHHhcC-CcceeeeEEEECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHH--------
Confidence 45789999999998 9999999998754 567899999999 69999997655 344544444
Q ss_pred hccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE
Q psy9855 81 NETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI 160 (470)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl 160 (470)
++.||+.||+|||+.||+||||||+||++
T Consensus 122 ---------------------------------------------------~~~~l~~~l~~LH~~~i~H~dlkp~Nili 150 (275)
T cd05046 122 ---------------------------------------------------LCTQIALGMDHLSNARFVHRDLAARNCLV 150 (275)
T ss_pred ---------------------------------------------------HHHHHHHHHHHhhhcCcccCcCccceEEE
Confidence 99999999999999999999999999999
Q ss_pred eCC-eEEEEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy9855 161 RGD-LVVVGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLD 236 (470)
Q Consensus 161 ~~~-~ikL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~ 236 (470)
+.+ .++++|||++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+........
T Consensus 151 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~ 229 (275)
T cd05046 151 SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN 229 (275)
T ss_pred eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH
Confidence 887 89999999886543221 123345677899999887654 7889999999999999998 888997655444333
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.+... .........++..+.+++.+||..||.+|||+.+++..
T Consensus 230 ~~~~~-----------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 230 RLQAG-----------------------------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHcC-----------------------------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 32210 00011123577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=269.56 Aligned_cols=244 Identities=29% Similarity=0.471 Sum_probs=185.0
Q ss_pred hhhhhHHHHHHhcCCCC-------CCeeeeceeee--cCCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHH
Q psy9855 10 EVANLKEISILRKIPDH-------LNVLCLCETYV--NRSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVK 78 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~H-------pnIv~l~~~~~--~~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~ 78 (470)
.++++-||++|++++.+ .+||+|++.|. ++++.|+|+|+|+++.+|..+|..... ++...++.
T Consensus 118 tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~------ 191 (590)
T KOG1290|consen 118 TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKE------ 191 (590)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHH------
Confidence 35779999999999743 47999999997 457889999999999999999987654 77777666
Q ss_pred hhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCc
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPEN 157 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~N 157 (470)
|++||+.||.|||.. ||+|.||||+|
T Consensus 192 -----------------------------------------------------I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 192 -----------------------------------------------------ICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhcCccccCCCcce
Confidence 999999999999975 99999999999
Q ss_pred EEEe----------------------------------------------------------------------------
Q psy9855 158 ILIR---------------------------------------------------------------------------- 161 (470)
Q Consensus 158 ILl~---------------------------------------------------------------------------- 161 (470)
||+.
T Consensus 219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~ 298 (590)
T KOG1290|consen 219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP 298 (590)
T ss_pred eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence 9983
Q ss_pred ---------------------------------------C----------------------------------------
Q psy9855 162 ---------------------------------------G---------------------------------------- 162 (470)
Q Consensus 162 ---------------------------------------~---------------------------------------- 162 (470)
.
T Consensus 299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~ 378 (590)
T KOG1290|consen 299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP 378 (590)
T ss_pred cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence 0
Q ss_pred --------C----eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC--
Q psy9855 163 --------D----LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPG-- 228 (470)
Q Consensus 163 --------~----~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~-- 228 (470)
+ .+||+|||.|+.... .++.-+.|+.|+|||++.|.+ |++.+||||++|++|||+||..+|.-
T Consensus 379 ~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 379 LVNPDIPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred ccCCCCCCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 0 356677776665432 234457899999999999988 89999999999999999999999953
Q ss_pred ----CChHHHHHHHHHHhCCCchHHHHH-------HhhhccCccccccccCCCCC----cccccccccHHHHHHHHHhcc
Q psy9855 229 ----DSEIDQLDRIHQVLGTPKAETLKK-------FEKYKSSNFTYQFKQYPGGG----IDVLVPQIHEKGKKLMSEMLK 293 (470)
Q Consensus 229 ----~~~~~~~~~i~~~~g~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~Li~~~L~ 293 (470)
..+.+.++.|+.++|.-+...... +.+.........++.|+-.. ...+......++.+||.-||+
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 235788999999999877654321 11111111112222222110 011222345678899999999
Q ss_pred cCCCCCcCHHHHHhcccCCChh
Q psy9855 294 YDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 294 ~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+|++||||.++|+|||+..+.
T Consensus 536 f~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred cCccccccHHHHhcCccccCCC
Confidence 9999999999999999999764
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=260.86 Aligned_cols=205 Identities=23% Similarity=0.357 Sum_probs=162.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+++.++ ||||+++++++.. ....++||||++ ++|.+++..... ++...+..
T Consensus 49 ~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 110 (269)
T cd05065 49 RRDFLSEASIMGQFD-HPNIIHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG--------------- 110 (269)
T ss_pred HHHHHHHHHHHHhCC-CcCcceEEEEECC--CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHH---------------
Confidence 456889999999998 9999999998854 667899999998 599999876433 56655555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||+|||++|++||||||+||+++.+ .++
T Consensus 111 --------------------------------------------i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 111 --------------------------------------------MLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCcc---cccc---ccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGLH---TEYI---ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~---~~~~---gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 239 (470)
|+|||++......... .... ++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~ 225 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 9999988765432211 1111 245799999987655 7999999999999999886 999998776655444442
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.... ...+..++..+.+++.+||..+|.+||++.++++
T Consensus 226 ~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 226 QDYR------------------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCc------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2110 0112356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=259.64 Aligned_cols=200 Identities=20% Similarity=0.300 Sum_probs=157.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|+.++ ||||+++++++.. ...++||||++ |+|.+++.... .++...+..
T Consensus 45 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 105 (259)
T cd05037 45 SLAFFETASLMSQLS-HKHLVKLYGVCVR---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLD--------------- 105 (259)
T ss_pred HHHHHHHHHHHHcCC-CcchhheeeEEec---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHH---------------
Confidence 457789999999998 9999999998864 45799999999 69999998765 466666655
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 106 --------------------------------------------~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 106 --------------------------------------------VAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred --------------------------------------------HHHHHHHHHHHHhhCCeecccCccceEEEecCcccc
Confidence 99999999999999999999999999999865
Q ss_pred ----eEEEEecCCcccccCCCccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy9855 164 ----LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDR 237 (470)
Q Consensus 164 ----~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~ 237 (470)
.++|+|||++..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+.......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~ 218 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218 (259)
T ss_pred CCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH
Confidence 399999999876543 2234667789999998765 357899999999999999999 5778766542221111
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
... . ..........+.++|.+||..+|.+|||+.++++
T Consensus 219 ~~~-----------------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 219 YQD-----------------------------Q---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred Hhc-----------------------------C---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 100 0 0000112278899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=260.69 Aligned_cols=204 Identities=23% Similarity=0.346 Sum_probs=163.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+++.++ ||||+++++++.. ...++||||++ |+|.+++..... ++...+..
T Consensus 51 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 111 (270)
T cd05056 51 REKFLQEAYIMRQFD-HPHIVKLIGVITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLIL--------------- 111 (270)
T ss_pred HHHHHHHHHHHHhCC-CCchhceeEEEcC---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHH---------------
Confidence 346789999999998 9999999998753 45789999998 699999976543 66666655
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+.|++||||||+||+++.+ .++
T Consensus 112 --------------------------------------------~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 112 --------------------------------------------YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeccccChheEEEecCCCeE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCccc--cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKGLHT--EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||++.......... ...++..|+|||.+.+.. ++.++|||||||++|++++ |..||.+.+..+....+...
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-- 224 (270)
T cd05056 148 LGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-- 224 (270)
T ss_pred EccCceeeecccccceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC--
Confidence 99999987665432221 223456799999886654 7899999999999999986 99999887765554443221
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....++.++..+.++|.+||..+|.+|||+.+++.
T Consensus 225 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 225 ----------------------------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011123467889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=261.16 Aligned_cols=206 Identities=30% Similarity=0.542 Sum_probs=161.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+.+++.++ ||||+++++.+.. .+..++||||++ ++|.+++... ..+++..+..
T Consensus 46 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~------------ 110 (267)
T cd08229 46 RADCIKEIDLLKQLN-HPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK------------ 110 (267)
T ss_pred HHHHHHHHHHHHHcc-CCchhhhhheeEe--CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHH------------
Confidence 346789999999998 9999999999865 567999999999 5999998642 2255555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||.|||++|++|+||||+||+++.+
T Consensus 111 -----------------------------------------------~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~ 143 (267)
T cd08229 111 -----------------------------------------------YFVQLCSALEHMHSRRVMHRDIKPANVFITATG 143 (267)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC
Confidence 99999999999999999999999999999887
Q ss_pred eEEEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI--DQLDRIHQ 240 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~--~~~~~i~~ 240 (470)
.++|+|||.+........ .....|+..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.... .....+..
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T cd08229 144 VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 222 (267)
T ss_pred CEEECcchhhhccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc
Confidence 899999998876543322 23457899999999987655 789999999999999999999999654321 11111110
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. .........++..+.++|.+||..||.+|||+.++++
T Consensus 223 ~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 223 C-----------------------------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred C-----------------------------CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 0000011347789999999999999999999998873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=279.74 Aligned_cols=207 Identities=24% Similarity=0.362 Sum_probs=172.2
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~ 85 (470)
.....+++|.+++++|+ |||||+++|+... ...+++|||+|. |+|.++|+..+. ++..+...
T Consensus 203 ~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~------------- 266 (474)
T KOG0194|consen 203 EQIKEFMKEARVMRQLN-HPNVVRFYGVAVL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLR------------- 266 (474)
T ss_pred HHHHHHHHHHHHHHhCC-CCCEEEEEEEEcC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHH-------------
Confidence 34567899999999999 9999999998865 677999999999 699999999885 77776666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++++.+.||+|||+++++||||-..|+|++.+ .
T Consensus 267 ----------------------------------------------~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 267 ----------------------------------------------FCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred ----------------------------------------------HHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe
Confidence 99999999999999999999999999999997 6
Q ss_pred EEEEecCCcccccCCCccc-cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 165 VVVGDLGSLQFIKSKGLHT-EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+||+|||+++......... ...-...|+|||.+... .|+.++|||||||++||+++ |..||++....+....|...
T Consensus 301 vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~- 378 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN- 378 (474)
T ss_pred EEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc-
Confidence 7999999987654222222 11245679999999775 59999999999999999998 88999999988887777431
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
.-....+...+.++..++.+||..||++|||+.++.
T Consensus 379 ----------------------------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 379 ----------------------------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred ----------------------------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 111112235678889999999999999999999987
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=256.27 Aligned_cols=206 Identities=23% Similarity=0.337 Sum_probs=167.4
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+.+|+.+|..++ |+||+++++++.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 44 ~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~------------- 107 (258)
T smart00219 44 QIEEFLREARIMRKLD-HPNIVKLLGVCTE--EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLS------------- 107 (258)
T ss_pred HHHHHHHHHHHHHhcC-CCchheEEEEEcC--CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHH-------------
Confidence 3457789999999997 9999999998865 578999999998 599999976554 66666666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||+.|++||||||+||+++.+ .
T Consensus 108 ----------------------------------------------~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~ 141 (258)
T smart00219 108 ----------------------------------------------FALQIARGMEYLESKNFIHRDLAARNCLVGENLV 141 (258)
T ss_pred ----------------------------------------------HHHHHHHHHHHHhcCCeeecccccceEEEccCCe
Confidence 99999999999999999999999999999988 7
Q ss_pred EEEEecCCcccccCCCccc--cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGLHT--EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
++|+|||.+.......... ...++..|+|||.+.+. .++.++||||+||++|+|++ |.+||.+.+.......+...
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (258)
T smart00219 142 VKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG 220 (258)
T ss_pred EEEcccCCceecccccccccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 9999999988765442222 12367889999988554 48999999999999999998 88999876665555444321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........++.++.+++.+||..||++|||+.++++
T Consensus 221 ------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 221 ------------------------------YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ------------------------------CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 011122347889999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=258.05 Aligned_cols=204 Identities=23% Similarity=0.334 Sum_probs=162.0
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~ 84 (470)
.....+.+|+.++..++ ||||+++++++.. ...++||||+. ++|.+++..... +++..+..
T Consensus 41 ~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~------------ 104 (254)
T cd05083 41 VTAQAFLEETAVMTKLH-HKNLVRLLGVILH---NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ------------ 104 (254)
T ss_pred chHHHHHHHHHHHHhCC-CCCcCeEEEEEcC---CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHH------------
Confidence 34457889999999999 9999999998853 34799999998 599999976543 55555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.|++.||.|||++|++||||||+||+++.+
T Consensus 105 -----------------------------------------------~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~ 137 (254)
T cd05083 105 -----------------------------------------------FSLDVAEGMEYLESKKLVHRDLAARNILVSEDG 137 (254)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCeeccccCcceEEEcCCC
Confidence 99999999999999999999999999999887
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++...... ......+..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||.+.+..+....+...
T Consensus 138 ~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 213 (254)
T cd05083 138 VAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG- 213 (254)
T ss_pred cEEECCCccceecccc--CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-
Confidence 8999999988754322 12234456799999887644 8899999999999999997 99999877655443333210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........++..+.+++.+||..+|.+||++++++.
T Consensus 214 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 214 -----------------------------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -----------------------------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000112357789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=263.14 Aligned_cols=223 Identities=19% Similarity=0.279 Sum_probs=163.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.++ |+||+++++++.. .+..++||||++ ++|.+++.........
T Consensus 63 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------------------- 119 (296)
T cd05095 63 RNDFLKEIKIMSRLK-DPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAA-------------------- 119 (296)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCccccc--------------------
Confidence 346789999999998 9999999998865 567899999998 6999998764321100
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
.......+....+..++.||+.||+|||+.|++||||||+|||++.+ .++|
T Consensus 120 ----------------------------~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l 171 (296)
T cd05095 120 ----------------------------EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKI 171 (296)
T ss_pred ----------------------------ccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEe
Confidence 00111123344455599999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++........ .....++..|+|||+..+.. ++.++|||||||++|||++ |..||...+..+.........
T Consensus 172 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~ 250 (296)
T cd05095 172 ADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF 250 (296)
T ss_pred ccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHH
Confidence 99999876543221 12234467899999877654 8999999999999999998 778887766544443221110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. . .. .......+..++..+.+|+.+||..||.+|||+.++++
T Consensus 251 ~-----------~---~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 251 R-----------D---QG---------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred h-----------h---cc---------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 0 00 00011112356788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=276.81 Aligned_cols=217 Identities=24% Similarity=0.302 Sum_probs=157.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...|.+|+.+|.+++ |||+|+|+|+|.+.+. +.+||+|||+ |+|.+.|.... .++.
T Consensus 115 ~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W------------------- 173 (361)
T KOG1187|consen 115 EREFLNEVEILSRLR-HPNLVKLLGYCLEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDW------------------- 173 (361)
T ss_pred hhHHHHHHHHHhcCC-CcCcccEEEEEecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCH-------------------
Confidence 345999999999999 9999999999976322 6999999999 89999987654 2333
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC---CeecCCCCCcEEEeCC
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK---VFHRDIKPENILIRGD 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g---IvHrDLKp~NILl~~~ 163 (470)
.....|+.++|+||+|||... ||||||||+|||+|.+
T Consensus 174 ----------------------------------------~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 174 ----------------------------------------ETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ----------------------------------------HHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 344449999999999999854 9999999999999988
Q ss_pred -eEEEEecCCcccccC-CCccccc-cccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHH
Q psy9855 164 -LVVVGDLGSLQFIKS-KGLHTEY-IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS---EIDQLDR 237 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~-~~~~~~~-~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~---~~~~~~~ 237 (470)
..||+|||+|+.... ....... .||.+|+|||++.. +..+.++||||||+++.||++|+.+..... .......
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 899999999976654 3333333 89999999999876 448999999999999999999998876432 1111111
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCc--ccccc-cccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGI--DVLVP-QIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
....+ .. ....... ...+ ..... ..-..+..+...|+..+|.+||++.|++
T Consensus 293 ~~~~~-----------~~---~~~~eii----D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 293 AKPLL-----------EE---GKLREIV----DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred HHHHH-----------HC---cchhhee----CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 11111 11 0000000 0000 11111 1223467788899999999999999975
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=270.36 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=170.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc---------------------ccH
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN---------------------ISE 67 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~---------------------l~~ 67 (470)
...+++|+.+|.++.+||||+++++++... ...+++|||||+ |+|.+++..... +++
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (343)
T cd05103 54 HRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132 (343)
T ss_pred HHHHHHHHHHHHhccCCccHhhhcceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhh
Confidence 345789999999996699999999987643 456899999999 699999976432 111
Q ss_pred HHHHHHHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhccc--ccCcccchhhhHHHHHHHHHHHHHHHHHh
Q psy9855 68 KRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLT--TFLPQQSKRLYHTTFVLYQIVNGLHHLHS 145 (470)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~i~~qIl~aL~yLH~ 145 (470)
..... ... ......+....+...+.+.+...... .......++...+..++.||+.||+|||+
T Consensus 133 ~~~~~--------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 197 (343)
T cd05103 133 DLKRR--------------LDS-ITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS 197 (343)
T ss_pred hhhhh--------------ccc-cccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh
Confidence 00000 000 00011112222222222222211111 11112345677788899999999999999
Q ss_pred CCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh
Q psy9855 146 YKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt 221 (470)
+||+||||||+|||++.+ .++|+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 198 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~ 276 (343)
T cd05103 198 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 276 (343)
T ss_pred CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHH
Confidence 999999999999999877 899999999876532211 11234567799999987654 8999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc
Q psy9855 222 -RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300 (470)
Q Consensus 222 -g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp 300 (470)
|..||.+............. ......+..+++++.+++..||..||.+||
T Consensus 277 ~g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rp 327 (343)
T cd05103 277 LGASPYPGVKIDEEFCRRLKE-----------------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 327 (343)
T ss_pred CCCCCCCCccccHHHHHHHhc-----------------------------cCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999765432222211110 000111223567889999999999999999
Q ss_pred CHHHHHhc
Q psy9855 301 TAQKILSC 308 (470)
Q Consensus 301 t~~elL~h 308 (470)
|+.++++|
T Consensus 328 s~~eil~~ 335 (343)
T cd05103 328 TFSELVEH 335 (343)
T ss_pred CHHHHHHH
Confidence 99999965
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=261.05 Aligned_cols=214 Identities=18% Similarity=0.226 Sum_probs=161.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.|+ ||||+++++++... ....++++||++ ++|.+++.......
T Consensus 52 ~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~---------------------- 107 (280)
T cd05043 52 VTLLLQESCLLYGLS-HQNILPILHVCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGE---------------------- 107 (280)
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEecC-CCCCEEEEEcCCCCcHHHHHHhccccc----------------------
Confidence 455789999999998 99999999987643 567899999998 69999986542100
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
......++...+..++.||+.||+|||++|++||||||+||+++.+ .++|
T Consensus 108 -----------------------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 108 -----------------------------ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred -----------------------------cccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 0001122233344499999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||+++.+..... .....++..|+|||++.+.. ++.++|||||||++|++++ |..||.+.+..+....+....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 236 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY- 236 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence 99999876543221 12234567799999987655 7999999999999999998 999998766554333322100
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.......+++++.+++.+||..||++|||+.++++
T Consensus 237 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 -----------------------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -----------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00011346788999999999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=256.78 Aligned_cols=206 Identities=23% Similarity=0.364 Sum_probs=164.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++++.++ ||||+++++++.. ....++||||++ ++|.+++..... +++..+..
T Consensus 43 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 104 (256)
T cd05112 43 EEDFIEEAQVMMKLS-HPKLVQLYGVCTE--RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLG--------------- 104 (256)
T ss_pred HHHHHHHHHHHHhCC-CCCeeeEEEEEcc--CCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHH---------------
Confidence 456889999999998 9999999998854 567899999999 599999876543 66666666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||+|||+.|++||||||+||+++.+ .++
T Consensus 105 --------------------------------------------~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~ 140 (256)
T cd05112 105 --------------------------------------------MCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVK 140 (256)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCccccccccceEEEcCCCeEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||.+........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 141 l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 218 (256)
T cd05112 141 VSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF- 218 (256)
T ss_pred ECCCcceeecccCcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-
Confidence 999998876543221 11233567899999887654 8899999999999999998 999998766555444432110
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+...+..+.+|+.+||..+|++|||+.+++++
T Consensus 219 -----------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 -----------------------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 001112357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=275.98 Aligned_cols=214 Identities=20% Similarity=0.285 Sum_probs=175.0
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.-|-.||..-. .+-||+||..|++ .+.+|+||+|++ ||+..+|.+.+.+.|..++.
T Consensus 675 HVKAERDILAEAD-n~WVVrLyySFQD--kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARF------------------ 733 (1034)
T KOG0608|consen 675 HVKAERDILAEAD-NEWVVRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARF------------------ 733 (1034)
T ss_pred hhhhhhhhHhhcC-CcceEEEEEEecc--CCceEEEEeccCCccHHHHHHHhccCHHHHHHH------------------
Confidence 4457888999998 9999999998865 778999999999 69999999988888887777
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
|+..+.+|+++.|..|+|||||||+|||||.+ +|||+|
T Consensus 734 -----------------------------------------YIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 734 -----------------------------------------YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred -----------------------------------------HHHHHHHHHHHHHhccceecccCccceEEccCCceeeee
Confidence 99999999999999999999999999999998 999999
Q ss_pred cCCcccccC---------CCc----------------------------------cccccccCcccCchhhccCCCCCCc
Q psy9855 170 LGSLQFIKS---------KGL----------------------------------HTEYIATRWYRSPECLLTEGYYSFE 206 (470)
Q Consensus 170 FG~a~~~~~---------~~~----------------------------------~~~~~gt~~Y~APE~l~~~~~~~~~ 206 (470)
||++.-+.. +.. ....+||+.|+|||++...+ |+..
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~ 851 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQL 851 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-cccc
Confidence 998864321 000 11247999999999998877 8999
Q ss_pred ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHH
Q psy9855 207 LDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK 286 (470)
Q Consensus 207 ~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 286 (470)
+|.||.|||||||+.|++||...+..+...++..+ ....-......++.++.+
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw---------------------------~~~l~~~~~~~ls~e~~~ 904 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW---------------------------RNFLHIPYQGNLSKEALD 904 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh---------------------------hhccccccccccCHHHHH
Confidence 99999999999999999999887765544444331 111112233578999999
Q ss_pred HHHHhcccCCCCCcC---HHHHHhcccCCChhH
Q psy9855 287 LMSEMLKYDPKRRPT---AQKILSCAYFADLTQ 316 (470)
Q Consensus 287 Li~~~L~~dP~~Rpt---~~elL~hp~f~~~~~ 316 (470)
||.++.. ++++|.. ++|+-.||||+.++.
T Consensus 905 li~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 905 LIQKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 9998654 7788874 788999999999874
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=255.04 Aligned_cols=205 Identities=23% Similarity=0.356 Sum_probs=162.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++++++. ||||+++++++.. ....++||||+. ++|.+++.... .++...+..
T Consensus 36 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~--------------- 97 (251)
T cd05041 36 KRKFLQEAEILKQYD-HPNIVKLIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ--------------- 97 (251)
T ss_pred HHHHHHHHHHHHhCC-CCCeEEEEEEEec--CCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHH---------------
Confidence 456789999999999 9999999998854 567999999998 59999986543 256655555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||+|||++|++||||||+|||++.+ .++
T Consensus 98 --------------------------------------------~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~ 133 (251)
T cd05041 98 --------------------------------------------MSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLK 133 (251)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||.+......... ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.........+....
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~ 212 (251)
T cd05041 134 ISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212 (251)
T ss_pred EeeccccccccCCcceeccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC
Confidence 9999998765422211 1123356799999887654 8999999999999999998 889997776544433332110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..++.++.+++.+||..+|.+|||+.++++
T Consensus 213 ------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 213 ------------------------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ------------------------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=258.76 Aligned_cols=203 Identities=20% Similarity=0.302 Sum_probs=162.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++..++ ||||+++++++.. ...++||||++ |+|.+++..... +++..+..
T Consensus 53 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~--------------- 113 (279)
T cd05057 53 NKEILDEAYVMASVD-HPHVVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLN--------------- 113 (279)
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHH---------------
Confidence 346789999999998 9999999998864 57899999998 699999977543 66766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+||+++.+ .++
T Consensus 114 --------------------------------------------~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 149 (279)
T cd05057 114 --------------------------------------------WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVK 149 (279)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCCccc---cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLHT---EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||.+.......... ...++..|+|||.+.... ++.++|||||||++||+++ |..||.+....+....+...
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 227 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG- 227 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-
Confidence 99999988665332211 122356799999886544 7899999999999999998 99999877655444333210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
.....+...+..+.+++.+||..||.+|||+.+++
T Consensus 228 -----------------------------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 228 -----------------------------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 00111234667889999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=256.64 Aligned_cols=204 Identities=19% Similarity=0.335 Sum_probs=163.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ |+||+++++++. ....++||||+. ++|.+++..... ++...+..
T Consensus 45 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 106 (260)
T cd05067 45 PEAFLAEANLMKQLQ-HPRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID-------------- 106 (260)
T ss_pred HHHHHHHHHHHHhcC-CcCeeeEEEEEc---cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHH--------------
Confidence 456789999999999 999999999863 346899999998 699999865432 55555555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.|++.||+|||+.|++||||||+||+++.+ .+
T Consensus 107 ---------------------------------------------i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~ 141 (260)
T cd05067 107 ---------------------------------------------MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCC 141 (260)
T ss_pred ---------------------------------------------HHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||.+......... ....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05067 142 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY 220 (260)
T ss_pred EEccCcceeecCCCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Confidence 99999998765522211 2234567899999887654 7899999999999999998 999998877655544432211
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. ......++.++.++|.+||..+|++|||++++++
T Consensus 221 ~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 R------------------------------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred C------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0112346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=256.36 Aligned_cols=205 Identities=21% Similarity=0.351 Sum_probs=164.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ ||||+++++++.. ....++||||++ ++|.+++.... .++...+..
T Consensus 45 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~-------------- 107 (261)
T cd05034 45 PEAFLQEAQIMKKLR-HDKLVQLYAVCSE--EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD-------------- 107 (261)
T ss_pred HHHHHHHHHHHhhCC-CCCEeeeeeeeec--CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHH--------------
Confidence 456889999999999 9999999998754 567999999998 59999997654 255655555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||++|++|+||||+||+++.+ .+
T Consensus 108 ---------------------------------------------~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~ 142 (261)
T cd05034 108 ---------------------------------------------MAAQIAEGMAYLESRNYIHRDLAARNILVGENLVC 142 (261)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||.+......... ....++..|+|||.+.+.. ++.++||||+||++|+|++ |+.||.+.+....+..+....
T Consensus 143 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 221 (261)
T cd05034 143 KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY 221 (261)
T ss_pred EECccccceeccchhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998766432211 1223456799999887655 7899999999999999998 999998877665555543211
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. ...+...+..+.+++.+||..+|.+||+++++++
T Consensus 222 ~------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 222 R------------------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred C------------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0 0112345788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=255.81 Aligned_cols=205 Identities=31% Similarity=0.563 Sum_probs=161.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc----cccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD----NISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~----~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|++++++++ |+||+++++.+.. .+..++||||++ ++|.+++.... .+++..+..
T Consensus 46 ~~~~~~ei~~l~~~~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~------------ 110 (267)
T cd08224 46 RQDCLKEIDLLKQLD-HPNVIKYLASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK------------ 110 (267)
T ss_pred HHHHHHHHHHHHhCC-CCCeeeeeeeeec--CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHH------------
Confidence 456789999999998 9999999999865 567999999999 59999986432 255555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||+.||+||||+|+||+++.+
T Consensus 111 -----------------------------------------------~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~ 143 (267)
T cd08224 111 -----------------------------------------------YFVQLCSALEHMHSKRIMHRDIKPANVFITATG 143 (267)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCEecCCcChhhEEECCCC
Confidence 99999999999999999999999999999877
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE--IDQLDRIHQ 240 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~ 240 (470)
.++|+|||.+....... ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... .+....+..
T Consensus 144 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T cd08224 144 VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222 (267)
T ss_pred cEEEeccceeeeccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc
Confidence 89999999887654332 223457889999999987655 78999999999999999999999965431 111111110
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCccccc-ccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLV-PQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+ ..++..+.++|.+||..+|++|||+.++++
T Consensus 223 ------------------------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 223 ------------------------------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ------------------------------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0011111 256788999999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=281.76 Aligned_cols=159 Identities=27% Similarity=0.440 Sum_probs=140.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccc-cCHHHHHHhccc---ccHHHHHHHHHHHHhhh
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLME-LNLEEYIRTTDN---ISEKRAKEILYQVKAAN 81 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~-gsL~~~l~~~~~---l~~~~~~~~~~~~~~~~ 81 (470)
.+...+|+++|++|+ |||||+++++-.... .....+|||||. |||..++++... +++.++..
T Consensus 55 ~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~--------- 124 (732)
T KOG4250|consen 55 RERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLD--------- 124 (732)
T ss_pred HHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHH---------
Confidence 456789999999999 999999999754433 456799999999 699999987654 88888777
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.+++.||.|||++|||||||||+||++-
T Consensus 125 --------------------------------------------------lL~d~~~al~~LrEn~IvHRDlKP~NIvl~ 154 (732)
T KOG4250|consen 125 --------------------------------------------------LLSDLVSALRHLRENGIVHRDLKPGNIVLQ 154 (732)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHcCceeccCCCCcEEEe
Confidence 999999999999999999999999999984
Q ss_pred CC-----eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy9855 162 GD-----LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPG 228 (470)
Q Consensus 162 ~~-----~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~ 228 (470)
.+ ..||+|||.|+.+.++......+||..|.+||++...+.|+..+|.|||||++|+.+||..||..
T Consensus 155 ~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 155 IGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 33 57899999999999998999999999999999987656799999999999999999999999953
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=254.63 Aligned_cols=204 Identities=19% Similarity=0.318 Sum_probs=161.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+++.++ |+||+++++.+.. ...++||||++ ++|.+++..... ++...+..
T Consensus 45 ~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 106 (260)
T cd05073 45 VEAFLAEANVMKTLQ-HDKLVKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-------------- 106 (260)
T ss_pred HHHHHHHHHHHHhcC-CCCcceEEEEEcC---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHH--------------
Confidence 456889999999998 9999999998753 56899999998 699999976432 44444444
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||+.|++||||||+||+++.+ .+
T Consensus 107 ---------------------------------------------~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~ 141 (260)
T cd05073 107 ---------------------------------------------FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC 141 (260)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCccccccCcceEEEcCCCcE
Confidence 99999999999999999999999999999888 89
Q ss_pred EEEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||.+......... ....++..|+|||++.+.. ++.++|||||||++|++++ |..||.+.+..+....+....
T Consensus 142 ~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05073 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 220 (260)
T ss_pred EECCCcceeeccCCCcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence 99999988765432211 2234567799999887644 7899999999999999998 999998776555444332110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........+.++.+++.+||..+|++||++.++++
T Consensus 221 ------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 ------------------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ------------------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00112456788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=269.52 Aligned_cols=205 Identities=21% Similarity=0.322 Sum_probs=168.7
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
+...|++|..+|+.|+ |||+|+|+|+|+. ...+|||+|||. |+|.+||+++.. ++.-...
T Consensus 306 eveEFLkEAAvMKeik-HpNLVqLLGVCT~--EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLl-------------- 368 (1157)
T KOG4278|consen 306 EVEEFLKEAAVMKEIK-HPNLVQLLGVCTH--EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLL-------------- 368 (1157)
T ss_pred hHHHHHHHHHHHHhhc-CccHHHHhhhhcc--CCCeEEEEecccCccHHHHHHHhchhhcchhHHH--------------
Confidence 3567899999999999 9999999999865 677999999999 899999998764 2222222
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
.++.||..|++||..+++|||||-..|.|+..+ .
T Consensus 369 ---------------------------------------------yMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi 403 (1157)
T KOG4278|consen 369 ---------------------------------------------YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI 403 (1157)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce
Confidence 278899999999999999999999999999998 7
Q ss_pred EEEEecCCcccccCCCccccccc---cCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIA---TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~g---t~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
+|++|||+++++...... ...| ..-|.|||.+.... ++.++|||+|||+|||+.| |..||+|-+.......+.+
T Consensus 404 VKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk 481 (1157)
T KOG4278|consen 404 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK 481 (1157)
T ss_pred EEeeccchhhhhcCCcee-cccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc
Confidence 899999999988754432 2233 55699999887655 8999999999999999998 9999999876666655544
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+.. .-+..+++.+.+||+.||+++|.+||++.++-+
T Consensus 482 gyRM------------------------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 482 GYRM------------------------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred cccc------------------------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 2211 112478899999999999999999999998753
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=282.91 Aligned_cols=214 Identities=23% Similarity=0.352 Sum_probs=183.9
Q ss_pred CCCCCCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHH
Q psy9855 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVK 78 (470)
Q Consensus 1 ~k~~~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~ 78 (470)
||.-..+-....|+.|..||-++. ||||++|.|+.+. ...+.||+|||+ |+|..||+.++. ++.-++..
T Consensus 665 LK~GytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTk--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVg------ 735 (996)
T KOG0196|consen 665 LKAGYTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTK--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVG------ 735 (996)
T ss_pred eccCccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEec--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHH------
Confidence 355556666788999999999999 9999999999864 678999999999 899999998875 55544444
Q ss_pred hhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENI 158 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NI 158 (470)
+++.|+.|++||-++|+|||||-..||
T Consensus 736 -----------------------------------------------------MLrGIAsGMkYLsdm~YVHRDLAARNI 762 (996)
T KOG0196|consen 736 -----------------------------------------------------MLRGIASGMKYLSDMNYVHRDLAARNI 762 (996)
T ss_pred -----------------------------------------------------HHHHHHHHhHHHhhcCchhhhhhhhhe
Confidence 899999999999999999999999999
Q ss_pred EEeCC-eEEEEecCCcccccCCCc--cccccc--cCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChH
Q psy9855 159 LIRGD-LVVVGDLGSLQFIKSKGL--HTEYIA--TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEI 232 (470)
Q Consensus 159 Ll~~~-~ikL~DFG~a~~~~~~~~--~~~~~g--t~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~ 232 (470)
|++.+ .+|++|||+++.+.++.. .++.-| ...|.|||.+...+ ++.++||||+|++|||.++ |..||.+.++.
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchH
Confidence 99999 899999999998765431 222222 45799999998866 8999999999999999886 99999999999
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+.+..|.+.++.|++ .+++..+..||..||++|-..||++.||+.
T Consensus 842 dVIkaIe~gyRLPpP------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 842 DVIKAIEQGYRLPPP------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHhccCCCCC------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 999999886655543 468899999999999999999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=288.66 Aligned_cols=102 Identities=21% Similarity=0.285 Sum_probs=91.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. ...+|+||||+. ++|.+++.....+++..++.
T Consensus 49 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~~--~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~----------------- 108 (669)
T cd05610 49 HQVQAERDALALSK-SPFIVHLYYSLQS--ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVK----------------- 108 (669)
T ss_pred HHHHHHHHHHHhcC-CCCcCeEEEEEEE--CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHH-----------------
Confidence 56789999999999 9999999988754 678999999998 69999998766677777666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|+.||+.||+|||.+|||||||||+|||++.+ .++|+
T Consensus 109 ------------------------------------------i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~ 146 (669)
T cd05610 109 ------------------------------------------YISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLT 146 (669)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcc
Q psy9855 169 DLGSLQ 174 (470)
Q Consensus 169 DFG~a~ 174 (470)
|||+++
T Consensus 147 DFGls~ 152 (669)
T cd05610 147 DFGLSK 152 (669)
T ss_pred eCCCCc
Confidence 999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=261.64 Aligned_cols=215 Identities=20% Similarity=0.280 Sum_probs=183.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
.+-.+.|-++|.-....|.+++++..|+. -+.+|+||||+. |+|.-.|.+-+.+.+..+..
T Consensus 393 vectm~EKrvLAL~~kppFL~qlHScFQT--mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvF---------------- 454 (683)
T KOG0696|consen 393 VECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVF---------------- 454 (683)
T ss_pred ccceehhhhheecCCCCchHHHHHHHhhh--hhheeeEEEEecCchhhhHHHHhcccCCchhhh----------------
Confidence 34456787888777667889999888854 677999999998 59988888877777776666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++..|+-||-|||++||++||||.+|||++.+ ++||
T Consensus 455 -------------------------------------------YAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 455 -------------------------------------------YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred -------------------------------------------hhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEe
Confidence 99999999999999999999999999999988 9999
Q ss_pred EecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||.++... .+....++||||.|+|||++..++ |+.++|.||+||+||||+.|++||.|.++.+.+..|.+.-
T Consensus 492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---- 566 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---- 566 (683)
T ss_pred eecccccccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----
Confidence 9999887543 455567899999999999988766 9999999999999999999999999999999998887621
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-----HHHHhcccCCChhHH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-----QKILSCAYFADLTQL 317 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-----~elL~hp~f~~~~~~ 317 (470)
-.++..+|.++.++...+|...|.+|..+ .++-.||||+.++.-
T Consensus 567 ---------------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 567 ---------------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred ---------------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 12346789999999999999999999864 579999999988753
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=260.29 Aligned_cols=202 Identities=18% Similarity=0.286 Sum_probs=159.3
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.+.+|+.++..++ ||||+++++++.. ...++|+||++ |+|.+++..... +++..+..
T Consensus 55 ~~~~e~~~~~~l~-h~niv~~~~~~~~---~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~----------------- 113 (303)
T cd05110 55 EFMDEALIMASMD-HPHLVRLLGVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN----------------- 113 (303)
T ss_pred HHHHHHHHHHhCC-CCCcccEEEEEcC---CCceeeehhcCCCCHHHHHHhcccCCCHHHHHH-----------------
Confidence 5789999999998 9999999998753 34679999999 799999876543 66666665
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|+
T Consensus 114 ------------------------------------------~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 114 ------------------------------------------WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred ------------------------------------------HHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEc
Confidence 99999999999999999999999999999876 89999
Q ss_pred ecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q psy9855 169 DLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 169 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|||++........ .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--- 227 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG--- 227 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC---
Confidence 9999986543221 12234567899999987655 7999999999999999997 89999776543332222110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+..+..+.+++.+||..+|++||++.++++
T Consensus 228 ---------------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 228 ---------------------------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred ---------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000112345678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=253.44 Aligned_cols=206 Identities=24% Similarity=0.424 Sum_probs=163.2
Q ss_pred hhhhHHHHHHhc-CCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhccc
Q psy9855 11 VANLKEISILRK-IPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 11 ~~~~rEi~iL~~-L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
..+.+|+.++.+ ++ ||||+++++++.. .+..++||||++ ++|.+++... ..+++..++.
T Consensus 53 ~~~~~e~~~l~~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~------------ 117 (269)
T cd08528 53 GDIVSEVTIIKEQLR-HPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN------------ 117 (269)
T ss_pred HHHHHHHHHHhhcCC-CCCeeeEEeeEcc--CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHH------------
Confidence 456789998876 56 9999999998864 678999999998 5999887431 1255555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~ 163 (470)
++.|++.||.|||+ .|++|+||+|+||+++.+
T Consensus 118 -----------------------------------------------~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 118 -----------------------------------------------IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED 150 (269)
T ss_pred -----------------------------------------------HHHHHHHHHHHhccCCceeecCCCHHHEEECCC
Confidence 99999999999996 789999999999999888
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||.+.............|+..|+|||.+.+.. ++.++|||||||++|+|++|.+||...........+....
T Consensus 151 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 151 DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred CcEEEecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 89999999988766544445567899999999987654 7999999999999999999999997665544443332210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
. .......+++.+.++|.+||..||++||++.|+.++
T Consensus 230 ~-----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 Y-----------------------------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred C-----------------------------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0 000112467889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=287.83 Aligned_cols=215 Identities=23% Similarity=0.278 Sum_probs=159.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc---ccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN---ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~---l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|++++..++ ||||+++++++.. .+..|+||||++ |+|.+++..... ++...
T Consensus 46 ~~rflrEi~ILs~L~-HPNIVkl~~v~~d--~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~---------------- 106 (932)
T PRK13184 46 KKRFLREAKIAADLI-HPGIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL---------------- 106 (932)
T ss_pred HHHHHHHHHHHHhCC-CcCcCeEEEEEee--CCEEEEEEEcCCCCCHHHHHHHhhhccccchhh----------------
Confidence 346889999999999 9999999998854 678999999999 599999864211 11100
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
........+..++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 107 -----------------------------------~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~ 151 (932)
T PRK13184 107 -----------------------------------AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE 151 (932)
T ss_pred -----------------------------------hcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC
Confidence 0111223344599999999999999999999999999999887 8
Q ss_pred EEEEecCCcccccCC-------------------CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy9855 165 VVVGDLGSLQFIKSK-------------------GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL 225 (470)
Q Consensus 165 ikL~DFG~a~~~~~~-------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~p 225 (470)
++|+|||++...... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..|
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999998765210 0112357999999999987765 79999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHH
Q psy9855 226 FPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305 (470)
Q Consensus 226 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~el 305 (470)
|.+......... .....| .. ......+++.+.+++.+||..||++|++..+.
T Consensus 231 F~~~~~~ki~~~--~~i~~P-------------------------~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~ee 282 (932)
T PRK13184 231 YRRKKGRKISYR--DVILSP-------------------------IE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQE 282 (932)
T ss_pred CCCcchhhhhhh--hhccCh-------------------------hh-ccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 976543322111 000000 00 00113577889999999999999999887666
Q ss_pred Hh
Q psy9855 306 LS 307 (470)
Q Consensus 306 L~ 307 (470)
+.
T Consensus 283 Ll 284 (932)
T PRK13184 283 LK 284 (932)
T ss_pred HH
Confidence 54
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=252.88 Aligned_cols=213 Identities=20% Similarity=0.267 Sum_probs=158.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCC----CeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRST----RQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~----~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+++|+.++ ||||+++++++..... ...++++||+. |+|.+++.....-
T Consensus 45 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~------------------- 104 (273)
T cd05074 45 IEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG------------------- 104 (273)
T ss_pred HHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhccc-------------------
Confidence 345789999999998 9999999998864322 23478899998 6999887432100
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
.....+....+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 105 ----------------------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~ 150 (273)
T cd05074 105 ----------------------------------EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM 150 (273)
T ss_pred ----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC
Confidence 000012223334499999999999999999999999999999877
Q ss_pred eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 239 (470)
.++|+|||++........ .....+++.|++||.+.+.. ++.++|||||||++|+|++ |.+||.+....+....+.
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 899999999886543221 12334567899999887655 7899999999999999999 899998766544433332
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. ......+..+..+.+++.+||..+|++|||+.++++
T Consensus 230 ~~------------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 230 KG------------------------------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred cC------------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 10 000112356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=259.63 Aligned_cols=216 Identities=25% Similarity=0.456 Sum_probs=175.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.||..|.+.|. ||.||++|++|.. +.+.+|-|+|||+| ||.=||+.+..+++.+++.
T Consensus 512 KHAcREyrIHKeLD-HpRIVKlYDyfsl-DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARS----------------- 572 (775)
T KOG1151|consen 512 KHACREYRIHKELD-HPRIVKLYDYFSL-DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARS----------------- 572 (775)
T ss_pred HHHHHHHhhhhccC-cceeeeeeeeeee-ccccceeeeeecCCCchhHHHHhhhhhhHHHHHH-----------------
Confidence 45789999999999 9999999999975 46789999999997 9999999998899999998
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC--CCeecCCCCCcEEEeCC----
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY--KVFHRDIKPENILIRGD---- 163 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~--gIvHrDLKp~NILl~~~---- 163 (470)
|+.||+.||.||... .|+|-||||.|||+-++
T Consensus 573 ------------------------------------------IiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 573 ------------------------------------------IIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred ------------------------------------------HHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 999999999999975 69999999999999765
Q ss_pred eEEEEecCCcccccCCC--------ccccccccCcccCchhhccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCh-
Q psy9855 164 LVVVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTE---GYYSFELDIWAAGCVFYETLTRNPLFPGDSE- 231 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~- 231 (470)
.+||+|||+++.+.... ......||.||++||.+.-. +..+.++||||+|||+|..+.|+.||.....
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 79999999999876432 23456899999999987532 3478999999999999999999999955422
Q ss_pred HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 232 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.+.+..- .++ ..-...|+ .-|.++.++++||++||.+--++|....++..||||
T Consensus 691 QdILqeN-TIl----------------kAtEVqFP---------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 691 QDILQEN-TIL----------------KATEVQFP---------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred HHHHhhh-chh----------------cceeccCC---------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 2222110 000 00011111 225789999999999999999999999999999999
Q ss_pred CC
Q psy9855 312 AD 313 (470)
Q Consensus 312 ~~ 313 (470)
..
T Consensus 745 lP 746 (775)
T KOG1151|consen 745 LP 746 (775)
T ss_pred cc
Confidence 74
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=246.16 Aligned_cols=212 Identities=33% Similarity=0.561 Sum_probs=170.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++++++ |+||+++++.+.. ....++++||+++ +|.+++.....++...+..
T Consensus 31 ~~~~~~e~~~~~~l~-~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~---------------- 91 (244)
T smart00220 31 RERILREISILKKLK-HPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARF---------------- 91 (244)
T ss_pred HHHHHHHHHHHHhCC-CCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHH----------------
Confidence 357789999999997 9999999998864 5789999999996 9999987655456655555
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.+++.||.|||+.|++|+||+|+||+++.+ .++|
T Consensus 92 -------------------------------------------~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l 128 (244)
T smart00220 92 -------------------------------------------YARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKL 128 (244)
T ss_pred -------------------------------------------HHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
+|||.+.............++..|++||.+.+.. ++.++||||||+++|+|++|..||.............. ..
T Consensus 129 ~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---~~-- 202 (244)
T smart00220 129 ADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---KP-- 202 (244)
T ss_pred ccccceeeeccccccccccCCcCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---cc--
Confidence 9999988776554455667899999999887544 78899999999999999999999977333222222111 00
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
..........++.++.+++.+||..+|++||++.++++||||
T Consensus 203 ----------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 203 ----------------------KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ----------------------CCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 000000111177889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=254.09 Aligned_cols=221 Identities=22% Similarity=0.341 Sum_probs=163.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++++.+. ||||+++++++........++||||++ ++|.+++..... ++...+..
T Consensus 50 ~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~--------------- 113 (284)
T cd05038 50 RSDFEREIEILRTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL--------------- 113 (284)
T ss_pred HHHHHHHHHHHHhCC-CCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHH---------------
Confidence 456889999999998 999999999887655678999999998 699999976552 66666555
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++|++||||||+||+++.+ .++
T Consensus 114 --------------------------------------------~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~ 149 (284)
T cd05038 114 --------------------------------------------FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVK 149 (284)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEE
Confidence 99999999999999999999999999999988 899
Q ss_pred EEecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||.+......... ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||....... ....
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~ 223 (284)
T cd05038 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMI 223 (284)
T ss_pred EcccccccccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchh-----cccc
Confidence 9999998876532211 1224456799999887654 7899999999999999999999885532211 0000
Q ss_pred CCCch-HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKA-ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+.... .....+..... ..........++.++.+|+.+||..+|.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 224 GIAQGQMIVTRLLELLK-----------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccccccccHHHHHHHHH-----------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 10000 00000000000 00001112346688999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=275.21 Aligned_cols=227 Identities=24% Similarity=0.396 Sum_probs=181.2
Q ss_pred CCCCCc-hhhhhhhHHHHHHhcCCCCCCeeeeceeeec---CCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHH
Q psy9855 2 KATCPD-FAEVANLKEISILRKIPDHLNVLCLCETYVN---RSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEIL 74 (470)
Q Consensus 2 k~~~~~-~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~---~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~ 74 (470)
|+...+ ..++.+.-|.+||+.+.+|||++.++|+|.- ...+.+|||||||. |+.-++++.... +.+.
T Consensus 50 kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~------ 123 (953)
T KOG0587|consen 50 KIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEE------ 123 (953)
T ss_pred EeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhH------
Confidence 444343 3456678899999999999999999999873 24567999999999 699999875432 3333
Q ss_pred HHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCC
Q psy9855 75 YQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIK 154 (470)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLK 154 (470)
.+..|++.++.||.+||.+.++|||||
T Consensus 124 -----------------------------------------------------~IaYI~re~lrgl~HLH~nkviHRDik 150 (953)
T KOG0587|consen 124 -----------------------------------------------------WIAYILREILRGLAHLHNNKVIHRDIK 150 (953)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHHhhcceeeeccc
Confidence 334499999999999999999999999
Q ss_pred CCcEEEeCC-eEEEEecCCcccccC-CCccccccccCcccCchhhccCC----CCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy9855 155 PENILIRGD-LVVVGDLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEG----YYSFELDIWAAGCVFYETLTRNPLFPG 228 (470)
Q Consensus 155 p~NILl~~~-~ikL~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~----~~~~~~DIwSlG~il~elltg~~pf~~ 228 (470)
-.|||++.+ .|||+|||++..+.. .....+.+||+.|||||++.... .|+..+|+||||++..||.-|.+|+.+
T Consensus 151 G~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 151 GQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred CceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 999999988 999999998887763 33456789999999999986543 377899999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 229 DSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 229 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
..+...+..|- ..|++. ..-+...+.++.+||..||..|-.+||+..++|+|
T Consensus 231 mHPmraLF~Ip---RNPPPk-------------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 231 MHPMRALFLIP---RNPPPK-------------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cchhhhhccCC---CCCCcc-------------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 77665554332 111111 01123567899999999999999999999999999
Q ss_pred ccCCChh
Q psy9855 309 AYFADLT 315 (470)
Q Consensus 309 p~f~~~~ 315 (470)
||+.+..
T Consensus 283 pFi~e~~ 289 (953)
T KOG0587|consen 283 PFITEQP 289 (953)
T ss_pred Ccccccc
Confidence 9999554
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=257.04 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=184.4
Q ss_pred CchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 6 PDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 6 ~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
.......+..|+++|..++|+.||+++.+.+ +.++..++|+||++ .+..++... ++..+++.
T Consensus 74 ~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~------------ 136 (418)
T KOG1167|consen 74 RTSSPSRILNELEMLYRLGGSDNIIKLNGCF--RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRW------------ 136 (418)
T ss_pred cccCchHHHHHHHHHHHhccchhhhcchhhh--ccCCeeEEEecccCccCHHHHHhc---CCHHHHHH------------
Confidence 3344567889999999999999999999987 56889999999999 588888754 44555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
+++.++.||+++|.+|||||||||+|+|++..
T Consensus 137 -----------------------------------------------Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t 169 (418)
T KOG1167|consen 137 -----------------------------------------------YLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT 169 (418)
T ss_pred -----------------------------------------------HHHHHHHHhhhhhccCccccCCCcccccccccc
Confidence 99999999999999999999999999999887
Q ss_pred -eEEEEecCCcccccC--------C----------C----------------c-----------cccccccCcccCchhh
Q psy9855 164 -LVVVGDLGSLQFIKS--------K----------G----------------L-----------HTEYIATRWYRSPECL 197 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~--------~----------~----------------~-----------~~~~~gt~~Y~APE~l 197 (470)
.-.|+|||+|..... . + . .....||++|+|||++
T Consensus 170 ~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL 249 (418)
T KOG1167|consen 170 QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL 249 (418)
T ss_pred CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH
Confidence 678999999972110 0 0 0 0123699999999999
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchHHHHHHhhh--cc--Cc------cccccc
Q psy9855 198 LTEGYYSFELDIWAAGCVFYETLTRNPLF-PGDSEIDQLDRIHQVLGTPKAETLKKFEKY--KS--SN------FTYQFK 266 (470)
Q Consensus 198 ~~~~~~~~~~DIwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~--~~--~~------~~~~~~ 266 (470)
...+.-++++||||.|||+.-++++..|| ...++.+.+.+|..++|.-.......+... -. .. ....+.
T Consensus 250 ~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~ 329 (418)
T KOG1167|consen 250 FRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE 329 (418)
T ss_pred hhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence 88877899999999999999999999887 456677778888888776433322221111 00 00 000000
Q ss_pred cC-----CC-----CCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHHH
Q psy9855 267 QY-----PG-----GGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQ 319 (470)
Q Consensus 267 ~~-----~~-----~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~~ 319 (470)
.. .. ..........+..+.+|+.+||+.||.+|+|++++|.||||.+......
T Consensus 330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~ 392 (418)
T KOG1167|consen 330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTER 392 (418)
T ss_pred ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhh
Confidence 00 00 0011111234568899999999999999999999999999997665443
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=250.61 Aligned_cols=222 Identities=21% Similarity=0.294 Sum_probs=173.7
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHh-----cccccHHHHHHHHHHHHhhhc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRT-----TDNISEKRAKEILYQVKAANE 82 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~-----~~~l~~~~~~~~~~~~~~~~~ 82 (470)
-+..+++.|.+...+-.+.||||+++|+... ++..|+.||+|+-+|..+.+. ...++|..+-.
T Consensus 104 keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~---------- 171 (361)
T KOG1006|consen 104 KEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGH---------- 171 (361)
T ss_pred HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhh----------
Confidence 3466789999988888779999999998765 677999999999877766532 12255554444
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEe
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIR 161 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~ 161 (470)
|..-.+.||.||-. ..|+|||+||+|||++
T Consensus 172 -------------------------------------------------ItvatV~AL~yLK~~lkiIHRDvKPSNILld 202 (361)
T KOG1006|consen 172 -------------------------------------------------ITVATVDALDYLKEELKIIHRDVKPSNILLD 202 (361)
T ss_pred -------------------------------------------------eeeeehhHHHHHHHHhhhhhccCChhheEEe
Confidence 77778899999976 5899999999999999
Q ss_pred CC-eEEEEecCCcccccCCCccccccccCcccCchhhccCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGY-YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
.. .+||||||.+..+.+.-..+.-.|-..|||||.+..... |+-++||||||++|||+.||..||.+.+. +++++.
T Consensus 203 r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~ 280 (361)
T KOG1006|consen 203 RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLC 280 (361)
T ss_pred cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHH
Confidence 87 899999999887766555556689999999999875544 89999999999999999999999987543 444444
Q ss_pred HHh-CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 240 QVL-GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 240 ~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+. |.|+.- ..+.-.-.++..+..+|.-||.+|-.+||...+++.+||+....
T Consensus 281 ~Vv~gdpp~l-----------------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 281 QVVIGDPPIL-----------------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHcCCCCee-----------------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 432 222110 00111124788899999999999999999999999999998654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=253.17 Aligned_cols=209 Identities=15% Similarity=0.172 Sum_probs=153.3
Q ss_pred HHHHHHhcCCCCCCeeeeceeeecCCC--CeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccC
Q psy9855 15 KEISILRKIPDHLNVLCLCETYVNRST--RQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWD 92 (470)
Q Consensus 15 rEi~iL~~L~~HpnIv~l~~~~~~~~~--~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (470)
.++..+..+. |+||+++++....... ...++++|++..++.+++......++..+..
T Consensus 72 ~~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------- 130 (294)
T PHA02882 72 ALWKNIHNID-HLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN-------------------- 130 (294)
T ss_pred HHHHHhccCC-CCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHH--------------------
Confidence 4445566777 9999999986543222 2457888988888888776544455555555
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecC
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG 171 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG 171 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+|||
T Consensus 131 ---------------------------------------i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFG 171 (294)
T PHA02882 131 ---------------------------------------IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYG 171 (294)
T ss_pred ---------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcC
Confidence 99999999999999999999999999999877 89999999
Q ss_pred CcccccCCC--------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 172 SLQFIKSKG--------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 172 ~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.............
T Consensus 172 la~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~-- 248 (294)
T PHA02882 172 IASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC-- 248 (294)
T ss_pred CceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH--
Confidence 987654221 112347999999999887755 899999999999999999999999876332222111110
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+.+.... .. ....+..+..+.+++..||..+|++||+++++++
T Consensus 249 ----~~~~~~~---------------~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ----DFIKRLH---------------EG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ----HHHHHhh---------------hh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0000000 00 0012345788999999999999999999999874
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=263.23 Aligned_cols=212 Identities=19% Similarity=0.301 Sum_probs=172.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccc--cHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNI--SEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l--~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+||++|.+|+ ||||+.|+|++.. .+.+|+|+|||+ |||.+|+..+..- ......
T Consensus 579 r~~F~kEIkiLsqLk-hPNIveLvGVC~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~v--------------- 640 (807)
T KOG1094|consen 579 RNDFLKEIKILSRLK-HPNIVELLGVCVQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGV--------------- 640 (807)
T ss_pred HHHHHHHHHHHhccC-CCCeeEEEeeeec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhH---------------
Confidence 457899999999998 9999999999975 567999999999 8999999876431 111111
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
.|+.||+.|++||.+.++|||||.+.|+|++++ ++
T Consensus 641 --------------------------------------------si~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~i 676 (807)
T KOG1094|consen 641 --------------------------------------------SICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTI 676 (807)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHhhchhhccccccceeecCcccE
Confidence 199999999999999999999999999999999 99
Q ss_pred EEEecCCcccccCCCccc---cccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGLHT---EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~ 240 (470)
||+|||.++.+-.+..+. ..+-...|||+|.+...+ +++++|+|+||+++||+++ ...||...++.+..++...
T Consensus 677 KiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~ 755 (807)
T KOG1094|consen 677 KIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE 755 (807)
T ss_pred EecCcccccccccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh
Confidence 999999999776554432 235567899999988756 8999999999999999875 6789988877777666655
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+..+. .......++-++..+.+||..||..|-.+||+++++..
T Consensus 756 ~~~~~~-----------------------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 756 FFRDQG-----------------------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hcCCCC-----------------------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 443221 22233345678899999999999999999999999863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=276.55 Aligned_cols=226 Identities=20% Similarity=0.308 Sum_probs=148.3
Q ss_pred CCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhccccc
Q psy9855 40 STRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTF 118 (470)
Q Consensus 40 ~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~ 118 (470)
....+++|+||++ ++|.+++.... .++.+++|+.++ ....
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~-------------------------------~~~~v~~~l~~~-~~~l------- 246 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKE-------------------------------FPYNVEPYLLGK-VQDL------- 246 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcC-------------------------------CchhHHHHhccc-hhhc-------
Confidence 4567999999999 69999986543 123344444432 1111
Q ss_pred CcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eEEEEecCCcccccCC--CccccccccCcccCc
Q psy9855 119 LPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVVVGDLGSLQFIKSK--GLHTEYIATRWYRSP 194 (470)
Q Consensus 119 ~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ikL~DFG~a~~~~~~--~~~~~~~gt~~Y~AP 194 (470)
..........+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...... ......++++.|+||
T Consensus 247 ~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~AP 326 (566)
T PLN03225 247 PKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAP 326 (566)
T ss_pred cccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccCh
Confidence 111122334566799999999999999999999999999999864 7999999999765422 233456899999999
Q ss_pred hhhccCC---------------------CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHH
Q psy9855 195 ECLLTEG---------------------YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKF 253 (470)
Q Consensus 195 E~l~~~~---------------------~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 253 (470)
|.+.... .++.++|||||||++|||+++..+ .......+..+....+.... .|...
T Consensus 327 E~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~-~~~~~ 403 (566)
T PLN03225 327 EQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLV-AWRKL 403 (566)
T ss_pred HHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHH-HHHHh
Confidence 9764321 134567999999999999986654 34444444444443333221 12111
Q ss_pred hhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 254 EKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.. ....... .... ..........++||.+||.+||.+|||+.++|+||||++..
T Consensus 404 ~~---~~~~~~~----~~~~-~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 404 VE---PRASPDL----RRGF-EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred hc---cccchhh----hhhh-hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 00 0000000 0000 11122345667999999999999999999999999998744
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=263.99 Aligned_cols=208 Identities=21% Similarity=0.273 Sum_probs=172.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
-..|++|+.+|.+|+ |||+|+|||+..+ ..+.+|||+++ |+|.+.|+.... +.......
T Consensus 155 mddflrEas~M~~L~-H~hliRLyGvVl~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcd-------------- 216 (1039)
T KOG0199|consen 155 MDDFLREASHMLKLQ-HPHLIRLYGVVLD---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCD-------------- 216 (1039)
T ss_pred HHHHHHHHHHHHhcc-CcceeEEeeeecc---chhhHHhhhcccchHHHHHhhccccceeHHHHHH--------------
Confidence 357899999999999 9999999999864 56899999999 799999987222 44433333
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+.||+.|+.||.++++|||||-..|||+... .|
T Consensus 217 ---------------------------------------------ya~QiA~aM~YLeskrlvHRDLAARNlllasprtV 251 (1039)
T KOG0199|consen 217 ---------------------------------------------YAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTV 251 (1039)
T ss_pred ---------------------------------------------HHHHHHHHHHHHhhhhhhhhhhhhhhheeccccee
Confidence 99999999999999999999999999999776 89
Q ss_pred EEEecCCcccccCCCcccccc----ccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYI----ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~----gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
||+|||+.+.++.+.....+. -...|+|||.+.... ++.++|||++||++|||++ |..||.|.....++++|.+
T Consensus 252 KI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~ 330 (1039)
T KOG0199|consen 252 KICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA 330 (1039)
T ss_pred eeecccceeccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc
Confidence 999999999887655443322 245699999998866 8999999999999999998 8999999999888887753
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
. ..-..++.+++.+.+++..||..+|.+|||+..|.+.-+.
T Consensus 331 ~------------------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 331 G------------------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred c------------------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 1 1122335789999999999999999999999998754333
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=290.04 Aligned_cols=202 Identities=15% Similarity=0.251 Sum_probs=148.2
Q ss_pred HhcCCCC-CCeeeeceeeecC-----CCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccccccC
Q psy9855 20 LRKIPDH-LNVLCLCETYVNR-----STRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYRVGWD 92 (470)
Q Consensus 20 L~~L~~H-pnIv~l~~~~~~~-----~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (470)
++.+. | +||++++++|... ....+++++|+++++|.++|.... .+++..++.
T Consensus 26 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~-------------------- 84 (793)
T PLN00181 26 SKSLS-HIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFH-------------------- 84 (793)
T ss_pred cchhh-HHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHH--------------------
Confidence 45666 6 7999999988321 124578889999999999997543 377777776
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC----------
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG---------- 162 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---------- 162 (470)
|++||+.||+|||++||+||||||+|||++.
T Consensus 85 ---------------------------------------i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 85 ---------------------------------------VFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESA 125 (793)
T ss_pred ---------------------------------------HHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeecc
Confidence 9999999999999999999999999999953
Q ss_pred ---------C-eEEEEecCCcccccCCC-----------------ccccccccCcccCchhhccCCCCCCcccHHHHHHH
Q psy9855 163 ---------D-LVVVGDLGSLQFIKSKG-----------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCV 215 (470)
Q Consensus 163 ---------~-~ikL~DFG~a~~~~~~~-----------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~i 215 (470)
+ .+|++|||+++...... .....+||++|||||++.+.. |+.++|||||||+
T Consensus 126 ~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~sDVwSlGvi 204 (793)
T PLN00181 126 SCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS-SNCASDVYRLGVL 204 (793)
T ss_pred ccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC-CCchhhhhhHHHH
Confidence 2 56777888776422100 011246899999999988765 8999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccC
Q psy9855 216 FYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYD 295 (470)
Q Consensus 216 l~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~d 295 (470)
||||++|.+|+.... .....+.... .| . ..........+++.+||..|
T Consensus 205 L~ELl~~~~~~~~~~--~~~~~~~~~~-~~------------------------~-----~~~~~~~~~~~~~~~~L~~~ 252 (793)
T PLN00181 205 LFELFCPVSSREEKS--RTMSSLRHRV-LP------------------------P-----QILLNWPKEASFCLWLLHPE 252 (793)
T ss_pred HHHHhhCCCchhhHH--HHHHHHHHhh-cC------------------------h-----hhhhcCHHHHHHHHHhCCCC
Confidence 999999988874321 1111111100 00 0 00011344578999999999
Q ss_pred CCCCcCHHHHHhcccCCCh
Q psy9855 296 PKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 296 P~~Rpt~~elL~hp~f~~~ 314 (470)
|.+|||+.|+|+||||.+.
T Consensus 253 P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 253 PSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhCcChHHHhhchhhhhh
Confidence 9999999999999999864
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=271.32 Aligned_cols=186 Identities=23% Similarity=0.385 Sum_probs=139.8
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecC
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG 171 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG 171 (470)
....||=||||..-++.++++..-... ....+..+++||++||+|+|++|||||||||.||+++.+ .|||+|||
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~-----~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFG 742 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNS-----QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFG 742 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccch-----hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccc
Confidence 445788999999999999997654332 345566699999999999999999999999999999987 89999999
Q ss_pred Cccccc-------------------CCCccccccccCcccCchhhccCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy9855 172 SLQFIK-------------------SKGLHTEYIATRWYRSPECLLTEG--YYSFELDIWAAGCVFYETLTRNPLFPGDS 230 (470)
Q Consensus 172 ~a~~~~-------------------~~~~~~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlG~il~elltg~~pf~~~~ 230 (470)
+|.... .....+..+||..|+|||++.+.. .|+.|+|+||||+||+||+. ||..
T Consensus 743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-- 817 (1351)
T KOG1035|consen 743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT-- 817 (1351)
T ss_pred cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc--
Confidence 998721 011345679999999999987766 69999999999999999985 4532
Q ss_pred hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 231 EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 231 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
.++-...+..+ +.+.+. .. ..++..--+.-..+|+.||..||.+||||.|+|++.|
T Consensus 818 sMERa~iL~~L---------------R~g~iP-------~~--~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 818 SMERASILTNL---------------RKGSIP-------EP--ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred hHHHHHHHHhc---------------ccCCCC-------CC--cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 23332222221 111110 00 1111122344478999999999999999999999999
Q ss_pred CC
Q psy9855 311 FA 312 (470)
Q Consensus 311 f~ 312 (470)
|-
T Consensus 874 lp 875 (1351)
T KOG1035|consen 874 LP 875 (1351)
T ss_pred CC
Confidence 98
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=270.50 Aligned_cols=228 Identities=20% Similarity=0.310 Sum_probs=174.0
Q ss_pred CCCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhc
Q psy9855 4 TCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANE 82 (470)
Q Consensus 4 ~~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~ 82 (470)
...+.+...++.|+++|+.++.||||+.++|++.. .+.+++|+|||. |+|.++++.++. ...+
T Consensus 339 ~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~--~~~~------------ 402 (609)
T KOG0200|consen 339 NASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRV--TESI------------ 402 (609)
T ss_pred ccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--CCceEEEEEeccCCcHHHHHHhccc--cccc------------
Confidence 34445667889999999999999999999998865 778999999999 899999988760 0000
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
..+| ........++......+++||+.|++||++.++|||||-..|||+..
T Consensus 403 --------------------~~~~---------~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 403 --------------------DGSG---------VFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred --------------------cccC---------CCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 0000 00000023555666669999999999999999999999999999999
Q ss_pred C-eEEEEecCCcccccCCCccc--cccc--cCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC-hHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHT--EYIA--TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDS-EIDQL 235 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~--~~~g--t~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~-~~~~~ 235 (470)
+ .+||+|||+|+......... ...| ...|||||.+.. ..|+.++||||||++||||++ |..||++-. ..+.+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 9 89999999999765544332 1222 334999999987 459999999999999999998 899998844 33333
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
..+.. +.....+..+++++.++|+.||+.+|++||++.++.+
T Consensus 533 ~~l~~------------------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKE------------------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhc------------------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 33322 1222334467899999999999999999999999873
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=234.70 Aligned_cols=221 Identities=20% Similarity=0.298 Sum_probs=178.2
Q ss_pred CCCchhhhh-hhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhh
Q psy9855 4 TCPDFAEVA-NLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 4 ~~~~~~~~~-~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~ 81 (470)
.+.+.++.. +..|-.+..+..+||.+|-++..|+. ...+++|.||.+ |+|.=.+.+.++++++.++.
T Consensus 287 l~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrlffvieyv~ggdlmfhmqrqrklpeeharf--------- 355 (593)
T KOG0695|consen 287 LVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF--------- 355 (593)
T ss_pred hcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceEEEEEEEecCcceeeehhhhhcCcHHHhhh---------
Confidence 344544444 35778888888889999999998854 678999999999 59988887777788877766
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
+...|+.||.|||++||+.||||.+|||++
T Consensus 356 --------------------------------------------------ys~ei~lal~flh~rgiiyrdlkldnvlld 385 (593)
T KOG0695|consen 356 --------------------------------------------------YSAEICLALNFLHERGIIYRDLKLDNVLLD 385 (593)
T ss_pred --------------------------------------------------hhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence 999999999999999999999999999999
Q ss_pred CC-eEEEEecCCccc-ccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC-------CChH
Q psy9855 162 GD-LVVVGDLGSLQF-IKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPG-------DSEI 232 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~-~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~-------~~~~ 232 (470)
.. .+||+|+|.++. +..+....++||||.|.|||++.+.. |+..+|.|+|||+++||+.|+.||.- .+..
T Consensus 386 aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte 464 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE 464 (593)
T ss_pred cCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh
Confidence 88 999999998774 34666778899999999999998876 99999999999999999999999941 2222
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC------HHHHH
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT------AQKIL 306 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt------~~elL 306 (470)
+.+.++.- .....++..++-.+..+++..|+.||.+|.. +.++-
T Consensus 465 dylfqvil------------------------------ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik 514 (593)
T KOG0695|consen 465 DYLFQVIL------------------------------EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIK 514 (593)
T ss_pred HHHHHHHh------------------------------hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhh
Confidence 22222211 0011233467777889999999999999974 67899
Q ss_pred hcccCCChhH
Q psy9855 307 SCAYFADLTQ 316 (470)
Q Consensus 307 ~hp~f~~~~~ 316 (470)
.|+||..++.
T Consensus 515 ~h~ffr~idw 524 (593)
T KOG0695|consen 515 SHAFFRSIDW 524 (593)
T ss_pred cchhhhhCCH
Confidence 9999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=251.21 Aligned_cols=246 Identities=20% Similarity=0.263 Sum_probs=160.3
Q ss_pred hhhHHHHHHhcCCCCCCe-----eeeceeeecC------CCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHH
Q psy9855 12 ANLKEISILRKIPDHLNV-----LCLCETYVNR------STRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVK 78 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnI-----v~l~~~~~~~------~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~ 78 (470)
..+.|+.++.+++ |.++ ++++++|... ..+..+||+||++ ++|.+++..... ++.
T Consensus 218 ~~~vE~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~----------- 285 (507)
T PLN03224 218 TGMVEAYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPG----------- 285 (507)
T ss_pred hhHHHHHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcc-----------
Confidence 3456888888887 5544 6677776531 2356899999999 699999975321 110
Q ss_pred hhhccccccccccCCCccceeeeccCCC-CchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSR-NLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPEN 157 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~N 157 (470)
.+.+|...+ .+.+.+ ......+..++.++.||+.||.|||+.||+||||||+|
T Consensus 286 -------------------~L~e~l~~g~~l~~~~-------~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~N 339 (507)
T PLN03224 286 -------------------CLEEFMMAGKKIPDNM-------PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPEN 339 (507)
T ss_pred -------------------hHHHHHhcCCchhhhc-------ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHh
Confidence 111222222 121111 22335566778899999999999999999999999999
Q ss_pred EEEeCC-eEEEEecCCcccccCCCcccc--ccccCcccCchhhccCCC-------------------C--CCcccHHHHH
Q psy9855 158 ILIRGD-LVVVGDLGSLQFIKSKGLHTE--YIATRWYRSPECLLTEGY-------------------Y--SFELDIWAAG 213 (470)
Q Consensus 158 ILl~~~-~ikL~DFG~a~~~~~~~~~~~--~~gt~~Y~APE~l~~~~~-------------------~--~~~~DIwSlG 213 (470)
||++.+ .++|+|||++........... ..+|+.|+|||.+..... | ....||||+|
T Consensus 340 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 340 LLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred EEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 999887 899999999876543322222 234789999998753221 1 1347999999
Q ss_pred HHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhc
Q psy9855 214 CVFYETLTRNP-LFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEML 292 (470)
Q Consensus 214 ~il~elltg~~-pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L 292 (470)
|++|+|++|.. ||.+.......... .. .....+..+....+ . .......++.++||+.+||
T Consensus 420 vil~em~~~~l~p~~~~~~f~~~~~~---~~----~~~~~~r~~~~~~~----------~-~~~~d~~s~~~~dLi~~LL 481 (507)
T PLN03224 420 VLLMQMCVPELRPVANIRLFNTELRQ---YD----NDLNRWRMYKGQKY----------D-FSLLDRNKEAGWDLACKLI 481 (507)
T ss_pred HHHHHHHhCCCCCccchhhhhhHHhh---cc----chHHHHHhhcccCC----------C-cccccccChHHHHHHHHHh
Confidence 99999999875 66443211111000 00 00011111111111 0 1123467899999999999
Q ss_pred ccCC---CCCcCHHHHHhcccCCC
Q psy9855 293 KYDP---KRRPTAQKILSCAYFAD 313 (470)
Q Consensus 293 ~~dP---~~Rpt~~elL~hp~f~~ 313 (470)
..+| .+|+|++|+|+||||..
T Consensus 482 ~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 482 TKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccCCCCcccCCCHHHHhCCCCcCC
Confidence 9866 68999999999999964
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=219.76 Aligned_cols=178 Identities=25% Similarity=0.369 Sum_probs=146.7
Q ss_pred CCCCCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHH----hcccccHHHHHHHHHHH
Q psy9855 2 KATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR----TTDNISEKRAKEILYQV 77 (470)
Q Consensus 2 k~~~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~----~~~~l~~~~~~~~~~~~ 77 (470)
+.+.++-+....++|+.+..+...+|.+|.++|.+.. .+.+|+.||.|..+|..+-+ ....++|..+-+
T Consensus 80 ~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGk----- 152 (282)
T KOG0984|consen 80 RATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGK----- 152 (282)
T ss_pred hhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhH-----
Confidence 3456677788899999999998889999999998754 67799999999998887653 333366655555
Q ss_pred HhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCC
Q psy9855 78 KAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPE 156 (470)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~ 156 (470)
|+..++.||.|||++ .|+|||+||+
T Consensus 153 ------------------------------------------------------Ia~Svv~al~~L~~kL~vIHRDvKPs 178 (282)
T KOG0984|consen 153 ------------------------------------------------------IAVSVVHALEFLHSKLSVIHRDVKPS 178 (282)
T ss_pred ------------------------------------------------------hHHHHHHHHHHHHHHhhhhhccCCcc
Confidence 999999999999986 8999999999
Q ss_pred cEEEeCC-eEEEEecCCcccccCCCccccccccCcccCchhhccC---CCCCCcccHHHHHHHHHHHHhCCCCCCC-CCh
Q psy9855 157 NILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE---GYYSFELDIWAAGCVFYETLTRNPLFPG-DSE 231 (470)
Q Consensus 157 NILl~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlG~il~elltg~~pf~~-~~~ 231 (470)
|||++.+ ++|+||||.+..+.+.-..+--.|...|||||.+... ..|+-++||||||+.++||.+++.||+. .++
T Consensus 179 NiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 179 NILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred eEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 9999988 9999999999887765544445788899999988543 2489999999999999999999999975 566
Q ss_pred HHHHHHHHH
Q psy9855 232 IDQLDRIHQ 240 (470)
Q Consensus 232 ~~~~~~i~~ 240 (470)
.+++.++..
T Consensus 259 F~qLkqvVe 267 (282)
T KOG0984|consen 259 FQQLKQVVE 267 (282)
T ss_pred HHHHHHHhc
Confidence 777766654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=214.15 Aligned_cols=144 Identities=22% Similarity=0.326 Sum_probs=108.4
Q ss_pred HHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHH
Q psy9855 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIW 210 (470)
Q Consensus 132 i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIw 210 (470)
|+.||+.||+|||+++ ||+|||++.+ .+++ ||++...... ...||+.|+|||++.+.. |+.++|||
T Consensus 22 i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~~~~~-~~~~~Diw 88 (176)
T smart00750 22 VCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDPYFMAPEVIQGQS-YTEKADIY 88 (176)
T ss_pred HHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcccccChHHhcCCC-CcchhhHH
Confidence 9999999999999999 9999999888 6777 9988765432 236899999999998765 89999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccH--HHHHH
Q psy9855 211 AAGCVFYETLTRNPLFPGDSEID-QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHE--KGKKL 287 (470)
Q Consensus 211 SlG~il~elltg~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~L 287 (470)
||||++|||++|..||....... .+..+........ +. .......++. .+.++
T Consensus 89 SlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~~--~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 89 SLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------------PR--DRSNLESVSAARSFADF 144 (176)
T ss_pred HHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------------cc--ccccHHHHHhhhhHHHH
Confidence 99999999999999996654322 2222211100000 00 0000112333 68999
Q ss_pred HHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 288 MSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 288 i~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
|.+||..||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999885
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=266.81 Aligned_cols=209 Identities=22% Similarity=0.266 Sum_probs=146.4
Q ss_pred hHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccC
Q psy9855 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWD 92 (470)
Q Consensus 14 ~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (470)
..|++++++++ |||||+++|++.. .+..|+||||++ |+|.++++. ++...+..
T Consensus 731 ~~~~~~l~~l~-HpnIv~~~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~-------------------- 784 (968)
T PLN00113 731 SSEIADMGKLQ-HPNIVKLIGLCRS--EKGAYLIHEYIEGKNLSEVLRN---LSWERRRK-------------------- 784 (968)
T ss_pred HHHHHHHhhCC-CCCcceEEEEEEc--CCCCEEEEeCCCCCcHHHHHhc---CCHHHHHH--------------------
Confidence 46799999998 9999999999865 567899999999 699999853 45555544
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH---hCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH---SYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH---~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|+.||+.||+||| +.+|+||||||+||+++.+ ..++.
T Consensus 785 ---------------------------------------i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~ 825 (968)
T PLN00113 785 ---------------------------------------IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825 (968)
T ss_pred ---------------------------------------HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence 9999999999999 6799999999999999887 44443
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH-hCCCc
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-DQLDRIHQV-LGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~-~g~p~ 246 (470)
||....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+....+. .....
T Consensus 826 -~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 900 (968)
T PLN00113 826 -LSLPGLLCT---DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900 (968)
T ss_pred -ecccccccc---CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc
Confidence 554433221 12347889999999987755 899999999999999999999998532110 000000000 00000
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. . +..+.... ..........++.+++.+||..||++|||+.|+++
T Consensus 901 ---~~---~-------~~~~~~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 901 ---LD---M-------WIDPSIRG--DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred ---hh---h-------eeCccccC--CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 00 0 00000000 00111223446789999999999999999999984
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=229.60 Aligned_cols=233 Identities=22% Similarity=0.239 Sum_probs=160.4
Q ss_pred CCchhhhhhhHHHHHHhc--CCCCCCeeeeceeeecC--CCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHh
Q psy9855 5 CPDFAEVANLKEISILRK--IPDHLNVLCLCETYVNR--STRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKA 79 (470)
Q Consensus 5 ~~~~~~~~~~rEi~iL~~--L~~HpnIv~l~~~~~~~--~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~ 79 (470)
|+..+...+..|-.|..- +. |+||++++++-... ....++||++|.+ |+|.+||+.+- ++......
T Consensus 241 fp~~~kqs~~~Ek~Iy~lp~m~-h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt-isw~~~cr------- 311 (534)
T KOG3653|consen 241 FPEQEKQSFQNEKNIYSLPGMK-HENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT-ISWNSLCR------- 311 (534)
T ss_pred cCHHHHHHHHhHHHHHhccCcc-chhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc-ccHHHHHH-------
Confidence 555667778877777665 45 99999999864321 1337999999999 89999997653 34433333
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh---------CCCee
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS---------YKVFH 150 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~---------~gIvH 150 (470)
++..+++||+|||+ .+|+|
T Consensus 312 ----------------------------------------------------ia~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 312 ----------------------------------------------------IAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred ----------------------------------------------------HHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 99999999999995 46999
Q ss_pred cCCCCCcEEEeCC-eEEEEecCCcccccCCC---ccccccccCcccCchhhccCCCCC-----CcccHHHHHHHHHHHHh
Q psy9855 151 RDIKPENILIRGD-LVVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYS-----FELDIWAAGCVFYETLT 221 (470)
Q Consensus 151 rDLKp~NILl~~~-~ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~-----~~~DIwSlG~il~ellt 221 (470)
||||..|||+.+| ...|+|||+|..+..+. .....+||..|||||++.+.-.+. ...||||+|.+||||++
T Consensus 340 RDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S 419 (534)
T KOG3653|consen 340 RDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS 419 (534)
T ss_pred ccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999 89999999998876433 223479999999999998765444 36899999999999999
Q ss_pred CCCCCC-CCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc
Q psy9855 222 RNPLFP-GDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300 (470)
Q Consensus 222 g~~pf~-~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp 300 (470)
+...+. +..+.-++.--..+-..|..+.+..+.-.... .+.++.. +. -..-...+.+.+..||..||+.|.
T Consensus 420 RC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~-----RP~~p~~-W~--~h~~~~~l~et~EeCWDhDaeARL 491 (534)
T KOG3653|consen 420 RCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQ-----RPKIPDA-WR--KHAGMAVLCETIEECWDHDAEARL 491 (534)
T ss_pred hcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhcc-----CCCChhh-hh--cCccHHHHHHHHHHHcCCchhhhh
Confidence 765553 32222222111222233444444432211110 1111110 00 012345678999999999999999
Q ss_pred CHHHHH
Q psy9855 301 TAQKIL 306 (470)
Q Consensus 301 t~~elL 306 (470)
|+.=+-
T Consensus 492 TA~Cv~ 497 (534)
T KOG3653|consen 492 TAGCVE 497 (534)
T ss_pred hhHHHH
Confidence 986553
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=235.95 Aligned_cols=153 Identities=31% Similarity=0.482 Sum_probs=139.9
Q ss_pred hhHHHHHHhcCC--CCCCeeeeceeeecCCCCeEEEEeeccc-c-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 13 NLKEISILRKIP--DHLNVLCLCETYVNRSTRQVTLVFPLME-L-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 13 ~~rEi~iL~~L~--~HpnIv~l~~~~~~~~~~~~~lV~E~~~-g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
+-.||+||..|+ .|+||++++++|.+ ++.+||+||--+ | ||.++|..+..++|.+++-
T Consensus 613 Vp~EIqIla~l~~~sH~NIlKlLdfFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~---------------- 674 (772)
T KOG1152|consen 613 VPSEIQILATLNKHSHENILKLLDFFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKL---------------- 674 (772)
T ss_pred cchhHHHHHHhhhcCccchhhhhheeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHH----------------
Confidence 457999999996 59999999999954 788999999988 6 9999999999999999888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|++||+.|+++||+.||||||||-+||.++++ .+||
T Consensus 675 -------------------------------------------IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 675 -------------------------------------------IFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred -------------------------------------------HHHHHHhccccccccCceecccccccEEEecCCeEEE
Confidence 99999999999999999999999999999998 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFP 227 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~ 227 (470)
+|||.+..... ++...++||..|.|||++.|..+.+..-|||++|++||.++....||.
T Consensus 712 idfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999877654 455678999999999999999888999999999999999999988885
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=236.05 Aligned_cols=203 Identities=21% Similarity=0.303 Sum_probs=164.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...++.|+-+|.+|+ |||+++|+|++... .+-||++|++ |+|.++++.++. +-......
T Consensus 742 s~e~LdeAl~masld-Hpnl~RLLgvc~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLn--------------- 802 (1177)
T KOG1025|consen 742 SIELLDEALRMASLD-HPNLLRLLGVCMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLN--------------- 802 (1177)
T ss_pred hHHHHHHHHHHhcCC-CchHHHHhhhcccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHH---------------
Confidence 456899999999999 99999999998642 3889999999 899999987654 54444444
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
|.+||++||.|||.+++|||||-..|||+..- .+|
T Consensus 803 --------------------------------------------w~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvk 838 (1177)
T KOG1025|consen 803 --------------------------------------------WCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVK 838 (1177)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEE
Confidence 99999999999999999999999999999876 999
Q ss_pred EEecCCcccccCCCcc-ccc--cccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLH-TEY--IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~-~~~--~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+.|||+++........ ... ...+.|||=|.+.... |+.++|||||||++||++| |..|+.+....+.-..+...
T Consensus 839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g- 916 (1177)
T KOG1025|consen 839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG- 916 (1177)
T ss_pred EEecchhhccCcccccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-
Confidence 9999999987644322 222 2245699999887755 9999999999999999998 99999887765544333221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
..-.-++.++-++.-+|.+||..|+..||+++++.
T Consensus 917 -----------------------------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 917 -----------------------------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred -----------------------------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 11223456788899999999999999999999875
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=213.86 Aligned_cols=219 Identities=17% Similarity=0.197 Sum_probs=172.9
Q ss_pred CCchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcc
Q psy9855 5 CPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 5 ~~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~ 83 (470)
-.......++.|--+|..+. |||++.+.++... .....++++++++ |+|..|+...+...
T Consensus 326 AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie-~~~~P~V~y~~~~~gNLK~FL~~Cr~~~----------------- 386 (563)
T KOG1024|consen 326 ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIE-DYATPFVLYPATGVGNLKSFLQICRGDD----------------- 386 (563)
T ss_pred ccHHHHHHHHHHHHHHhcCc-CCCccceeEEEee-ccCcceEEEeccCcchHHHHHHHhccCC-----------------
Confidence 33444556788888888998 9999999998875 4566788999999 89999997544211
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
....+..+..+.-.++.|++.|++|||++||||.||-..|.+|++.
T Consensus 387 ----------------------------------~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 387 ----------------------------------PSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred ----------------------------------CccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 1112233344445589999999999999999999999999999999
Q ss_pred -eEEEEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy9855 164 -LVVVGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRI 238 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i 238 (470)
.+||+|=.+++.+-..+.. ........||+||.+.... |+.++|+|||||+||||++ |+.|+..-++.+....+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 9999999999876544432 2223456799999998865 8999999999999999998 99999888888877766
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+... -.-+-++++++..+|.-||..+|++||+++|+..
T Consensus 512 kdGyR------------------------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 512 KDGYR------------------------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred hccce------------------------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 54221 1112378999999999999999999999999874
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-27 Score=236.89 Aligned_cols=215 Identities=25% Similarity=0.334 Sum_probs=174.3
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
....|+-+++.++ ||||+.++|.|.- ...+|++||||+ |+|.+.-.-.+.+++.++..
T Consensus 58 ~iqqei~~~~dc~-h~nivay~gsylr--~dklwicMEycgggslQdiy~~Tgplselqiay------------------ 116 (829)
T KOG0576|consen 58 GIQQEIGMLRDCR-HPNIVAYFGSYLR--RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAY------------------ 116 (829)
T ss_pred ccccceeeeecCC-CcChHHHHhhhhh--hcCcEEEEEecCCCcccceeeecccchhHHHHH------------------
Confidence 4568999999999 9999999999854 567999999999 69999877777788877776
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
+.+..+.||+|||++|-+|||||-.|||+++. .++++|
T Consensus 117 -----------------------------------------vcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 117 -----------------------------------------VCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred -----------------------------------------HHhhhhccchhhhcCCcccccccccceeecccCceeecc
Confidence 88999999999999999999999999999887 899999
Q ss_pred cCCcccccCC-CccccccccCcccCchhhc--cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 170 LGSLQFIKSK-GLHTEYIATRWYRSPECLL--TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 170 FG~a~~~~~~-~~~~~~~gt~~Y~APE~l~--~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
||.+..++.. .....+.||++|||||+.. ..+.|...+|||++|+...|+.--++|......+..+..+.+..-.|+
T Consensus 156 fgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 156 FGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred cCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 9988766532 2335679999999999863 234489999999999999999988888766655555554443211111
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
. ..-....++.+.+|++.+|..+|.+|||++.+|+|||...-
T Consensus 236 ~--------------------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 236 T--------------------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred c--------------------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 0 00113467888999999999999999999999999999864
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=217.55 Aligned_cols=222 Identities=24% Similarity=0.282 Sum_probs=154.8
Q ss_pred CCchhhhhhhHHHHHHhc--CCCCCCeeeeceeeecC--CCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHh
Q psy9855 5 CPDFAEVANLKEISILRK--IPDHLNVLCLCETYVNR--STRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKA 79 (470)
Q Consensus 5 ~~~~~~~~~~rEi~iL~~--L~~HpnIv~l~~~~~~~--~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~ 79 (470)
|.+.++..+.||.+|+.. |+ |+||+.+++.=... +-..+|||++|.+ |+|+|||.+. .++.....+
T Consensus 242 F~srdE~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-tv~~~~ml~------- 312 (513)
T KOG2052|consen 242 FSSRDERSWFRETEIYQTVMLR-HENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-TVTTEGMLK------- 312 (513)
T ss_pred ecccchhhhhhHHHHHHHHHhc-cchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc-cCCHHHHHH-------
Confidence 556778899999999876 58 99999999864321 2245899999999 9999999873 366666655
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh--------CCCeec
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS--------YKVFHR 151 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~--------~gIvHr 151 (470)
++..++.||++||. -.|.||
T Consensus 313 ----------------------------------------------------LalS~AsGLaHLH~eI~GTqgKPaIAHR 340 (513)
T KOG2052|consen 313 ----------------------------------------------------LALSIASGLAHLHMEIVGTQGKPAIAHR 340 (513)
T ss_pred ----------------------------------------------------HHHHHhhhHHHHHHHHhcCCCCchhhcc
Confidence 99999999999994 359999
Q ss_pred CCCCCcEEEeCC-eEEEEecCCcccccCCC-----ccccccccCcccCchhhccCCC---C--CCcccHHHHHHHHHHHH
Q psy9855 152 DIKPENILIRGD-LVVVGDLGSLQFIKSKG-----LHTEYIATRWYRSPECLLTEGY---Y--SFELDIWAAGCVFYETL 220 (470)
Q Consensus 152 DLKp~NILl~~~-~ikL~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~---~--~~~~DIwSlG~il~ell 220 (470)
|||..|||+..+ ...|+|+|+|....... ..+..+||..|||||++...-. + =..+||||||.++||++
T Consensus 341 DlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 341 DLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred ccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 999999999988 88999999997665331 2356799999999999854322 1 13589999999999998
Q ss_pred hC----------CCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHH
Q psy9855 221 TR----------NPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSE 290 (470)
Q Consensus 221 tg----------~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~ 290 (470)
.+ ++||.+-.+. .|.-+.+.+.-.. ..+.......+.. ...-..+..+|+.
T Consensus 421 rRc~~ggi~eey~~Pyyd~Vp~-----------DPs~eeMrkVVCv------~~~RP~ipnrW~s--~~~l~~m~klMke 481 (513)
T KOG2052|consen 421 RRCESGGIVEEYQLPYYDVVPS-----------DPSFEEMRKVVCV------QKLRPNIPNRWKS--DPALRVMAKLMKE 481 (513)
T ss_pred HHhhcCCEehhhcCCcccCCCC-----------CCCHHHHhcceee------cccCCCCCccccc--CHHHHHHHHHHHH
Confidence 63 4566543221 1122222211110 0000000111110 1122355788999
Q ss_pred hcccCCCCCcCHHHHH
Q psy9855 291 MLKYDPKRRPTAQKIL 306 (470)
Q Consensus 291 ~L~~dP~~Rpt~~elL 306 (470)
||..||.-|.||-.+-
T Consensus 482 CW~~Np~aRltALriK 497 (513)
T KOG2052|consen 482 CWYANPAARLTALRIK 497 (513)
T ss_pred hhcCCchhhhHHHHHH
Confidence 9999999999986553
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=198.03 Aligned_cols=175 Identities=37% Similarity=0.631 Sum_probs=148.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+++++.+. |++|+++++++.. ....++++|+++ ++|.+++... ..++...+..
T Consensus 36 ~~~~~e~~~~~~l~-~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~---------------- 96 (215)
T cd00180 36 EELLREIEILKKLN-HPNIVKLYGVFED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILR---------------- 96 (215)
T ss_pred HHHHHHHHHHHhcC-CCCeeeEeeeeec--CCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHH----------------
Confidence 56889999999999 9999999998864 478999999999 6999999765 3466666655
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-C-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-D-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~-~ik 166 (470)
++.+++.+|++||+.|++|+||+|.||+++. + .++
T Consensus 97 -------------------------------------------~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~ 133 (215)
T cd00180 97 -------------------------------------------ILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVK 133 (215)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEE
Confidence 9999999999999999999999999999998 4 899
Q ss_pred EEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||.+....... ......+...|++||.+.....++.+.|+|++|+++++|
T Consensus 134 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------- 187 (215)
T cd00180 134 LADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------- 187 (215)
T ss_pred EecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------
Confidence 99999887665432 123356788899999887653478999999999999998
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcc
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp 309 (470)
..+.+++.+||..||.+||++.+++.|+
T Consensus 188 ------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1237899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-26 Score=241.69 Aligned_cols=220 Identities=18% Similarity=0.303 Sum_probs=169.7
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccC
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWD 92 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (470)
+..|+-+-..|. ||||+..+..+.. .....-+||||++||..++.....+...++-.
T Consensus 368 i~sE~~i~~~l~-h~~~~e~l~~~~~--~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c-------------------- 424 (601)
T KOG0590|consen 368 ITSEFCIGSSLS-HPNIIETLDIVQE--IDGILQSMEYCPYDLFSLVMSNGKLTPLEADC-------------------- 424 (601)
T ss_pred hhhheeeccccc-CCchhhhHHHHhh--cccchhhhhcccHHHHHHHhcccccchhhhhH--------------------
Confidence 556777788888 9999888887654 33344449999999999998765566655555
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecC
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG 171 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG 171 (470)
++.||+.||+|+|+.||.|||||++|+++..+ .+||+|||
T Consensus 425 ---------------------------------------~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 425 ---------------------------------------FFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred ---------------------------------------HHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecC
Confidence 99999999999999999999999999999998 99999999
Q ss_pred CcccccCC-----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 172 SLQFIKSK-----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 172 ~a~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
.+...... ......+|+..|+|||++.+..+-...+||||.|++++.|.+|+.||......+....-.
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------- 538 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------- 538 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------
Confidence 88765422 234567899999999999887755567899999999999999999996543322211000
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.+........+...+...++...+.+|.+||++||.+|.|+++|++.+||+.+..
T Consensus 539 ---------------~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 539 ---------------NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ---------------ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 0000001122333344567888999999999999999999999999999998764
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-25 Score=202.60 Aligned_cols=205 Identities=22% Similarity=0.270 Sum_probs=152.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.||...--.|..|.||+.-+++.. +..+.+++++||++ |||..-+...+ +-|...+.
T Consensus 63 t~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~--------------- 125 (378)
T KOG1345|consen 63 TQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKK--------------- 125 (378)
T ss_pred hHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEeeccCccchhhhhcCccc-ccHHHHHH---------------
Confidence 35578899988888888999999888754 34668999999999 89999887643 66666666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-C--e
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-D--L 164 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~--~ 164 (470)
++.|++.|+.|+|++++||||||.+|||+-. + .
T Consensus 126 --------------------------------------------v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~r 161 (378)
T KOG1345|consen 126 --------------------------------------------VFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYR 161 (378)
T ss_pred --------------------------------------------HHHHHHHHHHHhhccchhhcccccceEEEecCCccE
Confidence 9999999999999999999999999999954 3 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEG----YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+||||||.....+..-.. .--+-.|.+||+..... ...+..|||.||+++|.+++|++||+.....+
T Consensus 162 vKlcDFG~t~k~g~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d------- 232 (378)
T KOG1345|consen 162 VKLCDFGLTRKVGTTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD------- 232 (378)
T ss_pred EEeeecccccccCceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-------
Confidence 999999988765432211 12345689999765322 25678999999999999999999997433221
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCC
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R 299 (470)
++-..|..|.+... ......+..+++.+..+.++-|..+|++|
T Consensus 233 ----~~Y~~~~~w~~rk~------------~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 233 ----KPYWEWEQWLKRKN------------PALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ----chHHHHHHHhcccC------------ccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 11122222222111 12223345678999999999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-23 Score=191.60 Aligned_cols=157 Identities=37% Similarity=0.571 Sum_probs=134.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|++.+..++ |+||+++++.+.. ....++++|++++ +|.+++..... +++..+..
T Consensus 41 ~~~~~~e~~~~~~~~-~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 102 (225)
T smart00221 41 REEFLREIRILKKLK-HPNIVKLYGVFED--PEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARF--------------- 102 (225)
T ss_pred HHHHHHHHHHHHhCC-CCChhhheeeeec--CCceEEEEeccCCCCHHHHHHhcccCCCHHHHHH---------------
Confidence 456789999999998 9999999998754 5679999999996 99999987665 66666655
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.+|.|||+.|++|+||+|.||+++.+ .++
T Consensus 103 --------------------------------------------~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~ 138 (225)
T smart00221 103 --------------------------------------------YLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVK 138 (225)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy9855 167 VGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPG 228 (470)
Q Consensus 167 L~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~ 228 (470)
|+|||.+....... ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.+
T Consensus 139 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 139 LADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999888765442 334567888999999874333477899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=188.06 Aligned_cols=192 Identities=26% Similarity=0.396 Sum_probs=141.4
Q ss_pred CCCCCCeeeeceeeecC-------------------------CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHH
Q psy9855 23 IPDHLNVLCLCETYVNR-------------------------STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQV 77 (470)
Q Consensus 23 L~~HpnIv~l~~~~~~~-------------------------~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~ 77 (470)
|..|||||++.+.|.+. ....+|+||..+..+|.+++..+. .+.
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-~s~---------- 340 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-RSY---------- 340 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-Cch----------
Confidence 33599999999998751 245689999999999999986543 222
Q ss_pred HhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q psy9855 78 KAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPEN 157 (470)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~N 157 (470)
.....++.|+++|+.|||.+||.|||+|.+|
T Consensus 341 -------------------------------------------------r~~~~~laQlLEav~hL~~hgvAhRDlKSDN 371 (598)
T KOG4158|consen 341 -------------------------------------------------RTGRVILAQLLEAVTHLHKHGVAHRDLKSDN 371 (598)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHHHHHHccchhhcccccc
Confidence 2223389999999999999999999999999
Q ss_pred EEEe--CC---eEEEEecCCcccccCCCc-------cccccccCcccCchhhccCCC-----CCCcccHHHHHHHHHHHH
Q psy9855 158 ILIR--GD---LVVVGDLGSLQFIKSKGL-------HTEYIATRWYRSPECLLTEGY-----YSFELDIWAAGCVFYETL 220 (470)
Q Consensus 158 ILl~--~~---~ikL~DFG~a~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~-----~~~~~DIwSlG~il~ell 220 (470)
||+. +| .++|+|||++--....+. .....|.-..||||+....+. .-.++|.|+.|.+.||++
T Consensus 372 iL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIf 451 (598)
T KOG4158|consen 372 ILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIF 451 (598)
T ss_pred eEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHh
Confidence 9994 33 788999997643332211 122346777899998754321 124789999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc
Q psy9855 221 TRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300 (470)
Q Consensus 221 tg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp 300 (470)
+...||.+..+...- ...+....+..++..+++.+.+|+..+|+.||++|+
T Consensus 452 g~~NPFY~rGem~L~-----------------------------~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRv 502 (598)
T KOG4158|consen 452 GRSNPFYKRGEMLLD-----------------------------TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRV 502 (598)
T ss_pred ccCCcccccchheec-----------------------------hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccC
Confidence 999999774322111 111223345556678899999999999999999999
Q ss_pred CHH
Q psy9855 301 TAQ 303 (470)
Q Consensus 301 t~~ 303 (470)
+..
T Consensus 503 sp~ 505 (598)
T KOG4158|consen 503 SPN 505 (598)
T ss_pred Ccc
Confidence 954
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-20 Score=179.45 Aligned_cols=221 Identities=33% Similarity=0.475 Sum_probs=166.6
Q ss_pred hhhhhHHHHHHhcCCCCC-CeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc---cccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHL-NVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD---NISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~Hp-nIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~---~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+.++..+. |+ +|+++.+.+.. ....+++++++. ++|.+++.... .+.+..+..
T Consensus 41 ~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~------------ 105 (384)
T COG0515 41 VERFLREIQILASLN-HPPNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF------------ 105 (384)
T ss_pred HHHHHHHHHHHHHcc-CCcceeeEEEEEec--CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHH------------
Confidence 556889999999999 66 89999999843 455899999999 58887777654 455555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.|++.++.|+|..|++|||+||+||+++..
T Consensus 106 -----------------------------------------------~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~ 138 (384)
T COG0515 106 -----------------------------------------------ILAQILSALEYLHSKGIIHRDIKPENILLDRDG 138 (384)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC
Confidence 99999999999999999999999999999987
Q ss_pred -eEEEEecCCcccccCCC-------ccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCh--
Q psy9855 164 -LVVVGDLGSLQFIKSKG-------LHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSE-- 231 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~-------~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~-- 231 (470)
.++++|||.+....... .....+||..|+|||.+.+. ..++...|+||+|++++++++|..||.....
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~ 218 (384)
T COG0515 139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218 (384)
T ss_pred CeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 58999999987555332 34667899999999998874 4578999999999999999999999877653
Q ss_pred -HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 232 -IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 232 -~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
...........+.+ ...... . ..........+.+++..++..+|..|.+..+...++|
T Consensus 219 ~~~~~~~~~~~~~~~--------------~~~~~~----~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~ 277 (384)
T COG0515 219 ATSQTLKIILELPTP--------------SLASPL----S---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277 (384)
T ss_pred cHHHHHHHHHhcCCc--------------cccccc----C---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchH
Confidence 22222222211111 000000 0 0000122357789999999999999999999988865
Q ss_pred CCC
Q psy9855 311 FAD 313 (470)
Q Consensus 311 f~~ 313 (470)
...
T Consensus 278 ~~~ 280 (384)
T COG0515 278 LAH 280 (384)
T ss_pred hhC
Confidence 554
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-21 Score=198.95 Aligned_cols=204 Identities=21% Similarity=0.284 Sum_probs=170.6
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
....|..++..++.||.+|+++..|+. ....++++++.. |+|...+.....+.+...+.
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~------------------ 101 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFLRGGDLFTRLSKEVMFDELDVAF------------------ 101 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhcccchhhhccccCCchHHHHHHH------------------
Confidence 556788999999889999999988854 677999999998 49988887776666666665
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
+...++-|++++|+.||+|||+|++||+++.+ ++++.|
T Consensus 102 -----------------------------------------~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~td 140 (612)
T KOG0603|consen 102 -----------------------------------------YLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTD 140 (612)
T ss_pred -----------------------------------------HHHHHHHHHhhcchhHHHHhcccccceeecccCccccCC
Confidence 89999999999999999999999999999988 799999
Q ss_pred cCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Q psy9855 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249 (470)
Q Consensus 170 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~ 249 (470)
||.++........ |||..|||||++.+ ...++|.||||++++||++|..||.+ +....|.+.
T Consensus 141 fglske~v~~~~~---cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-------- 202 (612)
T KOG0603|consen 141 FGLSKEAVKEKIA---CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-------- 202 (612)
T ss_pred chhhhHhHhhhhc---ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--------
Confidence 9999877654433 99999999999873 57899999999999999999999977 344444331
Q ss_pred HHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-----HHHHhcccCCChhHH
Q psy9855 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-----QKILSCAYFADLTQL 317 (470)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-----~elL~hp~f~~~~~~ 317 (470)
....+..++..+.+++..++..+|..|.-. .++++|+||+.+...
T Consensus 203 -----------------------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 203 -----------------------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -----------------------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 112335678889999999999999999864 799999999988753
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-20 Score=200.03 Aligned_cols=204 Identities=25% Similarity=0.310 Sum_probs=148.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+-++|++ ....+ |||.+.+.-+. ......|+|-+|...+|+|.|..++.+..-+.++
T Consensus 67 ~qrL~~ik-~~l~~-~pn~lPfqk~~--~t~kAAylvRqyvkhnLyDRlSTRPFL~~iEKkW------------------ 124 (1431)
T KOG1240|consen 67 KQRLEEIK-FALMK-APNCLPFQKVL--VTDKAAYLVRQYVKHNLYDRLSTRPFLVLIEKKW------------------ 124 (1431)
T ss_pred HHHHHHHH-HHhhc-CCcccchHHHH--HhhHHHHHHHHHHhhhhhhhhccchHHHHHHHHH------------------
Confidence 34567777 55556 99999997764 3466789999999999999999888887777777
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
|+.||+.||.-+|..||+|||||.+|||++.- .+.|+|
T Consensus 125 -----------------------------------------iaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtD 163 (1431)
T KOG1240|consen 125 -----------------------------------------IAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTD 163 (1431)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhc
Confidence 99999999999999999999999999999886 788999
Q ss_pred cCCcccc--cCCCc--cc----cccccCcccCchhhccCC----------CCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q psy9855 170 LGSLQFI--KSKGL--HT----EYIATRWYRSPECLLTEG----------YYSFELDIWAAGCVFYETLT-RNPLFPGDS 230 (470)
Q Consensus 170 FG~a~~~--~~~~~--~~----~~~gt~~Y~APE~l~~~~----------~~~~~~DIwSlG~il~ellt-g~~pf~~~~ 230 (470)
|...+.. .++++ .+ +...-..|.|||.+.... ..+++-||||+||+++||++ |++||.-
T Consensus 164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-- 241 (1431)
T KOG1240|consen 164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-- 241 (1431)
T ss_pred ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--
Confidence 9866532 22221 11 112234699999875421 15678899999999999998 8999931
Q ss_pred hHHHHHHHHHHhCCCch-HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 231 EIDQLDRIHQVLGTPKA-ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 231 ~~~~~~~i~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.++-.....- .... ..++. --+..++.||..|++.||++|.+|++.|+-
T Consensus 242 --SQL~aYr~~~-~~~~e~~Le~--------------------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 242 --SQLLAYRSGN-ADDPEQLLEK--------------------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --HHHHhHhccC-ccCHHHHHHh--------------------------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1221111100 0000 00000 012356899999999999999999999964
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=165.87 Aligned_cols=199 Identities=20% Similarity=0.244 Sum_probs=154.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..|..|+-.|+-+. ||||+.++|.+.. ...+.++..||+ |+|++++..... ++..++..
T Consensus 232 rdfneefp~lrifs-hpnilpvlgacns--ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~--------------- 293 (448)
T KOG0195|consen 232 RDFNEEFPALRIFS-HPNILPVLGACNS--PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVR--------------- 293 (448)
T ss_pred chhhhhCcceeeec-CCchhhhhhhccC--CCCceEeeeeccchHHHHHHhcCccEEEecchHHH---------------
Confidence 35667888888888 9999999998854 577999999999 899999987665 44445444
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCC-e
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILIRGD-L 164 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~~-~ 164 (470)
++.+|++|++|||+.. |.---|....++++++ .
T Consensus 294 --------------------------------------------faldiargmaflhslep~ipr~~lns~hvmidedlt 329 (448)
T KOG0195|consen 294 --------------------------------------------FALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT 329 (448)
T ss_pred --------------------------------------------HHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh
Confidence 9999999999999863 4444688889999998 3
Q ss_pred --EEEEecCCcccccCCCccccccccCcccCchhhccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 165 --VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 165 --ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+-.+|--++-. .......|.||+||.+...+. .-.++|+|||++++|||.|...||.+.++++.-.+|.-
T Consensus 330 arismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial 403 (448)
T KOG0195|consen 330 ARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL 403 (448)
T ss_pred hheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh
Confidence 33445333221 122345788999999876542 23578999999999999999999998887776555432
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
.+....++|.++..+..||.-|++.||.+||.++.++
T Consensus 404 -----------------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 -----------------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----------------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 2333456789999999999999999999999998876
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-19 Score=192.18 Aligned_cols=154 Identities=25% Similarity=0.368 Sum_probs=127.4
Q ss_pred HHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCC----------------ccccccccCcccCchhh
Q psy9855 135 QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKG----------------LHTEYIATRWYRSPECL 197 (470)
Q Consensus 135 qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~----------------~~~~~~gt~~Y~APE~l 197 (470)
+++.+++|||+.||||||+||+|.+|+.- .+|++|||+++...... .....|||+.|+|||++
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 34789999999999999999999999876 99999999887543110 11346999999999999
Q ss_pred ccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCccccc
Q psy9855 198 LTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLV 277 (470)
Q Consensus 198 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (470)
..++ |+..+|.|++|+|+||.+-|+.||.|++..+.+..+...... +..-.
T Consensus 231 lrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~----------------------------wpE~d 281 (1205)
T KOG0606|consen 231 LRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE----------------------------WPEED 281 (1205)
T ss_pred hhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc----------------------------ccccC
Confidence 8877 899999999999999999999999999999988877653221 11113
Q ss_pred ccccHHHHHHHHHhcccCCCCCc---CHHHHHhcccCCChhHH
Q psy9855 278 PQIHEKGKKLMSEMLKYDPKRRP---TAQKILSCAYFADLTQL 317 (470)
Q Consensus 278 ~~~s~~~~~Li~~~L~~dP~~Rp---t~~elL~hp~f~~~~~~ 317 (470)
..++++++++|.++|..+|..|. .+-++.+|+||+.++..
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 45788999999999999999995 46788899999987754
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.4e-20 Score=183.15 Aligned_cols=175 Identities=22% Similarity=0.360 Sum_probs=118.3
Q ss_pred ceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCccc
Q psy9855 97 FLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQF 175 (470)
Q Consensus 97 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~ 175 (470)
||.|++|..++|.+||.+..... ...+..++.++.|++.|++| +|.+|+|+||.||++..+ .++|+|||+...
T Consensus 332 yI~Mn~c~~~tledWl~rr~~~e---~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 332 YIQMNLCEKETLEDWLRRRRTGE---ERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred hhhhhhhhhhhHHHHhhCCCccc---ccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 34444444444444443322221 12234445599999999999 999999999999999888 799999998876
Q ss_pred ccCCC-------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 176 IKSKG-------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 176 ~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
..... ..+..+||.+||+||.+.+.. |+.++||||||+||+|++. -...| +.....
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~--------- 469 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQF------ERIATL--------- 469 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHH------HHHHhh---------
Confidence 65444 446679999999999999866 9999999999999999987 21111 111111
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
..++.+.+.. ....+. +.-.+|+.+||...|.+||++.+.--|+|.
T Consensus 470 ------~d~r~g~ip~-----------~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 470 ------TDIRDGIIPP-----------EFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ------hhhhcCCCCh-----------HHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111111110 001112 333689999999999999988777767664
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-17 Score=164.85 Aligned_cols=209 Identities=20% Similarity=0.171 Sum_probs=155.1
Q ss_pred hhhHHHHHHhcCC---CCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 12 ANLKEISILRKIP---DHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 12 ~~~rEi~iL~~L~---~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.+..|+.+|..+. +-.++..+++... .....-++||+.++.+|.++..... .++...+..
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~-------------- 126 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLR-------------- 126 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHH--------------
Confidence 5678999999997 2468999988663 3466789999999999999986554 266666655
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--- 163 (470)
|+.|++.+|++||+.|++||||||+|+++...
T Consensus 127 ---------------------------------------------ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~ 161 (322)
T KOG1164|consen 127 ---------------------------------------------IAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRS 161 (322)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCc
Confidence 99999999999999999999999999999743
Q ss_pred ---eEEEEecCCcc--ccc-CCC-------c-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy9855 164 ---LVVVGDLGSLQ--FIK-SKG-------L-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229 (470)
Q Consensus 164 ---~ikL~DFG~a~--~~~-~~~-------~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~ 229 (470)
.+.|.|||+++ ... ..+ . .....||..|+++.+..+.. .+.+.|+||++.++.+++.|..||.+.
T Consensus 162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 58899999998 321 111 0 12345999999999887766 689999999999999999999999776
Q ss_pred ChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 230 SEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 230 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
........+...... ..........+.++..++..+-..+...+|....+..
T Consensus 241 ~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 241 EMTDLKSKFEKDPRK--------------------------LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred cccchHHHHHHHhhh--------------------------hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 543333333221100 0000012234567777777777789999999887764
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.5e-18 Score=173.32 Aligned_cols=201 Identities=19% Similarity=0.281 Sum_probs=146.8
Q ss_pred HhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccccccCCCccc
Q psy9855 20 LRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRVGWDLKLPF 97 (470)
Q Consensus 20 L~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (470)
|+.+. |.|+.+++|...+ ....++|.+||. |+|.+.+..... ++......
T Consensus 1 l~~l~-h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s------------------------- 52 (484)
T KOG1023|consen 1 LRQLD-HDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILS------------------------- 52 (484)
T ss_pred Ccccc-hhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHH-------------------------
Confidence 46788 9999999999887 478999999999 899999987433 54444444
Q ss_pred eeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCC-eecCCCCCcEEEeCC-eEEEEecCCccc
Q psy9855 98 LLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKV-FHRDIKPENILIRGD-LVVVGDLGSLQF 175 (470)
Q Consensus 98 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gI-vHrDLKp~NILl~~~-~ikL~DFG~a~~ 175 (470)
++++|+.||+|||...| .|+.++..|.+++.. .+||+|||+...
T Consensus 53 ----------------------------------~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~ 98 (484)
T KOG1023|consen 53 ----------------------------------FIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSL 98 (484)
T ss_pred ----------------------------------HHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhccc
Confidence 89999999999998866 999999999999999 899999998876
Q ss_pred ccCC---CccccccccCcccCchhhccCCC------CCCcccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHh
Q psy9855 176 IKSK---GLHTEYIATRWYRSPECLLTEGY------YSFELDIWAAGCVFYETLTRNPLFPGDSE----IDQLDRIHQVL 242 (470)
Q Consensus 176 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~------~~~~~DIwSlG~il~elltg~~pf~~~~~----~~~~~~i~~~~ 242 (470)
.... .......-...|.|||.+.+... .+.+.||||+|++++|+++...||..... .+.+..+.+ .
T Consensus 99 ~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~ 177 (484)
T KOG1023|consen 99 LEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-G 177 (484)
T ss_pred ccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-c
Confidence 6421 11112223456999999876421 36779999999999999999999975322 223333222 0
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
+.++ . ....... ....+++..++..||..+|.+||+++++-
T Consensus 178 ~~~~--------------------~--rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 178 GSNP--------------------F--RPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CCCC--------------------c--Ccchhhh-hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 0000 0 0000101 14455789999999999999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.2e-18 Score=154.55 Aligned_cols=147 Identities=18% Similarity=0.046 Sum_probs=110.2
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+++|++|.+|++|.+++++ +..+++|||+.| +|.+.+.. . ...
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvmeyI~G~~L~~~~~~------~-~~~------------------ 95 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW------DGRHLDRSYLAGAAMYQRPPR------G-DLA------------------ 95 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEeeecCccHHhhhhh------h-hHH------------------
Confidence 467999999999867999999885 236999999997 67544211 0 012
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCC-CCCcEEEeCC-eEEEE
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDI-KPENILIRGD-LVVVG 168 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDL-Kp~NILl~~~-~ikL~ 168 (470)
++.|++.+|+++|++||+|||| ||+|||++.+ .++|+
T Consensus 96 -----------------------------------------~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LI 134 (218)
T PRK12274 96 -----------------------------------------YFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVI 134 (218)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEE
Confidence 7789999999999999999999 7999999876 79999
Q ss_pred ecCCcccccCCCcc--------------ccccccCcccCchhhccCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCC
Q psy9855 169 DLGSLQFIKSKGLH--------------TEYIATRWYRSPECLLTEGYYS-FELDIWAAGCVFYETLTRNPLFPGDS 230 (470)
Q Consensus 169 DFG~a~~~~~~~~~--------------~~~~gt~~Y~APE~l~~~~~~~-~~~DIwSlG~il~elltg~~pf~~~~ 230 (470)
|||++......... .....++.|++|+.-.-....+ ...+.++.|+-+|.++||..++.+++
T Consensus 135 DFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 135 DFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 99999865533310 0113577788888543222223 45577799999999999998876654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-17 Score=161.59 Aligned_cols=132 Identities=26% Similarity=0.351 Sum_probs=90.3
Q ss_pred HHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCccccccccCcccCchhhccC-------CC
Q psy9855 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE-------GY 202 (470)
Q Consensus 131 ~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~ 202 (470)
.+..|+++.+++||..|+||+||+|+|++++.+ .+.|+||+.....+..... ...+..|.+||..... -.
T Consensus 149 ~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 149 SLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp HHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred HHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccce
Confidence 366899999999999999999999999999998 8999999976655432222 3455779999976442 23
Q ss_pred CCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccH
Q psy9855 203 YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHE 282 (470)
Q Consensus 203 ~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 282 (470)
++.+.|.|+||+++|.|++|..||......... .. .+.... ++++
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~--------------------------~~--------~f~~C~-~~Pe 271 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLSSPEADP--------------------------EW--------DFSRCR-DMPE 271 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS--------------------------GG--------GGTTSS----H
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCCCccccc--------------------------cc--------cchhcC-CcCH
Confidence 788999999999999999999999654321000 00 111222 6889
Q ss_pred HHHHHHHHhcccCCCCC
Q psy9855 283 KGKKLMSEMLKYDPKRR 299 (470)
Q Consensus 283 ~~~~Li~~~L~~dP~~R 299 (470)
.++.||..+|+.||.+|
T Consensus 272 ~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 272 PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCcccC
Confidence 99999999999999988
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.6e-17 Score=147.22 Aligned_cols=211 Identities=16% Similarity=0.143 Sum_probs=158.7
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....++..|.++.+.|++...|..+..++.+ ...-.+||++.+.+|.++..-+.. ++...+..
T Consensus 52 a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLM-------------- 115 (341)
T KOG1163|consen 52 AKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLM-------------- 115 (341)
T ss_pred CCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeeeeccCccHHHHHHHHhhhhhHHhHHH--------------
Confidence 3456788999999999977888888776643 667799999999999998865443 55554444
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--- 163 (470)
++-|++.-++|+|.++++||||||+|+|..-+
T Consensus 116 ---------------------------------------------LaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~ 150 (341)
T KOG1163|consen 116 ---------------------------------------------LADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHC 150 (341)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhhccccccCCccceeecccccc
Confidence 99999999999999999999999999999755
Q ss_pred -eEEEEecCCcccccCCCc--------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy9855 164 -LVVVGDLGSLQFIKSKGL--------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ 234 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~ 234 (470)
.+.|+|||+|+...+... .....||..|.+--...+.. -+..-|+=|+|.+|..+..|..||+|......
T Consensus 151 ~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 151 NKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred ceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 688999999987653221 23468999999877666544 46778999999999999999999998766555
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHH
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~ 303 (470)
.++..++..... ......+...+|.++.-.|.-|-..--++-|...
T Consensus 230 ~QKyEkI~EkK~-----------------------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 230 KQKYEKISEKKM-----------------------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHHHHHHHhhc-----------------------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 554444322111 2233344457788888888888776666666643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-17 Score=165.18 Aligned_cols=117 Identities=22% Similarity=0.264 Sum_probs=90.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeee-eceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLC-LCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~-l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|.+|+ |+||+. +++. +..|+|||||+| +|.. +... . ...
T Consensus 65 ~~~~~~E~~iL~~L~-h~~iv~~l~~~------~~~~LVmE~~~G~~L~~-~~~~---~---~~~--------------- 115 (365)
T PRK09188 65 RHLAAREIRALKTVR-GIGVVPQLLAT------GKDGLVRGWTEGVPLHL-ARPH---G---DPA--------------- 115 (365)
T ss_pred HHHHHHHHHHHHhcc-CCCCCcEEEEc------CCcEEEEEccCCCCHHH-hCcc---c---hHH---------------
Confidence 456889999999999 999985 4431 347999999996 7752 2100 0 012
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCC-CCCcEEEeCC-eE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDI-KPENILIRGD-LV 165 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDL-Kp~NILl~~~-~i 165 (470)
++.|++.||.|||++||+|||| ||+|||++.+ .+
T Consensus 116 --------------------------------------------~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 116 --------------------------------------------WFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCE
Confidence 7889999999999999999999 9999999766 89
Q ss_pred EEEecCCcccccCCCc---------cccccccCcccCchhhcc
Q psy9855 166 VVGDLGSLQFIKSKGL---------HTEYIATRWYRSPECLLT 199 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~---------~~~~~gt~~Y~APE~l~~ 199 (470)
+|+|||+++....... .....+++.|+|||.+..
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999986654321 134578888999998754
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=3e-16 Score=149.37 Aligned_cols=164 Identities=20% Similarity=0.210 Sum_probs=136.3
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
+..++.-|....+.|.+.++|..++. .++.+-+-.||+|+++.+|.++..-++. ++...+..
T Consensus 66 ~APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~m--------------- 128 (449)
T KOG1165|consen 66 EAPQLRDEYRTYKLLGGTEGIPQVYY--FGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAM--------------- 128 (449)
T ss_pred CcchHHHHHHHHHHHcCCCCCCceee--eccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHH---------------
Confidence 34567789999999998999999854 5566777899999999999999887776 77777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-----
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG----- 162 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~----- 162 (470)
++.|++.-++|+|++.+|.|||||+|+||..
T Consensus 129 --------------------------------------------iA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~ 164 (449)
T KOG1165|consen 129 --------------------------------------------IAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKD 164 (449)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhcceeecccCccceeecCCCCCC
Confidence 9999999999999999999999999999953
Q ss_pred -CeEEEEecCCcccccCCCc--------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy9855 163 -DLVVVGDLGSLQFIKSKGL--------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233 (470)
Q Consensus 163 -~~ikL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~ 233 (470)
+.|.++|||+|+...+... .....||..||+--..+|.. -+..-|+=|||-++++.|-|..||.|.....
T Consensus 165 ~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 165 ANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred CceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 2788999999997764332 23467999999988777766 5778899999999999999999998854433
Q ss_pred H
Q psy9855 234 Q 234 (470)
Q Consensus 234 ~ 234 (470)
.
T Consensus 244 n 244 (449)
T KOG1165|consen 244 N 244 (449)
T ss_pred h
Confidence 3
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.4e-17 Score=152.67 Aligned_cols=127 Identities=16% Similarity=0.174 Sum_probs=96.8
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecCC------CCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNRS------TRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~~------~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
+.+|+..+.+|. ||+|..+.+++.... .+..++||||++| +|.++.. +++ .
T Consensus 82 ~e~Ea~~l~rL~-~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~------------- 139 (232)
T PRK10359 82 YENLIVQTDRVR-SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----D------------- 139 (232)
T ss_pred HHHHHHHHHHHH-HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----H-------------
Confidence 579999999998 999999998876432 2458999999997 8877632 111 1
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeE
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLV 165 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~i 165 (470)
...+|+.+|..||..|++|||+||+||+++.+.+
T Consensus 140 ----------------------------------------------~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi 173 (232)
T PRK10359 140 ----------------------------------------------VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGL 173 (232)
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCE
Confidence 5669999999999999999999999999988779
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYET 219 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~el 219 (470)
+|+|||........... ..++.. ..|+.++|+|+||+++.-+
T Consensus 174 ~liDfg~~~~~~e~~a~-----------d~~vle-r~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-----------DRIDLE-RHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEECCCcccccchhhH-----------HHHHHH-hHhcccccccceeEeehHH
Confidence 99999977644221110 112333 3377899999999987754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.1e-15 Score=138.81 Aligned_cols=99 Identities=17% Similarity=0.241 Sum_probs=76.1
Q ss_pred hHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccC
Q psy9855 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWD 92 (470)
Q Consensus 14 ~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (470)
.+|+++|.+|. +++|.....+.. . ..+|||||++| +|...+.....++...+..
T Consensus 67 ~~E~~~l~~l~-~~~v~~p~~~~~---~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~-------------------- 121 (190)
T cd05147 67 EKEMRNLKRLV-TAGIPCPEPILL---K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARE-------------------- 121 (190)
T ss_pred HHHHHHHHHHH-HCCCCCCcEEEe---c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHH--------------------
Confidence 46999999998 777644333221 1 23899999996 5554433334466666665
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHH-HhCCCeecCCCCCcEEEeCCeEEEEecC
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHL-HSYKVFHRDIKPENILIRGDLVVVGDLG 171 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yL-H~~gIvHrDLKp~NILl~~~~ikL~DFG 171 (470)
++.||+.+|.|+ |+.||+||||||+|||++.+.++|+|||
T Consensus 122 ---------------------------------------i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~LiDFG 162 (190)
T cd05147 122 ---------------------------------------LYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLYIIDVS 162 (190)
T ss_pred ---------------------------------------HHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEEEEEcc
Confidence 999999999999 7999999999999999998899999999
Q ss_pred Ccccc
Q psy9855 172 SLQFI 176 (470)
Q Consensus 172 ~a~~~ 176 (470)
++...
T Consensus 163 ~a~~~ 167 (190)
T cd05147 163 QSVEH 167 (190)
T ss_pred ccccC
Confidence 88653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.5e-15 Score=138.36 Aligned_cols=102 Identities=18% Similarity=0.221 Sum_probs=79.3
Q ss_pred hhhhhHHHHHHhcCC----CCCCeeeeceeeecCCC-Ce-EEEEeeccc---cCHHHHHHhcccccHHHHHHHHHHHHhh
Q psy9855 10 EVANLKEISILRKIP----DHLNVLCLCETYVNRST-RQ-VTLVFPLME---LNLEEYIRTTDNISEKRAKEILYQVKAA 80 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~----~HpnIv~l~~~~~~~~~-~~-~~lV~E~~~---gsL~~~l~~~~~l~~~~~~~~~~~~~~~ 80 (470)
...+.+|+++++.|. .||||++++|++....+ +. +.+|+||++ |+|.+++.+. .+++. ..
T Consensus 40 ~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~-------- 108 (210)
T PRK10345 40 DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VA-------- 108 (210)
T ss_pred HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HH--------
Confidence 456899999999994 28999999999975322 34 347899954 5999999663 24433 23
Q ss_pred hccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHH-HHHHhCCCeecCCCCCcEE
Q psy9855 81 NETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGL-HHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL-~yLH~~gIvHrDLKp~NIL 159 (470)
++.|++.++ +|||+++||||||||+|||
T Consensus 109 ---------------------------------------------------~~~~~L~~l~~yLh~~~IvhrDlKp~NIL 137 (210)
T PRK10345 109 ---------------------------------------------------QLRQLLKKLKRYLLDNRIVTMELKPQNIL 137 (210)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 678888888 9999999999999999999
Q ss_pred EeC----C-eEEEEecCCc
Q psy9855 160 IRG----D-LVVVGDLGSL 173 (470)
Q Consensus 160 l~~----~-~ikL~DFG~a 173 (470)
++. + .++|+||+.+
T Consensus 138 l~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 138 CQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EeccCCCCCcEEEEECCCC
Confidence 973 2 7999995533
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=2e-16 Score=168.76 Aligned_cols=215 Identities=24% Similarity=0.319 Sum_probs=165.7
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHH-Hhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYI-RTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l-~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..-.|..+-..+..|.|++.+++... +....++++++..| ++.+.+ .... ..+...+..
T Consensus 66 ~i~~e~~~~~~~s~h~n~~~~~~~~~--~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~---------------- 127 (601)
T KOG0590|consen 66 HIDTETDIQKKLSKHSNTVHMIEPSS--SPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASR---------------- 127 (601)
T ss_pred hcCccccccccccccccccccCCccC--CCcccccccCcccccccccccccCCccCCCCcchhh----------------
Confidence 44567777778877999999999764 46778999999884 888887 3332 244444444
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCC--eE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH-SYKVFHRDIKPENILIRGD--LV 165 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH-~~gIvHrDLKp~NILl~~~--~i 165 (470)
++.|+..|+.|+| ..|+.|||+||+|.+++.. .+
T Consensus 128 -------------------------------------------~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l 164 (601)
T KOG0590|consen 128 -------------------------------------------YLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSAL 164 (601)
T ss_pred -------------------------------------------hhhhhccCccccCcccccccCCCCCccchhccCCCcc
Confidence 9999999999999 9999999999999999876 59
Q ss_pred EEEecCCcccccC-CC---ccccccc-cCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKS-KG---LHTEYIA-TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~-~~---~~~~~~g-t~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+++|||+|..... .+ .....+| ++.|+|||...+..+.....|+||.|+++.-+++|..|+......+..
T Consensus 165 ~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~----- 239 (601)
T KOG0590|consen 165 KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR----- 239 (601)
T ss_pred cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----
Confidence 9999999987665 32 2345688 999999999888666788999999999999999999998554322100
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...+...........+..++....+++.+++..+|..|.+.+++-.+||+..
T Consensus 240 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 ---------------------YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ---------------------ceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0111111111123344577888899999999999999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.1e-14 Score=132.34 Aligned_cols=100 Identities=18% Similarity=0.201 Sum_probs=76.9
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHH-HHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEE-YIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~-~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
..+|++.+.++. |++|.....+... ..++||||++| ++.. .+. ...++......
T Consensus 66 ~~~E~~~l~~l~-~~~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~------------------ 121 (190)
T cd05145 66 AEKEFRNLKRLY-EAGVPVPEPILLK----KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEE------------------ 121 (190)
T ss_pred HHHHHHHHHHHH-hCCCCCceEEEec----CCEEEEEEecCCCchhhhhh-hccCCHHHHHH------------------
Confidence 458999999998 8987554443322 24899999996 3433 333 23355555555
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCeEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGDLVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~~ikL~D 169 (470)
++.|++.+|.++|. .||+||||||+|||++++.++|+|
T Consensus 122 -----------------------------------------i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~~~liD 160 (190)
T cd05145 122 -----------------------------------------LYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGKPYIID 160 (190)
T ss_pred -----------------------------------------HHHHHHHHHHHHHHhCCEecCCCChhhEEEECCCEEEEE
Confidence 99999999999999 999999999999999966999999
Q ss_pred cCCccccc
Q psy9855 170 LGSLQFIK 177 (470)
Q Consensus 170 FG~a~~~~ 177 (470)
||++....
T Consensus 161 FG~a~~~~ 168 (190)
T cd05145 161 VSQAVELD 168 (190)
T ss_pred cccceecC
Confidence 99987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.9e-14 Score=154.81 Aligned_cols=136 Identities=19% Similarity=0.220 Sum_probs=109.2
Q ss_pred CCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccCCCccceeeeccCC
Q psy9855 27 LNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKS 105 (470)
Q Consensus 27 pnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 105 (470)
+.|..+...+.. .+.-+||+||.+ |+|.+++.....+++..+..
T Consensus 754 ~~~~~~~~a~~~--~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~--------------------------------- 798 (974)
T KOG1166|consen 754 PSIMHISSAHVF--QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMF--------------------------------- 798 (974)
T ss_pred cchHHHHHHHcc--CCcceeeeeccccccHHHhhccCCCCCchhhhH---------------------------------
Confidence 344455444443 344678888888 78888888666566655555
Q ss_pred CCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--------eEEEEecCCccccc
Q psy9855 106 RNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--------LVVVGDLGSLQFIK 177 (470)
Q Consensus 106 ~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--------~ikL~DFG~a~~~~ 177 (470)
+..|++.-|+.||..|||||||||+|.||... .++|+|||.+..+.
T Consensus 799 --------------------------~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 799 --------------------------FSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred --------------------------HHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999999999999999999999999532 68999999886543
Q ss_pred ---CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCC
Q psy9855 178 ---SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224 (470)
Q Consensus 178 ---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~ 224 (470)
++......++|-.+-.+|+..|.. ++..+|.|.|+.+++.||.|+.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 444567778999999999988866 9999999999999999999974
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.2e-13 Score=123.35 Aligned_cols=99 Identities=20% Similarity=0.319 Sum_probs=81.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+. |++|.....++.. ....++||||++| +|.+++..... ....
T Consensus 44 ~~~~~E~~~l~~l~-~~~i~~p~~~~~~--~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~----------------- 99 (211)
T PRK14879 44 ERTRREARIMSRAR-KAGVNVPAVYFVD--PENFIIVMEYIEGEPLKDLINSNGM----EELE----------------- 99 (211)
T ss_pred HHHHHHHHHHHHHH-HCCCCCCeEEEEe--CCCCEEEEEEeCCcCHHHHHHhccH----HHHH-----------------
Confidence 45779999999998 8988776666544 4567899999996 99988754321 2233
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEEe
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGD 169 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~D 169 (470)
++.+|+.+|.++|+.|++|||++|.|||++.+.++|+|
T Consensus 100 ------------------------------------------i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liD 137 (211)
T PRK14879 100 ------------------------------------------LSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLID 137 (211)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEE
Confidence 89999999999999999999999999999966899999
Q ss_pred cCCccc
Q psy9855 170 LGSLQF 175 (470)
Q Consensus 170 FG~a~~ 175 (470)
||.+..
T Consensus 138 f~~a~~ 143 (211)
T PRK14879 138 FGLAEF 143 (211)
T ss_pred CCcccC
Confidence 998754
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.3e-13 Score=138.62 Aligned_cols=208 Identities=24% Similarity=0.253 Sum_probs=162.4
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.-++|+...+.++.|+|.++.+..+. +.+..++-+|+|+.+|.++...... +++..++.
T Consensus 163 ~k~~~~~s~~~i~~~~~~v~~~~~~e--~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~------------------ 222 (524)
T KOG0601|consen 163 RKLREFLSHHKIDSHENPVRDSPAWE--GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWN------------------ 222 (524)
T ss_pred cccchhhcccccCccccccccCcccc--cCCcceeeeccccchhHHhhhcccccCCchhhhh------------------
Confidence 34789999999999999999888774 4788999999999999999987776 77777776
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHH----HHHHHHhCCCeecCCCCCcEEEeCC--e
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVN----GLHHLHSYKVFHRDIKPENILIRGD--L 164 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~----aL~yLH~~gIvHrDLKp~NILl~~~--~ 164 (470)
++.+... ||.++|+.+++|-|+||.||+...+ .
T Consensus 223 -----------------------------------------~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 223 -----------------------------------------SLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred -----------------------------------------HHhhhhhcccccccccCCCcccccccchhheecccccce
Confidence 7777777 9999999999999999999999888 6
Q ss_pred EEEEecCCcccccCCCcccc------ccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC--ChHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGLHTE------YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD--SEIDQLD 236 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~------~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~--~~~~~~~ 236 (470)
.+++|||+...+........ .-|...|++||++.+. ++...|||++|.++.+..+|..++... +...++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 78999999988876653322 2466779999987653 789999999999999999887665332 1111110
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
. ......+....+..+...+..|+..+|..|+++..+++|+++...
T Consensus 340 ~--------------------------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 340 Q--------------------------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred c--------------------------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0 001111223445556668999999999999999999999999853
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-12 Score=124.84 Aligned_cols=103 Identities=17% Similarity=0.239 Sum_probs=78.4
Q ss_pred hhhhhhhHHHHHHhcCCCCCCe--eeeceeeecCCCC--eEEEEeecccc--CHHHHHHhcccccHHHHHHHHHHHHhhh
Q psy9855 8 FAEVANLKEISILRKIPDHLNV--LCLCETYVNRSTR--QVTLVFPLMEL--NLEEYIRTTDNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnI--v~l~~~~~~~~~~--~~~lV~E~~~g--sL~~~l~~~~~l~~~~~~~~~~~~~~~~ 81 (470)
.....+.+|+.++..|. |++| +..+++....... ..++|||+++| +|.+++... .+++.
T Consensus 82 ~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~------------- 146 (239)
T PRK01723 82 LERTRAFAEFRLLAQLY-EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-PLSEE------------- 146 (239)
T ss_pred hhhhHHHHHHHHHHHHH-hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH-------------
Confidence 34566789999999998 8775 6676654332221 23599999995 888887542 12211
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
.+.||+.+|.+||++||+||||||+|||++
T Consensus 147 --------------------------------------------------~~~~i~~~l~~lH~~GI~HrDlkp~NILv~ 176 (239)
T PRK01723 147 --------------------------------------------------QWQAIGQLIARFHDAGVYHADLNAHNILLD 176 (239)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHCCCCCCCCCchhEEEc
Confidence 567899999999999999999999999998
Q ss_pred CC-eEEEEecCCccc
Q psy9855 162 GD-LVVVGDLGSLQF 175 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~ 175 (470)
.+ .++|+|||.+..
T Consensus 177 ~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 177 PDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCEEEEECCCccc
Confidence 76 799999997754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.5e-12 Score=138.74 Aligned_cols=95 Identities=18% Similarity=0.265 Sum_probs=80.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++..++ |++|+....++.. ....++||||++| +|.+++.. ...
T Consensus 381 ~~~~~E~~~l~~l~-~~~i~~p~~~~~~--~~~~~lv~E~~~g~~L~~~l~~--------~~~----------------- 432 (535)
T PRK09605 381 ERTRAEARLLSEAR-RAGVPTPVIYDVD--PEEKTIVMEYIGGKDLKDVLEG--------NPE----------------- 432 (535)
T ss_pred HHHHHHHHHHHhhc-ccCCCeeEEEEEe--CCCCEEEEEecCCCcHHHHHHH--------HHH-----------------
Confidence 45789999999999 9999887665544 3457899999995 99988741 222
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEEe
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGD 169 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~D 169 (470)
++.||+.+|.|||+.||+||||||+|||++.+.++|+|
T Consensus 433 ------------------------------------------~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liD 470 (535)
T PRK09605 433 ------------------------------------------LVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLID 470 (535)
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEe
Confidence 89999999999999999999999999999777999999
Q ss_pred cCCccc
Q psy9855 170 LGSLQF 175 (470)
Q Consensus 170 FG~a~~ 175 (470)
||+++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-12 Score=119.86 Aligned_cols=96 Identities=23% Similarity=0.312 Sum_probs=76.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|++++..+. |++|.....++.. ....++||||++| +|.+++..... .
T Consensus 42 ~~~~~E~~~l~~l~-~~~i~~p~~~~~~--~~~~~lv~e~~~g~~l~~~~~~~~~-------~----------------- 94 (199)
T TIGR03724 42 ERTRNEARLLSRAR-KAGVNTPVVYDVD--PDNKTIVMEYIEGKPLKDVIEEGND-------E----------------- 94 (199)
T ss_pred HHHHHHHHHHHHHH-HCCCCCCEEEEEE--CCCCEEEEEEECCccHHHHHhhcHH-------H-----------------
Confidence 45678999999998 7765443333333 3456899999985 89888753210 2
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEEe
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGD 169 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~D 169 (470)
++.|++.+|.+||+.|++|||++|.||+++.+.++++|
T Consensus 95 ------------------------------------------~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liD 132 (199)
T TIGR03724 95 ------------------------------------------LLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLID 132 (199)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEE
Confidence 89999999999999999999999999999966999999
Q ss_pred cCCccc
Q psy9855 170 LGSLQF 175 (470)
Q Consensus 170 FG~a~~ 175 (470)
||++..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=124.00 Aligned_cols=99 Identities=20% Similarity=0.155 Sum_probs=72.8
Q ss_pred hhhHHHHHHhcCCCCC--CeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 12 ANLKEISILRKIPDHL--NVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 12 ~~~rEi~iL~~L~~Hp--nIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
.+.+|+.++.++. +. .+.++++. ...++||||++| +|..++..........+..
T Consensus 96 ~~~~E~~~L~~L~-~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~---------------- 152 (237)
T smart00090 96 WAEKEFRNLQRLY-EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFE---------------- 152 (237)
T ss_pred HHHHHHHHHHHHH-hcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHH----------------
Confidence 3568999999997 53 23344331 124899999997 6655542222233323333
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC-CeecCCCCCcEEEeCCeEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK-VFHRDIKPENILIRGDLVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g-IvHrDLKp~NILl~~~~ikL 167 (470)
++.||+.+|++||+.| |+||||||+||+++.+.++|
T Consensus 153 -------------------------------------------i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~i~L 189 (237)
T smart00090 153 -------------------------------------------LYDDILEEMRKLYKEGELVHGDLSEYNILVHDGKVVI 189 (237)
T ss_pred -------------------------------------------HHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCCEEE
Confidence 8999999999999999 99999999999999568999
Q ss_pred EecCCcccc
Q psy9855 168 GDLGSLQFI 176 (470)
Q Consensus 168 ~DFG~a~~~ 176 (470)
+|||.+...
T Consensus 190 iDFg~a~~~ 198 (237)
T smart00090 190 IDVSQSVEL 198 (237)
T ss_pred EEChhhhcc
Confidence 999987643
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=5e-13 Score=143.98 Aligned_cols=201 Identities=22% Similarity=0.306 Sum_probs=150.9
Q ss_pred CCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccCCCccceeeeccC
Q psy9855 26 HLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGK 104 (470)
Q Consensus 26 HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 104 (470)
||-++...-.+. .....+||++|++ ++|...+...+..+..-.+.
T Consensus 863 ~P~v~~~~~s~~--~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs-------------------------------- 908 (1205)
T KOG0606|consen 863 SPAVVRSFPSFP--CRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARS-------------------------------- 908 (1205)
T ss_pred CCceecccCCCC--CCCCcchhhHHhccCCchhhhhcCCCcccccccc--------------------------------
Confidence 466665544432 3556889999998 58888876655444333333
Q ss_pred CCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCC----
Q psy9855 105 SRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSK---- 179 (470)
Q Consensus 105 ~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~---- 179 (470)
++..+..+++|||...++|+|++|.|+|...+ ..+++|||.....+.-
T Consensus 909 ---------------------------~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 909 ---------------------------PILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred ---------------------------hhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 77888999999999999999999999999877 7888888733322100
Q ss_pred ----------------------------CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy9855 180 ----------------------------GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE 231 (470)
Q Consensus 180 ----------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~ 231 (470)
......+||+.|.+||.+.+.. ....+|.|++|++++|.++|.+||.....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0012347899999999998877 68889999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHH---HHHhc
Q psy9855 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ---KILSC 308 (470)
Q Consensus 232 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~---elL~h 308 (470)
...+..|... ...+..-....+.++.+++..+|..+|.+|..+. ++-.|
T Consensus 1041 q~~f~ni~~~----------------------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1041 QQIFENILNR----------------------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred hhhhhccccC----------------------------CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccC
Confidence 7766555331 1122222335678899999999999999999988 88999
Q ss_pred ccCCChhH
Q psy9855 309 AYFADLTQ 316 (470)
Q Consensus 309 p~f~~~~~ 316 (470)
|||+.+..
T Consensus 1093 ~~~~~~~~ 1100 (1205)
T KOG0606|consen 1093 PFFQDVDW 1100 (1205)
T ss_pred CccCCCCc
Confidence 99998763
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-12 Score=124.60 Aligned_cols=207 Identities=18% Similarity=0.244 Sum_probs=139.8
Q ss_pred HHHHhcCCCCCCeeeeceeeecC---CCCeEEEEeeccc-cCHHHHHHhccc----ccHHHHHHHHHHHHhhhccccccc
Q psy9855 17 ISILRKIPDHLNVLCLCETYVNR---STRQVTLVFPLME-LNLEEYIRTTDN----ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 17 i~iL~~L~~HpnIv~l~~~~~~~---~~~~~~lV~E~~~-gsL~~~l~~~~~----l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
+.-|.++. |.|||+++.++.+. +.....+++|||. |+|.++|++... +.....++
T Consensus 118 Fdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkk---------------- 180 (458)
T KOG1266|consen 118 FDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKK---------------- 180 (458)
T ss_pred HHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHH----------------
Confidence 34555666 99999999998753 3456899999999 899999987553 33333333
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC--CCeecCCCCCcEEEeCC-eE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY--KVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~--gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||+- -|+|+++..+-|++..+ .+
T Consensus 181 -------------------------------------------w~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLI 217 (458)
T KOG1266|consen 181 -------------------------------------------WCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLI 217 (458)
T ss_pred -------------------------------------------HHHHHHhhhhhhhccCCccccCCcchhheeecCCceE
Confidence 999999999999985 69999999999999977 44
Q ss_pred EEEecCCcccccC------CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHH
Q psy9855 166 VVGDLGSLQFIKS------KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRI 238 (470)
Q Consensus 166 kL~DFG~a~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~~~~i 238 (470)
|+ |-+.-..... ........+-++|.|||.-... ..+.++|||+||....+|.-|..- -.+.+.......+
T Consensus 218 ki-g~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i 295 (458)
T KOG1266|consen 218 KI-GSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI 295 (458)
T ss_pred Ee-cccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh
Confidence 43 3321111110 0011122466789999964432 357789999999999999877542 2222222222222
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
....- .--.+--++++.+||+-.|..||++.+++.||.+-++..++
T Consensus 296 a~~i~----------------------------------~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslk 341 (458)
T KOG1266|consen 296 ANVII----------------------------------GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLK 341 (458)
T ss_pred hhhee----------------------------------eccCccccCcCcccccCCCCCCcchhhhhcCceeeecchHH
Confidence 11100 00001115789999999999999999999999998876554
Q ss_pred H
Q psy9855 319 Q 319 (470)
Q Consensus 319 ~ 319 (470)
.
T Consensus 342 l 342 (458)
T KOG1266|consen 342 L 342 (458)
T ss_pred H
Confidence 3
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.3e-11 Score=111.67 Aligned_cols=46 Identities=22% Similarity=0.278 Sum_probs=41.9
Q ss_pred HHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCccccc
Q psy9855 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIK 177 (470)
Q Consensus 132 i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~ 177 (470)
++.+|+.++.++|..||+||||||+||+++.+ .++|+|||.+....
T Consensus 130 ~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 130 VLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 88999999999999999999999999999876 89999999885443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.7e-10 Score=114.46 Aligned_cols=142 Identities=17% Similarity=0.295 Sum_probs=102.9
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGW 91 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (470)
.+.+-++-|+.|+ ||||+++++.+. ..+.+|||+|.+. .|..++++-. ...+..
T Consensus 55 ~~~~A~k~lKtlR-HP~Il~yL~t~e--~~~~~ylvTErV~-Pl~~~lk~l~---~~~v~~------------------- 108 (690)
T KOG1243|consen 55 LAKRAVKRLKTLR-HPNILSYLDTTE--EEGTLYLVTERVR-PLETVLKELG---KEEVCL------------------- 108 (690)
T ss_pred HHHHHHHHhhhcc-Cchhhhhhhhhc--ccCceEEEeeccc-cHHHHHHHhH---HHHHHH-------------------
Confidence 4567789999999 999999999874 4678999999886 3334443322 222222
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH-SYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH-~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
.+.||+.||.||| +.+++|++|.-+.|+++.. ..||++
T Consensus 109 ----------------------------------------Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLgg 148 (690)
T KOG1243|consen 109 ----------------------------------------GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGG 148 (690)
T ss_pred ----------------------------------------HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEee
Confidence 8899999999998 5689999999999999987 899999
Q ss_pred cCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC
Q psy9855 170 LGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222 (470)
Q Consensus 170 FG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg 222 (470)
|..+........ .....---.|..|+.+.. -+...|.|-|||++++++.|
T Consensus 149 le~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 149 LELVSKASGFNAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eEEEeccccCCcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 987654332221 111111223666765432 22467999999999999999
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.2e-10 Score=99.74 Aligned_cols=98 Identities=22% Similarity=0.312 Sum_probs=77.0
Q ss_pred hhhhhHHHHHHhcCCCC-CCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDH-LNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~H-pnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++..|+.+ .++.++++++.. .+..+++|||++| .+..+ +......
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g~~~~~~-------~~~~~~~--------------- 90 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEGETLDEV-------SEEEKED--------------- 90 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCCeecccC-------CHHHHHH---------------
Confidence 34678999999999833 688898887643 4678999999986 55433 1222222
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC---CCeecCCCCCcEEEeCC-
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY---KVFHRDIKPENILIRGD- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~---gIvHrDLKp~NILl~~~- 163 (470)
++.+++.+|++||.. +++|+|++|+||+++..
T Consensus 91 --------------------------------------------~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~ 126 (155)
T cd05120 91 --------------------------------------------IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126 (155)
T ss_pred --------------------------------------------HHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc
Confidence 889999999999985 79999999999999985
Q ss_pred eEEEEecCCccc
Q psy9855 164 LVVVGDLGSLQF 175 (470)
Q Consensus 164 ~ikL~DFG~a~~ 175 (470)
.++++|||.+..
T Consensus 127 ~~~l~Df~~~~~ 138 (155)
T cd05120 127 ILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecccccC
Confidence 899999997753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-10 Score=119.46 Aligned_cols=210 Identities=23% Similarity=0.253 Sum_probs=149.2
Q ss_pred CchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 6 PDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 6 ~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...++...+.|+.+...|.-|.+++.+...|.. ....|+=.|||+ +++...+.....+.+...+.
T Consensus 305 ~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~------------ 370 (524)
T KOG0601|consen 305 TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLR------------ 370 (524)
T ss_pred chHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccccCchhhhcCcchhhhhHHHHhcCcchhhh------------
Confidence 345566778999999999889999998887754 556779999998 46665554333355555555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
+..|++.|+.++|++.++|+|+||+||++..+
T Consensus 371 -----------------------------------------------~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 371 -----------------------------------------------LTAQILTALNVIHSKLFVHLDVKPSNILISNDG 403 (524)
T ss_pred -----------------------------------------------hHHHHHhccccccchhhhcccccccceeeccch
Confidence 89999999999999999999999999999884
Q ss_pred -eEEEEecCCcccccCCCccccccccCccc-CchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYR-SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~-APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
..+++|||++..+.-. .....+.-++. ..|++.....+..++|++|||.-+.+.++|.+.-...... ..|
T Consensus 404 ~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i--- 475 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI--- 475 (524)
T ss_pred hhhhcccccccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee---
Confidence 6779999987642211 11122333344 3555655555788999999999999999987543222110 000
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
....-...+....++..+...++..++..|+.+.++..|.=|.
T Consensus 476 ----------------------------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 ----------------------------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----------------------------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111122234457778899999999999999999998876554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.7e-10 Score=102.01 Aligned_cols=45 Identities=20% Similarity=0.260 Sum_probs=41.4
Q ss_pred HHHHHHHHHHHH-HhCCCeecCCCCCcEEEeCCeEEEEecCCcccc
Q psy9855 132 VLYQIVNGLHHL-HSYKVFHRDIKPENILIRGDLVVVGDLGSLQFI 176 (470)
Q Consensus 132 i~~qIl~aL~yL-H~~gIvHrDLKp~NILl~~~~ikL~DFG~a~~~ 176 (470)
+..|++.+|..| |..|||||||++.|||+.++.+.|+|||.+...
T Consensus 129 i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~~~v~iIDF~qav~~ 174 (197)
T cd05146 129 AYYQVLSMMKQLYKECNLVHADLSEYNMLWHDGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEECCcEEEEECCCceeC
Confidence 788999999999 899999999999999999889999999977654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.2e-10 Score=121.59 Aligned_cols=154 Identities=19% Similarity=0.281 Sum_probs=112.4
Q ss_pred HHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCcc----------ccccccCcccCchhhccC
Q psy9855 133 LYQIVNGLHHLHSY-KVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLH----------TEYIATRWYRSPECLLTE 200 (470)
Q Consensus 133 ~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~~----------~~~~gt~~Y~APE~l~~~ 200 (470)
+.+++.||.|+|.. ++||+.|.|++|.++.+ ..||+.|+++......... .-......|.|||++.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44666899999974 89999999999999998 8999999977654431111 111235569999998874
Q ss_pred CCCCCcccHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCccccccc
Q psy9855 201 GYYSFELDIWAAGCVFYETL-TRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ 279 (470)
Q Consensus 201 ~~~~~~~DIwSlG~il~ell-tg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (470)
..+.++|+||+||++|.+. .|+..+.+.........-.... +.........
T Consensus 185 -~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~---------------------------~~~~~~~s~~ 236 (700)
T KOG2137|consen 185 -TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL---------------------------NAGAFGYSNN 236 (700)
T ss_pred -cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc---------------------------cccccccccc
Confidence 4789999999999999999 5776665543222111111000 1111122257
Q ss_pred ccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 280 IHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 280 ~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
++.++++-|.+++..++..||++.+++..|||.+.
T Consensus 237 ~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 237 LPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred CcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 89999999999999999999999999999999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.4e-09 Score=99.47 Aligned_cols=47 Identities=23% Similarity=0.212 Sum_probs=42.6
Q ss_pred HHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCCeEEEEecCCcccc
Q psy9855 130 TFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGDLVVVGDLGSLQFI 176 (470)
Q Consensus 130 ~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~~ikL~DFG~a~~~ 176 (470)
..++.+++.++.++|. .||+||||||+||+++++.++|+|||.+...
T Consensus 117 ~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~~~~liDfg~a~~~ 164 (187)
T cd05119 117 EELYDQILELMRKLYREAGLVHGDLSEYNILVDDGKVYIIDVPQAVEI 164 (187)
T ss_pred HHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECCcEEEEECcccccc
Confidence 3389999999999999 9999999999999999669999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.2e-08 Score=97.30 Aligned_cols=197 Identities=15% Similarity=0.120 Sum_probs=127.7
Q ss_pred cceeeeccCCCCchh-hhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCc
Q psy9855 96 PFLLLVFGKSRNLGT-LIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSL 173 (470)
Q Consensus 96 ~~~~~e~~~~~~l~~-~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a 173 (470)
.-++|..+.|..--. +..-...--.-....++-....++.|+.+.+-||..|.+-+|+.++|+|++++ .+.|.|-...
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 667899888875332 22222222222234456677799999999999999999999999999999988 7888886655
Q ss_pred ccccCCCccccccccCcccCchhhc-----cCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 174 QFIKSKGLHTEYIATRWYRSPECLL-----TEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 174 ~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
.....+..+...+|...|.+||.-. +.. -+...|.|.||+++|+++.| +.||.|-.. ....|.+
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ap~p 234 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDAPNP 234 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCCCCc
Confidence 4444555566779999999999643 212 36778999999999999985 999976321 0111111
Q ss_pred HHHHHHhhhccCcccccccc---CCCCCcccccccccHHHHHHHHHhccc--CCCCCcCHHHHH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQ---YPGGGIDVLVPQIHEKGKKLMSEMLKY--DPKRRPTAQKIL 306 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~Li~~~L~~--dP~~Rpt~~elL 306 (470)
-. ..+..+.|.+...+ ........-+.-+++.+..|..+|+.. ++.-|||++.-+
T Consensus 235 ~E----~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 235 LE----TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred ch----hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 00 00112222222111 111112222245678889999999976 456899997543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.7e-09 Score=93.24 Aligned_cols=96 Identities=21% Similarity=0.319 Sum_probs=73.2
Q ss_pred hhhhhHHHHHHhcCCC-CCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPD-HLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~-HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
.....+|..+|..+.. --++..+++ .+ .....|+|||.+| .|.+++.... ..
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~d--vD--~~~~~I~me~I~G~~lkd~l~~~~-------~~--------------- 96 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYD--VD--PDNGLIVMEYIEGELLKDALEEAR-------PD--------------- 96 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEE--Ec--CCCCEEEEEEeCChhHHHHHHhcc-------hH---------------
Confidence 4567899999988861 233444444 33 3446899999998 7777886541 11
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVV 167 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL 167 (470)
++..+=.-+.-||..||||+||.++||++.++.+.+
T Consensus 97 --------------------------------------------~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~ 132 (204)
T COG3642 97 --------------------------------------------LLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYF 132 (204)
T ss_pred --------------------------------------------HHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEE
Confidence 666777778889999999999999999999999999
Q ss_pred EecCCccc
Q psy9855 168 GDLGSLQF 175 (470)
Q Consensus 168 ~DFG~a~~ 175 (470)
+|||++..
T Consensus 133 IDfGLg~~ 140 (204)
T COG3642 133 IDFGLGEF 140 (204)
T ss_pred EECCcccc
Confidence 99998863
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.8e-09 Score=94.77 Aligned_cols=43 Identities=28% Similarity=0.315 Sum_probs=39.2
Q ss_pred HHHHHHHHHHHHHhCCC-----eecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 132 VLYQIVNGLHHLHSYKV-----FHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 132 i~~qIl~aL~yLH~~gI-----vHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
++.+++.+|+.||..++ +|+|++|.||+++++.++++|||.+.
T Consensus 88 ~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 88 NLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 67899999999999985 99999999999997789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.6e-08 Score=97.34 Aligned_cols=200 Identities=13% Similarity=0.163 Sum_probs=135.5
Q ss_pred HHHHHHhcCCCCCCeeeeceeeecC--CCCeEEEEeecccc--CHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 15 KEISILRKIPDHLNVLCLCETYVNR--STRQVTLVFPLMEL--NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 15 rEi~iL~~L~~HpnIv~l~~~~~~~--~~~~~~lV~E~~~g--sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.=+++++++. |+|||++.++|... ....+++|++|+++ +|.++--.........
T Consensus 322 ~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~--------------------- 379 (655)
T KOG3741|consen 322 SLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRT--------------------- 379 (655)
T ss_pred HHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccccc---------------------
Confidence 3488999999 99999999999732 34568999999994 8888764433211000
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
.........+.....+..|+.||..||.++|+.|+.-+-|.|.+||++++ .++|..
T Consensus 380 -----------------------n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~ 436 (655)
T KOG3741|consen 380 -----------------------NSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISG 436 (655)
T ss_pred -----------------------ccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEec
Confidence 00011122234445566699999999999999999999999999999999 899887
Q ss_pred cCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCchH
Q psy9855 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 170 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
.|....+..+. . |.+.+ -.+-|.=.||.+++.|.+|..- +..+..... .+
T Consensus 437 C~i~Dvl~~d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~---------- 487 (655)
T KOG3741|consen 437 CGIMDVLQEDP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--HL---------- 487 (655)
T ss_pred ccceeeecCCC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH--HH----------
Confidence 77665444322 0 11222 2356888999999999999643 111111111 11
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc---ccCCCh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC---AYFADL 314 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h---p~f~~~ 314 (470)
..+-+.++.++.++|.-+...++++ -++.+++.+ -||..+
T Consensus 488 -------------------------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vm 530 (655)
T KOG3741|consen 488 -------------------------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVM 530 (655)
T ss_pred -------------------------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHH
Confidence 1122467888899999999999887 678888865 445433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.6e-08 Score=94.09 Aligned_cols=103 Identities=16% Similarity=0.167 Sum_probs=74.0
Q ss_pred hhhHHHHHHhcCCCCCC--eeeeceeeecC---CCCeEEEEeecccc--CHHHHHHhcc--cccHHHHHHHHHHHHhhhc
Q psy9855 12 ANLKEISILRKIPDHLN--VLCLCETYVNR---STRQVTLVFPLMEL--NLEEYIRTTD--NISEKRAKEILYQVKAANE 82 (470)
Q Consensus 12 ~~~rEi~iL~~L~~Hpn--Iv~l~~~~~~~---~~~~~~lV~E~~~g--sL~~~l~~~~--~l~~~~~~~~~~~~~~~~~ 82 (470)
.+.+|+..+..|. .-+ +...+++.... .....+||||++++ +|.+++.... ..+......
T Consensus 74 ~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~---------- 142 (268)
T PRK15123 74 GADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRM---------- 142 (268)
T ss_pred HHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHH----------
Confidence 4789999998884 222 22333333221 13357899999996 7999986421 123333333
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.+++..+.-||..||+|+|+++.|||++.
T Consensus 143 -------------------------------------------------ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 143 -------------------------------------------------LIKRVATMVRDMHAAGINHRDCYICHFLLHL 173 (268)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHCcCccCCCChhhEEEec
Confidence 8999999999999999999999999999974
Q ss_pred -------C-eEEEEecCCcc
Q psy9855 163 -------D-LVVVGDLGSLQ 174 (470)
Q Consensus 163 -------~-~ikL~DFG~a~ 174 (470)
+ .+.|+||+.+.
T Consensus 174 ~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 174 PFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred cccCCCCCceEEEEECCccc
Confidence 2 78899999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.7e-08 Score=90.17 Aligned_cols=109 Identities=17% Similarity=0.295 Sum_probs=79.9
Q ss_pred hhhhhhhHHHHHHhcCCC-CCCeeeeceeeecCC--CCeEEEEeecccc--CHHHHHHhcccccHHHHHHHHHHHHhhhc
Q psy9855 8 FAEVANLKEISILRKIPD-HLNVLCLCETYVNRS--TRQVTLVFPLMEL--NLEEYIRTTDNISEKRAKEILYQVKAANE 82 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~-HpnIv~l~~~~~~~~--~~~~~lV~E~~~g--sL~~~l~~~~~l~~~~~~~~~~~~~~~~~ 82 (470)
.....+.+|...+..|.. .-.+.+.+++..... ....+||+|+++| +|.+++......+......
T Consensus 53 ~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~---------- 122 (206)
T PF06293_consen 53 LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRE---------- 122 (206)
T ss_pred ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHH----------
Confidence 456678899998888751 122334444433221 2346899999996 8999987644344444444
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.+++..++-||.+||+|+|+++.|||++.
T Consensus 123 -------------------------------------------------ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~ 153 (206)
T PF06293_consen 123 -------------------------------------------------LLRALARLIAKLHDAGIYHGDLNPSNILVDP 153 (206)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHCcCCCCCCCcccEEEeC
Confidence 9999999999999999999999999999987
Q ss_pred C----eEEEEecCCccc
Q psy9855 163 D----LVVVGDLGSLQF 175 (470)
Q Consensus 163 ~----~ikL~DFG~a~~ 175 (470)
+ .+.++||+.+..
T Consensus 154 ~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 154 DDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CCCceeEEEEcchhcee
Confidence 7 488999996653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.6e-08 Score=90.21 Aligned_cols=102 Identities=21% Similarity=0.238 Sum_probs=65.7
Q ss_pred hhhhhhhHHHHHHhcCCCC-CCeeeeceeeecCCCCeEEEEeeccc--c-CHHHHHHhcccccHHHHHHHHHHHHhhhcc
Q psy9855 8 FAEVANLKEISILRKIPDH-LNVLCLCETYVNRSTRQVTLVFPLME--L-NLEEYIRTTDNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~H-pnIv~l~~~~~~~~~~~~~lV~E~~~--g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~ 83 (470)
.....+.+|+++|.++... -++.+.+++. ..+|||||++ | .+..+.... ++......
T Consensus 50 ~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~------~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~----------- 110 (188)
T PF01163_consen 50 LIREWAKKEFRNLKRLYEAGVPVPKPYDYN------RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKE----------- 110 (188)
T ss_dssp HHHHHHHHHHHHHHHCCCTT-SS--EEEEE------TTEEEEE--EETTEEGGCHHHCG--GGGSTHHH-----------
T ss_pred HHHHHHHHHHHHHHHHHHCCccCCcEEEEe------CCEEEEEecCCCccchhhHHhcc--ccchhHHH-----------
Confidence 3456778999999999832 2566776532 2379999999 6 444332211 11111222
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHH-HHhCCCeecCCCCCcEEEeC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHH-LHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~y-LH~~gIvHrDLKp~NILl~~ 162 (470)
++.+++..+.. +|..|||||||.+.|||+++
T Consensus 111 ------------------------------------------------~~~~il~~~~~~~~~~givHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 111 ------------------------------------------------LLEEILEEIIKMLHKAGIVHGDLSEYNILVDD 142 (188)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHHCTTEEESS-STTSEEEET
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHhcCceecCCChhhEEeec
Confidence 77888886555 57999999999999999999
Q ss_pred CeEEEEecCCcccc
Q psy9855 163 DLVVVGDLGSLQFI 176 (470)
Q Consensus 163 ~~ikL~DFG~a~~~ 176 (470)
+.+.++|||.+...
T Consensus 143 ~~~~iIDf~qav~~ 156 (188)
T PF01163_consen 143 GKVYIIDFGQAVDS 156 (188)
T ss_dssp TCEEE--GTTEEET
T ss_pred ceEEEEecCcceec
Confidence 99999999977543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.69 E-value=6.6e-08 Score=86.20 Aligned_cols=105 Identities=20% Similarity=0.286 Sum_probs=75.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc--CHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL--NLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g--sL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.....+|+++|.++. --.|..-.=+|.+ ...-+|+|||.+| ++.+++..... -.++..
T Consensus 54 r~Rt~~Ear~l~k~~-~~GI~~P~l~~~D--~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~---------------- 114 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCR-ALGIPAPRLIFID--TYGGQIYMEFIDGASTVKDFILSTMEDESEDEG---------------- 114 (229)
T ss_pred HHHHHHHHHHHHHHH-HhCCCCceEEEEe--cCCCeEEEEeccchhHHHHHHHHHccCcccchh----------------
Confidence 345688999999986 3344333224444 3345889999998 89999876543 111111
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--- 163 (470)
...++.+|=+.+.-||.++|+|+||..+||++..+
T Consensus 115 ------------------------------------------~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 115 ------------------------------------------LAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred ------------------------------------------HHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCc
Confidence 01278888889999999999999999999999766
Q ss_pred -eEEEEecCCccc
Q psy9855 164 -LVVVGDLGSLQF 175 (470)
Q Consensus 164 -~ikL~DFG~a~~ 175 (470)
.+.++|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 458999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.6e-08 Score=99.50 Aligned_cols=46 Identities=22% Similarity=0.380 Sum_probs=38.5
Q ss_pred HHHHHHH-HHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCccccc
Q psy9855 132 VLYQIVN-GLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIK 177 (470)
Q Consensus 132 i~~qIl~-aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~ 177 (470)
++.+++. .+..+|..|++|+|+||.||+++.+ .++++|||++..+.
T Consensus 261 ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 261 LAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 5555655 4778899999999999999999877 89999999886654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.5e-07 Score=93.23 Aligned_cols=40 Identities=25% Similarity=0.428 Sum_probs=33.1
Q ss_pred HHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----eEEEEecCCcccccC
Q psy9855 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-----LVVVGDLGSLQFIKS 178 (470)
Q Consensus 132 i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-----~ikL~DFG~a~~~~~ 178 (470)
++.||+ ..|++|+|+||+||+++.+ .++++|||++..+..
T Consensus 272 ~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 566665 5899999999999999865 699999998876643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.1e-06 Score=78.26 Aligned_cols=107 Identities=12% Similarity=0.127 Sum_probs=77.9
Q ss_pred hhhhhhHHHHHHhcCCC-CCCeeeeceeee--cCCCCeEEEEeecccc--CHHHHHHhccc--ccHHHHHHHHHHHHhhh
Q psy9855 9 AEVANLKEISILRKIPD-HLNVLCLCETYV--NRSTRQVTLVFPLMEL--NLEEYIRTTDN--ISEKRAKEILYQVKAAN 81 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~-HpnIv~l~~~~~--~~~~~~~~lV~E~~~g--sL~~~l~~~~~--l~~~~~~~~~~~~~~~~ 81 (470)
-..++.+|+..|.+|.. .-.+.+....-. .......+||+|-++| +|.+++..... .++.....
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~--------- 132 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQA--------- 132 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHH---------
Confidence 46789999999999861 122444431111 2223457999998884 99999865432 34443334
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.+|+..+.-||+.|+.|+|+-+.|||++
T Consensus 133 --------------------------------------------------il~~va~~ia~LH~~Gv~Hgdly~khIll~ 162 (216)
T PRK09902 133 --------------------------------------------------MLKAVALAFKKMHSVNRQHGCCYVRHIYVK 162 (216)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHCCCcCCCCCHhheeec
Confidence 899999999999999999999999999997
Q ss_pred CC---eEEEEecCCcc
Q psy9855 162 GD---LVVVGDLGSLQ 174 (470)
Q Consensus 162 ~~---~ikL~DFG~a~ 174 (470)
.+ .+.++||.-++
T Consensus 163 ~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 163 TEGKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCeeEEEEEhhccc
Confidence 43 48999998554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.6e-06 Score=80.54 Aligned_cols=68 Identities=19% Similarity=0.214 Sum_probs=55.9
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEEecCC
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGS 172 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~DFG~ 172 (470)
....+++|||+.|..|.+...-.. .+...|+.++.-||..|++|+|.+|+|++++++.++++||+.
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~i~e--------------~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~ 180 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIEDIDE--------------DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQG 180 (229)
T ss_pred eeEEEEEEEEecCeecccchhcCH--------------HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECcc
Confidence 455678999999999877542100 156778889999999999999999999999999999999986
Q ss_pred cc
Q psy9855 173 LQ 174 (470)
Q Consensus 173 a~ 174 (470)
.+
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.7e-06 Score=79.46 Aligned_cols=50 Identities=14% Similarity=0.095 Sum_probs=33.7
Q ss_pred hhhhhHHHHHHhcCCC-CCCeeeeceeeecCC-CCeEEEEeecccc-CHHHHH
Q psy9855 10 EVANLKEISILRKIPD-HLNVLCLCETYVNRS-TRQVTLVFPLMEL-NLEEYI 59 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~-HpnIv~l~~~~~~~~-~~~~~lV~E~~~g-sL~~~l 59 (470)
...+.+|++++..+.. +.++.+++.+..... .+..++||||++| ++.+.+
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~ 91 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRL 91 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCC
Confidence 3467899999999973 234566666543211 1356899999997 676654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.1e-06 Score=92.71 Aligned_cols=201 Identities=15% Similarity=0.177 Sum_probs=131.4
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCC--eEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTR--QVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~--~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...-|+..+..+. |+|++.++++-..+-.. ...+..++|.+ ++...+..-...+....+.
T Consensus 228 ~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~---------------- 290 (1351)
T KOG1035|consen 228 TTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRI---------------- 290 (1351)
T ss_pred HHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHH----------------
Confidence 4456788888898 99999998876543222 22344566664 7777766655555555544
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCC---cEEEeCC-e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPE---NILIRGD-L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~---NILl~~~-~ 164 (470)
+..++++||+|+|+....|.-+..+ +-..++. .
T Consensus 291 -------------------------------------------~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~ 327 (1351)
T KOG1035|consen 291 -------------------------------------------LHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGV 327 (1351)
T ss_pred -------------------------------------------HHHHHhhhHHHHHHhccceeEEecccccccccCccce
Confidence 8999999999999986555544443 2222233 3
Q ss_pred EEEE--ecCCcccccCCCccccccccCcccCchhhccCCCCCC--cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 165 VVVG--DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSF--ELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 165 ikL~--DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~--~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+.++ ||+...............-+..|.++|...... +.. ..|+|.+|.....+..|..+-.... .+..
T Consensus 328 ~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll~~~~~~~~~i~~~~~------~~~~ 400 (1351)
T KOG1035|consen 328 VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLLLLQLSQGEDISEKSA------VPVS 400 (1351)
T ss_pred eecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHHHhhhhhcCccccccc------chhh
Confidence 4444 888777666554444445566678888765433 333 3699999999999988764421100 0000
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
. +.........+++.+|+.-++++|+++.+++.|+|...
T Consensus 401 ~----------------------------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 401 L----------------------------------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred h----------------------------------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 0 00111125678999999999999999999999999874
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.12 E-value=9.4e-07 Score=92.01 Aligned_cols=208 Identities=15% Similarity=0.069 Sum_probs=138.1
Q ss_pred hhhHHHHHHhcCCCCCC-eeeeceeeecCCCCeEEEEeeccccC--HHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 12 ANLKEISILRKIPDHLN-VLCLCETYVNRSTRQVTLVFPLMELN--LEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 12 ~~~rEi~iL~~L~~Hpn-Iv~l~~~~~~~~~~~~~lV~E~~~gs--L~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...-++++|.+++ ||| .+..++.+ +.+...+++++++.+. -...+. ..++..
T Consensus 279 ~~rl~~eLLdK~n-~P~~~v~~~~d~--~~E~~~~i~~~i~s~~rs~~~~~~------~se~~~---------------- 333 (829)
T KOG0576|consen 279 SRRLAIELLDKVN-NPNPVVRYLEDY--DGEDYLWIPMRICSTGRSSALEMT------VSEIAL---------------- 333 (829)
T ss_pred hhHHHHHHHHHcc-CCCCcccccccC--CcccccchhhhhhcCCccccccCC------hhhHhh----------------
Confidence 3456899999999 999 66666655 3467789999999842 222211 111111
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG 168 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~ 168 (470)
.......+.+.-.++|+++|+.--+|+| ||+...+..+..
T Consensus 334 ------------------------------------~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~ 373 (829)
T KOG0576|consen 334 ------------------------------------EQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLL 373 (829)
T ss_pred ------------------------------------hhhhhhhhhhhhcccccccccccccCcc----cccccccccccc
Confidence 0111112666778899999998888998 999998899999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
||+....+......+...+|+.++|||+..... +....|+|++|+--.++.-|-+|-... ...... .|..+
T Consensus 374 ~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~----~g~~p-- 444 (829)
T KOG0576|consen 374 DFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPM----IGNGP-- 444 (829)
T ss_pred cccCCcccCcccccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCC--ccccCC----CCCCC--
Confidence 999988777665567788999999999887765 889999999998877888887775331 000000 00000
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
..+ .......+..... .++...|+...|..|++...++-|-+|++
T Consensus 445 ----------~s~----~L~~~~aw~~~~~------~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 445 ----------NSP----MLTDKSAWSPVFH------RDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ----------Ccc----ccchhhhcCcccc------cCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 000 0000000110000 14677899999999999999999988886
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3e-05 Score=73.69 Aligned_cols=98 Identities=19% Similarity=0.218 Sum_probs=70.9
Q ss_pred chhhhhhhHHHHHHhcCCCC-CCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 7 DFAEVANLKEISILRKIPDH-LNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~H-pnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
.....++.+|+++|..|.++ -.|.+.++ .+..++|||+.+| -|...- ++......
T Consensus 150 ~~sRl~A~rEf~~L~~L~~~G~~VP~P~~------~nRHaVvMe~ieG~eL~~~r-----~~~en~~~------------ 206 (304)
T COG0478 150 YVSRLAAEREFEALQRLYPEGVKVPKPIA------WNRHAVVMEYIEGVELYRLR-----LDVENPDE------------ 206 (304)
T ss_pred hhHHHHHHHHHHHHHHhhhcCCCCCCccc------cccceeeeehcccceeeccc-----CcccCHHH------------
Confidence 44566789999999999733 36777766 3456899999998 444332 11112222
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++..|++-+.-+-..||||+|+++-||+++.+
T Consensus 207 -----------------------------------------------il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 207 -----------------------------------------------ILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 56666666666668999999999999999998
Q ss_pred eEEEEecCCcc
Q psy9855 164 LVVVGDLGSLQ 174 (470)
Q Consensus 164 ~ikL~DFG~a~ 174 (470)
.+.++||--+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 89999997543
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0002 Score=73.60 Aligned_cols=93 Identities=16% Similarity=0.226 Sum_probs=68.2
Q ss_pred CcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHH
Q psy9855 205 FELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKG 284 (470)
Q Consensus 205 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 284 (470)
+++||||+|.++.++.-|...+......+.+..+.+..-.+.....-...+ .+.-.++..+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-------------------~~~~~~d~~~ 170 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH-------------------LIQLLADKKR 170 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH-------------------HHHHhhhHhH
Confidence 499999999999999999988888777777777766543332211111111 0112345667
Q ss_pred HHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 285 KKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 285 ~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.++..+|+-..|..||...++..++-|.++-+
T Consensus 171 ~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 171 LPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 88999999999999999999999999988743
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.53 E-value=2.5e-05 Score=88.50 Aligned_cols=215 Identities=13% Similarity=-0.054 Sum_probs=137.0
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.|..-++... |+++.....-.........|.+++|+. |++.+.|-..-. .+.
T Consensus 1275 mll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~---------------------- 1331 (2724)
T KOG1826|consen 1275 MLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD---------------------- 1331 (2724)
T ss_pred hhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCc----------------------
Confidence 3445555566677 999888776555555666788899888 688888754332 100
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-----CCeecCCCCCcEEEeCC-
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-----KVFHRDIKPENILIRGD- 163 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-----gIvHrDLKp~NILl~~~- 163 (470)
+...-+.....+.+.+..-+|+. -.+|++||+-|.+|..+
T Consensus 1332 ----------------------------------ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny 1377 (2724)
T KOG1826|consen 1332 ----------------------------------LDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY 1377 (2724)
T ss_pred ----------------------------------chhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC
Confidence 00011111333436777777753 26999999999999988
Q ss_pred eEEEEecCCcc-cccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQ-FIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~-~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++++++|+.+ ...........++++.|++|++...-. ++.++|+|..|+-+|+...|..+|. ..+..+.+.
T Consensus 1378 ~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkg- 1450 (2724)
T KOG1826|consen 1378 NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKG- 1450 (2724)
T ss_pred cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcC-
Confidence 79999999998 333333445668889999999776544 7777999999999999988887762 122222110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.-. ......+..-.|.++..+...+|-+.-..||.-...+.-+.|...
T Consensus 1451 -iid-----------------------n~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1451 -IID-----------------------NHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred -ccc-----------------------ccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence 000 000111111223333444455555666789999999988888753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00089 Score=63.33 Aligned_cols=28 Identities=25% Similarity=0.368 Sum_probs=24.6
Q ss_pred CCeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 147 KVFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 147 gIvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
.++|+|+.|.||+++++.+.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKGTYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCCcEEEechhcC
Confidence 5789999999999998778899999653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0013 Score=62.05 Aligned_cols=95 Identities=19% Similarity=0.192 Sum_probs=65.1
Q ss_pred HHHhhhccccccccccCCCcc------ceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCC
Q psy9855 76 QVKAANETAAHYRVGWDLKLP------FLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKV 148 (470)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gI 148 (470)
.-+....+.--|.++-.-+.| .++|||+...... .+-+.........+..+..++++++.-|-. .|+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~p------AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~L 188 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLP------APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGL 188 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCC------CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCc
Confidence 333444444445555333333 4699999777321 222333333444566688899999998877 899
Q ss_pred eecCCCCCcEEEeCCeEEEEecCCcccc
Q psy9855 149 FHRDIKPENILIRGDLVVVGDLGSLQFI 176 (470)
Q Consensus 149 vHrDLKp~NILl~~~~ikL~DFG~a~~~ 176 (470)
||+||+.=|||+.++.+.++|||-|...
T Consensus 189 VHgDLSEyNiL~~~~~p~iID~~QaV~~ 216 (268)
T COG1718 189 VHGDLSEYNILVHDGEPYIIDVSQAVTI 216 (268)
T ss_pred ccccchhhheEEECCeEEEEECcccccc
Confidence 9999999999999889999999977544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0011 Score=63.12 Aligned_cols=46 Identities=13% Similarity=0.001 Sum_probs=33.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHH
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEY 58 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~ 58 (470)
....+|+++++.|..+--+.+++++... .+..++|||+++| +|.+.
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCCccHhHh
Confidence 3567999999999755456667665533 3567899999998 66544
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.002 Score=59.14 Aligned_cols=98 Identities=14% Similarity=0.072 Sum_probs=72.7
Q ss_pred hHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHH---HHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEY---IRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 14 ~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~---l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..|.-+|..|.+.+++.+++|++ + -++|+||.+ +++.+. +......+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~------------------ 62 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----G--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRA------------------ 62 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----C--CEEEEEeecCccccccccccccccccCHHHHH------------------
Confidence 46899999999668999999977 2 367899998 555422 1111112333333
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh---CCCeecCCCCCcEEEeCC-eE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS---YKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~---~gIvHrDLKp~NILl~~~-~i 165 (470)
.|+.++++.+.+|+. ..+.-.|++|+|+-++++ .+
T Consensus 63 -----------------------------------------~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~l 101 (188)
T PF12260_consen 63 -----------------------------------------KIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRL 101 (188)
T ss_pred -----------------------------------------HHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcE
Confidence 399999999999987 458889999999999987 99
Q ss_pred EEEecCCcccc
Q psy9855 166 VVGDLGSLQFI 176 (470)
Q Consensus 166 kL~DFG~a~~~ 176 (470)
+++|...+...
T Consensus 102 k~iDld~v~~~ 112 (188)
T PF12260_consen 102 KLIDLDDVFVE 112 (188)
T ss_pred EEEechhcchh
Confidence 99999866543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0012 Score=69.64 Aligned_cols=80 Identities=19% Similarity=0.206 Sum_probs=56.9
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEec
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDL 170 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DF 170 (470)
-.+.-.++|||+.|-.+.+...-.....+...+...-+..++.|+ -..|++|.|.+|.||+++.+ .+.+.||
T Consensus 237 ~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~-------~~dgffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 237 YTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQL-------LRDGFFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred ccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhcCccccCCCccceEEecCCcEEEEcC
Confidence 367778999999999999986443333332222222233333333 34899999999999999998 8999999
Q ss_pred CCcccccC
Q psy9855 171 GSLQFIKS 178 (470)
Q Consensus 171 G~a~~~~~ 178 (470)
|....+.+
T Consensus 310 Gi~g~l~~ 317 (517)
T COG0661 310 GIVGRLDP 317 (517)
T ss_pred cceecCCH
Confidence 98876553
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0094 Score=55.06 Aligned_cols=96 Identities=19% Similarity=0.265 Sum_probs=66.1
Q ss_pred hhhhhhhHHHHHHhcCC-----CCCCeeeeceeeecCCCCeEEEEeeccc---c----CHHHHHHhcccccHHHHHHHHH
Q psy9855 8 FAEVANLKEISILRKIP-----DHLNVLCLCETYVNRSTRQVTLVFPLME---L----NLEEYIRTTDNISEKRAKEILY 75 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~-----~HpnIv~l~~~~~~~~~~~~~lV~E~~~---g----sL~~~l~~~~~l~~~~~~~~~~ 75 (470)
.......+|+.-...+. .+.+|.+++|+... +....+|+|... | +|.+++.... +++ .
T Consensus 53 ~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~------ 122 (199)
T PF10707_consen 53 SRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-E------ 122 (199)
T ss_pred chhHHHHHHHHHHHHHhhccCCcccccccEeEEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-H------
Confidence 34456677776665554 38899999998743 556778888653 3 6777774433 333 1
Q ss_pred HHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q psy9855 76 QVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKP 155 (470)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp 155 (470)
+...+-+-.+||-+.+|+.+||+|
T Consensus 123 --------------------------------------------------------~~~~L~~f~~~l~~~~Iv~~dl~~ 146 (199)
T PF10707_consen 123 --------------------------------------------------------LRQALDEFKRYLLDHHIVIRDLNP 146 (199)
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHHcCCeecCCCc
Confidence 334444556788899999999999
Q ss_pred CcEEEeCC-----eEEEEe
Q psy9855 156 ENILIRGD-----LVVVGD 169 (470)
Q Consensus 156 ~NILl~~~-----~ikL~D 169 (470)
.||++... .+.|+|
T Consensus 147 ~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccEEEEecCCCceEEEEEe
Confidence 99999654 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0026 Score=59.42 Aligned_cols=49 Identities=16% Similarity=0.187 Sum_probs=30.9
Q ss_pred hhhhhhHHHHHHhcCCCC-CCeeeeceeeec-CCCCeEEEEeecccc-CHHH
Q psy9855 9 AEVANLKEISILRKIPDH-LNVLCLCETYVN-RSTRQVTLVFPLMEL-NLEE 57 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~H-pnIv~l~~~~~~-~~~~~~~lV~E~~~g-sL~~ 57 (470)
....+.+|..++..|..+ ..+.+++..... ......+++|++++| .+..
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 345677999999888633 235566553332 223457999999997 6666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0026 Score=67.00 Aligned_cols=76 Identities=22% Similarity=0.296 Sum_probs=51.0
Q ss_pred CccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHH-HHHhCCCeecCCCCCcEEEeC----C-eEEE
Q psy9855 94 KLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLH-HLHSYKVFHRDIKPENILIRG----D-LVVV 167 (470)
Q Consensus 94 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~-yLH~~gIvHrDLKp~NILl~~----~-~ikL 167 (470)
....++|||+.|..+.|.-.-.....+.. . ++..+.++.. -+-..|++|+|-+|.||+++. + .+.+
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~gi~~~-----~---i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivl 346 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRGISPH-----D---ILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVL 346 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcCCCHH-----H---HHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEE
Confidence 46678999999999988743222222222 1 3333333322 223578999999999999993 2 7899
Q ss_pred EecCCccccc
Q psy9855 168 GDLGSLQFIK 177 (470)
Q Consensus 168 ~DFG~a~~~~ 177 (470)
.|||+...+.
T Consensus 347 lDhGl~~~is 356 (538)
T KOG1235|consen 347 LDHGLYAVIS 356 (538)
T ss_pred Eccccccccc
Confidence 9999877654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0054 Score=69.09 Aligned_cols=44 Identities=18% Similarity=0.190 Sum_probs=31.6
Q ss_pred hhhhHHHHHHhcCCCCCCe--eeeceeeecCC-CCeEEEEeeccccC
Q psy9855 11 VANLKEISILRKIPDHLNV--LCLCETYVNRS-TRQVTLVFPLMELN 54 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnI--v~l~~~~~~~~-~~~~~lV~E~~~gs 54 (470)
..+.+|+++|+.|..|.+| .++++++.+.+ .+..|+||||++|.
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~ 129 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGR 129 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCc
Confidence 3577999999999645554 67766654321 24578999999984
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0064 Score=57.69 Aligned_cols=30 Identities=33% Similarity=0.548 Sum_probs=25.1
Q ss_pred hCCCeecCCCCCcEEEeCCeE-EEEecCCcc
Q psy9855 145 SYKVFHRDIKPENILIRGDLV-VVGDLGSLQ 174 (470)
Q Consensus 145 ~~gIvHrDLKp~NILl~~~~i-kL~DFG~a~ 174 (470)
..+++|+|+.|.|||++++.+ -|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 346999999999999998865 599999653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0081 Score=56.76 Aligned_cols=29 Identities=21% Similarity=0.172 Sum_probs=25.0
Q ss_pred CCCeecCCCCCcEEEeC--CeEEEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRG--DLVVVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~--~~ikL~DFG~a~ 174 (470)
.+++|+|+.+.|||+++ +.+.|+||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 46999999999999998 379999998653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.011 Score=57.92 Aligned_cols=29 Identities=31% Similarity=0.276 Sum_probs=25.0
Q ss_pred CCCeecCCCCCcEEEeCCe-EEEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGDL-VVVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~-ikL~DFG~a~ 174 (470)
.+++|+|+.|.|||++++. +.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4799999999999999885 4699998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.0077 Score=57.88 Aligned_cols=28 Identities=14% Similarity=0.169 Sum_probs=25.1
Q ss_pred CCeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 147 KVFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 147 gIvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
.++|+|+.|.||+++++.+.|+||+.+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQGLKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCCCEEEeccccC
Confidence 5899999999999998888899998664
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.044 Score=54.74 Aligned_cols=27 Identities=26% Similarity=0.482 Sum_probs=24.0
Q ss_pred CeecCCCCCcEEEeCCe--EEEEecCCcc
Q psy9855 148 VFHRDIKPENILIRGDL--VVVGDLGSLQ 174 (470)
Q Consensus 148 IvHrDLKp~NILl~~~~--ikL~DFG~a~ 174 (470)
+||+|+.|+||+++++. +.++|||.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999984 7799999653
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.016 Score=56.93 Aligned_cols=93 Identities=17% Similarity=0.235 Sum_probs=64.6
Q ss_pred hhhhhhHHHHHHhcCCCCCC-eeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLN-VLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~Hpn-Iv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..-++.+|+..|+.|..|-. |.+.++ .+..|+|||+..| .|.+.-.-. +...
T Consensus 153 SRlaa~kEfafmkaL~e~gfpVPkpiD------~~RH~Vvmelv~g~Pl~~v~~v~---d~~~----------------- 206 (465)
T KOG2268|consen 153 SRLAATKEFAFMKALYERGFPVPKPID------HNRHCVVMELVDGYPLRQVRHVE---DPPT----------------- 206 (465)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCccc------ccceeeHHHhhcccceeeeeecC---ChHH-----------------
Confidence 35567899999999974433 333433 3457899999987 666552111 1111
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
+...++.-+.-|-.+|+||+|..-=||++.++ .+
T Consensus 207 ---------------------------------------------ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 207 ---------------------------------------------LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 44455555667778999999999999999966 79
Q ss_pred EEEecCC
Q psy9855 166 VVGDLGS 172 (470)
Q Consensus 166 kL~DFG~ 172 (470)
+++||--
T Consensus 242 ~vIDFPQ 248 (465)
T KOG2268|consen 242 VVIDFPQ 248 (465)
T ss_pred EEeechH
Confidence 9999963
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.11 Score=53.15 Aligned_cols=51 Identities=10% Similarity=-0.113 Sum_probs=34.8
Q ss_pred hhhhhHHHHHHhcCCCC--CCeeeeceeeecCCCCeEEEEeecccc--CHHHHHHhccc
Q psy9855 10 EVANLKEISILRKIPDH--LNVLCLCETYVNRSTRQVTLVFPLMEL--NLEEYIRTTDN 64 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~H--pnIv~l~~~~~~~~~~~~~lV~E~~~g--sL~~~l~~~~~ 64 (470)
......|.+.|..+..+ .++.+++.+ + ....++|||++++ .+.+.+.....
T Consensus 74 ~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~~~~lVME~L~~~~~lr~~Ll~g~~ 128 (401)
T PRK09550 74 LDRARIEAEALKIQAKYVPDLVPKVYHY--D--EELAVTVMEDLSDHKILRKGLIDGKK 128 (401)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CCCCEEEEecCCCccHHHHHHhcCCc
Confidence 34567899999887533 467778664 2 3457899999984 57676655543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.052 Score=48.82 Aligned_cols=101 Identities=18% Similarity=0.137 Sum_probs=68.0
Q ss_pred CCCCCchhhhhhhHHHHHHhcCCCCCCee-eeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHh
Q psy9855 2 KATCPDFAEVANLKEISILRKIPDHLNVL-CLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKA 79 (470)
Q Consensus 2 k~~~~~~~~~~~~rEi~iL~~L~~HpnIv-~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~ 79 (470)
|....|....++..|.++|..+. -.++. +++.+- ..++.|||..| .|.++-... +..
T Consensus 51 Kvrr~ds~r~~l~kEakiLeil~-g~~~~p~vy~yg------~~~i~me~i~G~~L~~~~~~~---~rk----------- 109 (201)
T COG2112 51 KVRRRDSPRRNLEKEAKILEILA-GEGVTPEVYFYG------EDFIRMEYIDGRPLGKLEIGG---DRK----------- 109 (201)
T ss_pred EEecCCcchhhHHHHHHHHHHhh-hcCCCceEEEec------hhhhhhhhhcCcchhhhhhcc---cHH-----------
Confidence 55566777888999999999998 44443 343321 23556999998 887775321 001
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCC--Cc
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKP--EN 157 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp--~N 157 (470)
-+..++++---|-..||-|+.|.- .|
T Consensus 110 ----------------------------------------------------~l~~vlE~a~~LD~~GI~H~El~~~~k~ 137 (201)
T COG2112 110 ----------------------------------------------------HLLRVLEKAYKLDRLGIEHGELSRPWKN 137 (201)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhccchhhhcCCcee
Confidence 334455554445678999999874 46
Q ss_pred EEEeCCeEEEEecCCccc
Q psy9855 158 ILIRGDLVVVGDLGSLQF 175 (470)
Q Consensus 158 ILl~~~~ikL~DFG~a~~ 175 (470)
|++.+..+.|+||..|..
T Consensus 138 vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 138 VLVNDRDVYIIDFDSATF 155 (201)
T ss_pred EEecCCcEEEEEccchhh
Confidence 666666899999998863
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.049 Score=54.90 Aligned_cols=29 Identities=21% Similarity=0.307 Sum_probs=24.7
Q ss_pred CCCeecCCCCCcEEEeCC--eEEEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGD--LVVVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~--~ikL~DFG~a~ 174 (470)
..++|+|+++.|||++++ .+.++||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 368999999999999864 69999998664
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.14 Score=58.82 Aligned_cols=31 Identities=29% Similarity=0.303 Sum_probs=25.0
Q ss_pred hCCCeecCCCCCcEEEeCC---e---EEEEecCCccc
Q psy9855 145 SYKVFHRDIKPENILIRGD---L---VVVGDLGSLQF 175 (470)
Q Consensus 145 ~~gIvHrDLKp~NILl~~~---~---ikL~DFG~a~~ 175 (470)
..|+||+|+.+.|||++.+ . .-|+|||.+..
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 4689999999999999854 2 35999997643
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.078 Score=48.37 Aligned_cols=27 Identities=15% Similarity=0.140 Sum_probs=24.7
Q ss_pred CeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 148 VFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 148 IvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
.+|+|+.|+||+++++.++|+||+.+.
T Consensus 79 p~H~D~~~~N~~~~~~~~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASGLRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCCEEEEeCCccc
Confidence 599999999999999889999999764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.18 E-value=0.095 Score=51.68 Aligned_cols=28 Identities=29% Similarity=0.313 Sum_probs=25.3
Q ss_pred CCCeecCCCCCcEEEeCCeEEEEecCCc
Q psy9855 146 YKVFHRDIKPENILIRGDLVVVGDLGSL 173 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~ikL~DFG~a 173 (470)
.+++|||+.+.||+++.+.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECccc
Confidence 5899999999999999888889999954
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.11 Score=51.46 Aligned_cols=29 Identities=24% Similarity=0.296 Sum_probs=25.2
Q ss_pred CCeecCCCCCcEEEeCC-eEEEEecCCccc
Q psy9855 147 KVFHRDIKPENILIRGD-LVVVGDLGSLQF 175 (470)
Q Consensus 147 gIvHrDLKp~NILl~~~-~ikL~DFG~a~~ 175 (470)
.+||+|+++.||+++.+ -+-+.||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 48999999999999988 566899998764
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.24 Score=48.89 Aligned_cols=48 Identities=10% Similarity=0.068 Sum_probs=34.5
Q ss_pred hhhhhHHHHHHhcCCCC--CCeeeeceeeecC-CCCeEEEEeecccc-CHHH
Q psy9855 10 EVANLKEISILRKIPDH--LNVLCLCETYVNR-STRQVTLVFPLMEL-NLEE 57 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~H--pnIv~l~~~~~~~-~~~~~~lV~E~~~g-sL~~ 57 (470)
...+.+|...|+.|..+ -.|.++++++... ..+..+||||+++| ++.+
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~ 102 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEA 102 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCC
Confidence 34778999999999743 3677787765432 24568999999996 5543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.25 E-value=0.49 Score=54.65 Aligned_cols=30 Identities=30% Similarity=0.438 Sum_probs=25.4
Q ss_pred CCCeecCCCCCcEEEeCC---eEE-EEecCCccc
Q psy9855 146 YKVFHRDIKPENILIRGD---LVV-VGDLGSLQF 175 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~---~ik-L~DFG~a~~ 175 (470)
.++||+|+.+.|||++.+ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 579999999999999877 455 999997654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.21 E-value=0.16 Score=47.25 Aligned_cols=28 Identities=32% Similarity=0.426 Sum_probs=18.7
Q ss_pred CCeecCCCCCcEEE--eCCeEEEEecCCcc
Q psy9855 147 KVFHRDIKPENILI--RGDLVVVGDLGSLQ 174 (470)
Q Consensus 147 gIvHrDLKp~NILl--~~~~ikL~DFG~a~ 174 (470)
.++|+|+.|.|||+ ..+.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 44599999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.00 E-value=0.17 Score=50.04 Aligned_cols=29 Identities=34% Similarity=0.374 Sum_probs=25.3
Q ss_pred CCCeecCCCCCcEEEeCCe-EEEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGDL-VVVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~-ikL~DFG~a~ 174 (470)
.+++|+|+++.||+++.+. +.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 6899999999999999885 5799999653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.97 E-value=0.22 Score=50.95 Aligned_cols=28 Identities=21% Similarity=0.059 Sum_probs=24.7
Q ss_pred CCCeecCCCCCcEEEeCCeEEEEecCCc
Q psy9855 146 YKVFHRDIKPENILIRGDLVVVGDLGSL 173 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~ikL~DFG~a 173 (470)
...+|.|+-+.||+.+++.+.++||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecCCCEEEEEeccc
Confidence 4679999999999998889999999754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.091 Score=52.15 Aligned_cols=29 Identities=28% Similarity=0.285 Sum_probs=25.2
Q ss_pred CCCeecCCCCCcEEEeCCeE-EEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGDLV-VVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~i-kL~DFG~a~ 174 (470)
.|++|+|++|.||+++++.+ -|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 48999999999999998855 699999664
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.35 E-value=0.4 Score=44.88 Aligned_cols=36 Identities=25% Similarity=0.365 Sum_probs=30.4
Q ss_pred HHHHHHHHh--CCCeecCCCCCcEEEeCC-eEEEEecCC
Q psy9855 137 VNGLHHLHS--YKVFHRDIKPENILIRGD-LVVVGDLGS 172 (470)
Q Consensus 137 l~aL~yLH~--~gIvHrDLKp~NILl~~~-~ikL~DFG~ 172 (470)
+.+|.-.|+ .+.+|||-.|+||+-+.. .+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 466777884 479999999999999988 899999774
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.47 Score=47.47 Aligned_cols=26 Identities=19% Similarity=0.249 Sum_probs=22.8
Q ss_pred CeecCCCCCcEEEeCC--eEEEEecCCc
Q psy9855 148 VFHRDIKPENILIRGD--LVVVGDLGSL 173 (470)
Q Consensus 148 IvHrDLKp~NILl~~~--~ikL~DFG~a 173 (470)
++|.|+.+.|||++++ .++++||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 7999999999999743 7999999865
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=91.40 E-value=0.42 Score=48.07 Aligned_cols=44 Identities=18% Similarity=0.232 Sum_probs=35.7
Q ss_pred HHHHHHHHHHHH-HhCCCeecCCCCCcEEEeCCeEEEEecCCccc
Q psy9855 132 VLYQIVNGLHHL-HSYKVFHRDIKPENILIRGDLVVVGDLGSLQF 175 (470)
Q Consensus 132 i~~qIl~aL~yL-H~~gIvHrDLKp~NILl~~~~ikL~DFG~a~~ 175 (470)
+-.|++.-+.-| |..++||.||.-=|+|+.++.+.++|.+-+..
T Consensus 269 ~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 269 LYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKLYIIDVSQSVE 313 (520)
T ss_pred HHHHHHHHHHHHHHHhceeccchhhhhheEECCEEEEEEcccccc
Confidence 556666666666 45689999999999999999999999986643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=90.79 E-value=0.51 Score=43.61 Aligned_cols=60 Identities=22% Similarity=0.173 Sum_probs=44.9
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEEec
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDL 170 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~DF 170 (470)
......-||.||+....... ..-+.+|++-|..+|..||+-+|+++.|.. .-+|+||
T Consensus 147 ~~~~~~aIVKD~v~~~~~~~-------------------~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~----~G~lvDf 203 (207)
T PF13095_consen 147 RPLPIRAIVKDFVPDDPPLQ-------------------IRDIPQMLRDLKILHKLGIVPRDVKPRNYR----GGKLVDF 203 (207)
T ss_pred CCCccEEEEEeecCCccccc-------------------hhHHHHHHHHHHHHHHCCeeeccCcccccc----CCEEEec
Confidence 34445567888888776111 115778999999999999999999999876 2378999
Q ss_pred CCc
Q psy9855 171 GSL 173 (470)
Q Consensus 171 G~a 173 (470)
|.+
T Consensus 204 s~~ 206 (207)
T PF13095_consen 204 SSS 206 (207)
T ss_pred ccC
Confidence 854
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=90.68 E-value=0.21 Score=55.13 Aligned_cols=121 Identities=11% Similarity=0.040 Sum_probs=73.7
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
++.+...|.........+++|||+.|++|.+++.....+.. ..+..++..| +.....+|. .+|+
T Consensus 63 hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~----------~~~~~i~~qi--l~aL~yLH~----~gIi 126 (669)
T cd05610 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE----------EMAVKYISEV--ALALDYLHR----HGII 126 (669)
T ss_pred CCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCH----------HHHHHHHHHH--HHHHHHHHh----CCEE
Confidence 45556667777778889999999999999999865432111 1444444322 223346675 3554
Q ss_pred EeCC---eEEEEecCCcccccCCC---------ccccccccCcccCchhhccCCCCCCcccHHHHHHHH
Q psy9855 160 IRGD---LVVVGDLGSLQFIKSKG---------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVF 216 (470)
Q Consensus 160 l~~~---~ikL~DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il 216 (470)
-.+- .+.|.+-|..+...-+- .....++|+.|++||...........+++|++|+-.
T Consensus 127 HrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~ 195 (669)
T cd05610 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFNT 195 (669)
T ss_pred eCCccHHHEEEcCCCCEEEEeCCCCccccCCcccccccccCccccCccccccCCCCceeeeeeecCcCC
Confidence 4322 56666555444332110 112457899999999776555455667888888543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.14 E-value=0.51 Score=46.34 Aligned_cols=28 Identities=25% Similarity=0.338 Sum_probs=24.4
Q ss_pred CCeecCCCCCcEEEeC-----CeEEEEecCCcc
Q psy9855 147 KVFHRDIKPENILIRG-----DLVVVGDLGSLQ 174 (470)
Q Consensus 147 gIvHrDLKp~NILl~~-----~~ikL~DFG~a~ 174 (470)
+++|+|+.|.|||++. +.+.++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 6899999999999987 578999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=89.85 E-value=0.17 Score=50.81 Aligned_cols=45 Identities=16% Similarity=0.161 Sum_probs=36.7
Q ss_pred HHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhccccc
Q psy9855 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTF 118 (470)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~ 118 (470)
+++.++ ++.+..-+...++++..|+|||||.||+|.++|......
T Consensus 62 iLkel~-H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l 106 (429)
T KOG0595|consen 62 ILKELK-HPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRL 106 (429)
T ss_pred HHHhcC-CcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCC
Confidence 466666 566666688889999999999999999999999876543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=89.58 E-value=0.38 Score=46.71 Aligned_cols=45 Identities=18% Similarity=0.203 Sum_probs=33.9
Q ss_pred HHHHHHHHHHHHHHHhC--CCeecCCCCCcEEEeC-CeEEEEecCCcc
Q psy9855 130 TFVLYQIVNGLHHLHSY--KVFHRDIKPENILIRG-DLVVVGDLGSLQ 174 (470)
Q Consensus 130 ~~i~~qIl~aL~yLH~~--gIvHrDLKp~NILl~~-~~ikL~DFG~a~ 174 (470)
...+..+-.++.-++.. -++|+|+.|+|+|.++ +.++|+||..|.
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 33445555555555544 5899999999999999 799999998664
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.35 E-value=0.86 Score=45.82 Aligned_cols=85 Identities=18% Similarity=0.258 Sum_probs=55.6
Q ss_pred cchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCCeEEEEecCCcccccCCCccccccccCcccCchhhccC
Q psy9855 122 QSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE 200 (470)
Q Consensus 122 ~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~ 200 (470)
......++..|+.+.+.-+.-+..+ ..-|||+.-.||||+.+.|.|+||-+++.-...+.. .-...--|-.+.|.
T Consensus 316 k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsRl~~~q~~i----sy~rldhp~lF~G~ 391 (488)
T COG5072 316 KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSRLSYSQGII----SYNRLDHPDLFNGV 391 (488)
T ss_pred ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeeecccCCcee----eccccCchhhhcCc
Confidence 3344566777888887777766654 688999999999999889999999999843322211 00111234445443
Q ss_pred CCCCCcccHHHH
Q psy9855 201 GYYSFELDIWAA 212 (470)
Q Consensus 201 ~~~~~~~DIwSl 212 (470)
. +..-+||-+
T Consensus 392 d--d~QFeIYrl 401 (488)
T COG5072 392 D--DYQFEIYRL 401 (488)
T ss_pred c--ceeeeHHHH
Confidence 3 556677654
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=88.02 E-value=0.93 Score=45.85 Aligned_cols=141 Identities=12% Similarity=0.110 Sum_probs=82.8
Q ss_pred hHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccC
Q psy9855 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWD 92 (470)
Q Consensus 14 ~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (470)
++-+++|+.|+ .-.|=.++=+-. .+...++.|..++ ..|...=+-.+...|.++.. ..-|+.+..-|+.-++
T Consensus 76 l~~f~llk~LG-~GdiG~VyL~~l--~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~----~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 76 LRHFRLLKRLG-CGDIGTVYLVEL--RGTNCLFAMKVMDKESLASRKKLKRAQTEREILS----LLDHPFLPTLYASFET 148 (459)
T ss_pred HHHHHHHHHcC-CCCceeEEEEEe--cCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHH----hcCCCccchhhheeec
Confidence 56788888887 555555433222 2333677777777 45554322222244555544 2336666666999999
Q ss_pred CCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---CeEEEEe
Q psy9855 93 LKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG---DLVVVGD 169 (470)
Q Consensus 93 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---~~ikL~D 169 (470)
....+++||||.||+|..++++...- .++. ..+=.-+++.|..|. ++| .--|...+ ++|.|-+
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~----~fse---~~aRFYaAEvl~ALE---YLH----mlGivYRDLKPENILvre 214 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGK----RFSE---SAARFYAAEVLLALE---YLH----MLGIVYRDLKPENILVRE 214 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCC----ccch---hhHHHHHHHHHHHHH---HHH----hhceeeccCCcceeEEec
Confidence 99999999999999999988764211 1111 113335556666655 333 33455433 2677777
Q ss_pred cCCccc
Q psy9855 170 LGSLQF 175 (470)
Q Consensus 170 FG~a~~ 175 (470)
=|....
T Consensus 215 dGHIML 220 (459)
T KOG0610|consen 215 DGHIML 220 (459)
T ss_pred CCcEEe
Confidence 775543
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.54 E-value=0.97 Score=44.81 Aligned_cols=37 Identities=30% Similarity=0.394 Sum_probs=26.5
Q ss_pred hHHHHHHHHHHHHHHHHHh----CCCeecCCCCCcEEEeCC
Q psy9855 127 YHTTFVLYQIVNGLHHLHS----YKVFHRDIKPENILIRGD 163 (470)
Q Consensus 127 ~~~~~i~~qIl~aL~yLH~----~gIvHrDLKp~NILl~~~ 163 (470)
.-++.++.||+.-.-.+-. .+.+|-||||+|||+-+.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 4566788888754433322 468999999999999543
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=87.50 E-value=1.5 Score=42.90 Aligned_cols=43 Identities=26% Similarity=0.302 Sum_probs=29.4
Q ss_pred HHHHHHHHHHHHHh------CCCeecCCCCCcEEEeCC------eEEEEecCCcc
Q psy9855 132 VLYQIVNGLHHLHS------YKVFHRDIKPENILIRGD------LVVVGDLGSLQ 174 (470)
Q Consensus 132 i~~qIl~aL~yLH~------~gIvHrDLKp~NILl~~~------~ikL~DFG~a~ 174 (470)
+...+...+..+.. .-++|||++..|||+..+ .+++.||..++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 195 LLDKFFERMQELVDPSKEPFNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred HHHHHHHHHHHHhccccCCceEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 34444444444441 238999999999999654 47899998653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=86.29 E-value=0.94 Score=44.76 Aligned_cols=28 Identities=7% Similarity=0.005 Sum_probs=24.7
Q ss_pred CCeecCCCCCcEEEeCC-eEEEEecCCcc
Q psy9855 147 KVFHRDIKPENILIRGD-LVVVGDLGSLQ 174 (470)
Q Consensus 147 gIvHrDLKp~NILl~~~-~ikL~DFG~a~ 174 (470)
+++|+|+.++|||++++ .+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999877 78899998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 470 | ||||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-35 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-35 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-35 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-35 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-35 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-35 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-35 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-35 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-35 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-35 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-35 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-35 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-35 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-34 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-34 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-34 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-34 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-34 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-34 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-34 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-34 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-34 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-34 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-34 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-34 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-34 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-34 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-34 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-34 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-34 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-34 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-34 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-34 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-34 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-33 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-32 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-32 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-32 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-32 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-32 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-32 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-32 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-32 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-32 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-32 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-32 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-32 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-32 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-32 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-32 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-32 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-32 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-32 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-32 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-32 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-32 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-32 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-32 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-32 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-32 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-32 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-32 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-32 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-32 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-32 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-32 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-32 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-32 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-32 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-32 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-32 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-32 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-32 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-32 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-32 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-32 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-32 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-32 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-32 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-32 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-32 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-32 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-31 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-31 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-31 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-31 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-31 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-31 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-31 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-31 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-31 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-31 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-31 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-30 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-30 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-30 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-30 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-30 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-30 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-30 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-30 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-30 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-30 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-30 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-30 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-30 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-30 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-30 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-30 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-30 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-30 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-30 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-30 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-30 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-30 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-30 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-30 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-30 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-30 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-30 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-29 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-29 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-29 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-29 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-29 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-29 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-29 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-29 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-29 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-29 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-28 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-28 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-28 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-28 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-28 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-28 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-28 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-28 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-28 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-28 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-28 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-28 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-28 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-27 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-27 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-27 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-27 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-27 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-27 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-27 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-27 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-27 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-27 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-27 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-27 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-27 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-27 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-26 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-26 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-26 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-26 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-26 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-26 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-26 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-26 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-26 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-26 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-26 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-26 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-26 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-26 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-26 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-26 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-26 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-26 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-26 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-26 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-26 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-26 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-26 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-26 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-26 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-26 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-25 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-25 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-25 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-25 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-25 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-25 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-25 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-25 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-25 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-25 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-25 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-24 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-24 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-24 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-23 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-23 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-23 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-22 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-22 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-22 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-21 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-21 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-18 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-17 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-17 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-16 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-16 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-16 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-16 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-16 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-16 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-16 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-16 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-16 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-16 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-16 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-15 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-15 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-15 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-15 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-15 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-15 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-15 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-15 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-15 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-12 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-09 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-04 |
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-61
Identities = 78/308 (25%), Positives = 126/308 (40%), Gaps = 63/308 (20%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
L+EI +L+++ H N++ L E V R R++ LVF EY T
Sbjct: 50 LREIRMLKQL-KHPNLVNLLE--VFRRKRRLHLVF--------EYCDHT----------- 87
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
+L G K +
Sbjct: 88 -------------------------VLHELDRYQRG--------VPEHLVKSI------T 108
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG-LHTEYIATRWY 191
+Q + ++ H + HRD+KPENILI V+ + D G + + + + +ATRWY
Sbjct: 109 WQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
RSPE L+ + Y +D+WA GCVF E L+ PL+PG S++DQL I + LG +
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311
F + + +++ P I L+ L DP R T +++L YF
Sbjct: 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288
Query: 312 ADLTQLKQ 319
++ +++
Sbjct: 289 ENIREIED 296
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-61
Identities = 85/331 (25%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 2 KATCPDFAEVA----------NLKEISILRKIPDHLNVLCLCETYVNRSTRQ----VTLV 47
+A + EVA +E+ I+R + H NV+ L + + ++ + LV
Sbjct: 58 QAKLVESDEVAIKKVLQDKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 48 FPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRN 107
+ + R HY
Sbjct: 117 LEYVPETVYRASR-------------------------HYA------------------- 132
Query: 108 LGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLV 165
L +P +LY +YQ++ L ++HS + HRDIKP+N+L+ ++
Sbjct: 133 ------KLKQTMPMLLIKLY-----MYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181
Query: 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL 225
+ D GS + + + + YI +R+YR+PE + Y+ +DIW+ GCV E + PL
Sbjct: 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241
Query: 226 FPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFT-YQFKQYPGGGI-DVLVPQIHEK 283
FPG+S IDQL I +VLGTP E +K + N+ ++F Q V P+
Sbjct: 242 FPGESGIDQLVEIIKVLGTPSREQIKT----MNPNYMEHKFPQIRPHPFSKVFRPRTPPD 297
Query: 284 GKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314
L+S +L+Y P R TA + L +F +L
Sbjct: 298 AIDLISRLLEYTPSARLTAIEALCHPFFDEL 328
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-60
Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 68/309 (22%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQ----VTLVFPLMELNLEEYIRTTDNISEKR 69
+E+ I+RK+ DH N++ L + + ++ + LV + + R
Sbjct: 95 NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR--------- 144
Query: 70 AKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHT 129
HY LP +LY
Sbjct: 145 ----------------HYS-------------------------RAKQTLPVIYVKLY-- 161
Query: 130 TFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTEYIA 187
+YQ+ L ++HS+ + HRDIKP+N+L+ ++ + D GS + + + YI
Sbjct: 162 ---MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
+R+YR+PE + Y+ +D+W+AGCV E L P+FPGDS +DQL I +VLGTP
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278
Query: 248 ETLKKFEKYKSSNFT-YQFKQYPGGGID-VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
E +++ + N+T ++F Q V P+ + L S +L+Y P R T +
Sbjct: 279 EQIRE----MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334
Query: 306 LSCAYFADL 314
+ ++F +L
Sbjct: 335 CAHSFFDEL 343
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 4e-60
Identities = 81/314 (25%), Positives = 135/314 (42%), Gaps = 63/314 (20%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
++EI +L+++ H N++ L E V + ++ LVF E++ T
Sbjct: 72 MREIKLLKQL-RHENLVNLLE--VCKKKKRWYLVF--------EFVDHT----------- 109
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
+L + G Q ++ L
Sbjct: 110 -------------------------ILDDLELFPNG--------LDYQVVQKY------L 130
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG-LHTEYIATRWY 191
+QI+NG+ HS+ + HRDIKPENIL+ VV + D G + + + G ++ + +ATRWY
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWY 190
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
R+PE L+ + Y +D+WA GC+ E PLFPGDS+IDQL I LG +
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311
F K + ++ P++ E L + L DP +RP ++L +F
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
Query: 312 ADLTQLKQYLEQKQ 325
+++ ++ Q
Sbjct: 311 QMDGFAERFSQELQ 324
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-59
Identities = 81/308 (26%), Positives = 127/308 (41%), Gaps = 76/308 (24%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
L+EI +L+++ H N++ L + + ++S ++LVF ME +LE I+ +
Sbjct: 60 LREIKLLQEL-SHPNIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLV-------- 108
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
P K +
Sbjct: 109 --------------------------------------------LTPSHIKAY------M 118
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSL--QFIKSKGLHTEYIATR 189
+ GL +LH + + HRD+KP N+L+ G L + D G L F +T + TR
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL-ADFG-LAKSFGSPNRAYTHQVVTR 176
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
WYR+PE L Y +D+WA GC+ E L R P PGDS++DQL RI + LGTP E
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236
Query: 250 LKKFEK---YKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
Y + FK +PG + + + L+ + ++P R TA + L
Sbjct: 237 WPDMCSLPDYVT------FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
Query: 307 SCAYFADL 314
YF++
Sbjct: 291 KMKYFSNR 298
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-58
Identities = 86/304 (28%), Positives = 134/304 (44%), Gaps = 67/304 (22%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
++EISIL+++ H N++ L + + ++ LVF ++
Sbjct: 48 IREISILKEL-KHSNIVKLYDVIHTKK--RLVLVFEHLDQ-------------------- 84
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
DLK G +K L
Sbjct: 85 ------------------DLK------KLLDVCEGG--------LESVTAKSF------L 106
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRW 190
Q++NG+ + H +V HRD+KP+N+LI G+L + D G + F +T I T W
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI-ADFGLARAFGIPVRKYTHEIVTLW 165
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+P+ L+ YS +DIW+ GC+F E + PLFPG SE DQL RI ++LGTP ++
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
+ + F Y + + + E G L+S+MLK DP +R TA++ L AY
Sbjct: 226 PNVTELP--KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 311 FADL 314
F +
Sbjct: 284 FKEN 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-58
Identities = 84/307 (27%), Positives = 136/307 (44%), Gaps = 72/307 (23%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
++EIS+L+++ H N++ L + + +TLVF ME
Sbjct: 67 IREISLLKEL-HHPNIVSLIDVIHSER--CLTLVFEFMEK-------------------- 103
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
DLK G Q K L
Sbjct: 104 ------------------DLK------KVLDENKTG--------LQDSQIKIY------L 125
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRW 190
YQ++ G+ H H +++ HRD+KP+N+LI G L + D G + F +T + T W
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL-ADFGLARAFGIPVRSYTHEVVTLW 184
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET- 249
YR+P+ L+ YS +DIW+ GC+F E +T PLFPG ++ DQL +I +LGTP
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244
Query: 250 --LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+++ +K F+ + ++P ++G L+S ML +DP +R +A+ ++
Sbjct: 245 PQVQELPLWKQ----RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300
Query: 308 CAYFADL 314
YF DL
Sbjct: 301 HPYFKDL 307
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-57
Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 63/307 (20%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
++EIS+++++ H N++ L + V + ++TLVF M+ +L++Y+ + + R
Sbjct: 51 IREISLMKEL-KHENIVRLYD--VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG--- 104
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
K
Sbjct: 105 --------------------------------------------LELNLVKYF------Q 114
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRW 190
+Q++ GL H K+ HRD+KP+N+LI RG L + GD G + F + + T W
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKL-GDFGLARAFGIPVNTFSSEVVTLW 173
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET- 249
YR+P+ L+ YS +DIW+ GC+ E +T PLFPG ++ +QL I ++GTP
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 250 --LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ K KY + + + + +L+ +P R +A++ L
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293
Query: 308 CAYFADL 314
+FA+
Sbjct: 294 HPWFAEY 300
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 8e-57
Identities = 81/341 (23%), Positives = 142/341 (41%), Gaps = 71/341 (20%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
++E+S+L+ + H N++ L + + + + +TLVF EY+
Sbjct: 48 IREVSLLKDL-KHANIVTLHD--IIHTEKSLTLVF--------EYLDK------------ 84
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
DLK + K L
Sbjct: 85 ------------------DLK------QYLDDCGNI--------INMHNVKLF------L 106
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRWY 191
+Q++ GL + H KV HRD+KP+N+LI + + D G + + + T WY
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWY 166
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET-- 249
R P+ LL YS ++D+W GC+FYE T PLFPG + +QL I ++LGTP ET
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 250 -LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308
+ E++K TY + +Y + P++ G L++++L+++ + R +A+ +
Sbjct: 227 GILSNEEFK----TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 309 AYFADLTQLKQYLEQKQVMKKL-AKKNYMAGGMQKTSHPTH 348
+F L + L + L + ++ H H
Sbjct: 283 PFFLSLGERIHKLPDTTSIFALKEIQLQKEASLRSAHHHHH 323
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-56
Identities = 83/314 (26%), Positives = 131/314 (41%), Gaps = 82/314 (26%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
++E+S+L+++ H N++ L V ++ L+F E
Sbjct: 81 IREVSLLKEL-QHRNIIELKS--VIHHNHRLHLIFEYAEN-------------------- 117
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
DLK + + K L
Sbjct: 118 ------------------DLK---------------KYMDKNPDVSMRVIKSF------L 138
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSL---------QFIKSKGLHTE 184
YQ++NG++ HS + HRD+KP+N+L+ + + L F T
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLL--SVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
I T WYR PE LL +YS +DIW+ C++ E L + PLFPGDSEIDQL +I +VLG
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256
Query: 245 PKAET---LKKFEKYKSSNFTYQFKQYPGGGI-DVLVPQIHEKGKKLMSEMLKYDPKRRP 300
P T + +K S F ++ G + VL + ++G L++ ML+ DP +R
Sbjct: 257 PDDTTWPGVTALPDWKQS-----FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311
Query: 301 TAQKILSCAYFADL 314
+A+ L YF+
Sbjct: 312 SAKNALEHPYFSHN 325
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 78/313 (24%), Positives = 127/313 (40%), Gaps = 80/313 (25%)
Query: 14 LKEISILR--KIPDHLNVLCLCETYVNRSTR---QVTLVFPLMELNLEEYIRTTDNISEK 68
++E+++LR + +H NV+ L + T +VTLVF E++
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVF--------EHVDQ------- 103
Query: 69 RAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLI--VGLTTFLPQQSKRL 126
DL+ T + + K L
Sbjct: 104 -----------------------DLR---------------TYLDKAPPPGLPAETIKDL 125
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTE 184
+ Q + GL LH+ + HRD+KPENIL+ G + + D G +
Sbjct: 126 ------MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL-ADFG---LARIYSYQMA 175
Query: 185 Y---IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
+ T WYR+PE LL Y + +D+W+ GC+F E R PLF G+SE DQL +I +
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
+G P + + F + +VP++ E G +L+ EML ++P +R +
Sbjct: 235 IGLPPEDDWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 302 AQKILSCAYFADL 314
A + L +Y
Sbjct: 291 AFRALQHSYLHKD 303
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-54
Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 76/309 (24%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
L+EI +L+++ H N++ L + V S +++TLVF +
Sbjct: 49 LREICLLKEL-KHKNIVRLHD--VLHSDKKLTLVFEFCDQ-------------------- 85
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
DLK + S N P+ K L
Sbjct: 86 ------------------DLK------KYFDSCNGD--------LDPEIVKSF------L 107
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRW 190
+Q++ GL HS V HRD+KP+N+LI G+L + + G + F ++ + T W
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL-ANFGLARAFGIPVRCYSAEVVTLW 166
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKAET 249
YR P+ L YS +D+W+AGC+F E PLFPG+ DQL RI ++LGTP E
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 250 ---LKKFEKYKSSNFTYQFKQYPGG-GIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
+ K YK + YP + +VP+++ G+ L+ +LK +P +R +A++
Sbjct: 227 WPSMTKLPDYKP------YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 306 LSCAYFADL 314
L YF+D
Sbjct: 281 LQHPYFSDF 289
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-54
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 6/190 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTEY 185
+ +YQ+ + +HS + HRDIKP+N+L+ + + + + D GS + + Y
Sbjct: 142 LISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY 201
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
I +R+YR+PE +L Y+ +D+W+ GCVF E + PLF G++ IDQL RI Q++GTP
Sbjct: 202 ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTP 261
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIH-EKGKKLMSEMLKYDPKRRPTAQK 304
E + + +F ++P+ L+ ++L+Y+P R +
Sbjct: 262 TKEQMIRM---NPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318
Query: 305 ILSCAYFADL 314
++ +F L
Sbjct: 319 AMAHPFFDHL 328
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-54
Identities = 84/340 (24%), Positives = 141/340 (41%), Gaps = 78/340 (22%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIR 60
+K ++ +EI++LR++ H NV+ L + +++ + R+V L+F E +L I+
Sbjct: 53 LKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK 111
Query: 61 TTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLP 120
+
Sbjct: 112 FHRASKANKKPVQ--------------------------------------------LPR 127
Query: 121 QQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL-----VVVGDLGSL-- 173
K L LYQI++G+H+LH+ V HRD+KP NIL+ G+ V + D+G
Sbjct: 128 GMVKSL------LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG-FAR 180
Query: 174 QF---IKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
F +K + T WYR+PE LL +Y+ +DIWA GC+F E LT P+F
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
Query: 231 EI---------DQLDRIHQVLGTPKAET---LKKFEKYKSSNFTYQFKQYP----GGGID 274
E DQLDRI V+G P + +KK ++ + ++ Y ++
Sbjct: 241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300
Query: 275 VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314
+ K L+ ++L DP +R T+++ + YF +
Sbjct: 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-54
Identities = 84/310 (27%), Positives = 132/310 (42%), Gaps = 74/310 (23%)
Query: 14 LKEISILR--KIPDHLNVLCLCETYVNRSTR---QVTLVFPLMELNLEEYIRTTDNISEK 68
++E+++LR + +H NV+ L + T ++TLVF E++
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF--------EHVDQ------- 103
Query: 69 RAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLI--VGLTTFLPQQSKRL 126
DL T + V + K +
Sbjct: 104 -----------------------DLT---------------TYLDKVPEPGVPTETIKDM 125
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTE 184
++Q++ GL LHS++V HRD+KP+NIL+ G + + D G + + T
Sbjct: 126 ------MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL-ADFGLARIYSFQMALTS 178
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
+ T WYR+PE LL Y + +D+W+ GC+F E R PLF G S++DQL +I V+G
Sbjct: 179 VVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
P E + F I+ V I E GK L+ + L ++P +R +A
Sbjct: 238 PGEEDWPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 305 ILSCAYFADL 314
LS YF DL
Sbjct: 294 ALSHPYFQDL 303
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 59/189 (31%), Positives = 99/189 (52%), Gaps = 2/189 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYI 186
H + +Y I+ GLH LH V HRD+ P NIL+ + + + D + + T Y+
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
RWYR+PE ++ ++ +D+W+AGCV E R LF G + +QL++I +V+GTPK
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 247 AETLKKFEKYKSSNF-TYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
E + F + ++ P +VP L+++ML+++P+RR + ++
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 306 LSCAYFADL 314
L YF L
Sbjct: 315 LRHPYFESL 323
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 65/192 (33%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG----SLQFIKSKGLH 182
H + LYQI+ GL ++HS V HRD+KP N+L+ + + D G + G
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 183 TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
TEY+ATRWYR+PE +L Y+ +DIW+ GC+ E L+ P+FPG +DQL+ I +L
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
G+P E L K+ N+ + L P K L+ +ML ++P +R
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 303 QKILSCAYFADL 314
++ L+ Y
Sbjct: 309 EQALAHPYLEQY 320
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-53
Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 69/312 (22%)
Query: 16 EISILR--KIPDHLNVLCLCETYVNRSTRQ-----VTLVFPLMELNLEEYIRTTDNISEK 68
E+ I++ + H N++ L + R + +V + L R
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA 125
Query: 69 RAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYH 128
P +++
Sbjct: 126 --------------------------------------------------PPPILIKVF- 134
Query: 129 TTFVLYQIVNGLH--HLHSYKVFHRDIKPENILI---RGDLVVVGDLGSLQFIKSKGLHT 183
L+Q++ + HL S V HRDIKP N+L+ G L + D GS + + +
Sbjct: 135 ----LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL-CDFGSAKKLSPSEPNV 189
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243
YI +R+YR+PE + +Y+ +DIW+ GC+F E + P+F GD+ QL I +VLG
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGI-DVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
P E L+K + Y K P + + ++ L+S +L+Y P+ R
Sbjct: 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP 309
Query: 303 QKILSCAYFADL 314
+ L YF +L
Sbjct: 310 YEALCHPYFDEL 321
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 5e-53
Identities = 61/188 (32%), Positives = 100/188 (53%), Gaps = 3/188 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYI 186
+++YQ++ GL ++HS V HRD+KP N+ + D + + D G L + T Y+
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG-LARHADAEM-TGYV 184
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
TRWYR+PE +L+ +Y+ +DIW+ GC+ E LT LF G +DQL +I +V G P
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
E ++K + ++ Q P L P+ + L+ +ML+ D +R TA + L
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304
Query: 307 SCAYFADL 314
+ +F
Sbjct: 305 THPFFEPF 312
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-53
Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 7/193 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVVVGDLG----SLQFIKSKGL 181
H +YQ++ GL ++HS V HRD+KP N+ I + ++ +GD G KG
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 182 HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
+E + T+WYRSP LL+ Y+ +D+WAAGC+F E LT LF G E++Q+ I +
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
+ E ++ + P + L+P I + + ++L + P R T
Sbjct: 241 IPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299
Query: 302 AQKILSCAYFADL 314
A++ LS Y +
Sbjct: 300 AEEALSHPYMSIY 312
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 7e-53
Identities = 59/188 (31%), Positives = 99/188 (52%), Gaps = 3/188 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYI 186
F++YQ++ GL ++H+ + HRD+KP N+ + D + + D G L + T Y+
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG-LARQADSEM-TGYV 186
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
TRWYR+PE +L Y+ +DIW+ GC+ E +T LF G +DQL I +V GTP
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
AE +++ + ++ N+ + ++ L+ +ML D ++R TA + L
Sbjct: 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306
Query: 307 SCAYFADL 314
+ YF L
Sbjct: 307 AHPYFESL 314
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 7e-53
Identities = 74/315 (23%), Positives = 118/315 (37%), Gaps = 76/315 (24%)
Query: 14 LKEISILRKIPDHLNVLCLCE------TYVNRSTRQVTLVFPLMELNLEEYIRTTDNISE 67
L+EI IL+ + H NV+ L E + NR + LVF E +L +
Sbjct: 64 LREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---- 118
Query: 68 KRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLY 127
F + KR+
Sbjct: 119 ------------------------------------------------VKFTLSEIKRV- 129
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-----SLQFIKSKG 180
+ ++NGL+++H K+ HRD+K N+LI G L + D G SL
Sbjct: 130 -----MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL-ADFGLARAFSLAKNSQPN 183
Query: 181 LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
+T + T WYR PE LL E Y +D+W AGC+ E TR+P+ G++E QL I Q
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIH--EKGKKLMSEMLKYDPKR 298
+ G+ E + Y+ + + + + L+ ++L DP +
Sbjct: 244 LCGSITPEVWPNVDNYELYE-KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 299 RPTAQKILSCAYFAD 313
R + L+ +F
Sbjct: 303 RIDSDDALNHDFFWS 317
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-----------SLQF 175
H + +YQ + + LH V HRD+KP N+LI + + V D G + +
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 176 IKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
+ E++ATRWYR+PE +LT YS +D+W+ GC+ E R P+FPG QL
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 236 DRIHQVLGTPKAE-TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKY 294
I ++GTP ++ L+ E ++ + YP ++ + P+++ KG L+ ML +
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 295 DPKRRPTAQKILSCAYFADL 314
DP +R TA++ L Y
Sbjct: 293 DPAKRITAKEALEHPYLQTY 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 71/188 (37%), Positives = 104/188 (55%), Gaps = 3/188 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYI 186
H F++YQI+ GL ++HS + HRD+KP N+ + D + + D G L + + T Y+
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG-LARHTADEM-TGYV 190
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
ATRWYR+PE +L +Y+ +DIW+ GC+ E LT LFPG IDQL I +++GTP
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
AE LKK + N+ Q P + + L+ +ML D +R TA + L
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 307 SCAYFADL 314
+ AYFA
Sbjct: 311 AHAYFAQY 318
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 69/311 (22%), Positives = 117/311 (37%), Gaps = 72/311 (23%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
+EI IL + N++ L + + +R LVF E++ TD
Sbjct: 78 KREIKILENLRGGPNIITLADIVKDPVSRTPALVF--------EHVNNTD---------- 119
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
L LT Y F +
Sbjct: 120 ----------------------------------FKQLYQTLT---------DYDIRFYM 136
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI---RGDLVVVGDLGSLQFIKSKGLHTEYIATRW 190
Y+I+ L + HS + HRD+KP N++I L + D G +F + +A+R+
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL-IDWGLAEFYHPGQEYNVRVASRY 195
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPKAET 249
++ PE L+ Y + LD+W+ GC+ + R P F G DQL RI +VLGT
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 250 -LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-----IHEKGKKLMSEMLKYDPKRRPTAQ 303
+ K+ F ++ + V + + + ++L+YD + R TA+
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 304 KILSCAYFADL 314
+ + YF +
Sbjct: 316 EAMEHPYFYTV 326
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-50
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYI 186
+++LYQ++ G+ HLHS + HRD+KP NI+++ D + + D G + + + T Y+
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
TR+YR+PE +L GY +DIW+ GC+ E + LFPG IDQ +++ + LGTP
Sbjct: 188 VTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 247 AETLKKFE-----------KYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYD 295
E +KK + KY +F F + + L+S+ML D
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 296 PKRRPTAQKILSCAYFADL 314
+R + + L Y
Sbjct: 307 ASKRISVDEALQHPYINVW 325
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYI 186
+++LYQ++ G+ HLHS + HRD+KP NI+++ D + + D G + + + T Y+
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
TR+YR+PE +L GY +DIW+ GC+ E + LFPG IDQ +++ + LGTP
Sbjct: 225 VTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 247 AETLKKFE-----------KYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYD 295
E +KK + KY F F + + L+S+ML D
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 296 PKRRPTAQKILSCAYFADL 314
P +R + L Y
Sbjct: 344 PAKRISVDDALQHPYINVW 362
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-48
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG--------------- 171
H +V+YQ++ + +LHS + HRD+KP NIL+ + V V D G
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 172 -------SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
+ F + + T+Y+ATRWYR+PE LL Y+ +D+W+ GC+ E L P
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 225 LFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKG 284
+FPG S ++QL+RI V+ P E ++ + + K+ +
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWK 289
Query: 285 KK----------------LMSEMLKYDPKRRPTAQKILSCAYFADL 314
L+ ++L+++P +R +A L + +
Sbjct: 290 NLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 19/64 (29%), Positives = 32/64 (50%), Gaps = 1/64 (1%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEI 73
+EI IL ++ H N++ L + R V LVF ME +L IR + + + +
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR-ANILEPVHKQYV 114
Query: 74 LYQV 77
+YQ+
Sbjct: 115 VYQL 118
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 60/247 (24%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG--------------- 171
H +LY ++ G+ ++HS + HRD+KP N L+ D V V D G
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 172 -------------SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYE 218
K T ++ TRWYR+PE +L + Y+ +D+W+ GC+F E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 219 TLT-----------RNPLFPGDS--------------------EIDQLDRIHQVLGTPKA 247
L R PLFPG S DQL+ I +LGTP
Sbjct: 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE 336
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
E ++ EK + + F + G + P L+ ML ++P +R T + L+
Sbjct: 337 EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
Query: 308 CAYFADL 314
+F ++
Sbjct: 397 HPFFKEV 403
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 14/67 (20%), Positives = 37/67 (55%), Gaps = 4/67 (5%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRST---RQVTLVFPLMELNLEEYIRTTDNISEKRA 70
L+EI+IL ++ +H +V+ + + + + ++ +V + + + ++ RT ++E
Sbjct: 100 LREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI 158
Query: 71 KEILYQV 77
K +LY +
Sbjct: 159 KTLLYNL 165
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 67/239 (28%), Positives = 98/239 (41%), Gaps = 52/239 (21%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG--------------- 171
H +LY ++ G + +H + HRD+KP N L+ D V V D G
Sbjct: 130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 172 --------SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-- 221
K T ++ TRWYR+PE +L + Y+ +DIW+ GC+F E L
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 222 ---------RNPLFPGDSE-----------------IDQLDRIHQVLGTPKAETLKKFEK 255
R PLFPG S DQL+ I ++GTP + LK K
Sbjct: 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK 309
Query: 256 YKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314
+ + F + P I + G L+ MLK++P +R T + L Y D+
Sbjct: 310 PEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 63/227 (27%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 118 FLPQQSKRLYHTTFV---LYQIVNGLHHLHSYK--VFHRDIKPENILIRGD---LVVVGD 169
L + R Q+ L L + + + H D+KPENIL+ + + D
Sbjct: 145 LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204
Query: 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229
GS + + +YI +R+YRSPE LL Y +D+W+ GC+ E T PLF G
Sbjct: 205 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGA 261
Query: 230 SEIDQLDRIHQVLGTPKAETLKKFEK-----YKSSNFTYQFKQYPGGGIDVLVPQI---- 280
+E+DQ+++I +VLG P A L + K K + T+ K+ G + P
Sbjct: 262 NEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLH 321
Query: 281 ---------------HEKGKK---------LMSEMLKYDPKRRPTAQ 303
E G L+ ML YDPK R
Sbjct: 322 NILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 39/223 (17%), Positives = 73/223 (32%), Gaps = 27/223 (12%)
Query: 95 LPFLLLVFGKSRNLGTLIVGLTTFLPQQSK-RLYHTTFVLYQIVNGLHHLHSYKVFHRDI 153
+LLL+ S +L L L + + + Q++ +L S + H
Sbjct: 161 ANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220
Query: 154 KPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGY-YSFELDIWA 211
P+N+ I D +++GD+ +L + ++G Y E L ++ L+ W
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 212 AGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGG 271
G Y F + + L P ++L F
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL---------AFGS-------- 321
Query: 272 GIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314
+ + K L+ L +D +RR + + F L
Sbjct: 322 -----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 43/221 (19%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG--------------------DLGSL 173
YQI ++ LHS K+ H D+KPENIL D GS
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
+ H+ ++TR YR+PE +L +S D+W+ GC+ E +FP +
Sbjct: 185 TYDDEH--HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGI-------------DVLVPQI 280
L + ++LG ++K K K F + + + ++ Q
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRK--YFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 281 --HEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQ 319
HE+ L+ +ML+YDP +R T ++ L +F LK+
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFF---DLLKK 337
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 34/204 (16%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDL---VVVGDLGSLQFIKSKGLHTEYIATRW 190
+ I+ L LH ++ H D+KPENIL++ + V D GS + + YI +R+
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRF 264
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+PE +L Y +D+W+ GC+ E LT PL PG+ E DQL + ++LG P + L
Sbjct: 265 YRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 251 KKFEKYK-----SSNFTYQFKQYPGGGIDVLVPQIHEKGKK------------------- 286
++ K Y G VL +GK
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 287 ----LMSEMLKYDPKRRPTAQKIL 306
+ + L++DP R T + L
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQAL 407
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 57/217 (26%), Positives = 85/217 (39%), Gaps = 40/217 (18%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG--------------------DLGSL 173
YQ+ + L LH ++ H D+KPENIL D GS
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 174 QFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
F HT +ATR YR PE +L E ++ D+W+ GC+ +E LF +
Sbjct: 190 TFDHEH--HTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK------- 286
L + ++LG + + + K K F + D + + K K
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQK--YFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 287 --------LMSEMLKYDPKRRPTAQKILSCAYFADLT 315
LM ML++DP +R T + L +FA LT
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 28/199 (14%)
Query: 133 LYQIVNGLHHLHSY-KVFHRDIKPENILIRG-------DLVVVGDLGSLQFIKSKGLHTE 184
Q++ GL ++H + H DIKPEN+L+ + + DLG+ + +T
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTN 194
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS------EIDQLDRI 238
I TR YRSPE LL + DIW+ C+ +E +T + LF D + D + +I
Sbjct: 195 SIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 239 HQVLGTPKAETLKK-------FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKK----L 287
++LG + L+ F + K +P + + + K
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 288 MSEMLKYDPKRRPTAQKIL 306
+S ML+ DP++R A ++
Sbjct: 314 LSPMLQLDPRKRADAGGLV 332
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 45/214 (21%), Positives = 76/214 (35%), Gaps = 44/214 (20%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG------------------------- 168
+I+ L++L + H D+KPENIL+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 169 -DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFP 227
D G F H I TR YR+PE +L G + D+W+ GCV E T + LF
Sbjct: 204 IDFGCATFKSDY--HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFR 260
Query: 228 GDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNF---------------TYQFKQYPGGG 272
++ L + ++ L + K S + + ++
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 273 IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+ + HE + +L+ DP RP+ ++L
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 48/220 (21%), Positives = 78/220 (35%), Gaps = 47/220 (21%)
Query: 109 GTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-V 167
L + + + + QI + LHS + HRD+KP NI D VV V
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 205
Query: 168 GDLG-------------SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGC 214
GD G L + + HT + T+ Y SPE + YS ++DI++ G
Sbjct: 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGL 264
Query: 215 VFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGID 274
+ +E L + + + ++ F F Q
Sbjct: 265 ILFELLY--SFSTQMERVRIITDV------------------RNLKFPLLFTQK------ 298
Query: 275 VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314
+ + ++ +ML P RP A I+ A F +L
Sbjct: 299 ------YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 43/189 (22%), Positives = 68/189 (35%), Gaps = 39/189 (20%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATRWY 191
QI G+ ++HS K+ +RD+KP NI + V +GD G + +K+ G T T Y
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
SPE ++ Y E+D++A G + E L E +
Sbjct: 188 MSPE-QISSQDYGKEVDLYALGLILAELLH--VCDTA-FETSKF--------------FT 229
Query: 252 KFEKYK-SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
S F + K L+ ++L P+ RP +IL
Sbjct: 230 DLRDGIISDIFDKKEKT-------------------LLQKLLSKKPEDRPNTSEILRTLT 270
Query: 311 FADLTQLKQ 319
+ K
Sbjct: 271 VWKKSPEKN 279
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 52/214 (24%), Positives = 78/214 (36%), Gaps = 52/214 (24%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-------------SLQFIKS 178
QI + LHS + HRD+KP NI D VV VGD G L + +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 179 KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
HT + T+ Y SPE + YS ++DI++ G + +E L F E +
Sbjct: 184 YARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLYP---FSTQMERVRT--- 236
Query: 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR 298
++ F F Q ++ +ML P
Sbjct: 237 --------------LTDVRNLKFPPLFTQKY------------PCEYVMVQDMLSPSPME 270
Query: 299 RPTAQKILSCAYFADLTQLKQYLEQKQVMKKLAK 332
RP A I+ A F DL K V+++ ++
Sbjct: 271 RPEAINIIENAVFEDL-----DFPGKTVLRQRSR 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 55/303 (18%), Positives = 106/303 (34%), Gaps = 59/303 (19%)
Query: 15 KEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEI 73
E+ +++K+ H N+ L E Y + + LV L +L + + + S +
Sbjct: 77 TEVRLMKKL-HHPNIARLYEVYEDEQ--YICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133
Query: 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL 133
+ + + + G + + +
Sbjct: 134 VVKTQICPCPECNEEAI-------------NGSIHGFRESLDFVQREKLISNI------M 174
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGD---LVVVGDLG-SLQFIKSKGLHTEYIATR 189
QI + LH+LH+ + HRDIKPEN L + + + D G S +F K + T+
Sbjct: 175 RQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 190 ----WYRSPECLLTEGY-YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
++ +PE L T Y + D W+AG + + L FPG ++ D + ++
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV------ 288
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
+ ++ Y + + L+S +L + R A +
Sbjct: 289 ------------LNKKLCFENPNY---------NVLSPLARDLLSNLLNRNVDERFDAMR 327
Query: 305 ILS 307
L
Sbjct: 328 ALQ 330
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 39/313 (12%), Positives = 81/313 (25%), Gaps = 55/313 (17%)
Query: 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKR 69
+ + P + + + +V + L + ++ +
Sbjct: 105 SFE-VHVPYFTERPPSNA---------IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 70 AKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHT 129
Q K R W L L NL T L + ++H
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMW--VLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212
Query: 130 TF-VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGL--HTEY 185
+ Q++ L LH Y + H ++P +I++ V + L + +
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRG 272
Query: 186 IATRWYRSPECLLTEGY----YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
A + L + +F D W G Y + D+ + + I +
Sbjct: 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR- 331
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
I + + L+ L+Y + R
Sbjct: 332 ----------------------------------SCKNIPQPVRALLEGFLRYPKEDRLL 357
Query: 302 AQKILSCAYFADL 314
+ + + L
Sbjct: 358 PLQAMETPEYEQL 370
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 35/227 (15%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATR 189
QI L H+H K+ HRDIK +NI + D V +GD G + + L I T
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
+Y SPE + Y+ + DIWA GCV YE T F S + + +I
Sbjct: 190 YYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--------- 239
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
F S +++Y + L+S++ K +P+ RP+ IL
Sbjct: 240 -GSFPPV-SLHYSYDLRS-------------------LVSQLFKRNPRDRPSVNSILEKG 278
Query: 310 YFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSS 356
+ A +++++L + + ++ K + G Q S
Sbjct: 279 FIAK--RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSIS 323
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 45/189 (23%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG---------------SLQFIKS 178
QI+ L ++HS + HRD+KP NI I V +GD G S S
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 179 KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
T I T Y + E L G+Y+ ++D+++ G +F+E + P G ++ L ++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKL 241
Query: 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR 298
E F+ K KK++ ++ +DP +
Sbjct: 242 RS----VSIEFPPDFDDNKMKVE-----------------------KKIIRLLIDHDPNK 274
Query: 299 RPTAQKILS 307
RP A+ +L+
Sbjct: 275 RPGARTLLN 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 40/201 (19%), Positives = 73/201 (36%), Gaps = 44/201 (21%)
Query: 132 VLYQIVNGLHHLHSYK-----VFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTE 184
V+ Q+ L H V HRD+KP N+ + V +GD G +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
++ T +Y SPE + Y+ + DIW+ GC+ YE P F S+ + +I +
Sbjct: 176 FVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---- 230
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
KF + ++ + + +++ ML RP+ ++
Sbjct: 231 ------GKFRRI-PYRYSDELNE-------------------IITRMLNLKDYHRPSVEE 264
Query: 305 ILSCAYFADLTQLKQYLEQKQ 325
IL + ++
Sbjct: 265 ILENPL------ILEHHHHHH 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 37/232 (15%), Positives = 65/232 (28%), Gaps = 50/232 (21%)
Query: 95 LPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVL-YQIVNGLHHLHSYKVFHRDI 153
L L NL T L + ++H L Q++ L LH Y + H +
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232
Query: 154 KPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEG----------Y 202
+P +I++ V + L G +R + PE
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 203 YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFT 262
+F D WA G V Y + D+ + + I +
Sbjct: 290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR---------------------- 327
Query: 263 YQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314
I + + L+ L+Y + R + + + L
Sbjct: 328 -------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 42/178 (23%), Positives = 64/178 (35%), Gaps = 35/178 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATR 189
L + L HLHS + H D+KP NI + +GD G L + + G
Sbjct: 161 GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP 220
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
Y +PE L +G Y D+++ G E L G QL
Sbjct: 221 RYMAPELL--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------------- 264
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ Y FT + + + ++ ML+ DPK R TA+ +L+
Sbjct: 265 ---RQGYLPPEFT---------------AGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 49/182 (26%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLG-SLQFIKSKGLHTEYIATRW 190
Q+ + L H+HS +V HRDIKP N+ I +V +GDLG F + T +
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS-EIDQL-DRIHQVLGTPKAE 248
Y SPE + G Y+F+ DIW+ GC+ YE F GD + L +I Q
Sbjct: 202 YMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------- 252
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308
+ S +++ + +Q L++ + DP++RP +
Sbjct: 253 --CDYPPLPSDHYSEELRQ-------------------LVNMCINPDPEKRPDVTYVYDV 291
Query: 309 AY 310
A
Sbjct: 292 AK 293
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 43/188 (22%), Positives = 74/188 (39%), Gaps = 39/188 (20%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL------VVVGDLGSLQFIK----SKGL 181
+L Q +GL HLHS + HRD+KP NILI ++ D G + + S
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 182 HTEYIATRWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239
+ T + +PE L + ++ +DI++AGCVFY ++ G S Q +
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--- 239
Query: 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
+ ++L+ +M+ DP++R
Sbjct: 240 ----------------ILLGACSLDCLHPE--------KHEDVIARELIEKMIAMDPQKR 275
Query: 300 PTAQKILS 307
P+A+ +L
Sbjct: 276 PSAKHVLK 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 13/64 (20%), Positives = 26/64 (40%), Gaps = 3/64 (4%)
Query: 15 KEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYI-RTTDNISEKRAKEI 73
+E+ +LR+ +H NV+ T + + + L L+EY+ + +
Sbjct: 66 REVQLLRESDEHPNVIRYFCTE--KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL 123
Query: 74 LYQV 77
L Q
Sbjct: 124 LQQT 127
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 62/327 (18%), Positives = 110/327 (33%), Gaps = 105/327 (32%)
Query: 6 PDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNI 65
DF ++A EI +L + DH NV+ + + R + + L LNL++ +
Sbjct: 49 IDFCDIAL-MEIKLLTESDDHPNVIRYYCSE--TTDRFLYIALELCNLNLQDLV------ 99
Query: 66 SEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKR 125
E +
Sbjct: 100 -ESKNVSDENLKLQKEYNPIS--------------------------------------- 119
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--------------LVVVGDLG 171
+L QI +G+ HLHS K+ HRD+KP+NIL+ +++ D G
Sbjct: 120 ------LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 172 -SLQFIKSKGLHTEYIATR----WYRSPECLL------TEGYYSFELDIWAAGCVFYETL 220
+ + + +R+PE L T+ + +DI++ GCVFY L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 221 TRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI 280
++ G D+ R ++ + + +
Sbjct: 234 SKGKHPFG----DKYSRESNII-----------------RGIFSLDEMKCLHDR----SL 268
Query: 281 HEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ L+S+M+ +DP +RPTA K+L
Sbjct: 269 IAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 42/189 (22%), Positives = 68/189 (35%), Gaps = 41/189 (21%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGS------LQFIKSKGLHTE 184
+L I GL +H+ HRD+KP NIL+ V+ DLGS + L +
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 185 YIATR----WYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
A + YR+PE + + D+W+ GCV Y + + D +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY---------DMV 249
Query: 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR 298
Q + + +S + Q L++ M+ DP +
Sbjct: 250 FQKGDSVALAVQNQLSIPQSPRHSSALWQ-------------------LLNSMMTVDPHQ 290
Query: 299 RPTAQKILS 307
RP +LS
Sbjct: 291 RPHIPLLLS 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 46/211 (21%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ Q+++G+ ++H K+ HRD+KPEN+L+ + + D G ++ + I
Sbjct: 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y +PE L G Y + D+W+ G + Y L+ P F G +E D L ++
Sbjct: 191 TAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--------- 239
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ +T++ Q+ ++ E K L+ +ML Y P R +A+ L
Sbjct: 240 ---------EKGKYTFELPQWK---------KVSESAKDLIRKMLTYVPSMRISARDALD 281
Query: 308 CAYFADLTQLKQYLEQKQVMKKLAK-KNYMA 337
+ T+ + ++ + + + +
Sbjct: 282 HEWIQTYTKEQISVDVPSLDNAILNIRQFQG 312
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 37/212 (17%), Positives = 77/212 (36%), Gaps = 46/212 (21%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLG---SLQFIKSKGLHTEYIA 187
++ +H +H + + H D+KP N LI ++ + D G +Q + + +
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 188 TRWYRSPECLLTEGY----------YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
T Y PE + S + D+W+ GC+ Y F +Q+ +
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISK 248
Query: 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
+H ++ + ++ + +P + + ++ LK DPK
Sbjct: 249 LHAII-----------------DPNHEIE-FP--------DIPEKDLQDVLKCCLKRDPK 282
Query: 298 RRPTAQKILSCAYFADLTQLKQYLEQKQVMKK 329
+R + ++L+ Y Q Q+ K
Sbjct: 283 QRISIPELLAHPYVQ-----IQTHPVNQMAKG 309
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 43/212 (20%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ Q+++G+ +LH + + HRD+KPEN+L+ L+ + D G +++ E +
Sbjct: 141 IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y +PE L Y + D+W+ G + + L P F G ++ + L ++
Sbjct: 201 TAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--------- 249
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ +T+ ++ + E K L+ +ML++D +RR +AQ+ L
Sbjct: 250 ---------EKGKYTFDSPEW---------KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
Query: 308 CAYFADLTQLKQYLEQKQVMKKLAK--KNYMA 337
+ ++ K+ + + + + +
Sbjct: 292 HPWIKEMCSKKESGIELPSLANAIENMRKFQN 323
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 32/181 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
YQ++ + +LH + HRD+KPEN+L+ L+ + D G + + L
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303
Query: 188 TRWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
T Y +PE L++ G Y+ +D W+ G + + L+ P F L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 353
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
++ S + + + + ++ EK L+ ++L DPK R T ++
Sbjct: 354 -------KDQITSGKYNFIPEVW---------AEVSEKALDLVKKLLVVDPKARFTTEEA 397
Query: 306 L 306
L
Sbjct: 398 L 398
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 46/246 (18%), Positives = 83/246 (33%), Gaps = 42/246 (17%)
Query: 101 VFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK-VFHRDIKPENIL 159
+ L T F+P Q + + ++N ++H+ K + HRD+KP NIL
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCI-----IKSVLNSFSYIHNEKNICHRDVKPSNIL 184
Query: 160 IRGDLVV-VGDLGSLQFIKSKGLHT-----EYIATRWYRSPECLLTEG-YYSFELDIWAA 212
+ + V + D G +++ K + E++ PE E Y ++DIW+
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMP------PEFFSNESSYNGAKVDIWSL 238
Query: 213 GCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTY------QFK 266
G Y F + +L F ++ N Y
Sbjct: 239 GICLYVMFYNVVPFSLKISLVEL-----------------FNNIRTKNIEYPLDRNHFLY 281
Query: 267 QYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQYLEQKQV 326
+ + + L+ +P R T++ L + AD K++
Sbjct: 282 PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKEL 341
Query: 327 MKKLAK 332
KK K
Sbjct: 342 YKKRKK 347
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ QI++G+ +LH + + HRDIKPENIL+ + + D G F + +
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y +PE L + Y+ + D+W+ G + Y L P F G ++ D + ++
Sbjct: 211 TAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--------- 259
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + + F + I ++ K+L+ ML YD +R TA++ L+
Sbjct: 260 ---------EKGKYYFDFNDWK---------NISDEAKELIKLMLTYDYNKRCTAEEALN 301
Query: 308 CAYFADLTQLKQYLEQKQVMKKLAK-KNYMA 337
+ +QK + L+ + +
Sbjct: 302 SRWIKKYANNINKSDQKTLCGALSNMRKFEG 332
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 35/212 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ Q+ +G+ ++H + + HRD+KPENIL+ + + D G + + I
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y +PE L G Y + D+W+AG + Y L+ P F G +E D L R+
Sbjct: 186 TAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------- 234
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
Y F I + K L+ +ML + P R TA + L
Sbjct: 235 -----------ETGKYAFDLPQW-------RTISDDAKDLIRKMLTFHPSLRITATQCLE 276
Query: 308 CAYFADLTQLKQYLEQKQVMKKLAK--KNYMA 337
+ + + ++ + + A
Sbjct: 277 HPWIQKYSSETPTISDLPSLESAMTNIRQFQA 308
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 45/261 (17%), Positives = 90/261 (34%), Gaps = 43/261 (16%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLG---SLQFIKSKGLHTEYIA 187
++ +H +H + + H D+KP N LI ++ + D G +Q + + +
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 188 TRWYRSPECLLTEGY----------YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
T Y PE + S + D+W+ GC+ Y F I+Q+ +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISK 229
Query: 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
+H ++ + ++ + +P + + ++ LK DPK
Sbjct: 230 LHAII-----------------DPNHEIE-FP--------DIPEKDLQDVLKCCLKRDPK 263
Query: 298 RRPTAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSH 357
+R + ++L+ Y T + + + + G S A T H
Sbjct: 264 QRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS--ILKAAKTLYEH 321
Query: 358 QMDMSKFIQSDLNTHQTKKTK 378
S T + K+ K
Sbjct: 322 YSGGESHNSSSSKTFEKKRGK 342
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 46/187 (24%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG--LHT-----E 184
L QIV G +LH +V HRD+K N+ + DL V +GD G ++ G
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
YIA PE +L++ +SFE+D+W+ GC+ Y L P F + RI +
Sbjct: 181 YIA------PE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--- 230
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
Y ++ I+ L+ +ML+ DP RPT +
Sbjct: 231 -----------------EYSIPKH-----------INPVAASLIQKMLQTDPTARPTINE 262
Query: 305 ILSCAYF 311
+L+ +F
Sbjct: 263 LLNDEFF 269
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 49/267 (18%), Positives = 98/267 (36%), Gaps = 38/267 (14%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR-----GDLVVVGDLGSLQFIKSKGLHTEYI 186
+ QI++G+++LH+ K+ H D+KPENI++ + + D G I+
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T + +PE + E E D+W+ G + Y L+ F GD++ + L I V
Sbjct: 180 GTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
++ + F Q E K + ++L + ++R T Q+ L
Sbjct: 234 -----SYD-FDEEFF----------------SQTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 307 -----SCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMDM 361
+ ++ + + KK + S HL + +
Sbjct: 272 RHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRT 331
Query: 362 SKFIQSDLNTHQTKKTKSDFFSQARTS 388
S+ +++ + + + R S
Sbjct: 332 SEDLRNCESDTEENIARRKALHPRRRS 358
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 46/187 (24%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG--LHT-----E 184
L QIV G +LH +V HRD+K N+ + DL V +GD G ++ G
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
YIA PE +L++ +SFE+D+W+ GC+ Y L P F + RI +
Sbjct: 207 YIA------PE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--- 256
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
Y ++ I+ L+ +ML+ DP RPT +
Sbjct: 257 -----------------EYSIPKH-----------INPVAASLIQKMLQTDPTARPTINE 288
Query: 305 ILSCAYF 311
+L+ +F
Sbjct: 289 LLNDEFF 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 35/210 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR-----GDLVVVGDLGSLQFIKSKGLHTEYI 186
L QI+NG+++LHS ++ H D+KPENI++ + + D G I
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T + +PE + E E D+W+ G + Y L+ F GD++ + L + V
Sbjct: 179 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+E ++ F K + +L DPK+R T Q L
Sbjct: 233 -----NYE-FEDEYF----------------SNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 307 SCAYFADLTQLKQ--YLEQKQVMKKLAKKN 334
+ + M+K K
Sbjct: 271 QHPWIKPKDTQQALSRKASAVNMEKFKKFA 300
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 38/187 (20%), Positives = 79/187 (42%), Gaps = 46/187 (24%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG--SLQFIKSKGLHT-----E 184
++QI+ G+ +LHS+ + HRD+ N+L+ ++ + + D G + + + +T
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
YI+ PE + T + E D+W+ GC+FY L P F D+ + L+++
Sbjct: 178 YIS------PE-IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--- 227
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
Y+ + + + K L+ ++L+ +P R +
Sbjct: 228 -----------------DYEMPSF-----------LSIEAKDLIHQLLRRNPADRLSLSS 259
Query: 305 ILSCAYF 311
+L +
Sbjct: 260 VLDHPFM 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-21
Identities = 47/255 (18%), Positives = 87/255 (34%), Gaps = 37/255 (14%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI---RGDLVVVGDLGSLQFIKSKGLHTEYIAT 188
+ Q+ GL H+H H D+KPENI+ R + + + D G + K T
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 319
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
+ +PE + + D+W+ G + Y L+ F G+++ + L +
Sbjct: 320 AEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------- 371
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS- 307
+ S F I E GK + ++L DP R T + L
Sbjct: 372 ---DWN-MDDSAF----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411
Query: 308 ---CAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMDMSKF 364
A + + ++ K Y A + P ++N S + ++
Sbjct: 412 PWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP--EPLPPLGRISNYSSLRKHRPQEY 469
Query: 365 IQSDLNTHQTKKTKS 379
D +++
Sbjct: 470 SIRDAFWDRSEAQPR 484
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 42/222 (18%), Positives = 81/222 (36%), Gaps = 52/222 (23%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR-----GDLVVVGDLGSLQFIKSKGLHTEYI 186
+ QI++G+++LH+ K+ H D+KPENI++ + + D G I+
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T + +PE + E E D+W+ G + Y L+ F GD++ + L I V
Sbjct: 180 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
++ + F E K + ++L + ++R T Q+ L
Sbjct: 234 -----SYD-FDEEFF----------------SHTSELAKDFIRKLLVKETRKRLTIQEAL 271
Query: 307 S---------------CAYFADLTQLKQYLEQKQVMKKLAKK 333
+L ++ V ++
Sbjct: 272 RHPWITPVDNQQAMVRRESVVNLENFRKQ----YVRRRWKLS 309
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 33/180 (18%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ Q+ +G+ ++H + + HRD+KPENIL+ + + D G + + I
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y +PE L G Y + D+W+AG + Y L+ P F G +E D L R+
Sbjct: 186 TAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------- 234
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
++ + + Q+ I + K L+ +ML + P R TA + L
Sbjct: 235 ---------ETGKYAFDLPQW---------RTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 34/180 (18%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ Q++N L + HS V H+D+KPENIL + + + D G + KS T
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T Y +PE + +F+ DIW+AG V Y LT F G S
Sbjct: 189 TALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---------------E 231
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
E +K + + + + L+ +ML DP+RRP+A ++L
Sbjct: 232 EVQQKATYKE-----PNYAVECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 44/210 (20%), Positives = 83/210 (39%), Gaps = 35/210 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
YQ++ + +LH + HRD+KPEN+L+ L+ + D G + + L
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178
Query: 188 TRWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
T Y +PE L++ G Y+ +D W+ G + + L+ P F L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
++ S + + + + + EK L+ ++L DPK R T ++
Sbjct: 229 -------KDQITSGKYNFIPEVWAE---------VSEKALDLVKKLLVVDPKARFTTEEA 272
Query: 306 LSCAYFAD---LTQLKQYLEQKQVMKKLAK 332
L + D + + L ++ L +
Sbjct: 273 LRHPWLQDEDMKRKFQDLLSEENESTALPQ 302
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 45/263 (17%), Positives = 85/263 (32%), Gaps = 47/263 (17%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLG---SLQFIKSKGLHTEYIA 187
++ +H +H + + H D+KP N LI ++ + D G +Q + + +
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 188 TRWYRSPECLLTEGY----------YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
Y PE + S + D+W+ GC+ Y F
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--- 275
Query: 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
K N +F + + ++ LK DPK
Sbjct: 276 --------------KLHAIIDPNHEIEFPDI-----------PEKDLQDVLKCCLKRDPK 310
Query: 298 RRPTAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLL--ANTKS 355
+R + ++L+ Y Q++ + + + Y+ G + + P +L A T
Sbjct: 311 QRISIPELLAHPYV----QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLY 366
Query: 356 SHQMDMSKFIQSDLNTHQTKKTK 378
H S T + K+ K
Sbjct: 367 EHYSGGESHNSSSSKTFEKKRGK 389
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 41/182 (22%), Positives = 73/182 (40%), Gaps = 33/182 (18%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATRW 190
++ ++ + LH + HRD+KPENIL+ D+ + + D G + E T
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS 188
Query: 191 YRSPECLLTEGY-----YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
Y +PE + Y E+D+W+ G + Y L +P F ++ L I
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 241
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
S N+ + ++ + K L+S L P++R TA++
Sbjct: 242 -----------MSGNYQFGSPEW---------DDYSDTVKDLVSRFLVVQPQKRYTAEEA 281
Query: 306 LS 307
L+
Sbjct: 282 LA 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 25/71 (35%), Positives = 38/71 (53%), Gaps = 7/71 (9%)
Query: 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLM---ELNLEEYIRTTDNIS 66
A LKE+ ILRK+ H N++ L +TY + LVF LM EL +Y+ +S
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELF--DYLTEKVTLS 122
Query: 67 EKRAKEILYQV 77
EK ++I+ +
Sbjct: 123 EKETRKIMRAL 133
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 42/180 (23%), Positives = 74/180 (41%), Gaps = 33/180 (18%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ +++ + + H V HRD+KPEN L D + + D G K + +
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y SP+ L EG Y E D W+AG + Y L P F ++ + + +I
Sbjct: 171 TPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------- 219
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ FT+ K + + + + L+ +L PK+R T+ + L
Sbjct: 220 ---------REGTFTFPEKDW---------LNVSPQAESLIRRLLTKSPKQRITSLQALE 261
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 33/181 (18%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR-----GDLVVVGDLGSLQFIKSKGLHTEYI 186
L QI++G+H+LHS ++ H D+KPENI++ + + D G I++
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T + +PE + E E D+W+ G + Y L+ F G+++ + L I V
Sbjct: 173 GTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
++ + F E K + +L DPKRR T + L
Sbjct: 227 -----NYD-FDEEYF----------------SNTSELAKDFIRRLLVKDPKRRMTIAQSL 264
Query: 307 S 307
Sbjct: 265 E 265
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 39/210 (18%), Positives = 77/210 (36%), Gaps = 36/210 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI---RGDLVVVGDLGSLQFIKSKGLHTEYIAT 188
++Q+ L LHS+ + H DI+PENI+ R + + + G + +K
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
Y +PE + S D+W+ G + Y L+ F ++ ++ I
Sbjct: 167 PEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA------- 218
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS- 307
++ + F +I + + +L + K R TA + L
Sbjct: 219 ---EYT-FDEEAF----------------KEISIEAMDFVDRLLVKERKSRMTASEALQH 258
Query: 308 ---CAYFADL-TQLKQYLEQKQVMKKLAKK 333
+ T++ + L+ ++ L KK
Sbjct: 259 PWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 32/189 (16%), Positives = 71/189 (37%), Gaps = 16/189 (8%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVV-VGDLGSLQFIKSKGLHTEYI 186
VL +V G++HL + HR+IKP NI+ G V + D G+ + ++
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 187 ATRWYRSPECL-------LTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI- 238
T Y P+ + Y +D+W+ G FY T + F + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR 298
++++ + + +K ++ + L + +++ +L+ D ++
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANILEADQEK 293
Query: 299 RPTAQKILS 307
+ +
Sbjct: 294 CWGFDQFFA 302
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 15/74 (20%), Positives = 29/74 (39%), Gaps = 11/74 (14%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL----NLEEYIR---TTDNIS 66
++E +L+K+ +H N++ L +TR L+ ME +L + +
Sbjct: 55 MREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLP 110
Query: 67 EKRAKEILYQVKAA 80
E +L V
Sbjct: 111 ESEFLIVLRDVVGG 124
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 38/195 (19%), Positives = 63/195 (32%), Gaps = 56/195 (28%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI--------------------RGDLVVVGDLG 171
+L Q+ GL ++HS + H DIKP NI I + +GDLG
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 172 SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE 231
+ + + E L + + DI+A PL
Sbjct: 180 H---VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RN 233
Query: 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEM 291
DQ I Q G + + + ++ +L+ M
Sbjct: 234 GDQWHEIRQ------------------------------GRLPRIPQVLSQEFTELLKVM 263
Query: 292 LKYDPKRRPTAQKIL 306
+ DP+RRP+A ++
Sbjct: 264 IHPDPERRPSAMALV 278
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 39/176 (22%), Positives = 69/176 (39%), Gaps = 31/176 (17%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI---RGDLVVVGDLGSLQFIKSKGLHTEYIATRWY 191
Q GL H+H + + H DIKPENI+ + V + D G + + AT +
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
+PE + E F D+WA G + Y L+ F G+ +++ L + +
Sbjct: 217 AAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------- 265
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+E + F + + K + +L+ +P++R T L
Sbjct: 266 DWE-FDEDAF----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 49/247 (19%), Positives = 98/247 (39%), Gaps = 36/247 (14%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVVVGDLG-SLQFIKSKGLHTEYI 186
+ QI+ + H H V HR++KPEN+L+ G V + D G +++ + +
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T Y SPE L + Y +D+WA G + Y L P F + + +I
Sbjct: 175 GTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-------- 225
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
K+ + + ++ + + K L+++ML +P +R TA + L
Sbjct: 226 ----------KAGAYDFPSPEW---------DTVTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 307 SCAYFADLTQLKQYLEQKQV---MKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMDMSK 363
+ + + + + +++ +KK + + G + T + K +
Sbjct: 267 KHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIKVTEQ 326
Query: 364 FIQSDLN 370
I++ N
Sbjct: 327 LIEAISN 333
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 39/180 (21%), Positives = 72/180 (40%), Gaps = 29/180 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ I + LHS+ + HRD+KPEN+L ++ + D G + L T
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CY 191
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y +PE L E Y D+W+ G + Y L P F ++ +
Sbjct: 192 TPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--------- 241
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + + + ++ ++ E K+L+ +LK DP R T + ++
Sbjct: 242 -----KRRIRLGQYGFPNPEW---------SEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 45/216 (20%), Positives = 84/216 (38%), Gaps = 38/216 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLG-SLQFIKSKGLHTEYI 186
+ QI+ L + H + HRD+KP +L+ V +G G ++Q +S + +
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T + +PE + E Y +D+W G + + L+ F G E R+
Sbjct: 195 GTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKE-----RL-------- 240
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
FE + +Q+ I E K L+ ML DP R T + L
Sbjct: 241 ------FEGIIKGKYKMNPRQW---------SHISESAKDLVRRMLMLDPAERITVYEAL 285
Query: 307 SCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQK 342
+ + + + + + +++L + + A +K
Sbjct: 286 NHPWLKERDRYAYKIHLPETVEQL--RKFNA--RRK 317
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 32/180 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVVVGDLGSLQFIKSKGLHTEYIA 187
+ QI+ + + HS + HR++KPEN+L+ G V + D G + +
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T Y SPE L + YS +DIWA G + Y L P F + + R+
Sbjct: 170 TPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ----HRL--------- 215
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + K+ + Y ++ + + K L+ ML +PK+R TA + L
Sbjct: 216 -----YAQIKAGAYDYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 261
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 42/212 (19%), Positives = 81/212 (38%), Gaps = 38/212 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVVVGDLGSLQFIKSKGLHTEYIA 187
+ QI+ + +LH + HRD+KPEN+L + + D G + ++ + L
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T Y +PE L Y E+D+W+ G + Y L F + +
Sbjct: 213 TPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFM------------ 259
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
F + + + + + ++ K L+ +++ DPK+R T + L
Sbjct: 260 -----FRRILNCEYYFISPWW---------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305
Query: 308 -------CAYFADLTQLKQYLEQKQVMKKLAK 332
A F + ++ L++ +KL
Sbjct: 306 HPWVTGKAANFVHMDTAQKKLQEFNARRKLKA 337
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 40/193 (20%), Positives = 67/193 (34%), Gaps = 51/193 (26%)
Query: 132 VLYQIVNGLHHLHSYK--VFHRDIKPENILIRGD-LVVVGDLGS---------LQFIKSK 179
+ YQ + H+H K + HRD+K EN+L+ + + D GS + +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 180 GLHTEYIATR----WYRSPEC--LLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
E TR YR+PE L + + DIWA GC+ Y R F +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA--- 257
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
K + N Y + + L+ ML+
Sbjct: 258 ---------------------KLRIVNGKYSIPPH---------DTQYTVFHSLIRAMLQ 287
Query: 294 YDPKRRPTAQKIL 306
+P+ R + +++
Sbjct: 288 VNPEERLSIAEVV 300
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 45/217 (20%), Positives = 86/217 (39%), Gaps = 46/217 (21%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIK 177
Q+ + T + ++ N L + HS +V HRDIKPEN+L+ + + D G
Sbjct: 101 QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 178 SKGLHT-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232
S +Y+ PE + + ++D+W+ G + YE L P F ++
Sbjct: 161 SSRRTDLCGTLDYLP------PEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
Query: 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEML 292
+ RI +V ++ +P + E + L+S +L
Sbjct: 214 ETYKRISRV-------------EFT----------FP--------DFVTEGARDLISRLL 242
Query: 293 KYDPKRRPTAQKILSCAYFADLTQLKQYLEQKQVMKK 329
K++P +RP +++L + + + K+ K
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 32/189 (16%), Positives = 71/189 (37%), Gaps = 16/189 (8%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVV-VGDLGSLQFIKSKGLHTEYI 186
VL +V G++HL + HR+IKP NI+ G V + D G+ + ++
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 187 ATRWYRSPECL-------LTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI- 238
T Y P+ + Y +D+W+ G FY T + F + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR 298
++++ + + +K ++ + L + +++ +L+ D ++
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANILEADQEK 293
Query: 299 RPTAQKILS 307
+ +
Sbjct: 294 CWGFDQFFA 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 16/74 (21%), Positives = 30/74 (40%), Gaps = 11/74 (14%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL----NLEEYIRTTDN---IS 66
++E +L+K+ +H N++ L +TR L+ ME +L + N +
Sbjct: 55 MREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLP 110
Query: 67 EKRAKEILYQVKAA 80
E +L V
Sbjct: 111 ESEFLIVLRDVVGG 124
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 36/215 (16%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVVVGDLGSLQFIKSKGLHTEYIA 187
+ QI+ + + HS + HR++KPEN+L+ G V + D G + +
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T Y SPE L + YS +DIWA G + Y L P F + + R+
Sbjct: 193 TPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ----HRL--------- 238
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + K+ + Y ++ + + K L+ ML +PK+R TA + L
Sbjct: 239 -----YAQIKAGAYDYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 284
Query: 308 CAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQK 342
+ + ++ + ++ + L K + A +K
Sbjct: 285 VPWICNRERVASAIHRQDTVDCL--KKFNA--RRK 315
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 40/179 (22%), Positives = 74/179 (41%), Gaps = 31/179 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR---GDLVVVGDLGSLQFIKSKGLHTEYIAT 188
+ QI G+ H+H + H D+KPENIL + + D G + K + T
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
+ +PE ++ + SF D+W+ G + Y L+ F GD++ + L+ I
Sbjct: 252 PEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC------- 303
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+++ + F I E+ K+ +S++L + R +A + L
Sbjct: 304 ---RWD-LEDEEF----------------QDISEEAKEFISKLLIKEKSWRISASEALK 342
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 45/220 (20%), Positives = 84/220 (38%), Gaps = 32/220 (14%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVVVGDLGSLQFIKSKGLHTEYIA 187
++ QI+ G+++LH + H D+KP+NIL+ + + D G + I E +
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T Y +PE L + + D+W G + Y LT F G+ + I QV
Sbjct: 196 TPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------ 248
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ Y F + + + +L +P++RPTA+ LS
Sbjct: 249 ----NVD-YSEETF----------------SSVSQLATDFIQSLLVKNPEKRPTAEICLS 287
Query: 308 CAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPT 347
++ + ++ + + + KTS +
Sbjct: 288 HSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSS 327
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 41/182 (22%), Positives = 73/182 (40%), Gaps = 33/182 (18%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATRW 190
++ ++ + LH+ + HRD+KPENIL+ ++ + + D G ++ E T
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPG 264
Query: 191 YRSPECLLTEGY-----YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
Y +PE L Y E+D+WA G + + L +P F +I L I
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI------- 317
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
+ + ++ K L+S +L+ DP+ R TA++
Sbjct: 318 -----------MEGQYQFSSPEW---------DDRSSTVKDLISRLLQVDPEARLTAEQA 357
Query: 306 LS 307
L
Sbjct: 358 LQ 359
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 20/66 (30%), Positives = 36/66 (54%), Gaps = 7/66 (10%)
Query: 15 KEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLM---ELNLEEYIRTTDNISEKRAK 71
+E ILR++ H +++ L ++Y S+ + LVF LM EL +Y+ +SEK +
Sbjct: 148 RETHILRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELF--DYLTEKVALSEKETR 203
Query: 72 EILYQV 77
I+ +
Sbjct: 204 SIMRSL 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 9e-19
Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 46/195 (23%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIK 177
Q+ R + + ++ + LH+ H KV HRDIKPEN+L+ + + D G
Sbjct: 106 QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165
Query: 178 SKGLHT-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232
S T +Y+ PE + + + ++D+W AG + YE L P F S
Sbjct: 166 SLRRRTMCGTLDYLP------PEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218
Query: 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEML 292
+ RI V K +P P + + K L+S++L
Sbjct: 219 ETHRRIVNV-------------DLK----------FP--------PFLSDGSKDLISKLL 247
Query: 293 KYDPKRRPTAQKILS 307
+Y P +R + ++
Sbjct: 248 RYHPPQRLPLKGVME 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 46/241 (19%), Positives = 92/241 (38%), Gaps = 31/241 (12%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ I + +LHS + HRD+KPEN+L ++ + D G + S T
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T +Y +PE L E Y D+W+ G + Y L P F + + +
Sbjct: 226 TPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------- 275
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + + + ++ ++ E+ K L+ +LK +P +R T + ++
Sbjct: 276 -----KTRIRMGQYEFPNPEW---------SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321
Query: 308 CAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMDMSKFIQS 367
+ T++ Q + K K+ + + T + L Q+ + K +
Sbjct: 322 HPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMT---SALATMRVDYEQIKIKKIEDA 378
Query: 368 D 368
Sbjct: 379 S 379
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 59/215 (27%), Positives = 85/215 (39%), Gaps = 37/215 (17%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR-----GDLVVVGDLG-SLQFIKSKGLHTEY 185
VL+ I + +LH+ V HRD+KP NIL + + + D G + Q GL
Sbjct: 121 VLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF---PGDSEIDQLDRIHQVL 242
T + +PE L +G Y DIW+ G + Y LT F P D+ + L RI
Sbjct: 181 CYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---- 235
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
S F+ + + + K L+S+ML DP +R TA
Sbjct: 236 --------------GSGKFSLSGGYW---------NSVSDTAKDLVSKMLHVDPHQRLTA 272
Query: 303 QKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMA 337
+L + QL QY +Q L K A
Sbjct: 273 ALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAA 307
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 36/180 (20%), Positives = 70/180 (38%), Gaps = 26/180 (14%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLG-SLQFIKSKGLHTEYI 186
++ ++V+ + H+H V HRD+KPEN+L + + + D G +
Sbjct: 111 IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T Y +PE L G Y D+W+ G + Y L+ F ++
Sbjct: 171 FTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI----- 224
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+K K +F+++ + + + ++ K L+ +L DP +R +
Sbjct: 225 ------MKKIKKGDFSFEGEAWKN---------VSQEAKDLIQGLLTVDPNKRLKMSGLR 269
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 65/331 (19%), Positives = 122/331 (36%), Gaps = 45/331 (13%)
Query: 12 ANLKEISILRKI----PDHLN---VLCLCE--TYVNRSTRQVTLVFPLMELNLEEYIRTT 62
L EI +L+ + P+ N V+ L + + + +VF ++ +L ++I +
Sbjct: 79 TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKS 138
Query: 63 DN--ISEKRAKEILYQVKAANETAAHYRVGW---DLKLPFLLLVFGKSRNLGTLIVGLTT 117
+ + K+I+ QV + H + D+K +LL +
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYL-HTKCRIIHTDIKPENILLSVNEQ----------YI 187
Query: 118 FLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIK 177
+ + + + + E V + DLG+ ++
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247
Query: 178 SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPG-DSEIDQLD 236
TE I TR YRS E L+ GY + DIW+ C+ +E T + LF E D
Sbjct: 248 KH--FTEDIQTRQYRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
Query: 237 RIH-----QVLGTPKAETLKKFE---KY--KSSNFTYQFKQYPGGGIDVLVPQIHEKGK- 285
H ++LG + + + ++ K + + K P G +VLV + +
Sbjct: 305 EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE 364
Query: 286 -----KLMSEMLKYDPKRRPTAQKILSCAYF 311
+ ML+ P++R TA + L +
Sbjct: 365 AAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 41/176 (23%), Positives = 63/176 (35%), Gaps = 42/176 (23%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDL--VVVGDLGSLQFIKSKGLHTEYIATRWYR 192
Q+V + H HS V HRDIK ENILI + D GS + + + TR Y
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYS 205
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
PE + Y++ +W+ G + Y+ + P F D EI + +
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIP-FERDQEILEAE--------------- 249
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
F + + L+ L P RP+ ++IL
Sbjct: 250 -----------LHFPAH-----------VSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 12/189 (6%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
+L I + L +LH ++ HRD+KPENI+++ + + DLG + + L TE++
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T Y +PE L + Y+ +D W+ G + +E +T F + + Q +
Sbjct: 186 TLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV------RE 238
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
++ + Y +F L + K ++ + ML + ++R T + +
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNH-LSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297
Query: 308 CAYFADLTQ 316
F L
Sbjct: 298 VGCFQALDS 306
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 41/176 (23%), Positives = 65/176 (36%), Gaps = 42/176 (23%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDL--VVVGDLGSLQFIKSKGLHTEYIATRWYR 192
Q++ + H H+ V HRDIK ENILI + + + D GS +K + TR Y
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYS 215
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
PE + Y+ +W+ G + Y+ + P F D EI
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-FEHDEEI------------------- 255
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
F+Q + + + L+ L P RPT ++I +
Sbjct: 256 -------IRGQVFFRQR-----------VSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTEYIATRWY 191
L +I+ L +LHS + + D+KPENI++ + + + DLG++ I S G T +
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGY---LYGTPGF 243
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
++PE + + DI+ G P G
Sbjct: 244 QAPE--IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 30/234 (12%)
Query: 132 VLYQIVNGLHHLHS-YKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
V ++ GL +L +K+ HRD+KP NIL+ RG+ + + D G S Q I S ++ ++
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMA-NS-FVG 192
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
TR Y SPE L +YS + DIW+ G E P + + A
Sbjct: 193 TRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI-HEKGKKLMSEM------------LKY 294
ET + + P I L+ I +E KL S + L
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311
Query: 295 DPKRRPTAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTH 348
+P R ++++ A+ K+ ++ G+ + S PTH
Sbjct: 312 NPAERADLKQLMVHAFI------KRSDAEEVDFAGWLCS---TIGLNQPSTPTH 356
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 44/191 (23%), Positives = 71/191 (37%), Gaps = 28/191 (14%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVVVGDLGSLQFIKSKGLHTEYIA 187
V+ + + L LH+ + HRD+KPENIL V + D IK G +
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 188 TRW--------YRSPECLLTEGY----YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
Y +PE + Y D+W+ G + Y L+ P F G D
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235
Query: 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYD 295
+ + FE + + + K + I K L+S++L D
Sbjct: 236 WDRGEACPACQNML---FESIQEGKYEFPDKDWAH---------ISCAAKDLISKLLVRD 283
Query: 296 PKRRPTAQKIL 306
K+R +A ++L
Sbjct: 284 AKQRLSAAQVL 294
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 33/176 (18%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRWYR 192
++ G+ +LH K+ HRDIKP N+L+ D + + D G S +F S L + + T +
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFM 204
Query: 193 SPECL--LTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
+PE L + + LD+WA G Y + F + I L
Sbjct: 205 APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCL--------------- 248
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
K KS ++P P I E K L++ ML +P+ R +I
Sbjct: 249 --HSKIKSQAL-----EFPDQ------PDIAEDLKDLITRMLDKNPESRIVVPEIK 291
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 41/184 (22%), Positives = 70/184 (38%), Gaps = 39/184 (21%)
Query: 132 VLYQIVNGLHHLHS-YKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
+ IV L++L + V HRD+KP NIL+ RG + + D G S + + K
Sbjct: 129 MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKA-KDRSAG 186
Query: 188 TRWYRSPE----CLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242
Y +PE T+ Y D+W+ G E T + P ++ + L ++ +
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQ 244
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
P L + S +F + + + L D ++RP
Sbjct: 245 EEP--PLLPGHMGF-SGDF-----------------------QSFVKDCLTKDHRKRPKY 278
Query: 303 QKIL 306
K+L
Sbjct: 279 NKLL 282
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 44/193 (22%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG-LHTEYIATRWYR 192
Q+V+ + +L + HRDIK ENI+I D + + D GS +++ +T + T Y
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYC 196
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKAETLK 251
+PE L+ Y EL++W+ G Y + NP F E
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENP-FCELEET------------------- 236
Query: 252 KFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
+ P + ++ L+S +L+ P+RR T +K+++ +
Sbjct: 237 -----VEAAIH--------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277
Query: 311 FADLTQLKQYLEQ 323
L Y +
Sbjct: 278 VTQPVNLADYTWE 290
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 36/210 (17%), Positives = 74/210 (35%), Gaps = 49/210 (23%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIA 187
++ I + +LHS + HRD+KPEN+L ++ + D G A
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------FA 167
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
E Y D+W+ G + Y L P F + + +
Sbjct: 168 ------KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------- 210
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + + + ++ ++ E+ K L+ +LK +P +R T + ++
Sbjct: 211 -----KTRIRMGQYEFPNPEW---------SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
Query: 308 CAYFADLTQLKQYLEQKQVMKKLAKKNYMA 337
+ T++ Q + K K+ +
Sbjct: 257 HPWIMQSTKVPQTPLHTSRVLKEDKERWED 286
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 52/235 (22%), Positives = 84/235 (35%), Gaps = 45/235 (19%)
Query: 132 VLYQIVNGLHHLHS-YKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
+ V L+HL K+ HRDIKP NIL+ G+ + + D G S Q + S T
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN-IKLCDFGISGQLVDSIA-KTRDAG 187
Query: 188 TRWYRSPE---CLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243
R Y +PE + Y D+W+ G YE T R P +S DQL ++ V G
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKG 245
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
P + + F+ F + ++ L D +RP +
Sbjct: 246 DP-----PQLSNSEEREFSPSFINF-------------------VNLCLTKDESKRPKYK 281
Query: 304 KILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQ 358
++L + Y E+ + K + + + + H
Sbjct: 282 ELLKHPFI------LMYEERAVEVACYVCK---ILDQMPATPSSPMYVDHHHHHH 327
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 46/184 (25%), Positives = 69/184 (37%), Gaps = 39/184 (21%)
Query: 132 VLYQIVNGLHHLHS-YKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
+ IV L HLHS V HRD+KP N+LI G V + D G S +
Sbjct: 114 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDDVAKDI-DAG 171
Query: 188 TRWYRSPE---CLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243
+ Y +PE L + YS + DIW+ G E R P + QL ++ V
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEE 229
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
+ + F+ +F + S+ LK + K RPT
Sbjct: 230 PSP--------QLPADKFSAEFVDF-------------------TSQCLKKNSKERPTYP 262
Query: 304 KILS 307
+++
Sbjct: 263 ELMQ 266
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 37/175 (21%), Positives = 72/175 (41%), Gaps = 34/175 (19%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRWYR 192
QIV+ + + H ++ HRD+K EN+L+ D+ + + D G S +F L + Y
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYA 180
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKK 252
+PE + Y E+D+W+ G + Y ++ + F G + + +L
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKEL----------------- 222
Query: 253 FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
E+ + P + + L+ L +P +R T ++I+
Sbjct: 223 RERVLRGKYR-----IP--------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 43/188 (22%), Positives = 72/188 (38%), Gaps = 48/188 (25%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG----SLQFIKSKGLHTE----- 184
Q+++GL +LHS + H+DIKP N+L+ + + LG F T
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 185 YIATRWYRSPECLL-TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243
+ PE + + F++DIW+AG Y T F GD+ I +L
Sbjct: 177 FQP------PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKL-------- 221
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
FE ++ P L+ ML+Y+P +R + +
Sbjct: 222 ---------FENIGKGSYA-----IP--------GDCGPPLSDLLKGMLEYEPAKRFSIR 259
Query: 304 KILSCAYF 311
+I ++F
Sbjct: 260 QIRQHSWF 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 10/105 (9%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTE---YIA 187
++ QI + L H+ HRD+KPENIL+ D + D G + L T+ +
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVG 197
Query: 188 TRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
T +Y +PE Y + DI+A CV YE LT +P + GD
Sbjct: 198 TLYYMAPERFSESHATYRA---DIYALTCVLYECLTGSPPYQGDQ 239
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 45/280 (16%), Positives = 84/280 (30%), Gaps = 51/280 (18%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKS-------KGL 181
++L ++ L ++H HR +K +ILI D V + L +L I
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 182 HTEYIATRWYRSPECLL-TEGYYSFELDIWAAGC-------------------VFYETLT 221
+ + SPE L Y + DI++ G + E L
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 222 RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIH 281
D+ + + A + S+ P H
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 282 EKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQ 341
+ + L+ +P RP+A +L+ ++F K K+ + +
Sbjct: 312 H----FVEQCLQRNPDARPSASTLLNHSFF-----------------KQIKRR-ASEALP 349
Query: 342 KTSHPTHLLANTKSSHQMDMSKFIQSDLNTHQTKKTKSDF 381
+ P + N + S D S N + + +F
Sbjct: 350 ELLRPVTPITNFEGSQSQDHSGIFGLVTNLEELEVDDWEF 389
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 13/115 (11%), Positives = 21/115 (18%), Gaps = 28/115 (24%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRW 190
+ + H V P + + D VV+ +
Sbjct: 134 AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------TMPDAN 180
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ DI G Y L P L +
Sbjct: 181 PQD--------------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 40/151 (26%), Positives = 61/151 (40%), Gaps = 18/151 (11%)
Query: 87 YRVGWDLKLPFLL--LVFGKSRNLGTLIVGLTTFLPQQSKRL--YHTTFVLYQIVNGLHH 142
V + +L+ + G L I + L QI++G+ H
Sbjct: 77 IDVDEEDDCYYLVMEYIEG--PTLSEYI--------ESHGPLSVDTAINFTNQILDGIKH 126
Query: 143 LHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGL-HT-EYIATRWYRSPECLLT 199
H ++ HRDIKP+NILI + + + D G + + L T + T Y SPE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAK 185
Query: 200 EGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
DI++ G V YE L P F G++
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGET 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 42/202 (20%), Positives = 75/202 (37%), Gaps = 46/202 (22%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHT-----EYIA 187
++V L +L + ++ HRD+KP+NIL+ V + D + + + T Y+A
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMA 182
Query: 188 TRWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
PE + YSF +D W+ G YE L + S T
Sbjct: 183 ------PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS------------TS 224
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR-PTAQK 304
E + FE YP ++ L+ ++L+ +P +R
Sbjct: 225 SKEIVHTFETTV--------VTYP--------SAWSQEMVSLLKKLLEPNPDQRFSQLSD 268
Query: 305 ILSCAYFADLTQLKQYLEQKQV 326
+ + Y D+ + QK++
Sbjct: 269 VQNFPYMNDINWDA--VFQKRL 288
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 9e-14
Identities = 47/196 (23%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTE-----YIA 187
QI++ + + H + V HRD+KPEN+L+ + + D G S + L T Y A
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 178
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
PE + Y E+DIW+ G + Y L F + + L
Sbjct: 179 ------PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTL------------ 219
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKIL 306
F+K + F +P+ ++ L+ ML+ DP +R T + I
Sbjct: 220 -----FKKIRGGVFY--------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIR 260
Query: 307 SCAYFADLTQLKQYLE 322
+F L YL
Sbjct: 261 EHEWF--KQDLPSYLF 274
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 33/184 (17%), Positives = 64/184 (34%), Gaps = 37/184 (20%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG------SLQFIKSKGLH 182
+ L Q + GL +LH+ ++ H D+K +N+L+ G + D G KS
Sbjct: 154 YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 183 TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
T + +PE ++ + ++DIW++ C+ L + +I
Sbjct: 214 DYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-E 271
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
P E + P + + E L+ +P R +A
Sbjct: 272 PPPIRE---------------------------IPPSCAPLTAQAIQEGLRKEPVHRASA 304
Query: 303 QKIL 306
++
Sbjct: 305 MELR 308
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 49/213 (23%), Positives = 81/213 (38%), Gaps = 35/213 (16%)
Query: 132 VLYQIVNGLHHLHSY--------KVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH 182
+ Y V+GL HLH+ + HRD+K +NIL++ + + DLG L +
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG-LAVKFISDTN 197
Query: 183 TEYIA------TRWYRSPECLLTEGYY----SFE-LDIWAAGCVFYETLTRNPLFPGDSE 231
I T+ Y PE L S+ D+++ G + +E R G E
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVE 256
Query: 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEM 291
QL V P E +++ K K P + + KLM+E
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIK--------KLRPSFPNRWSSDECLRQMGKLMTEC 308
Query: 292 LKYDPKRRPTAQKILSCAYFADLTQLKQYLEQK 324
++P R TA ++ L ++ + + K
Sbjct: 309 WAHNPASRLTALRVKK-----TLAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 51/213 (23%), Positives = 81/213 (38%), Gaps = 30/213 (14%)
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY--------KVFHRDIKPENILIRGDLVV 166
L +L + ++ I +GL HLH + HRD+K +NIL++ +
Sbjct: 93 LYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC 152
Query: 167 -VGDLGSLQFIKSKGLHTEYIA------TRWYRSPECL----LTEGYYSFE-LDIWAAGC 214
+ DLG L + S+ + + T+ Y +PE L + + S++ +DIWA G
Sbjct: 153 CIADLG-LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211
Query: 215 VFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGID 274
V +E R G E + V P E ++K +Q P
Sbjct: 212 VLWEVARRMVSN-GIVEDYKPPFYDVVPNDPSFEDMRKVVCVD--------QQRPNIPNR 262
Query: 275 VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
KLM E +P R TA +I
Sbjct: 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 2e-13
Identities = 39/199 (19%), Positives = 71/199 (35%), Gaps = 46/199 (23%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG----SLQFIKSKGLHTE----- 184
Q++ G+ +LH + HRDIKPEN+L+ + + D G + + L+
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
Y+A PE L +++ +D+W+ G V L + S+ Q
Sbjct: 173 YVA------PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------- 217
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
+ + P ID L+ ++L +P R T
Sbjct: 218 -----YSD--WKEK-----KTYLNPWKKIDSAP-------LALLHKILVENPSARITIPD 258
Query: 305 ILSCAYFADLTQLKQYLEQ 323
I ++ LK+ ++
Sbjct: 259 IKKDRWY--NKPLKKGAKR 275
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 39/178 (21%), Positives = 62/178 (34%), Gaps = 40/178 (22%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHT--- 183
F +I+ GL H+H+ V +RD+KP NIL+ V + DLG K H
Sbjct: 293 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352
Query: 184 --EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
Y+A PE L Y D ++ GC+ ++ L + F D+ +
Sbjct: 353 THGYMA------PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
L + P + + L+ +L+ D RR
Sbjct: 407 LTMA--------------------VELP--------DSFSPELRSLLEGLLQRDVNRR 436
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 37/189 (19%), Positives = 70/189 (37%), Gaps = 26/189 (13%)
Query: 136 IVNGLHHLHSY----------KVFHRDIKPENILIRGDL-VVVGDLGSLQFIKSKGLHTE 184
+ GL +LH + HRDIK +N+L++ +L + D G ++ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 185 YIA---TRWYRSPECLLTEGYYSFEL----DIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
TR Y +PE L + + D++A G V +E +R G + L
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
++ P E +++ +K K+ P + + E +D +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHK--------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 298 RRPTAQKIL 306
R +A +
Sbjct: 302 ARLSAGCVG 310
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 43/232 (18%), Positives = 80/232 (34%), Gaps = 71/232 (30%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLG----SLQFIKSKGLHTEYIATR 189
+IV G+ +LH+ + H+D+K +N+ VV+ D G S + I
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 190 WYR----------SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239
W SP+ + +S D++A G ++YE R F I
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT---QPAEAIIW 253
Query: 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ--IHEKGKKLMSEMLKYDPK 297
Q+ G G+ + Q + ++ ++ ++ +
Sbjct: 254 QM----------------------------GTGMKPNLSQIGMGKEISDILLFCWAFEQE 285
Query: 298 RRPTAQKILSCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHL 349
RPT K++ +++KL K+N ++ SHP H
Sbjct: 286 ERPTFTKLM------------------DMLEKLPKRN------RRLSHPGHF 313
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 50/195 (25%), Positives = 72/195 (36%), Gaps = 30/195 (15%)
Query: 132 VLYQIVNGLHHLHSYKVF--------HRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH 182
+ +GL HLH V HRD+K +NIL++ + + DLG L
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG-LAVRHDSATD 202
Query: 183 TEYIA------TRWYRSPECLLTEGYY----SFE-LDIWAAGCVFYETLTRNPLFPGDSE 231
T IA T+ Y +PE L SF+ DI+A G VF+E R + +
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEM 291
QL V P E ++K + K P + K+M E
Sbjct: 263 Y-QLPYYDLVPSDPSVEEMRKVVCEQ--------KLRPNIPNRWQSCEALRVMAKIMREC 313
Query: 292 LKYDPKRRPTAQKIL 306
+ R TA +I
Sbjct: 314 WYANGAARLTALRIK 328
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 58/315 (18%), Positives = 97/315 (30%), Gaps = 58/315 (18%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHT-----EYIA 187
QI++G+ + H + V HRD+KPEN+L+ + + D G S + L T Y A
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 183
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
PE + Y E+DIW++G + Y L F D + L
Sbjct: 184 ------PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTL------------ 224
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKIL 306
F+K F PQ ++ L+ ML+ DP +R T + I
Sbjct: 225 -----FKKICDGIFY--------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIR 265
Query: 307 SCAYFADLTQLKQYLEQKQVMKKLAKKN-------YMAGGMQKTSHPTHLLANTKSSHQM 359
+F L +YL + + + + L
Sbjct: 266 EHEWF--KQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLA 323
Query: 360 DMSKFIQSDLNTHQTKKTKSDFFSQARTSKYRFDQSSSIVLHPKNPPNKSKHRFDQSSST 419
I ++ + DF+ D HP+ P +
Sbjct: 324 VAYHLI---IDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTL 380
Query: 420 VLHSKNPPNRSKLDR 434
+ + +
Sbjct: 381 DELNPQKSKHQGVRK 395
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 45/175 (25%), Positives = 72/175 (41%), Gaps = 36/175 (20%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRWYR 192
QI+ + + H +K+ HRD+KPEN+L+ +L V + D G S L T + Y
Sbjct: 116 QIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYA 174
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKK 252
+PE + + Y E+D+W+ G V Y L F + I L
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNL----------------- 216
Query: 253 FEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKIL 306
F+K S + +P + + L+ M+ DP +R T Q+I
Sbjct: 217 FKKVNSCVYV--------------MPDFLSPGAQSLIRRMIVADPMQRITIQEIR 257
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 41/180 (22%), Positives = 70/180 (38%), Gaps = 31/180 (17%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATR-WY 191
Q G+ +LH+ + HRD+K NI + D V +GD G ++
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 192 R--SPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
+PE + + YSF+ D++A G V YE +T + + DQ+ I V
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVG----- 239
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + + ++ K+LM+E LK RP+ +IL+
Sbjct: 240 ------------------RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 36/104 (34%), Positives = 45/104 (43%), Gaps = 6/104 (5%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEY----I 186
V+ L+ H + HRD+KP NI+I V V D G + I G I
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
T Y SPE D+++ GCV YE LT P F GDS
Sbjct: 181 GTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 3/115 (2%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTEY 185
F QIV+GL HLH + +RD+KPEN+L+ D V + DLG +++ + Y
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
T + +PE LL E Y F +D +A G YE + F E + + Q
Sbjct: 350 AGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 32/120 (26%), Positives = 55/120 (45%), Gaps = 14/120 (11%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHT-- 183
F +I GL LH ++ +RD+KPENIL+ + + DLG ++ + + +
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV 346
Query: 184 ---EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240
Y+A PE + E Y+F D WA GC+ YE + F + + + + +
Sbjct: 347 GTVGYMA------PEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 41/185 (22%), Positives = 71/185 (38%), Gaps = 35/185 (18%)
Query: 135 QIVNGLHHLHS--YKVFHRDIKPENILIRGD--LVVVGDLGSLQFIKSKGLHTEYIATRW 190
QI+ GL LH+ + HRD+K +NI I G V +GDLG ++ I T
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPE 195
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
+ +PE + E Y +D++A G E T + Q+ R T +
Sbjct: 196 FMAPE-MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----VTSGVKPA 249
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
F+K K+++ ++ + R + + +L+ A+
Sbjct: 250 -SFDKVAIPEV-----------------------KEIIEGCIRQNKDERYSIKDLLNHAF 285
Query: 311 FADLT 315
F + T
Sbjct: 286 FQEET 290
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 36/128 (28%), Positives = 51/128 (39%), Gaps = 25/128 (19%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL---VVVGDLGSLQFIKSKGLHT- 183
F L +IV + +H HRDIKP+NIL+ D + + D GS +++ G
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRS 220
Query: 184 -------EYIATRWYRSPECLLTEG------YYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+Y++ PE L G Y E D WA G YE F DS
Sbjct: 221 LVAVGTPDYLS------PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
Query: 231 EIDQLDRI 238
+ +I
Sbjct: 275 TAETYGKI 282
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 37/183 (20%), Positives = 64/183 (34%), Gaps = 44/183 (24%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG----SLQFIKSKGLHTE----- 184
Q++ G+ +LH + HRDIKPEN+L+ + + D G + + L+
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244
Y+A PE L +++ +D+W+ G V L + S+ Q
Sbjct: 173 YVA------PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------- 217
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
+ + P ID L+ ++L +P R T
Sbjct: 218 -----YSD--WKEK-----KTYLNPWKKIDSAP-------LALLHKILVENPSARITIPD 258
Query: 305 ILS 307
I
Sbjct: 259 IKK 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 54/275 (19%), Positives = 92/275 (33%), Gaps = 50/275 (18%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV---VGDLG-SLQFIKSKGLHTEYIATRW 190
Q+++G+ + HS ++ HRD+K EN L+ G + D G S + + + T
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPA 182
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
Y +PE LL + Y D+W+ G Y L F D E + R
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPRDYR------------- 228
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
K ++ S ++ I + L+S + DP R + +I + ++
Sbjct: 229 KTIQRILSVKYSIPDDIR-----------ISPECCHLISRIFVADPATRISIPEIKTHSW 277
Query: 311 FADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMDMSKFIQSDLN 370
F L L L + + P + + + Q+ I + N
Sbjct: 278 F--LKNLPADLMNESNT------------GSQFQEPEQPMQSLDTIMQIISEATIPAVRN 323
Query: 371 THQTKKTKS------DFFSQARTSKYRFDQSSSIV 399
D S+ D S IV
Sbjct: 324 RCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGEIV 358
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 33/121 (27%), Positives = 54/121 (44%), Gaps = 19/121 (15%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHT----- 183
F L ++V + +H HRDIKP+NIL+ + + + D G L+ ++ + +
Sbjct: 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238
Query: 184 --EYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
+YI+ PE L G Y E D W+ G YE L F +S ++ +
Sbjct: 239 TPDYIS------PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 238 I 238
I
Sbjct: 293 I 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEY 185
V + + L LHS +V HRDIK +NIL+ D V + D G Q + +
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ T ++ +PE ++T Y ++DIW+ G + E + P + ++ + L I GTP
Sbjct: 177 VGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP 234
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
L+ EK S+ F + ++ L+ D ++R +A+++
Sbjct: 235 ---ELQNPEKL-SAIF-----------------------RDFLNRCLEMDVEKRGSAKEL 267
Query: 306 LSCAYF---ADLTQLKQYLEQKQVMKK 329
L + L+ L + + K
Sbjct: 268 LQHQFLKIAKPLSSLTPLIAAAKEATK 294
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 34/123 (27%), Positives = 55/123 (44%), Gaps = 18/123 (14%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHT--- 183
F ++V L +HS HRD+KP+N+L+ + + D G+ + +G+
Sbjct: 169 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 184 -----EYIATRWYRSPECLLTEG---YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235
+YI+ PE L ++G YY E D W+ G YE L + F DS +
Sbjct: 229 AVGTPDYIS------PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 282
Query: 236 DRI 238
+I
Sbjct: 283 SKI 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 46/241 (19%), Positives = 90/241 (37%), Gaps = 41/241 (17%)
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVF---------HRDIKPENILIRGDL- 164
L +L + + + + + GL +LH+ HRD+ N+L++ D
Sbjct: 99 LXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158
Query: 165 VVVGDLG-SLQFIKSKGLHTEYIA--------TRWYRSPECL------LTEGYYSFELDI 209
V+ D G S++ ++ + T Y +PE L ++D+
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218
Query: 210 WAAGCVFYETLTR-NPLFPGDSEID-QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQ 267
+A G +++E R LFPG+S + Q+ +V P E ++ + KQ
Sbjct: 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE--------KQ 270
Query: 268 YPGGGIDVLVPQIHEKG-KKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQYLEQKQV 326
P + + K+ + + D + R TAQ + +L E+ +
Sbjct: 271 RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE-----RMAELMMIWERNKS 325
Query: 327 M 327
+
Sbjct: 326 V 326
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 5e-12
Identities = 38/119 (31%), Positives = 59/119 (49%), Gaps = 15/119 (12%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGL-HT- 183
F L +I L HLH + +RD+KPENI++ V + D G + I + HT
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181
Query: 184 ----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
EY+A PE L+ G ++ +D W+ G + Y+ LT P F G++ +D+I
Sbjct: 182 CGTIEYMA------PEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 45/194 (23%), Positives = 84/194 (43%), Gaps = 35/194 (18%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
+L +I+ GL +LHS K HRDIK N+L+ G+ V + D G + Q ++ ++
Sbjct: 123 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTFVG 181
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T ++ +PE ++ + Y + DIW+ G E P SE+ + ++ ++
Sbjct: 182 TPFWMAPE-VIKQSAYDSKADIWSLGITAIELARGEPPH---SELHPM-KVLFLIPKNNP 236
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
TL+ N++ K++ + L +P RPTA+++L
Sbjct: 237 PTLEG-------NYSKPLKEF-------------------VEACLNKEPSFRPTAKELLK 270
Query: 308 CAYFADLTQLKQYL 321
+ + YL
Sbjct: 271 HKFILRNAKKTSYL 284
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 37/119 (31%), Positives = 53/119 (44%), Gaps = 15/119 (12%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGL-HT- 183
F +I + L +LHS + +RD+KPENIL+ +V+ D G + I+ T
Sbjct: 140 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF 199
Query: 184 ----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
EY+A PE L + Y +D W G V YE L P F + + D I
Sbjct: 200 CGTPEYLA------PEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 17/114 (14%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILIRGDL-VVVGDLGSLQFIKSKGLHT---------E 184
+IV+ L +LH + HRD+KPENIL+ D+ + + D G+ + + + +
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
Y++ PE L + D+WA GC+ Y+ + P F +E +I
Sbjct: 198 YVS------PELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 17/115 (14%), Positives = 43/115 (37%), Gaps = 16/115 (13%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL------------VVVGDLGS---LQF 175
+++ + +H ++ H DIKP+N ++ + + DLG ++
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 176 IKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+ T T ++ E L + +++++D + Y L + +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 37/128 (28%), Positives = 57/128 (44%), Gaps = 17/128 (13%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFI 176
Q + TF +I+ GL LHS + +RD+K +NIL+ D + + D G + +
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169
Query: 177 KSKGL-HT-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+T +YIA PE LL + Y+ +D W+ G + YE L F G
Sbjct: 170 LGDAKTNTFCGTPDYIA------PEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
Query: 231 EIDQLDRI 238
E + I
Sbjct: 223 EEELFHSI 230
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 41/120 (34%), Positives = 57/120 (47%), Gaps = 20/120 (16%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHT-- 183
H F QIV +LHS + +RD+KPEN+LI +G + V D G F K T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT-DFG---FAKRVKGRTWT 197
Query: 184 -----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
E +A PE +L++G Y+ +D WA G + YE P F D I ++I
Sbjct: 198 LCGTPEALA------PEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 42/176 (23%), Positives = 68/176 (38%), Gaps = 32/176 (18%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIATRWY 191
QI+ GL +LH ++ HRDIK +N+LI ++ + D G S + + T Y
Sbjct: 130 QILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQY 189
Query: 192 RSPECLLTEGY-YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
+PE + Y DIW+ GC E T P F +L +
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-------- 235
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+K FK +P + + + K + + + DP +R A +L
Sbjct: 236 -----FK----VGMFKVHP-----EIPESMSAEAKAFILKCFEPDPDKRACANDLL 277
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 34/119 (28%), Positives = 48/119 (40%), Gaps = 15/119 (12%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGL-HT- 183
F +IV+ L +LHS V +RDIK EN+++ D + + D G + I T
Sbjct: 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 184 ----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
EY+A PE L Y +D W G V YE + F + I
Sbjct: 166 CGTPEYLA------PEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 31/181 (17%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEY 185
V ++ L +LH+ V HRDIK ++IL+ D V + D G Q K
Sbjct: 142 QIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ T ++ +PE +++ Y+ E+DIW+ G + E + P + DS + + R+ P
Sbjct: 202 VGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPP 259
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
LK K S + + ML DP+ R TAQ++
Sbjct: 260 ---KLKNSHKV-SPVL-----------------------RDFLERMLVRDPQERATAQEL 292
Query: 306 L 306
L
Sbjct: 293 L 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 41/207 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTE---- 184
+L +++ GL +LH HRD+K NIL+ D V + D G S +
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 185 -YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL- 242
++ T + +PE + Y F+ DIW+ G E T + + + +VL
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPM----KVLM 237
Query: 243 -----GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
P ET +K + F +K++S L+ DP+
Sbjct: 238 LTLQNDPPSLET-GVQDKEMLKKYGKSF-------------------RKMISLCLQKDPE 277
Query: 298 RRPTAQKILSCAYFADLTQLKQYLEQK 324
+RPTA ++L +F + K++L++K
Sbjct: 278 KRPTAAELLRHKFFQK-AKNKEFLQEK 303
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 46/211 (21%), Positives = 87/211 (41%), Gaps = 37/211 (17%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
++ +I+ GL HLH +KV HRDIK +N+L+ + V + D G S Q ++ G +I
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGRRNTFIG 191
Query: 188 TRWYRSPECLL----TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243
T ++ +PE + + Y F+ D+W+ G E P ++ + R ++
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMHPM-RALFLIP 247
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
A L KS ++ +F+ + + L + +RP +
Sbjct: 248 RNPAPRL------KSKKWSKKFQSF-------------------IESCLVKNHSQRPATE 282
Query: 304 KILSCAYFADLTQLKQYLEQKQVMKKLAKKN 334
+++ + D +Q Q + KK
Sbjct: 283 QLMKHPFIRDQPNERQVRIQLKDHIDRTKKK 313
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 34/128 (26%), Positives = 52/128 (40%), Gaps = 17/128 (13%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG--SLQF 175
QQ R H F +I GL L S + +RD+K +N+++ + + + D G
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172
Query: 176 IKSKGLHT-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
T +YIA PE + + Y +D WA G + YE L F G+
Sbjct: 173 WDGVTTKTFCGTPDYIA------PEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGED 225
Query: 231 EIDQLDRI 238
E + I
Sbjct: 226 EDELFQSI 233
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 17/128 (13%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFI 176
Q+S+R F +I++ L LH + +RD+K +N+L+ + + D G + I
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175
Query: 177 KSKGL-HT-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+ T +YIA PE L Y +D WA G + YE L + F ++
Sbjct: 176 CNGVTTATFCGTPDYIA------PEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
Query: 231 EIDQLDRI 238
E D + I
Sbjct: 229 EDDLFEAI 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 35/123 (28%), Positives = 54/123 (43%), Gaps = 16/123 (13%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHT-- 183
+ +IV L HLH + +RDIK ENIL+ + VV+ D G S +F+ +
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 184 -----EYIATRWYRSPECLLTEGY-YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
EY+A P+ + + +D W+ G + YE LT F D E +
Sbjct: 220 FCGTIEYMA------PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 238 IHQ 240
I +
Sbjct: 274 ISR 276
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 33/126 (26%), Positives = 55/126 (43%), Gaps = 17/126 (13%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFI 176
Q+ ++L H F +I L++LH + +RD+K +N+L+ + + + D G + +
Sbjct: 102 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161
Query: 177 KSKGL-HT-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+ T YIA PE L E Y F +D WA G + +E + F
Sbjct: 162 RPGDTTSTFCGTPNYIA------PEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 231 EIDQLD 236
D D
Sbjct: 215 SSDNPD 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 45/188 (23%), Positives = 70/188 (37%), Gaps = 49/188 (26%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
+L + GL +LH + HRDIK NIL+ G + D G + Q + I
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH-AKLADFGVAGQLTDTMAKRNTVIG 187
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH--QVL--- 242
T ++ +PE ++ E Y+ DIW+ G E P P IH + +
Sbjct: 188 TPFWMAPE-VIQEIGYNCVADIWSLGITAIEMAEGKP--P-------YADIHPMRAIFMI 237
Query: 243 ---GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299
P T +K E + S NF + + L P++R
Sbjct: 238 PTNPPP---TFRKPELW-SDNF-----------------------TDFVKQCLVKSPEQR 270
Query: 300 PTAQKILS 307
TA ++L
Sbjct: 271 ATATQLLQ 278
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 15/119 (12%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGL-HT- 183
F L ++ L HLHS + +RD+KPENIL+ + + + D G S + I + ++
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 184 ----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
EY+A PE + G ++ D W+ G + +E LT F G + + I
Sbjct: 187 CGTVEYMA------PEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 34/128 (26%), Positives = 52/128 (40%), Gaps = 17/128 (13%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG--SLQF 175
QQ R H F +I GL L S + +RD+K +N+++ + + + D G
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493
Query: 176 IKSKGLHT-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
T +YIA PE + + Y +D WA G + YE L F G+
Sbjct: 494 WDGVTTKTFCGTPDYIA------PEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGED 546
Query: 231 EIDQLDRI 238
E + I
Sbjct: 547 EDELFQSI 554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 41/211 (19%), Positives = 79/211 (37%), Gaps = 57/211 (27%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +LP+ ++ + Y QI G+ +L S + HRD+ N+L+ + V +GD G
Sbjct: 112 LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
+ I++ Y WY +PECL+ + + D+W+ G +E LT
Sbjct: 172 LTKAIETD--KEYYTVKDDRDSPVFWY-APECLM-QSKFYIASDVWSFGVTLHELLTY-- 225
Query: 225 LFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPG-GGIDVLVPQIHEK 283
DS+ + +++G + ++ ++
Sbjct: 226 ---CDSDSSPMALFLKMIGPT----------------------HGQMTVTRLV--NTLKE 258
Query: 284 GK-------------KLMSEMLKYDPKRRPT 301
GK +LM + ++ P R +
Sbjct: 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 33/126 (26%), Positives = 55/126 (43%), Gaps = 17/126 (13%)
Query: 121 QQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLG-SLQFI 176
Q+ ++L H F +I L++LH + +RD+K +N+L+ + + + D G + +
Sbjct: 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204
Query: 177 KSKGL-HT-----EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+ T YIA PE L E Y F +D WA G + +E + F
Sbjct: 205 RPGDTTSTFCGTPNYIA------PEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVG 257
Query: 231 EIDQLD 236
D D
Sbjct: 258 SSDNPD 263
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 29/132 (21%), Positives = 49/132 (37%), Gaps = 19/132 (14%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L + + + V I +G+ +LHS + HRD+ N L+R + V V D G
Sbjct: 94 LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFG 153
Query: 172 -------------SLQFIKSKGLHTEYIATRWYR--SPECLLTEGYYSFELDIWAAGCVF 216
L+ +K Y +PE + Y ++D+++ G V
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVL 212
Query: 217 YETLTRNPLFPG 228
E + R P
Sbjct: 213 CEIIGRVNADPD 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 20/113 (17%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHT-------EY 185
++ L +LHS + +RD+KPENIL+ G + + D G F K T +Y
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKIT-DFG---FAKYVPDVTYTLCGTPDY 169
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
IA PE + T+ Y+ +D W+ G + YE L F + + ++I
Sbjct: 170 IA------PEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 45/233 (19%), Positives = 81/233 (34%), Gaps = 64/233 (27%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L + +R+ H + Y QI G+ +L + + HRD+ NIL+ + V +GD G
Sbjct: 131 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224
+ + Y WY +PE L E +S D+W+ G V YE T
Sbjct: 191 LTKVLPQD--KEYYKVKEPGESPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFT--- 243
Query: 225 LFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKG 284
+ S+ + + + + L+ + +
Sbjct: 244 -YIEKSKSPPAEFMRMIGNDK----------------------QGQMIVFHLIELL-KNN 279
Query: 285 K-------------KLMSEMLKYDPKRRPTAQKILSCAYFADL-TQLKQYLEQ 323
+M+E + +RP+ F DL ++ Q +Q
Sbjct: 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPS---------FRDLALRVDQIRDQ 323
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L + +R+ H + Y QI G+ +L + + HRD+ NIL+ + V +GD G
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ + + WY +PE L E +S D+W+ G V YE T
Sbjct: 160 LTKVLPQD--KEFFKVKEPGESPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFT 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 42/191 (21%), Positives = 76/191 (39%), Gaps = 50/191 (26%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIAT 188
V Q++ L+ LHS ++ HRD+K N+L+ + + + D G S + +K+ +I T
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 189 RWYRSPE----CLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH--QVL 242
++ +PE + + Y ++ DIW+ G E P P ++ +VL
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP--P-------HHELNPMRVL 231
Query: 243 ------GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDP 296
P TL K+ S F + + L +P
Sbjct: 232 LKIAKSDPP---TLLTPSKW-SVEF-----------------------RDFLKIALDKNP 264
Query: 297 KRRPTAQKILS 307
+ RP+A ++L
Sbjct: 265 ETRPSAAQLLE 275
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 52/234 (22%), Positives = 83/234 (35%), Gaps = 65/234 (27%)
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSL 173
L +LP+ S L QI G+ +LH+ HRD+ N+L+ D +V +GD G
Sbjct: 122 LRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 174 QFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226
+ + H Y WY +PECL E + + D+W+ G YE LT
Sbjct: 182 KAVPEG--HEYYRVREDGDSPVFWY-APECLK-EYKFYYASDVWSFGVTLYELLTH---- 233
Query: 227 PGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPG-GGIDVLVPQIHEKGK 285
DS + +++G + + ++ E+G+
Sbjct: 234 -CDSSQSPPTKFLELIGIA----------------------QGQMTVLRLT--ELLERGE 268
Query: 286 -------------KLMSEMLKYDPKRRPTAQKILSCAYFADL-TQLKQYLEQKQ 325
LM + + RPT F +L LK E+ Q
Sbjct: 269 RLPRPDKCPAEVYHLMKNCWETEASFRPT---------FENLIPILKTVHEKYQ 313
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 43/214 (20%), Positives = 88/214 (41%), Gaps = 43/214 (20%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLG-SLQFIKSKGLHTEYIA 187
V + + GL +LHS+ + HRD+K NIL+ G V +GD G + ++
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAP----ANSFVG 212
Query: 188 TRWYRSPE--CLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
T ++ +PE + EG Y ++D+W+ G E R P ++ + +
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAM-SALYHIAQN 268
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
++ L +S +++ F+ + + L+ P+ RPT++ +
Sbjct: 269 ESPAL------QSGHWSEYFRNF-------------------VDSCLQKIPQDRPTSEVL 303
Query: 306 LSCAYFA---DLTQLKQYLEQ-KQVMKKLAKKNY 335
L + T + +++ K +++L Y
Sbjct: 304 LKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 337
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 39/194 (20%), Positives = 74/194 (38%), Gaps = 43/194 (22%)
Query: 134 YQIVNGLHHLHSYK---VFHRDIKPENILIRGDLVV--VGDLGSLQFIKSKGLHTEYIAT 188
Q G+ +LHS + + HRD+KP N+L+ V + D G+ I++ T +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGS 166
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
+ +PE YS + D+++ G + +E +TR F RI +
Sbjct: 167 AAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH--NGT 221
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + + + + LM+ DP +RP+ ++I+
Sbjct: 222 RPP-------------------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256
Query: 308 CAYFADLTQLKQYL 321
+T L +Y
Sbjct: 257 -----IMTHLMRYF 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 35/117 (29%), Positives = 54/117 (46%), Gaps = 14/117 (11%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L FL + RL + +LY QI G+ +L S + HRD+ NIL+ + V + D G
Sbjct: 113 LRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ + Y+ WY +PE L + +S + D+W+ G V YE T
Sbjct: 173 LAKLLPLD--KDYYVVREPGQSPIFWY-APESLS-DNIFSRQSDVWSFGVVLYELFT 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 30/184 (16%), Positives = 66/184 (35%), Gaps = 42/184 (22%)
Query: 132 VLYQIVNGLHHLHSYK--VFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIA 187
+ Y + G+++LH+ + HR++K N+L+ V V D G S +
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
T + +PE L E + + D+++ G + +E T + ++ + V
Sbjct: 202 TPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAVG----- 252
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI----HEKGKKLMSEMLKYDPKRRPTAQ 303
F+ + +I + + ++ +P +RP+
Sbjct: 253 -----FKCKR--------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFA 287
Query: 304 KILS 307
I+
Sbjct: 288 TIMD 291
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 33/114 (28%), Positives = 49/114 (42%), Gaps = 4/114 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYK-VFHRDIKPENILIRGD-LVVVGDLG-SLQFIKSKGLHTE 184
F +IV+ L +LHS K V +RD+K EN+++ D + + D G + IK
Sbjct: 249 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRI 238
+ T Y +PE L Y +D W G V YE + F + I
Sbjct: 309 FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 28/180 (15%), Positives = 58/180 (32%), Gaps = 40/180 (22%)
Query: 134 YQIVNGLHHLHSYK--VFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATR 189
+ G+ LH+ + + + +++I D+ + F ++
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA----PA 173
Query: 190 WYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
W +PE L + D+W+ + +E +TR F + ++ +V
Sbjct: 174 WV-APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD---LSNMEIGMKVA----- 224
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
E + + + P I KLM + DP +RP I+
Sbjct: 225 -----LEGLRPT----------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 50/246 (20%), Positives = 90/246 (36%), Gaps = 25/246 (10%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYI 59
+K A + E+ IL I HLNV+ L + + ++ + NL Y+
Sbjct: 60 LKEGATHSEHRALMSELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEFCKFGNLSTYL 118
Query: 60 RTTDNISEKRAKEILYQVKA---ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLT 116
R+ N + + + D +L
Sbjct: 119 RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178
Query: 117 TFLPQQSKRLYHTTFVL----YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
P+ + + T L +Q+ G+ L S K HRD+ NIL+ VV + D G
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 238
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTR 222
+ I +Y+ +W +PE + + Y+ + D+W+ G + +E +L
Sbjct: 239 LARDIYKDP---DYVRKGDARLPLKWM-APETIF-DRVYTIQSDVWSFGVLLWEIFSLGA 293
Query: 223 NPLFPG 228
+P +PG
Sbjct: 294 SP-YPG 298
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 1e-08
Identities = 30/175 (17%), Positives = 56/175 (32%), Gaps = 28/175 (16%)
Query: 132 VLYQIVNGLHHLH-SYKVFHRDIKPENILIRGDL---VVVGDLGSLQFIKSKGLHTEYIA 187
+L+Q+ L S + HRD+ N+L++ + G I S GL I
Sbjct: 166 ILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII- 224
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
Y+ VF + LF GD D I++++
Sbjct: 225 --------------DYTLSRLERDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENN 268
Query: 248 ETLKKFEKYKS-------SNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYD 295
++ Y + ++ + + + QI K ++ ML +
Sbjct: 269 NRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 33/208 (15%), Positives = 69/208 (33%), Gaps = 48/208 (23%)
Query: 115 LTTFLPQQSKRL--YHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILI-----RGDLV 165
L L ++ + ++ I G+ ++ + + HRD++ NI + +
Sbjct: 108 LYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167
Query: 166 V-VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEG-YYSFELDIWAAGCVFYETLTRN 223
V D G L + + + + +PE + E Y+ + D ++ + Y LT
Sbjct: 168 AKVADFG-LSQQSVHSV-SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
Query: 224 PLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI--- 280
F S ++ I+ + E + P I
Sbjct: 226 GPFDEYSYG-KIKFINMIR----------EEGLR--------------------PTIPED 254
Query: 281 -HEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ + ++ DPK+RP I+
Sbjct: 255 CPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 45/245 (18%), Positives = 89/245 (36%), Gaps = 67/245 (27%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCL---CETYVNRSTRQ--VTLVFPLMEL-N 54
+K L E ++L+++ +H +V+ L C ++ + L+ + +
Sbjct: 61 LKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGAC-------SQDGPLLLIVEYAKYGS 112
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFL-LLVFGKSRNLGTLIV 113
L ++R E R Y + ++ + L L+ F
Sbjct: 113 LRGFLR------ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA---------- 156
Query: 114 GLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGS 172
+QI G+ +L K+ HRD+ NIL+ + + D G
Sbjct: 157 --------------------WQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 173 LQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRN 223
+ + + Y+ +W + E L + Y+ + D+W+ G + +E TL N
Sbjct: 197 SRDVYEED---SYVKRSQGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 224 PLFPG 228
P +PG
Sbjct: 252 P-YPG 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 67/232 (28%)
Query: 14 LKEISILRKIPDHLNVLCL---CETYVNRSTRQVTLVFPLMEL----NLEEYIRTTDNIS 66
+ E+ ++ ++ H N++ L C + + + E +L Y+R
Sbjct: 96 MSELKMMTQLGSHENIVNLLGAC------TLSGPIYL--IFEYCCYGDLLNYLR------ 141
Query: 67 EKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRL 126
KR K +++ N+ ++ LL F
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA----------------------- 178
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEY 185
YQ+ G+ L HRD+ N+L+ VV + D G + I S Y
Sbjct: 179 -------YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS---NY 228
Query: 186 IAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
+ +W +PE L EG Y+ + D+W+ G + +E +L NP +PG
Sbjct: 229 VVRGNARLPVKWM-APESLF-EGIYTIKSDVWSYGILLWEIFSLGVNP-YPG 277
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 45/241 (18%), Positives = 86/241 (35%), Gaps = 70/241 (29%)
Query: 115 LTTFLPQQSKRLYHTTFVL----YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGD 169
L +L ++ R + VL QI + + +L HR++ N L+ + +V V D
Sbjct: 303 LLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVAD 361
Query: 170 LGSLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT- 221
G + + Y A +W PE L +S + D+WA G + +E T
Sbjct: 362 FGLSRLMTGD----TYTAHAGAKFPIKWTA-PES-LAYNKFSIKSDVWAFGVLLWEIATY 415
Query: 222 -RNPLFPGDSEIDQLDRIHQ--VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP 278
+P +PG + + + + P +
Sbjct: 416 GMSP-YPGIDLSQVYELLEKDYRMERP----------------------------EGCPE 446
Query: 279 QIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL-TQLKQYLE----QKQVMKKLAKK 333
+++E LM +++P RP+ FA++ + + +V K+L K+
Sbjct: 447 KVYE----LMRACWQWNPSDRPS---------FAEIHQAFETMFQESSISDEVEKELGKR 493
Query: 334 N 334
Sbjct: 494 G 494
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 42/190 (22%), Positives = 64/190 (33%), Gaps = 51/190 (26%)
Query: 134 YQIVNGLHHLHSYK---VFHRDIKPENILI--------RGDLVV-VGDLGSLQFIKSKGL 181
QI G+++LH + HRD+K NILI + ++ + D G L +
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG-LAREWHRTT 170
Query: 182 HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
+ +PE + +S D+W+ G + +E LT F G ID L + V
Sbjct: 171 KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG---IDGLAVAYGV 226
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI----HEKGKKLMSEMLKYDPK 297
+ I E KLM + DP
Sbjct: 227 A----------------------MNKLA--------LPIPSTCPEPFAKLMEDCWNPDPH 256
Query: 298 RRPTAQKILS 307
RP+ IL
Sbjct: 257 SRPSFTNILD 266
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 32/138 (23%), Positives = 62/138 (44%), Gaps = 19/138 (13%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L K L + + Y + G+ L S++ HRD+ N L+ DL V V D G
Sbjct: 90 LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG 149
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--R 222
+++ +Y+++ +W +PE YS + D+WA G + +E + +
Sbjct: 150 MTRYVLD----DQYVSSVGTKFPVKWS-APEVFH-YFKYSSKSDVWAFGILMWEVFSLGK 203
Query: 223 NPLFPGDSEIDQLDRIHQ 240
P + + + + ++ Q
Sbjct: 204 MP-YDLYTNSEVVLKVSQ 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 31/138 (22%), Positives = 58/138 (42%), Gaps = 19/138 (13%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L+ +L Q T + + G+ +L V HRD+ N L+ + V+ V D G
Sbjct: 90 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 149
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--R 222
+F+ +Y ++ +W SPE YS + D+W+ G + +E + +
Sbjct: 150 MTRFVLD----DQYTSSTGTKFPVKWA-SPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGK 203
Query: 223 NPLFPGDSEIDQLDRIHQ 240
P + S + ++ I
Sbjct: 204 IP-YENRSNSEVVEDIST 220
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 52/249 (20%), Positives = 92/249 (36%), Gaps = 67/249 (26%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCL---CETYVNRSTRQVTLVFPLMEL-NLE 56
+K A + E+ IL I HLNV+ L C + + ++ + NL
Sbjct: 65 LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----KPGGPLMVIVEFCKFGNLS 120
Query: 57 EYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLT 116
Y+R KR + + Y+V + L L L+ +
Sbjct: 121 TYLR------SKRNEFVPYKVAPEDLYKDF------LTLE-HLICYS------------- 154
Query: 117 TFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQF 175
+Q+ G+ L S K HRD+ NIL+ VV + D G +
Sbjct: 155 -----------------FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 176 IKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLF 226
I +Y+ +W +PE + + Y+ + D+W+ G + +E +L +P +
Sbjct: 198 IYKDP---DYVRKGDARLPLKWM-APETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-Y 251
Query: 227 PGDSEIDQL 235
PG ++
Sbjct: 252 PGVKIDEEF 260
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 16/105 (15%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT---- 188
YQ+ G+ L S HRD+ NIL+ + + D G + IK+ Y+
Sbjct: 152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---NYVVKGNAR 208
Query: 189 ---RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
+W +PE + Y+FE D+W+ G +E +L +P +PG
Sbjct: 209 LPVKWM-APESIF-NCVYTFESDVWSYGIFLWELFSLGSSP-YPG 250
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 32/138 (23%), Positives = 57/138 (41%), Gaps = 19/138 (13%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L + R + + + +L S + HRD+ N L+ VV V D G
Sbjct: 106 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--R 222
+++ EY ++ RW PE L+ +S + DIWA G + +E + +
Sbjct: 166 LSRYVLD----DEYTSSVGSKFPVRWS-PPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGK 219
Query: 223 NPLFPGDSEIDQLDRIHQ 240
P + + + + I Q
Sbjct: 220 MP-YERFTNSETAEHIAQ 236
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 43/211 (20%), Positives = 77/211 (36%), Gaps = 61/211 (28%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +FL + L + + YQ+ L +L S + HRDI N+L+ + V +GD G
Sbjct: 102 LRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--R 222
++++ + Y +W +PE + ++ D+W G +E L
Sbjct: 162 LSRYMED----STYYKASKGKLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEILMHGV 215
Query: 223 NPLFPGDSE---IDQLD---RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVL 276
P F G I +++ R+ P
Sbjct: 216 KP-FQGVKNNDVIGRIENGERLPMPPNCP------------------------------- 243
Query: 277 VPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
P ++ LM++ YDP RRP ++ +
Sbjct: 244 -PTLYS----LMTKCWAYDPSRRPRFTELKA 269
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 15/135 (11%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +FL + + V L I +G+ +L HRD+ NILI +LV V D G
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 172 SLQFIKSKGLHTEYIAT------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RN 223
+ ++ Y RW SPE + ++ D+W+ G V +E ++
Sbjct: 193 LGRVLEDDP-EAAYTTRGGKIPIRWT-SPEA-IAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 224 PLFPGDSEIDQLDRI 238
P + S D + +
Sbjct: 250 P-YWEMSNQDVIKAV 263
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 47/244 (19%), Positives = 87/244 (35%), Gaps = 72/244 (29%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCL---CETYVNRSTRQ--VTLVFPLMEL-N 54
+K + + E+ +++ I H N++ L C T+ + ++ N
Sbjct: 75 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-------TQDGPLYVIVEYASKGN 127
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVG 114
L EY+R +R + Y + L+
Sbjct: 128 LREYLR------ARRPPGMEYSYDINRVP------EEQMTFK-DLVSCT----------- 163
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSL 173
YQ+ G+ +L S K HRD+ N+L+ + V+ + D G
Sbjct: 164 -------------------YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 174 QFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNP 224
+ I + Y T +W +PE L + Y+ + D+W+ G + +E TL +P
Sbjct: 205 RDINNID---YYKKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 225 LFPG 228
+PG
Sbjct: 260 -YPG 262
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT--- 188
QI +G+ ++ HRD++ NIL+ +LV V D G + I+ EY A
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN----EYTARQGA 424
Query: 189 ----RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRI 238
+W +PE G ++ + D+W+ G + E T R P +PG + LD++
Sbjct: 425 KFPIKWT-APEA-ALYGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQV 477
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 17/116 (14%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT--- 188
QI +G+ ++ HRD++ NIL+ +LV V D G + I+ EY A
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGA 341
Query: 189 ----RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRI 238
+W +PE G ++ + D+W+ G + E T R P +PG + LD++
Sbjct: 342 KFPIKWT-APEA-ALYGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQV 394
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 33/135 (24%), Positives = 56/135 (41%), Gaps = 15/135 (11%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L FL ++ V L I G+ +L + HRD+ NIL+ +LV V D G
Sbjct: 133 LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 172 SLQFIKSKGLHTEYIAT------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RN 223
+ ++ Y + RW +PE + ++ D+W+ G V +E +T
Sbjct: 193 LSRVLEDD-PEATYTTSGGKIPIRWT-APEAIS-YRKFTSASDVWSFGIVMWEVMTYGER 249
Query: 224 PLFPGDSEIDQLDRI 238
P + S + + I
Sbjct: 250 P-YWELSNHEVMKAI 263
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 44/237 (18%), Positives = 80/237 (33%), Gaps = 66/237 (27%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCL---CETYVNRSTRQ--VTLVFPLMEL-N 54
+K + +E +++ + D+ N++ L C + L+F M +
Sbjct: 85 LKEEASADMQADFQREAALMAEF-DNPNIVKLLGVC-------AVGKPMCLLFEYMAYGD 136
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVG 114
L E++R + + T A L +
Sbjct: 137 LNEFLR------SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC------------ 178
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSL 173
+ Q+ G+ +L K HRD+ N L+ ++VV + D G L
Sbjct: 179 -----------------IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG-L 220
Query: 174 QFIKSKGLHTE--YIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
S+ +++ Y A RW PE + Y+ E D+WA G V +E +
Sbjct: 221 ----SRNIYSADYYKADGNDAIPIRWM-PPESIF-YNRYTTESDVWAYGVVLWEIFS 271
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 35/139 (25%), Positives = 58/139 (41%), Gaps = 20/139 (14%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
TFL + RL T + + G+ +L S HRD+ N L+ V+ + D G
Sbjct: 199 FLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG 258
Query: 172 SLQFIKSKGLHTEYIAT--------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-- 221
+ Y A+ +W +PE L G YS E D+W+ G + +ET +
Sbjct: 259 MSREEAD----GVYAASGGLRQVPVKWT-APEALNY-GRYSSESDVWSFGILLWETFSLG 312
Query: 222 RNPLFPGDSEIDQLDRIHQ 240
+P +P S + + +
Sbjct: 313 ASP-YPNLSNQQTREFVEK 330
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 47/244 (19%), Positives = 88/244 (36%), Gaps = 72/244 (29%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCL---CETYVNRSTRQ--VTLVFPLMEL-N 54
+K + + E+ +++ I H N++ L C T+ + ++ N
Sbjct: 121 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-------TQDGPLYVIVEYASKGN 173
Query: 55 LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVG 114
L EY+R +R + Y + L+
Sbjct: 174 LREYLR------ARRPPGMEYSYDINRVP------EEQMTFKDLV--------------- 206
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSL 173
+ YQ+ G+ +L S K HRD+ N+L+ + V+ + D G
Sbjct: 207 ---------------SCT-YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 174 QFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNP 224
+ I + Y T +W +PE L + Y+ + D+W+ G + +E TL +P
Sbjct: 251 RDINNID---YYKKTTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 225 LFPG 228
+PG
Sbjct: 306 -YPG 308
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 16/118 (13%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L + L T VLY QI + +L S HRDI NIL+ V +GD G
Sbjct: 99 LGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
++I+ +Y +W SPE + ++ D+W +E L+
Sbjct: 159 LSRYIED----EDYYKASVTRLPIKWM-SPESINF-RRFTTASDVWMFAVCMWEILSF 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 27/118 (22%), Positives = 51/118 (43%), Gaps = 14/118 (11%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L FL + + + + L+Q+ G+ +L HRD+ N+L+ + D G
Sbjct: 96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
+ + + + Y A +WY +PEC+ +S D+W+ G +E L+
Sbjct: 156 LSKALGAD--DSYYTARSAGKWPLKWY-APECINF-RKFSSRSDVWSYGVTMWEALSY 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 43/271 (15%), Positives = 88/271 (32%), Gaps = 69/271 (25%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L ++ + + + QI G+++L ++ HRD+ N+L++ V + D G
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 172 SLQFIKSKGLHTEYIAT------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RN 223
+ + ++ EY A +W + E +L Y+ + D+W+ G +E +T
Sbjct: 163 LAKLLGAE--EKEYHAEGGKVPIKWM-ALESILH-RIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 224 PLFPG--DSE-IDQLD---RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLV 277
P + G SE L+ R+ Q
Sbjct: 219 P-YDGIPASEISSILEKGERLPQPPICT-------------------------------- 245
Query: 278 PQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL-TQLKQYLEQKQVMKKLAKKNYM 336
++ +M + D RP F +L + + Q + M
Sbjct: 246 IDVYM----IMVKCWMIDADSRPK---------FRELIIEFSKMARDPQRYLVIQGDERM 292
Query: 337 AGGMQKTSHP-THLLANTKSSHQMDMSKFIQ 366
S+ L+ +D +++
Sbjct: 293 HLPSPTDSNFYRALMDEEDMDDVVDADEYLI 323
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 26/117 (22%), Positives = 51/117 (43%), Gaps = 11/117 (9%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L F+ ++ + Q+ G+ +L S K HRD+ N ++ V V D G
Sbjct: 114 LRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 173
Query: 172 SLQFIKSKGLHTEYIAT------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
+ + K ++ + T +W + E L ++ + D+W+ G + +E +TR
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQ-TQKFTTKSDVWSFGVLLWELMTR 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 28/120 (23%), Positives = 53/120 (44%), Gaps = 19/120 (15%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L ++ + + + QI G+++L ++ HRD+ N+L++ V + D G
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 172 SLQFIKSKGLHT---EYIAT------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
L +K L EY A +W + E +L Y+ + D+W+ G +E +T
Sbjct: 163 -L----AKLLGAEEKEYHAEGGKVPIKWM-ALESILH-RIYTHQSDVWSYGVTVWELMTF 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 49/245 (20%), Positives = 89/245 (36%), Gaps = 74/245 (30%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCL---CETYVNRSTRQVTLVFPLMEL---- 53
+K+ + + E+ +++ I H N++ L C + V ++E
Sbjct: 109 LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC------TQDGPLYV--IVEYASKG 160
Query: 54 NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIV 113
NL EY++ +R + Y ++ L L+
Sbjct: 161 NLREYLQ------ARRPPGLEYSYNPSHNP------EEQLSSK-DLVSCA---------- 197
Query: 114 GLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGS 172
YQ+ G+ +L S K HRD+ N+L+ D V+ + D G
Sbjct: 198 --------------------YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
Query: 173 LQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRN 223
+ I Y T +W +PE L + Y+ + D+W+ G + +E TL +
Sbjct: 238 ARDIHHID---YYKKTTNGRLPVKWM-APEALF-DRIYTHQSDVWSFGVLLWEIFTLGGS 292
Query: 224 PLFPG 228
P +PG
Sbjct: 293 P-YPG 296
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 49/231 (21%), Positives = 84/231 (36%), Gaps = 71/231 (30%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +FL + L + + YQ+ L +L S + HRDI N+L+ + V +GD G
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--R 222
++++ + Y +W +PE + ++ D+W G +E L
Sbjct: 537 LSRYMED----STYYKASKGKLPIKWM-APES-INFRRFTSASDVWMFGVCMWEILMHGV 590
Query: 223 NPLFPGDS------EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVL 276
P F G I+ +R+ P
Sbjct: 591 KP-FQGVKNNDVIGRIENGERLPMPPNCP------------------------------- 618
Query: 277 VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL-TQLKQYLEQKQV 326
P ++ LM++ YDP RRP F +L QL LE++++
Sbjct: 619 -PTLYS----LMTKCWAYDPSRRPR---------FTELKAQLSTILEEEKL 655
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 11/117 (9%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L F+ ++ + Q+ G+ L S K HRD+ N ++ V V D G
Sbjct: 178 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 172 SLQFIKSKGLHTEYIAT------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
+ + K + + T +W + E L ++ + D+W+ G + +E +TR
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQ-TQKFTTKSDVWSFGVLLWELMTR 292
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 16/105 (15%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT---- 188
Q+ G+ L S HRD+ N+L+ V +GD G + I + YI
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIVKGNAR 227
Query: 189 ---RWYRSPECLLTEGYYSFELDIWAAGCVFYE--TLTRNPLFPG 228
+W +PE + + Y+ + D+W+ G + +E +L NP +PG
Sbjct: 228 LPVKWM-APESIF-DCVYTVQSDVWSYGILLWEIFSLGLNP-YPG 269
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 32/138 (23%), Positives = 54/138 (39%), Gaps = 17/138 (12%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L TFL + V L + G+ +L HRD+ N+L+ +LV V D G
Sbjct: 137 LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--R 222
+ ++ T RW +PE + +S D+W+ G V +E L
Sbjct: 197 LSRVLEDD--PDAAYTTTGGKIPIRWT-APEAIA-FRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 223 NPLFPGDSEIDQLDRIHQ 240
P + + D + + +
Sbjct: 253 RP-YWNMTNRDVISSVEE 269
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 77/541 (14%), Positives = 148/541 (27%), Gaps = 176/541 (32%)
Query: 6 PDFA-EVANLKEISILRKIPDHLN-VLCLCETYVNRSTRQV-TLVFPLMELN---LEEYI 59
D + + +EI + D ++ L L T +++ V V ++ +N L I
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98
Query: 60 RTTDNISEKRAKEILYQVKA---ANETAAHYRVG-----WDLK--L------PFLLLV-- 101
+T + + Q N+ A Y V L+ L +L+
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 102 --FGKSRNLGTLIVGLTTFLPQQSK----------RLYHTTFVLYQIVNGLHHLHSYKVF 149
GK+ + + + Q K + ++ + +++ L +
Sbjct: 159 LGSGKT----WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 150 HRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELD- 208
R NI +R + + + ++ Y CLL L
Sbjct: 215 SRSDHSSNIKLRIHSI-------------QAELRRLLKSKPY--ENCLLV-------LLN 252
Query: 209 -----IWAA---GCVFYETL--TRNPLFPGDSEIDQLDR--------IHQVLGTPKAETL 250
W A C + L TR D L H + E
Sbjct: 253 VQNAKAWNAFNLSC---KILLTTRFK-----QVTDFLSAATTTHISLDHHSMTLTPDEVK 304
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR---------RPT 301
KY + + P V + + +++E ++
Sbjct: 305 SLLLKY----LDCRPQDLP-----REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 302 AQKILSC----------AYFADL----------TQL-------KQYLEQKQVMKKLAKKN 334
I S F L T L + V+ KL K +
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 335 YMAGGMQKTSHPTHLLANTKSSHQMDMSKFIQSDLNTHQT--------KKTKSDFFSQAR 386
+ ++++ + +++ ++++ H++ K SD
Sbjct: 416 LVEKQPKESTISIPSI-------YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 387 TSKYRFDQSSSIVLHPKNPPNKSKHRFDQSSSTVLHSKNPPNRSKLDRKI-----FLREK 441
+Y + S I H L + P R L R + FL +K
Sbjct: 469 LDQYFY---SHIGHH-------------------LKNIEHPERMTLFRMVFLDFRFLEQK 506
Query: 442 I 442
I
Sbjct: 507 I 507
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 34/140 (24%), Positives = 60/140 (42%), Gaps = 22/140 (15%)
Query: 115 LTTFLPQQSKRLYHTTFVL----YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGD 169
L FL + + T L QI G+ + HRD++ NIL+ L + D
Sbjct: 94 LVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD 152
Query: 170 LGSLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT- 221
G + I+ EY A +W +PE + G ++ + D+W+ G + E +T
Sbjct: 153 FGLARLIED----NEYTAREGAKFPIKWT-APEAIN-YGTFTIKSDVWSFGILLTEIVTH 206
Query: 222 -RNPLFPGDSEIDQLDRIHQ 240
R P +PG + + + + +
Sbjct: 207 GRIP-YPGMTNPEVIQNLER 225
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 42/229 (18%), Positives = 84/229 (36%), Gaps = 62/229 (27%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L QQ++ + + ++Q+ G+ +L HRD+ N+L+ + D G
Sbjct: 104 LNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--R 222
+ +++ Y A +WY +PEC+ +S + D+W+ G + +E + +
Sbjct: 163 LSKALRAD--ENYYKAQTHGKWPVKWY-APECINY-YKFSSKSDVWSFGVLMWEAFSYGQ 218
Query: 223 NPLFPG--DSE-IDQLD---RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVL 276
P + G SE L+ R+ G P
Sbjct: 219 KP-YRGMKGSEVTAMLEKGERMGCPAGCP------------------------------- 246
Query: 277 VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC--AYFADLTQLKQYLEQ 323
++++ LM+ YD + RP + Y+ D+ +
Sbjct: 247 -REMYD----LMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHH 290
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 29/118 (24%), Positives = 46/118 (38%), Gaps = 14/118 (11%)
Query: 115 LTTFLPQQSKRLYHTTFVLY--QIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L L + T Y Q+ G+ +L S + HRD+ N+L+ +V +GD G
Sbjct: 107 LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
++ + Y+ W +PE L T +S D W G +E T
Sbjct: 167 LMRALPQN--DDHYVMQEHRKVPFAWC-APESLKT-RTFSHASDTWMFGVTLWEMFTY 220
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 15/98 (15%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFI--------KSKGLHTE 184
+I +G+ +L++ K HRD+ N ++ D V +GD G + I KGL
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL--- 201
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
+ RW SPE L +G ++ D+W+ G V +E T
Sbjct: 202 -LPVRWM-SPESLK-DGVFTTYSDVWSFGVVLWEIATL 236
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 47/243 (19%), Positives = 87/243 (35%), Gaps = 74/243 (30%)
Query: 115 LTTFLPQQSKRLYHTTFVL----YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGD 169
L +L ++ R + VL QI + + +L HRD+ N L+ + +V V D
Sbjct: 96 LLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 170 LGSLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT- 221
G + + Y A +W +PE L +S + D+WA G + +E T
Sbjct: 155 FGLSRLMTGD----TYTAHAGAKFPIKWT-APESLA-YNKFSIKSDVWAFGVLLWEIATY 208
Query: 222 -RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEK----YKSSNFTYQFKQYPGGGIDVL 276
+P +P G ++ + EK +
Sbjct: 209 GMSP-YP---------------GIDLSQVYELLEKDYRMERPEGCP-------------- 238
Query: 277 VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL-TQLKQYLE----QKQVMKKLA 331
+++E LM +++P RP+ FA++ + + +V K+L
Sbjct: 239 -EKVYE----LMRACWQWNPSDRPS---------FAEIHQAFETMFQESSISDEVEKELG 284
Query: 332 KKN 334
K+
Sbjct: 285 KRG 287
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 31/118 (26%), Positives = 54/118 (45%), Gaps = 17/118 (14%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT--- 188
QI G+ + HRD++ NIL+ LV + D G + I+ EY A
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGA 345
Query: 189 ----RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPGDSEIDQLDRIHQ 240
+W +PE + G ++ + D+W+ G + E +T R P +PG S + + + +
Sbjct: 346 KFPIKWT-APEA-INFGSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALER 400
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 20/120 (16%), Positives = 41/120 (34%), Gaps = 18/120 (15%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGD--------L 164
L T+L + + + Q+ +H L + H ++ +NIL+ +
Sbjct: 99 LDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158
Query: 165 VV-VGDLGSLQFIKSKGLHTEY--IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ + D G + + W PEC+ + D W+ G +E +
Sbjct: 159 FIKLSDPGISITVLP----KDILQERIPWV-PPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 24/125 (19%)
Query: 115 LTTFL-----PQQSKRLYHTTFVL--YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV- 166
L FL + L T V I G+ +L S HRD+ N ++ D+ V
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177
Query: 167 VGDLGSLQFIKSKGLHTE--YIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFY 217
V D G L S+ +++ Y +W + E L + Y+ D+WA G +
Sbjct: 178 VADFG-L----SRKIYSGDYYRQGCASKLPVKWL-ALESLA-DNLYTVHSDVWAFGVTMW 230
Query: 218 ETLTR 222
E +TR
Sbjct: 231 EIMTR 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 15/97 (15%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFI--------KSKGLHTE 184
Q+ G+ +L HRD+ N L+ LVV +GD G + I + +
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM--- 221
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ RW PE +L ++ E D+W+ G V +E T
Sbjct: 222 -LPIRWM-PPESIL-YRKFTTESDVWSFGVVLWEIFT 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 8e-06
Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 13/98 (13%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT-- 188
++ QI G+ +L S+ V H+D+ N+L+ L V + DLG + + + Y
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA---ADYYKLLGN 189
Query: 189 -----RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
RW +PE ++ G +S + DIW+ G V +E +
Sbjct: 190 SLLPIRWM-APEAIM-YGKFSIDSDIWSYGVVLWEVFS 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 45/231 (19%), Positives = 75/231 (32%), Gaps = 64/231 (27%)
Query: 1 MKATCPDFAEVANLKEISILRKIPDHLNVLCL---CETYVNRSTRQVTLVFPLMEL-NLE 56
MK E+ +L K+ H N++ L CE + L NL
Sbjct: 60 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLL 114
Query: 57 EYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLT 116
+++R + R E AN TA+ L LL
Sbjct: 115 DFLR------KSRVLETDPAFAIANSTAST------LSSQQLL----------------- 145
Query: 117 TFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG---- 171
+ G+ +L + HRD+ NIL+ + V + D G
Sbjct: 146 --------------HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 191
Query: 172 -SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ K+ G + RW + E L Y+ D+W+ G + +E ++
Sbjct: 192 QEVYVKKTMGR----LPVRWM-AIESLN-YSVYTTNSDVWSYGVLLWEIVS 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 44/276 (15%), Positives = 87/276 (31%), Gaps = 78/276 (28%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L + Q L + QI G+++L + + HR++ N+L++ V V D G
Sbjct: 101 LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160
Query: 172 SLQFIKSKGLHT--EYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT- 221
+ + L + + +W + E + G Y+ + D+W+ G +E +T
Sbjct: 161 -V----ADLLPPDDKQLLYSEAKTPIKWM-ALESIHF-GKYTHQSDVWSYGVTVWELMTF 213
Query: 222 -RNPLFPG--DSE-IDQLD---RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGID 274
P + G +E D L+ R+ Q
Sbjct: 214 GAEP-YAGLRLAEVPDLLEKGERLAQPQICT----------------------------- 243
Query: 275 VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL-TQLKQYLEQKQVMKKLAKK 333
++ +M + D RPT F +L + + + +
Sbjct: 244 ---IDVYM----VMVKCWMIDENIRPT---------FKELANEFTRMARDPPRYLVIKR- 286
Query: 334 NYMAGGMQKTSHPTHLLANTKSSHQMDMSKFIQSDL 369
G P K ++++ + DL
Sbjct: 287 ---ESGPGIAPGPEPHGLTNKKLEEVELEPELDLDL 319
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 19/121 (15%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L F+ + + Q+ G+ +L K HRD+ N ++ V V D G
Sbjct: 110 LLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFG 169
Query: 172 SLQFIKSKGLHTEYIAT----------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ I EY + +W + E L ++ + D+W+ G + +E LT
Sbjct: 170 LARDILD----REYYSVQQHRHARLPVKWT-ALESLQ-TYRFTTKSDVWSFGVLLWELLT 223
Query: 222 R 222
R
Sbjct: 224 R 224
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 17/113 (15%)
Query: 120 PQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFI 176
Q L + + QI +G+ +L S HRD+ N L+ +L+V +GD G + +
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 177 KSKGLHTEYIAT--------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
T+Y RW PE ++ ++ E D+W+ G + +E T
Sbjct: 184 ----YSTDYYRVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFT 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 26/118 (22%), Positives = 51/118 (43%), Gaps = 14/118 (11%)
Query: 115 LTTFLPQQSKRLYHTTFV--LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L FL + + + + L+Q+ G+ +L HR++ N+L+ + D G
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 172 SLQFIKSKGLHTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
+ + + + Y A +WY +PEC+ +S D+W+ G +E L+
Sbjct: 482 LSKALGAD--DSYYTARSAGKWPLKWY-APECINF-RKFSSRSDVWSYGVTMWEALSY 535
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 17/99 (17%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTE--YIAT-- 188
I G+ +L + HRD+ N ++R D+ V V D G L SK +++ Y
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG-L----SKKIYSGDYYRQGRI 208
Query: 189 -----RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222
+W + E L + Y+ + D+WA G +E TR
Sbjct: 209 AKMPVKWI-AIESLA-DRVYTSKSDVWAFGVTMWEIATR 245
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATRWYR 192
+ + +L HRD+ N+L+ D V V D G + S + + +W
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVKWT- 353
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT--RNPLFPG 228
+PE L E +S + D+W+ G + +E + R P +P
Sbjct: 354 APEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 389
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 21/71 (29%), Positives = 33/71 (46%), Gaps = 12/71 (16%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI----RGDLVVVGDLG-SLQFIKSK-GLHTEY--- 185
Q++N + +HS HRDIKP+N L+ R + V + D G + ++ + H Y
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 186 ---IATRWYRS 193
T Y S
Sbjct: 171 KNLTGTARYAS 181
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 32/141 (22%), Positives = 53/141 (37%), Gaps = 28/141 (19%)
Query: 115 LTTFLPQQSKRLYHTTFVL----YQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGD 169
L +L + R L + + +L HRD+ N+L+ D V V D
Sbjct: 102 LVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 160
Query: 170 LGSLQFIKSKGL-HTEYIAT-------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
F GL +W +PE L E +S + D+W+ G + +E +
Sbjct: 161 -----F----GLTKEASSTQDTGKLPVKWT-APEALR-EKKFSTKSDVWSFGILLWEIYS 209
Query: 222 --RNPLFPGDSEIDQLDRIHQ 240
R P +P D + R+ +
Sbjct: 210 FGRVP-YPRIPLKDVVPRVEK 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 15/34 (44%), Positives = 22/34 (64%), Gaps = 1/34 (2%)
Query: 139 GLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
GLH+LH+ + HRD+K NIL+ + V + D G
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 36/119 (30%), Positives = 54/119 (45%), Gaps = 9/119 (7%)
Query: 140 LHHLHSYKVFHRDIKPENILIRGDL-VVVGDLGSLQFIKSKGLH--TEYIATRWYRSPEC 196
LH K+ HRD+K NIL+ + VVGD G + + K H T T + +PE
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY 206
Query: 197 LLTEGYYSFELDIWAAGCVFYETLT-RNPL----FPGDSEIDQLDRIHQVLGTPKAETL 250
L T G S + D++ G + E +T + D ++ LD + +L K E L
Sbjct: 207 LST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 18/73 (24%), Positives = 29/73 (39%), Gaps = 14/73 (19%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI------RGDLVVVGDLG-SLQFIKSK-GLHTEY- 185
Q++ + +H + +RDIKP+N LI +++ V D G + H Y
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 186 -----IATRWYRS 193
T Y S
Sbjct: 174 EKKNLSGTARYMS 186
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 20/72 (27%), Positives = 37/72 (51%), Gaps = 12/72 (16%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILI----RGDLVVVGDLG-SLQFIKSK-GLHTEY-- 185
Q+++ + ++HS HRD+KP+N L+ +G+LV + D G + ++ ++ H Y
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 186 ----IATRWYRS 193
T Y S
Sbjct: 172 NKNLTGTARYAS 183
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 24/100 (24%), Positives = 37/100 (37%), Gaps = 18/100 (18%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRG---DLVV-VGDLGSLQFIKSKGLHTEYIAT- 188
I G +L HRDI N L+ V +GD G + I Y
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----ASYYRKG 202
Query: 189 -------RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+W PE + EG ++ + D W+ G + +E +
Sbjct: 203 GCAMLPVKWM-PPEAFM-EGIFTSKTDTWSFGVLLWEIFS 240
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 12/55 (21%), Positives = 24/55 (43%), Gaps = 5/55 (9%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI---RGDLVVVGDLG-SLQFIKSKGLHTEY 185
++++ L LH + H ++ ENI + V + G + ++ S H Y
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK-HVAY 220
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 10/89 (11%)
Query: 139 GLHHLHSYKVFHRDIKPENILIRGDLV-VVGDLGSLQFIKSKGLHTEYIATRW-----YR 192
G++ LH HRDIK NIL+ + D G L K T + +R Y
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFG-LARASEKFAQT-VMTSRIVGTTAYM 202
Query: 193 SPECLLTEGYYSFELDIWAAGCVFYETLT 221
+PE L G + + DI++ G V E +T
Sbjct: 203 APEAL--RGEITPKSDIYSFGVVLLEIIT 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 18/73 (24%), Positives = 34/73 (46%), Gaps = 14/73 (19%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI------RGDLVVVGDLG-SLQFIKSK-GLHTEY- 185
Q+++ + ++HS + +RD+KPEN LI ++ + D + ++I + H Y
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 186 -----IATRWYRS 193
T Y S
Sbjct: 173 EHKSLTGTARYMS 185
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 15/55 (27%), Positives = 28/55 (50%), Gaps = 5/55 (9%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI---RGDLVVVGDLG-SLQFIKSKGLHTEY 185
+I++ L ++H ++ H DIK N+L+ D V + D G + ++ H Y
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV-HKAY 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 18/100 (18%)
Query: 134 YQIVNGLHHLHSYKVFHRDIKPENILIRG---DLVV-VGDLGSLQFIKSKGLHTEY---- 185
I G +L HRDI N L+ V +GD G + I Y
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----AGYYRKG 243
Query: 186 ----IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221
+ +W PE + EG ++ + D W+ G + +E +
Sbjct: 244 GCAMLPVKWM-PPEAFM-EGIFTSKTDTWSFGVLLWEIFS 281
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 15/54 (27%), Positives = 26/54 (48%), Gaps = 3/54 (5%)
Query: 135 QIVNGLHHLHSYKVFHRDIKPENILI---RGDLVVVGDLGSLQFIKSKGLHTEY 185
++++ L ++H + H DIK N+L+ D V + D G G H +Y
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 470 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.66 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.47 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.98 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.77 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.48 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.89 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.01 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.74 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.6 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.88 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.46 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.0 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.23 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 93.55 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.51 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 92.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.88 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 89.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 88.49 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 83.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 82.45 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 80.44 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=425.90 Aligned_cols=246 Identities=30% Similarity=0.573 Sum_probs=209.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+++|+++|+.|+ |||||++++++... +.+.+|||||||+|+|.++|...+.+++..++.
T Consensus 97 ~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~------------- 162 (398)
T 4b99_A 97 AKRTLRELKILKHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRY------------- 162 (398)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcC-CCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHH-------------
Confidence 456789999999999 99999999987642 346799999999999999999888899988888
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
|++||+.||+|||++|||||||||+|||++.+ .
T Consensus 163 ----------------------------------------------~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~ 196 (398)
T 4b99_A 163 ----------------------------------------------FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE 196 (398)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC
Confidence 99999999999999999999999999999987 8
Q ss_pred EEEEecCCcccccC-----CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKS-----KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 165 ikL~DFG~a~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
+||+|||+|+.+.. .....+.+||++|||||++.+...|+.++||||+|||+|||++|++||.+.+..+++..|.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~ 276 (398)
T 4b99_A 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 276 (398)
T ss_dssp EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999999987643 2234567999999999999887778999999999999999999999999999999999999
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...|.|+...+..........+...++......+..+.+.++++++|||.+||.+||.+|||++|+|+||||++..
T Consensus 277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 9999998877655444333333333444444555666678899999999999999999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=404.29 Aligned_cols=211 Identities=25% Similarity=0.395 Sum_probs=176.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
...+.+|+++|++|+ |||||+++++|.+ .+.+|+|||||+|+|.+++...+.+++..++.
T Consensus 57 ~~~~~~Ei~il~~l~-HpnIv~~~~~~~~--~~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~----------------- 116 (275)
T 3hyh_A 57 QGRIEREISYLRLLR-HPHIIKLYDVIKS--KDEIIMVIEYAGNELFDYIVQRDKMSEQEARR----------------- 116 (275)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEEECCCEEHHHHHHHSCSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHHHCC-CCCCCeEEEEEEE--CCEEEEEEeCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 456889999999999 9999999999965 67899999999999999999888899988888
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 117 ------------------------------------------~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~ 154 (275)
T 3hyh_A 117 ------------------------------------------FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIA 154 (275)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||+|+.........+.+||+.|||||++.+..+++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 155 DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------ 228 (275)
T 3hyh_A 155 DFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------ 228 (275)
T ss_dssp CSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------
T ss_pred ecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------
Confidence 99999887766666778999999999999887766789999999999999999999999988777666664410
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
..++..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 229 -------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 -------------------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1123468899999999999999999999999999999963
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=407.00 Aligned_cols=211 Identities=23% Similarity=0.411 Sum_probs=186.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|++|+ |||||+++++|.+ .+.+|||||||+ |+|.++|...+.+++..++.
T Consensus 77 ~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~----------------- 136 (311)
T 4aw0_A 77 PYVTRERDVMSRLD-HPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF----------------- 136 (311)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCCCeEEEEEEe--CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 46789999999999 9999999999965 678999999999 59999999888899988888
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||+
T Consensus 137 ------------------------------------------~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~ 174 (311)
T 4aw0_A 137 ------------------------------------------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 174 (311)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC---CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 169 DLGSLQFIKSK---GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 169 DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|||+|+.+... ....+.+||+.|||||++.+.. |+.++||||+||++|+|++|.+||.+.+..+.+..|...-
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--- 250 (311)
T 4aw0_A 175 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--- 250 (311)
T ss_dssp CCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---
T ss_pred EcCCceecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---
Confidence 99999876532 2345679999999999998866 8999999999999999999999999998888877775410
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHH------HHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK------ILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~e------lL~hp~f~~~~ 315 (470)
..++..+++++++||.+||+.||.+|||++| +++||||++++
T Consensus 251 ----------------------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 251 ----------------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ----------------------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 1123468899999999999999999999987 68999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=408.67 Aligned_cols=213 Identities=23% Similarity=0.398 Sum_probs=185.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.|+ |||||+++++|.. .+.+|||||||+ |+|.+++.. ..+++..++.
T Consensus 115 ~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~---------------- 174 (346)
T 4fih_A 115 RELLFNEVVIMRDYQ-HENVVEMYNSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAA---------------- 174 (346)
T ss_dssp GGGGHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHH----------------
Confidence 456789999999999 9999999999976 678999999999 599999975 3488888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 175 -------------------------------------------~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl 211 (346)
T 4fih_A 175 -------------------------------------------VCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL 211 (346)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999887 9999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||+|+.+... ....+.+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|.....
T Consensus 212 ~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--- 287 (346)
T 4fih_A 212 SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--- 287 (346)
T ss_dssp CCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---
T ss_pred ecCcCceecCCCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---
Confidence 999999877543 4456789999999999987765 89999999999999999999999999988887777654210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
........+++++++||.+||+.||++|||++|+|+||||++.
T Consensus 288 -------------------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 288 -------------------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp -------------------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 0111234689999999999999999999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=411.58 Aligned_cols=214 Identities=28% Similarity=0.441 Sum_probs=185.7
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~ 83 (470)
+.+...+.+|+++|++|+ |||||+++++|.+ .+.+|||||||+ |+|.++|..... +++..++.
T Consensus 64 ~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~--~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~----------- 129 (350)
T 4b9d_A 64 SKEREESRREVAVLANMK-HPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD----------- 129 (350)
T ss_dssp HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHH-----------
T ss_pred HHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHH-----------
Confidence 344567899999999999 9999999999965 678999999999 699999976543 67777777
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
|+.||+.||+|||++|||||||||+|||++.+
T Consensus 130 ------------------------------------------------~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~ 161 (350)
T 4b9d_A 130 ------------------------------------------------WFVQICLALKHVHDRKILHRDIKSQNIFLTKD 161 (350)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHHTTCEETTCCGGGEEECTT
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHCCeeeccCCHHHEEECCC
Confidence 99999999999999999999999999999887
Q ss_pred -eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 -LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.+||+|||+|+...... .....+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 162 g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~ 240 (350)
T 4b9d_A 162 GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG 240 (350)
T ss_dssp CCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred CCEEEcccccceeecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 89999999998765432 335578999999999998865 899999999999999999999999999888887777541
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
. .......+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 241 ~------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 S------------------------------FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp C------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred C------------------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1 11233568999999999999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=396.99 Aligned_cols=215 Identities=22% Similarity=0.349 Sum_probs=178.5
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeec--CCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
.....+.+|+++|++|+ |||||+++++|.. .....+|||||||+ |+|.++|.....+++..+..
T Consensus 67 ~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~------------ 133 (290)
T 3fpq_A 67 SERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS------------ 133 (290)
T ss_dssp HHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH------------
T ss_pred HHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHH------------
Confidence 34456899999999999 9999999999864 23466899999999 69999999887788888887
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeC
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILIRG 162 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~ 162 (470)
|+.||+.||+|||++| ||||||||+|||+++
T Consensus 134 -----------------------------------------------~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~ 166 (290)
T 3fpq_A 134 -----------------------------------------------WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 166 (290)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCCCEEecccChhheeEEC
Confidence 9999999999999998 999999999999975
Q ss_pred -C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 163 -D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 163 -~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+ .+||+|||+|+... .....+.+||+.|||||++.+ . |+.++|||||||++|||++|++||.+......+.....
T Consensus 167 ~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~ 243 (290)
T 3fpq_A 167 PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp TTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence 4 89999999997543 334566799999999998864 3 89999999999999999999999987655444433221
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
. + ......+..+++++.+||.+||..||++|||++|+|+||||++
T Consensus 244 ~-~---------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 244 S-G---------------------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp T-T---------------------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred c-C---------------------------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0 0 0011123457789999999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=403.08 Aligned_cols=213 Identities=22% Similarity=0.331 Sum_probs=181.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|.+|+ |||||+++++|.+ .+.+|+|||||+ |+|.++|.....+++..++.
T Consensus 70 ~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~---------------- 130 (304)
T 3ubd_A 70 RVRTKMERDILVEVN-HPFIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF---------------- 130 (304)
T ss_dssp CC------CCCCCCC-CTTEECEEEEEEE--TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHHCC-CCCCCeEEEEEEE--CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHH----------------
Confidence 345789999999999 9999999999975 678999999999 69999999888899988888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 131 -------------------------------------------~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl 167 (304)
T 3ubd_A 131 -------------------------------------------YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167 (304)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEe
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||+|+.... .....+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|.+..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---- 242 (304)
T 3ubd_A 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK---- 242 (304)
T ss_dssp ESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----
T ss_pred cccccceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC----
Confidence 99999986543 33456679999999999998765 8999999999999999999999999998888877775410
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
..++..+|+++.+||.+||+.||++||| ++|+++||||++++.
T Consensus 243 ---------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 243 ---------------------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp ---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 1123468999999999999999999998 589999999998763
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=410.25 Aligned_cols=213 Identities=23% Similarity=0.402 Sum_probs=185.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.|+ |||||+++++|.. .+.+|||||||+ |+|.+++... .+++..++.
T Consensus 192 ~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--~~~~~iVmEy~~gG~L~~~i~~~-~l~e~~~~~---------------- 251 (423)
T 4fie_A 192 RELLFNEVVIMRDYQ-HENVVEMYNSYLV--GDELWVVMEFLEGGALTDIVTHT-RMNEEQIAA---------------- 251 (423)
T ss_dssp GGGHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHHHHHS-CCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCceEEEEEE--CCEEEEEEeCCCCCcHHHHHhcc-CCCHHHHHH----------------
Confidence 456789999999999 9999999999976 678999999999 5999999754 488888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 252 -------------------------------------------~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl 288 (423)
T 4fie_A 252 -------------------------------------------VCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL 288 (423)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||+|+.+... ....+.+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|.....
T Consensus 289 ~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--- 364 (423)
T 4fie_A 289 SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--- 364 (423)
T ss_dssp CCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---
T ss_pred ecCccceECCCCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---
Confidence 999999877543 3456789999999999987765 89999999999999999999999999988887777654210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
........+++++++||.+||..||.+|||++|+|+||||++.
T Consensus 365 -------------------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 365 -------------------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -------------------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 0111234689999999999999999999999999999999753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=402.39 Aligned_cols=245 Identities=19% Similarity=0.299 Sum_probs=189.5
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
......+.+|+++|..+.+||||++++++|.. .+++|+|||||+ |+|.+++. .+++..++.
T Consensus 60 ~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~------------- 121 (361)
T 4f9c_A 60 TSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVVIAMPYLEHESFLDILN---SLSFQEVRE------------- 121 (361)
T ss_dssp TSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEEEEECCCCCCHHHHHT---TCCHHHHHH-------------
T ss_pred ccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEEEEEeCCCcccHHHHHc---CCCHHHHHH-------------
Confidence 33455678999999999669999999999965 678999999998 69999984 377877777
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-- 163 (470)
|++||+.||+|||++|||||||||+|||++.+
T Consensus 122 ----------------------------------------------~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 122 ----------------------------------------------YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC
Confidence 99999999999999999999999999999875
Q ss_pred eEEEEecCCcccccCCC-----------------------------ccccccccCcccCchhhccCCCCCCcccHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKG-----------------------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGC 214 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-----------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~ 214 (470)
.+||+|||+|+...... .....+||++|+|||++.+...|+.++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 89999999997543221 1234689999999999988777999999999999
Q ss_pred HHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchHHHHHHhhhcc---C---------------ccccccccC-----CC
Q psy9855 215 VFYETLTRNPLF-PGDSEIDQLDRIHQVLGTPKAETLKKFEKYKS---S---------------NFTYQFKQY-----PG 270 (470)
Q Consensus 215 il~elltg~~pf-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~---~---------------~~~~~~~~~-----~~ 270 (470)
|+|||++|++|| .+.++.+++..|..++|++....+........ . ......+.. ..
T Consensus 236 il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 315 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGH 315 (361)
T ss_dssp HHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccc
Confidence 999999999988 56778899999999999765544332211000 0 000000000 00
Q ss_pred CCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 271 GGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 271 ~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.........++++++|||.+||++||.+|+|++|+|+||||+++.
T Consensus 316 ~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 316 ATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp ------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 011122356889999999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=397.11 Aligned_cols=211 Identities=20% Similarity=0.303 Sum_probs=178.0
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccccc
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGW 91 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (470)
..+|+.+|..|+ |||||+++++|.+ .+.+|||||||+ |+|.++|+..+.+++..+..
T Consensus 97 ~~~E~~il~~l~-HpnIV~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~------------------- 154 (336)
T 4g3f_A 97 RVEELVACAGLS-SPRIVPLYGAVRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY------------------- 154 (336)
T ss_dssp CTHHHHTTTTCC-CTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHH-------------------
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHH-------------------
Confidence 468999999999 9999999999965 678999999999 69999999888899988888
Q ss_pred CCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eEEEEe
Q psy9855 92 DLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVVVGD 169 (470)
Q Consensus 92 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ikL~D 169 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||+|
T Consensus 155 ----------------------------------------~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~D 194 (336)
T 4g3f_A 155 ----------------------------------------YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCD 194 (336)
T ss_dssp ----------------------------------------HHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECC
T ss_pred ----------------------------------------HHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEee
Confidence 99999999999999999999999999999876 599999
Q ss_pred cCCcccccCCCc------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 170 LGSLQFIKSKGL------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 170 FG~a~~~~~~~~------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
||+|+....... ....+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-- 271 (336)
T 4g3f_A 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-- 271 (336)
T ss_dssp CTTCEEC------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--
T ss_pred CCCCeEccCCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--
Confidence 999987654321 23468999999999998865 899999999999999999999999887765555555431
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH-------------hccc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL-------------SCAY 310 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL-------------~hp~ 310 (470)
. .....+++.+++++.+||.+||..||.+|||+.|++ +|||
T Consensus 272 ~--------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 272 P--------------------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp C--------------------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred C--------------------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 0 111234567899999999999999999999999984 6788
Q ss_pred CCCh
Q psy9855 311 FADL 314 (470)
Q Consensus 311 f~~~ 314 (470)
+.+.
T Consensus 326 ~~~~ 329 (336)
T 4g3f_A 326 KGEY 329 (336)
T ss_dssp SSSC
T ss_pred cCCC
Confidence 8754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=376.81 Aligned_cols=217 Identities=27% Similarity=0.448 Sum_probs=162.1
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCC----------CeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHH
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRST----------RQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQV 77 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~----------~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~ 77 (470)
....+++|+++|++|+ |||||+++++|...+. ..+|+|||||+ |+|.+++.....+++..
T Consensus 46 ~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~-------- 116 (299)
T 4g31_A 46 AREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE-------- 116 (299)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSC--------
T ss_pred HHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhH--------
Confidence 3457899999999999 9999999999875332 34799999998 69999998765433211
Q ss_pred HhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q psy9855 78 KAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPEN 157 (470)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~N 157 (470)
...+..|+.||+.||+|||++|||||||||+|
T Consensus 117 ------------------------------------------------~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~N 148 (299)
T 4g31_A 117 ------------------------------------------------RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSN 148 (299)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHHHHHCcCccccCcHHH
Confidence 11223399999999999999999999999999
Q ss_pred EEEeCC-eEEEEecCCcccccCCC-------------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCC
Q psy9855 158 ILIRGD-LVVVGDLGSLQFIKSKG-------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN 223 (470)
Q Consensus 158 ILl~~~-~ikL~DFG~a~~~~~~~-------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~ 223 (470)
||++.+ .+||+|||+|+...... ..+..+||+.|||||++.+.. |+.++|||||||++|||++
T Consensus 149 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp EEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS--
T ss_pred eEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc--
Confidence 999887 89999999998765322 123468999999999998765 8999999999999999996
Q ss_pred CCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHH
Q psy9855 224 PLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303 (470)
Q Consensus 224 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~ 303 (470)
||.+. .+....+..+... ......+..++.+.+||.+||+.||.+|||+.
T Consensus 226 -Pf~~~--~~~~~~~~~~~~~---------------------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 275 (299)
T 4g31_A 226 -PFSTQ--MERVRTLTDVRNL---------------------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI 275 (299)
T ss_dssp -CCSSH--HHHHHHHHHHHTT---------------------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -CCCCc--cHHHHHHHHHhcC---------------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHH
Confidence 77543 2333333222111 11112234567788999999999999999999
Q ss_pred HHHhcccCCChh
Q psy9855 304 KILSCAYFADLT 315 (470)
Q Consensus 304 elL~hp~f~~~~ 315 (470)
|+|+||||++++
T Consensus 276 eil~h~~~~~~~ 287 (299)
T 4g31_A 276 NIIENAVFEDLD 287 (299)
T ss_dssp HHHTSGGGCCC-
T ss_pred HHhcCHhhCCCC
Confidence 999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.29 Aligned_cols=211 Identities=22% Similarity=0.308 Sum_probs=169.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|.+|+ |||||+++|++. .+.+|||||||+ |+|.++|.... .+++..+..
T Consensus 76 ~~~f~~E~~il~~l~-HpNIV~l~g~~~---~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~--------------- 136 (307)
T 3omv_A 76 FQAFRNEVAVLRKTR-HVNILLFMGYMT---KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLID--------------- 136 (307)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEE---CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHH---------------
Confidence 456889999999999 999999999874 345899999999 69999997654 377777777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+|
T Consensus 137 --------------------------------------------i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~K 172 (307)
T 3omv_A 137 --------------------------------------------IARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVK 172 (307)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEE
Confidence 99999999999999999999999999999998 899
Q ss_pred EEecCCcccccCC---CccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSK---GLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||+|+..... ......+||+.|||||++.+. ..|+.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 173 i~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~ 252 (307)
T 3omv_A 173 IGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR 252 (307)
T ss_dssp ECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT
T ss_pred EeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 9999999866432 233557899999999998653 34899999999999999999999999887766555444321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
... ........+.+++++.+||.+||+.||++|||+.|++++
T Consensus 253 ~~~-------------------------~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 253 GYA-------------------------SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TCC-------------------------CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred CCC-------------------------CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 000 111223445788999999999999999999999998743
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=371.54 Aligned_cols=218 Identities=20% Similarity=0.277 Sum_probs=174.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+++|.+|+ |||||+++|++.+ .+.+|||||||+ |+|.++|...+......
T Consensus 58 ~~~~f~~E~~il~~l~-HpnIV~l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~------------------ 116 (299)
T 4asz_A 58 ARKDFHREAELLTNLQ-HEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLM------------------ 116 (299)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHHHHTSHHHHHC------------------
T ss_pred HHHHHHHHHHHHHhCC-CCCCccEEEEEee--CCEEEEEEEcCCCCcHHHHHHhcCcccccc------------------
Confidence 3457899999999999 9999999999865 677999999999 79999998654100000
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
........+++..+..|+.||+.||+|||+++||||||||+|||++.+ .+|
T Consensus 117 ----------------------------~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 117 ----------------------------AEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred ----------------------------cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 000111223344445599999999999999999999999999999988 899
Q ss_pred EEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||+|+....... ....+||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..+....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987654332 23357999999999998765 8999999999999999998 999999988877776665411
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
....+..+++++.+||.+||+.||++|||+.+++
T Consensus 248 ------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 248 ------------------------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 1122356889999999999999999999999995
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=367.02 Aligned_cols=223 Identities=21% Similarity=0.291 Sum_probs=176.1
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.+|.+|+ |||||+++|++.. .+.++||||||+ |+|.++|.........
T Consensus 72 ~~~~f~~E~~il~~l~-HpNIV~l~g~~~~--~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~------------------- 129 (308)
T 4gt4_A 72 LREEFRHEAMLRARLQ-HPNVVCLLGVVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDV------------------- 129 (308)
T ss_dssp CHHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSCEEEEECCSSCBHHHHHHTTCSSCCC-------------------
T ss_pred HHHHHHHHHHHHHhCC-CCCCCCcceEEEE--CCEEEEEEEcCCCCcHHHHHHhhCccccc-------------------
Confidence 3467899999999999 9999999999864 667999999999 7999999754321000
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
+.. .........+++..+..|+.||+.||+|||+++||||||||+|||++.+ .+|
T Consensus 130 ------------------~~~------~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 130 ------------------GST------DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp ------------------C-----------CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred ------------------ccc------ccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 000 0000111234445555699999999999999999999999999999988 899
Q ss_pred EEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||+++...... .....+||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+.+..+...
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~- 263 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR- 263 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 99999998764322 334568999999999998765 8999999999999999998 89999998887776665431
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..+++++.+||.+||..||.+|||+.||+++
T Consensus 264 -----------------------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 264 -----------------------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1112345688999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=368.15 Aligned_cols=221 Identities=19% Similarity=0.265 Sum_probs=169.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|.+|+ |||||+++|++.. .+.+|||||||+ |+|.++|............
T Consensus 87 ~~~f~~E~~il~~l~-HpnIV~l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~----------------- 146 (329)
T 4aoj_A 87 RQDFQREAELLTMLQ-HQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG----------------- 146 (329)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHHHTSSCC-----------------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEEcCCCCcHHHHHHhcCcccccccc-----------------
Confidence 457899999999999 9999999999864 677999999999 7999999875431100000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
........+++..+..|+.||+.||+|||+++||||||||+|||++.+ .+||
T Consensus 147 ---------------------------~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 147 ---------------------------GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp --------------------------------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred ---------------------------cccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 000111234455566699999999999999999999999999999998 8999
Q ss_pred EecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||+++...... .....+||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..+....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~- 277 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR- 277 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999998765332 224568999999999998765 8999999999999999998 899999988877776665421
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+..+++++.+||.+||+.||++|||+.|++++
T Consensus 278 -----------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 278 -----------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp -----------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred -----------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 011234688999999999999999999999999853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=395.73 Aligned_cols=216 Identities=23% Similarity=0.365 Sum_probs=188.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+++|+.|+ |||||+++++|.+ .+.+|||||||+ |+|.++|... ..+++..++.
T Consensus 197 ~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~-------------- 259 (573)
T 3uto_A 197 DKETVRKEIQTMSVLR-HPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE-------------- 259 (573)
T ss_dssp HHHHHHHHHHHHHHTC-CTTBCCEEEEEEC--SSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHH--------------
T ss_pred hHHHHHHHHHHHHhCC-CCCCCeEEEEEEE--CCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHH--------------
Confidence 3456789999999999 9999999999965 778999999999 6999999654 3488888887
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--- 163 (470)
|+.||+.||+|||++||+||||||+|||++.+
T Consensus 260 ---------------------------------------------~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~ 294 (573)
T 3uto_A 260 ---------------------------------------------YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 294 (573)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeeeccCChhhccccCCCCC
Confidence 99999999999999999999999999999753
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.+||+|||+++.+.........+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..|.....
T Consensus 295 ~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~ 373 (573)
T 3uto_A 295 ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373 (573)
T ss_dssp CEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred CEEEeeccceeEccCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC
Confidence 79999999999887776667789999999999998866 89999999999999999999999999998888877754211
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.. .....+.+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 374 ~~---------------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 374 NM---------------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp CC---------------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CC---------------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 11 112235689999999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=372.49 Aligned_cols=225 Identities=23% Similarity=0.323 Sum_probs=174.0
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~ 84 (470)
.+...+++|+++|.+|.+|||||+++|++.. .++.+|||||||+ |+|.++|+.... .+.....
T Consensus 109 ~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~------------- 174 (353)
T 4ase_A 109 SEHRALMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP------------- 174 (353)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-----------------
T ss_pred HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccc-------------
Confidence 3455789999999999856999999998864 3456899999999 799999976542 0000000
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
.......+++..+..|+.||+.||+|||+++||||||||+|||++.+
T Consensus 175 --------------------------------~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 175 --------------------------------EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp -----------------------------------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred --------------------------------hhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 00011234556666699999999999999999999999999999987
Q ss_pred eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 239 (470)
.+||+|||+|+....... ....+||+.|||||++.+.. |+.++|||||||++|||+| |..||.+....+.+..+.
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999987654332 24568999999999998765 8999999999999999998 999998866444433332
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.. | .....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 302 ~~-g----------------------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 KE-G----------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HH-T----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hc-C----------------------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 21 0 1112234678999999999999999999999999976
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=377.26 Aligned_cols=246 Identities=30% Similarity=0.580 Sum_probs=202.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC---CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR---STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~---~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|+++|+.|+ ||||+++++++... ....+|+||||++|+|.+++.....+++..++.
T Consensus 96 ~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~-------------- 160 (458)
T 3rp9_A 96 CKRILREIAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT-------------- 160 (458)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHH--------------
Confidence 456789999999998 99999999998643 236799999999999999998877788888877
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|++||+.||+|||++|||||||||+|||++.+ .+
T Consensus 161 ---------------------------------------------~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 161 ---------------------------------------------LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCC----------------------------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG----------------------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFY 217 (470)
Q Consensus 166 kL~DFG~a~~~~~~~----------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ 217 (470)
||+|||+++...... .....+||++|+|||++.....|+.++||||||||+|
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 999999998754211 2345688999999998766566999999999999999
Q ss_pred HHHh-----------CCCCCCCCC--------------------hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccc
Q psy9855 218 ETLT-----------RNPLFPGDS--------------------EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFK 266 (470)
Q Consensus 218 ellt-----------g~~pf~~~~--------------------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 266 (470)
||++ |.++|++.+ ..+++..|..++|.|..+.+..+.......+...++
T Consensus 276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 355 (458)
T 3rp9_A 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355 (458)
T ss_dssp HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC
T ss_pred HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC
Confidence 9998 788887765 367888999999999998877655444333433444
Q ss_pred cCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 267 QYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 267 ~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
......+....+.+++++.+||.+||.+||.+|||++|+|+||||+++.
T Consensus 356 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 4444555566678899999999999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=391.90 Aligned_cols=208 Identities=22% Similarity=0.313 Sum_probs=176.3
Q ss_pred HHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccCC
Q psy9855 15 KEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDL 93 (470)
Q Consensus 15 rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (470)
+|+.++..++ |||||+++++|.+ .+.+|||||||+ |+|.++|...+.+++..++.
T Consensus 241 ~~l~ll~~~~-HP~IV~l~~~f~~--~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~--------------------- 296 (689)
T 3v5w_A 241 IMLSLVSTGD-CPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--------------------- 296 (689)
T ss_dssp HHHHHHSSSC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHH---------------------
T ss_pred HHHHHHhhCC-CCCEeEEEEEEEE--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHH---------------------
Confidence 3467777888 9999999999965 678999999999 69999999888899988888
Q ss_pred CccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCC
Q psy9855 94 KLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGS 172 (470)
Q Consensus 94 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~ 172 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||+|||+
T Consensus 297 --------------------------------------y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 297 --------------------------------------YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp --------------------------------------HHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred --------------------------------------HHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence 99999999999999999999999999999987 999999999
Q ss_pred cccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHH
Q psy9855 173 LQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI---DQLDRIHQVLGTPKAET 249 (470)
Q Consensus 173 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~---~~~~~i~~~~g~p~~~~ 249 (470)
|+...... ..+.+||+.|||||++.+...|+.++|||||||++|||++|.+||.+.+.. .....+..
T Consensus 339 A~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--------- 408 (689)
T 3v5w_A 339 ACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------- 408 (689)
T ss_dssp CEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH---------
T ss_pred eeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC---------
Confidence 98765443 456799999999999975555899999999999999999999999764322 22222211
Q ss_pred HHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
....++..+|+++++||.+||..||.+|++ ++||++||||++++.
T Consensus 409 ----------------------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 409 ----------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp ----------------------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ----------------------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 001233568999999999999999999998 799999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.39 Aligned_cols=248 Identities=30% Similarity=0.546 Sum_probs=197.0
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
.....+.+|+.+|..+.+||||+++++++...+...+|+|||||+|+|.+++... .+++..+..
T Consensus 50 ~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~--------------- 113 (388)
T 3oz6_A 50 TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN-ILEPVHKQY--------------- 113 (388)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHHT-CCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHcC-CCCHHHHHH---------------
Confidence 3355678999999999889999999999987666789999999999999999763 466666666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .+|
T Consensus 114 --------------------------------------------i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~k 149 (388)
T 3oz6_A 114 --------------------------------------------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVK 149 (388)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEE
Confidence 99999999999999999999999999999988 899
Q ss_pred EEecCCcccccC----------------------CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKS----------------------KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224 (470)
Q Consensus 167 L~DFG~a~~~~~----------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~ 224 (470)
|+|||+++.... .......+||++|+|||++.+...|+.++|||||||++|||++|++
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 999999976532 1123456899999999999876668999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccC---CCCCcccc-------------cccccHHHHHHH
Q psy9855 225 LFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQY---PGGGIDVL-------------VPQIHEKGKKLM 288 (470)
Q Consensus 225 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------------~~~~s~~~~~Li 288 (470)
||.+.+..+++..+...+|.|..+.+..........+....... ........ ...+++++.+||
T Consensus 230 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 99999999999999999999988766533221100000000000 00011111 126789999999
Q ss_pred HHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 289 SEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 289 ~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+||..||.+|||++|+|+||||+...
T Consensus 310 ~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred HHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=370.25 Aligned_cols=247 Identities=32% Similarity=0.584 Sum_probs=201.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCC---CeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRST---RQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~---~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|+++|+.|+ ||||+++++++..... ..+|+||||++|+|.+++.....+++..++.
T Consensus 69 ~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~-------------- 133 (432)
T 3n9x_A 69 CKRILREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT-------------- 133 (432)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHcC-CCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHH--------------
Confidence 457889999999999 9999999999875322 6799999999999999998877788888877
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
+++||+.||+|||++||+||||||+|||++.+ .+
T Consensus 134 ---------------------------------------------i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 134 ---------------------------------------------ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCC-----------------------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-
Q psy9855 166 VVGDLGSLQFIKSKG-----------------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT- 221 (470)
Q Consensus 166 kL~DFG~a~~~~~~~-----------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt- 221 (470)
||+|||+++...... .....+||++|+|||++.....|+.++|||||||++|||++
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 999999998765322 23567899999999997666669999999999999999997
Q ss_pred ----------CCCCCCCCC-----------------hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcc
Q psy9855 222 ----------RNPLFPGDS-----------------EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGID 274 (470)
Q Consensus 222 ----------g~~pf~~~~-----------------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (470)
|.++|.+.+ ..+++..+...+|.|..+.+..........+....+........
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLK 328 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHH
Confidence 566666654 47889999999999998877654433322222233333333344
Q ss_pred cccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 275 VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 275 ~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
...+.+++++.+||.+||..||.+|||++|+|+||||+++..
T Consensus 329 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 329 QKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 455678999999999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=353.26 Aligned_cols=242 Identities=32% Similarity=0.635 Sum_probs=200.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|++++ ||||+++++++.. .+.+++|||||+|+|.+++..... +++..+..
T Consensus 64 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~----------------- 123 (311)
T 3niz_A 64 STAIREISLLKELH-HPNIVSLIDVIHS--ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI----------------- 123 (311)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCEEEEECC--SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHHcC-CCCEeeeeeEEcc--CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHH-----------------
Confidence 56789999999998 9999999999854 678999999999999999877654 77777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 124 ------------------------------------------~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 124 ------------------------------------------YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.+.+
T Consensus 162 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 241 (311)
T 3niz_A 162 DFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241 (311)
T ss_dssp CCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT
T ss_pred cCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh
Confidence 99999876532 23345688999999999987666899999999999999999999999999999999999999999887
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..|.......... ...+.......+....+.+++++.+||.+||..||.+|||++|+|+||||+++.
T Consensus 242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 242 REWPQVQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSGGGTTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred HHhhhhhccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 7665543321100 011111223334445567889999999999999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=358.51 Aligned_cols=244 Identities=29% Similarity=0.566 Sum_probs=206.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+++|+.|+ ||||+++++++.... ...+|+||||++++|.+++.. ..+++..+..
T Consensus 68 ~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~------------- 132 (367)
T 1cm8_A 68 AKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQF------------- 132 (367)
T ss_dssp HHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhCC-CcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHH-------------
Confidence 456789999999999 999999999987532 245799999998899999976 3477777766
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 133 ----------------------------------------------~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 166 (367)
T 1cm8_A 133 ----------------------------------------------LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE 166 (367)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC
Confidence 99999999999999999999999999999988 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+||+|||+++..... ....+||++|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+....|.
T Consensus 167 ~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 167 LKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244 (367)
T ss_dssp EEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999999875432 345689999999999987556899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
|+.+.+..+.......+...++......+..+.+.+++.+.+||.+||..||.+|||++++|+||||++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 998877654433333333334444455556666788999999999999999999999999999999997653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.43 Aligned_cols=240 Identities=34% Similarity=0.623 Sum_probs=196.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|+.|+ ||||+++++++.. .+.+++||||++++|.+++.... .+++..+..
T Consensus 45 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~----------------- 104 (288)
T 1ob3_A 45 STTIREISILKELK-HSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS----------------- 104 (288)
T ss_dssp HHHHHHHHGGGGCC-CTTBCCEEEEEEC--SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHH-----------------
T ss_pred hhHHHHHHHHHhcC-CCCEeeeeeEEcc--CCeEEEEEEecCCCHHHHHHhcccCCCHHHHHH-----------------
Confidence 46789999999999 9999999999865 67899999999999999998653 377777666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 105 ------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 105 ------------------------------------------FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..
T Consensus 143 Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (288)
T 1ob3_A 143 DFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222 (288)
T ss_dssp CTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCCh
Confidence 99998766432 22345588999999999977666899999999999999999999999999999999999999888877
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
..|....... .+...+.......+......+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 223 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 223 KNWPNVTELP--KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTSTTGGGST--TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred hhchhhhccc--ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 6665443321 1111222222333445556789999999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=368.99 Aligned_cols=242 Identities=31% Similarity=0.579 Sum_probs=190.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+|+.++ ||||+++++++.... ...+|+|||||+++|.+.+.. .+++..++.
T Consensus 105 ~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~------------- 168 (464)
T 3ttj_A 105 AKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSY------------- 168 (464)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHH-------------
Confidence 456789999999998 999999999986532 357899999999988888753 366766666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 169 ----------------------------------------------~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 169 ----------------------------------------------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC
Confidence 99999999999999999999999999999988 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+||+|||+++...........+||++|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+++..+.+.+|.
T Consensus 203 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 203 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp EEECCCCCC-----CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999998877666667789999999999998865 899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccc------------cccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP------------QIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
|.++.+..+.... ..+....+......+....+ ..++++.+||.+||.+||.+|||++|+|+||||+
T Consensus 282 p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 282 PCPEFMKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp CCHHHHTTSCHHH-HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred CCHHHHHHcchhh-hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 9888765442211 00111111111111111111 1267899999999999999999999999999998
Q ss_pred Chh
Q psy9855 313 DLT 315 (470)
Q Consensus 313 ~~~ 315 (470)
...
T Consensus 361 ~~~ 363 (464)
T 3ttj_A 361 VWY 363 (464)
T ss_dssp GGC
T ss_pred hcc
Confidence 643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=340.75 Aligned_cols=242 Identities=30% Similarity=0.584 Sum_probs=198.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|++++ ||||+++++++.. .+.+++|||||+|+|.+++... ..+++..++.
T Consensus 45 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~---------------- 105 (292)
T 3o0g_A 45 PSSALREICLLKELK-HKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS---------------- 105 (292)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHH----------------
T ss_pred chHHHHHHHHHhcCC-CCCEeeEEeEEEe--CCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHH----------------
Confidence 356789999999999 9999999999865 6789999999999888877664 3478877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 106 -------------------------------------------~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl 142 (292)
T 3o0g_A 106 -------------------------------------------FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~g~p 245 (470)
+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~ 222 (292)
T 3o0g_A 143 ANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_dssp CCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 999999876533 2335568999999999998766689999999999999999986655 78888889999999999999
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
....|............... ..........+.+++.+.+||.+||+.||++|||++|+|+||||++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 223 TEEQWPSMTKLPDYKPYPMY--PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CTTTCTTGGGSTTCCCCCCC--CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred Chhhhhhhcccccccccccc--cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 88877665543221110000 112223344567899999999999999999999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=348.88 Aligned_cols=212 Identities=21% Similarity=0.366 Sum_probs=186.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.++ ||||+++++++.. .+.+|+||||++ |+|.+++...+.+++..+..
T Consensus 58 ~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~---------------- 118 (328)
T 3fe3_A 58 LQKLFREVRIMKILN-HPNIVKLFEVIET--EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---------------- 118 (328)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEEE--CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 456789999999999 9999999999854 678999999998 69999998887788888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 119 -------------------------------------------~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl 155 (328)
T 3fe3_A 119 -------------------------------------------KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKI 155 (328)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999888 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
+|||++............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----- 230 (328)
T 3fe3_A 156 ADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK----- 230 (328)
T ss_dssp CSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----
T ss_pred eeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----
Confidence 999999887766666778999999999999887755689999999999999999999999988777666654410
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
...+..+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 231 --------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 231 --------------------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 11223578999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=346.77 Aligned_cols=241 Identities=27% Similarity=0.560 Sum_probs=196.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc------cccHHHHHHHHHHHHhhhccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD------NISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~------~l~~~~~~~~~~~~~~~~~~~ 84 (470)
..+.+|+.+|+.|+ ||||+++++++.. .+.+++||||++|+|.+++.... .+++..++.
T Consensus 48 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------------ 112 (317)
T 2pmi_A 48 STAIREISLMKELK-HENIVRLYDVIHT--ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY------------ 112 (317)
T ss_dssp HHHHHHHHHHTTCC-BTTBCCEEEEECC--TTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHH------------
T ss_pred HHHHHHHHHHHhcC-CCCcceEEEEEEE--CCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHH------------
Confidence 56789999999998 9999999999854 67899999999999999987543 244544444
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 113 -----------------------------------------------~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~ 145 (317)
T 2pmi_A 113 -----------------------------------------------FQWQLLQGLAFCHENKILHRDLKPQNLLINKRG 145 (317)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC
Confidence 99999999999999999999999999999887
Q ss_pred eEEEEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.+||+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 225 (317)
T 2pmi_A 146 QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225 (317)
T ss_dssp CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 8999999999876532 233456899999999999876568999999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCc-----ccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGI-----DVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
|.+....|........ +.......+.... ......++.++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 226 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPK--YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CSCCTTTCGGGGGCTT--CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred CCCChhHhhhhhhhhh--cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 9988777665544221 1111111111111 112235789999999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=347.53 Aligned_cols=242 Identities=33% Similarity=0.631 Sum_probs=192.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
...+.+|+.+|+.|+ ||||+++++++.. .+.+++|||||+|+|.+++.....+++..+..
T Consensus 77 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~----------------- 136 (329)
T 3gbz_A 77 PGTAIREVSLLKELQ-HRNIIELKSVIHH--NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKS----------------- 136 (329)
T ss_dssp ---CHHHHHHGGGCC-CTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHCTTCCHHHHHH-----------------
T ss_pred chhHHHHHHHHHHcC-CCCcceEEEEEec--CCEEEEEEecCCCCHHHHHhhcCCCCHHHHHH-----------------
Confidence 345789999999998 9999999999865 67899999999999999999887788888777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC------
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD------ 163 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~------ 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 137 ------------------------------------------i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 174 (329)
T 3gbz_A 137 ------------------------------------------FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP 174 (329)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CC
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccc
Confidence 99999999999999999999999999999532
Q ss_pred eEEEEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 254 (329)
T 3gbz_A 175 VLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254 (329)
T ss_dssp EEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh
Confidence 5999999999876532 233456789999999999876668999999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcc-cccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGID-VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+.|....+........ +...++........ .+...+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 255 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 255 GLPDDTTWPGVTALPD--WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp CCCCTTTSTTGGGSTT--CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred CCCchhhhhhhhhhhh--hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 9888776654433211 11111111111111 12234789999999999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.51 Aligned_cols=240 Identities=31% Similarity=0.545 Sum_probs=197.3
Q ss_pred hhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHh----cccccHHHHHHHHHHHHhhhccc
Q psy9855 13 NLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRT----TDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 13 ~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~----~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
..+|+++|+.|+ ||||++++++|.... ...+++|||||+++|...+.. ...+++..++.
T Consensus 79 ~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~------------ 145 (394)
T 4e7w_A 79 KNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL------------ 145 (394)
T ss_dssp CCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHH------------
T ss_pred HHHHHHHHHhCC-CCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHH------------
Confidence 458999999999 999999999986432 234889999999877766543 23366666555
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe-CC
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR-GD 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~-~~ 163 (470)
++.||+.||+|||++||+||||||+|||++ .+
T Consensus 146 -----------------------------------------------~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~ 178 (394)
T 4e7w_A 146 -----------------------------------------------YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPS 178 (394)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCC
Confidence 999999999999999999999999999998 44
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.+||+|||++............+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..+.+.+
T Consensus 179 ~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 179 GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp TEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 8999999999887666666677899999999999876668999999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcc-cccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGID-VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
|+|..+.+....... ....++......+. .+.+.+++++.+||.+||+.||.+|||+.|+++||||+++.
T Consensus 259 g~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 259 GTPSREQIKTMNPNY---MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CCCCHHHHHHHCGGG---SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred CCCCHHHHHhhChhh---hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 999998876653311 11122222222222 23345889999999999999999999999999999999765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.94 Aligned_cols=241 Identities=32% Similarity=0.615 Sum_probs=197.3
Q ss_pred hhhhHHHHHHhcCC--CCCCeeeeceeeecCCC---CeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhcc
Q psy9855 11 VANLKEISILRKIP--DHLNVLCLCETYVNRST---RQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 11 ~~~~rEi~iL~~L~--~HpnIv~l~~~~~~~~~---~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~ 83 (470)
..+.+|+.+++.+. .||||+++++++..... ..+++||||++++|.+++..... +++..+..
T Consensus 56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~----------- 124 (308)
T 3g33_A 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD----------- 124 (308)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHH-----------
T ss_pred hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHH-----------
Confidence 35678888877764 39999999999875332 25899999999999999987665 77777777
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 125 ------------------------------------------------i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 125 ------------------------------------------------LMRQFLRGLDFLHANCIVHRDLKPENILVTSG 156 (308)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC
Confidence 99999999999999999999999999999877
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCEEEeeCccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 89999999998776665566778999999999998765 8999999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+.++...|......... .+............+.+++.+.+||.+||..||.+|||+.|+|+||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRG----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CCCCTTTSCSSCSSCGG----GSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred CCCChhhccchhhcccc----ccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 98877665432221111 1122222333445567899999999999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=355.10 Aligned_cols=243 Identities=33% Similarity=0.578 Sum_probs=190.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+|+.|+ ||||+++++++... ....+|+|+|+++++|.+++.. ..+++..+..
T Consensus 72 ~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~------------- 136 (367)
T 2fst_X 72 AKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQF------------- 136 (367)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHH-------------
Confidence 456789999999999 99999999998642 2356899999999999999865 3477777766
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 137 ----------------------------------------------i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 137 ----------------------------------------------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC
Confidence 99999999999999999999999999999987 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+||+|||+++..... ....+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.
T Consensus 171 ~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 248 (367)
T 2fst_X 171 LKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248 (367)
T ss_dssp EEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999999865432 345689999999999987566899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
|..+.+..+.......+.......+...+....+.+++.+.+||.+||..||.+|||+.|+|+||||++..
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 98877665433222222233333344444555567899999999999999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=349.85 Aligned_cols=242 Identities=31% Similarity=0.608 Sum_probs=194.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|+.++ ||||+++++++.. .+..++||||++|+|.+++..... +++..++.
T Consensus 45 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~----------------- 104 (324)
T 3mtl_A 45 CTAIREVSLLKDLK-HANIVTLHDIIHT--EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL----------------- 104 (324)
T ss_dssp CCCCCCHHHHSCCC-CTTBCCEEEEEEC--SSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHH-----------------
T ss_pred hhHHHHHHHHHhcC-CCCCCeeeeEEee--CCEEEEEecccccCHHHHHHhcCCCCCHHHHHH-----------------
Confidence 35679999999999 9999999999864 677999999999999999987654 77777766
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 105 ------------------------------------------~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 142 (324)
T 3mtl_A 105 ------------------------------------------FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLA 142 (324)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+.+|.|..
T Consensus 143 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (324)
T 3mtl_A 143 DFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222 (324)
T ss_dssp SSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99998765432 23345688999999999987666899999999999999999999999999999999999999999988
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..|........ .....++...........+.+++++.+||.+||+.||.+|||++|+|+||||.++.
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 223 ETWPGILSNEE-FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TTSTTGGGCHH-HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred Hhchhhhcchh-hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 76654322110 00111122222233334467899999999999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=346.66 Aligned_cols=217 Identities=26% Similarity=0.428 Sum_probs=187.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..|+ ||||++++++|.. ...+|+|||||+ |+|.+++.....+++..+..
T Consensus 59 ~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~---------------- 119 (361)
T 2yab_A 59 REEIEREVSILRQVL-HPNIITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATS---------------- 119 (361)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CcCCCcEEEEEEe--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 356789999999999 9999999999864 678999999997 69999998877788888887
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 120 -------------------------------------------i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 120 -------------------------------------------FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCcc
Confidence 99999999999999999999999999999755
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++|+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 157 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235 (361)
T ss_dssp CEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred CEEEEecCCceEcCCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 59999999998877665566778999999999987755 89999999999999999999999999888777766654221
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
... ......+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 236 ~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 236 DFD---------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp CCC---------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred CCC---------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 111 1122467899999999999999999999999999999997653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=354.67 Aligned_cols=241 Identities=30% Similarity=0.544 Sum_probs=197.0
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHHh----cccccHHHHHHHHHHHHhhhcc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIRT----TDNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~~----~~~l~~~~~~~~~~~~~~~~~~ 83 (470)
...+|+++|+.|+ ||||++++++|... +...+++||||++++|.+++.. ...+++..++.
T Consensus 93 ~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~----------- 160 (420)
T 1j1b_A 93 FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL----------- 160 (420)
T ss_dssp SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHH-----------
T ss_pred hHHHHHHHHHHcC-CCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHH-----------
Confidence 3468999999999 99999999998642 2234789999999988877753 22366655555
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 161 ------------------------------------------------~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~ 192 (420)
T 1j1b_A 161 ------------------------------------------------YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 192 (420)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHTTTEECSCCSGGGEEEETT
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHCCccccCCChhhEEEeCC
Confidence 99999999999999999999999999999965
Q ss_pred --eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 --LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 --~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.+||+|||+++...........+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++..+.+.
T Consensus 193 ~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~ 272 (420)
T 1j1b_A 193 TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272 (420)
T ss_dssp TTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 689999999987765555566789999999999987656899999999999999999999999999999999999999
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCccc-ccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDV-LVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+|.|..+.+...... ...+.++......+.. +.+.+++++.+||.+||.+||.+|||+.|+|+||||+++.
T Consensus 273 lg~p~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 273 LGTPTREQIREMNPN---YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HCSCCHHHHHHHCSC---CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hCCCCHHHHHhhChh---hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 999998887765321 1112222222222222 3356789999999999999999999999999999998654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=336.79 Aligned_cols=247 Identities=30% Similarity=0.539 Sum_probs=192.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++++++ ||||+++++++.. .+..++|||||++ +|.+++.....+++..+..
T Consensus 46 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~---------------- 106 (311)
T 4agu_A 46 KKIALREIRMLKQLK-HPNLVNLLEVFRR--KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS---------------- 106 (311)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCccchhheeec--CCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHH----------------
Confidence 455789999999999 9999999999865 6789999999995 7888887777788887777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 107 -------------------------------------------i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl 143 (311)
T 4agu_A 107 -------------------------------------------ITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKL 143 (311)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++..... .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+...++...
T Consensus 144 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (311)
T 4agu_A 144 CDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI 223 (311)
T ss_dssp CCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred eeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccc
Confidence 99999987653 22335568999999999998766689999999999999999999999999999999999999888877
Q ss_pred hHHHHHHhhhccCcccccccc-CCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHHH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQ-YPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQ 319 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~~ 319 (470)
+.....+........ ...+. ..........+.++.++.+||.+||..||.+|||++|+|+||||+++.+..+
T Consensus 224 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 224 PRHQQVFSTNQYFSG-VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296 (311)
T ss_dssp HHHHHHHHTCGGGTT-CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred ccccccccccccccc-CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence 665544433111000 00000 0011122233578899999999999999999999999999999999876543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=358.45 Aligned_cols=254 Identities=31% Similarity=0.517 Sum_probs=185.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
...+.+|+.+|+.|+ ||||+++++++.......+|+||||++|+|.+++........
T Consensus 62 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~---------------------- 118 (405)
T 3rgf_A 62 SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKA---------------------- 118 (405)
T ss_dssp CHHHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-----------------------
T ss_pred CHHHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccc----------------------
Confidence 346789999999999 999999999998767788999999999999999864321000
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----eCC-e
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI----RGD-L 164 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl----~~~-~ 164 (470)
......+....++.|+.||+.||+|||++||+||||||+|||+ +.+ .
T Consensus 119 ----------------------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 119 ----------------------------NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp ----------------------------------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred ----------------------------cccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 0000112233444499999999999999999999999999999 333 8
Q ss_pred EEEEecCCcccccCC----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh---------
Q psy9855 165 VVVGDLGSLQFIKSK----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE--------- 231 (470)
Q Consensus 165 ikL~DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--------- 231 (470)
++|+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999999876532 2234568999999999998766689999999999999999999999987654
Q ss_pred HHHHHHHHHHhCCCchHHHHHHhhhccCccc---cccccCCCCCc----ccccccccHHHHHHHHHhcccCCCCCcCHHH
Q psy9855 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFT---YQFKQYPGGGI----DVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304 (470)
Q Consensus 232 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~e 304 (470)
.+++..+...+|.|....|..+......... .....+..... .......++.+.+||.+||.+||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 4788999999999988777655432211000 00000000000 0011233678899999999999999999999
Q ss_pred HHhcccCCCh
Q psy9855 305 ILSCAYFADL 314 (470)
Q Consensus 305 lL~hp~f~~~ 314 (470)
+|+||||.+.
T Consensus 331 ~L~hp~f~~~ 340 (405)
T 3rgf_A 331 AMQDPYFLED 340 (405)
T ss_dssp HHTSGGGTSS
T ss_pred HhcChhhccC
Confidence 9999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=348.39 Aligned_cols=245 Identities=32% Similarity=0.589 Sum_probs=205.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC---CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS---TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~---~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+++|.+|+ ||||+++++++.... ...+|+||||++|+|.+++... .+++..+..
T Consensus 69 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~-------------- 132 (364)
T 3qyz_A 69 CQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICY-------------- 132 (364)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhcC-CCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHhC-CCCHHHHHH--------------
Confidence 356789999999999 999999999986432 2568999999999999999754 477777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 133 ---------------------------------------------i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~ 167 (364)
T 3qyz_A 133 ---------------------------------------------FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDL 167 (364)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+|+|||++....... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 247 (364)
T 3qyz_A 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247 (364)
T ss_dssp EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH
T ss_pred EEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH
Confidence 999999998665322 2345689999999999876666899999999999999999999999999999999999999
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+|.|..+.+..........+....+......+....+.+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 99999887765444333333333333333444555677899999999999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.42 Aligned_cols=242 Identities=26% Similarity=0.523 Sum_probs=198.4
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecC------------------------------------CCCeEEEEeeccccCH
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNR------------------------------------STRQVTLVFPLMELNL 55 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~------------------------------------~~~~~~lV~E~~~gsL 55 (470)
...+|+++|+.|+ ||||++++++|... ....+++|||||+|+|
T Consensus 46 ~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L 124 (383)
T 3eb0_A 46 YKNRELDIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124 (383)
T ss_dssp SCCHHHHHHTTCC-CTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEH
T ss_pred hHHHHHHHHHHcC-CCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccH
Confidence 3468999999998 99999999998642 2345889999999988
Q ss_pred HHHHHh----cccccHHHHHHHHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHH
Q psy9855 56 EEYIRT----TDNISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTF 131 (470)
Q Consensus 56 ~~~l~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 131 (470)
.+++.. ...+++..++.
T Consensus 125 ~~~l~~~~~~~~~l~~~~~~~----------------------------------------------------------- 145 (383)
T 3eb0_A 125 HKVLKSFIRSGRSIPMNLISI----------------------------------------------------------- 145 (383)
T ss_dssp HHHHHHHHHTTCCCCHHHHHH-----------------------------------------------------------
T ss_pred HHHHHHHHhcCCCCCHHHHHH-----------------------------------------------------------
Confidence 887754 23366666655
Q ss_pred HHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccH
Q psy9855 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRG-D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDI 209 (470)
Q Consensus 132 i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DI 209 (470)
++.||+.||+|||++||+||||||+|||++. + .++|+|||++............+||+.|+|||++.+...++.++||
T Consensus 146 i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 9999999999999999999999999999984 3 8999999999877666666677899999999999876668999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCccc-ccccccHHHHHHH
Q psy9855 210 WAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDV-LVPQIHEKGKKLM 288 (470)
Q Consensus 210 wSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li 288 (470)
||+||++|+|++|++||.+.+..+.+..+...+|.|..+.+....... ....++......+.. ++..+++++.+||
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY---TEVRFPTLKAKDWRKILPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccc---ccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence 999999999999999999999999999999999999988776654311 111222222222222 3346889999999
Q ss_pred HHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 289 SEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 289 ~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.+||..||.+|||+.|+|+||||+++..
T Consensus 303 ~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 9999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=332.19 Aligned_cols=217 Identities=21% Similarity=0.341 Sum_probs=182.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. .+.+|+|||||+ |+|.+++... .+++..+..
T Consensus 61 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~---------------- 120 (297)
T 3fxz_A 61 KELIINEILVMRENK-NPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAA---------------- 120 (297)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHH----------------
T ss_pred HHHHHHHHHHHhcCC-CCCCCeEeEEEEE--CCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHH----------------
Confidence 445789999999999 9999999999875 667999999998 6999999764 477777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 121 -------------------------------------------~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl 157 (297)
T 3fxz_A 121 -------------------------------------------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL 157 (297)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--- 233 (297)
T 3fxz_A 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--- 233 (297)
T ss_dssp CCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS---
T ss_pred eeCCCceecCCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Confidence 9999988765433 334568999999999998765 89999999999999999999999998887766655543210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHHH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLK 318 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~~ 318 (470)
.....+..+++.+.+||.+||..||.+|||+.|+|+||||+......
T Consensus 234 -------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 280 (297)
T 3fxz_A 234 -------------------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280 (297)
T ss_dssp -------------------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred -------------------------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccc
Confidence 01112346789999999999999999999999999999998765443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=343.03 Aligned_cols=239 Identities=31% Similarity=0.601 Sum_probs=198.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|..|+ ||||+++++++.. .+..++||||++++|.+++..... +++..+..
T Consensus 57 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~----------------- 116 (346)
T 1ua2_A 57 RTALREIKLLQELS-HPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA----------------- 116 (346)
T ss_dssp THHHHHHHHHHHCC-CTTBCCEEEEECC--TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHH-----------------
T ss_pred HHHHHHHHHHhhCC-CCCCCeEEEEEee--CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHH-----------------
Confidence 45789999999999 9999999999854 677999999999999999876543 66666666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 117 ------------------------------------------~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 117 ------------------------------------------YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|.+..
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 155 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234 (346)
T ss_dssp CCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred ecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999876533 23455689999999999977666899999999999999999999999999999999999999998887
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+.|......... ..+...+..........+++++.+||.+||..||.+|||+.|+|+||||.+.
T Consensus 235 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 235 EQWPDMCSLPDY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTSSSTTSSTTC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhhhccCccc---ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 766544332111 1111122222333446788999999999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=344.04 Aligned_cols=213 Identities=22% Similarity=0.321 Sum_probs=180.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..+.+||||++++++|.. .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 68 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~----------------- 128 (353)
T 3txo_A 68 ECTMTEKRILSLARNHPFLTQLFCCFQT--PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF----------------- 128 (353)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhccCCCceeeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 4568999999999669999999999865 678999999999 59999998887788888887
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 129 ------------------------------------------~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 129 ------------------------------------------YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....+....
T Consensus 167 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----- 240 (353)
T 3txo_A 167 DFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----- 240 (353)
T ss_dssp CCTTCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----
T ss_pred cccceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----
Confidence 999998643 333445678999999999987765 8999999999999999999999999998888777775410
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH------HHHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA------QKILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~------~elL~hp~f~~~~~ 316 (470)
..++..+++.+.+||.+||..||.+||++ +++++||||++++.
T Consensus 241 --------------------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 241 --------------------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 11234578999999999999999999999 99999999998864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=337.39 Aligned_cols=212 Identities=23% Similarity=0.316 Sum_probs=183.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..++.
T Consensus 50 ~~~~~E~~~l~~l~-hp~iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~----------------- 109 (337)
T 1o6l_A 50 AHTVTESRVLQNTR-HPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARF----------------- 109 (337)
T ss_dssp HHHHHHHHHHHSCC-CTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCcCcceEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45789999999998 9999999999865 678999999998 59999998877788888877
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 110 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~ 147 (337)
T 1o6l_A 110 ------------------------------------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKIT 147 (337)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+...
T Consensus 148 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------ 220 (337)
T 1o6l_A 148 DFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------ 220 (337)
T ss_dssp CCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------
T ss_pred eccchhhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------
Confidence 999998643 333456678999999999987755 899999999999999999999999988776666555431
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
...++..+++++.+||.+||..||.+|| +++++++||||.++..
T Consensus 221 -------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 221 -------------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp -------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 0112346789999999999999999999 9999999999998763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=342.40 Aligned_cols=245 Identities=31% Similarity=0.562 Sum_probs=193.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeec---CCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVN---RSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~---~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+.+|.+|+ ||||+++++++.. .....+|+||||++|+|.+++..... +++..+..
T Consensus 74 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~-------------- 138 (362)
T 3pg1_A 74 KRVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-------------- 138 (362)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHhCC-CcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHH--------------
Confidence 56789999999999 9999999999864 33457899999999999999876553 77777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||++||+||||||+|||++.+ .+
T Consensus 139 ---------------------------------------------~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 139 ---------------------------------------------FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||++............+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....|.+
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999999866655555667899999999998875568999999999999999999999999999999999999999999
Q ss_pred chHHHHHHhhhccCccc-cccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFT-YQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
....+..+.......+. ......+...+....+.+++.+.+||.+||..||.+|||+.|+|+||||+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 87765543221111111 11122233344455567899999999999999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=339.56 Aligned_cols=217 Identities=24% Similarity=0.347 Sum_probs=185.7
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
.....+.+|+.+|+.++ ||||+++++++.. .+.+++|||||+ |+|.+++.... .+++..+..
T Consensus 43 ~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~------------- 106 (321)
T 1tki_A 43 TDQVLVKKEISILNIAR-HRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVS------------- 106 (321)
T ss_dssp HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEE--TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHH-------------
T ss_pred ccHHHHHHHHHHHHhCC-CCCCCeEeEEEec--CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHH-------------
Confidence 34556789999999999 9999999999865 678999999999 59999997765 478877777
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC--C
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG--D 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~--~ 163 (470)
++.||+.||+|||++||+||||||+|||++. +
T Consensus 107 ----------------------------------------------i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~ 140 (321)
T 1tki_A 107 ----------------------------------------------YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS 140 (321)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCC
Confidence 9999999999999999999999999999985 3
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 141 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 219 (321)
T 1tki_A 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp CCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred CCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC
Confidence 89999999998876665556678999999999987754 7999999999999999999999999988887777766532
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
..... ...+.++.++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 220 ~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 220 YTFDE---------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCCH---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCh---------------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 21111 1124678999999999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=344.36 Aligned_cols=215 Identities=27% Similarity=0.365 Sum_probs=184.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.|+ ||||+++++++.. .+..|+|||||+ |+|.+++.....+++..+..
T Consensus 72 ~~~~~~E~~il~~l~-hpnIv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~---------------- 132 (362)
T 2bdw_A 72 FQKLEREARICRKLQ-HPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASH---------------- 132 (362)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEEe--CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHH----------------
Confidence 456789999999998 9999999999865 678999999999 59999998877788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 133 -------------------------------------------~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (362)
T 2bdw_A 133 -------------------------------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 169 (362)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCC
Confidence 99999999999999999999999999999754 5
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+||+|||++............+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 170 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 248 (362)
T 2bdw_A 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248 (362)
T ss_dssp EEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEeecCcceEecCCcccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999999998777655556678999999999987755 899999999999999999999999988877766666542110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
. .......+++++.+||.+||..||.+|||+.++|+||||...
T Consensus 249 ~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 249 Y---------------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp C---------------------------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred C---------------------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 0 011124678999999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.68 Aligned_cols=244 Identities=28% Similarity=0.454 Sum_probs=193.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC------CCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS------TRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANE 82 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~------~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~ 82 (470)
...+++|+.+|+.++ ||||+++++++.... .+.+|+|||||+|+|.+.+.... .+++..+..
T Consensus 60 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~---------- 128 (351)
T 3mi9_A 60 PITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR---------- 128 (351)
T ss_dssp CHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHH----------
T ss_pred hHHHHHHHHHHHhcc-CCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHH----------
Confidence 346789999999999 999999999987533 45789999999999998887654 377777766
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.||+.||+|||++||+||||||+|||++.
T Consensus 129 -------------------------------------------------i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~ 159 (351)
T 3mi9_A 129 -------------------------------------------------VMQMLLNGLYYIHRNKILHRDMKAANVLITR 159 (351)
T ss_dssp -------------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC
Confidence 9999999999999999999999999999997
Q ss_pred C-eEEEEecCCcccccC-----CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKS-----KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
+ .++|+|||++..... .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 160 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 239 (351)
T 3mi9_A 160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239 (351)
T ss_dssp TSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 7 899999999986542 2223456889999999999876668999999999999999999999999999999999
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCccccc--ccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLV--PQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+....+.++...+................ .......... ...++.+.+||.+||..||.+|||++|+|+||||.+.
T Consensus 240 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 240 LISQLCGSITPEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHHHHHCCCCTTTSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HHHHHhCCCChhhccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 999999988877665544322110000000 0000000000 1136789999999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=333.76 Aligned_cols=217 Identities=29% Similarity=0.430 Sum_probs=186.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.|+ ||||+++++++.. ...+++|||||+ |+|.+++.....+++..+..
T Consensus 58 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 118 (326)
T 2y0a_A 58 REDIEREVSILKEIQ-HPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATE---------------- 118 (326)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEEe--CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHH----------------
Confidence 456789999999999 9999999999864 678999999998 69999998777788888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 119 -------------------------------------------i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 119 -------------------------------------------FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCC
Confidence 99999999999999999999999999999765
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++|+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 156 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234 (326)
T ss_dssp CEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred CEEEEECCCCeECCCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence 59999999998876555556678999999999987655 89999999999999999999999998887777766654221
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
... ....+.++..+.+||.+||..||.+|||+.++|+||||.....
T Consensus 235 ~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 235 EFE---------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp CCC---------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred CcC---------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 111 1122467889999999999999999999999999999997653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=346.47 Aligned_cols=210 Identities=23% Similarity=0.379 Sum_probs=180.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
..+.+|+.+|+.++ ||||+++++++.. .+.+++||||++|+|.+++.....+++..+..
T Consensus 54 ~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~------------------ 112 (336)
T 3h4j_B 54 MRVEREISYLKLLR-HPHIIKLYDVITT--PTDIVMVIEYAGGELFDYIVEKKRMTEDEGRR------------------ 112 (336)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEECCCCEEHHHHHHHHCSCCHHHHHH------------------
T ss_pred HHHHHHHHHHHhCC-CCCCCeEEEEEEe--CCEEEEEEECCCCcHHHHHHHcCCCCHHHHHH------------------
Confidence 35789999999999 9999999999865 67899999999999999998877788888877
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEe
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGD 169 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~D 169 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+|
T Consensus 113 -----------------------------------------i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 113 -----------------------------------------FFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp -----------------------------------------HHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECC
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEE
Confidence 99999999999999999999999999999988 899999
Q ss_pred cCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Q psy9855 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249 (470)
Q Consensus 170 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~ 249 (470)
||++............+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.......
T Consensus 152 FG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------- 217 (336)
T 3h4j_B 152 FGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------- 217 (336)
T ss_dssp SSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------------
T ss_pred eccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------------
Confidence 999988776666677899999999999987665578999999999999999999999764321100
Q ss_pred HHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
..........+..+++++.+||.+||..||.+|||++|+++||||+.
T Consensus 218 -----------------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 218 -----------------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -----------------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -----------------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 00011222344568999999999999999999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.96 Aligned_cols=216 Identities=25% Similarity=0.364 Sum_probs=184.3
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
+...+.+|+.+|+.|+ ||||+++++++.. .+..|+|||||+ |+|.+++.....+++..+..
T Consensus 53 ~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~--------------- 114 (444)
T 3soa_A 53 DHQKLEREARICRLLK-HPNIVRLHDSISE--EGHHYLIFDLVTGGELFEDIVAREYYSEADASH--------------- 114 (444)
T ss_dssp HHHHHHHHHHHHHHCC-BTTBCCEEEEEEC--SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHHhCC-CcCCCeEEEEEEE--CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHH---------------
Confidence 3456789999999998 9999999999864 778999999998 59999999888888888887
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---C-
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG---D- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---~- 163 (470)
++.||+.||+|||++||+||||||+|||++. +
T Consensus 115 --------------------------------------------i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 115 --------------------------------------------CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTC
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCC
Confidence 9999999999999999999999999999974 2
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.+||+|||++....... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 151 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 229 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229 (444)
T ss_dssp CEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred cEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Confidence 79999999998765433 335678999999999987755 8999999999999999999999999988877777665421
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
... .....+.+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 230 ~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 230 YDF---------------------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp CCC---------------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CCC---------------------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 110 011124678999999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=341.14 Aligned_cols=242 Identities=31% Similarity=0.582 Sum_probs=196.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCC----CeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRST----RQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~----~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+|+.++ ||||+++++++...+. ..+|+||||++++|.+++.. .+++..+..
T Consensus 85 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~------------- 148 (371)
T 4exu_A 85 AKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM--EFSEEKIQY------------- 148 (371)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTS--CCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcC-CCCchhhhhheeccCCcccceeEEEEEccccccHHHHhhc--CCCHHHHHH-------------
Confidence 456789999999999 9999999999865322 13499999999999998743 377777776
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 149 ----------------------------------------------i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 149 ----------------------------------------------LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC
Confidence 99999999999999999999999999999988 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++...... ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....|.
T Consensus 183 ~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 260 (371)
T 4exu_A 183 LKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 260 (371)
T ss_dssp EEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999999765432 345688999999999987556899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+..+.+..+.......+.......+........+.+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 98876654433222222222333333444445567899999999999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=332.89 Aligned_cols=243 Identities=30% Similarity=0.520 Sum_probs=192.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.++ ||||+++++++.. .+..++||||+++ +|.+++.....+++..+..
T Consensus 68 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~---------------- 128 (331)
T 4aaa_A 68 KKIAMREIKLLKQLR-HENLVNLLEVCKK--KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQK---------------- 128 (331)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHhhCC-CCCEeeEEEEeec--CCEEEEEEecCCcchHHHHHhhccCCCHHHHHH----------------
Confidence 445679999999999 9999999999865 6789999999995 7777766666688877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 129 -------------------------------------------~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 129 -------------------------------------------YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|...
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (331)
T 4aaa_A 166 CDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI 245 (331)
T ss_dssp CCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred EeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence 999999765532 2334568999999999998765689999999999999999999999999999999999999888887
Q ss_pred hHHHHHHhhhccCcccccccc-CCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQ-YPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+.....+........ ...+. ..........+.+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 246 PRHQELFNKNPVFAG-VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp HHHHHHHHHCGGGTT-CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred hhhhhHhhhcccccc-ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 766555443211110 01111 011122233457899999999999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.38 Aligned_cols=210 Identities=22% Similarity=0.366 Sum_probs=182.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||+++++++.. ...+|+||||++ |+|.+++.....+++..++.
T Consensus 51 ~~~~~E~~~l~~l~-hp~Iv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~----------------- 110 (318)
T 1fot_A 51 EHTNDERLMLSIVT-HPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF----------------- 110 (318)
T ss_dssp HHHHHHHHHHHSCC-BTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHhhCC-CCCCceEeEEEEe--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 35678999999998 9999999999865 678999999998 59999998877788888777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 111 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~ 148 (318)
T 1fot_A 111 ------------------------------------------YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKIT 148 (318)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+....
T Consensus 149 Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------ 219 (318)
T 1fot_A 149 DFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------ 219 (318)
T ss_dssp CCSSCEECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------
T ss_pred ecCcceecCC--ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Confidence 9999986543 234568999999999987755 8999999999999999999999999888777766665410
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
..+++.+++++.+||.+||..||.+|| +++++++||||+++..
T Consensus 220 -------------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 220 -------------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp -------------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 112346789999999999999999999 9999999999998763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.12 Aligned_cols=241 Identities=29% Similarity=0.557 Sum_probs=180.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+++.++ ||||+++++++.... ...+|+|||||+|+|.+++.. .+++..+..
T Consensus 68 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~------------- 131 (371)
T 2xrw_A 68 AKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSY------------- 131 (371)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS--CCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcC-CCCccceEEeeccccccccccceEEEEEcCCCCHHHHHhh--ccCHHHHHH-------------
Confidence 456789999999998 999999999986532 247899999999999999853 367766666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 132 ----------------------------------------------i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 132 ----------------------------------------------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC
Confidence 99999999999999999999999999999987 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+||+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...+|.
T Consensus 166 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 166 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp EEECCCCC----------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEEEeecccccccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999998776554555678999999999998755 899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCccc------------ccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDV------------LVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
|.++.+..+...... +....+......... .....+.++.+||.+||..||.+|||++|+|+||||+
T Consensus 245 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRT-YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CCHHHHTTSCHHHHH-HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCHHHHHHhhhHHHH-HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 887766443221000 000000000000000 0112367899999999999999999999999999997
Q ss_pred Ch
Q psy9855 313 DL 314 (470)
Q Consensus 313 ~~ 314 (470)
..
T Consensus 324 ~~ 325 (371)
T 2xrw_A 324 VW 325 (371)
T ss_dssp TT
T ss_pred hh
Confidence 54
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.25 Aligned_cols=213 Identities=19% Similarity=0.269 Sum_probs=183.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|..+|..+.+||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 65 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~----------------- 125 (353)
T 2i0e_A 65 ECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF----------------- 125 (353)
T ss_dssp HHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 4578999999998559999999999865 678999999998 59999998877788888777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 126 ------------------------------------------~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 126 ------------------------------------------YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+....+....
T Consensus 164 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----- 237 (353)
T 2i0e_A 164 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----- 237 (353)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----
T ss_pred eCCcccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-----
Confidence 999998643 333445678999999999997765 8999999999999999999999999988777776665410
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
..++..+++++.+||.+||..||.+||+ ++++++||||+.++.
T Consensus 238 --------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 238 --------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 1123468899999999999999999994 799999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.61 Aligned_cols=213 Identities=20% Similarity=0.301 Sum_probs=177.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|..+|.++.+||||++++++|.. .+.+|+|||||+ |+|..++.....+++..++.
T Consensus 97 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~----------------- 157 (396)
T 4dc2_A 97 DWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF----------------- 157 (396)
T ss_dssp CHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 3467999999988459999999999865 678999999998 59999998877788888887
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 158 ------------------------------------------~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 158 ------------------------------------------YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999888 89999
Q ss_pred ecCCcccc-cCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHH
Q psy9855 169 DLGSLQFI-KSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID---------QLDRI 238 (470)
Q Consensus 169 DFG~a~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~---------~~~~i 238 (470)
|||+++.. .........+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+....+ ....+
T Consensus 196 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i 274 (396)
T 4dc2_A 196 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274 (396)
T ss_dssp CCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred ecceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence 99999863 3444556779999999999998765 8999999999999999999999996532111 11111
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH------HHHHhcccCC
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA------QKILSCAYFA 312 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~------~elL~hp~f~ 312 (470)
.. ....++..++.++.+||.+||+.||.+||++ +|+++||||+
T Consensus 275 ~~-------------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 275 LE-------------------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp HH-------------------------------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred hc-------------------------------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 11 0112334688999999999999999999995 8999999999
Q ss_pred ChhH
Q psy9855 313 DLTQ 316 (470)
Q Consensus 313 ~~~~ 316 (470)
+++.
T Consensus 324 ~i~w 327 (396)
T 4dc2_A 324 NVDW 327 (396)
T ss_dssp TCCH
T ss_pred CCCH
Confidence 8864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=336.18 Aligned_cols=213 Identities=22% Similarity=0.342 Sum_probs=183.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|..+|..+..||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 62 ~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~----------------- 122 (345)
T 1xjd_A 62 ECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF----------------- 122 (345)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 4567899999987449999999999865 678999999998 69999998877788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 123 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 123 ------------------------------------------YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+....
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----- 234 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----- 234 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-----
Confidence 999997643 233445678999999999998765 8999999999999999999999999988777766664310
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHH-HHHhcccCCChhH
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ-KILSCAYFADLTQ 316 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~-elL~hp~f~~~~~ 316 (470)
..++..+++++.+||.+||..||.+||++. ++++||||+++..
T Consensus 235 --------------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 235 --------------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 112245789999999999999999999998 9999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.80 Aligned_cols=210 Identities=25% Similarity=0.344 Sum_probs=183.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||+++++++.. .+.+|+||||++ |+|.+++.....+++..+..
T Consensus 86 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~----------------- 145 (350)
T 1rdq_E 86 EHTLNEKRILQAVN-FPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF----------------- 145 (350)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCCCeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 45789999999998 9999999999865 678999999998 69999998877788888777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 146 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~ 183 (350)
T 1rdq_E 146 ------------------------------------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 184 DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------ 254 (350)
T 1rdq_E 184 DFGFAKRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------ 254 (350)
T ss_dssp CCTTCEECSSC--BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------
T ss_pred ccccceeccCC--cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC------
Confidence 99999876433 34568999999999998765 8999999999999999999999999888777766665410
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
..++..++.++.+||.+||..||.+||+ ++++++||||.+++.
T Consensus 255 -------------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 255 -------------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 1123467899999999999999999998 999999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=335.99 Aligned_cols=242 Identities=31% Similarity=0.581 Sum_probs=194.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCC----CeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRST----RQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~----~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+|+.++ ||||+++++++..... ..+|+||||++++|.+++.. .+++..+..
T Consensus 67 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~------------- 130 (353)
T 3coi_A 67 AKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL--KFSEEKIQY------------- 130 (353)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTTS--CCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcC-CCCcccHhheEecccccccceeEEEEeccccCCHHHHhcC--CCCHHHHHH-------------
Confidence 456789999999999 9999999999865322 24699999999999888743 377777666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 131 ----------------------------------------------i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 131 ----------------------------------------------LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc
Confidence 99999999999999999999999999999987 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++...... ....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....|.
T Consensus 165 ~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 165 LKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp EEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred EEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999998765432 345688999999999887556899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+..+.+..+.......+....+..+...+....+.+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 88776654332211112222222233334445567899999999999999999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=339.46 Aligned_cols=213 Identities=21% Similarity=0.355 Sum_probs=181.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||++++++|.. .+.+|+|||||. |+|.+++.....+++..++.
T Consensus 60 ~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~----------------- 119 (384)
T 4fr4_A 60 RNVFKELQIMQGLE-HPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL----------------- 119 (384)
T ss_dssp HHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCCCcEEEEEEe--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 46789999999998 9999999999865 678999999998 59999999877788888877
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 120 ------------------------------------------~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~ 157 (384)
T 4fr4_A 120 ------------------------------------------FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHIT 157 (384)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEI---DQLDRIHQVLG 243 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~---~~~~~i~~~~g 243 (470)
|||++............+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+.... .....+..
T Consensus 158 DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--- 234 (384)
T 4fr4_A 158 DFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--- 234 (384)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---
T ss_pred ccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---
Confidence 99999887766666778999999999998642 24889999999999999999999999754322 22222111
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-HHHHHhcccCCChhH
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-AQKILSCAYFADLTQ 316 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-~~elL~hp~f~~~~~ 316 (470)
.....+..++..+.+||.+||..||.+||+ ++++++||||+++..
T Consensus 235 ----------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 235 ----------------------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp ----------------------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred ----------------------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 011223467899999999999999999999 999999999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=329.16 Aligned_cols=244 Identities=24% Similarity=0.432 Sum_probs=191.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.|.+||||+++++++........++||||++ ++|.+++.. +++..+..
T Consensus 74 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~---------------- 134 (330)
T 3nsz_A 74 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRF---------------- 134 (330)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---CCHHHHHH----------------
T ss_pred hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---CCHHHHHH----------------
Confidence 4567899999999988999999999998766778999999999 599998753 66666666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 135 -------------------------------------------~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~k 171 (330)
T 3nsz_A 135 -------------------------------------------YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 171 (330)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999855 799
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF-PGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||++............+||+.|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+...++.+
T Consensus 172 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 172 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251 (330)
T ss_dssp ECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred EEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence 999999987766666667789999999999987566899999999999999999999998 4566777777777777754
Q ss_pred chHHHHHHhhhc-cCccccccccCCCCCc-----ccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYK-SSNFTYQFKQYPGGGI-----DVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
....+....... ...+...........+ ......+++++.+||.+||..||.+|||++|+|+||||+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 332221111100 0000000000011111 112234789999999999999999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.97 Aligned_cols=217 Identities=24% Similarity=0.374 Sum_probs=183.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|.+|+ ||||+++++++.. .+.+++|||||+ ++|.+++.... .+++..+..
T Consensus 130 ~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~--------------- 191 (373)
T 2x4f_A 130 KEEVKNEISVMNQLD-HANLIQLYDAFES--KNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL--------------- 191 (373)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHH---------------
Confidence 456789999999998 9999999999865 678999999998 59999887654 377766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe--CC-e
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR--GD-L 164 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~--~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||+. .+ .
T Consensus 192 --------------------------------------------i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 227 (373)
T 2x4f_A 192 --------------------------------------------FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ 227 (373)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCc
Confidence 999999999999999999999999999994 33 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 228 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 306 (373)
T 2x4f_A 228 IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD 306 (373)
T ss_dssp EEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred EEEEeCCCceecCCccccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Confidence 9999999998877665556678999999999987654 899999999999999999999999998888777776542111
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
......+.+++++.+||.+||..||.+|||+.|+|+||||.+...
T Consensus 307 ---------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 307 ---------------------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp ---------------------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred ---------------------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 011122467899999999999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.98 Aligned_cols=215 Identities=23% Similarity=0.386 Sum_probs=182.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|..|+ ||||+++++++.. ...+++|||||+ |+|.+++.... .+++..+..
T Consensus 92 ~~~~~~E~~il~~l~-hpnIv~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~--------------- 153 (387)
T 1kob_A 92 KYTVKNEISIMNQLH-HPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN--------------- 153 (387)
T ss_dssp HHHHHHHHHHHTTCC-STTBCCEEEEEEC--SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CcCCCeEEEEEEe--CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHH---------------
Confidence 456789999999998 9999999999865 678999999998 59999997654 378877777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---e
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---L 164 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 154 --------------------------------------------i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~ 189 (387)
T 1kob_A 154 --------------------------------------------YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189 (387)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCC
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCc
Confidence 99999999999999999999999999999743 6
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 190 vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~- 267 (387)
T 1kob_A 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW- 267 (387)
T ss_dssp EEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-
T ss_pred eEEEecccceecCCCcceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-
Confidence 9999999998876655555668999999999987755 89999999999999999999999999887776666544110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.........+++++.+||.+||..||.+|||+.++|+||||++.
T Consensus 268 --------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 268 --------------------------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp --------------------------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------------------------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 00111234678999999999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=331.16 Aligned_cols=224 Identities=23% Similarity=0.220 Sum_probs=154.2
Q ss_pred hHHHHHHhcCCCCCCeeeeceeeecCCC--CeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 14 LKEISILRKIPDHLNVLCLCETYVNRST--RQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 14 ~rEi~iL~~L~~HpnIv~l~~~~~~~~~--~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+|+..+.+|+ |||||+++|++...+. ..+|||||||+ |+|.++|.... +++..+..
T Consensus 45 e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-l~~~~~~~------------------ 104 (303)
T 3hmm_A 45 EAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIK------------------ 104 (303)
T ss_dssp HHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BCHHHHHH------------------
T ss_pred HHHHHHHhcCC-CCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC-CCHHHHHH------------------
Confidence 34566667888 9999999999875432 36899999999 69999997643 66666666
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCcEEEeC
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY--------KVFHRDIKPENILIRG 162 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~--------gIvHrDLKp~NILl~~ 162 (470)
++.|++.||+|||++ |||||||||+|||++.
T Consensus 105 -----------------------------------------i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~ 143 (303)
T 3hmm_A 105 -----------------------------------------LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp -----------------------------------------HHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred -----------------------------------------HHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC
Confidence 999999999999987 9999999999999998
Q ss_pred C-eEEEEecCCcccccCCCc-----cccccccCcccCchhhccCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy9855 163 D-LVVVGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLTEG-----YYSFELDIWAAGCVFYETLTRNPLFPGDSE 231 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~-----~~~~~~DIwSlG~il~elltg~~pf~~~~~ 231 (470)
+ .+||+|||+++....... ....+||+.|||||++.+.. .|+.++|||||||++|||++|.+||.....
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~ 223 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc
Confidence 8 899999999987654322 23458999999999987642 267799999999999999999887643221
Q ss_pred HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 232 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
...... ......+..+.+..... ..... +...........+..+.+||.+||..||++|||+.|+++
T Consensus 224 ~~~p~~-~~~~~~~~~~~~~~~~~--~~~~r------p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 224 YQLPYY-DLVPSDPSVEEMRKVVC--EQKLR------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCCTTT-TTSCSSCCHHHHHHHHT--TSCCC------CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccch-hcccccchHHHHHHHHh--cccCC------CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 000000 00000000011100000 00000 000000111234567899999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=329.71 Aligned_cols=211 Identities=24% Similarity=0.381 Sum_probs=174.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|+.++ ||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 66 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 125 (327)
T 3a62_A 66 AHTKAERNILEEVK-HPFIVDLIYAFQT--GGKLYLILEYLSGGELFMQLEREGIFMEDTACF----------------- 125 (327)
T ss_dssp -----HHHHHHHCC-CTTBCCEEEEEEC--SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCccceeEEEEc--CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHH-----------------
Confidence 45679999999999 9999999999865 678999999998 69999998777788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 126 ------------------------------------------~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 126 ------------------------------------------YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++..... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----- 237 (327)
T 3a62_A 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK----- 237 (327)
T ss_dssp CCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----
T ss_pred eCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----
Confidence 9999876432 23345568999999999987755 8999999999999999999999999888777666664410
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
..+++.++.++.+||.+||..||.+|| ++.++++||||+++.
T Consensus 238 --------------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 238 --------------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 112346789999999999999999999 899999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=327.01 Aligned_cols=241 Identities=33% Similarity=0.640 Sum_probs=198.0
Q ss_pred hhhhHHHHHHhcC---CCCCCeeeeceeeec---CCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhc
Q psy9855 11 VANLKEISILRKI---PDHLNVLCLCETYVN---RSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANE 82 (470)
Q Consensus 11 ~~~~rEi~iL~~L---~~HpnIv~l~~~~~~---~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~ 82 (470)
..+.+|+.+++.+ + ||||+++++++.. .....+++||||++|+|.+++..... +++..+..
T Consensus 56 ~~~~~e~~~l~~l~~~~-h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~---------- 124 (326)
T 1blx_A 56 LSTIREVAVLRHLETFE-HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD---------- 124 (326)
T ss_dssp CTHHHHHHHHHHHHHTC-CTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHH----------
T ss_pred chhhHHHHHHHhhhccC-CCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHH----------
Confidence 3567898888877 6 9999999999862 24567999999999999999987543 67766666
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.||+.||.|||++||+||||||+|||++.
T Consensus 125 -------------------------------------------------~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 125 -------------------------------------------------MMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 155 (326)
T ss_dssp -------------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHCCceeccCCHHHeEEcC
Confidence 9999999999999999999999999999987
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+ .++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp TCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCCEEEecCcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 7 89999999998766544455678999999999987755 899999999999999999999999999999999999998
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.+.+....|........ ..+..........+.+.++..+.+||.+||..||.+|||+.++|+||||+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp HCCCCGGGSCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cCCCCcccCccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 88887766543221111 111111222344455678999999999999999999999999999999997653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=324.76 Aligned_cols=218 Identities=26% Similarity=0.424 Sum_probs=186.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..++ ||||+++++++.. .+.+++||||++ ++|.+++.....+++..+..
T Consensus 59 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 119 (321)
T 2a2a_A 59 REEIEREVSILRQVL-HHNVITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATS---------------- 119 (321)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEec--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 456789999999999 9999999999864 678999999998 69999998877788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 120 -------------------------------------------i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 120 -------------------------------------------FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcC
Confidence 99999999999999999999999999999765
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 157 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 235 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235 (321)
T ss_dssp CEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred CEEEccCccceecCccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 59999999998776655556678999999999987755 89999999999999999999999998887776666543211
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHH
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~ 317 (470)
..+ ......+++.+.+||.+||..||.+|||+.++++||||......
T Consensus 236 ~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 236 DFD---------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282 (321)
T ss_dssp CCC---------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred ccC---------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence 111 11224678899999999999999999999999999999987643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=331.52 Aligned_cols=213 Identities=19% Similarity=0.279 Sum_probs=176.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|.++.+||||++++++|.. .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 54 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~----------------- 114 (345)
T 3a8x_A 54 DWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF----------------- 114 (345)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH-----------------
Confidence 4578999999998449999999999865 678999999998 59999998877788888877
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 115 ------------------------------------------~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 115 ------------------------------------------YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHH
Q psy9855 169 DLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE---------IDQLDRI 238 (470)
Q Consensus 169 DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~---------~~~~~~i 238 (470)
|||++.... ........+||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ......+
T Consensus 153 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 153 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred eccccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 999997643 333445679999999999998765 89999999999999999999999965211 1111111
Q ss_pred HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH------HHHHhcccCC
Q psy9855 239 HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA------QKILSCAYFA 312 (470)
Q Consensus 239 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~------~elL~hp~f~ 312 (470)
.. ....++..++.++.+||.+||..||.+||++ +++++||||+
T Consensus 232 ~~-------------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 232 LE-------------------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp HH-------------------------------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred Hc-------------------------------CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 11 0011234688999999999999999999995 8999999999
Q ss_pred ChhH
Q psy9855 313 DLTQ 316 (470)
Q Consensus 313 ~~~~ 316 (470)
++..
T Consensus 281 ~~~w 284 (345)
T 3a8x_A 281 NVDW 284 (345)
T ss_dssp TCCH
T ss_pred CCCH
Confidence 8763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=327.45 Aligned_cols=212 Identities=26% Similarity=0.369 Sum_probs=174.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|+.|+ ||||+++++++.......+|+||||++ ++|.+++.. ..+++..+..
T Consensus 81 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~----------------- 141 (298)
T 2zv2_A 81 EQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARF----------------- 141 (298)
T ss_dssp CHHHHHHHHHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHH-----------------
Confidence 46789999999998 999999999998766788999999998 588776432 3466766666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 142 ------------------------------------------~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 179 (298)
T 2zv2_A 142 ------------------------------------------YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIA 179 (298)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCC-ccccccccCcccCchhhccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 169 DLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 169 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~--~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|||++....... .....+||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.........+....
T Consensus 180 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--- 256 (298)
T 2zv2_A 180 DFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA--- 256 (298)
T ss_dssp CCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---
T ss_pred cCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhccc---
Confidence 999998765432 3345689999999999876542 4778999999999999999999998876655444443210
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
......+.+++++.+||.+||..||.+|||+.|+++||||+
T Consensus 257 --------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 257 --------------------------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp --------------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred --------------------------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 00011246789999999999999999999999999999995
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=331.68 Aligned_cols=242 Identities=28% Similarity=0.471 Sum_probs=195.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC-----CCeEEEEeeccccCHHHHHHh----cccccHHHHHHHHHHHHhhh
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS-----TRQVTLVFPLMELNLEEYIRT----TDNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~-----~~~~~lV~E~~~gsL~~~l~~----~~~l~~~~~~~~~~~~~~~~ 81 (470)
....+|++.+..++ ||||++++++|.... ...+++||||++++|...+.. ...+++..+..
T Consensus 64 ~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~--------- 133 (360)
T 3e3p_A 64 NRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV--------- 133 (360)
T ss_dssp CHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHH---------
T ss_pred HHHHHHHHHHHhcC-CCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHH---------
Confidence 35678888888898 999999999986422 223889999999987766543 23355555555
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH--hCCCeecCCCCCcEE
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH--SYKVFHRDIKPENIL 159 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH--~~gIvHrDLKp~NIL 159 (470)
++.||+.||.||| ++||+||||||+|||
T Consensus 134 --------------------------------------------------~~~qi~~al~~lH~~~~~ivH~Dlkp~NIl 163 (360)
T 3e3p_A 134 --------------------------------------------------FLFQLIRSIGCLHLPSVNVCHRDIKPHNVL 163 (360)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHTSTTTCCBCSCCCGGGEE
T ss_pred --------------------------------------------------HHHHHHHHHHHHhCCCCCeecCcCCHHHEE
Confidence 9999999999999 999999999999999
Q ss_pred EeC-C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 160 IRG-D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 160 l~~-~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
++. + .++|+|||++............+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..
T Consensus 164 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 164 VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp EETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 986 4 89999999998877666666778999999999997766689999999999999999999999999999999999
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcc----cccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGID----VLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
+.+.++.+..+.+..+...... ..........+. ......++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCC---GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHcCCCCHHHHHhcccchhh---ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 9999999998887766432111 111111111111 122346789999999999999999999999999999987
Q ss_pred hh
Q psy9855 314 LT 315 (470)
Q Consensus 314 ~~ 315 (470)
..
T Consensus 321 ~~ 322 (360)
T 3e3p_A 321 LH 322 (360)
T ss_dssp GG
T ss_pred cC
Confidence 64
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.05 Aligned_cols=245 Identities=31% Similarity=0.611 Sum_probs=192.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC---CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR---STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~---~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|..++ ||||+++++++... .....++||||++|+|.+++... .+++..+..
T Consensus 53 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~-------------- 116 (353)
T 2b9h_A 53 ALRTLREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-MLSDDHIQY-------------- 116 (353)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHHC-CCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhCc-CCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhhc-CCCHHHHHH--------------
Confidence 446789999999999 99999999987542 23679999999999999998763 477777766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 117 ---------------------------------------------~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~ 151 (353)
T 2b9h_A 117 ---------------------------------------------FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDL 151 (353)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCc-----------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy9855 166 VVGDLGSLQFIKSKGL-----------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ 234 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~-----------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~ 234 (470)
+|+|||++........ ....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 231 (353)
T 2b9h_A 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231 (353)
T ss_dssp EECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999986643211 22357899999999987656689999999999999999999999999999999
Q ss_pred HHHHHHHhCCCchHHHHH-HhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 235 LDRIHQVLGTPKAETLKK-FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
+..+....|.+....... ........+....+..+........+.+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 999988888876322110 0000000001111222233334445678999999999999999999999999999999986
Q ss_pred hh
Q psy9855 314 LT 315 (470)
Q Consensus 314 ~~ 315 (470)
..
T Consensus 312 ~~ 313 (353)
T 2b9h_A 312 YH 313 (353)
T ss_dssp TC
T ss_pred cC
Confidence 54
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.01 Aligned_cols=210 Identities=23% Similarity=0.385 Sum_probs=183.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|+.++ ||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 61 ~~~~~Ei~~l~~l~-HpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~----------------- 120 (476)
T 2y94_A 61 GKIRREIQNLKLFR-HPHIIKLYQVIST--PSDIFMVMEYVSGGELFDYICKNGRLDEKESRR----------------- 120 (476)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45789999999999 9999999999865 678999999997 69999998877788888877
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 121 ------------------------------------------i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~ 158 (476)
T 2y94_A 121 ------------------------------------------LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 158 (476)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEE
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++............+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------ 232 (476)
T 2y94_A 159 DFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------ 232 (476)
T ss_dssp CCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------
T ss_pred eccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------
Confidence 99999887766666678999999999999887656789999999999999999999999887766665553310
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...+..+++++.+||.+||..||.+|||+.++++||||++
T Consensus 233 -------------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 233 -------------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred -------------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 1122457889999999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=329.73 Aligned_cols=239 Identities=24% Similarity=0.408 Sum_probs=190.7
Q ss_pred hhhhhHHHHHHhcCC----CCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhcc
Q psy9855 10 EVANLKEISILRKIP----DHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~----~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~ 83 (470)
...+.+|+.+|+.+. +||||+++++++.. .+..|+||||++++|.+++..... +++..+..
T Consensus 75 ~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~----------- 141 (360)
T 3llt_A 75 TRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKL----------- 141 (360)
T ss_dssp HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHH-----------
T ss_pred hhhhHHHHHHHHHhcccCCCCCCeecccceeeE--CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHH-----------
Confidence 445678999999996 49999999999875 578999999998899999987653 66666666
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG- 162 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~- 162 (470)
++.||+.||+|||++||+||||||+|||++.
T Consensus 142 ------------------------------------------------i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 142 ------------------------------------------------YCIEILKALNYLRKMSLTHTDLKPENILLDDP 173 (360)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEESCT
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHCCeeeCCCCcccEEEccc
Confidence 9999999999999999999999999999974
Q ss_pred ------------------------C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHH
Q psy9855 163 ------------------------D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFY 217 (470)
Q Consensus 163 ------------------------~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ 217 (470)
+ .++|+|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ 250 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLA 250 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHH
Confidence 3 799999999986543 234568999999999998765 899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccc---cccCCCCC------------cccccccccH
Q psy9855 218 ETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQ---FKQYPGGG------------IDVLVPQIHE 282 (470)
Q Consensus 218 elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~------------~~~~~~~~s~ 282 (470)
+|++|+.||.+.+..+.+..+....+.++...+..........+... ...++... ........++
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 99999999999999999999999988888776655433221111000 00011000 0111122357
Q ss_pred HHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 283 KGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 283 ~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 888999999999999999999999999995
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=340.55 Aligned_cols=242 Identities=28% Similarity=0.463 Sum_probs=191.0
Q ss_pred hhhhhHHHHHHhcCC-----CCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHHHHHhhhc
Q psy9855 10 EVANLKEISILRKIP-----DHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILYQVKAANE 82 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~-----~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~ 82 (470)
...+.+|+.+|..|+ +|+||+++++++.. .+.+|+||||++++|.+++..... +++..+..
T Consensus 137 ~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~---------- 204 (429)
T 3kvw_A 137 HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK---------- 204 (429)
T ss_dssp HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHH----------
T ss_pred HHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHH----------
Confidence 345678888888873 37899999999865 678999999999999999987653 67766666
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
++.||+.||+|||++||+||||||+|||++.
T Consensus 205 -------------------------------------------------i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~ 235 (429)
T 3kvw_A 205 -------------------------------------------------FAHSILQCLDALHKNRIIHCDLKPENILLKQ 235 (429)
T ss_dssp -------------------------------------------------HHHHHHHHHHHHHHHTEECSCCSGGGEEESS
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHeEEcc
Confidence 9999999999999999999999999999988
Q ss_pred C-e--EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 163 D-L--VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 163 ~-~--ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
+ . ++|+|||++..... .....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+.
T Consensus 236 ~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 236 QGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp TTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7 3 99999999976543 234568999999999998766 8999999999999999999999999999999999999
Q ss_pred HHhCCCchHHHHHHhhhc---cC-cccc------------------------ccccCCCCCcccccccccHHHHHHHHHh
Q psy9855 240 QVLGTPKAETLKKFEKYK---SS-NFTY------------------------QFKQYPGGGIDVLVPQIHEKGKKLMSEM 291 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~---~~-~~~~------------------------~~~~~~~~~~~~~~~~~s~~~~~Li~~~ 291 (470)
..+|.|+...+....... .. .+.. ............+....++.+.+||.+|
T Consensus 313 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~ 392 (429)
T 3kvw_A 313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392 (429)
T ss_dssp HHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHH
T ss_pred HHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHH
Confidence 999999887665432211 00 0000 0000000000112223478899999999
Q ss_pred cccCCCCCcCHHHHHhcccCCChh
Q psy9855 292 LKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 292 L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
|++||.+|||+.|+|+||||++..
T Consensus 393 L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 393 LEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp TCSSTTTSCCHHHHHTSTTTC---
T ss_pred CCCChhhCCCHHHHhCChhhccCC
Confidence 999999999999999999999653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=331.88 Aligned_cols=215 Identities=25% Similarity=0.362 Sum_probs=175.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc----cccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD----NISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~----~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+.+|+.|+ ||||+++++++.. .+.+|+|||||+ |+|.+++.... .+++..+..
T Consensus 70 ~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~------------ 134 (351)
T 3c0i_A 70 TEDLKREASICHMLK-HPHIVELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH------------ 134 (351)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHH------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEEe--CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHH------------
Confidence 456789999999998 9999999999865 678999999999 69998886543 256666666
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 135 -----------------------------------------------i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~ 167 (351)
T 3c0i_A 135 -----------------------------------------------YMRQILEALRYCHDNNIIHRDVKPHCVLLASKE 167 (351)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCceeccCChHHeEEecCC
Confidence 99999999999999999999999999999764
Q ss_pred ---eEEEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 164 ---LVVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 164 ---~ikL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
.++|+|||++........ ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ......+.
T Consensus 168 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~ 245 (351)
T 3c0i_A 168 NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGII 245 (351)
T ss_dssp TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHH
T ss_pred CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHH
Confidence 499999999987765433 34568999999999987755 8999999999999999999999998753 33333333
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
....... ....+.+++++.+||.+||..||.+|||+.++|+||||++..
T Consensus 246 ~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 246 KGKYKMN---------------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HTCCCCC---------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred cCCCCCC---------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 2111000 011235789999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.26 Aligned_cols=217 Identities=25% Similarity=0.376 Sum_probs=163.9
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.+|.+|+ ||||+++++++.. .+.+++||||++ |+|.+++.....+++..+..
T Consensus 91 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~--------------- 152 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRLS-HPNIIKLKEIFET--PTEISLVLELVTGGELFDRIVEKGYYSERDAAD--------------- 152 (349)
T ss_dssp --------CHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHH---------------
T ss_pred hHHHHHHHHHHHHhCC-CCCCcceeeeEec--CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHH---------------
Confidence 3456789999999999 9999999999865 678999999998 69999998877788888777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---C-
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG---D- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---~- 163 (470)
++.||+.||+|||++||+||||||+|||++. +
T Consensus 153 --------------------------------------------i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~ 188 (349)
T 2w4o_A 153 --------------------------------------------AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA 188 (349)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC
Confidence 9999999999999999999999999999974 3
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID-QLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~ 242 (470)
.++|+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..... ....+....
T Consensus 189 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~ 267 (349)
T 2w4o_A 189 PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267 (349)
T ss_dssp CEEECCCC----------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred CEEEccCccccccCcccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence 89999999998776555556678999999999988755 8999999999999999999999997765544 232222100
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
. .........++.++.+||.+||..||++|||+.++|+||||.+..
T Consensus 268 ------------------~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 268 ------------------Y---------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ------------------C---------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ------------------C---------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 0 001112346789999999999999999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.91 Aligned_cols=216 Identities=24% Similarity=0.338 Sum_probs=164.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.|+ ||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 60 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 120 (361)
T 3uc3_A 60 DENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIIMEYASGGELYERICNAGRFSEDEARF---------------- 120 (361)
T ss_dssp CHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred cHHHHHHHHHHHhCC-CCCCCcEEEEEee--CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHH----------------
Confidence 356789999999999 9999999999865 678999999998 69999998877788888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---eE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---LV 165 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 121 -------------------------------------------i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~ 157 (361)
T 3uc3_A 121 -------------------------------------------FFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRL 157 (361)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceE
Confidence 99999999999999999999999999999866 49
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ-VLGT 244 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~-~~g~ 244 (470)
||+|||++............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.. ....
T Consensus 158 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 237 (361)
T 3uc3_A 158 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV 237 (361)
T ss_dssp EECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT
T ss_pred EEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC
Confidence 999999998655444455678999999999998866444558999999999999999999977543222222111 1100
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
... ......+++++.+||.+||..||.+|||+.|+++||||..
T Consensus 238 -----------------~~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 238 -----------------KYS---------IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp -----------------CCC---------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred -----------------CCC---------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 000 0011257899999999999999999999999999999954
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.76 Aligned_cols=212 Identities=25% Similarity=0.322 Sum_probs=175.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+++|+.+|..++ ||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 193 ~~~~~e~~~l~~l~-h~~iv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 252 (446)
T 4ejn_A 193 AHTLTENRVLQNSR-HPFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARF----------------- 252 (446)
T ss_dssp --------CCCCCS-CTTSCCEEEEEEE--TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCeEeeEEEEEee--CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45679999999999 9999999999865 678999999999 59999998877788888777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||+ +||+||||||+|||++.+ .++|
T Consensus 253 ------------------------------------------~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl 290 (446)
T 4ejn_A 253 ------------------------------------------YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKI 290 (446)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEE
T ss_pred ------------------------------------------HHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEE
Confidence 99999999999998 999999999999999887 8999
Q ss_pred EecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.... ........+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+.+.......+....
T Consensus 291 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---- 365 (446)
T 4ejn_A 291 TDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---- 365 (446)
T ss_dssp CCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----
T ss_pred ccCCCceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC----
Confidence 9999997643 333445678999999999997755 8999999999999999999999999888777666654310
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
..++..+++++.+||.+||..||.+|| |++|+++||||+++..
T Consensus 366 ---------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 366 ---------------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp ---------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 112346789999999999999999999 9999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.82 Aligned_cols=217 Identities=23% Similarity=0.343 Sum_probs=182.4
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.+.+|+.+|..++ ||||++++++|.. .+.+|+|||||+ |+|.+++... ..+++..++.
T Consensus 120 ~~~~E~~il~~~~-hp~Iv~l~~~~~~--~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~----------------- 179 (437)
T 4aw2_A 120 CFREERDVLVNGD-SKWITTLHYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF----------------- 179 (437)
T ss_dssp CHHHHHHHHHHSC-TTTBCCEEEEEEC--SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHhCC-CCCEEEEEEEEee--CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHH-----------------
Confidence 4789999999998 9999999999865 678999999998 6999999874 4588887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++|||||||||+|||++.+ .+||+
T Consensus 180 ------------------------------------------~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 180 ------------------------------------------YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCCc--cccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 169 DLGSLQFIKSKGL--HTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 169 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|||++........ ....+||+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+....+....
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 9999976654332 234689999999999862 3458999999999999999999999999998888777765321
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC--CcCHHHHHhcccCCChhH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR--RPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--Rpt~~elL~hp~f~~~~~ 316 (470)
+ .. ........+++++++||.+||..+|++ |++++|+++||||++++.
T Consensus 298 ~------------------~~--------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 298 E------------------RF--------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp H------------------HC--------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred c------------------cc--------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 0 00 011112458899999999999998888 999999999999998763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=315.81 Aligned_cols=213 Identities=25% Similarity=0.375 Sum_probs=182.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.++ ||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 50 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~---------------- 110 (277)
T 3f3z_A 50 VDRFKQEIEIMKSLD-HPNIIRLYETFED--NTDIYLVMELCTGGELFERVVHKRVFRESDAAR---------------- 110 (277)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEec--CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 346789999999998 9999999999864 678999999998 59999998877788888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---eCC-e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI---RGD-L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl---~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||+ +.+ .
T Consensus 111 -------------------------------------------i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~ 147 (277)
T 3f3z_A 111 -------------------------------------------IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP 147 (277)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc
Confidence 99999999999999999999999999999 444 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++.............||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+....+......
T Consensus 148 ~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (277)
T 3f3z_A 148 LKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225 (277)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EEEEecccceeccCccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 999999999877766666677899999999988653 799999999999999999999999988877777666542221
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.+.. ....+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 226 ~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 226 FPEK---------------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CCHH---------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CCch---------------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 1111 11257889999999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=329.68 Aligned_cols=215 Identities=22% Similarity=0.245 Sum_probs=176.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. .+..|+|||||+ |+|.+++.....+++..+..
T Consensus 49 ~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 109 (323)
T 3tki_A 49 PENIKKEICINKMLN-HENVVKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---------------- 109 (323)
T ss_dssp --CHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEec--CCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHH----------------
Confidence 356789999999999 9999999998864 678999999998 59999998777788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 110 -------------------------------------------i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 146 (323)
T 3tki_A 110 -------------------------------------------FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKI 146 (323)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCC---CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 168 GDLGSLQFIKSK---GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 168 ~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.............
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--- 223 (323)
T 3tki_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--- 223 (323)
T ss_dssp CCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT---
T ss_pred EEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---
Confidence 999999765422 22345689999999999987765688999999999999999999999775543222111110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
..........+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 224 -------------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 224 -------------------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -------------------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -------------------------ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 001111124678999999999999999999999999999999853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=336.51 Aligned_cols=244 Identities=19% Similarity=0.217 Sum_probs=174.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc--ccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT--DNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~--~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|+.|+ ||||+++++++.. .+.+|+|||||+ |+|.+++... ..+++..+..
T Consensus 70 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~-------------- 132 (389)
T 3gni_B 70 VTFLQGELHVSKLFN-HPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-------------- 132 (389)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEeEEEEE--CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHH--------------
Confidence 456778999999999 9999999999975 678999999999 6999999876 4477777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 133 ---------------------------------------------~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~ 167 (389)
T 3gni_B 133 ---------------------------------------------ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167 (389)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 99999999999999999999999999999977 89
Q ss_pred EEEecCCcccccCCC--------ccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 166 kL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
+|+|||.+....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+.
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999876543221 22334789999999999774 348999999999999999999999998876555544
Q ss_pred HHHHHhC--------CCchHHHHHHhhh-ccCc------cccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC
Q psy9855 237 RIHQVLG--------TPKAETLKKFEKY-KSSN------FTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301 (470)
Q Consensus 237 ~i~~~~g--------~p~~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt 301 (470)
.+....- .+........... .... .....+.............+++++.+||.+||..||.+|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 327 (389)
T 3gni_B 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327 (389)
T ss_dssp HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence 3322100 0000000000000 0000 00000000111112234568899999999999999999999
Q ss_pred HHHHHhcccCCChh
Q psy9855 302 AQKILSCAYFADLT 315 (470)
Q Consensus 302 ~~elL~hp~f~~~~ 315 (470)
+.|+|+||||+++.
T Consensus 328 a~ell~hp~f~~~~ 341 (389)
T 3gni_B 328 ASTLLNHSFFKQIK 341 (389)
T ss_dssp HHHHTTSGGGGGC-
T ss_pred HHHHhcCHHHHHHh
Confidence 99999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=317.85 Aligned_cols=216 Identities=27% Similarity=0.363 Sum_probs=184.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++++++ ||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 49 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~---------------- 109 (284)
T 3kk8_A 49 FQKLEREARICRKLQ-HPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASH---------------- 109 (284)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHHcC-CCCcCeEEEEEEc--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHH----------------
Confidence 356789999999998 9999999999854 677899999998 59999998877788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ 164 (470)
++.||+.||+|||++||+||||||+||+++.+ .
T Consensus 110 -------------------------------------------~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 110 -------------------------------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCc
Confidence 99999999999999999999999999999765 4
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||.+.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+......
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 225 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225 (284)
T ss_dssp EEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc
Confidence 9999999998777666556678999999999987755 799999999999999999999999988877766665442111
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
. .......+++++.+||.+||..||.+|||+.|+|+||||.+..
T Consensus 226 ~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 226 Y---------------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp C---------------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred C---------------------------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 0 0111246789999999999999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.26 Aligned_cols=215 Identities=25% Similarity=0.386 Sum_probs=181.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|..++ ||||++++++|.+ .+.+|+|||||+ |+|.+++... .+++..++.
T Consensus 114 ~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~----------------- 172 (410)
T 3v8s_A 114 AFFWEERDIMAFAN-SPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARF----------------- 172 (410)
T ss_dssp STHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHC-CCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCCCeEEEEEEE--CCEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHH-----------------
Confidence 34679999999998 9999999999865 678999999997 6999998754 477777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 173 ------------------------------------------~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 173 ------------------------------------------YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCc--cccccccCcccCchhhccCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 169 DLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEG---YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 169 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~---~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
|||++........ ....+||+.|+|||++.+.. .|+.++|||||||++|||++|.+||.+.+..+....|.....
T Consensus 211 DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290 (410)
T ss_dssp CCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred ccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc
Confidence 9999987654432 34678999999999997644 278899999999999999999999999988887777654210
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC--CcCHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR--RPTAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--Rpt~~elL~hp~f~~~~ 315 (470)
...++ ....+++++++||.+||..+|.+ |++++|+++||||+++.
T Consensus 291 ------------------~~~~p---------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 291 ------------------SLTFP---------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp ------------------HCCCC---------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ------------------cccCC---------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 00000 11368899999999999999988 99999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.25 Aligned_cols=217 Identities=25% Similarity=0.417 Sum_probs=159.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
.....+|+.+|+.+.+||||+++++++.+ ....|+|||||+ |+|.+++.....+++..+..
T Consensus 49 ~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 110 (325)
T 3kn6_A 49 EANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGELFERIKKKKHFSETEASY---------------- 110 (325)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHH----------------
T ss_pred hhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 45678999999999889999999999864 678999999998 59999999887788888887
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 111 -------------------------------------------i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 147 (325)
T 3kn6_A 111 -------------------------------------------IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLE 147 (325)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCccc
Confidence 99999999999999999999999999999764 6
Q ss_pred EEEEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH-------HHHH
Q psy9855 165 VVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-------DQLD 236 (470)
Q Consensus 165 ikL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-------~~~~ 236 (470)
++|+|||++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.... +...
T Consensus 148 ~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 226 (325)
T 3kn6_A 148 IKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226 (325)
T ss_dssp EEECCCTTCEECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH
T ss_pred EEEeccccceecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH
Confidence 999999999865433 2335568899999999987755 899999999999999999999999765431 2222
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+.. ..+. ........+++++.+||.+||..||.+|||+.++++||||++..
T Consensus 227 ~i~~------------------~~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 227 KIKK------------------GDFS---------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHTT------------------TCCC---------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HHHc------------------CCCC---------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 2211 0000 01111245789999999999999999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=344.13 Aligned_cols=214 Identities=26% Similarity=0.458 Sum_probs=184.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.|+ ||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 80 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~---------------- 140 (494)
T 3lij_A 80 NSKLLEEVAVLKLLD-HPNIMKLYDFFED--KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---------------- 140 (494)
T ss_dssp THHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEEe--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 456789999999999 9999999999864 678999999998 59999998877788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ 164 (470)
++.||+.||+|||++||+||||||+|||++.. .
T Consensus 141 -------------------------------------------i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 141 -------------------------------------------IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCc
Confidence 99999999999999999999999999999753 5
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++............+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..+......
T Consensus 178 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (494)
T 3lij_A 178 IKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255 (494)
T ss_dssp EEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEEECCCCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999999988776655667789999999998854 3899999999999999999999999998888777776552211
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.. ......+++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 256 ~~---------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 256 FD---------------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp CC---------------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CC---------------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 10 11124678999999999999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=318.33 Aligned_cols=212 Identities=29% Similarity=0.439 Sum_probs=168.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+++|+.++ ||||+++++++.. .+..++||||++ |+|.+++... ..+++..+..
T Consensus 64 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~------------ 128 (285)
T 3is5_A 64 MEQIEAEIEVLKSLD-HPNIIKIFEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE------------ 128 (285)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHH------------
T ss_pred HHHHHHHHHHHHhCC-CchHHhHHHheec--CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHH------------
Confidence 356789999999999 9999999999864 678999999999 5999998653 3366666666
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC--
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-- 162 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-- 162 (470)
++.||+.||+|||++||+||||||+|||++.
T Consensus 129 -----------------------------------------------i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~ 161 (285)
T 3is5_A 129 -----------------------------------------------LMKQMMNALAYFHSQHVVHKDLKPENILFQDTS 161 (285)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC
Confidence 9999999999999999999999999999954
Q ss_pred -C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 163 -D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 163 -~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
+ .++|+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..
T Consensus 162 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~ 239 (285)
T 3is5_A 162 PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239 (285)
T ss_dssp TTCCEEECCCCCCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence 2 699999999987765555566789999999998753 379999999999999999999999988776655444332
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.. .........+++++.+||.+||..||.+|||+.|+|+||||++
T Consensus 240 ~~----------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 240 KE----------------------------PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CC----------------------------CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CC----------------------------cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 10 0111112347889999999999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=332.23 Aligned_cols=213 Identities=25% Similarity=0.368 Sum_probs=175.8
Q ss_pred hhhhhHHHHH-HhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISI-LRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~i-L~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+++|..+ ++.++ ||||++++++|.. .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 82 ~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~--------------- 143 (373)
T 2r5t_A 82 EKHIMSERNVLLKNVK-HPFLVGLHFSFQT--ADKLYFVLDYINGGELFYHLQRERCFLEPRARF--------------- 143 (373)
T ss_dssp ---------CCBCCCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHHhCC-CCCCCCEEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHH---------------
Confidence 3456788887 46677 9999999999865 678999999998 59999998877788877777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 144 --------------------------------------------~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ik 179 (373)
T 2r5t_A 144 --------------------------------------------YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179 (373)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||+++... ........+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....+...
T Consensus 180 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---- 254 (373)
T 2r5t_A 180 LTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---- 254 (373)
T ss_dssp ECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----
T ss_pred EeeCccccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----
Confidence 99999998643 333456679999999999998765 899999999999999999999999998877777666541
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH----HHHHhcccCCChhH
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA----QKILSCAYFADLTQ 316 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~----~elL~hp~f~~~~~ 316 (470)
...+++.++..+.+||.+||..||.+||++ .++++||||++++.
T Consensus 255 ---------------------------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 255 ---------------------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp ---------------------------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 011235688999999999999999999996 69999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.51 Aligned_cols=244 Identities=30% Similarity=0.543 Sum_probs=193.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeec------------CCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHH
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVN------------RSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQV 77 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~------------~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~ 77 (470)
...+.+|+++++.|+ ||||+++++++.. ......++||||++|+|.+++.. ..+++..+..
T Consensus 52 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~----- 124 (320)
T 2i6l_A 52 VKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARL----- 124 (320)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHH-----
T ss_pred HHHHHHHHHHHHhcC-CCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHH-----
Confidence 356789999999998 9999999998743 23467899999999999999865 3477776666
Q ss_pred HhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q psy9855 78 KAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPEN 157 (470)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~N 157 (470)
++.||+.||+|||++||+||||||+|
T Consensus 125 ------------------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~N 150 (320)
T 2i6l_A 125 ------------------------------------------------------FMYQLLRGLKYIHSANVLHRDLKPAN 150 (320)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 99999999999999999999999999
Q ss_pred EEEeC-C-eEEEEecCCcccccCC----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh
Q psy9855 158 ILIRG-D-LVVVGDLGSLQFIKSK----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE 231 (470)
Q Consensus 158 ILl~~-~-~ikL~DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~ 231 (470)
||++. + .++|+|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.
T Consensus 151 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 151 LFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp EEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 99984 4 8999999999865422 2233457799999999987755689999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 232 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.+....+....+.+..+.+..+......... .....+........+.++.++.+||.+||..||.+|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIR-NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHH-HHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHHHHhcCCCchhhhhhhhhcCccccc-ccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 8888888887777766665554331110000 000111222333446789999999999999999999999999999999
Q ss_pred CChh
Q psy9855 312 ADLT 315 (470)
Q Consensus 312 ~~~~ 315 (470)
+...
T Consensus 310 ~~~~ 313 (320)
T 2i6l_A 310 SIYS 313 (320)
T ss_dssp HTTC
T ss_pred cccc
Confidence 8654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.33 Aligned_cols=211 Identities=25% Similarity=0.391 Sum_probs=177.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|..|+ ||||+++++++.. .+..++||||+.|+|.+++.... .+++..+..
T Consensus 99 ~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~----------------- 158 (348)
T 1u5q_A 99 QDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------------- 158 (348)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCEeeEEEEEEE--CCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHH-----------------
Confidence 46789999999999 9999999999875 67899999999999999886543 377777766
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 159 ------------------------------------------i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 196 (348)
T 1u5q_A 159 ------------------------------------------VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 196 (348)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++...... ...+||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+.+....+..+....
T Consensus 197 DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~---- 269 (348)
T 1u5q_A 197 DFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---- 269 (348)
T ss_dssp CCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----
T ss_pred eccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----
Confidence 99999765432 35689999999999853 3458999999999999999999999998887766665554310
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
........+++.+.+||.+||..||.+|||++++++||||....
T Consensus 270 -------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 270 -------------------------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp -------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred -------------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 00111245788999999999999999999999999999997643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=330.33 Aligned_cols=214 Identities=30% Similarity=0.446 Sum_probs=176.1
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
...+|+++|.++.+||||+++++++.+ .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~------------------ 120 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASA------------------ 120 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHH------------------
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH------------------
Confidence 456899999998559999999999864 678999999998 59999998877788888877
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----eE
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-----LV 165 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-----~i 165 (470)
++.||+.||+|||++||+||||||+|||+..+ .+
T Consensus 121 -----------------------------------------~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~ 159 (342)
T 2qr7_A 121 -----------------------------------------VLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESI 159 (342)
T ss_dssp -----------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGE
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeE
Confidence 99999999999999999999999999998543 49
Q ss_pred EEEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD---SEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~---~~~~~~~~i~~~ 241 (470)
+|+|||++...... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.+. +..+.+..+...
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 238 (342)
T 2qr7_A 160 RICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238 (342)
T ss_dssp EECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred EEEECCCcccCcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC
Confidence 99999999876533 3445678999999999987755 789999999999999999999999763 333334333321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+. ......+.+++++.+||.+||..||.+|||+.++++||||.+.
T Consensus 239 ------------------~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 239 ------------------KFS---------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp ------------------CCC---------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ------------------Ccc---------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 000 0111234688999999999999999999999999999999654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=333.00 Aligned_cols=215 Identities=19% Similarity=0.308 Sum_probs=172.2
Q ss_pred hhhhhHHHHHHhcCCC-CCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPD-HLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~-HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..|.+ ||||+++++++.. .+.+|+|||+++++|.+++.....+++..+..
T Consensus 98 ~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~---------------- 159 (390)
T 2zmd_A 98 LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKS---------------- 159 (390)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECCSEEHHHHHHHCSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEEEEecCCCCHHHHHHhcCCCCHHHHHH----------------
Confidence 4567899999999973 6999999998865 56799999977789999998877777777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG 168 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++++.+||+
T Consensus 160 -------------------------------------------i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~ 196 (390)
T 2zmd_A 160 -------------------------------------------YWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI 196 (390)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEEC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEE
Confidence 9999999999999999999999999999987799999
Q ss_pred ecCCcccccCCC---ccccccccCcccCchhhccC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCChH-HH
Q psy9855 169 DLGSLQFIKSKG---LHTEYIATRWYRSPECLLTE----------GYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-DQ 234 (470)
Q Consensus 169 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~----------~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~ 234 (470)
|||++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.... ..
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 276 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence 999998765332 23456899999999998652 34889999999999999999999999765432 22
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+..+.. . ......+...+.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 277 ~~~~~~---~--------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 277 LHAIID---P--------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHC---T--------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHhC---c--------------------------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 222211 0 00111223457889999999999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=323.46 Aligned_cols=209 Identities=22% Similarity=0.283 Sum_probs=168.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
....++|+..+..+..||||+++++++.. .+.+|+|||||+++|.+++..... +++..+..
T Consensus 100 ~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~---------------- 161 (311)
T 3p1a_A 100 RARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYLQTELCGPSLQQHCEAWGASLPEAQVWG---------------- 161 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHH----------------
Confidence 44567788777777449999999999865 678999999999999999877654 77777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||
T Consensus 162 -------------------------------------------i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 162 -------------------------------------------YLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
+|||++.............||+.|+|||++.+ .++.++|||||||++|||++|..+|.+..... .+.. +
T Consensus 199 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~---- 267 (311)
T 3p1a_A 199 GDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--G---- 267 (311)
T ss_dssp CCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--T----
T ss_pred ccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--c----
Confidence 99999987766555566789999999998875 38999999999999999999977765432211 1111 0
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.....+...+++++.+||.+||..||++|||+.|+|+||||++
T Consensus 268 -----------------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 -----------------------YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------------------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0011123467899999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.53 Aligned_cols=213 Identities=28% Similarity=0.431 Sum_probs=181.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|++|+ ||||+++++++.. .+.+|+|||||. |+|.+++.....+++..+..
T Consensus 65 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~---------------- 125 (486)
T 3mwu_A 65 TSTILREVELLKKLD-HPNIMKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------------- 125 (486)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCcCeEEEEEEc--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 456789999999998 9999999999864 678999999998 59999998877788888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ 164 (470)
++.||+.||.|||++||+||||||+|||++.. .
T Consensus 126 -------------------------------------------i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 162 (486)
T 3mwu_A 126 -------------------------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCD 162 (486)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCC
Confidence 99999999999999999999999999999542 6
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 240 (486)
T 3mwu_A 163 IKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240 (486)
T ss_dssp EEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999999987766655667789999999999875 3899999999999999999999999999888777776542111
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
. .......+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 241 ~---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 241 F---------------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp S---------------------------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred C---------------------------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0 01112467899999999999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=336.03 Aligned_cols=216 Identities=24% Similarity=0.316 Sum_probs=179.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.+|..++ ||||++++++|.+ .+.+|+|||||+ |+|.+++...+ .+++..++.
T Consensus 106 ~~~~~E~~il~~~~-hp~Iv~l~~~~~~--~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~---------------- 166 (412)
T 2vd5_A 106 SCFREERDVLVNGD-RRWITQLHFAFQD--ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF---------------- 166 (412)
T ss_dssp CCHHHHHHHHHHSC-TTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHhcC-CCCeeeEEEEEee--CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHH----------------
Confidence 45679999999998 9999999999865 678999999997 69999998754 478877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||
T Consensus 167 -------------------------------------------~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 167 -------------------------------------------YLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCCc--cccccccCcccCchhhcc------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 168 GDLGSLQFIKSKGL--HTEYIATRWYRSPECLLT------EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 168 ~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~------~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
+|||++........ ....+||+.|+|||++.. ...|+.++|||||||++|||++|.+||.+.+..+....+.
T Consensus 204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999987654432 234689999999999873 2348999999999999999999999999988877777665
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCC---cCHHHHHhcccCCChh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR---PTAQKILSCAYFADLT 315 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R---pt~~elL~hp~f~~~~ 315 (470)
..... .........+++++++||.+||. +|.+| ++++++++||||++++
T Consensus 284 ~~~~~--------------------------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 284 HYKEH--------------------------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp THHHH--------------------------CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred hcccC--------------------------cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 32100 00111224688999999999999 99998 5999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=320.66 Aligned_cols=213 Identities=23% Similarity=0.401 Sum_probs=178.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. .+..++||||++ ++|.+++... .+++..+..
T Consensus 86 ~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~l~~~~~~~---------------- 145 (321)
T 2c30_A 86 RELLFNEVVIMRDYQ-HFNVVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQV-RLNEEQIAT---------------- 145 (321)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTTC-CCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCcceEEEEEEE--CCEEEEEEecCCCCCHHHHHHhc-CCCHHHHHH----------------
Confidence 345789999999999 9999999999875 567999999998 5999998643 477777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 146 -------------------------------------------i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 182 (321)
T 2c30_A 146 -------------------------------------------VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182 (321)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEE
Confidence 99999999999999999999999999999977 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.....
T Consensus 183 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--- 258 (321)
T 2c30_A 183 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP--- 258 (321)
T ss_dssp CCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---
T ss_pred eeeeeeeecccCccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---
Confidence 9999988765432 335568999999999987654 89999999999999999999999988877666555543110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
........+++.+.+||.+||..||.+|||+.++++||||.+.
T Consensus 259 -------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 259 -------------------------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -------------------------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -------------------------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0001123578899999999999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=326.02 Aligned_cols=207 Identities=25% Similarity=0.338 Sum_probs=178.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-c-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-L-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|..|+ ||||+++++++.. .+.+++||||+. | +|.+++.....+++..+..
T Consensus 73 ~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~--~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~--------------- 134 (335)
T 3dls_A 73 LGKVTLEIAILSRVE-HANIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY--------------- 134 (335)
T ss_dssp TEEEEHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEee--CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHH---------------
Confidence 346789999999998 9999999999864 678999999997 6 9999999887788888877
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 135 --------------------------------------------i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 170 (335)
T 3dls_A 135 --------------------------------------------IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK 170 (335)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEE
Confidence 99999999999999999999999999999888 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|+|||++............+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....
T Consensus 171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------- 236 (335)
T 3dls_A 171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------- 236 (335)
T ss_dssp ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------
T ss_pred EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------
Confidence 999999988776666667789999999999988765588999999999999999999999652110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.......+..+++++.+||.+||..||.+|||+.++++||||++..
T Consensus 237 -----------------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 237 -----------------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp -----------------------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred -----------------------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 0001112235789999999999999999999999999999998743
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=325.47 Aligned_cols=217 Identities=24% Similarity=0.356 Sum_probs=178.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc--ccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT--DNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~--~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.++..+.+||||+++++++.. .+.+++|||||+ |+|.+++... ..+++..+..
T Consensus 72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~-------------- 135 (327)
T 3lm5_A 72 RAEILHEIAVLELAKSCPRVINLHEVYEN--TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR-------------- 135 (327)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHH--------------
Confidence 45678999999999878999999999864 678999999999 5999998553 3377777666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---C
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG---D 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---~ 163 (470)
++.||+.||+|||++||+||||||+|||++. +
T Consensus 136 ---------------------------------------------i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 136 ---------------------------------------------LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTB
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCC
Confidence 9999999999999999999999999999987 3
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 171 ~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249 (327)
T ss_dssp CCEEECCGGGCEEC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CcEEEeeCccccccCCccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence 89999999998776655556678999999999987755 8999999999999999999999999988777766665432
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
... .......+++.+.+||.+||..||.+|||++++|+||||++..
T Consensus 250 ~~~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 250 VDY---------------------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp CCC---------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred ccc---------------------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 111 1122346789999999999999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.84 Aligned_cols=218 Identities=26% Similarity=0.351 Sum_probs=168.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|.++.+||||+++++++.. .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 54 ~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 115 (316)
T 2ac3_A 54 RSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---------------- 115 (316)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHH----------------
Confidence 45678999999996559999999999865 678999999998 69999998877788887777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 116 -------------------------------------------i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~ 152 (316)
T 2ac3_A 116 -------------------------------------------VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSP 152 (316)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCS
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCc
Confidence 99999999999999999999999999999876 3
Q ss_pred EEEEecCCcccccCCC--------ccccccccCcccCchhhccC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy9855 165 VVVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~ 232 (470)
++|+|||++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+....
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 9999999987654211 12345699999999998641 23789999999999999999999999775421
Q ss_pred ---------------HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCC
Q psy9855 233 ---------------DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297 (470)
Q Consensus 233 ---------------~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~ 297 (470)
.....+... .+. ........++..+.+||.+||..||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~i~~~------------------~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~ 285 (316)
T 2ac3_A 233 DCGWDRGEACPACQNMLFESIQEG------------------KYE---------FPDKDWAHISCAAKDLISKLLVRDAK 285 (316)
T ss_dssp CSCC----CCHHHHHHHHHHHHHC------------------CCC---------CCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred cccccccccchhHHHHHHHHHhcc------------------Ccc---------cCchhcccCCHHHHHHHHHHhhCChh
Confidence 111111110 000 00011135788999999999999999
Q ss_pred CCcCHHHHHhcccCCChh
Q psy9855 298 RRPTAQKILSCAYFADLT 315 (470)
Q Consensus 298 ~Rpt~~elL~hp~f~~~~ 315 (470)
+|||+.|+|+||||++..
T Consensus 286 ~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 286 QRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp TSCCHHHHHHSTTCC---
T ss_pred hCCCHHHHhcChhhcCCC
Confidence 999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.58 Aligned_cols=215 Identities=28% Similarity=0.444 Sum_probs=181.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..+.+||||+++++++.. .+..|+||||++| +|.+++.....+++..+..
T Consensus 144 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~----------------- 204 (365)
T 2y7j_A 144 EATRRETHILRQVAGHPHIITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETRS----------------- 204 (365)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEEB--SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHHhcCCCCEeEEEEEEee--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 4578999999999449999999998865 6789999999994 9999998776788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||.|||+.||+||||||+|||++.+ .++|+
T Consensus 205 ------------------------------------------i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 205 ------------------------------------------IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTE-----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
|||++............+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+......+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999887766556677999999999998642 2478899999999999999999999988877666655544211
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.... .....++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 323 ~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSS---------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCH---------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCC---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 1110 111356888999999999999999999999999999973
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=342.68 Aligned_cols=215 Identities=27% Similarity=0.435 Sum_probs=185.1
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.+|++|+ ||||+++++++.. .+.+|+|||||. |+|.+++.....+++..+..
T Consensus 69 ~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~--------------- 130 (484)
T 3nyv_A 69 DKESLLREVQLLKQLD-HPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--------------- 130 (484)
T ss_dssp CHHHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHH---------------
T ss_pred HHHHHHHHHHHHHhCC-CCCCCcEEEEEEe--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHH---------------
Confidence 3456889999999998 9999999999864 678999999998 69999998887788888877
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe---CC-
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR---GD- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~---~~- 163 (470)
++.||+.||+|||++||+||||||+|||++ .+
T Consensus 131 --------------------------------------------i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 131 --------------------------------------------IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC
Confidence 999999999999999999999999999995 33
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++|+|||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 167 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 244 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244 (484)
T ss_dssp CEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred cEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC
Confidence 899999999988776665666789999999999876 389999999999999999999999999988887777654211
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.. .......+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 245 ~~---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 245 TF---------------------------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CC---------------------------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CC---------------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 10 011124678999999999999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.29 Aligned_cols=214 Identities=20% Similarity=0.325 Sum_probs=170.3
Q ss_pred hhhhhHHHHHHhcCCCC-CCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDH-LNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~H-pnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..|++| |||+++++++.. .+.+|+|||+++++|.+++.....+++..+..
T Consensus 51 ~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~---------------- 112 (343)
T 3dbq_A 51 LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKS---------------- 112 (343)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHH----------------
Confidence 35678999999999832 999999998864 67899999987789999999887788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG 168 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++++.++|+
T Consensus 113 -------------------------------------------i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~ 149 (343)
T 3dbq_A 113 -------------------------------------------YWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI 149 (343)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEEC
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEe
Confidence 9999999999999999999999999999998899999
Q ss_pred ecCCcccccCCC---ccccccccCcccCchhhcc----------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH-HH
Q psy9855 169 DLGSLQFIKSKG---LHTEYIATRWYRSPECLLT----------EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-DQ 234 (470)
Q Consensus 169 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~----------~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~ 234 (470)
|||++....... .....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.... ..
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 229 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence 999998765332 2245689999999999864 244889999999999999999999999764332 22
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
+..+. . .......+...+.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 230 ~~~~~---~--------------------------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 230 LHAII---D--------------------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHHHH---C--------------------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHh---c--------------------------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 22111 1 01111223455788999999999999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.82 Aligned_cols=214 Identities=28% Similarity=0.443 Sum_probs=184.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|++|+ ||||+++++++.. ...+|+|||||+ |+|.+++.....+++..+..
T Consensus 90 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~---------------- 150 (504)
T 3q5i_A 90 HEEIYNEISLLKSLD-HPNIIKLFDVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---------------- 150 (504)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHH----------------
Confidence 356789999999998 9999999999864 678999999998 59999998877788888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 151 -------------------------------------------i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 151 -------------------------------------------IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999999999865 5
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++............+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..+......
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999999988776656667789999999998864 3899999999999999999999999999888877777652111
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.... ....+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 266 ~~~~---------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 266 FDFN---------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCHH---------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCcc---------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 1111 124578999999999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=335.21 Aligned_cols=217 Identities=23% Similarity=0.402 Sum_probs=166.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeec--CCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+.+|+.++.++.+||||++++++|.. .+...+|+|||||+ |+|.+++..... +++..+..
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~------------- 165 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE------------- 165 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHH-------------
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHH-------------
Confidence 3567999998666559999999998853 33567999999998 599999987543 77777777
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG--- 162 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~--- 162 (470)
|+.||+.||+|||++||+||||||+|||++.
T Consensus 166 ----------------------------------------------i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~ 199 (400)
T 1nxk_A 166 ----------------------------------------------IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 199 (400)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSST
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCccccCcCcceEEEecCCC
Confidence 9999999999999999999999999999986
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH----HHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID----QLDR 237 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~----~~~~ 237 (470)
+ .+||+|||++............+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.+..... ....
T Consensus 200 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 278 (400)
T 1nxk_A 200 NAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 278 (400)
T ss_dssp TCCEEECCCTTCEECC-----------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH
T ss_pred CccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH
Confidence 3 79999999998776555556779999999999987655 8999999999999999999999997654321 1111
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+.. ..+.. .......+++++.+||.+||..||.+|||+.++++||||.+.
T Consensus 279 i~~------------------~~~~~---------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 279 IRM------------------GQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHH------------------TCCCC---------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHc------------------CcccC---------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 111 00000 011124678999999999999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=320.40 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=162.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCC-------eEEEEeeccccCHHHHHHhc---------ccccHHHHHH
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTR-------QVTLVFPLMELNLEEYIRTT---------DNISEKRAKE 72 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~-------~~~lV~E~~~gsL~~~l~~~---------~~l~~~~~~~ 72 (470)
....+.+|+++|++|+ ||||++++++|...... ..+++.+.....+....... ..+......
T Consensus 47 ~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 124 (332)
T 3qd2_B 47 AREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV- 124 (332)
T ss_dssp HHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc-
Confidence 4567889999999998 99999999998653221 12222222111111000000 000000000
Q ss_pred HHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecC
Q psy9855 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRD 152 (470)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrD 152 (470)
. .... .......+++|||+.+++|.+++....... ......+..++.||+.||+|||++||+|||
T Consensus 125 --~------~~~~----~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 189 (332)
T 3qd2_B 125 --G------QLQP----SSPKVYLYIQMQLCRKENLKDWMNRRCSLE---DREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189 (332)
T ss_dssp -------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG---GSCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --c------cccC----CCCCceEEEEEEecCCCCHHHHHhcccCcc---chhhHHHHHHHHHHHHHHHHHHhCCeeecC
Confidence 0 0000 012233455555555555555554433221 122234556999999999999999999999
Q ss_pred CCCCcEEEeCC-eEEEEecCCcccccCCC-------------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHH
Q psy9855 153 IKPENILIRGD-LVVVGDLGSLQFIKSKG-------------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYE 218 (470)
Q Consensus 153 LKp~NILl~~~-~ikL~DFG~a~~~~~~~-------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~e 218 (470)
|||+|||++.+ .++|+|||++....... .....+||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 190 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~e 268 (332)
T 3qd2_B 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFE 268 (332)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHH
T ss_pred CCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHH
Confidence 99999999977 89999999998765432 224457999999999998765 8999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCC
Q psy9855 219 TLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKR 298 (470)
Q Consensus 219 lltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~ 298 (470)
|++|..|+. +....+..... ..........++++.+||.+||..||.+
T Consensus 269 l~~~~~~~~-----~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 269 LLYSFSTQM-----ERVRIITDVRN---------------------------LKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp HHSCCCCHH-----HHHHHHHHHHT---------------------------TCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred HHHcCCChh-----HHHHHHHHhhc---------------------------cCCCcccccCChhHHHHHHHHccCCCCc
Confidence 999876642 11111111111 1111122356778899999999999999
Q ss_pred CcCHHHHHhcccCCCh
Q psy9855 299 RPTAQKILSCAYFADL 314 (470)
Q Consensus 299 Rpt~~elL~hp~f~~~ 314 (470)
|||+.|+|+||||+++
T Consensus 317 Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 317 RPEATDIIENAIFENL 332 (332)
T ss_dssp SCCHHHHHHSTTCCCC
T ss_pred CCCHHHHhhchhhhcC
Confidence 9999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.27 Aligned_cols=212 Identities=27% Similarity=0.414 Sum_probs=179.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+++|+.+|..++ ||||+++++++.. .+.+|+|||||+ |+|.+++..... +++..+..
T Consensus 229 ~~~~~E~~iL~~l~-hp~Iv~l~~~~~~--~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~--------------- 290 (576)
T 2acx_A 229 AMALNEKQILEKVN-SRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF--------------- 290 (576)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHcC-CCCEeeEEEEEee--CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHH---------------
Confidence 45789999999998 9999999999865 678999999998 699999987554 77777766
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++|||||||||+|||++.+ .+|
T Consensus 291 --------------------------------------------i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 291 --------------------------------------------YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeE
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE----IDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~----~~~~~~i~~~~ 242 (470)
|+|||++............+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+... ......+...
T Consensus 327 L~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~- 404 (576)
T 2acx_A 327 ISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV- 404 (576)
T ss_dssp ECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-
T ss_pred EEecccceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-
Confidence 99999998876665556679999999999998755 89999999999999999999999987542 2222222110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
...++..+++++.+||.+||..||.+|| +++|+++||||++++.
T Consensus 405 ------------------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 405 ------------------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp ------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred ------------------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 0112346889999999999999999999 8999999999998763
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=336.32 Aligned_cols=216 Identities=25% Similarity=0.411 Sum_probs=167.6
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+.+|++|+ ||||+++++++. .+..|+|||||+ |+|.+++.....+++..+..
T Consensus 186 ~~~~E~~~l~~l~-hpniv~l~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~------------------ 243 (419)
T 3i6u_A 186 NVETEIEILKKLN-HPCIIKIKNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKL------------------ 243 (419)
T ss_dssp CHHHHHHHHHHCC-CTTBCCCCEEEE---SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHH------------------
T ss_pred HHHHHHHHHHhCC-CCCEeeEEEEEe---cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHH------------------
Confidence 5789999999998 999999999874 345899999998 59999988777788888777
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----eEE
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVV 166 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .+|
T Consensus 244 -----------------------------------------i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 244 -----------------------------------------YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -----------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -----------------------------------------HHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEE
Confidence 99999999999999999999999999999753 599
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
|+|||++............+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+......+...... +
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~-~- 360 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-G- 360 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-T-
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-C-
Confidence 999999988776665667789999999999864 344788999999999999999999999765432222111110 0
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
. ..........+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus 361 ---------------~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 361 ---------------K---------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp ---------------C---------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred ---------------C---------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 0 00011122467899999999999999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.10 Aligned_cols=214 Identities=19% Similarity=0.266 Sum_probs=186.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+++|..+|..+.+||||++++++|.. .+.+||||||++ |+|.+++.....+++..+..
T Consensus 385 ~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~---------------- 446 (674)
T 3pfq_A 385 VECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF---------------- 446 (674)
T ss_dssp THHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 34578999999999779999999998854 678999999998 59999999877788888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 447 -------------------------------------------~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL 483 (674)
T 3pfq_A 447 -------------------------------------------YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 483 (674)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEE
Confidence 99999999999999999999999999999888 8999
Q ss_pred EecCCccccc-CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIK-SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.... ........+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....|...
T Consensus 484 ~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----- 557 (674)
T 3pfq_A 484 ADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----- 557 (674)
T ss_dssp CCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----
T ss_pred eecceeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----
Confidence 9999998643 333456679999999999997765 899999999999999999999999998888777766431
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH-----HHHHhcccCCChhH
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA-----QKILSCAYFADLTQ 316 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~-----~elL~hp~f~~~~~ 316 (470)
...++..+++++.+||.+||..||.+||++ ++|++||||++++.
T Consensus 558 --------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 558 --------------------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred --------------------------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 011234689999999999999999999997 99999999998864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.63 Aligned_cols=243 Identities=22% Similarity=0.266 Sum_probs=177.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.|+ ||||+++++++.. .+..++|||||+ |+|.+++........
T Consensus 72 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~--------------------- 127 (345)
T 3hko_A 72 VERIKTEVRLMKKLH-HPNIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDST--------------------- 127 (345)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHEEEEEETTT---------------------
T ss_pred HHHHHHHHHHHHhCC-CCCcceeehhhcc--CCeEEEEEeCCCCCcHHHHHHHhhcccc---------------------
Confidence 356789999999999 9999999999865 678999999998 699999853211000
Q ss_pred cccCCCccceeeeccC--------------CCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCC
Q psy9855 89 VGWDLKLPFLLLVFGK--------------SRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIK 154 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~--------------~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLK 154 (470)
....++... ++.+..+.. ..........+..++.||+.||+|||++||+|||||
T Consensus 128 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 195 (345)
T 3hko_A 128 -------GKCAMDVVKTQICPCPECNEEAINGSIHGFRE-----SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195 (345)
T ss_dssp -------TEEEEEEECCCCCCSHHHHHHHHHSCC--CEE-----ECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred -------cccccccccccccccccccccccccccccccc-----cccccccHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 000000000 000000000 001123445566799999999999999999999999
Q ss_pred CCcEEEeCC---eEEEEecCCcccccCCC-----ccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCC
Q psy9855 155 PENILIRGD---LVVVGDLGSLQFIKSKG-----LHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPL 225 (470)
Q Consensus 155 p~NILl~~~---~ikL~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~p 225 (470)
|+|||++.+ .++|+|||++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..|
T Consensus 196 p~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 275 (345)
T 3hko_A 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275 (345)
T ss_dssp GGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999765 69999999998654321 12456899999999998753 4589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHH
Q psy9855 226 FPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305 (470)
Q Consensus 226 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~el 305 (470)
|.+.+..+....+...... ........+++.+.+||.+||..||.+|||+.++
T Consensus 276 f~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 276 FPGVNDADTISQVLNKKLC---------------------------FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp SCCSSHHHHHHHHHHCCCC---------------------------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCChHHHHHHHHhcccc---------------------------cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9998887777666542110 0111123578999999999999999999999999
Q ss_pred HhcccCCChh
Q psy9855 306 LSCAYFADLT 315 (470)
Q Consensus 306 L~hp~f~~~~ 315 (470)
|+||||++..
T Consensus 329 l~hp~~~~~~ 338 (345)
T 3hko_A 329 LQHPWISQFS 338 (345)
T ss_dssp HHSHHHHTTS
T ss_pred hcChhhccCh
Confidence 9999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=313.37 Aligned_cols=216 Identities=27% Similarity=0.441 Sum_probs=178.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.++ ||||+++++++.. ....++||||++ ++|.+++.....+++..+..
T Consensus 52 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 112 (283)
T 3bhy_A 52 REEIEREVNILREIR-HPNIITLHDIFEN--KTDVVLILELVSGGELFDFLAEKESLTEDEATQ---------------- 112 (283)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCeeehhheecC--CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 456789999999999 9999999999865 678999999998 69999998777788887777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.||+|||++||+||||||+||+++.+
T Consensus 113 -------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 113 -------------------------------------------FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence 99999999999999999999999999999765
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 150 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228 (283)
T ss_dssp CEEECCCTTCEECC--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred ceEEEecccceeccCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc
Confidence 59999999998776555555668999999999987655 89999999999999999999999998877666655533211
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.. .....+.+++.+.+||.+||..||.+|||+.++++||||+.+.
T Consensus 229 ~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 DF---------------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CC---------------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CC---------------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 10 0112246788999999999999999999999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=313.82 Aligned_cols=218 Identities=29% Similarity=0.424 Sum_probs=184.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|.++.+||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 128 (298)
T 1phk_A 67 REATLKEVDILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---------------- 128 (298)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeeeeecc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHH----------------
Confidence 34678999999999669999999999854 678999999998 69999998877788887777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|
T Consensus 129 -------------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 129 -------------------------------------------IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhcc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLT-----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 166 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 99999987766555566789999999998852 3347899999999999999999999998887766665554311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.. ........++..+.+||.+||..||.+|||+.++|+||||++..
T Consensus 246 ~~---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 246 YQ---------------------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CC---------------------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cc---------------------------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 00 00111246789999999999999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=311.82 Aligned_cols=208 Identities=25% Similarity=0.403 Sum_probs=175.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. .+..++||||++ |+|.+++.....+++..+..
T Consensus 54 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~----------------- 113 (279)
T 3fdn_A 54 HQLRREVEIQSHLR-HPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT----------------- 113 (279)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHcCC-CCCCcchhheEec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45789999999999 9999999999864 678999999999 59999998877788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 114 ------------------------------------------~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 151 (279)
T 3fdn_A 114 ------------------------------------------YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 151 (279)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEE
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 152 Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------ 223 (279)
T 3fdn_A 152 DFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------ 223 (279)
T ss_dssp SCCEESCC---------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------
T ss_pred eccccccCCcc-cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------
Confidence 99988654432 234568999999999987754 7899999999999999999999999887776666554311
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...+..+++.+.+||.+||..||.+|||+.|+++||||++
T Consensus 224 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 224 -------------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp -------------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred -------------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 1122457889999999999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=311.78 Aligned_cols=214 Identities=22% Similarity=0.338 Sum_probs=174.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecC--CCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNR--STRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~--~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+.+|+.+|+.++ ||||+++++++... ....+++||||++ ++|.+++.....+++..+..
T Consensus 68 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~------------- 133 (290)
T 1t4h_A 68 ERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS------------- 133 (290)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHH-------------
Confidence 3456789999999998 99999999988642 3567899999998 59999998877788877777
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEe-C
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILIR-G 162 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~-~ 162 (470)
++.||+.||+|||++| |+||||||+|||++ .
T Consensus 134 ----------------------------------------------~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~ 167 (290)
T 1t4h_A 134 ----------------------------------------------WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 167 (290)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST
T ss_pred ----------------------------------------------HHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECC
Confidence 9999999999999999 99999999999997 4
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+ .++|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.............
T Consensus 168 ~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 168 TGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp TSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred CCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence 4 8999999998754433 3345689999999998764 3899999999999999999999999875544433222110
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...........++++.+||.+||..||.+|||+.++|+||||++
T Consensus 245 ----------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 ----------------------------GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------------------TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------------------cCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 00111223456788999999999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=311.85 Aligned_cols=211 Identities=22% Similarity=0.360 Sum_probs=170.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+++.++ ||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 56 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 115 (276)
T 2h6d_A 56 GKIKREIQNLKLFR-HPHIIKLYQVIST--PTDFFMVMEYVSGGELFDYICKHGRVEEMEARR----------------- 115 (276)
T ss_dssp HHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHhcCC-CCCEeEEEEEEec--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHH-----------------
Confidence 35679999999999 9999999999865 678999999998 59999998877788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|+
T Consensus 116 ------------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~ 153 (276)
T 2h6d_A 116 ------------------------------------------LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 153 (276)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++.............||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+...
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------- 226 (276)
T 2h6d_A 154 DFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------- 226 (276)
T ss_dssp CCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------
T ss_pred ecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-------
Confidence 9999987765555556689999999999887654578999999999999999999999887766555444321
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
....+..++..+.+||.+||..||.+|||+.++++||||++.
T Consensus 227 ------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 227 ------------------------VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------------------cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 011224578899999999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.23 Aligned_cols=236 Identities=18% Similarity=0.295 Sum_probs=177.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc---ccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN---ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~---l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+++|+.|+ ||||+++++++........++||||++ ++|.+++..... +++..+..
T Consensus 52 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~-------------- 116 (319)
T 4euu_A 52 DVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-------------- 116 (319)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHhcC-CCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHH--------------
Confidence 45679999999999 999999999998766668999999998 699999987554 66766666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----eC
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI----RG 162 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl----~~ 162 (470)
++.||+.||+|||++||+||||||+|||+ +.
T Consensus 117 ---------------------------------------------i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 151 (319)
T 4euu_A 117 ---------------------------------------------VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG 151 (319)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTS
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCC
Confidence 99999999999999999999999999998 44
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhcc-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh-HH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLT-------EGYYSFELDIWAAGCVFYETLTRNPLFPGDSE-ID 233 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-------~~~~~~~~DIwSlG~il~elltg~~pf~~~~~-~~ 233 (470)
+ .++|+|||++............+||+.|+|||++.. ...++.++|||||||++|+|++|..||..... ..
T Consensus 152 ~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 152 QSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp CEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred CceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 4 799999999988776666667789999999998862 24489999999999999999999999965332 11
Q ss_pred HHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcc
Q psy9855 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309 (470)
Q Consensus 234 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp 309 (470)
....+..+.+..+...+..+.......+.+.... .....+...++..+.+||.+||+.||++|||++|+|+||
T Consensus 232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM---PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSC---CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred hHHHHHHHhcCCCcccchhhhcccCCccccCccC---CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 1222222222222222221111111111111000 011123356778899999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=309.80 Aligned_cols=212 Identities=22% Similarity=0.314 Sum_probs=170.2
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhh
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~ 81 (470)
......+++|+.++..+..||||+++++++.. .+..++||||++ ++|.+++... ..+++..+..
T Consensus 51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~--------- 119 (289)
T 1x8b_A 51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD--------- 119 (289)
T ss_dssp SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHH---------
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHH---------
Confidence 34456789999999999449999999999865 678999999998 5999999765 3366666666
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||+|||++||+||||||+|||++
T Consensus 120 --------------------------------------------------i~~qi~~al~~lH~~~ivH~Dikp~NIl~~ 149 (289)
T 1x8b_A 120 --------------------------------------------------LLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149 (289)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhCCEeecCCCHHHEEEc
Confidence 999999999999999999999999999997
Q ss_pred C-------------------C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh
Q psy9855 162 G-------------------D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221 (470)
Q Consensus 162 ~-------------------~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt 221 (470)
. . .++|+|||.+....... ...||+.|+|||++.+...++.++|||||||++|+|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (289)
T 1x8b_A 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226 (289)
T ss_dssp --------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence 3 2 68999999988765432 34699999999999876557789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC
Q psy9855 222 RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301 (470)
Q Consensus 222 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt 301 (470)
|.+++..... ...+.. .....++..+++++.+||.+||..||.+|||
T Consensus 227 ~~~~~~~~~~---~~~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 273 (289)
T 1x8b_A 227 AEPLPRNGDQ---WHEIRQ------------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273 (289)
T ss_dssp CCCCCSSSHH---HHHHHT------------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCcchhH---HHHHHc------------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCC
Confidence 9988754422 111111 1112234568899999999999999999999
Q ss_pred HHHHHhcccCCChh
Q psy9855 302 AQKILSCAYFADLT 315 (470)
Q Consensus 302 ~~elL~hp~f~~~~ 315 (470)
+.++++||||.+..
T Consensus 274 ~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 274 AMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHTCTTC----
T ss_pred HHHHhhChHhhhhc
Confidence 99999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=317.89 Aligned_cols=239 Identities=28% Similarity=0.476 Sum_probs=189.8
Q ss_pred hhhhhHHHHHHhcCCCCC------CeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhh
Q psy9855 10 EVANLKEISILRKIPDHL------NVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAAN 81 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~Hp------nIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~ 81 (470)
...+.+|++++..++ |+ +|+++++++.. .+.+++||||++++|.+++.... .+++..+..
T Consensus 55 ~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~--------- 122 (339)
T 1z57_A 55 CEAARSEIQVLEHLN-TTDPNSTFRCVQMLEWFEH--HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK--------- 122 (339)
T ss_dssp HHHHHHHHHHHHHHH-HHCTTCTTCBCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHH---------
T ss_pred hHHHHHHHHHHHHhh-hcCCCCceeeEeeeccccc--CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHH---------
Confidence 456789999999887 54 59999998865 67899999999889999998765 366666666
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||+|||++||+||||||+|||++
T Consensus 123 --------------------------------------------------~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 152 (339)
T 1z57_A 123 --------------------------------------------------MAYQICKSVNFLHSNKLTHTDLKPENILFV 152 (339)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 999999999999999999999999999997
Q ss_pred C-------------------C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh
Q psy9855 162 G-------------------D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221 (470)
Q Consensus 162 ~-------------------~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt 221 (470)
. + .++|+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHh
Confidence 6 3 5899999999765432 34568999999999998755 8999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCC---------------CCcccccccccHHHHH
Q psy9855 222 RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPG---------------GGIDVLVPQIHEKGKK 286 (470)
Q Consensus 222 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~s~~~~~ 286 (470)
|..||.+.+..+....+....+..+...+........ +......+.. ..........++++.+
T Consensus 230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (339)
T 1z57_A 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKY--FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307 (339)
T ss_dssp SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGG--EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhH--HhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence 9999999999999999999998887766554322100 0000000000 0001112345788999
Q ss_pred HHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 287 LMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 287 Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
||.+||..||.+|||+.|+|+||||+.++
T Consensus 308 li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 308 LIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 99999999999999999999999998765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=326.09 Aligned_cols=241 Identities=27% Similarity=0.419 Sum_probs=186.8
Q ss_pred hhhhhHHHHHHhcCC-------CCCCeeeeceeeecC--CCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHH
Q psy9855 10 EVANLKEISILRKIP-------DHLNVLCLCETYVNR--STRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVK 78 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~-------~HpnIv~l~~~~~~~--~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~ 78 (470)
...+.+|+.+|+.++ +|+||++++++|... ....+|+||||++++|.+++.... .+++..++.
T Consensus 77 ~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~------ 150 (397)
T 1wak_A 77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK------ 150 (397)
T ss_dssp HHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHH------
T ss_pred hHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHH------
Confidence 456789999999995 278899999998632 456899999999988888876553 377777766
Q ss_pred hhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCc
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPEN 157 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~N 157 (470)
|+.||+.||+|||++ ||+||||||+|
T Consensus 151 -----------------------------------------------------i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 151 -----------------------------------------------------IIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 999999999999999 99999999999
Q ss_pred EEEeCC--------------------------------------------------eEEEEecCCcccccCCCccccccc
Q psy9855 158 ILIRGD--------------------------------------------------LVVVGDLGSLQFIKSKGLHTEYIA 187 (470)
Q Consensus 158 ILl~~~--------------------------------------------------~ikL~DFG~a~~~~~~~~~~~~~g 187 (470)
||++.+ .++|+|||++...... ....+|
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~g 255 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQ 255 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCC
Confidence 999855 5999999999876533 345689
Q ss_pred cCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCchHHHHHHhhhccCcc
Q psy9855 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS------EIDQLDRIHQVLGTPKAETLKKFEKYKSSNF 261 (470)
Q Consensus 188 t~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 261 (470)
|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ ..+.+..+...+|.++...+...... ...+
T Consensus 256 t~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~ 333 (397)
T 1wak_A 256 TRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS-KEFF 333 (397)
T ss_dssp CGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG-GGTB
T ss_pred CCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc-cccc
Confidence 99999999998766 8999999999999999999999997655 56778888888998877655332110 0000
Q ss_pred cc--ccccCCCC-C---------cccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 262 TY--QFKQYPGG-G---------IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 262 ~~--~~~~~~~~-~---------~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.. ........ . ........+..+.+||.+||..||.+|||+.|+|+||||++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00 00000000 0 00122455778999999999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.94 Aligned_cols=242 Identities=30% Similarity=0.502 Sum_probs=186.5
Q ss_pred hhhhhHHHHHHhcCCCCC-----CeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhhc
Q psy9855 10 EVANLKEISILRKIPDHL-----NVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAANE 82 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~Hp-----nIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~ 82 (470)
...+.+|+.++..+..|+ +|+++++++.. .+.+|+||||++|+|.+++.... .+++..+..
T Consensus 94 ~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~---------- 161 (382)
T 2vx3_A 94 LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK---------- 161 (382)
T ss_dssp HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHH----------
T ss_pred HHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHH----------
Confidence 345678999998886455 49999998865 57899999999999999998764 266666666
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH--hCCCeecCCCCCcEEE
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH--SYKVFHRDIKPENILI 160 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH--~~gIvHrDLKp~NILl 160 (470)
++.||+.||.||| ..|||||||||+|||+
T Consensus 162 -------------------------------------------------i~~qi~~al~~lH~~~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 162 -------------------------------------------------FAQQMCTALLFLATPELSIIHCDLKPENILL 192 (382)
T ss_dssp -------------------------------------------------HHHHHHHHHHHHTSTTTCEECCCCSGGGEEE
T ss_pred -------------------------------------------------HHHHHHHHHHHhccCCCCEEcCCCCcccEEE
Confidence 9999999999999 5799999999999999
Q ss_pred eC--C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 161 RG--D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 161 ~~--~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
+. + .+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 269 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 64 3 7999999999876432 34568999999999998765 89999999999999999999999999999999999
Q ss_pred HHHHhCCCchHHHHHHhhh-------ccCccccccc-----cCCCCCcc---------------------cccccccHHH
Q psy9855 238 IHQVLGTPKAETLKKFEKY-------KSSNFTYQFK-----QYPGGGID---------------------VLVPQIHEKG 284 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~-------~~~~~~~~~~-----~~~~~~~~---------------------~~~~~~s~~~ 284 (470)
+....|.++...+...... ....+..... ........ ......++++
T Consensus 270 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (382)
T 2vx3_A 270 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKF 349 (382)
T ss_dssp HHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHH
T ss_pred HHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHH
Confidence 9999999887765432211 0110000000 00000000 0001122578
Q ss_pred HHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 285 KKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 285 ~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+||.+||++||.+|||+.|+|+||||++..
T Consensus 350 ~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 350 KDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred HHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.01 Aligned_cols=208 Identities=25% Similarity=0.400 Sum_probs=178.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. .+..++||||++ |+|.+++.....+++..+..
T Consensus 59 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 118 (284)
T 2vgo_A 59 HQLRREIEIQSHLR-HPNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT----------------- 118 (284)
T ss_dssp HHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHhcCC-CCCEeeEEEEEEc--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHH-----------------
Confidence 45789999999999 9999999999864 678999999998 59999998877788877777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|+
T Consensus 119 ------------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 156 (284)
T 2vgo_A 119 ------------------------------------------FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIA 156 (284)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||++...... ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+...
T Consensus 157 Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------- 227 (284)
T 2vgo_A 157 DFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------- 227 (284)
T ss_dssp CCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------
T ss_pred cccccccCccc-ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------
Confidence 99998765432 234568999999999987755 799999999999999999999999887766655444321
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...+++.++..+.+||.+||..||.+|||++++++||||+.
T Consensus 228 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 228 ------------------------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp ------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ------------------------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 01123467899999999999999999999999999999963
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=314.48 Aligned_cols=214 Identities=28% Similarity=0.416 Sum_probs=178.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..++ ||||+++++++.. .+.+++||||++ ++|.+++.....+++..+..
T Consensus 50 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 110 (304)
T 2jam_A 50 DSSLENEIAVLKKIK-HENIVTLEDIYES--TTHYYLVMQLVSGGELFDRILERGVYTEKDASL---------------- 110 (304)
T ss_dssp --HHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHH----------------
T ss_pred hHHHHHHHHHHHhCC-CCCeeehhhhccc--CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHH----------------
Confidence 345789999999998 9999999999864 678999999998 59999998777788887777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---eCC-e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI---RGD-L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl---~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||+ +.+ .
T Consensus 111 -------------------------------------------~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~ 147 (304)
T 2jam_A 111 -------------------------------------------VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK 147 (304)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCC
Confidence 99999999999999999999999999999 444 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 148 ~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (304)
T 2jam_A 148 IMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE 225 (304)
T ss_dssp EEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC
T ss_pred EEEccCCcceecCCC-ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999998765432 234457999999999987654 899999999999999999999999988877666665442110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
........+++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 226 ---------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 ---------------------------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---------------------------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---------------------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0111234678999999999999999999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=310.73 Aligned_cols=211 Identities=24% Similarity=0.417 Sum_probs=152.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.++..++ ||||+++++++.. .+..++||||++ ++|.+++.... .+++..+..
T Consensus 56 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------- 116 (278)
T 3cok_A 56 QRVQNEVKIHCQLK-HPSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH---------------- 116 (278)
T ss_dssp HHHHHHHHHHTTBC-CTTBCCEEEEEEC--SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHhCC-CCCeEeEEEEEcc--CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHH----------------
Confidence 45789999999999 9999999999865 678999999998 59999998763 377777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|
T Consensus 117 -------------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl 153 (278)
T 3cok_A 117 -------------------------------------------FMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKI 153 (278)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+.+..+.
T Consensus 154 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------- 225 (278)
T 3cok_A 154 ADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------- 225 (278)
T ss_dssp CCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------
T ss_pred EeecceeeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------
Confidence 999998866532 2233467999999999887654 7899999999999999999999997654332221110
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
......+..++.++.+||.+||..||.+|||++++++||||.+..
T Consensus 226 ------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 226 ------------------------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ------------------------SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ------------------------hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 000112345789999999999999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=311.65 Aligned_cols=210 Identities=22% Similarity=0.334 Sum_probs=157.1
Q ss_pred hHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHh----cccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRT----TDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 14 ~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
.+|..+++.++ ||||+++++++.. .+..++||||++|+|.+++.. ...+++..+..
T Consensus 54 ~~~~~~~~~~~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~----------------- 113 (290)
T 3fme_A 54 MDLDISMRTVD-CPFTVTFYGALFR--EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK----------------- 113 (290)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEEC--SSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHH-----------------
T ss_pred HHHHHHHHhCC-CCeEEEEeeeeec--cCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHH-----------------
Confidence 34444577777 9999999999865 667999999999999888764 23366666666
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC-eEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++ ||+||||||+|||++.+ .++|
T Consensus 114 ------------------------------------------i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 114 ------------------------------------------IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEB
T ss_pred ------------------------------------------HHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEE
Confidence 999999999999998 99999999999999987 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhh---ccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECL---LTEGYYSFELDIWAAGCVFYETLTRNPLFPGD-SEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l---~~~~~~~~~~DIwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~g 243 (470)
+|||++.............||+.|+|||++ .....++.++|||||||++|+|++|..||.+. .....+..+...
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-- 229 (290)
T 3fme_A 152 CDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-- 229 (290)
T ss_dssp CCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS--
T ss_pred eecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc--
Confidence 999999877655555556899999999997 23345899999999999999999999999763 333333332221
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.........+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 230 ---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 230 ---------------------------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ---------------------------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---------------------------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 00111123578999999999999999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.10 Aligned_cols=214 Identities=24% Similarity=0.407 Sum_probs=175.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|+.|+ ||||+++++++........++||||++++|.+++.... .+++..+..
T Consensus 50 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~--------------- 113 (305)
T 2wtk_C 50 EANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG--------------- 113 (305)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHH---------------
Confidence 456789999999999 99999999998766677899999999988888887643 266666666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 114 --------------------------------------------~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 114 --------------------------------------------YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccC---CCccccccccCcccCchhhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKS---KGLHTEYIATRWYRSPECLLTEG-YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++..... ........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~- 228 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG- 228 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-
Confidence 999999986642 22234567999999999987643 2477999999999999999999999988766655554331
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
....+..+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus 229 ------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 229 ------------------------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ------------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ------------------------------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 011234678999999999999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=312.79 Aligned_cols=221 Identities=23% Similarity=0.389 Sum_probs=173.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhh
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAAN 81 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~ 81 (470)
....+.+|+.++.++.+||||+++++++.... .+.+++||||++ |+|.+++.... .+++..+..
T Consensus 63 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~--------- 133 (326)
T 2x7f_A 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--------- 133 (326)
T ss_dssp TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHH---------
T ss_pred cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHH---------
Confidence 34567899999999955999999999987643 567999999998 49999998653 366766666
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||+|||++||+||||||+|||++
T Consensus 134 --------------------------------------------------i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 134 --------------------------------------------------ICREILRGLSHLHQHKVIHRDIKGQNVLLT 163 (326)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHCCccccCCcHHHEEEc
Confidence 999999999999999999999999999998
Q ss_pred CC-eEEEEecCCcccccCC-CccccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQL 235 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 235 (470)
.+ .++|+|||++...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.......
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp TTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 77 8999999998765432 22345679999999999863 234889999999999999999999999887766555
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..+... .........++..+.+||.+||..||.+|||+.++++||||++..
T Consensus 244 ~~~~~~-----------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 244 FLIPRN-----------------------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HHHHHS-----------------------------CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred HHhhcC-----------------------------ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 444321 001112346789999999999999999999999999999999865
Q ss_pred HH
Q psy9855 316 QL 317 (470)
Q Consensus 316 ~~ 317 (470)
..
T Consensus 295 ~~ 296 (326)
T 2x7f_A 295 NE 296 (326)
T ss_dssp TH
T ss_pred cc
Confidence 43
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.30 Aligned_cols=215 Identities=22% Similarity=0.261 Sum_probs=176.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 49 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 109 (276)
T 2yex_A 49 PENIKKEICINKMLN-HENVVKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---------------- 109 (276)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHH----------------
T ss_pred hHHHHHHHHHHHhcC-CCCceeeeeEEEc--CCEEEEEEEecCCCcHHHHHhhccCCCHHHHHH----------------
Confidence 356789999999998 9999999998865 678999999998 59999987766678777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+||+++.+ .++|
T Consensus 110 -------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 110 -------------------------------------------FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEE
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccCC---CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhC
Q psy9855 168 GDLGSLQFIKSK---GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ-LDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~g 243 (470)
+|||.+...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+...... ...+..
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--- 223 (276)
T 2yex_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--- 223 (276)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---
T ss_pred eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---
Confidence 999998765432 2234568999999999988766557899999999999999999999977553221 111110
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
..........+++.+.+||.+||..||.+|||+.++++||||++..
T Consensus 224 --------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 224 --------------------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp --------------------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --------------------------cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 0000111246789999999999999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=316.67 Aligned_cols=216 Identities=25% Similarity=0.402 Sum_probs=174.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|..|+ ||||+++++++.. ...|+||||++ ++|.+++.....+++..+..
T Consensus 60 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~----------------- 118 (322)
T 2ycf_A 60 LNVETEIEILKKLN-HPCIIKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKL----------------- 118 (322)
T ss_dssp -CHHHHHHHHHHCC-CTTBCCEEEEEES---SSEEEEEECCTTEETHHHHSTTCCCCHHHHHH-----------------
T ss_pred hhHHHHHHHHHhCC-CCCCceEeeEEcC---CceEEEEecCCCCcHHHHHhccCCCCHHHHHH-----------------
Confidence 35789999999998 9999999999854 23899999998 59999998777788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----eE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LV 165 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 119 ------------------------------------------~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 119 ------------------------------------------YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCE
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeE
Confidence 99999999999999999999999999999865 49
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhc--cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLL--TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ-LDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~ 242 (470)
+|+|||++............+||+.|+|||++. +...++.++|||||||++|+|++|..||.+...... ...+....
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp EECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred EEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 999999998766544445568999999999874 234588999999999999999999999976543221 12221110
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
. .........+++.+.+||.+||..||.+|||+.++|+||||++...
T Consensus 237 ~---------------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 237 Y---------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp C---------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred c---------------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 0 0011122457899999999999999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=324.07 Aligned_cols=217 Identities=23% Similarity=0.335 Sum_probs=174.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|..+++||||+++++++.. .+.+++|||||+ |+|.+++.....+++..+..
T Consensus 103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 163 (355)
T 1vzo_A 103 EHTRTERQVLEHIRQSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQI----------------- 163 (355)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHHccCCCceeEEEEEEee--CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHH-----------------
Confidence 4577999999999559999999999865 668999999998 59999998877788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 164 ------------------------------------------~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 164 ------------------------------------------YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEES
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEe
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCC--ccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 169 DLGSLQFIKSKG--LHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 169 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|||++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+....
T Consensus 202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--- 278 (355)
T 1vzo_A 202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--- 278 (355)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---
T ss_pred eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH---
Confidence 999987654222 23446899999999998753 347899999999999999999999997543221111111100
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
.. .....+..++..+.+||.+||..||.+|| |++++++||||..+.
T Consensus 279 --------~~----------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 279 --------LK----------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp --------HH----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred --------hc----------------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 00 01112346789999999999999999999 999999999999865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.66 Aligned_cols=210 Identities=30% Similarity=0.459 Sum_probs=179.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+++.++ ||||+++++++.. .+.+|+||||++ ++|.+++.....+++..+..
T Consensus 85 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~---------------- 145 (335)
T 2owb_A 85 REKMSMEISIHRSLA-HQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARY---------------- 145 (335)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEec--CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHH----------------
Confidence 456789999999998 9999999999865 678999999999 59999998877788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 146 -------------------------------------------i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl 182 (335)
T 2owb_A 146 -------------------------------------------YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 182 (335)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEE
Confidence 99999999999999999999999999999988 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+...
T Consensus 183 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----- 256 (335)
T 2owb_A 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 256 (335)
T ss_dssp CCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----
T ss_pred eeccCceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-----
Confidence 999999876532 2334568999999999987755 799999999999999999999999887766655444331
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...++..+++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 257 --------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 257 --------------------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred --------------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 01122457889999999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.94 Aligned_cols=211 Identities=29% Similarity=0.456 Sum_probs=179.4
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.+++.++ ||||+++++++.. .+..++||||++ ++|.+++.....+++..+..
T Consensus 58 ~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~--------------- 119 (294)
T 2rku_A 58 QREKMSMEISIHRSLA-HQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARY--------------- 119 (294)
T ss_dssp HHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeeeeeeecc--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHH---------------
Confidence 3456789999999998 9999999999864 678999999999 69999998777788887777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 120 --------------------------------------------i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 120 --------------------------------------------YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEE
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---- 230 (294)
T 2rku_A 156 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---- 230 (294)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----
T ss_pred EEeccCceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----
Confidence 9999999876532 2334567999999999987755 789999999999999999999999887766554443220
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
....+..+++.+.+||.+||..||.+|||+.++++||||.+
T Consensus 231 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 231 ---------------------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp ---------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ---------------------------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 01123467889999999999999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=334.46 Aligned_cols=212 Identities=27% Similarity=0.417 Sum_probs=176.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc----cccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD----NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~----~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+++|+.+|..++ ||||++++++|.. ...+|+|||||+ |+|.+++.... .+++..+..
T Consensus 230 ~~~~~E~~iL~~l~-hp~Iv~l~~~~~~--~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~------------- 293 (543)
T 3c4z_A 230 QGAMVEKKILAKVH-SRFIVSLAYAFET--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF------------- 293 (543)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHH-------------
T ss_pred HHHHHHHHHHHhcC-CCCEeeEEEEEee--CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHH-------------
Confidence 45789999999998 9999999999865 678999999999 69999997643 367766666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 294 ----------------------------------------------~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~ 327 (543)
T 3c4z_A 294 ----------------------------------------------YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN 327 (543)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC
Confidence 99999999999999999999999999999987 8
Q ss_pred EEEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE----IDQLDRIH 239 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~----~~~~~~i~ 239 (470)
+||+|||++........ ....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+... .+....+.
T Consensus 328 vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~ 406 (543)
T 3c4z_A 328 VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406 (543)
T ss_dssp EEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH
T ss_pred EEEeecceeeeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh
Confidence 99999999987664433 34469999999999998755 89999999999999999999999987532 22222222
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCCh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADL 314 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~ 314 (470)
.. ...++..+++.+.+||.+||..||.+||+ ++++++||||+++
T Consensus 407 ~~-------------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 407 EQ-------------------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HC-------------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred hc-------------------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 10 01123568899999999999999999996 5899999999987
Q ss_pred hH
Q psy9855 315 TQ 316 (470)
Q Consensus 315 ~~ 316 (470)
..
T Consensus 456 ~w 457 (543)
T 3c4z_A 456 SW 457 (543)
T ss_dssp CH
T ss_pred CH
Confidence 63
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=316.08 Aligned_cols=240 Identities=28% Similarity=0.455 Sum_probs=189.2
Q ss_pred hhhhhHHHHHHhcCCCCCC------eeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhh
Q psy9855 10 EVANLKEISILRKIPDHLN------VLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAAN 81 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~Hpn------Iv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~ 81 (470)
...+.+|+.+|+.|+ |++ |+.+++++.. .+.+|+||||++++|.+++.... .+++..+..
T Consensus 60 ~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~--------- 127 (355)
T 2eu9_A 60 REAARLEINVLKKIK-EKDKENKFLCVLMSDWFNF--HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRH--------- 127 (355)
T ss_dssp HHHHHHHHHHHHHHH-HHCTTSCSCBCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHH---------
T ss_pred hhHHHHHHHHHHHHh-hcCCCCceeEEEeeeeeee--CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHH---------
Confidence 456788999999997 655 8999998865 67899999999989988887654 377776666
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE-
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI- 160 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl- 160 (470)
++.||+.||+|||++||+||||||+|||+
T Consensus 128 --------------------------------------------------i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~ 157 (355)
T 2eu9_A 128 --------------------------------------------------MAYQLCHALRFLHENQLTHTDLKPENILFV 157 (355)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHTTTEECCCCCGGGEEES
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 99999999999999999999999999999
Q ss_pred ------------------eCC-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh
Q psy9855 161 ------------------RGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT 221 (470)
Q Consensus 161 ------------------~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt 221 (470)
+.+ .++|+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHh
Confidence 334 7999999999765432 34568999999999998755 8999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCC---------------CCcccccccccHHHHH
Q psy9855 222 RNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPG---------------GGIDVLVPQIHEKGKK 286 (470)
Q Consensus 222 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~s~~~~~ 286 (470)
|..||.+....+.+..+....+.++...+........ +......+.. ..........+.++.+
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 312 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKY--FYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGG--EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhh--hcccccccccccchhccccccCCcccccccccchhHHHHHH
Confidence 9999999999999999999999887766554322100 0000000000 0000111234678999
Q ss_pred HHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 287 LMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 287 Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
||.+||..||.+|||+.|+|+||||+++..
T Consensus 313 li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 313 LMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 999999999999999999999999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=310.11 Aligned_cols=218 Identities=20% Similarity=0.330 Sum_probs=174.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|..++ ||||+++++++.. .+..++||||++ ++|.+++.... .+++..+..
T Consensus 60 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~--------------- 121 (302)
T 2j7t_A 60 LEDYIVEIEILATCD-HPYIVKLLGAYYH--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--------------- 121 (302)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHhcCC-CCCEeeeeeeeee--CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHH---------------
Confidence 356789999999998 9999999999865 567999999998 59999987643 377777776
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||++||+||||||+|||++.+ .++
T Consensus 122 --------------------------------------------~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 157 (302)
T 2j7t_A 122 --------------------------------------------VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIR 157 (302)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999977 899
Q ss_pred EEecCCcccccCC-CccccccccCcccCchhhc----cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSK-GLHTEYIATRWYRSPECLL----TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~----~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||++...... .......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (302)
T 2j7t_A 158 LADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237 (302)
T ss_dssp ECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc
Confidence 9999987543211 1223457999999999884 2344889999999999999999999999888776655544331
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~ 317 (470)
. .........++..+.+||.+||..||.+|||+.++++||||.+....
T Consensus 238 ~----------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 238 D----------------------------PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp C----------------------------CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred C----------------------------CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 0 00111234678899999999999999999999999999999987643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=334.83 Aligned_cols=216 Identities=18% Similarity=0.233 Sum_probs=162.6
Q ss_pred hhhhhHHHHH---HhcCCCCCCeeeec-------eeeecCCC----------C-----eEEEEeeccccCHHHHHHhccc
Q psy9855 10 EVANLKEISI---LRKIPDHLNVLCLC-------ETYVNRST----------R-----QVTLVFPLMELNLEEYIRTTDN 64 (470)
Q Consensus 10 ~~~~~rEi~i---L~~L~~HpnIv~l~-------~~~~~~~~----------~-----~~~lV~E~~~gsL~~~l~~~~~ 64 (470)
...+.+|+.+ |..++ ||||++++ +++..++. + ..|+||||++|+|.+++.....
T Consensus 117 ~~~~~~E~~~l~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~ 195 (377)
T 3byv_A 117 IKQMKEEVLRLRLLRGIK-NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195 (377)
T ss_dssp HHHHHHHHHGGGGSTTCC-SHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccC-CHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc
Confidence 4567899954 55556 99999999 54433211 1 3799999999999999987654
Q ss_pred ccHHHHHHHHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH
Q psy9855 65 ISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH 144 (470)
Q Consensus 65 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH 144 (470)
+++. ...+....+..|+.||+.||+|||
T Consensus 196 ~~~~----------------------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 196 HSST----------------------------------------------------HKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp TTTT----------------------------------------------------THHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccc----------------------------------------------------cccccHHHHHHHHHHHHHHHHHHH
Confidence 4440 011112233349999999999999
Q ss_pred hCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCccccccccCcccCchhhccC----------CCCCCcccHHHHH
Q psy9855 145 SYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE----------GYYSFELDIWAAG 213 (470)
Q Consensus 145 ~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~----------~~~~~~~DIwSlG 213 (470)
++||+||||||+|||++.+ .+||+|||++..... .....+| +.|+|||++.+. ..++.++||||||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 9999999999999999977 899999999986433 3345678 999999999876 2489999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcc
Q psy9855 214 CVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293 (470)
Q Consensus 214 ~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~ 293 (470)
|++|||++|+.||.+.........+ ....+.+++++.+||.+||.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~L~ 345 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWI-----------------------------------FRSCKNIPQPVRALLEGFLR 345 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGG-----------------------------------GSSCCCCCHHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCCcccccccchhhh-----------------------------------hhhccCCCHHHHHHHHHHcC
Confidence 9999999999999664321111000 01124678999999999999
Q ss_pred cCCCCCcCHHHHHhcccCCChhH
Q psy9855 294 YDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 294 ~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.||.+|||+.++++||||+++..
T Consensus 346 ~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 346 YPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp SSGGGCCCHHHHHTSHHHHHHHH
T ss_pred CCchhCCCHHHHhhChHHHHHHH
Confidence 99999999999999999987653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.11 Aligned_cols=232 Identities=19% Similarity=0.293 Sum_probs=177.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHH------HHh--cccccHHHHHHHHHHHHhhh
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEY------IRT--TDNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~------l~~--~~~l~~~~~~~~~~~~~~~~ 81 (470)
..+.+|+.+|.+|+ ||||+++++++.. .+.+++||||++| +|.++ +.. ...+++..+..
T Consensus 88 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~--------- 155 (348)
T 2pml_X 88 DDFKNELQIITDIK-NEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC--------- 155 (348)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHH---------
T ss_pred HHHHHHHHHHHhCC-CCCcceEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHH---------
Confidence 67889999999999 9999999999865 6789999999995 99988 554 33366666666
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEE
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILI 160 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl 160 (470)
++.||+.||+|||+ +||+||||||+|||+
T Consensus 156 --------------------------------------------------i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 156 --------------------------------------------------IIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred --------------------------------------------------HHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 99999999999999 999999999999999
Q ss_pred eCC-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q psy9855 161 RGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSF-ELDIWAAGCVFYETLTRNPLFPGDSE-IDQLDR 237 (470)
Q Consensus 161 ~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~ 237 (470)
+.+ .++|+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||.+... .+....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 887 8999999999876443 3455689999999999987644555 99999999999999999999988765 444444
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHH
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~ 317 (470)
+.......+.. ...+ ...............++.++.+||.+||..||.+|||+.++++||||++....
T Consensus 265 i~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 265 IRTKNIEYPLD---------RNHF---LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332 (348)
T ss_dssp HTSCCCCCCCS---------SSSS---TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred HhccCcCCccc---------hhhh---hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence 32210000000 0000 00000111122235688999999999999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=321.61 Aligned_cols=242 Identities=17% Similarity=0.282 Sum_probs=176.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.++ ||||+++++++.. .+.+++||||++ ++|.+++.....+++..+..
T Consensus 75 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 135 (360)
T 3eqc_A 75 RNQIIRELQVLHECN-SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---------------- 135 (360)
T ss_dssp HHHHHHHHGGGGGCC-CTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHHCC-CCCEEEEeEEEEE--CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHH----------------
Confidence 456789999999998 9999999999875 678999999998 59999998877788877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+. ||+||||||+|||++.+ .++
T Consensus 136 -------------------------------------------i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~k 172 (360)
T 3eqc_A 136 -------------------------------------------VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 172 (360)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEE
Confidence 999999999999996 99999999999999887 899
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCC
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL-GTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-g~p 245 (470)
|+|||++...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.... +.+
T Consensus 173 l~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 173 LCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp ECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred EEECCCCcccccc-cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 9999998765432 234568999999999987755 8999999999999999999999998876655433321111 111
Q ss_pred chHHHHHHhh-hccCcccccc----------cc-CCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 246 KAETLKKFEK-YKSSNFTYQF----------KQ-YPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 246 ~~~~~~~~~~-~~~~~~~~~~----------~~-~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.......... .....+.... .. ............++.++.+||.+||..||.+|||+.|+|+||||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 1000000000 0000000000 00 0000011112347889999999999999999999999999999986
Q ss_pred hh
Q psy9855 314 LT 315 (470)
Q Consensus 314 ~~ 315 (470)
..
T Consensus 331 ~~ 332 (360)
T 3eqc_A 331 SD 332 (360)
T ss_dssp HH
T ss_pred ch
Confidence 44
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.75 Aligned_cols=220 Identities=26% Similarity=0.391 Sum_probs=165.4
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
.+.+|+++|+.+.+||||+++++++.. ....|+|||||+|+|.+++..... ..+..+.
T Consensus 63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~------------------- 121 (432)
T 3p23_A 63 FADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIELCAATLQEYVEQKDFAHLGLEPI------------------- 121 (432)
T ss_dssp ECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHSSSCCCCSSCHH-------------------
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEECCCCCHHHHHHhcCCCccchhHH-------------------
Confidence 467999999999449999999998865 678999999999999999976543 2222222
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---C---e
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG---D---L 164 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---~---~ 164 (470)
.++.||+.||+|||++||+||||||+|||++. + .
T Consensus 122 ----------------------------------------~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~ 161 (432)
T 3p23_A 122 ----------------------------------------TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIK 161 (432)
T ss_dssp ----------------------------------------HHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCC
T ss_pred ----------------------------------------HHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCcee
Confidence 29999999999999999999999999999953 2 5
Q ss_pred EEEEecCCcccccCCC----ccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDR 237 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~ 237 (470)
++|+|||++....... .....+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......... .
T Consensus 162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~ 240 (432)
T 3p23_A 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-I 240 (432)
T ss_dssp EEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-H
T ss_pred EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-H
Confidence 8899999998765332 2345689999999999874 2346889999999999999999 99999655432221 1
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhHH
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~~ 317 (470)
+ .+... ..........+..+.+||.+||..||.+|||+.++++||||.++...
T Consensus 241 ~---~~~~~------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 241 L---LGACS------------------------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp H---TTCCC------------------------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHH
T ss_pred H---hccCC------------------------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHH
Confidence 1 11100 00001112456678999999999999999999999999999998764
Q ss_pred HHH
Q psy9855 318 KQY 320 (470)
Q Consensus 318 ~~~ 320 (470)
.+.
T Consensus 294 ~~~ 296 (432)
T 3p23_A 294 LQF 296 (432)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=311.27 Aligned_cols=215 Identities=21% Similarity=0.313 Sum_probs=178.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhc-ccccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTT-DNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++..++ ||||+++++++.. .+.+++||||++| +|.+++... ..+++..+..
T Consensus 68 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 129 (314)
T 3com_A 68 LQEIIKEISIMQQCD-SPHVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--------------- 129 (314)
T ss_dssp CHHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCCccEEEEEEe--CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHH---------------
Confidence 356789999999998 9999999999865 6679999999995 999999743 3477777776
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||++||+||||||+||+++.+ .++
T Consensus 130 --------------------------------------------i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 165 (314)
T 3com_A 130 --------------------------------------------ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAK 165 (314)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+....
T Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 241 (314)
T 3com_A 166 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--- 241 (314)
T ss_dssp ECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---
T ss_pred EeecccchhhhhhccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC---
Confidence 99999997665332 234567999999999987755 8999999999999999999999998877655444332210
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.........++..+.+||.+||..||.+|||+.++++||||++..
T Consensus 242 -------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 242 -------------------------PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -------------------------CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -------------------------CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 000112345788999999999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.24 Aligned_cols=215 Identities=23% Similarity=0.441 Sum_probs=177.1
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc----ccHHHHHHHHHHHHhhhcc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN----ISEKRAKEILYQVKAANET 83 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~----l~~~~~~~~~~~~~~~~~~ 83 (470)
....+.+|+.++++++ ||||+++++++.+.....+++||||++ ++|.+++..... +++..+..
T Consensus 48 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~----------- 115 (279)
T 2w5a_A 48 EKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR----------- 115 (279)
T ss_dssp HHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHH-----------
T ss_pred HHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHH-----------
Confidence 3456889999999998 999999999987666778999999998 599999976432 66666665
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCcE
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK-----VFHRDIKPENI 158 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g-----IvHrDLKp~NI 158 (470)
++.||+.||+|||++| |+||||||+||
T Consensus 116 ------------------------------------------------i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NI 147 (279)
T 2w5a_A 116 ------------------------------------------------VMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147 (279)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHHHC------CCCCCSGGGE
T ss_pred ------------------------------------------------HHHHHHHHHHHHhcccCCCCeeEEeccchhhE
Confidence 9999999999999999 99999999999
Q ss_pred EEeCC-eEEEEecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 159 LIRGD-LVVVGDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 159 Ll~~~-~ikL~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
|++.+ .++|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+...
T Consensus 148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 226 (279)
T 2w5a_A 148 FLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226 (279)
T ss_dssp EECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH
Confidence 99987 899999999876653322 23457899999999987755 8999999999999999999999998887666555
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+... ....++..++.++.+||.+||..||.+|||+.++++|+|+.+-
T Consensus 227 ~i~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 227 KIREG------------------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHT------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHhhc------------------------------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 54331 1112334678999999999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.52 Aligned_cols=224 Identities=25% Similarity=0.418 Sum_probs=161.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHh--------cccccHHHHHHHHHHHHhh
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRT--------TDNISEKRAKEILYQVKAA 80 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~--------~~~l~~~~~~~~~~~~~~~ 80 (470)
...+.+|+.++..++ ||||+++++++.. .+..++||||++ ++|.+++.. ...+++..+..
T Consensus 57 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~-------- 125 (303)
T 2vwi_A 57 MDELLKEIQAMSQCH-HPNIVSYYTSFVV--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-------- 125 (303)
T ss_dssp ---------CCCCCC-CTTBCCEEEEEES--SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHH--------
T ss_pred HHHHHHHHHHHhhcC-CCCEeeEEEEEee--cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHH--------
Confidence 345789999999998 9999999999865 567999999998 699999874 22255555555
Q ss_pred hccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE
Q psy9855 81 NETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI 160 (470)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl 160 (470)
++.||+.||.|||++||+||||||+||++
T Consensus 126 ---------------------------------------------------i~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 154 (303)
T 2vwi_A 126 ---------------------------------------------------ILREVLEGLEYLHKNGQIHRDVKAGNILL 154 (303)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhCCCCCCCCChhhEEE
Confidence 99999999999999999999999999999
Q ss_pred eCC-eEEEEecCCcccccCCC------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy9855 161 RGD-LVVVGDLGSLQFIKSKG------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233 (470)
Q Consensus 161 ~~~-~ikL~DFG~a~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~ 233 (470)
+.+ .++|+|||++....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.....
T Consensus 155 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 234 (303)
T 2vwi_A 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234 (303)
T ss_dssp CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence 887 89999999887654321 12345799999999998764448999999999999999999999998776544
Q ss_pred HHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 234 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
....... +.+.. .. ...........++.++.+||.+||..||.+|||+.++++||||++
T Consensus 235 ~~~~~~~--~~~~~-------------~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 235 VLMLTLQ--NDPPS-------------LE------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp HHHHHHT--SSCCC-------------TT------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred HHHHHhc--cCCCc-------------cc------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 4332211 10000 00 000112233567899999999999999999999999999999987
Q ss_pred hhH
Q psy9855 314 LTQ 316 (470)
Q Consensus 314 ~~~ 316 (470)
...
T Consensus 294 ~~~ 296 (303)
T 2vwi_A 294 AKN 296 (303)
T ss_dssp ---
T ss_pred CCC
Confidence 653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=308.64 Aligned_cols=206 Identities=17% Similarity=0.293 Sum_probs=163.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc---ccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN---ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~---l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+++|.+|+ ||||+++++++.. .+.+++||||++ |+|.+++..... +++..+..
T Consensus 78 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~------------- 141 (309)
T 3p86_A 78 VNEFLREVAIMKRLR-HPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS------------- 141 (309)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS--TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEEE--CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHH-------------
Confidence 346789999999999 9999999999854 667999999998 599999987653 66666666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCC
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILIRGD 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~~ 163 (470)
++.||+.||+|||++| |+||||||+|||++.+
T Consensus 142 ----------------------------------------------i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~ 175 (309)
T 3p86_A 142 ----------------------------------------------MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175 (309)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT
T ss_pred ----------------------------------------------HHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC
Confidence 9999999999999999 9999999999999988
Q ss_pred -eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 -LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.++|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 176 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 176 YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp CCEEECCCC-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred CcEEECCCCCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 89999999987654332 234568999999999998765 799999999999999999999999888776655544321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+..+++++.+||.+||..||.+|||+.++++
T Consensus 255 -----------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 255 -----------------------------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp -----------------------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1112234568899999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=305.75 Aligned_cols=214 Identities=28% Similarity=0.453 Sum_probs=179.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++++|+ ||||+++++++.. .+.+++||||++ ++|.+++.....+++..+..
T Consensus 65 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 125 (287)
T 2wei_A 65 TSTILREVELLKKLD-HPNIMKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------------- 125 (287)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhcc-CCCccEEEEEEeC--CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHH----------------
Confidence 456789999999998 9999999999864 678999999998 59999998777788877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----~ 164 (470)
++.||+.||+|||++||+||||||+||+++.+ .
T Consensus 126 -------------------------------------------i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 126 -------------------------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCccc
Confidence 99999999999999999999999999999753 6
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++|+|||++.............||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 163 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 239 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY- 239 (287)
T ss_dssp EEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-
T ss_pred EEEeccCcceeecCCCccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-
Confidence 999999999877655555556799999999988653 79999999999999999999999998887766655543110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
... ......+++++.+||.+||..||.+|||+.++|+||||++.
T Consensus 240 -----------------~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 240 -----------------AFD---------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -----------------CCC---------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -----------------CCC---------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 000 01124578999999999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=312.64 Aligned_cols=214 Identities=23% Similarity=0.341 Sum_probs=171.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCC--CCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRS--TRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~--~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.++..++ ||||+++++++.... ....|+||||++ ++|.+++.....+++..+..
T Consensus 57 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~--------------- 120 (311)
T 3ork_A 57 LRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE--------------- 120 (311)
T ss_dssp HHHHHHHTTCCCCC-CTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHH---------------
T ss_pred HHHHHHHHHHHcCC-CCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHH---------------
Confidence 45789999999998 999999999987532 234699999998 69999998877788888777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 121 --------------------------------------------~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 121 --------------------------------------------VIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+....
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 235 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence 99999998665332 223457999999999998765 8999999999999999999999999888776655544321
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
..+ .......+++++.+||.+||..||.+||++.+++.|+|++
T Consensus 236 ~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 236 PIP---------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCC---------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC---------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 111 1111245789999999999999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=323.11 Aligned_cols=227 Identities=15% Similarity=0.141 Sum_probs=154.2
Q ss_pred hhhhhHH---HHHHhcCCCCCCeeeec-------eeeecCCC---------------CeEEEEeeccccCHHHHHHhccc
Q psy9855 10 EVANLKE---ISILRKIPDHLNVLCLC-------ETYVNRST---------------RQVTLVFPLMELNLEEYIRTTDN 64 (470)
Q Consensus 10 ~~~~~rE---i~iL~~L~~HpnIv~l~-------~~~~~~~~---------------~~~~lV~E~~~gsL~~~l~~~~~ 64 (470)
...+.+| +++|.. + ||||++++ +++..+.. ..+|+|||||+|+|.+++.....
T Consensus 106 ~~~~~~E~~~~~~l~~-~-hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~ 183 (371)
T 3q60_A 106 LERLHEATFAAARLLG-E-SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183 (371)
T ss_dssp HHHHHHHHHHHHHHHC------------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcc-c-ChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc
Confidence 3445677 556666 5 99988865 33332221 45899999999999999986432
Q ss_pred -ccHHHHHHHHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHH-HHHHHHHHHHHHH
Q psy9855 65 -ISEKRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHT-TFVLYQIVNGLHH 142 (470)
Q Consensus 65 -l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~-~~i~~qIl~aL~y 142 (470)
+..... ....+ ..++.||+.||+|
T Consensus 184 ~~~~~~~------------------------------------------------------~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 184 VYVFRGD------------------------------------------------------EGILALHILTAQLIRLAAN 209 (371)
T ss_dssp SCCCCHH------------------------------------------------------HHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhh------------------------------------------------------hhhhhHHHHHHHHHHHHHH
Confidence 222211 00001 1266999999999
Q ss_pred HHhCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCccccccccCcccCchhhccC-CCCCCcccHHHHHHHHHHHH
Q psy9855 143 LHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE-GYYSFELDIWAAGCVFYETL 220 (470)
Q Consensus 143 LH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlG~il~ell 220 (470)
||++||+||||||+|||++.+ .+||+|||++...... .....+|+.|+|||++.+. ..++.++|||||||++|+|+
T Consensus 210 LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp HHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred HHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 999999999999999999987 8999999999866432 2245677999999999752 34899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc
Q psy9855 221 TRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300 (470)
Q Consensus 221 tg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp 300 (470)
+|+.||.+....... .+ ...... ............+.+++.+.+||.+||..||++||
T Consensus 288 tg~~Pf~~~~~~~~~----------------~~-----~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 345 (371)
T 3q60_A 288 CLFLPFGLVTPGIKG----------------SW-----KRPSLR-VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345 (371)
T ss_dssp HSSCSTTBCCTTCTT----------------CC-----CBCCTT-SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC
T ss_pred hCCCCCCCcCccccc----------------ch-----hhhhhh-hccccccchhhccCCCHHHHHHHHHHcCCChhhCC
Confidence 999999765321000 00 000000 00001111112347899999999999999999999
Q ss_pred CHHHHHhcccCCChhH
Q psy9855 301 TAQKILSCAYFADLTQ 316 (470)
Q Consensus 301 t~~elL~hp~f~~~~~ 316 (470)
|+.++|+||||+++..
T Consensus 346 t~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 346 LPLEAMETPEFLQLQN 361 (371)
T ss_dssp CHHHHTTSHHHHHHHH
T ss_pred CHHHHhcCHHHHHHHH
Confidence 9999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.88 Aligned_cols=217 Identities=20% Similarity=0.312 Sum_probs=169.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc---ccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN---ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~---l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+++.++ ||||+++++++.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 63 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~------------- 126 (295)
T 2clq_A 63 SQPLHEEIALHKHLK-HKNIVQYLGSFSE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF------------- 126 (295)
T ss_dssp -HHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEeeEEEe--CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHH-------------
Confidence 356789999999998 9999999999865 668999999998 699999976532 44555555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-C-
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG-D- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~-~- 163 (470)
++.||+.||+|||++||+||||||+|||++. +
T Consensus 127 ----------------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 160 (295)
T 2clq_A 127 ----------------------------------------------YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG 160 (295)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC
Confidence 9999999999999999999999999999986 4
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEG-YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.++|+|||++....... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.............
T Consensus 161 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 240 (295)
T 2clq_A 161 VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 240 (295)
T ss_dssp CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH
T ss_pred CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc
Confidence 89999999998665322 234567999999999986542 3789999999999999999999999754332221111110
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.. ....++..+++++.+||.+||..||++|||+.++|+||||+....
T Consensus 241 ~~----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 241 FK----------------------------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HC----------------------------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred cc----------------------------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 00 011233567899999999999999999999999999999997653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.55 Aligned_cols=223 Identities=19% Similarity=0.315 Sum_probs=171.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..|..||||+++++++.. .+.+|+||||++ |+|.+++.............
T Consensus 130 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~---------------- 191 (370)
T 2psq_A 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYD---------------- 191 (370)
T ss_dssp HHHHHHHHHHHHHSCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------------------
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEcc--CCCEEEEEEcCCCCCHHHHHHhhCCcccccccc----------------
Confidence 45688999999999449999999998854 667999999998 59999998754311110000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
....+...+....+..++.||+.||+|||++||+||||||+|||++.+ .+||
T Consensus 192 ---------------------------~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl 244 (370)
T 2psq_A 192 ---------------------------INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244 (370)
T ss_dssp -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred ---------------------------ccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEE
Confidence 000112234445566699999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 245 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-- 321 (370)
T 2psq_A 245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-- 321 (370)
T ss_dssp CCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--
T ss_pred ccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--
Confidence 99999986654322 23346788999999998755 8999999999999999999 99999887655544433221
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..++.++.+||.+||..||.+|||+.|++++
T Consensus 322 ----------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 322 ----------------------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp ----------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112234678999999999999999999999999953
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.98 Aligned_cols=216 Identities=19% Similarity=0.309 Sum_probs=169.8
Q ss_pred hhhhhHHHHHHhcCCC-CCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPD-HLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~-HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|.+|++ ||||+++++++.. .+.+++|||+++++|.+++.....+++..+..
T Consensus 70 ~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~---------------- 131 (313)
T 3cek_A 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKS---------------- 131 (313)
T ss_dssp HHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHH----------------
T ss_pred hHHHHHHHHHHHhccccCCceEEEEEEeec--CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHH----------------
Confidence 4567899999999983 5999999998865 66799999977789999998877788877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG 168 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++++.++|+
T Consensus 132 -------------------------------------------i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~ 168 (313)
T 3cek_A 132 -------------------------------------------YWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI 168 (313)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEEC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEe
Confidence 9999999999999999999999999999998899999
Q ss_pred ecCCcccccCCC---ccccccccCcccCchhhccC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCChH-HH
Q psy9855 169 DLGSLQFIKSKG---LHTEYIATRWYRSPECLLTE----------GYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-DQ 234 (470)
Q Consensus 169 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~----------~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~ 234 (470)
|||++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.... ..
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 999998665332 12345799999999998652 34788999999999999999999999765432 22
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+..+. . .......+...+.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 249 ~~~~~---~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 249 LHAII---D--------------------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHH---C--------------------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHH---h--------------------------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 21111 0 001111223457889999999999999999999999999999864
Q ss_pred h
Q psy9855 315 T 315 (470)
Q Consensus 315 ~ 315 (470)
.
T Consensus 300 ~ 300 (313)
T 3cek_A 300 T 300 (313)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=315.01 Aligned_cols=244 Identities=26% Similarity=0.420 Sum_probs=184.8
Q ss_pred hhhhhHHHHHHhcCC----------CCCCeeeeceeeecC--CCCeEEEEeeccccCHHHHHHhccc--ccHHHHHHHHH
Q psy9855 10 EVANLKEISILRKIP----------DHLNVLCLCETYVNR--STRQVTLVFPLMELNLEEYIRTTDN--ISEKRAKEILY 75 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~----------~HpnIv~l~~~~~~~--~~~~~~lV~E~~~gsL~~~l~~~~~--l~~~~~~~~~~ 75 (470)
...+.+|+.++.++. +||||+++++++... +...+++|||+++++|.+++..... +++..+..
T Consensus 59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~--- 135 (373)
T 1q8y_A 59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--- 135 (373)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHH---
T ss_pred hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHH---
Confidence 456789999999886 278999999998753 2347899999998899999987433 67766666
Q ss_pred HHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCC
Q psy9855 76 QVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIK 154 (470)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLK 154 (470)
++.||+.||+|||++ ||+|||||
T Consensus 136 --------------------------------------------------------i~~qi~~aL~~lH~~~~ivH~Dik 159 (373)
T 1q8y_A 136 --------------------------------------------------------ISKQLLLGLDYMHRRCGIIHTDIK 159 (373)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHHTTCEECSCCS
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHhcCCEEecCCC
Confidence 999999999999998 99999999
Q ss_pred CCcEEEeC-----C--eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy9855 155 PENILIRG-----D--LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFP 227 (470)
Q Consensus 155 p~NILl~~-----~--~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~ 227 (470)
|+|||++. + .++|+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999952 2 7999999999876543 34458999999999998765 8999999999999999999999998
Q ss_pred CCC------hHHHHHHHHHHhCCCchHHHHHHhhhc---cC-ccccccccCCCC-------CcccccccccHHHHHHHHH
Q psy9855 228 GDS------EIDQLDRIHQVLGTPKAETLKKFEKYK---SS-NFTYQFKQYPGG-------GIDVLVPQIHEKGKKLMSE 290 (470)
Q Consensus 228 ~~~------~~~~~~~i~~~~g~p~~~~~~~~~~~~---~~-~~~~~~~~~~~~-------~~~~~~~~~s~~~~~Li~~ 290 (470)
+.. ..+.+..+...+|.++...+....... .. ............ ....+...++.++.+||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 654 566778888888888776554321110 00 000000000000 0011234567889999999
Q ss_pred hcccCCCCCcCHHHHHhcccCCChh
Q psy9855 291 MLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 291 ~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
||..||.+|||+.|+|+||||++..
T Consensus 317 ~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp GGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HhccCccccCCHHHHhhChhhhccc
Confidence 9999999999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=316.52 Aligned_cols=212 Identities=19% Similarity=0.264 Sum_probs=172.6
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-------ccHHHHHHHHHHHH
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-------ISEKRAKEILYQVK 78 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-------l~~~~~~~~~~~~~ 78 (470)
......+.+|+.+|..|+ ||||+++++++.. ....++|||||+ |+|.+++..... +++..+..
T Consensus 115 ~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~------ 185 (367)
T 3l9p_A 115 EQDELDFLMEALIISKFN-HQNIVRCIGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------ 185 (367)
T ss_dssp HHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHH------
T ss_pred hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEec--CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHH------
Confidence 334556889999999998 9999999999854 667899999998 599999976542 44444444
Q ss_pred hhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q psy9855 79 AANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENI 158 (470)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NI 158 (470)
++.||+.||+|||++||+||||||+||
T Consensus 186 -----------------------------------------------------i~~qi~~aL~~LH~~~ivHrDlkp~NI 212 (367)
T 3l9p_A 186 -----------------------------------------------------VARDIACGCQYLEENHFIHRDIAARNC 212 (367)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 999999999999999999999999999
Q ss_pred EEeCC----eEEEEecCCcccccCC---CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q psy9855 159 LIRGD----LVVVGDLGSLQFIKSK---GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDS 230 (470)
Q Consensus 159 Ll~~~----~ikL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~ 230 (470)
|++.+ .++|+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+..
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99843 5999999999765322 2223457899999999987755 8999999999999999998 999999888
Q ss_pred hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 231 EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 231 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
..+....+.... .......++..+.+||.+||..||.+|||+.+++++.+
T Consensus 292 ~~~~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 292 NQEVLEFVTSGG------------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp HHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCC------------------------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 776665554311 11123467889999999999999999999999998765
Q ss_pred C
Q psy9855 311 F 311 (470)
Q Consensus 311 f 311 (470)
+
T Consensus 342 ~ 342 (367)
T 3l9p_A 342 Y 342 (367)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=300.86 Aligned_cols=217 Identities=23% Similarity=0.361 Sum_probs=164.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC-----------CCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHH
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR-----------STRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQ 76 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~-----------~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~ 76 (470)
...+.+|+.+++.++ ||||+++++++... ..+..|+||||++ |+|.+++..... +++..+..
T Consensus 46 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---- 120 (303)
T 1zy4_A 46 LSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR---- 120 (303)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHH----
T ss_pred HHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHH----
Confidence 356789999999998 99999999988642 2467899999998 599999986543 56666655
Q ss_pred HHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q psy9855 77 VKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPE 156 (470)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~ 156 (470)
++.||+.||+|||++||+||||||+
T Consensus 121 -------------------------------------------------------i~~qi~~~l~~LH~~~i~H~dlkp~ 145 (303)
T 1zy4_A 121 -------------------------------------------------------LFRQILEALSYIHSQGIIHRDLKPM 145 (303)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHhCCeecccCCHH
Confidence 9999999999999999999999999
Q ss_pred cEEEeCC-eEEEEecCCcccccCC---------------CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHH
Q psy9855 157 NILIRGD-LVVVGDLGSLQFIKSK---------------GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETL 220 (470)
Q Consensus 157 NILl~~~-~ikL~DFG~a~~~~~~---------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ell 220 (470)
|||++.+ .++|+|||++...... .......||+.|+|||++.+...++.++|||||||++|+|+
T Consensus 146 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 146 NIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp GEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH
T ss_pred hEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH
Confidence 9999887 8999999998765421 12234579999999999987656899999999999999999
Q ss_pred hCCCCCCCCC-hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCC
Q psy9855 221 TRNPLFPGDS-EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299 (470)
Q Consensus 221 tg~~pf~~~~-~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R 299 (470)
+ ||.... .......+... . ......+....+..+.+||.+||..||.+|
T Consensus 226 ~---p~~~~~~~~~~~~~~~~~------------------~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 275 (303)
T 1zy4_A 226 Y---PFSTGMERVNILKKLRSV------------------S---------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275 (303)
T ss_dssp S---CCSSHHHHHHHHHHHHST------------------T---------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGS
T ss_pred h---ccCCchhHHHHHHhcccc------------------c---------cccCccccccchHHHHHHHHHHHhcCcccC
Confidence 8 453321 11222211110 0 000112334667889999999999999999
Q ss_pred cCHHHHHhcccCCChhH
Q psy9855 300 PTAQKILSCAYFADLTQ 316 (470)
Q Consensus 300 pt~~elL~hp~f~~~~~ 316 (470)
||+.++++||||....+
T Consensus 276 ps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 276 PGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp CCHHHHHHSSCSCCCCH
T ss_pred cCHHHHhCCCCcCCCCh
Confidence 99999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=314.56 Aligned_cols=257 Identities=20% Similarity=0.271 Sum_probs=172.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHH--------------
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKE-------------- 72 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~-------------- 72 (470)
...+.+|+++|.+|.+||||+++++++.. ....+++|||||+ |+|.+++..... .+......
T Consensus 69 ~~~~~~E~~~l~~l~~hpniv~~~~~~~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (359)
T 3vhe_A 69 HRALMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147 (359)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------
T ss_pred HHHHHHHHHHHHhhcCCcceeeeeeeeec-CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccch
Confidence 45689999999999659999999999864 3455899999999 599999987542 00000000
Q ss_pred -HHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhccc-ccCcccchhhhHHHHHHHHHHHHHHHHHhCCCee
Q psy9855 73 -ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLT-TFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFH 150 (470)
Q Consensus 73 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvH 150 (470)
+.+++..... ....-.-.+...+.+.+...... .......+....+..++.||+.||+|||++||+|
T Consensus 148 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH 216 (359)
T 3vhe_A 148 DLKRRLDSITS-----------SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 216 (359)
T ss_dssp -----------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hhhccccccCc-----------cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 0000000000 00000011222222222222211 1112233667788889999999999999999999
Q ss_pred cCCCCCcEEEeCC-eEEEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy9855 151 RDIKPENILIRGD-LVVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPL 225 (470)
Q Consensus 151 rDLKp~NILl~~~-~ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~p 225 (470)
|||||+|||++.+ .++|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..|
T Consensus 217 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p 295 (359)
T 3vhe_A 217 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 295 (359)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCC
Confidence 9999999999877 89999999998654322 223457899999999988755 8999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHH
Q psy9855 226 FPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305 (470)
Q Consensus 226 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~el 305 (470)
|.+....+.+....... .....+..+++++.++|.+||..||.+|||+.++
T Consensus 296 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 346 (359)
T 3vhe_A 296 YPGVKIDEEFCRRLKEG-----------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 346 (359)
T ss_dssp STTCCCSHHHHHHHHHT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCccchhHHHHHHHHcC-----------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 98876544433332211 1111234578899999999999999999999999
Q ss_pred Hhc
Q psy9855 306 LSC 308 (470)
Q Consensus 306 L~h 308 (470)
++|
T Consensus 347 l~~ 349 (359)
T 3vhe_A 347 VEH 349 (359)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.15 Aligned_cols=226 Identities=27% Similarity=0.429 Sum_probs=164.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVG 90 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (470)
..+.+|+++|..+.+||||+++++++.. .+.+|+|||||+|+|.+++............
T Consensus 53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~------------------- 111 (434)
T 2rio_A 53 DIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALELCNLNLQDLVESKNVSDENLKL------------------- 111 (434)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHHTC----------------------------
T ss_pred HHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEecCCCCHHHHHhccCCCchhhhh-------------------
Confidence 3568999999987449999999998854 6789999999999999999865432211100
Q ss_pred cCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-------
Q psy9855 91 WDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD------- 163 (470)
Q Consensus 91 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~------- 163 (470)
.....+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 112 ---------------------------------~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 112 ---------------------------------QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp ------------------------------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred ---------------------------------ccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 0112234499999999999999999999999999999742
Q ss_pred -------eEEEEecCCcccccCCCc-----cccccccCcccCchhhcc------CCCCCCcccHHHHHHHHHHHHh-CCC
Q psy9855 164 -------LVVVGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLT------EGYYSFELDIWAAGCVFYETLT-RNP 224 (470)
Q Consensus 164 -------~ikL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~------~~~~~~~~DIwSlG~il~ellt-g~~ 224 (470)
.++|+|||++........ ....+||+.|+|||++.+ ...++.++|||||||++|||++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 799999999987654321 234589999999999865 2348999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHH
Q psy9855 225 LFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304 (470)
Q Consensus 225 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~e 304 (470)
||.+..... ..+.... .... .........+++++.+||.+||..||.+|||+.+
T Consensus 239 Pf~~~~~~~--~~i~~~~--------------------~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (434)
T 2rio_A 239 PFGDKYSRE--SNIIRGI--------------------FSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292 (434)
T ss_dssp TTCSTTTHH--HHHHHTC--------------------CCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCchhhH--HHHhcCC--------------------CCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence 997654332 1222110 0000 0001112356789999999999999999999999
Q ss_pred HHhcccCCChhH
Q psy9855 305 ILSCAYFADLTQ 316 (470)
Q Consensus 305 lL~hp~f~~~~~ 316 (470)
+++||||.....
T Consensus 293 il~hp~f~~~~~ 304 (434)
T 2rio_A 293 VLRHPLFWPKSK 304 (434)
T ss_dssp HHTSGGGSCHHH
T ss_pred HHhCCccCCcHH
Confidence 999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=302.92 Aligned_cols=211 Identities=21% Similarity=0.330 Sum_probs=177.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++..++ ||||+++++++.. ...+++||||++ ++|.+++.. ..+++..+..
T Consensus 64 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~---------------- 123 (303)
T 3a7i_A 64 IEDIQQEITVLSQCD-SPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLEP-GPLDETQIAT---------------- 123 (303)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeEEEEEEec--CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHH----------------
Confidence 356789999999998 9999999999875 568999999999 599999865 3477777766
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||.|||++||+||||||+||+++.+ .++|
T Consensus 124 -------------------------------------------~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 160 (303)
T 3a7i_A 124 -------------------------------------------ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKL 160 (303)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----- 234 (303)
T 3a7i_A 161 ADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN----- 234 (303)
T ss_dssp CCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----
T ss_pred eecccceecCccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-----
Confidence 9999997765432 234568999999999987755 789999999999999999999999887766555443321
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
....+...++..+.+||.+||..||.+|||+.++++||||...
T Consensus 235 -------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 235 -------------------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -------------------------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -------------------------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0112234678999999999999999999999999999999643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.29 Aligned_cols=207 Identities=21% Similarity=0.290 Sum_probs=170.2
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
.....+.+|+.+|..|+ ||||+++++++.. .+..|+||||++ |+|.+++.... .+++..+..
T Consensus 92 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------------- 155 (325)
T 3kul_A 92 RQRRDFLSEASIMGQFD-HPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG------------- 155 (325)
T ss_dssp HHHHHHHHHHHHHTTCC-CTTBCCEEEEECG--GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHH-------------
T ss_pred HHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe--CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHH-------------
Confidence 33556889999999998 9999999999854 677999999998 59999997654 377777776
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 156 ----------------------------------------------i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (325)
T 3kul_A 156 ----------------------------------------------MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV 189 (325)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC
Confidence 99999999999999999999999999999887 8
Q ss_pred EEEEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 239 (470)
++|+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 190 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 99999999987653321 12335677899999997755 8999999999999999999 999999888777666554
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
... ....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 269 ~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 269 EGY------------------------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCC------------------------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 311 11123467899999999999999999999999984
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=305.82 Aligned_cols=216 Identities=21% Similarity=0.297 Sum_probs=161.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCC----CeEEEEeeccc-cCHHHHHHhcc------cccHHHHHHHHHHH
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRST----RQVTLVFPLME-LNLEEYIRTTD------NISEKRAKEILYQV 77 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~----~~~~lV~E~~~-gsL~~~l~~~~------~l~~~~~~~~~~~~ 77 (470)
....+.+|++++++|+ ||||+++++++..... ...++||||++ |+|.+++.... .+++..+..
T Consensus 68 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~----- 141 (323)
T 3qup_A 68 DIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR----- 141 (323)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHH-----
T ss_pred HHHHHHHHHHHHHHCC-CCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHH-----
Confidence 3456889999999998 9999999999875322 12499999999 59999986543 255555555
Q ss_pred HhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCc
Q psy9855 78 KAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPEN 157 (470)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~N 157 (470)
++.||+.||+|||++||+||||||+|
T Consensus 142 ------------------------------------------------------i~~qi~~al~~LH~~~ivH~Dikp~N 167 (323)
T 3qup_A 142 ------------------------------------------------------FMVDIACGMEYLSSRNFIHRDLAARN 167 (323)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHcCCcccCCCCcce
Confidence 99999999999999999999999999
Q ss_pred EEEeCC-eEEEEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChH
Q psy9855 158 ILIRGD-LVVVGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEI 232 (470)
Q Consensus 158 ILl~~~-~ikL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~ 232 (470)
||++.+ .++|+|||++......... ....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....
T Consensus 168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 999988 8999999999876543322 2345678899999987755 8999999999999999999 99999887766
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-------HHHH
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-------AQKI 305 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-------~~el 305 (470)
+....+... ......+.+++++.+||.+||..||.+||| ++++
T Consensus 247 ~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 247 EIYNYLIGG------------------------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp GHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcC------------------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 555444321 111223567899999999999999999999 7778
Q ss_pred HhcccCCChh
Q psy9855 306 LSCAYFADLT 315 (470)
Q Consensus 306 L~hp~f~~~~ 315 (470)
++|||+....
T Consensus 297 l~~~~~~~~~ 306 (323)
T 3qup_A 297 LGHLSVLSTS 306 (323)
T ss_dssp HHC-------
T ss_pred HHHhhhcCCC
Confidence 8899987643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=302.30 Aligned_cols=230 Identities=17% Similarity=0.248 Sum_probs=171.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.|+ ||||+++++++.. .+..++||||++ |+|.+++.............
T Consensus 70 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 130 (314)
T 2ivs_A 70 LRDLLSEFNVLKQVN-HPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS---------------- 130 (314)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC------------------
T ss_pred HHHHHHHHHHHhhCC-CCceeeEEEEEec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccc----------------
Confidence 456789999999998 9999999998854 667999999999 69999998654311000000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++. .............+....+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 131 ----------------~~~---~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl 191 (314)
T 2ivs_A 131 ----------------GGS---RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKI 191 (314)
T ss_dssp ---------------------------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEE
T ss_pred ----------------ccc---ccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEE
Confidence 000 00000001112334556667799999999999999999999999999999987 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+...
T Consensus 192 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-- 268 (314)
T 2ivs_A 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG-- 268 (314)
T ss_dssp CCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--
T ss_pred ccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC--
Confidence 99999986653322 23346788899999987755 8999999999999999999 99999887655444333220
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 269 ----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 269 ----------------------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1112234688999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=296.14 Aligned_cols=206 Identities=21% Similarity=0.347 Sum_probs=171.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|++++ ||||+++++++.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 49 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 110 (269)
T 4hcu_A 49 EEDFIEEAEVMMKLS-HPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG--------------- 110 (269)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEec--CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHH---------------
Confidence 456889999999999 9999999999854 667999999998 599999976544 77777766
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+||+++.+ .++
T Consensus 111 --------------------------------------------i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k 146 (269)
T 4hcu_A 111 --------------------------------------------MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 146 (269)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~- 224 (269)
T 4hcu_A 147 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF- 224 (269)
T ss_dssp ECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-
T ss_pred eccccccccccccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-
Confidence 99999998654322 123346778899999987655 8999999999999999999 999999888776665553311
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 225 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 -----------------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111223568899999999999999999999999965
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=301.83 Aligned_cols=213 Identities=23% Similarity=0.301 Sum_probs=168.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++.+++ ||||+++++++.. .+.+|+||||++ ++|.+++.....+++..+..
T Consensus 55 ~~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~---------------- 115 (294)
T 4eqm_A 55 LKRFEREVHNSSQLS-HQNIVSMIDVDEE--DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN---------------- 115 (294)
T ss_dssp HHHHHHHHHHHTTCC-BTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHhcCC-CCCCceEEEeeee--CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHH----------------
Confidence 356789999999999 9999999998854 678999999998 59999998877788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 116 -------------------------------------------~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl 152 (294)
T 4eqm_A 116 -------------------------------------------FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKI 152 (294)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 168 GDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 168 ~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|||++....... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+........... ..
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~ 229 (294)
T 4eqm_A 153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SV 229 (294)
T ss_dssp CCCSSSTTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CC
T ss_pred EeCCCccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cC
Confidence 9999998765332 223457999999999998765 799999999999999999999999988766554333211 00
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
........+.+++.+.++|.+||..||.+||+..+.+.+.|.
T Consensus 230 ------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 230 ------------------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp ------------------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred ------------------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 000112235688999999999999999999965555555443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.93 Aligned_cols=229 Identities=19% Similarity=0.243 Sum_probs=170.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..|+ ||||+++++++.. .+.+++||||++ |+|.+++.............
T Consensus 94 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 154 (343)
T 1luf_A 94 QADFQREAALMAEFD-NPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH---------------- 154 (343)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCC------------------------
T ss_pred HHHHHHHHHHHHhCC-CCCEEEEEEEEcc--CCceEEEEecCCCCcHHHHHHHhCccccccccc----------------
Confidence 456789999999998 9999999999854 677999999998 59999998754211100000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
..+.. ...........+....+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 155 -----------------~~~~~--~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl 215 (343)
T 1luf_A 155 -----------------SDLST--RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 215 (343)
T ss_dssp ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred -----------------ccccc--cccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEE
Confidence 00000 000000111334556667799999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-- 292 (343)
T 1luf_A 216 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-- 292 (343)
T ss_dssp CCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--
T ss_pred eecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC--
Confidence 9999997654322 223457889999999988755 8999999999999999999 99999888776655544321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..++..+.+||.+||..||.+|||+.++++
T Consensus 293 ----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 293 ----------------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp ----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 111233467899999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=298.18 Aligned_cols=204 Identities=22% Similarity=0.344 Sum_probs=159.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++++++ ||||+++++++. .+..++||||++ ++|.+++.... .+++..+..
T Consensus 60 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 120 (281)
T 1mp8_A 60 REKFLQEALTMRQFD-HPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL--------------- 120 (281)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEC---SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCccceEEEEEc---cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHH---------------
Confidence 456889999999998 999999999874 356899999999 59999998655 377777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 121 --------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 156 (281)
T 1mp8_A 121 --------------------------------------------YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 156 (281)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEE
Confidence 99999999999999999999999999999876 899
Q ss_pred EEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-- 233 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-- 233 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC--
Confidence 999999987654332 22345678899999987655 8999999999999999996 99999887766555444321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....++.+++.+.+||.+||..||.+|||+.++++
T Consensus 234 ----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 234 ----------------------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111233568899999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=306.23 Aligned_cols=220 Identities=21% Similarity=0.312 Sum_probs=151.0
Q ss_pred hhhhhhHHHH-HHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHh-----cccccHHHHHHHHHHHHhhhc
Q psy9855 9 AEVANLKEIS-ILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRT-----TDNISEKRAKEILYQVKAANE 82 (470)
Q Consensus 9 ~~~~~~rEi~-iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~-----~~~l~~~~~~~~~~~~~~~~~ 82 (470)
....+.+|+. +++.++ ||||+++++++.. .+..++||||++|+|.+++.. ...+++..+..
T Consensus 63 ~~~~~~~e~~~~~~~~~-h~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~---------- 129 (327)
T 3aln_A 63 EQKQLLMDLDVVMRSSD-CPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK---------- 129 (327)
T ss_dssp HHHHHHHHHHHHHSSCC-CTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHH----------
T ss_pred HHHHHHHHHHHHHHcCC-CCcEeeeeeEEEe--CCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHH----------
Confidence 3445677777 666677 9999999999865 678999999999999988864 33366666555
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEe
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIR 161 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~ 161 (470)
++.||+.||.|||++ ||+||||||+|||++
T Consensus 130 -------------------------------------------------i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~ 160 (327)
T 3aln_A 130 -------------------------------------------------ITLATVKALNHLKENLKIIHRDIKPSNILLD 160 (327)
T ss_dssp -------------------------------------------------HHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE
T ss_pred -------------------------------------------------HHHHHHHHHHHHhccCCEeECCCCHHHEEEc
Confidence 999999999999999 999999999999998
Q ss_pred CC-eEEEEecCCcccccCCCccccccccCcccCchhhc---cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLL---TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
.+ .++|+|||++.............||+.|+|||++. ....++.++|||||||++|+|++|..||.+..... ..
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~ 238 (327)
T 3aln_A 161 RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQ 238 (327)
T ss_dssp TTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------
T ss_pred CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HH
Confidence 87 89999999998776554445568999999999983 22348999999999999999999999997643211 00
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+... ....+..........+++.+.+||.+||..||.+|||+.++++||||....
T Consensus 239 ~~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 239 LTQV-----------------------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp -CCC-----------------------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHH-----------------------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 0000 000000011112246789999999999999999999999999999997654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=293.60 Aligned_cols=207 Identities=20% Similarity=0.289 Sum_probs=171.9
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+++|.+++ ||||+++++++.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 46 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~-------------- 108 (268)
T 3sxs_A 46 SEDEFFQEAQTMMKLS-HPKLVKFYGVCSK--EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE-------------- 108 (268)
T ss_dssp CHHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHH--------------
T ss_pred cHHHHHHHHHHHHhCC-CCCEeeEEEEEcc--CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHH--------------
Confidence 3456889999999999 9999999998854 677999999998 699999987654 77777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 109 ---------------------------------------------i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 143 (268)
T 3sxs_A 109 ---------------------------------------------MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV 143 (268)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||++......... ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 144 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 222 (268)
T 3sxs_A 144 KVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222 (268)
T ss_dssp EECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred EEccCccceecchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC
Confidence 99999999866543322 2345677899999987755 7999999999999999998 999998887766655543211
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 223 ------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 ------------------------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------------------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111223468899999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=309.85 Aligned_cols=223 Identities=19% Similarity=0.298 Sum_probs=171.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|++++..+..||||+++++++.. .+.+++||||++ |+|.+++........
T Consensus 118 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------- 174 (382)
T 3tt0_A 118 LSDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGL--------------------- 174 (382)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCSSS---------------------
T ss_pred HHHHHHHHHHHHHhcCCchhhhheeeecc--CCceEEEEEecCCCcHHHHHHHhccccc---------------------
Confidence 35688999999999449999999999854 667999999998 599999986542000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
.+.+ .........+....+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 175 ----------~~~~------------~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 232 (382)
T 3tt0_A 175 ----------EYSY------------NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 232 (382)
T ss_dssp ----------SSCC------------CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred ----------cccc------------ccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEE
Confidence 0000 0000111223334444499999999999999999999999999999977 8999
Q ss_pred EecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-- 309 (382)
T 3tt0_A 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-- 309 (382)
T ss_dssp CSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--
T ss_pred cccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--
Confidence 9999998665432 223456788999999998755 8999999999999999999 99999888766655544321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..+++++.+||.+||..||.+|||+.+++++
T Consensus 310 ----------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 310 ----------------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp ----------------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111234678999999999999999999999999964
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=300.60 Aligned_cols=211 Identities=19% Similarity=0.185 Sum_probs=170.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.++..+.+|+||+++++++.. ....++||||++++|.+++..... +++..+..
T Consensus 48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~--------------- 110 (298)
T 1csn_A 48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--------------- 110 (298)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHH---------------
T ss_pred ccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEEEecCCCHHHHHHHhccCCCHHHHHH---------------
Confidence 345678999999999669999999998854 678999999998899999987654 77777777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC----
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 111 --------------------------------------------i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 146 (298)
T 1csn_A 111 --------------------------------------------AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKN 146 (298)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTT
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCC
Confidence 99999999999999999999999999999765
Q ss_pred --eEEEEecCCcccccCCCc--------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---
Q psy9855 164 --LVVVGDLGSLQFIKSKGL--------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS--- 230 (470)
Q Consensus 164 --~ikL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~--- 230 (470)
.++|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..
T Consensus 147 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 225 (298)
T 1csn_A 147 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 225 (298)
T ss_dssp TTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred CCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccc
Confidence 399999999987654322 24567999999999987755 8999999999999999999999998743
Q ss_pred hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 231 EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 231 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..+...... .......+.+++++.+||.+||..||.+|||++++++
T Consensus 226 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 226 NKQKYERIGEKKQS--------------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHHHHHHH--------------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cHHHHHHHHhhccC--------------------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 33333333221100 0111122467899999999999999999999999984
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.91 Aligned_cols=230 Identities=20% Similarity=0.274 Sum_probs=170.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|.+|.+||||+++++++.. .+.+++||||++ |+|.+++..... +++..+..
T Consensus 92 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~--------------- 154 (344)
T 1rjb_A 92 REALMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY--------------- 154 (344)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC----------------------
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEee--CCccEEEEecCCCCcHHHHHhhccccccccccch---------------
Confidence 45688999999999449999999999864 667999999998 599999987653 32222111
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
.. ............+....+..++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 155 ---------------~~-------~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k 212 (344)
T 1rjb_A 155 ---------------EN-------QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK 212 (344)
T ss_dssp ------------------------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred ---------------hh-------hcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEE
Confidence 00 0000001112234556667799999999999999999999999999999987 899
Q ss_pred EEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+...
T Consensus 213 L~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~- 290 (344)
T 1rjb_A 213 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN- 290 (344)
T ss_dssp ECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT-
T ss_pred eCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhc-
Confidence 999999986653322 23456788999999987755 8999999999999999998 99999887654444333221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
......+..+++++.+||.+||..||.+|||+.++++|
T Consensus 291 ----------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 291 ----------------------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp ----------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 01111234578999999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=311.16 Aligned_cols=205 Identities=21% Similarity=0.320 Sum_probs=168.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|++++ ||||+++++++.. .+.+|+|||||+ |+|.+++..... +++..+..
T Consensus 156 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~--------------- 217 (377)
T 3cbl_A 156 KAKFLQEARILKQYS-HPNIVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ--------------- 217 (377)
T ss_dssp HTTTTHHHHHHTTCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEEEEEEEEec--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHH---------------
Confidence 457899999999998 9999999999854 567999999998 699999986543 77766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .+|
T Consensus 218 --------------------------------------------~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~k 253 (377)
T 3cbl_A 218 --------------------------------------------MVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLK 253 (377)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++......... ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 254 l~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~- 331 (377)
T 3cbl_A 254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG- 331 (377)
T ss_dssp ECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-
T ss_pred ECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999998765432211 1224577899999987655 8999999999999999998 99999888766555444321
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++++.+||.+||..||.+|||+.++++
T Consensus 332 -----------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 -----------------------------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011123457889999999999999999999999984
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=307.09 Aligned_cols=209 Identities=18% Similarity=0.163 Sum_probs=167.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.|.+||||+++++++.. .+..++||||++++|.+++... ..+++..+..
T Consensus 48 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~---------------- 109 (330)
T 2izr_A 48 APQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLM---------------- 109 (330)
T ss_dssp SCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHH----------------
T ss_pred hHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHH----------------
Confidence 34678999999999449999999998865 6789999999988999999874 3477777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e---
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L--- 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~--- 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 110 -------------------------------------------i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~ 146 (330)
T 2izr_A 110 -------------------------------------------IAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQ 146 (330)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCT
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCC
Confidence 99999999999999999999999999999876 3
Q ss_pred --EEEEecCCcccccCCCc--------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH--
Q psy9855 165 --VVVGDLGSLQFIKSKGL--------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI-- 232 (470)
Q Consensus 165 --ikL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-- 232 (470)
++|+|||++........ ....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+....
T Consensus 147 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~ 225 (330)
T 2izr_A 147 QVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTL 225 (330)
T ss_dssp TSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred ceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence 99999999987653322 24568999999999998755 899999999999999999999999875432
Q ss_pred -HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 233 -DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 233 -~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+....+....... ........++ ++.+||..||..||.+||+++++++
T Consensus 226 ~~~~~~i~~~~~~~--------------------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 226 KERYQKIGDTKRAT--------------------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHHHHS--------------------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhccC--------------------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3333332211000 0011112344 8899999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=300.62 Aligned_cols=211 Identities=19% Similarity=0.260 Sum_probs=157.1
Q ss_pred HHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccccccccCC
Q psy9855 15 KEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTT-DNISEKRAKEILYQVKAANETAAHYRVGWDL 93 (470)
Q Consensus 15 rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (470)
.+..++..++ ||||+++++++.. .+.+++||||+++.+..+.... ..+++..+..
T Consensus 73 ~~~~~~~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~--------------------- 128 (318)
T 2dyl_A 73 DLDVVLKSHD-CPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--------------------- 128 (318)
T ss_dssp HHHHHHHTTT-CTTBCCEEEEEEC--SSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHH---------------------
T ss_pred HHHHHHHhcC-CCceeeEEEEEec--CCcEEEEEeccCCcHHHHHHHhccCCCHHHHHH---------------------
Confidence 4445677777 9999999999865 6789999999976777666543 3377776666
Q ss_pred CccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEeCC-eEEEEecC
Q psy9855 94 KLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY-KVFHRDIKPENILIRGD-LVVVGDLG 171 (470)
Q Consensus 94 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~-gIvHrDLKp~NILl~~~-~ikL~DFG 171 (470)
++.||+.||.|||++ ||+||||||+|||++.+ .++|+|||
T Consensus 129 --------------------------------------~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 129 --------------------------------------MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp --------------------------------------HHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred --------------------------------------HHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999995 99999999999999887 89999999
Q ss_pred CcccccCCCccccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCc
Q psy9855 172 SLQFIKSKGLHTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGD-SEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~g~p~ 246 (470)
++.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+. ...+.+..+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 246 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---- 246 (318)
T ss_dssp TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC----
T ss_pred CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC----
Confidence 9987665554556689999999999852 334889999999999999999999999764 3344443333210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.........++.++.+||.+||..||.+|||+.++++||||++..
T Consensus 247 ------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 247 ------------------------PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp ------------------------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred ------------------------CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 000111235789999999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=305.96 Aligned_cols=207 Identities=25% Similarity=0.432 Sum_probs=174.2
Q ss_pred hhhhHHHHHHhcCC-CCCCeeeeceeeecCCCCeEEEEeeccc--cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIP-DHLNVLCLCETYVNRSTRQVTLVFPLME--LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~-~HpnIv~l~~~~~~~~~~~~~lV~E~~~--gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+|+.+. +||||+++++++.. .+..++|||++. ++|.+++.....+++..+..
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~--------------- 153 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARS--------------- 153 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHH---------------
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEec--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHH---------------
Confidence 45779999999997 37999999999864 678999999997 69999998877788877777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe-CC-eE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR-GD-LV 165 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~-~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++ .+ .+
T Consensus 154 --------------------------------------------i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 154 --------------------------------------------FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCE
Confidence 999999999999999999999999999998 44 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
+|+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+... +.. +
T Consensus 190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~-- 258 (320)
T 3a99_A 190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--G-- 258 (320)
T ss_dssp EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--C--
T ss_pred EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--c--
Confidence 99999999876543 234568999999999988766567889999999999999999999965321 111 0
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
.......+++++.+||.+||..||.+|||++++++||||++...
T Consensus 259 ---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 259 ---------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp ---------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ---------------------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 01122467899999999999999999999999999999998653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=300.11 Aligned_cols=226 Identities=19% Similarity=0.266 Sum_probs=169.4
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccc-cHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNI-SEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l-~~~~~~~~~~~~~~~~~~~~~ 86 (470)
+...+.+|+.+|.+|.+||||+++++++.. .+..++||||++ |+|.+++...... .......
T Consensus 69 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~-------------- 132 (313)
T 1t46_A 69 EREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP-------------- 132 (313)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC---------------------
T ss_pred HHHHHHHHHHHHhhcccCCCeeeEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccc--------------
Confidence 346688999999999449999999999854 667899999998 5999999865420 0000000
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
.........+....+..++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 133 ----------------------------~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 133 ----------------------------AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEE
T ss_pred ----------------------------cccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCE
Confidence 0000011223445555699999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
+|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+...
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 263 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhcc
Confidence 9999999887654332 23446788999999987755 8999999999999999998 99999876654444333221
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
. ........++..+.+||.+||..||.+|||+.+++++
T Consensus 264 ~-----------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 264 G-----------------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp T-----------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-----------------------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 0 0011224578999999999999999999999999953
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=294.43 Aligned_cols=207 Identities=20% Similarity=0.296 Sum_probs=172.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+++|..++ ||||+++++++.. .+.+++||||++ ++|.+++.... .+++..+..
T Consensus 62 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~-------------- 124 (283)
T 3gen_A 62 SEDEFIEEAKVMMNLS-HEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------------- 124 (283)
T ss_dssp CHHHHHHHHHHHHTCC-CTTBCCEEEEECS--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHH--------------
T ss_pred CHHHHHHHHHHHhcCC-CCCEeeEEEEEec--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHH--------------
Confidence 3456889999999999 9999999998854 677999999998 69999998733 377777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 125 ---------------------------------------------i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~ 159 (283)
T 3gen_A 125 ---------------------------------------------MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 159 (283)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~ 238 (283)
T 3gen_A 160 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238 (283)
T ss_dssp EECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred EEccccccccccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc
Confidence 999999997654322 122345678899999988755 8999999999999999998 999999888776665554311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 239 ------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 239 ------------------------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 111223567899999999999999999999999965
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=291.57 Aligned_cols=205 Identities=20% Similarity=0.258 Sum_probs=170.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|++++ ||||+++++++.....+..++||||++ |+|.+++..... +++..+..
T Consensus 51 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~-------------- 115 (271)
T 3kmu_A 51 SRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK-------------- 115 (271)
T ss_dssp HHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHH--------------
Confidence 456889999999998 999999999997655678999999999 599999987664 67777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCC-
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILIRGD- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++| |+||||||+|||++.+
T Consensus 116 ---------------------------------------------i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~ 150 (271)
T 3kmu_A 116 ---------------------------------------------FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150 (271)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS
T ss_pred ---------------------------------------------HHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc
Confidence 9999999999999999 9999999999999988
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGY--YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.++|+|||++..... ....||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 151 ~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 226 (271)
T 3kmu_A 151 TARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226 (271)
T ss_dssp CEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS
T ss_pred ceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc
Confidence 788888887654322 34578999999999876542 333799999999999999999999888776665554331
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+..+++++.+||.+||..||.+|||+.++++
T Consensus 227 -----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 -----------------------------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1112233568899999999999999999999999984
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=303.68 Aligned_cols=223 Identities=17% Similarity=0.212 Sum_probs=168.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|.++.+||||+++++++.. .+.+++||||++ |+|.+++.............+
T Consensus 69 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 131 (327)
T 1fvr_A 69 HRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI--------------- 131 (327)
T ss_dssp -CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHH---------------
T ss_pred HHHHHHHHHHHHhccCCCchhhhceeeee--CCceEEEEecCCCCCHHHHHHhcccccccccccc---------------
Confidence 45678999999999449999999999865 678999999998 599999987652111100000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
.......+....+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 132 ----------------------------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 132 ----------------------------ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp ----------------------------HTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred ----------------------------cccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 00011123344455599999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||++.............+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~----- 257 (327)
T 1fvr_A 184 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 257 (327)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-----
T ss_pred cccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-----
Confidence 9999987544333334456788999999987654 7999999999999999998 99999888765544433210
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 258 -------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 258 -------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp -------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0111234678999999999999999999999999964
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.12 Aligned_cols=205 Identities=19% Similarity=0.267 Sum_probs=167.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|.+++ ||||+++++++.. +..++|+||+. |+|.+++..... +++..+..
T Consensus 61 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~--------------- 121 (327)
T 3poz_A 61 NKEILDEAYVMASVD-NPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN--------------- 121 (327)
T ss_dssp HHHHHHHHHHHHHCC-BTTBCCEEEEEES---SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeEEEEEEec---CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHH---------------
Confidence 456889999999999 9999999999864 34789999998 699999987543 77777766
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 122 --------------------------------------------~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~k 157 (327)
T 3poz_A 122 --------------------------------------------WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEE
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCCCcc---ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGLH---TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++......... ....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~- 235 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-
Confidence 9999999876543322 2345688999999998755 8999999999999999999 99999887655544333221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....++.++..+.+||.+||..||.+|||+.+++++
T Consensus 236 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 236 -----------------------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------------------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1111234678899999999999999999999999964
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=300.32 Aligned_cols=208 Identities=21% Similarity=0.324 Sum_probs=164.8
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+++|.+|+ ||||+++++++.. .+..++||||++ |+|.+++.... .+++..+..
T Consensus 50 ~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~-------------- 112 (310)
T 3s95_A 50 TQRTFLKEVKVMRCLE-HPNVLKFIGVLYK--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS-------------- 112 (310)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CcCcccEEEEEec--CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHH--------------
Confidence 3556889999999999 9999999999875 678999999998 59999998743 377777766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 113 ---------------------------------------------i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~ 147 (310)
T 3s95_A 113 ---------------------------------------------FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNV 147 (310)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCcc---------------ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy9855 166 VVGDLGSLQFIKSKGLH---------------TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~---------------~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~ 230 (470)
+|+|||++......... ...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp EECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred EEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 99999999876432221 1457999999999998755 8999999999999999999999986532
Q ss_pred hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 231 EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 231 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
...... + ...... .....++.+++.+.+||.+||..||++|||+.++++
T Consensus 227 ~~~~~~------~----~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 227 PRTMDF------G----LNVRGF------------------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp CBCTTS------S----BCHHHH------------------HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHH------h----hhhhcc------------------ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 110000 0 000000 000123467788999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.39 Aligned_cols=214 Identities=13% Similarity=0.097 Sum_probs=168.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeec--CCCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.++..++ ||||+++++++.. ......|+|||||+++|.+++.....+++..+..
T Consensus 93 ~~~~~e~~~~~~l~-h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~---------------- 155 (345)
T 2v62_A 93 KDCIKKWIERKQLD-YLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ---------------- 155 (345)
T ss_dssp HHHHHHHHHHHTCS-CCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHH----------------
T ss_pred hHHHHHHHhhcccc-ccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHH----------------
Confidence 34678899999998 9999999999875 2357799999999779999998777788888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---eE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---LV 165 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~---~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 156 -------------------------------------------i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 156 -------------------------------------------LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 99999999999999999999999999999865 79
Q ss_pred EEEecCCcccccCCC--------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC--ChHHHH
Q psy9855 166 VVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD--SEIDQL 235 (470)
Q Consensus 166 kL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~--~~~~~~ 235 (470)
+|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. ......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999997654221 124458999999999988754 899999999999999999999999653 222222
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
..........+...... .....+++++.+||.+||..||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKW----------------------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHHHH----------------------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHHhh----------------------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 22222111111110000 001267889999999999999999999999984
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=305.20 Aligned_cols=229 Identities=20% Similarity=0.203 Sum_probs=169.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC--CCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS--TRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~--~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.....+|+.+|.+++ ||||+++++++.... ...+++|||||+ |+|.+++.... +++..+..
T Consensus 62 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~-------------- 125 (322)
T 3soc_A 62 SWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCH-------------- 125 (322)
T ss_dssp HHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-BCHHHHHH--------------
T ss_pred HHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC-CCHHHHHH--------------
Confidence 445677999999999 999999999987543 445899999998 59999997643 77777766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC----------CCeecCCCCC
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY----------KVFHRDIKPE 156 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~----------gIvHrDLKp~ 156 (470)
++.||+.||+|||+. ||+||||||+
T Consensus 126 ---------------------------------------------i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~ 160 (322)
T 3soc_A 126 ---------------------------------------------IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160 (322)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGG
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhhccccccccCCCEEeCCCChH
Confidence 999999999999999 9999999999
Q ss_pred cEEEeCC-eEEEEecCCcccccCCCc---cccccccCcccCchhhccC----CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy9855 157 NILIRGD-LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTE----GYYSFELDIWAAGCVFYETLTRNPLFPG 228 (470)
Q Consensus 157 NILl~~~-~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~----~~~~~~~DIwSlG~il~elltg~~pf~~ 228 (470)
|||++.+ .+||+|||++........ ....+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 9999988 899999999977654322 2346899999999998763 2356788999999999999999999977
Q ss_pred CChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 229 DSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 229 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
..............+.+....+.......... +...........++++.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR--------PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC--------CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcccCC--------CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 54332222222223333333332221100000 000000011234567999999999999999999999984
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.26 Aligned_cols=206 Identities=22% Similarity=0.305 Sum_probs=159.7
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+.+|.+|+ ||||+++++++.. .+.+++|||||+ |+|.+++..... +++..+..
T Consensus 89 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~-------------- 151 (373)
T 2qol_A 89 QRRDFLGEASIMGQFD-HPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG-------------- 151 (373)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCCCeEEEEEee--CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHH--------------
Confidence 3456889999999998 9999999999854 677999999998 699999987653 77777666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 152 ---------------------------------------------i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 152 ---------------------------------------------MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
||+|||++........ .....+|..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+..
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987653321 11234577899999987755 8999999999999999997 9999988877665554432
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. .......++..+.+||.+||..||.+|||+.++++
T Consensus 266 ~~------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 266 GY------------------------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TE------------------------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------------------------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11 01112357889999999999999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.82 Aligned_cols=204 Identities=17% Similarity=0.213 Sum_probs=165.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.++..++ ||||+++++++. .+..++||||+. |+|.+++.... .+++..+..
T Consensus 60 ~~~~~e~~~l~~l~-h~~iv~~~~~~~---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------- 119 (325)
T 3kex_A 60 QAVTDHMLAIGSLD-HAHIVRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN---------------- 119 (325)
T ss_dssp CSCCHHHHHHHTCC-CTTBCCEEEEEC---BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHH----------------
T ss_pred HHHHHHHHHHhcCC-CCCcCeEEEEEc---CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHH----------------
Confidence 45789999999998 999999999874 456899999999 69999997753 366666666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 120 -------------------------------------------~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 156 (325)
T 3kex_A 120 -------------------------------------------WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQV 156 (325)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++....... ......||..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 157 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-- 233 (325)
T 3kex_A 157 ADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-- 233 (325)
T ss_dssp CSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT--
T ss_pred CCCCcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC--
Confidence 9999998765332 224456788999999997755 8999999999999999999 99999887655544443321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..++.++.+||.+||..||.+|||+.+++++
T Consensus 234 ----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 ----------------------------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ----------------------------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0111223466778999999999999999999999965
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.36 Aligned_cols=214 Identities=16% Similarity=0.118 Sum_probs=163.5
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCC--CCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRS--TRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~--~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..++|+..+..++ ||||+++++++.... ....|+|||||+++|.+++.... .+++..+..
T Consensus 94 ~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~---------------- 156 (364)
T 3op5_A 94 EQIQKWIRTRKLK-YLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ---------------- 156 (364)
T ss_dssp HHHHHHHHHTTCS-CCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHH----------------
T ss_pred HHHHHHHHHhhcc-CCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHH----------------
Confidence 4456667777787 999999999987532 35689999999779999998763 478877777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe--CC-eE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR--GD-LV 165 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~--~~-~i 165 (470)
|+.||+.||+|||++||+||||||+|||++ .+ .+
T Consensus 157 -------------------------------------------i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 157 -------------------------------------------LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 999999999999999999999999999998 54 89
Q ss_pred EEEecCCcccccCCCc--------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL--------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
+|+|||++........ ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999976543221 13446999999999998765 89999999999999999999999986433222221
Q ss_pred HHH-HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 238 IHQ-VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 238 i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
... ............. .....+++++.+||..||..||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLMDKC---------------------FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHHHHH---------------------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHHHHh---------------------cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111 1100000000000 001357899999999999999999999999984
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=299.42 Aligned_cols=220 Identities=20% Similarity=0.326 Sum_probs=165.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+++|..++ ||||+++++++...+...+++||||++ |+|.+++..... +++..+..
T Consensus 56 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------- 118 (295)
T 3ugc_A 56 RDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ---------------- 118 (295)
T ss_dssp HHHHHHHHHHHTCC-CTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHH----------------
T ss_pred HHHHHHHHHHHhCC-CCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHH----------------
Confidence 56789999999999 999999999987655567899999998 599999987654 77777666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 119 -------------------------------------------~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 119 -------------------------------------------YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++....... ......++..|+|||++.+.. ++.++|||||||++|+|++|..||..... . .....+
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~---~~~~~~ 229 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIG 229 (295)
T ss_dssp CCCCSCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHH--H---HHHHHC
T ss_pred ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChH--H---HHhhhc
Confidence 9999998765332 123345778899999988765 89999999999999999999999854321 1 111122
Q ss_pred CCchHHHHH--HhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKK--FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......... ...... .......+..+++++.+||.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 230 NDKQGQMIVFHLIELLK-----------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TTCCTHHHHHHHHHHHH-----------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccchhHHHHHHHHh-----------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 211111100 000000 01112234568899999999999999999999999984
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=294.30 Aligned_cols=206 Identities=18% Similarity=0.263 Sum_probs=170.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+++|..|+ ||||+++++++. .+..++||||++ ++|.+++..... +++..+..
T Consensus 53 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~-------------- 114 (287)
T 1u59_A 53 DTEEMMREAQIMHQLD-NPYIVRLIGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-------------- 114 (287)
T ss_dssp HHHHHHHHHHHHHHCC-CTTBCCEEEEEE---SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeEEEEEec---CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHH--------------
Confidence 3456789999999998 999999999984 345899999999 599999975543 77777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||++||+||||||+|||++.+ .+
T Consensus 115 ---------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 115 ---------------------------------------------LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
+|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 9999999987653322 22345688999999987655 8999999999999999998 9999988776665544432
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
. .....++.+++++.+||.+||..||.+|||+.+++++
T Consensus 229 ~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 229 G------------------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp T------------------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 1112335788999999999999999999999999965
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.64 Aligned_cols=223 Identities=23% Similarity=0.311 Sum_probs=167.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccc--cHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNI--SEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l--~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|.++.+||||+++++++.. ....+++|||||+ |+|.+++.....- +......
T Consensus 74 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~-------------- 138 (316)
T 2xir_A 74 HRALMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE-------------- 138 (316)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECC-TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------------------
T ss_pred HHHHHHHHHHHHhcccCCCeeeEEEEEec-CCCceEEEEEcCCCCcHHHHHHhcccccccccccch--------------
Confidence 45678999999999659999999999864 3456899999999 5999999875530 0000000
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
......+....+..++.||+.||.|||++||+||||||+|||++.+ .+
T Consensus 139 -------------------------------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~ 187 (316)
T 2xir_A 139 -------------------------------DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 187 (316)
T ss_dssp ---------------------------------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred -------------------------------hhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCE
Confidence 0001113334455599999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
+|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+......
T Consensus 188 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 266 (316)
T 2xir_A 188 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266 (316)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH
T ss_pred EECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc
Confidence 9999999976543322 23456788999999987755 8999999999999999998 99999876543333222211
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
. .....+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 267 ~-----------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 267 G-----------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp T-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-----------------------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0111224578899999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=291.47 Aligned_cols=204 Identities=22% Similarity=0.292 Sum_probs=160.7
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++++.++ ||||+++++++.. .+..++||||++ ++|.+++.. ..+++..+..
T Consensus 51 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~----------------- 109 (271)
T 3dtc_A 51 ENVRQEAKLFAMLK-HPNIIALRGVCLK--EPNLCLVMEFARGGPLNRVLSG-KRIPPDILVN----------------- 109 (271)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCEEEEECC--C--CEEEEECCTTEEHHHHHTS-SCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhcC-CCCEeeEEEEEec--CCceEEEEEcCCCCCHHHHhhc-CCCCHHHHHH-----------------
Confidence 46789999999999 9999999999854 667899999998 599999853 3477777776
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC---CeecCCCCCcEEEeC----
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK---VFHRDIKPENILIRG---- 162 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g---IvHrDLKp~NILl~~---- 162 (470)
++.||+.||+|||++| |+||||||+|||++.
T Consensus 110 ------------------------------------------i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 110 ------------------------------------------WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 9999999999999999 899999999999974
Q ss_pred ----C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy9855 163 ----D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237 (470)
Q Consensus 163 ----~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 237 (470)
+ .++|+|||++........ ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 225 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG 225 (271)
T ss_dssp SCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred ccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence 3 799999999976554332 3457999999999987755 89999999999999999999999988776655444
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
+.. ..........+++.+.+||.+||..||.+|||+.|++++
T Consensus 226 ~~~-----------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 226 VAM-----------------------------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHT-----------------------------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhc-----------------------------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 322 011112335678999999999999999999999999965
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.29 Aligned_cols=231 Identities=19% Similarity=0.311 Sum_probs=174.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc---ccHHHHHHHHHHHHhhhccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN---ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~---l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+.+|+++|+.|+ ||||+++++++........++|||||+ |+|.+++..... +++..+..
T Consensus 52 ~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~-------------- 116 (396)
T 4eut_A 52 DVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-------------- 116 (396)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHH--------------
Confidence 45679999999999 999999999998766668999999998 699999976544 66766666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----eC
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI----RG 162 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl----~~ 162 (470)
++.||+.||+|||++||+||||||+|||+ +.
T Consensus 117 ---------------------------------------------i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 151 (396)
T 4eut_A 117 ---------------------------------------------VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG 151 (396)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTS
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCC
Confidence 99999999999999999999999999998 44
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccC-------CCCCCcccHHHHHHHHHHHHhCCCCCCCCC----
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTE-------GYYSFELDIWAAGCVFYETLTRNPLFPGDS---- 230 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~~~~~~DIwSlG~il~elltg~~pf~~~~---- 230 (470)
+ .+||+|||++............+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+..
T Consensus 152 ~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 152 QSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp CEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred ceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 4 7999999999877665555667899999999988641 337889999999999999999999996432
Q ss_pred hHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 231 EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 231 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
..+.+..+ .+..+...+..+.......+.+.... .....+...++..+.+||.+||..||++|||++++++
T Consensus 232 ~~~~~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 232 NKEVMYKI---ITGKPSGAISGVQKAENGPIDWSGDM---PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CHHHHHHH---HHSCCTTCCEEEECSTTCCEEEESSC---CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hHHHHHHH---hcCCCcccchhheeccCCCcccCccC---CcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 23333333 22222222222222111111111110 0112233567788999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.04 Aligned_cols=211 Identities=20% Similarity=0.280 Sum_probs=170.6
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-------ccHHHHHHHHHHHHh
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-------ISEKRAKEILYQVKA 79 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-------l~~~~~~~~~~~~~~ 79 (470)
.....+.+|+.+|.+++ ||||+++++++.. ....|+||||++ |+|.+++..... +++..+..
T Consensus 75 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~------- 144 (327)
T 2yfx_A 75 QDELDFLMEALIISKFN-HQNIVRCIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------- 144 (327)
T ss_dssp HHHHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHH-------
T ss_pred hhHHHHHHHHHHHhhCC-CCCCCeEEEEEcC--CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHH-------
Confidence 34557889999999998 9999999999864 567899999997 699999987542 44444444
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
++.||+.||.|||++||+||||||+|||
T Consensus 145 ----------------------------------------------------i~~qi~~al~~LH~~~i~H~dlkp~NIl 172 (327)
T 2yfx_A 145 ----------------------------------------------------VARDIACGCQYLEENHFIHRDIAARNCL 172 (327)
T ss_dssp ----------------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHhhCCeecCcCCHhHEE
Confidence 9999999999999999999999999999
Q ss_pred EeCC----eEEEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCh
Q psy9855 160 IRGD----LVVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSE 231 (470)
Q Consensus 160 l~~~----~ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~ 231 (470)
++.+ .++|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+...
T Consensus 173 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp ESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 9843 69999999987654322 123456789999999987755 8999999999999999998 9999988776
Q ss_pred HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 232 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
.+....+... ........++..+.+||.+||..||.+|||+.++++|.|+
T Consensus 252 ~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 252 QEVLEFVTSG------------------------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhcC------------------------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 6655444321 1111234678999999999999999999999999988665
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.99 Aligned_cols=202 Identities=18% Similarity=0.289 Sum_probs=163.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|+.++ ||||+++++++.. .+..++||||++ |+|.+++..... +++..+..
T Consensus 56 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 117 (289)
T 4fvq_A 56 SESFFEAASMMSKLS-HKHLVLNYGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--------------- 117 (289)
T ss_dssp HHHHHHHHHHHHTSC-CTTBCCEEEEECC--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeEEEEEEEe--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHH---------------
Confidence 456789999999999 9999999999864 567899999999 699999987665 77777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e--
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L-- 164 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~-- 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 118 --------------------------------------------i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 118 --------------------------------------------VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGG
T ss_pred --------------------------------------------HHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccc
Confidence 99999999999999999999999999999876 3
Q ss_pred ------EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Q psy9855 165 ------VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDR 237 (470)
Q Consensus 165 ------ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~ 237 (470)
++|+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++| .+||...........
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred ccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 999999998654332 3346899999999998755589999999999999999995 555555444333222
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
... ....+...++++.+||.+||..||.+|||+.++++|
T Consensus 231 ~~~--------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YED--------------------------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHT--------------------------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhc--------------------------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 011123446678999999999999999999999964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=297.58 Aligned_cols=216 Identities=22% Similarity=0.308 Sum_probs=168.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|+.++ ||||+++++++.. .+..++||||++ |+|.+++....... ..
T Consensus 72 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~---------------- 128 (322)
T 1p4o_A 72 RIEFLNEASVMKEFN-CHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAM----AN---------------- 128 (322)
T ss_dssp HHHHHHHHHHGGGCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHH----HH----------------
T ss_pred HHHHHHHHHHHHhcC-CCCEeeeEEEEcc--CCccEEEEEeCCCCcHHHHHHHhchhh----cc----------------
Confidence 446789999999999 9999999998854 667899999998 59999997543100 00
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
...........+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 129 -----------------------------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 129 -----------------------------NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp -----------------------------CTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred -----------------------------CCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 0000112233444499999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-- 256 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-- 256 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT--
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC--
Confidence 99999876543321 23346788999999987755 8999999999999999999 89999887766555444321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
........++..+.+||.+||..||.+|||+.+++++
T Consensus 257 ----------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 257 ----------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp ----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1112234678999999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.04 Aligned_cols=206 Identities=19% Similarity=0.268 Sum_probs=168.4
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~ 84 (470)
.....+++|+.+|++|+ ||||+++++++.. ..+.+|+|||||+ |+|.+++..... +++..+..
T Consensus 228 ~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~------------ 293 (450)
T 1k9a_A 228 ATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK------------ 293 (450)
T ss_dssp TTSHHHHHHHHHHHTCC-CTTBCCEEEEEEC-TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHH------------
T ss_pred hHHHHHHHHHHHHHhcc-CCCEEEEEEEEEc-CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHH------------
Confidence 34567899999999999 9999999998764 3447999999998 599999987654 56666666
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 294 -----------------------------------------------~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~ 326 (450)
T 1k9a_A 294 -----------------------------------------------FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 326 (450)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC
Confidence 99999999999999999999999999999977
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
.+||+|||+++...... ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 327 ~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~- 402 (450)
T 1k9a_A 327 VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG- 402 (450)
T ss_dssp CEEECCCTTCEECC--------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-
T ss_pred CEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 89999999998554322 2346788999999998755 8999999999999999998 99999887665555444321
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 403 -----------------------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 -----------------------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 011223468899999999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=306.05 Aligned_cols=217 Identities=23% Similarity=0.386 Sum_probs=145.4
Q ss_pred hhHHHHH-HhcCCCCCCeeeeceeeec--CCCCeEEEEeecccc-CHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 13 NLKEISI-LRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLMEL-NLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 13 ~~rEi~i-L~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~g-sL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
..+|+.. +..++ ||||+++++++.. .....+++|||||+| +|.+++.... .+++..+..
T Consensus 68 ~~~e~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~-------------- 132 (336)
T 3fhr_A 68 ARQEVDHHWQASG-GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE-------------- 132 (336)
T ss_dssp HHHHHHHHHHHTT-STTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHH--------------
T ss_pred HHHHHHHHHHhcC-CCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHH--------------
Confidence 3455554 44555 9999999999864 234568999999985 9999998765 377777777
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 133 ---------------------------------------------i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~ 167 (336)
T 3fhr_A 133 ---------------------------------------------IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD 167 (336)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTT
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCC
Confidence 99999999999999999999999999999753
Q ss_pred -eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 164 -LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 164 -~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
.++|+|||++...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+....
T Consensus 168 ~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (336)
T 3fhr_A 168 AVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245 (336)
T ss_dssp CCEEECCCTTCEEC-----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred ceEEEeccccceecccc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh
Confidence 5999999999765533 234568899999999986654 7899999999999999999999997655433221111100
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
. ...+ .........+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 246 ~--------------~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 246 R--------------LGQY---------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred h--------------cccc---------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0 0000 00111224678999999999999999999999999999999763
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=299.37 Aligned_cols=206 Identities=26% Similarity=0.399 Sum_probs=167.8
Q ss_pred hhhhhHHHHHHhcC----CCCCCeeeeceeeecCCCCeEEEEeec-cc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcc
Q psy9855 10 EVANLKEISILRKI----PDHLNVLCLCETYVNRSTRQVTLVFPL-ME-LNLEEYIRTTDNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 10 ~~~~~rEi~iL~~L----~~HpnIv~l~~~~~~~~~~~~~lV~E~-~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~ 83 (470)
...+.+|+.++.++ + ||||+++++++.. .+..++|||+ +. ++|.+++.....+++..+..
T Consensus 78 ~~~~~~e~~~l~~l~~~~~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~----------- 143 (312)
T 2iwi_A 78 SVTCPLEVALLWKVGAGGG-HPGVIRLLDWFET--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC----------- 143 (312)
T ss_dssp -CCCCHHHHHHHHHHSSCC-CSSBCCEEEEC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHH-----------
T ss_pred hHHHHHHHHHHHhhcccCC-CCCeeeEEEEEec--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHH-----------
Confidence 34567899999999 6 9999999998854 5678999998 56 69999998877788888777
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe-C
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR-G 162 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~-~ 162 (470)
++.||+.||+|||++||+||||||+||+++ .
T Consensus 144 ------------------------------------------------~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 144 ------------------------------------------------FFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175 (312)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHHHTEECCCCSGGGEEEETT
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHCCeeecCCChhhEEEeCC
Confidence 999999999999999999999999999998 4
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+ .++|+|||++....... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+... +...
T Consensus 176 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~ 248 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA 248 (312)
T ss_dssp TTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT
T ss_pred CCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh
Confidence 4 89999999998765433 34567999999999987766456689999999999999999999965311 1110
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...+...++..+.+||.+||..||++|||+.++++||||+...
T Consensus 249 -------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 249 -------------------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -------------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -------------------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0112246789999999999999999999999999999999754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=291.40 Aligned_cols=206 Identities=19% Similarity=0.258 Sum_probs=166.4
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+.+|+.|+ ||||+++++++.. +..++||||++ ++|.+++..... +++..+..
T Consensus 56 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~-------------- 117 (281)
T 3cc6_A 56 NKEKFMSEAVIMKNLD-HPHIVKLIGIIEE---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-------------- 117 (281)
T ss_dssp HHHHHHHHHHHHHHHC-CTTBCCEEEEECS---SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCcceEEEEEcC---CCCEEEEecCCCCCHHHHHHhccccCCHHHHHH--------------
Confidence 3456889999999998 9999999998753 35689999999 699999976544 77776666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 118 ---------------------------------------------~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 152 (281)
T 3cc6_A 118 ---------------------------------------------YSLQICKAMAYLESINCVHRDIAVRNILVASPECV 152 (281)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCcccCCCccceEEECCCCcE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 153 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~ 231 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231 (281)
T ss_dssp EECCCCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC
T ss_pred EeCccCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC
Confidence 9999999886654322 23346788999999987655 8999999999999999998 999998766655544443311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 232 ------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 232 ------------------------------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 011224578899999999999999999999999964
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=298.45 Aligned_cols=205 Identities=19% Similarity=0.275 Sum_probs=163.0
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+.+|..++ ||||+++++++.. +..++|+||+. |+|.+++..... +++..+..
T Consensus 60 ~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~---~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~-------------- 121 (327)
T 3lzb_A 60 ANKEILDEAYVMASVD-NPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-------------- 121 (327)
T ss_dssp CHHHHHHHHHHHTTCC-BTTBCCCCEEEES---SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCeeEEEEEEec---CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHH--------------
Confidence 3456889999999999 9999999999864 24789999998 699999987543 77777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 122 ---------------------------------------------i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~ 156 (327)
T 3lzb_A 122 ---------------------------------------------WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE
T ss_pred ---------------------------------------------HHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCE
Confidence 99999999999999999999999999999876 89
Q ss_pred EEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
+|+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999987653322 22345678899999998755 8999999999999999999 99999887665544433221
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....++.++.++.+||.+||..||.+|||+.++++
T Consensus 236 ------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 236 ------------------------------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111223467889999999999999999999999995
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=296.95 Aligned_cols=206 Identities=21% Similarity=0.308 Sum_probs=164.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+.++..|+ ||||+++++++.. .+..++||||++ |+|.+++.... .+++..+..
T Consensus 89 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~-------------- 151 (333)
T 1mqb_A 89 QRVDFLGEAGIMGQFS-HHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVG-------------- 151 (333)
T ss_dssp HHHHHHHHHHHHHTCC-CTTBCCEEEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCCCcEEEEEec--CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHH--------------
Confidence 3456889999999998 9999999998854 678999999998 59999997653 377777766
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 152 ---------------------------------------------i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 152 ---------------------------------------------MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
+|+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 265 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC
Confidence 9999999987653221 12235678899999987655 8999999999999999998 9999988776665554432
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. .......++..+.+||.+||..||.+|||+.++++
T Consensus 266 ~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 266 GF------------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp TC------------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC------------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 10 01122467899999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=290.63 Aligned_cols=210 Identities=25% Similarity=0.370 Sum_probs=160.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|+.++ ||||++++++.. ....++|||||+ ++|.+++..... +++..+..
T Consensus 64 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 124 (289)
T 3og7_A 64 LQAFKNEVGVLRKTR-HVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHASETKFEMKKLID--------------- 124 (289)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCcEEEEEeecc---CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHH---------------
Confidence 456789999999999 999999999653 456899999999 699999965443 77766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 125 --------------------------------------------i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 125 --------------------------------------------IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCcccccC---CCccccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKS---KGLHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||++..... ........||+.|+|||++.. ...++.++|||||||++|+|++|..||.+....+.+..+...
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 999999876542 222344679999999999862 234788999999999999999999999887665555444331
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
... ..........+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~-------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 GSL-------------------------SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSC-------------------------CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc-------------------------CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 110 11122233567899999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.06 Aligned_cols=207 Identities=23% Similarity=0.298 Sum_probs=159.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+.+|++|+ ||||+++++++.. ..+..++||||++ |+|.+++..... +++..+..
T Consensus 133 ~~~~~~~E~~il~~l~-hpnIv~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~-------------- 196 (373)
T 3c1x_A 133 EVSQFLTEGIIMKDFS-HPNVLSLLGICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-------------- 196 (373)
T ss_dssp HHHHHHHHHTTSTTCC-CTTBCCCCEEECC-CSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCcceEEEEEEc-CCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHH--------------
Confidence 3467889999999998 9999999998653 3457899999999 599999976544 66666665
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 197 ---------------------------------------------i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 231 (373)
T 3c1x_A 197 ---------------------------------------------FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 231 (373)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCEecCccchheEEECCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCc-----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 239 (470)
||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~ 310 (373)
T 3c1x_A 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310 (373)
T ss_dssp EECCC---------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH
T ss_pred EEeeccccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH
Confidence 9999999986543221 13346778899999987755 8999999999999999999 788887765544443332
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. .....+..++..+.++|.+||..||.+|||+.++++
T Consensus 311 ~~------------------------------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 311 QG------------------------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp TT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 20 011123457889999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=287.59 Aligned_cols=206 Identities=20% Similarity=0.333 Sum_probs=170.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++++.++ ||||+++++++.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 47 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 108 (267)
T 3t9t_A 47 EEDFIEEAEVMMKLS-HPKLVQLYGVCLE--QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG--------------- 108 (267)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEECS--SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEcc--CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHH---------------
Confidence 456889999999998 9999999998854 567999999998 599999987543 67777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+||+++.+ .++
T Consensus 109 --------------------------------------------~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~k 144 (267)
T 3t9t_A 109 --------------------------------------------MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 144 (267)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||++....... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~- 222 (267)
T 3t9t_A 145 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF- 222 (267)
T ss_dssp ECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-
T ss_pred EcccccccccccccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-
Confidence 99999987654321 123346778899999987655 8999999999999999999 899998887766555543210
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 223 -----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 223 -----------------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011223568899999999999999999999999853
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=290.96 Aligned_cols=204 Identities=17% Similarity=0.271 Sum_probs=169.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.++..++ ||||+++++++. .+..++||||++ ++|.+++.....+++..+..
T Consensus 62 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------- 121 (291)
T 1xbb_A 62 KDELLAEANVMQQLD-NPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---------------- 121 (291)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEE---SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCEEEEEEEEC---CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHH----------------
Confidence 456789999999998 999999999883 456899999998 69999998877788887777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 122 -------------------------------------------i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 122 -------------------------------------------LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCcc----ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGLH----TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||++......... ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~- 236 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG- 236 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence 999999876543321 2235678899999987655 7899999999999999999 99999888766555444321
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++.+.++|.+||..||.+|||+.++++
T Consensus 237 -----------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 237 -----------------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111223568899999999999999999999999984
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.79 Aligned_cols=222 Identities=18% Similarity=0.269 Sum_probs=167.3
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.+|..|..||||+++++++.. .+.+++||||++ |+|.+++.......+....
T Consensus 92 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~---------------- 153 (333)
T 2i1m_A 92 EKEALMSELKIMSHLGQHENIVNLLGACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPA---------------- 153 (333)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC------------------
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeEEEEEec--CCceEEEEecCCCCcHHHHHHHhccccccccc----------------
Confidence 345688999999999339999999999854 667999999998 5999999764321000000
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
.......+....+..++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 154 -----------------------------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 154 -----------------------------FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEE
T ss_pred -----------------------------ccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEE
Confidence 00001123334455599999999999999999999999999999987 899
Q ss_pred EEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+....
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 283 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence 999999986543322 23446788999999987755 8999999999999999998 999998766544443333210
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 284 -----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 284 -----------------------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001122356889999999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=293.46 Aligned_cols=220 Identities=21% Similarity=0.373 Sum_probs=167.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.+|..|+ ||||+++++++.......+++||||++ |+|.+++.... .+++..+..
T Consensus 68 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------- 130 (302)
T 4e5w_A 68 ADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK---------------- 130 (302)
T ss_dssp HHHHHHHHHHHTCC-CTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHH----------------
T ss_pred HHHHHHHHHHHhCC-CCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHH----------------
Confidence 56789999999999 999999999998765677999999998 59999996544 377777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 131 -------------------------------------------~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl 167 (302)
T 4e5w_A 131 -------------------------------------------YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKI 167 (302)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred -------------------------------------------HHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....||..|+|||++.+.. ++.++|||||||++|+|++|..|+... ........+
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~ 241 (302)
T 4e5w_A 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIG 241 (302)
T ss_dssp CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHC
T ss_pred CcccccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccC
Confidence 99999987654332 23457888899999987755 789999999999999999999886432 111222222
Q ss_pred CCchHH-HHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAET-LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
...... ......... .......++.+++.+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 242 PTHGQMTVTRLVNTLK-----------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp SCCGGGHHHHHHHHHH-----------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CcccccCHHHHHHHHh-----------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 221111 111100000 11112234578899999999999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=298.24 Aligned_cols=223 Identities=19% Similarity=0.232 Sum_probs=170.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|+.|+ ||||+++++++..++...+++||||++ ++|.+++..... +++..+..
T Consensus 68 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 131 (327)
T 3lxl_A 68 QRDFQREIQILKALH-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL--------------- 131 (327)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhcC-CCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHH---------------
Confidence 345789999999998 999999999988767788999999997 699999987443 77777776
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 132 --------------------------------------------i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 132 --------------------------------------------YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ......
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~ 245 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCER 245 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC---
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hccccc
Confidence 999999987653331 23456888899999987755 799999999999999999999998654322111 000000
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
..+.......... ..........+++.+.+||.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 DVPALSRLLELLE--------------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -CCHHHHHHHHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHhh--------------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000000000000 111122345788999999999999999999999999853
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=296.63 Aligned_cols=223 Identities=19% Similarity=0.300 Sum_probs=170.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..+..||||+++++++.. .+.+++||||++ |+|.+++.......... .
T Consensus 84 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~------------------~ 143 (334)
T 2pvf_A 84 LSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEY------------------S 143 (334)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCS------------------C
T ss_pred HHHHHHHHHHHHHhhcCCCEeeEEEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccc------------------c
Confidence 35678999999999449999999998854 667999999998 59999998654200000 0
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
..........+....+..++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 144 -------------------------~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 198 (334)
T 2pvf_A 144 -------------------------YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198 (334)
T ss_dssp -------------------------C--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred -------------------------ccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEE
Confidence 00000011223444555599999999999999999999999999999877 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 199 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 276 (334)
T 2pvf_A 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH- 276 (334)
T ss_dssp CCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-
T ss_pred ccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-
Confidence 99999987654322 23346788899999987755 8999999999999999999 999998887666555443311
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 277 -----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 277 -----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111234678999999999999999999999999954
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=293.37 Aligned_cols=208 Identities=22% Similarity=0.289 Sum_probs=161.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCC---CeEEEEeeccc-cCHHHHHHhc------ccccHHHHHHHHHHHHh
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRST---RQVTLVFPLME-LNLEEYIRTT------DNISEKRAKEILYQVKA 79 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~---~~~~lV~E~~~-gsL~~~l~~~------~~l~~~~~~~~~~~~~~ 79 (470)
...+.+|+.++.+++ ||||+++++++..... ...++||||++ |+|.+++... ..+++..+..
T Consensus 80 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~------- 151 (313)
T 3brb_A 80 IEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK------- 151 (313)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHH-------
T ss_pred HHHHHHHHHHHhcCC-CCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHH-------
Confidence 356789999999999 9999999999875432 25699999999 5999998532 2256665555
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENIL 159 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NIL 159 (470)
++.||+.||.|||++||+||||||+|||
T Consensus 152 ----------------------------------------------------i~~qi~~aL~~LH~~~ivH~dikp~NIl 179 (313)
T 3brb_A 152 ----------------------------------------------------FMVDIALGMEYLSNRNFLHRDLAARNCM 179 (313)
T ss_dssp ----------------------------------------------------HHHHHHHHHHHHHTTTCCCCCCSGGGEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence 9999999999999999999999999999
Q ss_pred EeCC-eEEEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy9855 160 IRGD-LVVVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQ 234 (470)
Q Consensus 160 l~~~-~ikL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~ 234 (470)
++.+ .++|+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+......
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 9988 899999999986653321 23346788999999987755 8999999999999999999 9999988766555
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
...+... .....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 259 ~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 259 YDYLLHG------------------------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHTT------------------------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcC------------------------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4443321 1112234678999999999999999999999999854
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=293.53 Aligned_cols=204 Identities=24% Similarity=0.362 Sum_probs=156.9
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc---ccHHHHHHHHHHHHhhhc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN---ISEKRAKEILYQVKAANE 82 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~---l~~~~~~~~~~~~~~~~~ 82 (470)
......+.+|+++|.+++ ||||+++++++. +..++||||++ |+|.+++..... ++...+..
T Consensus 42 ~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~---------- 106 (307)
T 2eva_A 42 ESERKAFIVELRQLSRVN-HPNIVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS---------- 106 (307)
T ss_dssp TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCT----TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHH----------
T ss_pred hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEc----CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHH----------
Confidence 344567899999999998 999999999874 34799999998 599999986553 44555544
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh---CCCeecCCCCCcEE
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS---YKVFHRDIKPENIL 159 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~---~gIvHrDLKp~NIL 159 (470)
++.||+.||+|||+ +||+||||||+|||
T Consensus 107 -------------------------------------------------~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIl 137 (307)
T 2eva_A 107 -------------------------------------------------WCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137 (307)
T ss_dssp -------------------------------------------------HHHHHHHHHHHHHTCSSSCCCCCCCSGGGEE
T ss_pred -------------------------------------------------HHHHHHHHHHHHHhCCCCCeecCCCChhHEE
Confidence 99999999999999 89999999999999
Q ss_pred EeCC--eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH--HH
Q psy9855 160 IRGD--LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID--QL 235 (470)
Q Consensus 160 l~~~--~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~--~~ 235 (470)
++.+ .++|+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ..
T Consensus 138 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 214 (307)
T 2eva_A 138 LVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214 (307)
T ss_dssp EETTTTEEEECCCCC--------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH
T ss_pred EeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH
Confidence 9876 4899999998765432 23457999999999987755 8999999999999999999999997543221 11
Q ss_pred HHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 236 DRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 236 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
..+.. .........++..+.+||.+||..||.+|||+.++++
T Consensus 215 ~~~~~------------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 215 WAVHN------------------------------GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHT------------------------------TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhc------------------------------CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11110 1111233567899999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=290.63 Aligned_cols=206 Identities=25% Similarity=0.403 Sum_probs=167.5
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeec--------------CCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHH
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVN--------------RSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEI 73 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~--------------~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~ 73 (470)
..+.+|++++..++ ||||+++++++.. .....+++||||++ ++|.+++.... .+++..+..
T Consensus 49 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~- 126 (284)
T 2a19_B 49 EKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE- 126 (284)
T ss_dssp GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHH-
T ss_pred HHHHHHHHHHHhCC-CCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHH-
Confidence 46789999999999 9999999998753 12455899999999 49999997653 366666666
Q ss_pred HHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCC
Q psy9855 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDI 153 (470)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDL 153 (470)
++.||+.||.|||++||+||||
T Consensus 127 ----------------------------------------------------------i~~qi~~~l~~lH~~~i~H~dl 148 (284)
T 2a19_B 127 ----------------------------------------------------------LFEQITKGVDYIHSKKLINRDL 148 (284)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHHHTTEECSCC
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999999999
Q ss_pred CCCcEEEeCC-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH
Q psy9855 154 KPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232 (470)
Q Consensus 154 Kp~NILl~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~ 232 (470)
||+|||++.+ .++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus 149 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~-- 225 (284)
T 2a19_B 149 KPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS-- 225 (284)
T ss_dssp SGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--
T ss_pred CHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--
Confidence 9999999877 89999999998776655556678999999999987755 8999999999999999999998873211
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
.....+. . ..+...++..+.+||.+||..||.+|||+.++++|.|.-
T Consensus 226 ~~~~~~~---------------~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 226 KFFTDLR---------------D------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHHH---------------T------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhh---------------c------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111110 0 011235778899999999999999999999999886653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=291.43 Aligned_cols=206 Identities=23% Similarity=0.292 Sum_probs=166.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++++++ ||||+++++++.. ..+..++||||+++ +|.+++..... +++..+..
T Consensus 70 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 132 (298)
T 3f66_A 70 VSQFLTEGIIMKDFS-HPNVLSLLGICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG--------------- 132 (298)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCCCEEECC-SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeeeeEEEc-CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHH---------------
Confidence 456789999999999 9999999998653 35678999999994 99999976443 66766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 133 --------------------------------------------i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 133 --------------------------------------------FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEE
Confidence 99999999999999999999999999999888 899
Q ss_pred EEecCCcccccCCC-----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKG-----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 167 L~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+..
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence 99999997654322 123456788999999987755 8999999999999999999 6778877665554444332
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. .....+..+++.+.++|.+||..||.+|||+.++++
T Consensus 248 ~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 248 G------------------------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp T------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C------------------------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 111123457889999999999999999999999984
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=304.64 Aligned_cols=222 Identities=21% Similarity=0.241 Sum_probs=166.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc----cccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD----NISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~----~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+.+|..++ ||||+++++++.. .+..++||||++ |+|.+++.... .+++..+..
T Consensus 79 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~------------ 143 (321)
T 2qkw_B 79 IEEFETEIETLSFCR-HPHLVSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE------------ 143 (321)
T ss_dssp HHHHHHHHHGGGSCC-CTTBCCEEEECCC--TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHH------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEcC--CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHH------------
Confidence 356789999999999 9999999998854 677999999998 59999886543 255555554
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 144 -----------------------------------------------i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 144 -----------------------------------------------ICIGAARGLHYLHTRAIIHRDVKSINILLDENF 176 (321)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC
T ss_pred -----------------------------------------------HHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999999999999988
Q ss_pred eEEEEecCCcccccCC---CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSK---GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
.++|+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred CEEEeecccccccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 8999999998765422 1223457899999999987755 89999999999999999999999976543211110000
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.. .......+.... .........+.++..+.+++.+||..||++|||+.+++++
T Consensus 256 ----------~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 256 ----------AV-ESHNNGQLEQIV---DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp ----------TH-HHHTTTCCCSSS---SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------hh-hccccccHHHhc---ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 000000000000 0111223345677889999999999999999999999965
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=289.74 Aligned_cols=205 Identities=20% Similarity=0.291 Sum_probs=167.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|++++.+++ ||||+++++++.. ...++||||++ ++|.+++.... .+++..+..
T Consensus 65 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 125 (291)
T 1u46_A 65 MDDFIREVNAMHSLD-HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--------------- 125 (291)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCcccEEEEEcc---CCceeeEecccCCCHHHHHHhccCCcCHHHHHH---------------
Confidence 456789999999998 9999999999864 23899999999 69999997753 377777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||.|||++||+||||||+|||++.+ .++
T Consensus 126 --------------------------------------------~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~k 161 (291)
T 1u46_A 126 --------------------------------------------YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 161 (291)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEE
Confidence 99999999999999999999999999999876 899
Q ss_pred EEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||++........ .....+|..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 240 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc
Confidence 999999887654332 22346788899999987755 7899999999999999999 99999888776665554321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.........++.++.++|.+||..||.+|||+.++++
T Consensus 241 -----------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 -----------------------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----------------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0111123467899999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=310.52 Aligned_cols=205 Identities=19% Similarity=0.321 Sum_probs=169.7
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+++|+.+|+.|+ ||||+++++++. ...+++|||||. |+|.+++.... .++...+..
T Consensus 226 ~~~~~~~E~~~l~~l~-h~~iv~l~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~------------- 288 (454)
T 1qcf_A 226 SVEAFLAEANVMKTLQ-HDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID------------- 288 (454)
T ss_dssp CHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHH-------------
T ss_pred cHHHHHHHHHHHhhCC-CCCEeeEEEEEe---CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHH-------------
Confidence 3557899999999999 999999999874 456899999998 69999997643 255555555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 289 ----------------------------------------------~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~ 322 (454)
T 1qcf_A 289 ----------------------------------------------FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV 322 (454)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc
Confidence 99999999999999999999999999999987 8
Q ss_pred EEEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
+||+|||+++....... .....+|..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 323 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 401 (454)
T 1qcf_A 323 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401 (454)
T ss_dssp EEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred EEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987643221 12345678899999987655 8999999999999999999 99999998877776665442
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. ...+..+++++.+||.+||..||.+|||++++++
T Consensus 402 ~~------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 402 YR------------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------------------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11 1112467899999999999999999999999984
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.86 Aligned_cols=206 Identities=23% Similarity=0.327 Sum_probs=170.1
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+.+|+++++.++ ||||+++++++.. .+..++||||++ ++|.+++..... +++..+..
T Consensus 52 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~------------- 115 (288)
T 3kfa_A 52 EVEEFLKEAAVMKEIK-HPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY------------- 115 (288)
T ss_dssp HHHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHH-------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeeEEEEEcc--CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHH-------------
Confidence 3456889999999999 9999999998854 677999999999 699999987443 66766666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+||+++.+ .
T Consensus 116 ----------------------------------------------i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~ 149 (288)
T 3kfa_A 116 ----------------------------------------------MATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149 (288)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC
Confidence 99999999999999999999999999999877 8
Q ss_pred EEEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
++|+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+...
T Consensus 150 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~ 228 (288)
T 3kfa_A 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228 (288)
T ss_dssp EEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEccCccceeccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc
Confidence 99999999987654332 23346788899999987755 8999999999999999999 99999887655544433221
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 229 ------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 229 ------------------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 011123467899999999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=287.73 Aligned_cols=202 Identities=19% Similarity=0.252 Sum_probs=162.2
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+.+|+.+++.++ ||||+++++++.. . .++||||++ |+|.+++..... +++..+..
T Consensus 68 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------- 126 (287)
T 4f0f_A 68 QEFQREVFIMSNLN-HPNIVKLYGLMHN--P--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR---------------- 126 (287)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEETT--T--TEEEEECCTTCBHHHHHHCTTSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHhCC-CCCchhhheeecC--C--CeEEEEecCCCCHHHHHhcccCCccHHHHHH----------------
Confidence 46789999999998 9999999998853 2 279999999 699998866543 77777666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeCC-e-
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILIRGD-L- 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~~-~- 164 (470)
++.||+.||+|||++| |+||||||+|||++.+ .
T Consensus 127 -------------------------------------------~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 127 -------------------------------------------LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTT
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCC
Confidence 9999999999999999 9999999999999765 2
Q ss_pred ----EEEEecCCcccccCCCccccccccCcccCchhhcc-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH--HHH
Q psy9855 165 ----VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLT-EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ--LDR 237 (470)
Q Consensus 165 ----ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~--~~~ 237 (470)
++|+|||++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+...... ...
T Consensus 164 ~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 99999999875433 2345689999999998843 23478899999999999999999999976543322 222
Q ss_pred HHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 238 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+.. .......+..+++.+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~-----------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IRE-----------------------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHH-----------------------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hhc-----------------------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 211 11112233567899999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.59 Aligned_cols=205 Identities=18% Similarity=0.263 Sum_probs=167.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+++|+++|+.|+ ||||+++++++.. +.+++|||||+ |+|.+++..... +++..+..
T Consensus 379 ~~~~~~~E~~il~~l~-hpniv~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~-------------- 440 (613)
T 2ozo_A 379 DTEEMMREAQIMHQLD-NPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-------------- 440 (613)
T ss_dssp THHHHHHHHHHHTTCC-CTTBCCEEEEEES---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeeEEEEecc---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHH--------------
Confidence 3467899999999998 9999999999864 45999999999 699999976544 77777776
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 441 ---------------------------------------------i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~v 475 (613)
T 2ozo_A 441 ---------------------------------------------LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA 475 (613)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
||+|||+++....... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 476 kL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~ 554 (613)
T 2ozo_A 476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554 (613)
T ss_dssp EECCCSTTTTCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT
T ss_pred EEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987653221 12234568899999997755 8999999999999999998 9999998887776655543
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. .....+..+++++.+||.+||..||.+|||+.++++
T Consensus 555 ~------------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 555 G------------------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp T------------------------------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred C------------------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1 111233568899999999999999999999999973
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=294.50 Aligned_cols=207 Identities=17% Similarity=0.263 Sum_probs=165.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.++++++ ||||+++++++.. .+.+++||||++ ++|.+++.... .+++..+..
T Consensus 73 ~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 134 (319)
T 2y4i_B 73 LKAFKREVMAYRQTR-HENVVLFMGACMS--PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQ--------------- 134 (319)
T ss_dssp CCCCCTTGGGGTTCC-CTTBCCCCEEEEC--SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHH---------------
T ss_pred HHHHHHHHHHHhcCC-CCCEeEEEEEEec--CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHH---------------
Confidence 346789999999999 9999999999865 567999999998 59999998765 377777766
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVV 167 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++++.++|
T Consensus 135 --------------------------------------------i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l 170 (319)
T 2y4i_B 135 --------------------------------------------IAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVI 170 (319)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEE
Confidence 999999999999999999999999999999779999
Q ss_pred EecCCcccccC------CCccccccccCcccCchhhcc--------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy9855 168 GDLGSLQFIKS------KGLHTEYIATRWYRSPECLLT--------EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233 (470)
Q Consensus 168 ~DFG~a~~~~~------~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~ 233 (470)
+|||++..... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99998775431 122234568999999999865 2347889999999999999999999998877666
Q ss_pred HHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 234 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+.... ........++.++.+||.+||..||.+|||+.++++
T Consensus 251 ~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 251 IIWQMGTGM-----------------------------KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHTTC-----------------------------CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHhccCC-----------------------------CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 554443210 001111256788899999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=294.51 Aligned_cols=211 Identities=18% Similarity=0.143 Sum_probs=163.9
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.++..++ |++++..++.+.. .....++||||++++|.+++.... .+++..+..
T Consensus 47 ~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~-~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~--------------- 109 (296)
T 4hgt_A 47 KHPQLHIESKIYKMMQ-GGVGIPTIRWCGA-EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--------------- 109 (296)
T ss_dssp -CCCHHHHHHHHHHHT-TSTTCCCEEEEEE-ETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHH---------------
T ss_pred cchHHHHHHHHHHHhc-CCCCCCeeeeecC-CCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHH---------------
Confidence 3456789999999999 7776666665543 367789999999889999998543 377777776
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---eCC-
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI---RGD- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl---~~~- 163 (470)
++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 110 --------------------------------------------i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~ 145 (296)
T 4hgt_A 110 --------------------------------------------LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC
Confidence 99999999999999999999999999999 444
Q ss_pred eEEEEecCCcccccCCCc--------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH---
Q psy9855 164 LVVVGDLGSLQFIKSKGL--------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI--- 232 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~--- 232 (470)
.++|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....
T Consensus 146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 224 (296)
T 4hgt_A 146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224 (296)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS
T ss_pred eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhh
Confidence 899999999987654322 23568999999999988765 899999999999999999999999764332
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..... ..........+++++.+||.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 225 QKYERISEKKM--------------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SHHHHHHHHHH--------------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhcccc--------------------------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11211111000 00111122457899999999999999999999999984
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=289.62 Aligned_cols=205 Identities=20% Similarity=0.290 Sum_probs=159.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+.+|+.++..++ ||||+++++++.. ..+.+++||||+++ +|.+++..... +++..+..
T Consensus 57 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------------- 121 (278)
T 1byg_A 57 TAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK------------- 121 (278)
T ss_dssp --HHHHHTHHHHTTCC-CTTBCCEEEEECC-C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeeEEEEEEc-CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHH-------------
Confidence 4556889999999999 9999999998754 34578999999985 99999976543 56665555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+||+++.+ .
T Consensus 122 ----------------------------------------------~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 155 (278)
T 1byg_A 122 ----------------------------------------------FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 155 (278)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc
Confidence 99999999999999999999999999999877 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
++|+|||++....... ....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 156 ~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~--- 229 (278)
T 1byg_A 156 AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--- 229 (278)
T ss_dssp EEECCCCC--------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT---
T ss_pred EEEeeccccccccccc--cCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---
Confidence 9999999987654322 2346788999999987755 8999999999999999998 9999987665444433321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.........+++.+.++|.+||..||.+|||+.++++
T Consensus 230 ---------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 ---------------------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0011223467899999999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=286.97 Aligned_cols=206 Identities=23% Similarity=0.280 Sum_probs=165.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|+.++ ||||+++++++... .+..++||||+. |+|.+++..... +++..+..
T Consensus 66 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~--------------- 128 (298)
T 3pls_A 66 VEAFLREGLLMRGLN-HPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS--------------- 128 (298)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCCCEEECCS-SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCeeeEEEEEecC-CCCcEEEEecccCCCHHHHHhccccCCCHHHHHH---------------
Confidence 356789999999998 99999999998642 344589999997 699999987443 67766666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 129 --------------------------------------------i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~k 164 (298)
T 3pls_A 129 --------------------------------------------FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVK 164 (298)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 99999999999999999999999999999988 899
Q ss_pred EEecCCcccccCC-----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSK-----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 167 L~DFG~a~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
|+|||++...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 243 (298)
T 3pls_A 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243 (298)
T ss_dssp ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT
T ss_pred eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc
Confidence 9999999765432 1223457889999999987755 8999999999999999999 5566666555444433322
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.. ....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 244 ~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 244 GR------------------------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------------------------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 10 11123457889999999999999999999999984
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=291.14 Aligned_cols=206 Identities=23% Similarity=0.311 Sum_probs=159.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. .+.+|+||||++| +|.+++.....+++..+..
T Consensus 79 ~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----------------- 138 (309)
T 2h34_A 79 TRMQREARTAGRLQ-EPHVVPIHDFGEI--DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA----------------- 138 (309)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHhhcC-CCCeeEEEEEEee--CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHH-----------------
Confidence 56789999999998 9999999999865 6789999999995 9999998877788887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 139 ------------------------------------------i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 139 ------------------------------------------IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEe
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.. .
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~---- 250 (309)
T 2h34_A 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-A---- 250 (309)
T ss_dssp SCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-C----
T ss_pred cCccCccccccccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-C----
Confidence 999987665432 223557999999999987754 89999999999999999999999987654322222111 0
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-CHHHHHh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-TAQKILS 307 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-t~~elL~ 307 (470)
........+.++.++.+||.+||..||.+|| |++++++
T Consensus 251 -----------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 251 -----------------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -----------------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -----------------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0011223457888999999999999999999 8888874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=312.56 Aligned_cols=205 Identities=22% Similarity=0.324 Sum_probs=168.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|+.+|++|+ ||||+++++++.. .+.+|+|||||+ |+|.+++..... +++..+..
T Consensus 260 ~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~-------------- 322 (495)
T 1opk_A 260 VEEFLKEAAVMKEIK-HPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-------------- 322 (495)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHH--------------
T ss_pred hHHHHHHHHHHHhcC-CCCEeeEEEEEec--CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHH--------------
Confidence 456899999999999 9999999999854 567999999999 699999986432 66666655
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 323 ---------------------------------------------i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 357 (495)
T 1opk_A 323 ---------------------------------------------MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357 (495)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 358 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~- 435 (495)
T 1opk_A 358 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD- 435 (495)
T ss_dssp EECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-
T ss_pred EEeecccceeccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999987653322 12345678899999987755 8999999999999999999 99999887765544433221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 436 -----------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 436 -----------------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 011123467899999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=297.78 Aligned_cols=224 Identities=20% Similarity=0.240 Sum_probs=166.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc----ccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN----ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~----l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+.+|++++..++ ||||+++++++.. .+..++||||++ |+|.+++..... +++..+..
T Consensus 72 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~------------- 135 (326)
T 3uim_A 72 LQFQTEVEMISMAV-HRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR------------- 135 (326)
T ss_dssp CHHHHHHHGGGTCC-CTTBCCCCEEECC--SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHH-------------
T ss_pred HHHHHHHHHHHhcc-CCCccceEEEEec--CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHH-------------
Confidence 36789999999999 9999999999854 667899999998 599999976543 55555555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC---CCeecCCCCCcEEEeC
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY---KVFHRDIKPENILIRG 162 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~---gIvHrDLKp~NILl~~ 162 (470)
++.||+.||+|||++ ||+||||||+|||++.
T Consensus 136 ----------------------------------------------i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 136 ----------------------------------------------IALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 999999999999999 9999999999999998
Q ss_pred C-eEEEEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 239 (470)
+ .++|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~-------- 240 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARL-------- 240 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHH--------
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCccccccc--------
Confidence 8 89999999998765322 234456999999999987755 89999999999999999999999952100
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccC-CCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhccc
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQY-PGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~ 310 (470)
................... ..... ............+..+.+|+.+||..||.+|||+.++++|-.
T Consensus 241 --~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 241 --ANDDDVMLLDWVKGLLKEK---KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp --TTTSCSBHHHHHTTTTSSC---CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred --ccccchhHHHHHHHHhhch---hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 0000000000000000000 00000 011111233456788999999999999999999999998743
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=319.85 Aligned_cols=239 Identities=23% Similarity=0.321 Sum_probs=175.3
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeec----CCCCeEEEEeeccc-cCHHHHHHhcc---cccHHHHHHHHHHHHhh
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVN----RSTRQVTLVFPLME-LNLEEYIRTTD---NISEKRAKEILYQVKAA 80 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~----~~~~~~~lV~E~~~-gsL~~~l~~~~---~l~~~~~~~~~~~~~~~ 80 (470)
....+.+|+++|..|+ ||||+++++++.. ...+..++|||||+ |+|.+++.... .+++..+..
T Consensus 55 ~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~-------- 125 (676)
T 3qa8_A 55 NRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT-------- 125 (676)
T ss_dssp HHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHH--------
T ss_pred HHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHH--------
Confidence 3456889999999998 9999999998753 23567899999997 69999998654 255555555
Q ss_pred hccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE
Q psy9855 81 NETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI 160 (470)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl 160 (470)
++.||+.||+|||+.||+||||||+|||+
T Consensus 126 ---------------------------------------------------I~~QLl~aL~yLHs~gIVHrDLKP~NILl 154 (676)
T 3qa8_A 126 ---------------------------------------------------LLSDISSALRYLHENRIIHRDLKPENIVL 154 (676)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHTTBCCCCCCSTTEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHCCCccCCCCHHHeEe
Confidence 99999999999999999999999999999
Q ss_pred eCC----eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy9855 161 RGD----LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236 (470)
Q Consensus 161 ~~~----~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~ 236 (470)
+.+ .++|+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......+.
T Consensus 155 ~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~ 233 (676)
T 3qa8_A 155 QPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233 (676)
T ss_dssp ECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS
T ss_pred ecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh
Confidence 865 48999999998877666666779999999999987655 8999999999999999999999997754332211
Q ss_pred HHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 237 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
. .....................+... ......+...+++.+.+||.+||..||.+|||+.++++||||+.+.
T Consensus 234 ~------~i~~~~~~~~~~~~~l~g~~~~~~~-lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 234 G------KVREKSNEHIVVYDDLTGAVKFSSV-LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp T------TCC------CCSCCCCSSSCCCCSS-SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred h------hhhcccchhhhhhhhhccccccccc-cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 0 0000000000000000000001000 0111223456789999999999999999999999999999998654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=318.94 Aligned_cols=204 Identities=17% Similarity=0.272 Sum_probs=169.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+++|+++|.+|+ |||||++++++.. +.+++|||||+ |+|.+++.....+++..+..
T Consensus 414 ~~~~~~E~~il~~l~-hpnIv~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~---------------- 473 (635)
T 4fl3_A 414 KDELLAEANVMQQLD-NPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---------------- 473 (635)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEec---CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHH----------------
Confidence 356889999999999 9999999998853 45899999999 69999998877788887777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 474 -------------------------------------------i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL 510 (635)
T 4fl3_A 474 -------------------------------------------LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 510 (635)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||+++....... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+....
T Consensus 511 ~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~ 589 (635)
T 4fl3_A 511 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 589 (635)
T ss_dssp CCTTHHHHTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred EEcCCccccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987653321 23345678899999997755 8999999999999999998 999999988777665554311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..+++++.+||.+||..||++|||+.++++
T Consensus 590 ------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 590 ------------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11223468899999999999999999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=291.31 Aligned_cols=211 Identities=18% Similarity=0.135 Sum_probs=164.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.++..+. |++++..++.+.. ..+..++||||++++|.+++.... .+++..+..
T Consensus 47 ~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~-~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~--------------- 109 (296)
T 3uzp_A 47 KHPQLHIESKIYKMMQ-GGVGIPTIRWCGA-EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--------------- 109 (296)
T ss_dssp SCCHHHHHHHHHHHHT-TSTTCCCEEEEEE-ETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHH---------------
T ss_pred chhHHHHHHHHHHHhh-cCCCCCccccccC-CCCceEEEEEecCCCHHHHHHhhccCCCHHHHHH---------------
Confidence 3456789999999999 7776666665543 366789999999889999997543 377777776
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe---CC-
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR---GD- 163 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~---~~- 163 (470)
++.||+.||+|||++||+||||||+|||++ .+
T Consensus 110 --------------------------------------------i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~ 145 (296)
T 3uzp_A 110 --------------------------------------------LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC
Confidence 999999999999999999999999999994 33
Q ss_pred eEEEEecCCcccccCCCc--------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh---H
Q psy9855 164 LVVVGDLGSLQFIKSKGL--------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE---I 232 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~---~ 232 (470)
.++|+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+... .
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 224 (296)
T 3uzp_A 146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224 (296)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS
T ss_pred eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh
Confidence 899999999987654322 24568999999999988765 89999999999999999999999976432 1
Q ss_pred HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 233 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
..+..+..... ..........+++++.+||.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 225 QKYERISEKKM--------------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SHHHHHHHHHH--------------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccccc--------------------------CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 22222221100 00111122467899999999999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.24 Aligned_cols=219 Identities=22% Similarity=0.282 Sum_probs=166.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc---cccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD---NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~---~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+|+.++ ||||+++++++.. .+..++||||++ |+|.+++.... .+++..+..
T Consensus 74 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~------------- 137 (307)
T 2nru_A 74 KQQFDQEIKVMAKCQ-HENLVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK------------- 137 (307)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcC-CCCeEEEEEEEec--CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHH-------------
Confidence 456789999999999 9999999998854 667999999998 69999987533 255555555
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 138 ----------------------------------------------i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 171 (307)
T 2nru_A 138 ----------------------------------------------IAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171 (307)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc
Confidence 99999999999999999999999999999988 8
Q ss_pred EEEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
++|+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+......+..+...
T Consensus 172 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (307)
T 2nru_A 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249 (307)
T ss_dssp EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHH
T ss_pred EEEeecccccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHH
Confidence 9999999987655322 12345799999999988653 789999999999999999999999775443322222221
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....... ...+............+..+.++|.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 250 IEDEEKT----------------IEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHTTSCC----------------HHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhhhhhh----------------hhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1000000 00000111122334567889999999999999999999999853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.00 Aligned_cols=204 Identities=21% Similarity=0.352 Sum_probs=164.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|+++|++|+ ||||+++++++.. +.+++|||||+ |+|.+++.... .+++..+..
T Consensus 223 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~-------------- 284 (452)
T 1fmk_A 223 PEAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-------------- 284 (452)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEcC---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHH--------------
Confidence 457899999999999 9999999998753 56899999998 69999997532 266666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 285 ---------------------------------------------i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 319 (452)
T 1fmk_A 285 ---------------------------------------------MAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319 (452)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
||+|||++........ .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+....
T Consensus 320 kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~ 398 (452)
T 1fmk_A 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 398 (452)
T ss_dssp EECCCCTTC--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccceecCCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987653321 22345678899999987755 8999999999999999999 999999888776665553311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....++.+++.+.+||.+||..||++|||++++++
T Consensus 399 ------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 399 ------------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11123467899999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.60 Aligned_cols=220 Identities=20% Similarity=0.335 Sum_probs=168.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.|+ ||||+++++++...+...+++||||++ |+|.+++.... +++..+..
T Consensus 77 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~---------------- 138 (318)
T 3lxp_A 77 RSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLL---------------- 138 (318)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHH----------------
Confidence 456789999999999 999999999998766678999999998 59999997654 77777666
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .++|
T Consensus 139 -------------------------------------------i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 139 -------------------------------------------FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEE
Confidence 99999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||++........ .....||..|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~ 249 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIG 249 (318)
T ss_dssp CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHC
T ss_pred CCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhc
Confidence 99999987654332 23456888899999997755 789999999999999999999998653211 111111
Q ss_pred CCchHH-HHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAET-LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
...... ...+..... .......+..++.++.+||.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 250 IAQGQMTVLRLTELLE-----------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp SCCHHHHHHHHHHHHH-----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccchhHHHHHHHHh-----------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111100 000000000 11112233568899999999999999999999999984
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=284.81 Aligned_cols=205 Identities=20% Similarity=0.338 Sum_probs=168.7
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+.+|+++|+.++ ||||+++++++. .+..++||||++ ++|.+++.... .+++..+..
T Consensus 51 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~------------- 113 (279)
T 1qpc_A 51 SPDAFLAEANLMKQLQ-HQRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------------- 113 (279)
T ss_dssp CHHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHH-------------
T ss_pred cHHHHHHHHHHHHhCC-CcCcceEEEEEc---CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHH-------------
Confidence 3456889999999998 999999999875 345899999998 69999997654 366666666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 114 ----------------------------------------------i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~ 147 (279)
T 1qpc_A 114 ----------------------------------------------MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147 (279)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC
Confidence 99999999999999999999999999999988 8
Q ss_pred EEEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
++|+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 226 (279)
T 1qpc_A 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (279)
T ss_dssp EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred EEECCCcccccccCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc
Confidence 99999999987654332 22345678899999987654 7999999999999999999 99999888776655544321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. .......+++++.+||.+||..||++|||+.++++
T Consensus 227 ~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 Y------------------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp C------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c------------------------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 01122467899999999999999999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.51 Aligned_cols=207 Identities=22% Similarity=0.353 Sum_probs=147.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeec------CCCCeEEEEeeccccCHHHHHHh---cccccHHHHHHHHHHHHhh
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVN------RSTRQVTLVFPLMELNLEEYIRT---TDNISEKRAKEILYQVKAA 80 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~------~~~~~~~lV~E~~~gsL~~~l~~---~~~l~~~~~~~~~~~~~~~ 80 (470)
...+.+|+.+|.++.+||||+++++++.. .....+++||||++|+|.+++.. ...+++..+..
T Consensus 69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~-------- 140 (337)
T 3ll6_A 69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK-------- 140 (337)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHH--------
T ss_pred HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHH--------
Confidence 45678999999999669999999998852 33556899999999999999865 22366666666
Q ss_pred hccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcE
Q psy9855 81 NETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENI 158 (470)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NI 158 (470)
++.||+.||+|||++| |+||||||+||
T Consensus 141 ---------------------------------------------------i~~qi~~~l~~LH~~~~~ivH~Dikp~NI 169 (337)
T 3ll6_A 141 ---------------------------------------------------IFYQTCRAVQHMHRQKPPIIHRDLKVENL 169 (337)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHTSSSCCBCCCCCGGGC
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhCCCCEEEccCCcccE
Confidence 9999999999999999 99999999999
Q ss_pred EEeCC-eEEEEecCCcccccCCCcc-------------ccccccCcccCchhhc--cCCCCCCcccHHHHHHHHHHHHhC
Q psy9855 159 LIRGD-LVVVGDLGSLQFIKSKGLH-------------TEYIATRWYRSPECLL--TEGYYSFELDIWAAGCVFYETLTR 222 (470)
Q Consensus 159 Ll~~~-~ikL~DFG~a~~~~~~~~~-------------~~~~gt~~Y~APE~l~--~~~~~~~~~DIwSlG~il~elltg 222 (470)
|++.+ .++|+|||++......... ...+||+.|+|||++. ....++.++|||||||++|+|++|
T Consensus 170 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp EECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence 99987 8999999999876543221 1456899999999883 223478899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCH
Q psy9855 223 NPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302 (470)
Q Consensus 223 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~ 302 (470)
..||.+.......... .........+..+.+||.+||..||.+|||+
T Consensus 250 ~~p~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 296 (337)
T 3ll6_A 250 QHPFEDGAKLRIVNGK---------------------------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSI 296 (337)
T ss_dssp SCCC---------------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred CCCCcchhHHHhhcCc---------------------------------ccCCcccccchHHHHHHHHHccCChhhCcCH
Confidence 9999764432211100 0001113455668999999999999999999
Q ss_pred HHHHhc
Q psy9855 303 QKILSC 308 (470)
Q Consensus 303 ~elL~h 308 (470)
.++++|
T Consensus 297 ~e~l~~ 302 (337)
T 3ll6_A 297 AEVVHQ 302 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999965
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.66 Aligned_cols=213 Identities=15% Similarity=0.149 Sum_probs=165.3
Q ss_pred hhhhHHHHHHhcCCCCCCeee---------------eceeeecCCCCeEEEEeeccccCHHHHHHhc--ccccHHHHHHH
Q psy9855 11 VANLKEISILRKIPDHLNVLC---------------LCETYVNRSTRQVTLVFPLMELNLEEYIRTT--DNISEKRAKEI 73 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~---------------l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~--~~l~~~~~~~~ 73 (470)
..+.+|++++.+++ ||||++ +++++.. .....|+||||++++|.+++... ..+++..+..
T Consensus 87 ~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~- 163 (352)
T 2jii_A 87 GRLFNEQNFFQRAA-KPLQVNKWKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ- 163 (352)
T ss_dssp STHHHHHHHHHHHC-CHHHHHHHHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHH-
T ss_pred chHHHHHHHHHHhc-ccchhhhhhhhccCCccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHH-
Confidence 45789999999999 999998 4444432 35789999999977999999876 4477777777
Q ss_pred HHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCC
Q psy9855 74 LYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDI 153 (470)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDL 153 (470)
++.||+.||+|||++||+||||
T Consensus 164 ----------------------------------------------------------i~~qi~~~L~~LH~~~ivH~Di 185 (352)
T 2jii_A 164 ----------------------------------------------------------VACRLLDALEFLHENEYVHGNV 185 (352)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHHHTTCBCSCC
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHHhCCccCCCC
Confidence 9999999999999999999999
Q ss_pred CCCcEEEeCC---eEEEEecCCcccccCCC--------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC
Q psy9855 154 KPENILIRGD---LVVVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR 222 (470)
Q Consensus 154 Kp~NILl~~~---~ikL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg 222 (470)
||+|||++.+ .++|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhC
Confidence 9999999987 69999999997654322 123458999999999987755 89999999999999999999
Q ss_pred CCCCCCCC-hHHHHHHH-HHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc
Q psy9855 223 NPLFPGDS-EIDQLDRI-HQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP 300 (470)
Q Consensus 223 ~~pf~~~~-~~~~~~~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp 300 (470)
..||.+.. ....+... ....+.+. .+. ........+++++.+||.+||..||.+||
T Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~-------------~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMKQKQKFVDKPG-------------PFV---------GPCGHWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHSCC-------------CEE---------CTTSCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred CCCcccCCcCHHHHHHHHHhccCChh-------------hhh---------hhccccCCCcHHHHHHHHHHHhCChhhCC
Confidence 99997753 22222222 11111000 000 00001235789999999999999999999
Q ss_pred CHHHHHh
Q psy9855 301 TAQKILS 307 (470)
Q Consensus 301 t~~elL~ 307 (470)
|++++++
T Consensus 323 s~~~l~~ 329 (352)
T 2jii_A 323 PYAMLRN 329 (352)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999984
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=287.55 Aligned_cols=214 Identities=26% Similarity=0.352 Sum_probs=160.8
Q ss_pred hhhhhHHHHHHhc--CCCCCCeeeeceeeec--CCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRK--IPDHLNVLCLCETYVN--RSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~--L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|.+++.. ++ ||||+++++++.. .....+++||||++ |+|.++++.. .+++..+..
T Consensus 44 ~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~------------ 109 (301)
T 3q4u_A 44 EKSWFRETELYNTVMLR-HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLR------------ 109 (301)
T ss_dssp HHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC-CBCHHHHHH------------
T ss_pred chhhHHHHHHHHHhhcc-CcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc-ccCHHHHHH------------
Confidence 4456677777777 77 9999999998764 23466899999999 5999999543 477777766
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH--------hCCCeecCCCCC
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH--------SYKVFHRDIKPE 156 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH--------~~gIvHrDLKp~ 156 (470)
++.||+.||+||| ++||+||||||+
T Consensus 110 -----------------------------------------------i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~ 142 (301)
T 3q4u_A 110 -----------------------------------------------IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142 (301)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGG
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHhhhhccCCCCeecCCCChH
Confidence 9999999999999 999999999999
Q ss_pred cEEEeCC-eEEEEecCCcccccCCCc-----cccccccCcccCchhhccCCC-----CCCcccHHHHHHHHHHHHhC---
Q psy9855 157 NILIRGD-LVVVGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLTEGY-----YSFELDIWAAGCVFYETLTR--- 222 (470)
Q Consensus 157 NILl~~~-~ikL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~-----~~~~~DIwSlG~il~elltg--- 222 (470)
|||++.+ .+||+|||++........ ....+||+.|+|||++.+... ++.++|||||||++|||++|
T Consensus 143 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~ 222 (301)
T 3q4u_A 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222 (301)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred hEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcC
Confidence 9999987 899999999976654322 233489999999999876532 44689999999999999999
Q ss_pred -------CCCCCCCCh----HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHh
Q psy9855 223 -------NPLFPGDSE----IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEM 291 (470)
Q Consensus 223 -------~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~ 291 (470)
..||.+... ......+....+ ..+..........++..+.+||.+|
T Consensus 223 ~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~l~~li~~c 279 (301)
T 3q4u_A 223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ-----------------------QRPNIPNRWFSDPTLTSLAKLMKEC 279 (301)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-----------------------CCCCCCGGGGGSHHHHHHHHHHHHH
T ss_pred ccccccccccccccCCCCcchhhhhHHHhccC-----------------------CCCCCChhhccCccHHHHHHHHHHH
Confidence 888855321 121211111000 0001111112234678899999999
Q ss_pred cccCCCCCcCHHHHHh
Q psy9855 292 LKYDPKRRPTAQKILS 307 (470)
Q Consensus 292 L~~dP~~Rpt~~elL~ 307 (470)
|..||.+|||+.++++
T Consensus 280 l~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 280 WYQNPSARLTALRIKK 295 (301)
T ss_dssp CCSSGGGSCCHHHHHH
T ss_pred hhcChhhCCCHHHHHH
Confidence 9999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=284.84 Aligned_cols=206 Identities=30% Similarity=0.567 Sum_probs=153.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhc----ccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTT----DNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~----~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
...+.+|+.+|+.|+ ||||+++++++.. .+..++||||+++ +|.+++... ..+++..+..
T Consensus 76 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~------------ 140 (310)
T 2wqm_A 76 RADCIKEIDLLKQLN-HPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK------------ 140 (310)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHH------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEEc--CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHH------------
Confidence 456789999999998 9999999999875 6689999999994 999998752 2266666665
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||.|||++||+||||||+||+++.+
T Consensus 141 -----------------------------------------------i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~ 173 (310)
T 2wqm_A 141 -----------------------------------------------YFVQLCSALEHMHSRRVMHRDIKPANVFITATG 173 (310)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred -----------------------------------------------HHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC
Confidence 99999999999999999999999999999977
Q ss_pred eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE--IDQLDRIHQ 240 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~ 240 (470)
.++|+|||++....... ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+... ......+..
T Consensus 174 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 252 (310)
T 2wqm_A 174 VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252 (310)
T ss_dssp CEEECCC------------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT
T ss_pred CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc
Confidence 89999999987665332 223457899999999987755 89999999999999999999999976431 121111111
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. . + .......+++++.+||.+||..||.+|||+.++++
T Consensus 253 -~-----------------~----~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 253 -C-----------------D----Y-------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -T-----------------C----S-------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -c-----------------c----C-------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0 0 00112457899999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.42 Aligned_cols=204 Identities=21% Similarity=0.350 Sum_probs=168.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|+++|++|+ ||||+++++++.. +.+|+|||||+ |+|.+++.... .+++..+..
T Consensus 306 ~~~~~~E~~~l~~l~-hpniv~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~-------------- 367 (535)
T 2h8h_A 306 PEAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-------------- 367 (535)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEee---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHH--------------
Confidence 457899999999999 9999999998753 56899999998 59999997532 266666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 368 ---------------------------------------------i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 402 (535)
T 2h8h_A 368 ---------------------------------------------MAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 402 (535)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcE
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
||+|||+++...... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+..+....
T Consensus 403 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~ 481 (535)
T 2h8h_A 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 481 (535)
T ss_dssp EECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred EEcccccceecCCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998664321 112345678899999987755 8999999999999999999 999999888776665553311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....+..+++.+.+||.+||..||++|||++++++
T Consensus 482 ------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 482 ------------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123467899999999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=305.00 Aligned_cols=210 Identities=20% Similarity=0.174 Sum_probs=164.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++++.|.+|++|..+..++. .....+|||||++++|.+++.... .+++..+..
T Consensus 46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~--~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~---------------- 107 (483)
T 3sv0_A 46 HPQLLYESKIYRILQGGTGIPNVRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM---------------- 107 (483)
T ss_dssp SCCHHHHHHHHHHTTTSTTCCCEEEEEE--ETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHH----------------
T ss_pred cHHHHHHHHHHHHhcCCCCCCeEEEEEe--eCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHH----------------
Confidence 3467899999999995566666655543 367889999999889999998643 377777776
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe---CC-e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR---GD-L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~---~~-~ 164 (470)
|+.||+.||+|||++|||||||||+|||++ .+ .
T Consensus 108 -------------------------------------------i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 144 (483)
T 3sv0_A 108 -------------------------------------------LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (483)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe
Confidence 999999999999999999999999999994 33 8
Q ss_pred EEEEecCCcccccCCCc--------cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH---H
Q psy9855 165 VVVGDLGSLQFIKSKGL--------HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI---D 233 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~---~ 233 (470)
++|+|||++........ ....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.... .
T Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~ 223 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (483)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence 99999999987654332 12568999999999998765 899999999999999999999999875432 2
Q ss_pred HHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 234 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.+..+....- ......+...++.++.+||..||..||.+||++.++++
T Consensus 224 ~~~~i~~~~~--------------------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 224 KYEKISEKKV--------------------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHH--------------------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhccc--------------------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2222221100 00111222467899999999999999999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.38 Aligned_cols=204 Identities=22% Similarity=0.332 Sum_probs=167.8
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+.+|.+++ ||||+++++++. .+..|+||||++ |+|.+++..... +++..+..
T Consensus 435 ~~~~~~E~~~l~~l~-HpnIv~l~~~~~---~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~--------------- 495 (656)
T 2j0j_A 435 REKFLQEALTMRQFD-HPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL--------------- 495 (656)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEC---SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEe---cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHH---------------
Confidence 467889999999999 999999999874 345899999999 699999986543 66666666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 496 --------------------------------------------i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vk 531 (656)
T 2j0j_A 496 --------------------------------------------YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 531 (656)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEE
Confidence 99999999999999999999999999999876 899
Q ss_pred EEecCCcccccCCCcc--ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q psy9855 167 VGDLGSLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~g 243 (470)
|+|||++......... ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+....
T Consensus 532 L~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~- 609 (656)
T 2j0j_A 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 609 (656)
T ss_dssp ECCCCCCCSCCC----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-
T ss_pred EEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999999876543322 2345678999999987755 8999999999999999997 999999888777666654411
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
....++.+++.+.+||.+||..||.+|||+.++++
T Consensus 610 -----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 610 -----------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11123567899999999999999999999999984
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.35 Aligned_cols=221 Identities=19% Similarity=0.315 Sum_probs=166.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|+.++ ||||+++++++...+...+++||||++ ++|.+++..... +++..+..
T Consensus 86 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------------- 149 (326)
T 2w1i_A 86 LRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ--------------- 149 (326)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHH---------------
Confidence 356789999999998 999999999987655567899999998 599999987643 77777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .++
T Consensus 150 --------------------------------------------i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 185 (326)
T 2w1i_A 150 --------------------------------------------YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185 (326)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEE
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++|..||.... ....+..
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~ 259 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMI 259 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHH
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhh
Confidence 999999987654332 22345778899999987755 7899999999999999999999885421 1111222
Q ss_pred CCCchHHHH--HHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLK--KFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
+......+. .+..... .......+..+++++.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLK-----------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CTTCCTHHHHHHHHHHHH-----------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccchhhhHHHHHHHhh-----------cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222111110 0000000 00111223568899999999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=288.05 Aligned_cols=211 Identities=24% Similarity=0.324 Sum_probs=162.0
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecC--CCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhh
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNR--STRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~--~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~ 81 (470)
....+.+|+.+++.++ ||||+++++++... .....++||||++ |+|.+++... ..+++..+..
T Consensus 69 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~--------- 138 (317)
T 2buj_A 69 DREEAQREADMHRLFN-HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW--------- 138 (317)
T ss_dssp HHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHH---------
T ss_pred HHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHH---------
Confidence 3456789999999998 99999999998632 3457899999999 5999999762 3367766666
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||+|||++||+||||||+|||++
T Consensus 139 --------------------------------------------------i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~ 168 (317)
T 2buj_A 139 --------------------------------------------------LLLGICRGLEAIHAKGYAHRDLKPTNILLG 168 (317)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 999999999999999999999999999998
Q ss_pred CC-eEEEEecCCcccccCCCc----------cccccccCcccCchhhccCC--CCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy9855 162 GD-LVVVGDLGSLQFIKSKGL----------HTEYIATRWYRSPECLLTEG--YYSFELDIWAAGCVFYETLTRNPLFPG 228 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~~----------~~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlG~il~elltg~~pf~~ 228 (470)
.+ .++|+|||++........ .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||..
T Consensus 169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 77 899999998875432110 12346799999999886543 268899999999999999999999943
Q ss_pred CChH-HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 229 DSEI-DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 229 ~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.... ........ ........+.++..+.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 249 VFQKGDSVALAVQ-----------------------------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp HHHTTSCHHHHHH-----------------------------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcccchhhHHhh-----------------------------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 1000 00000000 00001112467899999999999999999999999996
Q ss_pred c
Q psy9855 308 C 308 (470)
Q Consensus 308 h 308 (470)
+
T Consensus 300 ~ 300 (317)
T 2buj_A 300 Q 300 (317)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=282.32 Aligned_cols=214 Identities=23% Similarity=0.331 Sum_probs=158.0
Q ss_pred hhhhhHHHHHHhcC--CCCCCeeeeceeeecCCC--CeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 10 EVANLKEISILRKI--PDHLNVLCLCETYVNRST--RQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 10 ~~~~~rEi~iL~~L--~~HpnIv~l~~~~~~~~~--~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
.....+|.+++..+ + ||||+++++++..... ..+++|||||+ |+|.+++... .+++..+..
T Consensus 73 ~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~------------ 138 (337)
T 3mdy_A 73 EASWFRETEIYQTVLMR-HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLK------------ 138 (337)
T ss_dssp HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHH------------
T ss_pred cchhhhHHHHHHHHhhc-CCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHH------------
Confidence 34556777777665 6 9999999999876432 67999999998 5999999654 477777666
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC--------CCeecCCCCC
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY--------KVFHRDIKPE 156 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~--------gIvHrDLKp~ 156 (470)
++.||+.||+|||++ ||+||||||+
T Consensus 139 -----------------------------------------------i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~ 171 (337)
T 3mdy_A 139 -----------------------------------------------LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171 (337)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGG
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHhhhhhccCCCEEecccchH
Confidence 999999999999999 9999999999
Q ss_pred cEEEeCC-eEEEEecCCcccccCCCc-----cccccccCcccCchhhccCCCCCCc------ccHHHHHHHHHHHHhC--
Q psy9855 157 NILIRGD-LVVVGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLTEGYYSFE------LDIWAAGCVFYETLTR-- 222 (470)
Q Consensus 157 NILl~~~-~ikL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~~~~------~DIwSlG~il~elltg-- 222 (470)
|||++.+ .+||+|||++........ ....+||+.|+|||++.+.. ++.. +|||||||++|||++|
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccC
Confidence 9999877 899999999976543322 13458999999999987654 3443 8999999999999999
Q ss_pred --------CCCCCCCCh----HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHH
Q psy9855 223 --------NPLFPGDSE----IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSE 290 (470)
Q Consensus 223 --------~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~ 290 (470)
..||..... ........... .. .+..........+++++.+||.+
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------~~------~~~~~~~~~~~~~~~~l~~li~~ 307 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK-----------------KL------RPSFPNRWSSDECLRQMGKLMTE 307 (337)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS-----------------CC------CCCCCGGGGGSHHHHHHHHHHHH
T ss_pred cccccccccccHhhhcCCCCchhhhHHHHhhh-----------------cc------CccccccchhhHHHHHHHHHHHH
Confidence 666644211 11111111000 00 00001111123567889999999
Q ss_pred hcccCCCCCcCHHHHHhc
Q psy9855 291 MLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 291 ~L~~dP~~Rpt~~elL~h 308 (470)
||..||.+|||+.++++|
T Consensus 308 ~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 308 CWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HSCSSGGGSCCHHHHHHH
T ss_pred hhhhChhhCCCHHHHHHH
Confidence 999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=283.38 Aligned_cols=201 Identities=20% Similarity=0.346 Sum_probs=152.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeec--CCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+.+|+.++.++.+||||+++++++.. .....+++||||++ |+|.+++.... .+++..+..
T Consensus 55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------------- 121 (299)
T 3m2w_A 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE------------- 121 (299)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHH-------------
T ss_pred HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHH-------------
Confidence 4567999999555449999999999864 34567999999998 59999998765 377777777
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG--- 162 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~--- 162 (470)
++.||+.||+|||++||+||||||+|||++.
T Consensus 122 ----------------------------------------------i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 155 (299)
T 3m2w_A 122 ----------------------------------------------IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 155 (299)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEESSSST
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCC
Confidence 9999999999999999999999999999986
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+ .++|+|||++..... ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 156 ~~~~kl~Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~- 212 (299)
T 3m2w_A 156 NAILKLTDFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT- 212 (299)
T ss_dssp TCCEEECCCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-
T ss_pred CCcEEEecccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-
Confidence 4 799999998854321 2367899999999999999999999976543221100000
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
................+++++.+||.+||..||.+|||+.|+|+||||.+..
T Consensus 213 ----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 213 ----------------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ----------------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ----------------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0000000000111146789999999999999999999999999999997643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=287.15 Aligned_cols=227 Identities=19% Similarity=0.242 Sum_probs=154.5
Q ss_pred hhHHHHH--HhcCCCCCCeeeeceeee---cCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 13 NLKEISI--LRKIPDHLNVLCLCETYV---NRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 13 ~~rEi~i--L~~L~~HpnIv~l~~~~~---~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
+..|.++ +..++ ||||+++++.+. ......+++|||||+ |+|.+++.... .++..+..
T Consensus 52 ~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~-------------- 115 (336)
T 3g2f_A 52 FINEKNIYRVPLME-HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCR-------------- 115 (336)
T ss_dssp HHHHHHHHTSTTCC-CTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHH--------------
T ss_pred HHHHHHHHHHHhcc-CcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHH--------------
Confidence 3444444 45587 999999998553 233456899999998 69999997654 35555555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhC---------CCeecCCCCCc
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY---------KVFHRDIKPEN 157 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~---------gIvHrDLKp~N 157 (470)
++.||+.||+|||+. ||+||||||+|
T Consensus 116 ---------------------------------------------i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~N 150 (336)
T 3g2f_A 116 ---------------------------------------------LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRN 150 (336)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGG
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhhhccccccccceeecccccce
Confidence 999999999999999 99999999999
Q ss_pred EEEeCC-eEEEEecCCcccccCCC---------ccccccccCcccCchhhccC------CCCCCcccHHHHHHHHHHHHh
Q psy9855 158 ILIRGD-LVVVGDLGSLQFIKSKG---------LHTEYIATRWYRSPECLLTE------GYYSFELDIWAAGCVFYETLT 221 (470)
Q Consensus 158 ILl~~~-~ikL~DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~------~~~~~~~DIwSlG~il~ellt 221 (470)
||++.+ .+||+|||++....... .....+||+.|+|||++.+. ..++.++|||||||++|||++
T Consensus 151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 999987 89999999998664321 12345799999999998762 235678999999999999999
Q ss_pred CCCCC-CCCChHHHHHHHHH-HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCC
Q psy9855 222 RNPLF-PGDSEIDQLDRIHQ-VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR 299 (470)
Q Consensus 222 g~~pf-~~~~~~~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R 299 (470)
|..|| .+....+....+.. ..+.+....+......... . +..+. .......+++.+.+||.+||..||++|
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~R 303 (336)
T 3g2f_A 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ--R---PKFPE--AWKENSLAVRSLKETIEDCWDQDAEAR 303 (336)
T ss_dssp TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC--C---CCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGS
T ss_pred cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccccc--C---CCCCc--ccccccchHHHHHHHHHHHhcCChhhC
Confidence 96554 33321111111111 1122222222211110000 0 00000 000112366789999999999999999
Q ss_pred cCHHHHHh
Q psy9855 300 PTAQKILS 307 (470)
Q Consensus 300 pt~~elL~ 307 (470)
||+.|+++
T Consensus 304 ps~~e~l~ 311 (336)
T 3g2f_A 304 LTAQXAEE 311 (336)
T ss_dssp CCHHHHHH
T ss_pred cchHHHHH
Confidence 99999973
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.80 Aligned_cols=216 Identities=23% Similarity=0.267 Sum_probs=162.5
Q ss_pred hhhhhhHHHHHHhc--CCCCCCeeeeceeeecCCC--CeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcc
Q psy9855 9 AEVANLKEISILRK--IPDHLNVLCLCETYVNRST--RQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 9 ~~~~~~rEi~iL~~--L~~HpnIv~l~~~~~~~~~--~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~ 83 (470)
....+.+|++++.. ++ ||||+++++++..... ..+++||||++ |+|.+++... .+++..+..
T Consensus 77 ~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~----------- 143 (342)
T 1b6c_B 77 EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIK----------- 143 (342)
T ss_dssp GHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHH-----------
T ss_pred hHHHHHHHHHHHHHhhcC-CCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHH-----------
Confidence 34567899999988 67 9999999999875432 37999999999 5999999754 477777666
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHH--------hCCCeecCCCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLH--------SYKVFHRDIKP 155 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH--------~~gIvHrDLKp 155 (470)
++.||+.||+||| ++||+||||||
T Consensus 144 ------------------------------------------------i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp 175 (342)
T 1b6c_B 144 ------------------------------------------------LALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175 (342)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHCCBCSTTCBCEEECSCCSG
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHhhhcccCCeeeCCCCH
Confidence 9999999999999 89999999999
Q ss_pred CcEEEeCC-eEEEEecCCcccccCCC-----ccccccccCcccCchhhccCCC-----CCCcccHHHHHHHHHHHHhC--
Q psy9855 156 ENILIRGD-LVVVGDLGSLQFIKSKG-----LHTEYIATRWYRSPECLLTEGY-----YSFELDIWAAGCVFYETLTR-- 222 (470)
Q Consensus 156 ~NILl~~~-~ikL~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~-----~~~~~DIwSlG~il~elltg-- 222 (470)
+|||++.+ .++|+|||++....... ......||+.|+|||++.+... ++.++|||||||++|+|++|
T Consensus 176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence 99999887 89999999998765443 2245589999999999876532 23689999999999999999
Q ss_pred --------CCCCCCCCh----HHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHH
Q psy9855 223 --------NPLFPGDSE----IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSE 290 (470)
Q Consensus 223 --------~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~ 290 (470)
..||.+... .+.+..... ..... +..........+++.+.+||.+
T Consensus 256 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~~------~~~~~~~~~~~~~~~l~~li~~ 312 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVC-----------------EQKLR------PNIPNRWQSCEALRVMAKIMRE 312 (342)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHT-----------------TSCCC------CCCCGGGGTSHHHHHHHHHHHH
T ss_pred cCCcccccccCccccCcCcccHHHHHHHHH-----------------HHHhC------CCCcccccchhHHHHHHHHHHH
Confidence 778865421 111111100 00000 0000000112456788999999
Q ss_pred hcccCCCCCcCHHHHHhc
Q psy9855 291 MLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 291 ~L~~dP~~Rpt~~elL~h 308 (470)
||..||.+|||+.++++|
T Consensus 313 cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 313 CWYANGAARLTALRIKKT 330 (342)
T ss_dssp HCCSSGGGSCCHHHHHHH
T ss_pred HhccChhhCCCHHHHHHH
Confidence 999999999999999964
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=298.74 Aligned_cols=149 Identities=18% Similarity=0.312 Sum_probs=121.5
Q ss_pred HHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCccccccccCcccCchhhc---------
Q psy9855 129 TTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLL--------- 198 (470)
Q Consensus 129 ~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~--------- 198 (470)
+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||++...... ....+| +.|+|||++.
T Consensus 213 ~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccc
Confidence 33489999999999999999999999999999988 8999999998765543 345678 9999999983
Q ss_pred cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccc
Q psy9855 199 TEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVP 278 (470)
Q Consensus 199 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (470)
....++.++|||||||++|+|++|+.||.+.+..+... ..+. ...
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~--------------------------~~~~---------~~~ 334 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE--------------------------WIFR---------SCK 334 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG--------------------------GGGS---------SCC
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH--------------------------HHHh---------hcc
Confidence 22347889999999999999999999997654211100 0000 113
Q ss_pred cccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 279 QIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 279 ~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+++.+.+||.+||..||.+|||+.++++||||+++.
T Consensus 335 ~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 335 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 5789999999999999999999999999999998664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=286.53 Aligned_cols=201 Identities=13% Similarity=0.149 Sum_probs=157.3
Q ss_pred hhhhhHHHHHHhcCCC--CCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-----ccccHHHHHHHHHHHHhhh
Q psy9855 10 EVANLKEISILRKIPD--HLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-----DNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~--HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-----~~l~~~~~~~~~~~~~~~~ 81 (470)
...+.+|++++..|+. |+||+++++++.. .+..|+|||||+ |+|.+++... ..+++..+..
T Consensus 108 ~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~--------- 176 (365)
T 3e7e_A 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS--------- 176 (365)
T ss_dssp HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHH---------
T ss_pred hhHHHHHHHHHHHhhhhhhhhhhhhheeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHH---------
Confidence 3456788888888863 8999999999865 667899999998 6999999752 3366666666
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
|+.||+.||+|||++|||||||||+|||++
T Consensus 177 --------------------------------------------------i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 177 --------------------------------------------------FAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred --------------------------------------------------HHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 999999999999999999999999999998
Q ss_pred C-----------C-eEEEEecCCccccc---CCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy9855 162 G-----------D-LVVVGDLGSLQFIK---SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF 226 (470)
Q Consensus 162 ~-----------~-~ikL~DFG~a~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf 226 (470)
. + .+||+|||++.... ........+||+.|+|||++.+.. |+.++|||||||++|||++|+.||
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCcc
Confidence 7 4 89999999997543 233345678999999999998866 899999999999999999999998
Q ss_pred CCCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 227 PGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 227 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
...... ..... ..... ...++.+.+++..||+.+|.+|++..+.+
T Consensus 286 ~~~~~~-----------------------------~~~~~----~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 286 VKNEGG-----------------------------ECKPE----GLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330 (365)
T ss_dssp EEEETT-----------------------------EEEEC----SCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred ccCCCC-----------------------------ceeec----hhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence 543210 00000 00000 12467789999999999999997655544
Q ss_pred h
Q psy9855 307 S 307 (470)
Q Consensus 307 ~ 307 (470)
.
T Consensus 331 ~ 331 (365)
T 3e7e_A 331 R 331 (365)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=283.58 Aligned_cols=150 Identities=15% Similarity=0.177 Sum_probs=113.0
Q ss_pred HHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCC---------------------eEEEEecCCcccccCCCccccc
Q psy9855 128 HTTFVLYQIVNGLHHLH-SYKVFHRDIKPENILIRGD---------------------LVVVGDLGSLQFIKSKGLHTEY 185 (470)
Q Consensus 128 ~~~~i~~qIl~aL~yLH-~~gIvHrDLKp~NILl~~~---------------------~ikL~DFG~a~~~~~~~~~~~~ 185 (470)
.++.|+.||+.||+||| ++||+||||||+|||++.+ .+||+|||+++..... ..
T Consensus 162 ~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~ 237 (336)
T 2vuw_A 162 TAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IV 237 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EE
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cE
Confidence 33349999999999999 9999999999999999865 7999999999876542 45
Q ss_pred cccCcccCchhhccCCCCCCcccHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchHHHHHHhhhccCcccc
Q psy9855 186 IATRWYRSPECLLTEGYYSFELDIWAAGCV-FYETLTRNPLFPGDSE-IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTY 263 (470)
Q Consensus 186 ~gt~~Y~APE~l~~~~~~~~~~DIwSlG~i-l~elltg~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 263 (470)
+||+.|+|||++.+.. +.++||||+|++ .++++.|..||.+... ......+....
T Consensus 238 ~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~--------------------- 294 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM--------------------- 294 (336)
T ss_dssp ECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC---------------------
T ss_pred EEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh---------------------
Confidence 8999999999998654 889999998777 7778889999843211 01111111100
Q ss_pred ccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH-hcccCC
Q psy9855 264 QFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL-SCAYFA 312 (470)
Q Consensus 264 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL-~hp~f~ 312 (470)
...........+.+++++.+||.+||+.| |++|+| +||||+
T Consensus 295 ---~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 295 ---TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ---CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ---ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 00011112233568899999999999987 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-33 Score=304.36 Aligned_cols=200 Identities=21% Similarity=0.254 Sum_probs=160.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCC---CeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRST---RQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~---~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+|.+|+ ||||+++++++...+. ...||||||++ ++|.+++.. .+++..+..
T Consensus 123 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~------------- 186 (681)
T 2pzi_A 123 QAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIA------------- 186 (681)
T ss_dssp HHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHH-------------
Confidence 346789999999999 9999999999875322 12699999999 599888754 477777666
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeE
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLV 165 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~i 165 (470)
|+.||+.||.|||++|||||||||+|||++.+.+
T Consensus 187 ----------------------------------------------~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~ 220 (681)
T 2pzi_A 187 ----------------------------------------------YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQL 220 (681)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCE
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCCeecccChHHeEEeCCcE
Confidence 9999999999999999999999999999999999
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
||+|||++...... ...+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... +.+
T Consensus 221 kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~ 285 (681)
T 2pzi_A 221 KLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP 285 (681)
T ss_dssp EECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC
T ss_pred EEEecccchhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------ccc
Confidence 99999999876543 456899999999998763 488999999999999999999888542100 000
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
........++.+.+||.+||..||.+||+..+++.|+|+.-
T Consensus 286 ---------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ---------------------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------------------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00011235678899999999999999999999999988753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=251.92 Aligned_cols=181 Identities=15% Similarity=0.046 Sum_probs=140.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.++..++ ||||+++++++.. .+..|+||||++ ++|.++++.. .....+..
T Consensus 76 ~~~~~e~~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~----------------- 133 (286)
T 3uqc_A 76 QETLSRTLRLSRID-KPGVARVLDVVHT--RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIR----------------- 133 (286)
T ss_dssp HHHHHHHHHHHTCC-CTTBCCEEEEEEE--TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHH-----------------
T ss_pred HHHHHHHHHHhcCC-CCCcceeeEEEEE--CCcEEEEEEecCCCCHHHHHhcC--CChHHHHH-----------------
Confidence 56899999999998 9999999999865 578999999998 5999998543 23334444
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|+.||+.||+|||++||+||||||+|||++.+ .++|+
T Consensus 134 ------------------------------------------i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 134 ------------------------------------------AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEE
Confidence 99999999999999999999999999999987 78877
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
++| |++| ++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 172 ~~~-------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------- 213 (286)
T 3uqc_A 172 YPA-------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------- 213 (286)
T ss_dssp SCC-------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------
T ss_pred ecc-------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------
Confidence 443 3332 68899999999999999999999987543110000
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
................+.+++++.+||.+||..||.+| |+.++++
T Consensus 214 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 214 -------------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -------------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -------------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00000000011122335789999999999999999999 9999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-31 Score=282.80 Aligned_cols=148 Identities=16% Similarity=0.173 Sum_probs=112.4
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|+++.+|+||+++++++.+ .+.+||||||++| +|.++|...+.+++. .
T Consensus 286 ~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~----------------- 343 (569)
T 4azs_A 286 YELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGWLVMEKLPGRLLSDMLAAGEEIDRE---K----------------- 343 (569)
T ss_dssp HHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEEEEEECCCSEEHHHHHHTTCCCCHH---H-----------------
T ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEEEEEecCCCCcHHHHHHhCCCCCHH---H-----------------
Confidence 4588999999999779999999999854 7889999999996 999999887666542 2
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||+
T Consensus 344 ------------------------------------------I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~ 381 (569)
T 4azs_A 344 ------------------------------------------ILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLI 381 (569)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEe
Confidence 88999999999999999999999999999888 89999
Q ss_pred ecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCC
Q psy9855 169 DLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNP 224 (470)
Q Consensus 169 DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~ 224 (470)
|||+|+..... ....+.+||+.|+|||++.+. +..++|+||+|++++++.++..
T Consensus 382 DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 382 DFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred ecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 99999876543 334567899999999998764 5778999999999988866543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-23 Score=218.45 Aligned_cols=144 Identities=15% Similarity=0.211 Sum_probs=119.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|++|+ ||||+++..++.. .+..|+|||||+ ++|.+++.. +..
T Consensus 384 ~~~~~E~~il~~l~-h~nIv~~~~~~~~--~~~~~lVmE~~~ggsL~~~l~~--------~~~----------------- 435 (540)
T 3en9_A 384 SRTAREARYLALVK-DFGIPAPYIFDVD--LDNKRIMMSYINGKLAKDVIED--------NLD----------------- 435 (540)
T ss_dssp HHHHHHHHHHHHGG-GGTCCCCCEEEEE--TTTTEEEEECCCSEEHHHHSTT--------CTH-----------------
T ss_pred HHHHHHHHHHHhcC-CCCcCceEEEEEe--CCccEEEEECCCCCCHHHHHHH--------HHH-----------------
Confidence 34789999999998 9999955444443 445699999998 699999864 122
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEEe
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGD 169 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~D 169 (470)
++.||+.||+|||++||+||||||+|||++. .+||+|
T Consensus 436 ------------------------------------------i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~D 472 (540)
T 3en9_A 436 ------------------------------------------IAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIID 472 (540)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEE
Confidence 9999999999999999999999999999999 999999
Q ss_pred cCCcccccCCCc--------cccccccCcccCchhhcc--CCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy9855 170 LGSLQFIKSKGL--------HTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLF 226 (470)
Q Consensus 170 FG~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlG~il~elltg~~pf 226 (470)
||+++....... ....+||+.|+|||++.. .. |+..+|+|+.++-..+...++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~-Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEG-YKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHH-HHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHhcccc
Confidence 999987754321 235689999999999875 33 788899999999888888776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.5e-17 Score=158.94 Aligned_cols=104 Identities=18% Similarity=0.217 Sum_probs=81.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|..|+ |+ ++.+++. .+..|+|||||+| +|.+ +.. .....
T Consensus 148 ~~~~~~E~~~l~~l~-~~---~v~~~~~---~~~~~lvmE~~~g~~L~~-l~~------~~~~~---------------- 197 (282)
T 1zar_A 148 IRSARNEFRALQKLQ-GL---AVPKVYA---WEGNAVLMELIDAKELYR-VRV------ENPDE---------------- 197 (282)
T ss_dssp HHHHHHHHHHHHHTT-TS---SSCCEEE---EETTEEEEECCCCEEGGG-CCC------SCHHH----------------
T ss_pred HHHHHHHHHHHHhcc-CC---CcCeEEe---ccceEEEEEecCCCcHHH-cch------hhHHH----------------
Confidence 456789999999998 54 4444442 2446999999985 8887 421 11112
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG 168 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~ 168 (470)
++.||+.||.|||++||+||||||+|||++++.++|+
T Consensus 198 -------------------------------------------i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~ 234 (282)
T 1zar_A 198 -------------------------------------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII 234 (282)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEEC
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEE
Confidence 9999999999999999999999999999994499999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhc
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLL 198 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~ 198 (470)
|||++. .+..|+|||++.
T Consensus 235 DFG~a~------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSV------------EVGEEGWREILE 252 (282)
T ss_dssp CCTTCE------------ETTSTTHHHHHH
T ss_pred ECCCCe------------ECCCCCHHHHHH
Confidence 999885 344578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=2.6e-14 Score=136.68 Aligned_cols=44 Identities=20% Similarity=0.332 Sum_probs=41.7
Q ss_pred HHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCCeEEEEecCCcccc
Q psy9855 132 VLYQIVNGLHHLH-SYKVFHRDIKPENILIRGDLVVVGDLGSLQFI 176 (470)
Q Consensus 132 i~~qIl~aL~yLH-~~gIvHrDLKp~NILl~~~~ikL~DFG~a~~~ 176 (470)
++.||+.||.||| +.||+||||||+|||++. .++|+|||++...
T Consensus 175 i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 175 IFNDVVENVKRLYQEAELVHADLSEYNIMYID-KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-cEEEEECcccccC
Confidence 9999999999999 999999999999999999 9999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.98 E-value=2.7e-10 Score=114.42 Aligned_cols=68 Identities=12% Similarity=0.129 Sum_probs=55.6
Q ss_pred cceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCe-----------
Q psy9855 96 PFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL----------- 164 (470)
Q Consensus 96 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~----------- 164 (470)
.+++|||+.|++|.++... ..+..++.||+.||.|||..|||||||||.|||++.+.
T Consensus 186 ~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp TEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred ceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccc
Confidence 3699999999988765421 12344889999999999999999999999999997652
Q ss_pred EEEEecCCccc
Q psy9855 165 VVVGDLGSLQF 175 (470)
Q Consensus 165 ikL~DFG~a~~ 175 (470)
+.|+||+-+..
T Consensus 254 ~~iID~~Q~V~ 264 (397)
T 4gyi_A 254 PIIIXFPQMVS 264 (397)
T ss_dssp EEECCCTTCEE
T ss_pred eEEEEeCCccc
Confidence 78999996643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.2e-08 Score=96.88 Aligned_cols=47 Identities=11% Similarity=-0.057 Sum_probs=38.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHH
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYI 59 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l 59 (470)
..+.+|+.+|+.|..+..|.++++++.. .+..|+||||++| +|.+.+
T Consensus 54 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~l~~~~ 101 (263)
T 3tm0_A 54 YDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp TCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCSSEEHHHHC
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEEEecCCeehhhcc
Confidence 3578999999999767788889887754 5678999999997 887763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=8e-08 Score=93.45 Aligned_cols=78 Identities=14% Similarity=0.238 Sum_probs=48.3
Q ss_pred CCCeecCCCCCcEEEeC--C-eEEEEecCCcccccCCCcccccc------c---------cCcccC-chhhccCCCCCCc
Q psy9855 146 YKVFHRDIKPENILIRG--D-LVVVGDLGSLQFIKSKGLHTEYI------A---------TRWYRS-PECLLTEGYYSFE 206 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~--~-~ikL~DFG~a~~~~~~~~~~~~~------g---------t~~Y~A-PE~l~~~~~~~~~ 206 (470)
..++|+|++|.||+++. + .+.|+||+.+............. + ..++.. |+.... ...-
T Consensus 191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r---~~~~ 267 (304)
T 3sg8_A 191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK---YRMK 267 (304)
T ss_dssp CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH---HHHH
T ss_pred ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH---HHHH
Confidence 46899999999999998 5 56799999876532110000000 0 001111 222111 1123
Q ss_pred ccHHHHHHHHHHHHhCCCCC
Q psy9855 207 LDIWAAGCVFYETLTRNPLF 226 (470)
Q Consensus 207 ~DIwSlG~il~elltg~~pf 226 (470)
.+.|++|.++|.+.+|..+|
T Consensus 268 ~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 268 EKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHcCCHHH
Confidence 58999999999999998776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.48 E-value=1.6e-07 Score=88.37 Aligned_cols=44 Identities=9% Similarity=-0.058 Sum_probs=32.2
Q ss_pred hhhhHHHHHHhcCCCCCC-eeeeceeeecCCCCeEEEEeecccc-CHH
Q psy9855 11 VANLKEISILRKIPDHLN-VLCLCETYVNRSTRQVTLVFPLMEL-NLE 56 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~Hpn-Iv~l~~~~~~~~~~~~~lV~E~~~g-sL~ 56 (470)
..+.+|+.+|+.|..+.- |.+++++... .+..++||||++| +|.
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEETT
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEecCCcccC
Confidence 456799999999974422 5568776643 4668999999997 663
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.40 E-value=3.8e-07 Score=90.75 Aligned_cols=46 Identities=11% Similarity=0.086 Sum_probs=32.6
Q ss_pred hhhhHHHHHHhcCCC-CCCeeeeceeeecCC-CCeEEEEeecccc-CHH
Q psy9855 11 VANLKEISILRKIPD-HLNVLCLCETYVNRS-TRQVTLVFPLMEL-NLE 56 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~-HpnIv~l~~~~~~~~-~~~~~lV~E~~~g-sL~ 56 (470)
..+.+|+.+|+.|.. +..|.++++++.+.+ .+..|+||||++| .+.
T Consensus 81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~ 129 (359)
T 3dxp_A 81 HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLW 129 (359)
T ss_dssp -CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCC
T ss_pred HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecC
Confidence 467899999999973 345778877664321 1558999999997 553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=0.0001 Score=69.77 Aligned_cols=49 Identities=6% Similarity=-0.039 Sum_probs=37.1
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHh
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRT 61 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~ 61 (470)
..+.+|..+|+.|..+--|.+++++..+ .+..++|||+++| ++.+....
T Consensus 64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G~~~~~~~~~ 113 (272)
T 4gkh_A 64 NDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPGKTAFQVLEE 113 (272)
T ss_dssp HHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCSEEHHHHHHH
T ss_pred hHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCCccccccccC
Confidence 4567899999999755456677776654 5678999999997 77776644
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00011 Score=71.37 Aligned_cols=48 Identities=19% Similarity=0.030 Sum_probs=33.1
Q ss_pred hhhhhHHHHHHhcCCCCC--CeeeeceeeecCCCCeEEEEeecccc-CHHHH
Q psy9855 10 EVANLKEISILRKIPDHL--NVLCLCETYVNRSTRQVTLVFPLMEL-NLEEY 58 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~Hp--nIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~ 58 (470)
...+.+|+.+|..|..|- .|.+++.+.. ...+..++|||+++| .|.+.
T Consensus 53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i~G~~l~~~ 103 (306)
T 3tdw_A 53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKVQGQILGED 103 (306)
T ss_dssp HHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECCCSEECHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEeccCCeECchh
Confidence 356789999999998431 2455555443 234567899999998 67653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.017 Score=52.66 Aligned_cols=76 Identities=17% Similarity=0.079 Sum_probs=41.6
Q ss_pred HHHHHHHHHHHHH-hCCCeecCCCCCcEEEeCC-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccH
Q psy9855 132 VLYQIVNGLHHLH-SYKVFHRDIKPENILIRGD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDI 209 (470)
Q Consensus 132 i~~qIl~aL~yLH-~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DI 209 (470)
+++|.+.+|.-+- .+.-..+=+-|..|++..+ .|-+.+ +.+. .....+.|||... ...+.+.=|
T Consensus 54 Lc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~~~~~pe~~~--~~~te~~~I 119 (229)
T 2yle_A 54 VCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEPPPVAGKLGY--SQCMETEVI 119 (229)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------------CCSS--SSSCHHHHH
T ss_pred HHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccccCCCChhhcc--ccchHHHHH
Confidence 9999999987762 1111223334577777766 443332 1110 1223456888653 224678889
Q ss_pred HHHHHHHHHHHh
Q psy9855 210 WAAGCVFYETLT 221 (470)
Q Consensus 210 wSlG~il~ellt 221 (470)
||||+++|..+-
T Consensus 120 ysLG~tLY~ALD 131 (229)
T 2yle_A 120 ESLGIIIYKALD 131 (229)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHhh
Confidence 999999999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0037 Score=61.42 Aligned_cols=30 Identities=23% Similarity=0.174 Sum_probs=25.3
Q ss_pred hCCCeecCCCCCcEEEeCC-eEEEEecCCcc
Q psy9855 145 SYKVFHRDIKPENILIRGD-LVVVGDLGSLQ 174 (470)
Q Consensus 145 ~~gIvHrDLKp~NILl~~~-~ikL~DFG~a~ 174 (470)
...++|+|++|.|||++++ .+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 3579999999999999976 46799999664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0033 Score=62.95 Aligned_cols=30 Identities=17% Similarity=0.098 Sum_probs=26.2
Q ss_pred hCCCeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 145 SYKVFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 145 ~~gIvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
...++|||+.|.|||++.+.+.++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSSCEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCCCeEEEeCcccc
Confidence 467999999999999988888999998653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.88 E-value=0.006 Score=58.57 Aligned_cols=28 Identities=25% Similarity=0.146 Sum_probs=24.2
Q ss_pred CCeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 147 KVFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 147 gIvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
.++|+|+.+.||+.+++.+.++||..+.
T Consensus 174 ~l~HgDl~~~Nil~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLDTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEEECCCCEEEEeccccc
Confidence 5899999999999666688999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.00 E-value=0.024 Score=54.88 Aligned_cols=29 Identities=24% Similarity=0.334 Sum_probs=25.1
Q ss_pred CCCeecCCCCCcEEEeCC-eEEEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGD-LVVVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~-~ikL~DFG~a~ 174 (470)
.+++|+|+++.|||++.+ .+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 689999999999999755 78999999653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.23 E-value=0.04 Score=54.90 Aligned_cols=28 Identities=25% Similarity=0.361 Sum_probs=24.4
Q ss_pred CCeecCCCCCcEEEeCC-----eEEEEecCCcc
Q psy9855 147 KVFHRDIKPENILIRGD-----LVVVGDLGSLQ 174 (470)
Q Consensus 147 gIvHrDLKp~NILl~~~-----~ikL~DFG~a~ 174 (470)
.++|+|+.+.|||++.+ .+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 58999999999999875 78899998664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=93.55 E-value=0.042 Score=57.80 Aligned_cols=122 Identities=14% Similarity=0.028 Sum_probs=74.2
Q ss_pred HHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecC
Q psy9855 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRD 152 (470)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrD 152 (470)
+++++..+..+...+...++....||||||+.|++|.+.|.....+. ..+|+. +-|..-..+|.
T Consensus 294 ~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~-------------~~~I~~--QIl~AL~ylH~- 357 (569)
T 4azs_A 294 FLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEID-------------REKILG--SLLRSLAALEK- 357 (569)
T ss_dssp HHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCC-------------HHHHHH--HHHHHHHHHHH-
T ss_pred HHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCC-------------HHHHHH--HHHHHHHHHHH-
Confidence 44555566777777899999999999999999999999998766542 445553 23334456675
Q ss_pred CCCCcEEEeC---CeEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy9855 153 IKPENILIRG---DLVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFP 227 (470)
Q Consensus 153 LKp~NILl~~---~~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~ 227 (470)
.+|+=.+ .+|.|.+=|..+.. +.+.... +.. ......+++|+.|++..|++.|..++.
T Consensus 358 ---~GIIHRDIKPeNILL~~dg~vKL~-DFGlAr~------------~~~-~~~~~~t~vGTp~YmAPE~l~g~~~~~ 418 (569)
T 4azs_A 358 ---QGFWHDDVRPWNVMVDARQHARLI-DFGSIVT------------TPQ-DCSWPTNLVQSFFVFVNELFAENKSWN 418 (569)
T ss_dssp ---TTCEESCCCGGGEEECTTSCEEEC-CCTTEES------------CC----CCSHHHHHHHHHHHHHHC-------
T ss_pred ---CCceeccCchHhEEECCCCCEEEe-ecccCee------------CCC-CCccccCceechhhccHHHhCCCCCCc
Confidence 4555433 26777665644322 2221110 001 113456799999999999999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.51 E-value=0.041 Score=55.42 Aligned_cols=32 Identities=16% Similarity=0.238 Sum_probs=28.2
Q ss_pred HhCCCeecCCCCCcEEEeCCeEEEEecCCccc
Q psy9855 144 HSYKVFHRDIKPENILIRGDLVVVGDLGSLQF 175 (470)
Q Consensus 144 H~~gIvHrDLKp~NILl~~~~ikL~DFG~a~~ 175 (470)
+...++|||++|.|||++.+.+.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDSTQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSCEEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCCCEEEeCccccc
Confidence 46789999999999999887799999997754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=92.99 E-value=0.22 Score=48.09 Aligned_cols=26 Identities=19% Similarity=0.244 Sum_probs=22.7
Q ss_pred CCCeecCCCCCcEEEeCCeEEEEecC
Q psy9855 146 YKVFHRDIKPENILIRGDLVVVGDLG 171 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~ikL~DFG 171 (470)
..+||+|+.+.||+++.+.+.|+|++
T Consensus 207 ~~l~HgD~~~~N~l~~~~~~~~iD~~ 232 (312)
T 3jr1_A 207 PSILHGNLWIENCIQVDDKIFVCNPA 232 (312)
T ss_dssp CEEECSSCSGGGEEEETTEEEECSCC
T ss_pred ceeEeCCCCcCcEeecCCCeEEEcCc
Confidence 46899999999999998877788874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.38 E-value=0.1 Score=50.10 Aligned_cols=29 Identities=24% Similarity=0.249 Sum_probs=24.9
Q ss_pred CCCeecCCCCCcEEEeCCeE-EEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGDLV-VVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~i-kL~DFG~a~ 174 (470)
.+++|+|+++.|||++++.+ .|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 47999999999999998855 699999664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=89.20 E-value=0.21 Score=47.96 Aligned_cols=29 Identities=28% Similarity=0.273 Sum_probs=24.5
Q ss_pred hCCCeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 145 SYKVFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 145 ~~gIvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
..+++|||+++.|||+++ .+.|+||+.+.
T Consensus 194 ~~~l~HgD~~~~Nil~~~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWRD-GPMFVDLDDAR 222 (328)
T ss_dssp CCEECCSSCSGGGEEESS-SEEECCCTTCC
T ss_pred CeeeeeCCCCcccEeEcC-CCEEEECCCCC
Confidence 346899999999999995 78899998654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.71 E-value=0.3 Score=47.96 Aligned_cols=29 Identities=17% Similarity=0.204 Sum_probs=24.7
Q ss_pred CCCeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
.+++|+|+++.|||++++.+.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKCLRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-CEEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCcEEEEEecCCC
Confidence 36899999999999988788999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.49 E-value=0.42 Score=47.65 Aligned_cols=27 Identities=22% Similarity=0.276 Sum_probs=22.4
Q ss_pred CeecCCCCCcEEEeC------C-eEEEEecCCcc
Q psy9855 148 VFHRDIKPENILIRG------D-LVVVGDLGSLQ 174 (470)
Q Consensus 148 IvHrDLKp~NILl~~------~-~ikL~DFG~a~ 174 (470)
++|+|+.+.|||+.. + .+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 579999999999943 2 68999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=88.49 E-value=0.17 Score=48.86 Aligned_cols=31 Identities=26% Similarity=0.300 Sum_probs=26.0
Q ss_pred hCCCeecCCCCCcEEEeC-----CeEEEEecCCccc
Q psy9855 145 SYKVFHRDIKPENILIRG-----DLVVVGDLGSLQF 175 (470)
Q Consensus 145 ~~gIvHrDLKp~NILl~~-----~~ikL~DFG~a~~ 175 (470)
...++|||+.+.|||++. +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 457999999999999987 4688999997753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=83.22 E-value=0.57 Score=45.64 Aligned_cols=38 Identities=13% Similarity=0.129 Sum_probs=32.6
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccc
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTT 117 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~ 117 (470)
|+.+...|.+..+....||+|||+.||+|.+++.....
T Consensus 109 HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~ 146 (336)
T 4g3f_A 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC 146 (336)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS
T ss_pred CCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCC
Confidence 56667778888899999999999999999999976544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=82.45 E-value=0.64 Score=45.12 Aligned_cols=30 Identities=23% Similarity=0.438 Sum_probs=25.7
Q ss_pred CCCeecCCCCCcEEEeCC-eEEEEecCCccc
Q psy9855 146 YKVFHRDIKPENILIRGD-LVVVGDLGSLQF 175 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~-~ikL~DFG~a~~ 175 (470)
.+++|+|+.+.||+++.+ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 469999999999999865 789999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=80.44 E-value=0.77 Score=44.01 Aligned_cols=38 Identities=13% Similarity=-0.104 Sum_probs=32.3
Q ss_pred hhccccccccccCCCccceeeeccCCCCchhhhhcccc
Q psy9855 80 ANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTT 117 (470)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~ 117 (470)
++.+...|.+..+.+..|++||||.||+|.+++.+...
T Consensus 85 HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~ 122 (304)
T 3ubd_A 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122 (304)
T ss_dssp CTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCC
T ss_pred CCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCC
Confidence 55666678888899999999999999999999976544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 470 | ||||
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-04 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-32 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-29 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 0.001 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-27 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-27 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 0.003 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-26 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-22 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-22 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-21 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-21 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-20 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-20 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-20 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-20 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-20 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-19 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-19 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-19 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-18 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-18 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-18 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-17 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-17 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-10 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-40
Identities = 62/189 (32%), Positives = 97/189 (51%), Gaps = 5/189 (2%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEY 185
H + + GL +LH + + HRD+KP N+L+ + V+ + D G + F +T
Sbjct: 101 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
+ TRWYR+PE L Y +D+WA GC+ E L R P PGDS++DQL RI + LGTP
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
T +++ S FK +PG + + + L+ + ++P R TA +
Sbjct: 221 ---TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
Query: 306 LSCAYFADL 314
L YF++
Sbjct: 278 LKMKYFSNR 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-39
Identities = 66/193 (34%), Positives = 100/193 (51%), Gaps = 6/193 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVG-DLGSLQFIKSKGLHTEYI 186
+++Q++ GL LHS++V HRD+KP+NIL+ + D G + + T +
Sbjct: 117 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 176
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T WYR+PE LL Y+ +D+W+ GC+F E R PLF G S++DQL +I V+G P
Sbjct: 177 VTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
E + F I+ V I E GK L+ + L ++P +R +A L
Sbjct: 236 EEDWPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
Query: 307 SCAYFADLTQLKQ 319
S YF DL + K+
Sbjct: 292 SHPYFQDLERCKE 304
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 74/257 (28%), Positives = 124/257 (48%), Gaps = 8/257 (3%)
Query: 63 DNISEKRAKEILYQVKAANETAAH---YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFL 119
D + R +I+ ++ N Y G +L LV V
Sbjct: 56 DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSR 114
Query: 120 PQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVVVGDLGSLQFIK 177
+Q+ + + +YQ+ L ++HS+ + HRDIKP+N+L+ D ++ + D GS + +
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 178 SKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDR 237
+ YI +R+YR+PE + Y+ +D+W+AGCV E L P+FPGDS +DQL
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 238 IHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
I +VLGTP E +++ + Q K +P V P+ + L S +L+Y P
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT--KVFRPRTPPEAIALCSRLLEYTPT 292
Query: 298 RRPTAQKILSCAYFADL 314
R T + + ++F +L
Sbjct: 293 ARLTPLEACAHSFFDEL 309
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-38
Identities = 74/188 (39%), Positives = 110/188 (58%), Gaps = 4/188 (2%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIAT 188
L+Q++ GL HS++V HRD+KP+N+LI + + + D G + F +T + T
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
WYR+PE LL YYS +DIW+ GC+F E +TR LFPGDSEIDQL RI + LGTP
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308
++ F ++ +VP + E G+ L+S+ML YDP +R +A+ L+
Sbjct: 226 VWPGVTSMP--DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 309 AYFADLTQ 316
+F D+T+
Sbjct: 284 PFFQDVTK 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-37
Identities = 66/188 (35%), Positives = 96/188 (51%), Gaps = 1/188 (0%)
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKSKGLHTEYI 186
H F++YQI+ GL ++HS + HRD+KP N+ + D + L +
Sbjct: 121 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
TRWYR+PE +L +Y+ +DIW+ GC+ E LT LFPG IDQL I +++GTP
Sbjct: 181 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
AE LKK + N+ Q P + + L+ +ML D +R TA + L
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 307 SCAYFADL 314
+ AYFA
Sbjct: 300 AHAYFAQY 307
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-36
Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 5/203 (2%)
Query: 117 TFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQF 175
L Q H + LYQI+ GL ++HS V HRD+KP N+L+ + + D G +
Sbjct: 99 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158
Query: 176 IKS----KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSE 231
G TEY+ATRWYR+PE +L Y+ +DIW+ GC+ E L+ P+FPG
Sbjct: 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218
Query: 232 IDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEM 291
+DQL+ I +LG+P E L K+ N+ + L P K L+ +M
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278
Query: 292 LKYDPKRRPTAQKILSCAYFADL 314
L ++P +R ++ L+ Y
Sbjct: 279 LTFNPHKRIEVEQALAHPYLEQY 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-36
Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG-----L 181
V+ ++NGL+++H K+ HRD+K N+LI D V+ + D G +
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 182 HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
+T + T WYR PE LL E Y +D+W AGC+ E TR+P+ G++E QL I Q+
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI-HEKGKKLMSEMLKYDPKRRP 300
G+ E + Y+ K D L + L+ ++L DP +R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 301 TAQKILSCAYF 311
+ L+ +F
Sbjct: 298 DSDDALNHDFF 308
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-36
Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEY 185
L+Q++ GL HS V HRD+KP+N+LI + + + + G + F ++
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGT 244
+ T WYR P+ L YS +D+W+AGC+F E PLFPG+ DQL RI ++LGT
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
P E K + + +VP+++ G+ L+ +LK +P +R +A++
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYP--ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 305 ILSCAYFADL 314
L YF+D
Sbjct: 280 ALQHPYFSDF 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (331), Expect = 9e-36
Identities = 68/183 (37%), Positives = 103/183 (56%), Gaps = 4/183 (2%)
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRW 190
L Q++NG+ + H +V HRD+KP+N+LI + + + D G + F +T I T W
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
Query: 191 YRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETL 250
YR+P+ L+ YS +DIW+ GC+F E + PLFPG SE DQL RI ++LGTP ++
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
+ + F Y + + + E G L+S+MLK DP +R TA++ L AY
Sbjct: 226 PNVTELP--KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 311 FAD 313
F +
Sbjct: 284 FKE 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 2e-34
Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI--RGDLVVVGDLGSLQFIKSKGLHTE 184
Y F +Y+I+ L + HS + HRD+KP N++I + + D G +F +
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 185 YIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLG 243
+A+R+++ PE L+ Y + LD+W+ GC+ + + P F G DQL RI +VLG
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 244 TPKAET------LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPK 297
T ++ ++ + K++ + + + ++L+YD +
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 298 RRPTAQKILSCAYFADLTQ 316
R TA++ + YF + +
Sbjct: 309 SRLTAREAMEHPYFYTVVK 327
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 39.4 bits (91), Expect = 6e-04
Identities = 21/134 (15%), Positives = 50/134 (37%), Gaps = 4/134 (2%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKE 72
+EI IL + N++ L + + +R LVF + + ++ +T +++ +
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRF 133
Query: 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFV 132
+Y++ A + + P +++ + R L + GL F +
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 193
Query: 133 LYQIVNGLHHLHSY 146
++ L Y
Sbjct: 194 YFKGPELLVDYQMY 207
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-34
Identities = 59/188 (31%), Positives = 99/188 (52%), Gaps = 3/188 (1%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLV-VVGDLGSLQFIKSKGLHTEYI 186
F++YQ++ GL ++H+ + HRD+KP N+ + D + D G + S+ T Y+
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 179
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
TRWYR+PE +L Y+ +DIW+ GC+ E +T LF G +DQL I +V GTP
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
AE +++ + ++ N+ + ++ L+ +ML D ++R TA + L
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
Query: 307 SCAYFADL 314
+ YF L
Sbjct: 300 AHPYFESL 307
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 121 bits (304), Expect = 5e-32
Identities = 52/260 (20%), Positives = 97/260 (37%), Gaps = 45/260 (17%)
Query: 68 KRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLY 127
+ +IL +V FL+ K L + T +++++
Sbjct: 57 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK-- 114
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYI 186
++ ++ + LH + HRD+KPENIL+ D+ + + D G + E
Sbjct: 115 ----IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 187 ATRWYRSPECLLTE-----GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241
T Y +PE + Y E+D+W+ G + Y L +P F ++ L I
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--- 227
Query: 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT 301
S N+ + ++ + K L+S L P++R T
Sbjct: 228 ---------------MSGNYQFGSPEW---------DDYSDTVKDLVSRFLVVQPQKRYT 263
Query: 302 AQKILSCAYFADLTQLKQYL 321
A++ L+ +F +QY+
Sbjct: 264 AEEALAHPFF------QQYV 277
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 6e-32
Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 34/182 (18%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATR 189
+ ++ N L + HS +V HRDIKPEN+L+ + + D G S T T
Sbjct: 110 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTL 168
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAET 249
Y PE + + ++D+W+ G + YE L P F ++ + RI +V T
Sbjct: 169 DYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--- 224
Query: 250 LKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA 309
+ E + L+S +LK++P +RP +++L
Sbjct: 225 ----------------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256
Query: 310 YF 311
+
Sbjct: 257 WI 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-31
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 19/199 (9%)
Query: 131 FVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIAT 188
V ++ GL +L +K+ HRD+KP NIL+ + + D G + ++ ++ T
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGT 166
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTPKA 247
R Y SPE L Y S + DIW+ G E R P+ P D++ +L QV G A
Sbjct: 167 RSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA-A 224
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQI-------------HEKGKKLMSEMLKY 294
ET + +Y P I L+ I + + +++ L
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 295 DPKRRPTAQKILSCAYFAD 313
+P R ++++ A+
Sbjct: 285 NPAERADLKQLMVHAFIKR 303
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (302), Expect = 5e-31
Identities = 38/204 (18%), Positives = 68/204 (33%), Gaps = 33/204 (16%)
Query: 115 LTTFLPQQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL---VVVGD 169
L + + ++ + Q+ GL H+H H D+KPENI+ + + D
Sbjct: 110 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 169
Query: 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229
G + K T + +PE + + D+W+ G + Y L+ F G+
Sbjct: 170 FGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGE 228
Query: 230 SEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMS 289
++ + L + D I E GK +
Sbjct: 229 NDDETLRNVKSCDWNMD---------------------------DSAFSGISEDGKDFIR 261
Query: 290 EMLKYDPKRRPTAQKILSCAYFAD 313
++L DP R T + L +
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTP 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-30
Identities = 40/199 (20%), Positives = 79/199 (39%), Gaps = 31/199 (15%)
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG-S 172
LT + + V + + L LHS +V HRDIK +NIL+ D V + D G
Sbjct: 104 LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 173 LQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI 232
Q + + + T ++ +PE + + Y ++DIW+ G + E + P + ++ +
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 233 DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEML 292
L I N T + + ++ + ++ L
Sbjct: 223 RALYLIAT-------------------NGTPELQNPE---------KLSAIFRDFLNRCL 254
Query: 293 KYDPKRRPTAQKILSCAYF 311
D ++R +A+++L +
Sbjct: 255 DMDVEKRGSAKELLQHQFL 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (294), Expect = 6e-30
Identities = 53/290 (18%), Positives = 94/290 (32%), Gaps = 39/290 (13%)
Query: 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY 146
+ D L+L F L I + + Y + Q GL H+H +
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACEGLKHMHEH 146
Query: 147 KVFHRDIKPENILIRGDL---VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYY 203
+ H DIKPENI+ V + D G + + AT + +PE + E
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE-PV 205
Query: 204 SFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTY 263
F D+WA G + Y L+ F G+ +++ L + + +
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED--------------- 250
Query: 264 QFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF-ADLTQLKQYLE 322
+ + K + +L+ +P++R T L + D + L +
Sbjct: 251 ------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 298
Query: 323 QKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKS--SHQMDMSKFIQSDLN 370
+ K K +AN S H+ + S +
Sbjct: 299 SSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFD 348
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-30
Identities = 36/188 (19%), Positives = 66/188 (35%), Gaps = 32/188 (17%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIK---SKGLHT 183
+Q++ G+ +LH + HRDIKPEN+L+ + + D G + + L
Sbjct: 104 DAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243
+ T Y +PE L +++ +D+W+ G V L + S+ Q +
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 223
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
T +I L+ ++L +P R T
Sbjct: 224 TYLNPW----------------------------KKIDSAPLALLHKILVENPSARITIP 255
Query: 304 KILSCAYF 311
I ++
Sbjct: 256 DIKKDRWY 263
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLV-VVGDLGSLQFIKSKGLHTEYI 186
+++LYQ++ G+ HLHS + HRD+KP NI+++ D + D G + + + T Y+
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 179
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
TR+YR+PE +L G Y +DIW+ GC+ E + LFPG IDQ +++ + LGTP
Sbjct: 180 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 247 AETLKK-----------FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYD 295
E +KK KY F F + + L+S+ML D
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 296 PKRRPTAQKILSCAYFADL 314
P +R + L Y
Sbjct: 299 PAKRISVDDALQHPYINVW 317
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-29
Identities = 39/231 (16%), Positives = 83/231 (35%), Gaps = 39/231 (16%)
Query: 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY 146
+ ++L+ F + +++ L L + ++ Q ++ L++LH
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV-----CKQTLDALNYLHDN 129
Query: 147 KVFHRDIKPENILIRGDLVV-VGDLG-SLQFIKSKGLHTEYIATRWYRSPECLLTE---- 200
K+ HRD+K NIL D + + D G S + ++ +I T ++ +PE ++ E
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 201 GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSN 260
Y ++ D+W+ G E P + + L +I +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--------------------AK 229
Query: 261 FTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311
P + K + + L+ + R T ++L +
Sbjct: 230 SEPPTLAQP--------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-29
Identities = 43/259 (16%), Positives = 88/259 (33%), Gaps = 41/259 (15%)
Query: 115 LTTFLPQQSKRL--YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD---LVVVGD 169
+ + + L ++Q+ L LHS+ + H DI+PENI+ + + + +
Sbjct: 88 IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE 147
Query: 170 LGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGD 229
G + +K Y +PE S D+W+ G + Y L+ F +
Sbjct: 148 FGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAE 206
Query: 230 SEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMS 289
+ ++ I T E +I + +
Sbjct: 207 TNQQIIENIMNAEYTFDEEAF---------------------------KEISIEAMDFVD 239
Query: 290 EMLKYDPKRRPTAQKILSCAYFAD-----LTQLKQYLEQKQVMKKLAKKNYMAGGMQKTS 344
+L + K R TA + L + T++ + L+ ++ L KK+ M ++
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLN---MVVSA 296
Query: 345 HPTHLLANTKSSHQMDMSK 363
+S + ++K
Sbjct: 297 ARISCGGAIRSQKGVSVAK 315
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-28
Identities = 52/246 (21%), Positives = 87/246 (35%), Gaps = 45/246 (18%)
Query: 93 LKLPFLLLVFGKSRNLGTLIV-------GLTTFLPQQSKRL--YHTTFVLYQIVNGLHHL 143
+ +LL G S IV L L + + Q G+ +L
Sbjct: 61 TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 144 HSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKS---KGLHTEYIATRWYRSPECLLT 199
H+ + HRD+K NI + DL V +GD G + + + +PE +
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 200 E--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYK 257
+ YSF+ D++A G V YE +T + + DQ+ +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------------- 223
Query: 258 SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQL 317
+ Y + + + K+LM+E LK RP +IL A + L
Sbjct: 224 --------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL-----ASIELL 270
Query: 318 KQYLEQ 323
+ L +
Sbjct: 271 ARSLPK 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 3e-28
Identities = 49/256 (19%), Positives = 99/256 (38%), Gaps = 41/256 (16%)
Query: 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY 146
+ +L++ L IV + + + RL ++Q+++ + +LH
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL------IFQVLDAVKYLHDL 126
Query: 147 KVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGY 202
+ HRD+KPEN+L +++ D G + + + T Y +PE L + Y
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186
Query: 203 YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFT 262
S +D W+ G + Y L P F +++ ++I + +
Sbjct: 187 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------------- 231
Query: 263 YQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQYLE 322
I + K + +++ DP++R T ++ L + A T L + +
Sbjct: 232 -------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278
Query: 323 Q---KQVMKKLAKKNY 335
Q +Q+ K AK +
Sbjct: 279 QSVSEQIKKNFAKSKW 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 47/244 (19%), Positives = 93/244 (38%), Gaps = 32/244 (13%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILI----RGDLVVVGDLGSLQFIKSKGLHTEYI 186
++ I + +LHS + HRD+KPEN+L ++ + D G + S T
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T +Y +PE +L Y D+W+ G + Y L P F + + +
Sbjct: 175 YTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------- 225
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+ + + + ++ ++ E+ K L+ +LK +P +R T + +
Sbjct: 226 ------KTRIRMGQYEFPNPEW---------SEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
Query: 307 SCAYFADLTQLKQYLEQKQVMKKLAKKNYMAGGMQKTSHPTHLLANTKSSHQMDMSKFIQ 366
+ + T++ Q + K K+ + T LA + ++ K I+
Sbjct: 271 NHPWIMQSTKVPQTPLHTSRVLKEDKERW----EDVKEEMTSALATMRVDYEQIKIKKIE 326
Query: 367 SDLN 370
N
Sbjct: 327 DASN 330
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (88), Expect = 0.001
Identities = 17/94 (18%), Positives = 38/94 (40%), Gaps = 8/94 (8%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL----NLEEYIRTTDN--ISE 67
+E+ + + +++ + + Y N + L+ +ME L I+ + +E
Sbjct: 52 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTE 110
Query: 68 KRAKEILYQVKAANETA-AHYRVGWDLKLPFLLL 100
+ A EI+ + A + + D+K LL
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 144
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (270), Expect = 5e-27
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 39/212 (18%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATR 189
V + + GL +LHS+ + HRD+K NIL+ +V +GD GS + ++ T
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTP 175
Query: 190 WYRSPECLLT--EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247
++ +PE +L EG Y ++D+W+ G E R P + + L I Q
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------- 228
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
+ E + + L+ P+ RPT++ +L
Sbjct: 229 ----------------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
Query: 308 CAYFA---DLTQLKQYLEQ-KQVMKKLAKKNY 335
+ T + +++ K +++L Y
Sbjct: 267 HRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 9e-27
Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 40/186 (21%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVVVGDLGSLQFIKSKGLHTEYIAT 188
+Q++ + H H+ V HRDIK ENILI + + + D GS +K +T++ T
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGT 172
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
R Y PE + Y+ +W+ G + Y+ + + F D EI + +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-------- 224
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308
++ + + L+ L P RPT ++I +
Sbjct: 225 -----------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255
Query: 309 AYFADL 314
+ D+
Sbjct: 256 PWMQDV 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 9e-27
Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 38/183 (20%)
Query: 131 FVLYQIVNGLHHLH-----SYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG-LHT 183
V+ Q+ L H + V HRD+KP N+ + G V +GD G + +
Sbjct: 113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 172
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243
++ T +Y SPE + Y + + DIW+ GC+ YE P F S+ + +I +
Sbjct: 173 AFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--- 228
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
G + + ++ ++++ ML RP+ +
Sbjct: 229 ---------------------------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVE 261
Query: 304 KIL 306
+IL
Sbjct: 262 EIL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.9 bits (85), Expect = 0.003
Identities = 23/125 (18%), Positives = 47/125 (37%), Gaps = 21/125 (16%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYI----RTTDNISEK 68
+ E+++LR++ H N++ + ++R+ + +V E +L I + + E+
Sbjct: 51 VSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 109
Query: 69 RAKEILYQVKAA------NETAAHYRVGWDLKLPFLLLV---------FGKSRNLGTLIV 113
++ Q+ A H + DLK + L FG +R L
Sbjct: 110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 169
Query: 114 GLTTF 118
F
Sbjct: 170 FAKAF 174
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 48/238 (20%)
Query: 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY 146
Y D + + L + K+ L I + +F ++ F +IV+ L +LH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR------FYTAEIVSALEYLHGK 127
Query: 147 KVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGY 202
+ HRD+KPENIL+ D+ + + D G+ + + + ++ T Y SPE LLTE
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 186
Query: 203 YSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFT 262
D+WA GC+ Y+ + P F +E +I ++
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---------------- 230
Query: 263 YQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCA------YFADL 314
+ K + L+ ++L D +R +++ +F +
Sbjct: 231 ---------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-25
Identities = 40/185 (21%), Positives = 67/185 (36%), Gaps = 35/185 (18%)
Query: 131 FVLYQIVNGLHHLHS--YKVFHRDIKPENILIRGDL--VVVGDLGSLQFIKSKGLHTEYI 186
QI+ GL LH+ + HRD+K +NI I G V +GDLG ++ I
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VI 174
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T + +PE E Y +D++A G E T + Q+ R P
Sbjct: 175 GTPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP- 231
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
F+K K+++ ++ + R + + +L
Sbjct: 232 ----ASFDKVAIPEV-----------------------KEIIEGCIRQNKDERYSIKDLL 264
Query: 307 SCAYF 311
+ A+F
Sbjct: 265 NHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 3e-24
Identities = 43/191 (22%), Positives = 71/191 (37%), Gaps = 33/191 (17%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-----LVVVGDLGSLQFIKSKGLH 182
T L QI+NG+++LHS ++ H D+KPENI++ + + D G I
Sbjct: 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 183 TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVL 242
T + +PE ++ E D+W+ G + Y L+ F GD++ + L + V
Sbjct: 174 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
+ E K + +L DPK+R T
Sbjct: 233 YEFEDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTI 265
Query: 303 QKILSCAYFAD 313
Q L +
Sbjct: 266 QDSLQHPWIKP 276
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (251), Expect = 3e-24
Identities = 45/224 (20%), Positives = 88/224 (39%), Gaps = 24/224 (10%)
Query: 120 PQQSKRLYHTTFVLYQIVNGLHHLH-SYKVFHRDIKPENILIR--GDLVVVGDLGSLQFI 176
+ L + + Q++ GL ++H + H DIKPEN+L+ + +
Sbjct: 118 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 177
Query: 177 KSKGLHTEYIAT---RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS--- 230
+ Y + R YRSPE LL + DIW+ C+ +E +T + LF D
Sbjct: 178 NACWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHS 236
Query: 231 ---EIDQLDRIHQVLGTPKAETLKKFEK-----------YKSSNFTYQFKQYPGGGIDVL 276
+ D + +I ++LG + L+ + S + +
Sbjct: 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 296
Query: 277 VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQY 320
++ +S ML+ DP++R A +++ + D +++
Sbjct: 297 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 340
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.2 bits (244), Expect = 1e-23
Identities = 37/181 (20%), Positives = 70/181 (38%), Gaps = 35/181 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH--TEYIA 187
+ QI +G+ ++ HRD++ NIL+ +LV V D G + I+
Sbjct: 117 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSEIDQLDRIHQVLGTPK 246
+ +PE L G ++ + D+W+ G + E T+ +PG + LD++ + P
Sbjct: 177 PIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP- 234
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
P+ E LM + + +P+ RPT + +
Sbjct: 235 -----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265
Query: 307 S 307
+
Sbjct: 266 A 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 2e-23
Identities = 49/277 (17%), Positives = 100/277 (36%), Gaps = 49/277 (17%)
Query: 59 IRTTDNISEKRAKEILYQVKAANETAAH------YRVGWDLKLPFLLLVFGKSRNLGTLI 112
++ + + + + + + + H + + F ++ + +L I
Sbjct: 35 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 94
Query: 113 VGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
F ++ F +I+ GL LHS + +RD+K +NIL+ D + + D G
Sbjct: 95 QSCHKFDLSRAT------FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 148
Query: 172 -SLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS 230
+ + + T Y +PE LL + Y + +D W+ G + YE L F G
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQD 207
Query: 231 EIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSE 290
E + I YP + ++ K L+ +
Sbjct: 208 EEELFHSIRM-----------------------DNPFYP--------RWLEKEAKDLLVK 236
Query: 291 MLKYDPKRRPTA-QKILSCAYFADLTQLKQYLEQKQV 326
+ +P++R I F ++ + LE+K++
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFREINWEE--LERKEI 271
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 47/300 (15%), Positives = 92/300 (30%), Gaps = 74/300 (24%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKE 72
+ E+ ++ ++ H N++ L + L+F +L Y+R+ + E
Sbjct: 88 MSELKMMTQLGSHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFV 132
Q + E + L + +
Sbjct: 146 YENQKRLEEEEDLNV-------------------------------LTFEDLLCF----- 169
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKG---LHTEYIAT 188
YQ+ G+ L HRD+ N+L+ VV + D G + I S +
Sbjct: 170 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPKA 247
+ +PE L G Y+ + D+W+ G + +E + +PG ++ Q
Sbjct: 230 VKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ------- 281
Query: 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
G E+ +M +D ++RP+ + S
Sbjct: 282 ----------------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.3 bits (239), Expect = 9e-23
Identities = 37/194 (19%), Positives = 72/194 (37%), Gaps = 40/194 (20%)
Query: 127 YHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEY 185
F ++ L +LHS + +RD+KPENIL+ + + + D G +++
Sbjct: 104 PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTL 161
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245
T Y +PE + T+ Y+ +D W+ G + YE L F + + ++I
Sbjct: 162 CGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----- 215
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR-----P 300
P +E K L+S ++ D +R
Sbjct: 216 --------------------------AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQN 249
Query: 301 TAQKILSCAYFADL 314
+ + + +F ++
Sbjct: 250 GTEDVKNHPWFKEV 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 5e-22
Identities = 47/268 (17%), Positives = 89/268 (33%), Gaps = 44/268 (16%)
Query: 68 KRAKEILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLY 127
+ +++L ++ + + L+L + L T + F
Sbjct: 76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH------ 129
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFI---KSKGLHT 183
+ +IV L HLH + +RDIK ENIL+ + V + D G + +++ +
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243
+ + + +D W+ G + YE LT F D E + I + +
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP--- 300
+ ++ K L+ +L DPK+R
Sbjct: 250 KSEPP---------------------------YPQEMSALAKDLIQRLLMKDPKKRLGCG 282
Query: 301 --TAQKILSCAYFADLTQLKQYLEQKQV 326
A +I +F + L K+V
Sbjct: 283 PRDADEIKEHLFFQKINWDD--LAAKKV 308
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 6e-22
Identities = 28/179 (15%), Positives = 54/179 (30%), Gaps = 35/179 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATR 189
+ + +L HRD+ N+L+ D V V D G + S
Sbjct: 107 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPV 164
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPKAE 248
+ +PE L + + S + D+W+ G + +E + +P D + R+ +
Sbjct: 165 KWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------- 215
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
G ++M D RP+ ++
Sbjct: 216 ----------------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 8e-22
Identities = 51/224 (22%), Positives = 80/224 (35%), Gaps = 33/224 (14%)
Query: 115 LTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSY--------KVFHRDIKPENILIRGDLVV 166
L +L + + + + +GL HLH + HRD+K +NIL++ +
Sbjct: 88 LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147
Query: 167 -VGDLGSLQFIKSKGLH-----TEYIATRWYRSPECLLTE-----GYYSFELDIWAAGCV 215
+ DLG S + T+ Y +PE L DI+A G V
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207
Query: 216 FYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDV 275
F+E R + G E QL V P E ++K + + + V
Sbjct: 208 FWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 266
Query: 276 LVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQLKQ 319
+ K+M E + R TA +I L+QL Q
Sbjct: 267 M--------AKIMRECWYANGAARLTALRIKK-----TLSQLSQ 297
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.4 bits (234), Expect = 8e-22
Identities = 42/193 (21%), Positives = 70/193 (36%), Gaps = 35/193 (18%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI-RGDLVVVGDLGSLQFIKSKGLHTEYI 186
F +I+ GL H+H+ V +RD+KP NIL+ V + DLG K H +
Sbjct: 108 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SV 166
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T Y +PE L Y D ++ GC+ ++ L + F D+
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------------ 214
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT----- 301
++ + L + + L+ +L+ D RR
Sbjct: 215 ----------------HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 258
Query: 302 AQKILSCAYFADL 314
AQ++ +F L
Sbjct: 259 AQEVKESPFFRSL 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 30/195 (15%), Positives = 59/195 (30%), Gaps = 36/195 (18%)
Query: 126 LYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR----GDLVVVGDLGSLQFIKSKGL 181
L + Q+++ + ++HS HRD+KP+N L+ G+LV + D G + +
Sbjct: 102 LKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161
Query: 182 H--------TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233
H T Y S L S D+ + G V + + G
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLK 293
+ + + ++ I+VL + ++
Sbjct: 221 KRQKYER-----------------------ISEKKMSTPIEVLCKGYPSEFATYLNFCRS 257
Query: 294 YDPKRRPTAQKILSC 308
+P +
Sbjct: 258 LRFDDKPDYSYLRQL 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.8 bits (227), Expect = 2e-21
Identities = 46/299 (15%), Positives = 87/299 (29%), Gaps = 73/299 (24%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKE 72
+E +++ + + V L V + + L+F M +L E++R+ +
Sbjct: 64 QREAALMAEFDNPNIVKLL---GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFV 132
+A + + +L +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQL-----------------------------------CI 145
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEY--IATR 189
Q+ G+ +L K HRD+ N L+ ++VV + D G + I S + A
Sbjct: 146 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 205
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSEIDQLDRIHQVLGTPKAE 248
P + Y+ E D+WA G V +E + + G + + + +
Sbjct: 206 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-------- 257
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307
G I + LM P RP+ I
Sbjct: 258 ----------------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 91.0 bits (225), Expect = 3e-21
Identities = 44/218 (20%), Positives = 75/218 (34%), Gaps = 39/218 (17%)
Query: 94 KLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDI 153
LP++++ + L ++ P+++ V+ L+ H + HRD+
Sbjct: 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALNFSHQNGIIHRDV 137
Query: 154 KPENILIRGDLVV-VGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELD 208
KP NI+I V V D G + I G I T Y SPE + D
Sbjct: 138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSD 196
Query: 209 IWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQY 268
+++ GCV YE LT P F GDS + + + P +
Sbjct: 197 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-------------------- 236
Query: 269 PGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+ ++ + L +P+ R +
Sbjct: 237 -------RHEGLSADLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 6e-21
Identities = 46/315 (14%), Positives = 95/315 (30%), Gaps = 87/315 (27%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKE 72
E+ +L K+ H N++ L +R + L NL +++R + + A
Sbjct: 58 AGELEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFV 132
I + + L
Sbjct: 116 IANSTAS--------TLSSQQLL-----------------------------------HF 132
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATRWY 191
+ G+ +L + HRD+ NIL+ + V + D G + + T +
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192
Query: 192 RSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPKAETL 250
+ E L Y+ D+W+ G + +E ++ + G + + +++ Q
Sbjct: 193 MAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---------- 241
Query: 251 KKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAY 310
G ++ LM + + P RP+ +IL
Sbjct: 242 --------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV--- 278
Query: 311 FADLTQLKQYLEQKQ 325
L + LE+++
Sbjct: 279 -----SLNRMLEERK 288
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 9e-21
Identities = 40/193 (20%), Positives = 69/193 (35%), Gaps = 37/193 (19%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYI 186
F +IV+ L +LHS V +RDIK EN+++ D + + D G + S G +
Sbjct: 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
+L + Y +D W G V YE + F + I
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-------- 217
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----T 301
+F + + K L++ +LK DPK+R
Sbjct: 218 ------------LMEEIRFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 302 AQKILSCAYFADL 314
A++++ +F +
Sbjct: 255 AKEVMEHRFFLSI 267
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.0 bits (225), Expect = 1e-20
Identities = 45/192 (23%), Positives = 67/192 (34%), Gaps = 40/192 (20%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDLGSLQFIKS-KGLHTEYI 186
H F QIV +LHS + +RD+KPEN+LI + + F K KG
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI--QVTDFGFAKRVKGRTWTLC 199
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
T +PE +L++G Y+ +D WA G + YE P F D I ++I
Sbjct: 200 GTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRR-----PT 301
K L+ +L+ D +R
Sbjct: 259 -------------------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287
Query: 302 AQKILSCAYFAD 313
I + +FA
Sbjct: 288 VNDIKNHKWFAT 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 89.5 bits (221), Expect = 1e-20
Identities = 33/206 (16%), Positives = 58/206 (28%), Gaps = 40/206 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDL------VVVGDLGSLQFIKSKGLH-- 182
Q++ + +H + +RDIKP+N LI + V D G ++F +
Sbjct: 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 183 ------TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLD 236
T Y S L S D+ A G VF L + + G
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223
Query: 237 RIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDP 296
+ ++ ++ L++ F K M
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEF-----------------------YKYMHYARNLAF 260
Query: 297 KRRPTAQKILSCAYFADLTQLKQYLE 322
P + F+ + + E
Sbjct: 261 DATPDYDYLQGL--FSKVLERLNTTE 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 3e-20
Identities = 31/182 (17%), Positives = 57/182 (31%), Gaps = 34/182 (18%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH---TEYI 186
Q+ G+ +L S + HRD+ N+L+ +V +GD G ++ + H E+
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSEIDQLDRIHQVLGTP 245
+ L +S D W G +E T + G + L +I +
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----- 229
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
G + +M + + P+ RPT +
Sbjct: 230 ------------------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265
Query: 306 LS 307
Sbjct: 266 RD 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.2 bits (218), Expect = 3e-20
Identities = 34/181 (18%), Positives = 63/181 (34%), Gaps = 35/181 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH--TEYIA 187
+ QI G+ + HRD++ NIL+ L + D G + I+
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPK 246
+ +PE + G ++ + D+W+ G + E +T +PG + + + + +
Sbjct: 173 PIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------ 225
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
G V E+ +LM K P+ RPT +
Sbjct: 226 ------------------------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261
Query: 307 S 307
S
Sbjct: 262 S 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.0 bits (215), Expect = 5e-20
Identities = 31/180 (17%), Positives = 59/180 (32%), Gaps = 35/180 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEY--IA 187
+ + G+ +L V HRD+ N L+ + V+ V D G +F+ +
Sbjct: 105 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 164
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPK 246
+ SPE YS + D+W+ G + +E + + S + ++ I K
Sbjct: 165 PVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
++M+ K P+ RP ++L
Sbjct: 224 PRL------------------------------ASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 6e-20
Identities = 36/199 (18%), Positives = 63/199 (31%), Gaps = 37/199 (18%)
Query: 115 LTTFLPQQSKRLY--HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLG 171
L +L + R + + + +L S + HRD+ N L+ VV V D G
Sbjct: 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 145
Query: 172 SLQFIKSKGLH--TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPG 228
+++ + PE L+ +S + DIWA G + +E + +
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYER 204
Query: 229 DSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLM 288
+ + + I Q L + EK +M
Sbjct: 205 FTNSETAEHIAQGLRLYRPHL------------------------------ASEKVYTIM 234
Query: 289 SEMLKYDPKRRPTAQKILS 307
RPT + +LS
Sbjct: 235 YSCWHEKADERPTFKILLS 253
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.0 bits (212), Expect = 2e-19
Identities = 35/205 (17%), Positives = 67/205 (32%), Gaps = 45/205 (21%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIATR 189
+L I G+ +L HRD+ NIL+ +LV V D G +F++ Y +
Sbjct: 132 GMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 190 WYRSPE-----CLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSEIDQLDRIHQVLG 243
+ P + ++ D+W+ G V +E ++ + + D ++ I Q
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ 303
P +LM + + D RP
Sbjct: 252 LPP------------------------------PMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 304 KILSCAYFADLTQLKQYLEQKQVMK 328
+I++ L + + +K
Sbjct: 282 QIVN--------TLDKMIRNPNSLK 298
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 85.2 bits (210), Expect = 4e-19
Identities = 30/205 (14%), Positives = 65/205 (31%), Gaps = 39/205 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEY-IAT 188
++ QI + + +L HRD+ N L+ + +V V D G + +
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 189 RWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248
+ L +S + D+WA G + +E T ++ Q+
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------- 225
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308
++ EK +LM +++P RP+ +I
Sbjct: 226 ----------------YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ- 268
Query: 309 AYFADLTQLKQYLEQKQVMKKLAKK 333
+ ++ + ++ K+
Sbjct: 269 -------AFETMFQESSISDEVEKE 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 6e-19
Identities = 46/299 (15%), Positives = 91/299 (30%), Gaps = 79/299 (26%)
Query: 14 LKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKE 72
+ E+ +L + +H+N++ L ++ +L ++R KR
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLR------RKRDSF 125
Query: 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFV 132
I + A + + L
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLL-----------------------------------SF 150
Query: 133 LYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH--TEYIATR 189
YQ+ G+ L S HRD+ NIL+ + + D G + IK+ +
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 190 WYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPKAE 248
+ Y+FE D+W+ G +E + + +PG + ++ +
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-------- 262
Query: 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQKIL 306
G +L P+ + +M DP +RPT ++I+
Sbjct: 263 ----------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.6 bits (206), Expect = 1e-18
Identities = 37/229 (16%), Positives = 78/229 (34%), Gaps = 46/229 (20%)
Query: 93 LKLPFLLLVFGKSRNLGTLIV-------GLTTFLPQQSKRL--YHTTFVLYQIVNGLHHL 143
L P+++ + G + ++V L FL + + + + +L+Q+ G+ +L
Sbjct: 66 LDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 144 HSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHTEYIA----TRWYRSPECLL 198
HRD+ N+L+ + D G + + + + + + +PEC+
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 199 TEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPKAETLKKFEKYK 257
+S D+W+ G +E L+ + + + I Q
Sbjct: 186 F-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------------- 227
Query: 258 SSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
G P+ + LMS+ Y + RP +
Sbjct: 228 -------------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (205), Expect = 1e-18
Identities = 41/200 (20%), Positives = 71/200 (35%), Gaps = 43/200 (21%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH--TEYIA 187
YQ+ L +L S + HRDI N+L+ + V +GD G ++++ + ++
Sbjct: 112 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 188 TRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPK 246
+ +PE + + D+W G +E L F G D + RI P
Sbjct: 172 PIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP- 229
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
+ P LM++ YDP RRP ++
Sbjct: 230 -----------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 260
Query: 307 SCAYFADLTQLKQYLEQKQV 326
+ QL LE+++
Sbjct: 261 A--------QLSTILEEEKA 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 2e-18
Identities = 28/203 (13%), Positives = 72/203 (35%), Gaps = 41/203 (20%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH---TEYI 186
QI G+++L ++ HRD+ N+L++ V + D G + + ++
Sbjct: 115 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTP 245
+ + E +L Y+ + D+W+ G +E +T + + G + + + P
Sbjct: 175 VPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
+ P +M + D RP +++
Sbjct: 234 QP------------------------------PICTIDVYMIMVKCWMIDADSRPKFREL 263
Query: 306 LSCAYFADLTQLKQYLEQKQVMK 328
+ + +++ + ++ V++
Sbjct: 264 II-----EFSKMARDPQRYLVIQ 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 4e-18
Identities = 39/182 (21%), Positives = 71/182 (39%), Gaps = 36/182 (19%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH---TEYI 186
+ +I +G+ +L++ K HRD+ N ++ D V +GD G + I + + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVLGTP 245
+ SPE L G ++ D+W+ G V +E T + G S L + +
Sbjct: 197 LPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME----- 250
Query: 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKI 305
GG+ + +LM +Y+PK RP+ +I
Sbjct: 251 -------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285
Query: 306 LS 307
+S
Sbjct: 286 IS 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 1e-17
Identities = 34/183 (18%), Positives = 61/183 (33%), Gaps = 37/183 (20%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLHT----EY 185
+L I G+ +L + HRD+ NIL+ +LV V D G + ++ T
Sbjct: 114 GMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGT 244
+ +PE + + D+W+ G V +E +T + S + + I+
Sbjct: 174 KIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
P +LM + + + RRP
Sbjct: 233 P------------------------------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262
Query: 305 ILS 307
I+S
Sbjct: 263 IVS 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 1e-17
Identities = 32/185 (17%), Positives = 63/185 (34%), Gaps = 35/185 (18%)
Query: 128 HTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV----VGDLGSLQFIKSKGLHT 183
H +Q+ G+ L S K HRD+ NIL+ VV G +
Sbjct: 135 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 184 EYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSEIDQLDRIHQVL 242
+ + +PE + Y+ + D+W+ G + +E + +PG ++ R
Sbjct: 195 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---- 249
Query: 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTA 302
LK+ + + + + M + +P +RPT
Sbjct: 250 -------LKEGTRMR------------------APDYTTPEMYQTMLDCWHGEPSQRPTF 284
Query: 303 QKILS 307
+++
Sbjct: 285 SELVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 1e-17
Identities = 33/180 (18%), Positives = 60/180 (33%), Gaps = 34/180 (18%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----LVVVGDLGSLQFIKSKGLHTEYI 186
YQ+ G+ +L S K HRD+ N+L+ D + G + I T
Sbjct: 139 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 198
Query: 187 ATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246
+ +PE L Y+ + D+W+ G + +E T +++L
Sbjct: 199 LPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL----------- 246
Query: 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306
FK G + +M + P +RPT ++++
Sbjct: 247 ------------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 1e-17
Identities = 35/184 (19%), Positives = 66/184 (35%), Gaps = 40/184 (21%)
Query: 132 VLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH-----TEY 185
Q+ G+ L S K HRD+ N ++ V V D G + + K T
Sbjct: 135 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSEIDQLDRIHQVLGT 244
+ + E L T ++ + D+W+ G + +E +TR P +P + D + Q
Sbjct: 195 KLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---- 249
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQ-IHEKGKKLMSEMLKYDPKRRPTAQ 303
G +L P+ + ++M + + RP+
Sbjct: 250 ---------------------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 282
Query: 304 KILS 307
+++S
Sbjct: 283 ELVS 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.5 bits (198), Expect = 2e-17
Identities = 27/182 (14%), Positives = 60/182 (32%), Gaps = 37/182 (20%)
Query: 131 FVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVV-VGDLGSLQFIKSKGLH----TEY 185
+++Q+ G+ +L HRD+ N+L+ + D G + +++ + T
Sbjct: 111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 186 IATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGT 244
+ +PEC+ +S + D+W+ G + +E + + G + + +
Sbjct: 171 KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---- 225
Query: 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK 304
G + LM+ YD + RP
Sbjct: 226 --------------------------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 259
Query: 305 IL 306
+
Sbjct: 260 VE 261
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 56.3 bits (135), Expect = 7e-10
Identities = 19/110 (17%), Positives = 39/110 (35%), Gaps = 7/110 (6%)
Query: 111 LIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGDL 170
+++ L R+ + VL I+ + + + H D+ N+L+ + + + D
Sbjct: 87 VLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDF 146
Query: 171 GSLQFIKSKGLHTEYIATRWYRSPECLLT--EGYYSFELDIWAAGCVFYE 218
S + E R ++T Y E DI +A +
Sbjct: 147 PQ-----SVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 470 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.66 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.47 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 83.24 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=386.62 Aligned_cols=214 Identities=22% Similarity=0.250 Sum_probs=179.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|++|+ |||||++++++.+ .+.+|+|||||+ |+|.++|.....+++..++.
T Consensus 47 ~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~---------------- 107 (271)
T d1nvra_ 47 PENIKKEICINKMLN-HENVVKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---------------- 107 (271)
T ss_dssp --CHHHHHHHHHTCC-CTTBCCEEEEEEE--TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEeeeecc--CceeEEEEeccCCCcHHHHHhcCCCCCHHHHHH----------------
Confidence 346789999999999 9999999999976 678999999999 59999998877788888888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||
T Consensus 108 -------------------------------------------i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL 144 (271)
T d1nvra_ 108 -------------------------------------------FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKI 144 (271)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEE
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCC---CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 168 GDLGSLQFIKSK---GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 168 ~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|||+|+..... ......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.............
T Consensus 145 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~--- 221 (271)
T d1nvra_ 145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--- 221 (271)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT---
T ss_pred ccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc---
Confidence 999999876532 23456789999999999988775678899999999999999999999776543332222110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
..........+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 222 -------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 222 -------------------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -------------------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -------------------------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 01111123467899999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=380.59 Aligned_cols=209 Identities=25% Similarity=0.405 Sum_probs=183.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.|+ |||||++++++.+ .+.+|+|||||+ |+|.+++.....+++..+..
T Consensus 50 ~~~~~~E~~il~~l~-hpnIv~~~~~~~~--~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~---------------- 110 (263)
T d2j4za1 50 EHQLRREVEIQSHLR-HPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---------------- 110 (263)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhcC-CCCCCeEEEEEEE--CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHH----------------
Confidence 345789999999999 9999999999965 678999999999 69999999888899988888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 111 -------------------------------------------i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 111 -------------------------------------------YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEee
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
+|||++....... ....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 148 ~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------ 219 (263)
T d2j4za1 148 ADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------ 219 (263)
T ss_dssp CCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------
T ss_pred cccceeeecCCCc-ccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------
Confidence 9999998765433 34568999999999998865 899999999999999999999999998877776665431
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...++..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 220 -------------------------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -------------------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 01123467899999999999999999999999999999963
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=385.98 Aligned_cols=239 Identities=30% Similarity=0.569 Sum_probs=198.3
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccC-HHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELN-LEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gs-L~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+++|+++|++++ |||||+++++|.. .+.+|+|||||.|+ +..++.....+++..++.
T Consensus 45 ~~~~~Ei~il~~l~-hpnIv~~~~~~~~--~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~----------------- 104 (299)
T d1ua2a_ 45 RTALREIKLLQELS-HPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA----------------- 104 (299)
T ss_dssp THHHHHHHHHHHCC-CTTBCCEEEEECC--TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHH-----------------
T ss_pred HHHHHHHHHHHhCC-CCCEeEEEeeecc--CCceeehhhhhcchHHhhhhhcccCCCHHHHHH-----------------
Confidence 46789999999999 9999999999965 67799999999964 444444444477777777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
+++||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 105 ------------------------------------------~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~ 142 (299)
T d1ua2a_ 105 ------------------------------------------YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLA 142 (299)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHhhccceecccCCcceEEecCCCccccc
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Q psy9855 169 DLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKA 247 (470)
Q Consensus 169 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~ 247 (470)
|||++....... .....+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|+|..
T Consensus 143 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 143 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222 (299)
T ss_dssp CCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 999998765433 3455689999999999987667899999999999999999999999999999999999999999887
Q ss_pred HHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 248 ETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+.+........ ...+...+........+.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 223 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 223 EQWPDMCSLPD---YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTSSSTTSSTT---CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccchhccch---hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 76644333211 11122223333444556789999999999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=380.29 Aligned_cols=213 Identities=22% Similarity=0.348 Sum_probs=182.7
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|++|+ |||||+++++|.. .+.+|+|||||+ |+|.+++... .+++..++.
T Consensus 61 ~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~---------------- 120 (293)
T d1yhwa1 61 KELIINEILVMRENK-NPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAA---------------- 120 (293)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEeEEEEE--CCEEEEEEEecCCCcHHHHhhcc-CCCHHHHHH----------------
Confidence 346889999999999 9999999999976 668999999999 5999987654 488888777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 121 -------------------------------------------i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl 157 (293)
T d1yhwa1 121 -------------------------------------------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL 157 (293)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEee
Confidence 99999999999999999999999999999877 8999
Q ss_pred EecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||+++..... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+.... .
T Consensus 158 ~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~-- 233 (293)
T d1yhwa1 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-T-- 233 (293)
T ss_dssp CCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-S--
T ss_pred ccchhheeeccccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-C--
Confidence 999999876543 3445678999999999998755 8999999999999999999999999988777766654421 0
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.....++.+++++++||.+||..||.+|||++|+|+||||+..
T Consensus 234 -------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 234 -------------------------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp -------------------------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 0111235689999999999999999999999999999999743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-49 Score=384.59 Aligned_cols=215 Identities=25% Similarity=0.412 Sum_probs=170.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|++|+ |||||+++++|.+ .+.+|+|||||+ |+|.++|...+.+++..+..
T Consensus 51 ~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~---------------- 111 (307)
T d1a06a_ 51 EGSMENEIAVLHKIK-HPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---------------- 111 (307)
T ss_dssp ----CHHHHHHHTCC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHH----------------
Confidence 456789999999999 9999999999865 678999999999 69999999888899988888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC---C-e
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG---D-L 164 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~---~-~ 164 (470)
++.||+.||+|||++|||||||||+|||+.. + .
T Consensus 112 -------------------------------------------~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 112 -------------------------------------------LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC
T ss_pred -------------------------------------------HHHHHHHHHHhhhhceeeeEEecccceeecccCCCce
Confidence 9999999999999999999999999999953 3 7
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+||+|||+++...........+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 149 vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~- 226 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY- 226 (307)
T ss_dssp EEECCC------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC-
T ss_pred EEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-
Confidence 9999999998877666667789999999999998765 89999999999999999999999999887777666654110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.......+.+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 227 --------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 227 --------------------------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --------------------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --------------------------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01112335789999999999999999999999999999999853
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=374.48 Aligned_cols=213 Identities=23% Similarity=0.360 Sum_probs=176.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeec--CCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
+...+.+|+++|++|+ |||||+++++|.. .+...+|+|||||+ |+|.+++.....+++..+..
T Consensus 51 ~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~------------- 116 (270)
T d1t4ha_ 51 ERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS------------- 116 (270)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHH-------------
Confidence 3456889999999999 9999999999864 23567899999999 59999998887788888877
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEeC-
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK--VFHRDIKPENILIRG- 162 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g--IvHrDLKp~NILl~~- 162 (470)
++.||+.||+|||++| |+||||||+|||+++
T Consensus 117 ----------------------------------------------~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~ 150 (270)
T d1t4ha_ 117 ----------------------------------------------WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 150 (270)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC
Confidence 9999999999999998 999999999999974
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+ .+||+|||+++.... ......+||+.|+|||++.+ . |+.++|||||||++|||++|+.||.+......+......
T Consensus 151 ~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~ 227 (270)
T d1t4ha_ 151 TGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227 (270)
T ss_dssp TSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred CCCEEEeecCcceeccC-CccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc
Confidence 4 899999999976443 33456789999999998865 3 899999999999999999999999876554443222110
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
+. ........+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 228 -~~---------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 228 -GV---------------------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -TC---------------------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -CC---------------------------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 00 01112345788999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=378.29 Aligned_cols=214 Identities=23% Similarity=0.449 Sum_probs=170.2
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc----ccccHHHHHHHHHHHHhhh
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT----DNISEKRAKEILYQVKAAN 81 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~----~~l~~~~~~~~~~~~~~~~ 81 (470)
+.+...+.+|+++|++|+ |||||++++++.+...+.+|+|||||+ |+|.+++... ..+++..++.
T Consensus 44 ~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~--------- 113 (269)
T d2java1 44 EAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR--------- 113 (269)
T ss_dssp HHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHH---------
T ss_pred HHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHH---------
Confidence 344566889999999999 999999999998766778999999999 6999998653 3377777777
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCC-----CeecCCCCC
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYK-----VFHRDIKPE 156 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~g-----IvHrDLKp~ 156 (470)
++.||+.||+|||++| |+||||||+
T Consensus 114 --------------------------------------------------i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 114 --------------------------------------------------VMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHHHCC---------CCGG
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 9999999999999976 999999999
Q ss_pred cEEEeCC-eEEEEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy9855 157 NILIRGD-LVVVGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ 234 (470)
Q Consensus 157 NILl~~~-~ikL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~ 234 (470)
|||++.+ .+||+|||+++...... .....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.
T Consensus 144 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~ 222 (269)
T d2java1 144 NVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222 (269)
T ss_dssp GEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH
Confidence 9999987 89999999998776433 345678999999999997755 89999999999999999999999999888777
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccC
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYF 311 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f 311 (470)
...+... ....++..+++++.+||.+||+.||.+|||++|+|+|||+
T Consensus 223 ~~~i~~~------------------------------~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 223 AGKIREG------------------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHT------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHcC------------------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 6666441 1112335688999999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=378.31 Aligned_cols=215 Identities=19% Similarity=0.289 Sum_probs=181.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|++|+ |||||++++++.. .+.+|+|||||+ |+|.+++.... .+++..++.
T Consensus 53 ~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~--------------- 114 (288)
T d2jfla1 53 LEDYMVEIDILASCD-HPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQV--------------- 114 (288)
T ss_dssp GGGTHHHHHHHHHCC-CTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEee--CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHH---------------
Confidence 457889999999999 9999999999975 678999999999 69999987654 488888877
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .+|
T Consensus 115 --------------------------------------------i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~K 150 (288)
T d2jfla1 115 --------------------------------------------VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIK 150 (288)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEE
Confidence 99999999999999999999999999999987 899
Q ss_pred EEecCCcccccCC-CccccccccCcccCchhhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLT----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||+|...... ......+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 151 l~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~ 230 (288)
T d2jfla1 151 LADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230 (288)
T ss_dssp ECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred EEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 9999998765432 22345789999999999853 234899999999999999999999999988877777666541
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
. ......+..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 231 ~----------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 231 E----------------------------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp C----------------------------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred C----------------------------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0 00112235689999999999999999999999999999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=389.10 Aligned_cols=242 Identities=19% Similarity=0.291 Sum_probs=176.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|++|+ |||||+++++|.. .+.+|+|||||+ |+|.+++.+...+++..++.
T Consensus 48 ~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~---------------- 108 (322)
T d1s9ja_ 48 RNQIIRELQVLHECN-SPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---------------- 108 (322)
T ss_dssp HHHHHHHGGGGGGCC-CTTBCCEEEEEEC--SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHH----------------
Confidence 457889999999999 9999999999965 678999999999 59999998887788888887
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEeCC-eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||+ +||+||||||+|||++.+ .+|
T Consensus 109 -------------------------------------------~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vk 145 (322)
T d1s9ja_ 109 -------------------------------------------VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 145 (322)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEE
Confidence 99999999999997 599999999999999877 999
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ-LDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~g~p 245 (470)
|+|||+|....... ..+.+||++|+|||++.+.. |+.++||||+||++|||++|+.||.+.+..+. ...+....|.+
T Consensus 146 l~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 223 (322)
T d1s9ja_ 146 LCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223 (322)
T ss_dssp ECCCCCCHHHHHHT-C---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred EeeCCCccccCCCc-cccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCc
Confidence 99999998765432 34679999999999998865 89999999999999999999999987654322 22222222222
Q ss_pred chHHHHHHhh-hccCcccc---------c-cccCCCCC-cccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 246 KAETLKKFEK-YKSSNFTY---------Q-FKQYPGGG-IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 246 ~~~~~~~~~~-~~~~~~~~---------~-~~~~~~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.......... ........ . ........ .......++.++.+||.+||.+||.+|||++|+|+||||++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 1110000000 00000000 0 00000000 00111246899999999999999999999999999999975
Q ss_pred hh
Q psy9855 314 LT 315 (470)
Q Consensus 314 ~~ 315 (470)
..
T Consensus 304 ~~ 305 (322)
T d1s9ja_ 304 SD 305 (322)
T ss_dssp HH
T ss_pred CC
Confidence 43
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=375.22 Aligned_cols=216 Identities=29% Similarity=0.426 Sum_probs=188.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|++|+ |||||+++++|.+ .+.+|+|||||+ |+|.++|.....+++..++.
T Consensus 57 ~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~---------------- 117 (293)
T d1jksa_ 57 REDIEREVSILKEIQ-HPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATE---------------- 117 (293)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEEcCCCccccchhccccccchhHHHH----------------
Confidence 456789999999999 9999999999965 678999999999 69999998887899888888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-----
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD----- 163 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~----- 163 (470)
++.||+.||+|||++|||||||||+|||++.+
T Consensus 118 -------------------------------------------~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 118 -------------------------------------------FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSC
T ss_pred -------------------------------------------HHHHHHHHHHhhhhcceeecccccceEEEecCCCccc
Confidence 99999999999999999999999999999765
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.+||+|||++............+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 155 ~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233 (293)
T ss_dssp CEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred ceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence 49999999999887766667789999999999998755 89999999999999999999999999988887777654211
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.. .....+.+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 234 ~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 234 EF---------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp CC---------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CC---------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 11 1122346889999999999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=378.12 Aligned_cols=211 Identities=23% Similarity=0.419 Sum_probs=181.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|++|+ ||||++++++|.+ .+.+|+|||||+ |+|.+++...+.+++..++.
T Consensus 53 ~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~----------------- 112 (288)
T d1uu3a_ 53 PYVTRERDVMSRLD-HPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF----------------- 112 (288)
T ss_dssp HHHHHHHHHHHHCC-STTBCCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHHcC-CCCeeEEEEEEEE--CCEEEEEEEccCCCCHHHhhhccCCCCHHHHHH-----------------
Confidence 45789999999999 9999999999865 678999999999 59999999888899988888
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++|||||||||+|||++.+ .++|+
T Consensus 113 ------------------------------------------~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~ 150 (288)
T d1uu3a_ 113 ------------------------------------------YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 150 (288)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHhhccccEEcCcCCccccccCCCceEEec
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCC---CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 169 DLGSLQFIKSK---GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 169 DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|||+|+..... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 151 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---- 225 (288)
T d1uu3a_ 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---- 225 (288)
T ss_dssp CCTTCEECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT----
T ss_pred ccccceecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC----
Confidence 99999876532 2334568999999999998765 899999999999999999999999998887777666431
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHH------HHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQK------ILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~e------lL~hp~f~~~~ 315 (470)
...++..+++++++||.+||+.||.+|||++| +++||||++++
T Consensus 226 ---------------------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 226 ---------------------------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp ---------------------------CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ---------------------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 01123468899999999999999999999987 68999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=376.22 Aligned_cols=242 Identities=36% Similarity=0.666 Sum_probs=202.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+++|+++|++++ |||||+++++|.+ .+.+|+|||||+|++.+++.... .+++..++.
T Consensus 45 ~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~--~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~--------------- 106 (298)
T d1gz8a_ 45 PSTAIREISLLKELN-HPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--------------- 106 (298)
T ss_dssp CHHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCcEEEecccccc--ccceeEEEeecCCchhhhhhhhcccCCCHHHHHH---------------
Confidence 456889999999999 9999999999975 67899999999987777765432 378887777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++|||||||||+|||++.+ .+|
T Consensus 107 --------------------------------------------~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~k 142 (298)
T d1gz8a_ 107 --------------------------------------------YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 142 (298)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred --------------------------------------------HHHHHHHHHHHhhcCCEEccccCchheeecccCcce
Confidence 99999999999999999999999999999887 899
Q ss_pred EEecCCcccccCC-CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSK-GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
|+|||.+...... ......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.+..+....|.+
T Consensus 143 l~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 143 LADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222 (298)
T ss_dssp ECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999999876533 344556899999999998887777899999999999999999999999999999999999999988
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
....+....... .....++...........+.+++++++||.+||+.||.+|||++|+|+||||+++.
T Consensus 223 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 223 DEVVWPGVTSMP--DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CTTTSTTGGGST--TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred chhhcccccccc--ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 877665543321 12222222333334445567899999999999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-48 Score=384.56 Aligned_cols=216 Identities=23% Similarity=0.365 Sum_probs=187.8
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhc-ccccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTT-DNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~-~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+++|.+|+ |||||+++++|.+ .+.+|+|||||+ |+|.+++... ..+++..+..
T Consensus 66 ~~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~-------------- 128 (350)
T d1koaa2 66 DKETVRKEIQTMSVLR-HPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE-------------- 128 (350)
T ss_dssp HHHHHHHHHHHHHHTC-CTTBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHH--------------
T ss_pred hHHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHH--------------
Confidence 3456789999999999 9999999999975 678999999999 6999999654 3488888887
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC---
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--- 163 (470)
|+.||+.||+|||++|||||||||+|||++.+
T Consensus 129 ---------------------------------------------i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~ 163 (350)
T d1koaa2 129 ---------------------------------------------YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 163 (350)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSC
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCC
Confidence 99999999999999999999999999999643
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.+||+|||++............+||+.|||||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 164 ~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 242 (350)
T d1koaa2 164 ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 242 (350)
T ss_dssp CEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eEEEeecchheecccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 79999999999887766667789999999999998865 89999999999999999999999999988888877765321
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+ .....+.+++++++||.+||..||.+|||++|+|+||||++.
T Consensus 243 ~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 243 NM---------------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp CS---------------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred CC---------------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11 112335689999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=375.85 Aligned_cols=210 Identities=24% Similarity=0.368 Sum_probs=179.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+++|++|+ |||||++++++.+ .+.+|+|||||. |+|..++.....+++..+..
T Consensus 60 ~~~~~Ei~il~~l~-HpnIv~~~~~~~~--~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~----------------- 119 (309)
T d1u5ra_ 60 QDIIKEVRFLQKLR-HPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------------- 119 (309)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEEE--TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHHCC-CCCEeeEEEEEEE--CCEEEEEEEecCCCchHHHHHhCCCCCHHHHHH-----------------
Confidence 45789999999999 9999999999975 678999999999 47776776666688888887
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||+
T Consensus 120 ------------------------------------------i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~ 157 (309)
T d1u5ra_ 120 ------------------------------------------VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 157 (309)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEe
Confidence 99999999999999999999999999999987 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
|||++...... ...+||+.|+|||++.+. ..|+.++|||||||++|||++|..||.+.+..+.+..+....
T Consensus 158 DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~---- 230 (309)
T d1u5ra_ 158 DFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---- 230 (309)
T ss_dssp CCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----
T ss_pred ecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----
Confidence 99999865543 456899999999998653 348999999999999999999999999888777776665411
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
........+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 231 -------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 231 -------------------------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp -------------------------CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------------------------CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 0111224578999999999999999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=377.59 Aligned_cols=212 Identities=24% Similarity=0.320 Sum_probs=187.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+++|+.+|+.++ ||||++++++|.+ .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 49 ~~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~---------------- 109 (337)
T d1o6la_ 49 VAHTVTESRVLQNTR-HPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARF---------------- 109 (337)
T ss_dssp HHHHHHHHHHHHSCC-CTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCEEEEEeeecc--ccccccceeccCCCchhhhhhcccCCcHHHHHH----------------
Confidence 356789999999999 9999999999965 678999999999 69999999888899988888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||
T Consensus 110 -------------------------------------------~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl 146 (337)
T d1o6la_ 110 -------------------------------------------YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEE
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||+|+.... .......+||+.|+|||++.+.+ |+.++|||||||++|||++|++||.+.+..+....+...
T Consensus 147 ~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----- 220 (337)
T d1o6la_ 147 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----- 220 (337)
T ss_dssp CCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----
T ss_pred eecccccccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----
Confidence 99999987643 44456689999999999998866 899999999999999999999999999887776665431
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~ 315 (470)
...++..+++++++||.+||++||.+|+ +++|+++||||+++.
T Consensus 221 --------------------------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 221 --------------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred --------------------------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 0112356899999999999999999999 499999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=375.95 Aligned_cols=242 Identities=33% Similarity=0.638 Sum_probs=198.3
Q ss_pred hhhhhHHHHHHhcC---CCCCCeeeeceeeec---CCCCeEEEEeeccccCHHHHHHhcc--cccHHHHHHHHHHHHhhh
Q psy9855 10 EVANLKEISILRKI---PDHLNVLCLCETYVN---RSTRQVTLVFPLMELNLEEYIRTTD--NISEKRAKEILYQVKAAN 81 (470)
Q Consensus 10 ~~~~~rEi~iL~~L---~~HpnIv~l~~~~~~---~~~~~~~lV~E~~~gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~ 81 (470)
...+++|+.+|+.| + ||||++++++|.. .....++++||||++++..+..... .+++..++.
T Consensus 51 ~~~~~~E~~~l~~l~~~~-HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~--------- 120 (305)
T d1blxa_ 51 PLSTIREVAVLRHLETFE-HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--------- 120 (305)
T ss_dssp BCTHHHHHHHHHHHHHTC-CTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHH---------
T ss_pred HHHHHHHHHHHHHHhhcC-CCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHH---------
Confidence 34567898888776 5 9999999999863 2346789999999976555443322 277777766
Q ss_pred ccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEe
Q psy9855 82 ETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIR 161 (470)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~ 161 (470)
++.||+.||+|||++|||||||||+|||++
T Consensus 121 --------------------------------------------------~~~qi~~aL~yLH~~~ivHrDiKp~NILi~ 150 (305)
T d1blxa_ 121 --------------------------------------------------MMFQLLRGLDFLHSHRVVHRDLKPQNILVT 150 (305)
T ss_dssp --------------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhCCEEecCCCccEEEEc
Confidence 999999999999999999999999999998
Q ss_pred CC-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 162 GD-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 162 ~~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
.+ .+||+|||++............+||+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+..+.+..+..
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 151 SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 87 99999999998776666667789999999999998765 89999999999999999999999999999999999999
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChhH
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLTQ 316 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~~ 316 (470)
..|.+....+......... .+..............+++.+.+||.+||++||++|||++|+|+||||+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQ----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGG----GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred hhCCCchhcccccccchhh----hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 9999887765433221111 11122233344455678999999999999999999999999999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-47 Score=382.88 Aligned_cols=216 Identities=23% Similarity=0.382 Sum_probs=188.0
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
+...+.+|+.+|++|+ |||||+++++|.+ .+.+|+|||||+ |+|.+++..... +++..++.
T Consensus 69 ~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~--~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~-------------- 131 (352)
T d1koba_ 69 DKYTVKNEISIMNQLH-HPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN-------------- 131 (352)
T ss_dssp HHHHHHHHHHHHTTCC-STTBCCEEEEEEC--SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCCCcEEEEEEE--CCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHH--------------
Confidence 3456789999999998 9999999999965 678999999999 699998876554 88888888
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC--C-
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG--D- 163 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~--~- 163 (470)
|+.||+.||+|||++|||||||||+|||++. +
T Consensus 132 ---------------------------------------------i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~ 166 (352)
T d1koba_ 132 ---------------------------------------------YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS 166 (352)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCeeecccccccccccccCCC
Confidence 9999999999999999999999999999973 2
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.+||+|||+|............+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 167 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 245 (352)
T d1koba_ 167 SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 245 (352)
T ss_dssp CEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC
T ss_pred eEEEeecccceecCCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 89999999999887776667789999999999998765 89999999999999999999999999988888877765221
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
.+ .....+.+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 246 ~~---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 246 EF---------------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CC---------------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CC---------------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11 112335789999999999999999999999999999999853
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.5e-47 Score=366.29 Aligned_cols=215 Identities=29% Similarity=0.429 Sum_probs=187.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+++|+.+|.+|+.||||++++++|.+ ++.+|+|||||+ |+|.++|...+.+++..++.
T Consensus 54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~----------------- 114 (277)
T d1phka_ 54 EATLKEVDILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK----------------- 114 (277)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEeeccc--CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHH-----------------
Confidence 4578999999999779999999999965 788999999998 69999999888899998888
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 115 ------------------------------------------~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 115 ------------------------------------------IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEc
Confidence 99999999999999999999999999999887 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhcc-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLT-----EGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
|||++..+.........+||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..+....+...--
T Consensus 153 DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 153 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999998877666677899999999999863 23478899999999999999999999999988777766654210
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
. ......+.+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus 233 ~---------------------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 233 Q---------------------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp C---------------------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred C---------------------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 0 011123478999999999999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-46 Score=364.95 Aligned_cols=240 Identities=34% Similarity=0.617 Sum_probs=198.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHH-HhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYI-RTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+.+|++|+ |||||+++++|.. .+..+++||++.+.+...+ .....+++..++.
T Consensus 44 ~~~~~~E~~il~~l~-hpnIv~~~~~~~~--~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~---------------- 104 (286)
T d1ob3a_ 44 PSTTIREISILKELK-HSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS---------------- 104 (286)
T ss_dssp CHHHHHHHHGGGGCC-CTTBCCEEEEEEC--SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCcEEeeeeeccc--CCceeEEEEeehhhhHHHHHhhcCCcchhhhHH----------------
Confidence 457889999999999 9999999999965 6779999999997554444 4455588888888
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 105 -------------------------------------------i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl 141 (286)
T d1ob3a_ 105 -------------------------------------------FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141 (286)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEe
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc-cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGL-HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||.+........ ....+|++.|+|||.+.+...++.++||||+||++|||++|++||.+.+..+++.++....|.+.
T Consensus 142 ~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~ 221 (286)
T d1ob3a_ 142 ADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221 (286)
T ss_dssp CCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence 99999987654332 34557999999999998877789999999999999999999999999999999999999999988
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...+....... .+...+............+.+++.+.|||.+||++||++|||++|+|+||||++
T Consensus 222 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 222 SKNWPNVTELP--KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTTSTTGGGST--TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhccchhhhh--hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 87776554422 222223333344455566788999999999999999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=373.95 Aligned_cols=244 Identities=29% Similarity=0.562 Sum_probs=206.9
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCC----CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRS----TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~----~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~ 84 (470)
....+++|+++|+.|+ |||||+++++|...+ ...+|+|||||+++|..+++. ..+++..++.
T Consensus 60 ~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~------------ 125 (346)
T d1cm8a_ 60 FAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQF------------ 125 (346)
T ss_dssp HHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHH------------
T ss_pred HHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHH------------
Confidence 3457889999999999 999999999997532 346899999998888888764 3588888877
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++||+||||||+|||++.+
T Consensus 126 -----------------------------------------------~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~ 158 (346)
T d1cm8a_ 126 -----------------------------------------------LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC 158 (346)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred -----------------------------------------------HHHHHHHHHHHHHhCCCcccccCcchhhccccc
Confidence 99999999999999999999999999999988
Q ss_pred eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q psy9855 164 LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g 243 (470)
.++|+|||++...... .+..+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+
T Consensus 159 ~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 159 ELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp CEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 8999999999876543 35678999999999998877789999999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.++.+.+..........+...........+....+.+++++.+||.+||..||.+|||++|+|+||||+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 998877665433322223333334444555566678899999999999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-46 Score=369.24 Aligned_cols=210 Identities=22% Similarity=0.361 Sum_probs=184.8
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|+.++ |||||++++++.. .+.+|+|||||+ |+|..++.....+++..++.
T Consensus 49 ~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~----------------- 108 (316)
T d1fota_ 49 EHTNDERLMLSIVT-HPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF----------------- 108 (316)
T ss_dssp HHHHHHHHHHHSCC-BTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHhcc-CcChhheeeeEee--CCeeeeEeeecCCccccccccccccccccHHHH-----------------
Confidence 45789999999999 9999999999965 678999999999 59999998888888887777
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||+
T Consensus 109 ------------------------------------------~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~ 146 (316)
T d1fota_ 109 ------------------------------------------YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKIT 146 (316)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEe
Confidence 99999999999999999999999999999887 99999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||+|+..... ....+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+....+...-
T Consensus 147 DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------ 217 (316)
T d1fota_ 147 DFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------ 217 (316)
T ss_dssp CCSSCEECSSC--BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------
T ss_pred cCccceEeccc--cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC------
Confidence 99999876543 34679999999999998765 8999999999999999999999999988887777765410
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
...++.+++++.++|.+||..||.+|+ |++++++||||+++..
T Consensus 218 -------------------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 218 -------------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp -------------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 112356889999999999999999996 9999999999998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=371.46 Aligned_cols=217 Identities=24% Similarity=0.349 Sum_probs=188.3
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~ 84 (470)
..+...+.+|+++|..++ |||||+++++|.+ .+.+|+|||||+ |+|.++|...+ .+++.+++.
T Consensus 42 ~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~--~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~------------ 106 (321)
T d1tkia_ 42 GTDQVLVKKEISILNIAR-HRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVS------------ 106 (321)
T ss_dssp THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEE--TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHH------------
T ss_pred cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEE--CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHH------------
Confidence 344556789999999999 9999999999965 678999999999 59999998766 488988888
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
|+.||+.||+|||++||+||||||+|||++.+
T Consensus 107 -----------------------------------------------i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~ 139 (321)
T d1tkia_ 107 -----------------------------------------------YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139 (321)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHcCCCcccccccceeecCCC
Confidence 99999999999999999999999999999754
Q ss_pred --eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 --LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 --~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.++|+|||++............+||+.|+|||.+.+.. |+.++||||+||++|+|++|.+||.+.+..+.+..|.+.
T Consensus 140 ~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~ 218 (321)
T d1tkia_ 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218 (321)
T ss_dssp CCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred ceEEEEcccchhhccccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 79999999998877666666778999999999887755 899999999999999999999999999988888877653
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
...++. ...+.+++++++||.+||..||.+|||++|+|+||||++
T Consensus 219 ~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 219 EYTFDE---------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp CCCCCH---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CCCCCh---------------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 221111 122467899999999999999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=371.98 Aligned_cols=241 Identities=30% Similarity=0.558 Sum_probs=198.5
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHH----hcccccHHHHHHHHHHHHhhhcc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIR----TTDNISEKRAKEILYQVKAANET 83 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~----~~~~l~~~~~~~~~~~~~~~~~~ 83 (470)
...+|+++|++|+ ||||++++++|... +..++|+|||||++++...+. ....+++..++.
T Consensus 59 ~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~----------- 126 (350)
T d1q5ka_ 59 FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL----------- 126 (350)
T ss_dssp SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHH-----------
T ss_pred HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHH-----------
Confidence 4569999999999 99999999998642 345689999999976655553 233377777776
Q ss_pred ccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC
Q psy9855 84 AAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD 163 (470)
Q Consensus 84 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~ 163 (470)
|+.||+.||+|||++||+||||||+|||++.+
T Consensus 127 ------------------------------------------------i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~ 158 (350)
T d1q5ka_ 127 ------------------------------------------------YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 158 (350)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHTTTEECCCCCGGGEEECTT
T ss_pred ------------------------------------------------HHHHHHHHHHHHHhcCCcccCCCcceEEEecC
Confidence 99999999999999999999999999999865
Q ss_pred --eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 --LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 --~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.+||+|||++............+||+.|+|||++.+...|+.++||||+||++|||++|.+||.+.+..+++..+.+.
T Consensus 159 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 159 TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp TCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred CCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence 799999999988876666677899999999999887767999999999999999999999999999999999999999
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCC-cccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGG-IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+|.+..+.+........ ...++...... .....+.+++++.+||.+||.+||.+|||+.|+|+||||+++.
T Consensus 239 ~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYT---EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCCCCHHHHHHHCC------CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hCCChHHhhhhhccchh---hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 99999887766543211 11122211111 1223456889999999999999999999999999999998664
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-46 Score=371.26 Aligned_cols=210 Identities=25% Similarity=0.344 Sum_probs=185.0
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+++|+++|+.|+ |||||+++++|.. ...+++||||+. |+|.+++.....+++..++.
T Consensus 86 ~~~~~E~~il~~l~-hpnIv~~~~~~~~--~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~----------------- 145 (350)
T d1rdqe_ 86 EHTLNEKRILQAVN-FPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF----------------- 145 (350)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHH-----------------
T ss_pred HHHHHHHHHHHHcC-CCcEeeccccccc--ccccccccccccccchhhhHhhcCCCCHHHHHH-----------------
Confidence 45789999999999 9999999999865 678999999999 69999998888899888888
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEE
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVG 168 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~ 168 (470)
|+.||+.||.|||++|||||||||+|||++.+ .+||+
T Consensus 146 ------------------------------------------i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~ 183 (350)
T d1rdqe_ 146 ------------------------------------------YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ------------------------------------------HHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEee
Confidence 99999999999999999999999999999877 89999
Q ss_pred ecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Q psy9855 169 DLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAE 248 (470)
Q Consensus 169 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~ 248 (470)
|||+|+..... ....+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+....+..+....
T Consensus 184 DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------ 254 (350)
T d1rdqe_ 184 DFGFAKRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------ 254 (350)
T ss_dssp CCTTCEECSSC--BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------
T ss_pred eceeeeecccc--cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC------
Confidence 99999876533 34578999999999998865 8999999999999999999999999988877777765411
Q ss_pred HHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 249 TLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
...+..+++++.+||.+||..||.+|+ |++++++||||++++.
T Consensus 255 -------------------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 255 -------------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 112346889999999999999999995 9999999999998763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.1e-46 Score=372.53 Aligned_cols=211 Identities=23% Similarity=0.326 Sum_probs=177.1
Q ss_pred HHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccccccCC
Q psy9855 15 KEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRVGWDL 93 (470)
Q Consensus 15 rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (470)
+|+++++.++ |||||+++++|.. .+.+|+|||||+ |+|.++|.....+++..++.
T Consensus 56 ~~~~~l~~~~-hpnIv~l~~~~~~--~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~--------------------- 111 (364)
T d1omwa3 56 IMLSLVSTGD-CPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--------------------- 111 (364)
T ss_dssp HHHHHHSSSC-CTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHH---------------------
T ss_pred HHHHHHhcCC-CCcEEEEEEEEEE--CCEEEEEEEecCCCcHHHHHHhcccccHHHHHH---------------------
Confidence 4477888888 9999999999865 678999999999 69999999888788888877
Q ss_pred CccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEEEecCC
Q psy9855 94 KLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVVGDLGS 172 (470)
Q Consensus 94 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL~DFG~ 172 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+||+|||+
T Consensus 112 --------------------------------------~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 112 --------------------------------------YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp --------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred --------------------------------------HHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeece
Confidence 99999999999999999999999999999887 899999999
Q ss_pred cccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Q psy9855 173 LQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPKAETLKK 252 (470)
Q Consensus 173 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 252 (470)
|+...... ....+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+.+..+.........
T Consensus 154 a~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~---------- 222 (364)
T d1omwa3 154 ACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------- 222 (364)
T ss_dssp CEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS----------
T ss_pred eeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Confidence 98766543 3456899999999999765568999999999999999999999998765433322221111
Q ss_pred HhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcC-----HHHHHhcccCCChhH
Q psy9855 253 FEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPT-----AQKILSCAYFADLTQ 316 (470)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt-----~~elL~hp~f~~~~~ 316 (470)
......+..+++++.+||.+||..||.+||| ++|+++||||+++..
T Consensus 223 ------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 223 ------------------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ------------------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ------------------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 1112233568999999999999999999999 799999999998763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=373.41 Aligned_cols=220 Identities=21% Similarity=0.363 Sum_probs=176.6
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeec--CCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhcccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVN--RSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~--~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
..+.+|+.++.++.+|||||+++++|.+ .....+|+|||||+ |+|.++|...+ .+++..++.
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~------------- 115 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE------------- 115 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHH-------------
Confidence 4567999997765449999999999864 34567999999998 69999998754 388888888
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-- 163 (470)
|+.||+.||+|||++||+||||||+|||++.+
T Consensus 116 ----------------------------------------------i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~ 149 (335)
T d2ozaa1 116 ----------------------------------------------IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 149 (335)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEESCSST
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHcCCccccccccccccccccc
Confidence 99999999999999999999999999999863
Q ss_pred --eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 164 --LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 164 --~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
.+||+|||+++...........+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 150 ~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~ 228 (335)
T d2ozaa1 150 NAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228 (335)
T ss_dssp TCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C
T ss_pred cccccccccceeeeccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH
Confidence 69999999999887766677789999999999987755 899999999999999999999999876654443333221
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
.. ...+. ........+++++.+||.+||+.||++|||+.|+|+||||.+
T Consensus 229 i~--------------~~~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 229 IR--------------MGQYE---------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CC--------------SCSSS---------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred Hh--------------cCCCC---------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 00 00000 001122468899999999999999999999999999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=363.17 Aligned_cols=211 Identities=22% Similarity=0.359 Sum_probs=182.7
Q ss_pred hhhhHHHHHHh-cCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 11 VANLKEISILR-KIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 11 ~~~~rEi~iL~-~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
..+++|+.++. .++ |||||++++++.+ .+.+|+|||||+ |+|.+++.....+++..++.
T Consensus 47 ~~~~~e~~~l~~~~~-hp~Iv~~~~~~~~--~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~---------------- 107 (320)
T d1xjda_ 47 ECTMVEKRVLSLAWE-HPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF---------------- 107 (320)
T ss_dssp HHHHHHHHHHHHHTT-CTTBCCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCcEEEEEEEEcc--CCceeEEEeecCCCcHHHHhhccCCCCHHHHHH----------------
Confidence 35678888776 577 9999999999965 678999999999 69999999888898888887
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++||+||||||+|||++.+ .+||
T Consensus 108 -------------------------------------------~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl 144 (320)
T d1xjda_ 108 -------------------------------------------YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 144 (320)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHHhCCeeeccCcccceeecCCCceec
Confidence 99999999999999999999999999999987 8999
Q ss_pred EecCCcccccC-CCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKS-KGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||+++.... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.+..+....+.. +.
T Consensus 145 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~-- 219 (320)
T d1xjda_ 145 ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DN-- 219 (320)
T ss_dssp CCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CC--
T ss_pred cccchhhhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CC--
Confidence 99999986653 33345578999999999998765 89999999999999999999999999988877766643 11
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHH-HHHhcccCCChh
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQ-KILSCAYFADLT 315 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~-elL~hp~f~~~~ 315 (470)
..++..+++++.+||.+||..||.+|||+. ++++||||+++.
T Consensus 220 ---------------------------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 220 ---------------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp ---------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ---------------------------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 112346889999999999999999999995 899999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=350.86 Aligned_cols=212 Identities=24% Similarity=0.332 Sum_probs=170.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+.+|+++|.+|+ |||||++++++. .+.+++|||||+ |+|.+++..... +++..+..
T Consensus 47 ~~~~~~~E~~~l~~l~-HpnIv~~~~~~~---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~-------------- 108 (276)
T d1uwha_ 47 QLQAFKNEVGVLRKTR-HVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID-------------- 108 (276)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCEEEEEC---SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeeeeEEEe---ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHH--------------
Confidence 3457889999999999 999999999764 346899999999 699999976544 77777777
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+
T Consensus 109 ---------------------------------------------i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~ 143 (276)
T d1uwha_ 109 ---------------------------------------------IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTV 143 (276)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSE
T ss_pred ---------------------------------------------HHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCC---CccccccccCcccCchhhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSK---GLHTEYIATRWYRSPECLLTE--GYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 240 (470)
||+|||+|+..... ......+||+.|+|||++.+. ..|+.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~ 223 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223 (276)
T ss_dssp EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 99999999776532 233456899999999998653 3489999999999999999999999988776665544433
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.... ..........+++++.+||.+||..||.+|||+.|++++
T Consensus 224 ~~~~-------------------------~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 224 RGYL-------------------------SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HTSC-------------------------CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC-------------------------CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1100 111223345688999999999999999999999999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.6e-45 Score=360.26 Aligned_cols=244 Identities=23% Similarity=0.409 Sum_probs=195.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|+.|.+||||++++++|.......+++|||||+ ++|..+. +.+++..++.
T Consensus 73 ~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~---------------- 133 (328)
T d3bqca1 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRF---------------- 133 (328)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHH----------------
Confidence 4567899999999977999999999998766778999999999 5876653 3477777777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LVV 166 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~ik 166 (470)
++.||+.||+|||++|||||||||+|||++.+ .++
T Consensus 134 -------------------------------------------i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vk 170 (328)
T d3bqca1 134 -------------------------------------------YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 170 (328)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred -------------------------------------------HHHHHHHHHHHHhhcccccccccccceEEcCCCCeee
Confidence 99999999999999999999999999999864 699
Q ss_pred EEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCC
Q psy9855 167 VGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPG-DSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~g~p 245 (470)
|+|||++............+||+.|+|||++.+...++.++||||+||++|+|++|+.||.. .+..++...+...+|.+
T Consensus 171 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 171 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp ECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred ecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 99999998887766677789999999999998877789999999999999999999999865 45667777888888876
Q ss_pred chHHHHHHhhhcc-CccccccccCCCCC-----cccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKS-SNFTYQFKQYPGGG-----IDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
....+........ ..+........... .......+++++.|||.+||++||.+|||++|+|+||||+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 5554443322211 11111111111111 1122345789999999999999999999999999999999764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=361.29 Aligned_cols=245 Identities=32% Similarity=0.585 Sum_probs=200.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC---CCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS---TRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~---~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|+.+|++|+ ||||+++++++.... ...+|+++++++|+|.+++... .+++..++.
T Consensus 50 ~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~-------------- 113 (345)
T d1pmea_ 50 CQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICY-------------- 113 (345)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC-CCCHHHHHH--------------
Confidence 456789999999998 999999999986432 3457888877778999999754 488888877
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++|||||||||+|||++.+ .+
T Consensus 114 ---------------------------------------------i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~ 148 (345)
T d1pmea_ 114 ---------------------------------------------FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDL 148 (345)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
||+|||++....... .....+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+....+...
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~ 228 (345)
T d1pmea_ 149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228 (345)
T ss_dssp EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence 999999997654322 2355689999999999877666899999999999999999999999999999999999888
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
.+.+...............+....+......+....+.+++++++||.+||+.||.+|||++|+|+||||++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 88887765543322222222222333333344455678899999999999999999999999999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=354.68 Aligned_cols=206 Identities=25% Similarity=0.427 Sum_probs=175.5
Q ss_pred hhhhHHHHHHhcCC-CCCCeeeeceeeecCCCCeEEEEeeccc--cCHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 11 VANLKEISILRKIP-DHLNVLCLCETYVNRSTRQVTLVFPLME--LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 11 ~~~~rEi~iL~~L~-~HpnIv~l~~~~~~~~~~~~~lV~E~~~--gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
..+.+|+.+|++++ +|||||+++++|.. .+.+|+||||+. +++.+++.....+++..++.
T Consensus 52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~--~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~--------------- 114 (273)
T d1xwsa_ 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARS--------------- 114 (273)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhccCCCCccEEEEEEee--CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHH---------------
Confidence 34679999999986 48999999999865 678999999997 38899998887899988888
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--eE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD--LV 165 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~--~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 115 --------------------------------------------~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 115 --------------------------------------------FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCCccccCcccceEEecCCCeE
Confidence 99999999999999999999999999999854 89
Q ss_pred EEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q psy9855 166 VVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGTP 245 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~p 245 (470)
||+|||++...... .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ .+.+ +
T Consensus 151 kl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--~-- 219 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--G-- 219 (273)
T ss_dssp EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--C--
T ss_pred EECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--c--
Confidence 99999999865443 34567899999999999887766788999999999999999999997532 1111 0
Q ss_pred chHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 246 KAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
...+.+.+|+++.+||.+||..||++|||++|+|+||||+++.
T Consensus 220 ---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 ---------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ---------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---------------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 0112346899999999999999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=357.64 Aligned_cols=245 Identities=28% Similarity=0.446 Sum_probs=188.5
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecC------CCCeEEEEeeccccCHHHHHHh-cccccHHHHHHHHHHHHhh
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNR------STRQVTLVFPLMELNLEEYIRT-TDNISEKRAKEILYQVKAA 80 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~------~~~~~~lV~E~~~gsL~~~l~~-~~~l~~~~~~~~~~~~~~~ 80 (470)
.....+++|+++|+.|+ ||||+++++++... ..+.+|+|||||++++...+.. ...+++..++.
T Consensus 51 ~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~-------- 121 (318)
T d3blha1 51 GFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR-------- 121 (318)
T ss_dssp SSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHH--------
T ss_pred HHHHHHHHHHHHHHHhc-CCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHH--------
Confidence 34456789999999999 99999999998642 2457899999999755555443 33477777776
Q ss_pred hccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE
Q psy9855 81 NETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILI 160 (470)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl 160 (470)
|+.||+.||+|||++||+||||||+|||+
T Consensus 122 ---------------------------------------------------i~~qil~~l~~lH~~~ivHrDlKp~NILl 150 (318)
T d3blha1 122 ---------------------------------------------------VMQMLLNGLYYIHRNKILHRDMKAANVLI 150 (318)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHhccCCEEecCcCchheee
Confidence 99999999999999999999999999999
Q ss_pred eCC-eEEEEecCCcccccCC-----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy9855 161 RGD-LVVVGDLGSLQFIKSK-----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQ 234 (470)
Q Consensus 161 ~~~-~ikL~DFG~a~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~ 234 (470)
+.+ .++|+|||++...... ......+||+.|+|||++.+...|+.++||||+||++|||++|++||.+.+..+.
T Consensus 151 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~ 230 (318)
T d3blha1 151 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230 (318)
T ss_dssp CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH
Confidence 888 8999999999765522 2234468999999999998876789999999999999999999999999999999
Q ss_pred HHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccc--cccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCC
Q psy9855 235 LDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVL--VPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFA 312 (470)
Q Consensus 235 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~ 312 (470)
+..+.+..|.+..+.+.................. ....... ....++++.|||.+||++||++|||++|+|+||||+
T Consensus 231 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 231 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp HHHHHHHHCCCCTTTSTTCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred HHHHHHhcCCCChhhccccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 9999999998877654433221111100000000 0000000 012367889999999999999999999999999998
Q ss_pred C
Q psy9855 313 D 313 (470)
Q Consensus 313 ~ 313 (470)
.
T Consensus 310 ~ 310 (318)
T d3blha1 310 S 310 (318)
T ss_dssp S
T ss_pred c
Confidence 5
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=351.44 Aligned_cols=209 Identities=17% Similarity=0.286 Sum_probs=174.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+++|+++|++|+ |||||+++|++.. +..++|||||+ |+|.+++.....+++..+..
T Consensus 52 ~~~~~~E~~il~~l~-HpnIv~~~g~~~~---~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~---------------- 111 (277)
T d1xbba_ 52 KDELLAEANVMQQLD-NPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---------------- 111 (277)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhCC-CCCCceEEEEecc---CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHH----------------
Confidence 456899999999999 9999999998853 35799999999 69999999888888888877
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
|+.||+.||+|||++|||||||||+|||++.+ .++|
T Consensus 112 -------------------------------------------i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl 148 (277)
T d1xbba_ 112 -------------------------------------------LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 148 (277)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred -------------------------------------------HHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccc
Confidence 99999999999999999999999999999887 8999
Q ss_pred EecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 168 GDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 168 ~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.+.
T Consensus 149 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~- 226 (277)
T d1xbba_ 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG- 226 (277)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-
T ss_pred cchhhhhhccccccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-
Confidence 99999987653322 23357899999999998755 8999999999999999997 89999988877665555321
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH---hcccCC
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL---SCAYFA 312 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL---~hp~f~ 312 (470)
.....+..+++++.+||.+||..||++|||+.+++ +|+|++
T Consensus 227 -----------------------------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 227 -----------------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------------------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 11123356889999999999999999999999984 565553
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=351.35 Aligned_cols=204 Identities=18% Similarity=0.268 Sum_probs=172.2
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc-cccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD-NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+++|+++|.+|+ |||||+++|++.. +.+|+|||||+ |+|.+++.... .+++..+..
T Consensus 52 ~~~~~~~E~~il~~l~-HpnIv~l~g~~~~---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~-------------- 113 (285)
T d1u59a_ 52 DTEEMMREAQIMHQLD-NPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-------------- 113 (285)
T ss_dssp HHHHHHHHHHHHHHCC-CTTBCCEEEEEES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeeEeeeecc---CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHH--------------
Confidence 3467899999999999 9999999998853 35899999999 69999986654 488877777
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 114 ---------------------------------------------i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~ 148 (285)
T d1u59a_ 114 ---------------------------------------------LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 148 (285)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCeecCcCchhheeeccCCce
Confidence 99999999999999999999999999999877 89
Q ss_pred EEEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
||+|||+++....... ....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~ 227 (285)
T d1u59a_ 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227 (285)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred eeccchhhhcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987754332 23457899999999987755 8999999999999999998 9999998887766655543
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
. .....++.+++++.+||.+||..||++|||+.+++
T Consensus 228 ~------------------------------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 228 G------------------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp T------------------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred C------------------------------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 1 11123457889999999999999999999999885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-44 Score=351.17 Aligned_cols=206 Identities=21% Similarity=0.328 Sum_probs=164.2
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+++|+++|++|+ |||||+++|++.. .+.+++|||||+ |+|.+++..... +++..+..
T Consensus 71 ~~~~~~E~~~l~~l~-HpnIv~l~g~~~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~--------------- 132 (299)
T d1jpaa_ 71 RRDFLSEASIMGQFD-HPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG--------------- 132 (299)
T ss_dssp HHHHHHHHHHHTTCC-CTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCCccEEEEEee--CCEEEEEEEecCCCcceeeeccccCCCCHHHHHH---------------
Confidence 456899999999998 9999999999854 667999999999 699999887543 77777777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
|+.||+.||+|||++||+||||||+|||++.+ .+|
T Consensus 133 --------------------------------------------i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~K 168 (299)
T d1jpaa_ 133 --------------------------------------------MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCK 168 (299)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHHhhCCCccCccccceEEECCCCcEE
Confidence 99999999999999999999999999999988 899
Q ss_pred EEecCCcccccCCCcc------ccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGLH------TEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 167 L~DFG~a~~~~~~~~~------~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 239 (470)
|+|||+++........ ....||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999876533221 2245789999999988755 8999999999999999998 899999988877666654
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.... ...+..+++++.+||.+||..||.+|||+.|++++
T Consensus 248 ~~~~------------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 248 QDYR------------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCC------------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3111 11234678999999999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=358.70 Aligned_cols=231 Identities=19% Similarity=0.284 Sum_probs=174.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+++|+.+|.++.+|||||++++++.. .+.+|+|||||+ |+|.++|..... +++.....
T Consensus 83 ~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~-------------- 146 (325)
T d1rjba_ 83 EREALMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY-------------- 146 (325)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred HHHHHHHHHHHHHHhcCCCcEeEEEEEEee--CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhh--------------
Confidence 345678999999999449999999999864 677999999999 699999987654 33322111
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
..... .........++...+..|+.||+.||+|||++|||||||||+|||++.+ .+
T Consensus 147 ----------------~~~~~-------~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~ 203 (325)
T d1rjba_ 147 ----------------ENQKR-------LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 203 (325)
T ss_dssp -------------------------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEE
T ss_pred ----------------ccccc-------cccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeE
Confidence 00000 0111122345667777899999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
||+|||+|+....... ....+||+.|||||++.+.. |+.++|||||||++|||++ |.+||.+.+....+..+...
T Consensus 204 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~ 282 (325)
T d1rjba_ 204 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 282 (325)
T ss_dssp EECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT
T ss_pred EEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 9999999987654332 23567899999999988755 8999999999999999997 89999887665555554431
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
......+..+++++.+||.+||+.||++|||++||++|
T Consensus 283 -----------------------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 283 -----------------------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp -----------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01112234678999999999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=343.39 Aligned_cols=242 Identities=29% Similarity=0.550 Sum_probs=198.8
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|+.+|+.++ ||||+++++++.. ....++|++++.| +|..++.....+++..+..
T Consensus 44 ~~~~~~~E~~il~~l~-h~niv~~~~~~~~--~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~--------------- 105 (292)
T d1unla_ 44 VPSSALREICLLKELK-HKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS--------------- 105 (292)
T ss_dssp HHHHHHHHHHHHTTCC-CTTBCCEEEEEEC--SSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHHhcC-cCCEEeecccccc--ccceeEEeeeccccccccccccccccchhHHHH---------------
Confidence 3567889999999999 9999999999965 6789999999995 7888777776788877777
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.|++.||+|||++|||||||||+|||++.+ .+|
T Consensus 106 --------------------------------------------~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~k 141 (292)
T d1unla_ 106 --------------------------------------------FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred --------------------------------------------HHHHHHHHHHHhhcCCEeeecccCcccccccCCcee
Confidence 99999999999999999999999999999877 899
Q ss_pred EEecCCcccccCCC-ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCC
Q psy9855 167 VGDLGSLQFIKSKG-LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPL-FPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 167 L~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~g~ 244 (470)
|+|||.+....... ......+++.|+|||++.+...++.++||||+||++|||++|+.| |.+.+..+.+..+....+.
T Consensus 142 l~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 142 LANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp ECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 99999998776433 334456788999999998777689999999999999999998877 5677788888899999998
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCCh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADL 314 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~ 314 (470)
+....+............... ..........+.+++.+.+||.+||+.||.+||||+|+|+||||++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPMY--PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCC--CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred CChhhhhhhhhcccccccccc--cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 887766555443221111111 11223344556789999999999999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=356.77 Aligned_cols=243 Identities=33% Similarity=0.573 Sum_probs=195.4
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+++|+++|++|+ |||||+++++|... +...+++++++++|+|.+++... .+++..++.
T Consensus 61 ~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~------------- 125 (348)
T d2gfsa1 61 AKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF------------- 125 (348)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC-CCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc-cccHHHHHH-------------
Confidence 456789999999999 99999999998642 23446666666668999998643 488888877
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 126 ----------------------------------------------i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~ 159 (348)
T d2gfsa1 126 ----------------------------------------------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159 (348)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCCcccccCCcccccccccc
Confidence 99999999999999999999999999999888 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++++|||++..... ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.
T Consensus 160 ~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 160 LKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp EEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccccccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999876543 2355689999999999888777899999999999999999999999999999999999999998
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCChh
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
+..+............+.......+...+......+++++++||.+||..||.+|||++|+|+||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 88776554333222222222333334444445567899999999999999999999999999999999753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-44 Score=355.75 Aligned_cols=242 Identities=30% Similarity=0.533 Sum_probs=185.0
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecC----CCCeEEEEeeccccCHHHHHHhcccccHHHHHHHHHHHHhhhcccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNR----STRQVTLVFPLMELNLEEYIRTTDNISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~----~~~~~~lV~E~~~gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~ 85 (470)
...+.+|+.+|++++ |||||+++++|... ...++|+|||||.|++.+.+. ..+++..++.
T Consensus 60 ~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~------------- 123 (355)
T d2b1pa1 60 AKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSY------------- 123 (355)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHH-------------
T ss_pred HHHHHHHHHHHHhcC-CCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh--cCCCHHHHHH-------------
Confidence 346789999999998 99999999999643 347899999999988777764 3477777776
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 124 ----------------------------------------------~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~ 157 (355)
T d2b1pa1 124 ----------------------------------------------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred ----------------------------------------------HHHHHHHHHHHhhhcccccccCCccccccccccc
Confidence 99999999999999999999999999999987 8
Q ss_pred EEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 165 VVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
++++|||+++...........+||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+.......+....+.
T Consensus 158 ~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp EEECCCCC---------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeeechhhhhccccccccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 9999999988877766667789999999999998865 899999999999999999999999999999999999999999
Q ss_pred CchHHHHHHhhhc----cCcccc-------ccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhcccCCC
Q psy9855 245 PKAETLKKFEKYK----SSNFTY-------QFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSCAYFAD 313 (470)
Q Consensus 245 p~~~~~~~~~~~~----~~~~~~-------~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~hp~f~~ 313 (470)
+..+.+....... ...... .+...............++++.+||.+||..||++||||+|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 8887765432211 000000 00000001111112346788999999999999999999999999999986
Q ss_pred h
Q psy9855 314 L 314 (470)
Q Consensus 314 ~ 314 (470)
.
T Consensus 317 ~ 317 (355)
T d2b1pa1 317 W 317 (355)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=340.96 Aligned_cols=207 Identities=21% Similarity=0.354 Sum_probs=164.3
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+++|++++++|+ |||||+++|++.. .+.+++|||||+ |+|.+++..... +++..+..
T Consensus 43 ~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~-------------- 105 (263)
T d1sm2a_ 43 SEEDFIEEAEVMMKLS-HPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG-------------- 105 (263)
T ss_dssp CHHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHH--------------
T ss_pred cHHHHHHHHHHHHhcC-CCCcccccceecc--CCceEEEEEecCCCcHHHHhhccccCCCHHHHHH--------------
Confidence 3567899999999999 9999999999865 567999999999 799999876544 67777666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 106 ---------------------------------------------i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~ 140 (263)
T d1sm2a_ 106 ---------------------------------------------MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 140 (263)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCE
T ss_pred ---------------------------------------------HHHHHHHHHHhhhccceeecccchhheeecCCCCe
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
||+|||+++....... .....||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 141 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~ 219 (263)
T d1sm2a_ 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 219 (263)
T ss_dssp EECSCC------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC
T ss_pred EecccchheeccCCCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999987654332 23457899999999998765 8999999999999999998 677787777766666654421
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
. ...+..+++++.+||.+||..||++|||++|+++|
T Consensus 220 ~------------------------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 R------------------------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp C------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1 11223568899999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-43 Score=343.80 Aligned_cols=205 Identities=23% Similarity=0.319 Sum_probs=167.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+++|+++|.+|+ |||||+++|++.. .+.+++|||||+ |+|.+++.... .+++..+..
T Consensus 57 ~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~-------------- 119 (287)
T d1opja_ 57 VEEFLKEAAVMKEIK-HPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-------------- 119 (287)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhCC-CCCEecCCccEee--CCeeEEEeecccCcchHHHhhhccccchHHHHHHH--------------
Confidence 456899999999999 9999999999864 677999999999 79999997653 367766666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 120 ---------------------------------------------i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~ 154 (287)
T d1opja_ 120 ---------------------------------------------MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 154 (287)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHCCcccCccccCeEEECCCCcE
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLF-PGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~ 242 (470)
||+|||+++....... .....||+.|+|||++.+.. |+.++|||||||++|||++|..|| .+.+.......+..
T Consensus 155 Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-- 231 (287)
T d1opja_ 155 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-- 231 (287)
T ss_dssp EECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT--
T ss_pred EEccccceeecCCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc--
Confidence 9999999987654332 23346889999999988765 899999999999999999966554 44444433332221
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......+..+++++.+||.+||+.||.+|||++|+++
T Consensus 232 ----------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 232 ----------------------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ----------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0111233568899999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=342.45 Aligned_cols=210 Identities=20% Similarity=0.345 Sum_probs=172.1
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhcccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~~ 85 (470)
....+++|+++|.+|+ |||||+++|++.. +.+++|||||+ |+|.+++..... +++..+..
T Consensus 51 ~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~---~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~------------- 113 (272)
T d1qpca_ 51 SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------------- 113 (272)
T ss_dssp CHHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHH-------------
T ss_pred CHHHHHHHHHHHHhCC-CCCEeEEEeeecc---CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHH-------------
Confidence 3456899999999998 9999999998743 45799999999 799998765443 66666655
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-e
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-L 164 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ 164 (470)
|+.||+.||+|||++||+||||||+|||++.+ .
T Consensus 114 ----------------------------------------------i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~ 147 (272)
T d1qpca_ 114 ----------------------------------------------MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147 (272)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC
T ss_pred ----------------------------------------------HHHHHHHHHHHHHhCCcccCccchhheeeecccc
Confidence 99999999999999999999999999999988 8
Q ss_pred EEEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 165 VVVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 165 ikL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
+||+|||+|+....... .....||+.|+|||++.+.. |+.++|||||||++|||++ |.+||...+..+.+..+...
T Consensus 148 ~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~ 226 (272)
T d1qpca_ 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (272)
T ss_dssp EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred eeeccccceEEccCCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 99999999987764432 24467899999999987755 8999999999999999999 56667776666655554321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh--cccCC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS--CAYFA 312 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~--hp~f~ 312 (470)
. ....+..+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 227 ~------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 Y------------------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp C------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C------------------------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1 11123468899999999999999999999999997 67764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-43 Score=333.87 Aligned_cols=207 Identities=20% Similarity=0.301 Sum_probs=175.6
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.+..+++|++++.+++ ||||++++|++.. .+.+++|||||+ |+|.+++..... +++..+..
T Consensus 42 ~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~--~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~-------------- 104 (258)
T d1k2pa_ 42 SEDEFIEEAKVMMNLS-HEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------------- 104 (258)
T ss_dssp CHHHHHHHHHHHHTCC-CTTBCCEEEEECC--SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHH--------------
T ss_pred CHHHHHHHHHHHHhcC-CCceeeEEEEEee--CCceEEEEEccCCCcHHHhhhccccCCcHHHHHH--------------
Confidence 4567899999999999 9999999999854 677999999998 799999766544 77766666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 105 ---------------------------------------------i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~ 139 (258)
T d1k2pa_ 105 ---------------------------------------------MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 139 (258)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHhhcCcccccccceeEEEcCCCcE
Confidence 99999999999999999999999999999987 89
Q ss_pred EEEecCCcccccCCCc--cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKGL--HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
||+|||+++....... .....||+.|+|||++.+.. |+.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 140 kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~ 218 (258)
T d1k2pa_ 140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218 (258)
T ss_dssp EECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EECcchhheeccCCCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999987654332 23467899999999988765 8999999999999999998 899999998877766664311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....+..+++++.+||.+||+.||++|||++++++|
T Consensus 219 ------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 ------------------------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 111234577899999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=338.52 Aligned_cols=208 Identities=22% Similarity=0.330 Sum_probs=164.4
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~ 84 (470)
+.....+++|+++|++|+ |||||+++|++. .+.+|+|||||+ |+|.+++..... +++..+..
T Consensus 49 ~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~---~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~------------ 112 (273)
T d1mp8a_ 49 DSVREKFLQEALTMRQFD-HPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL------------ 112 (273)
T ss_dssp HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC---SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHH------------
T ss_pred HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe---cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHH------------
Confidence 334567899999999998 999999999884 356899999999 699998766543 77777777
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
++.||+.||+|||++||+||||||+||+++.+
T Consensus 113 -----------------------------------------------~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~ 145 (273)
T d1mp8a_ 113 -----------------------------------------------YAYQLSTALAYLESKRFVHRDIAARNVLVSSND 145 (273)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred -----------------------------------------------HHHHHHHHhhhhcccCeeccccchhheeecCCC
Confidence 99999999999999999999999999999887
Q ss_pred eEEEEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
.+||+|||+++...... ......||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 146 ~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~ 224 (273)
T d1mp8a_ 146 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224 (273)
T ss_dssp EEEECC-------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred cEEEccchhheeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999998765332 224457899999999998755 8999999999999999998 8999998887776665543
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
. .....++.+++++.+||.+||..||.+|||+.|+++|
T Consensus 225 ~------------------------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 225 G------------------------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp T------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1 1112345789999999999999999999999999965
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.7e-43 Score=336.54 Aligned_cols=213 Identities=23% Similarity=0.322 Sum_probs=169.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCC--CCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRS--TRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~--~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+++|+.++ ||||+++++++...+ ...+|+|||||+ ++|.+++...+.+++..+..
T Consensus 51 ~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~-------------- 115 (277)
T d1o6ya_ 51 YLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE-------------- 115 (277)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhcC-CCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHH--------------
Confidence 346789999999999 999999999987543 345899999999 59999998888888888888
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+
T Consensus 116 ---------------------------------------------i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 116 ---------------------------------------------VIADACQALNFSHQNGIIHRDVKPANIMISATNAV 150 (277)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHhCCccCccccCcccccCccccc
Confidence 99999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCC----CccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSK----GLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 241 (470)
+|+|||.+...... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~ 229 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc
Confidence 99999988755422 2334568999999999998755 899999999999999999999999998887776665442
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-CHHHHHhcccC
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-TAQKILSCAYF 311 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-t~~elL~hp~f 311 (470)
... ......+.+|+++.+||.+||+.||.+|| |+++++ |+|+
T Consensus 230 ~~~---------------------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~ 272 (277)
T d1o6ya_ 230 DPI---------------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLV 272 (277)
T ss_dssp CCC---------------------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred CCC---------------------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence 111 11123357899999999999999999999 555554 5554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=333.48 Aligned_cols=206 Identities=21% Similarity=0.297 Sum_probs=161.5
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
....+++|+++|.+|+ |||||+++|++.. .+.+++|||||. |+|.+++..... +++..+..
T Consensus 52 ~~~~~~~E~~il~~l~-H~nIv~~~g~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~-------------- 114 (283)
T d1mqba_ 52 QRVDFLGEAGIMGQFS-HHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVG-------------- 114 (283)
T ss_dssp HHHHHHHHHHHHHTCC-CTTBCCEEEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhcC-CCCEeeeeEEEec--CCceEEEEEecccCcchhhhhcccccccHHHHHH--------------
Confidence 3456889999999999 9999999999854 667999999999 588888766543 77777666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 115 ---------------------------------------------i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 115 ---------------------------------------------MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHhhhhccccccccCccccceEEECCCCeE
Confidence 99999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCC----ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG----LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 166 kL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~ 240 (470)
||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+.+..+.+..+..
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~ 228 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc
Confidence 999999998765332 123356899999999987755 89999999999999999995 555655555554444432
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
. .....+..++..+.+||.+||..||++|||+.|+++
T Consensus 229 ~------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 229 G------------------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp T------------------------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred c------------------------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1 111223467899999999999999999999999984
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=338.92 Aligned_cols=225 Identities=23% Similarity=0.330 Sum_probs=166.4
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANETA 84 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~~~ 84 (470)
.+...+++|+.++.++.+|+||+.+++++.. ....+++|||||+ |+|.++|..... .+......
T Consensus 58 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~------------ 124 (299)
T d1ywna1 58 SEHRALMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE------------ 124 (299)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTSCCEEEEECCTTCBHHHHHHHTGGGBCC------------------
T ss_pred HHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-CCCeEEEEEEecCCCcHHHHHHhccccccccccchh------------
Confidence 4456788999999998779999999998754 3567899999999 799999976543 11000000
Q ss_pred cccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-
Q psy9855 85 AHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD- 163 (470)
Q Consensus 85 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~- 163 (470)
......++...+..++.||+.||+|||++|||||||||+|||++.+
T Consensus 125 ---------------------------------~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 125 ---------------------------------DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp --------------------------------------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred ---------------------------------hhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 0011234456666699999999999999999999999999999887
Q ss_pred eEEEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q psy9855 164 LVVVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIH 239 (470)
Q Consensus 164 ~ikL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~ 239 (470)
.+||+|||+|+...... .....+||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+....+.+..+.
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 89999999998655332 234568999999999998755 89999999999999999986 57887765544443332
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.. ......+..+++++.+||.+||+.||.+|||++|+++|
T Consensus 251 ~~-----------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 251 KE-----------------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HH-----------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hc-----------------------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 21 00112234678999999999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=343.87 Aligned_cols=219 Identities=22% Similarity=0.318 Sum_probs=180.9
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|++|++||||+++++++.+ ...+++|||||. |+|.+++.....+++..+..
T Consensus 72 ~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~---------------- 133 (322)
T d1vzoa_ 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQI---------------- 133 (322)
T ss_dssp GGGCCCHHHHHHHHHTCTTBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHH----------------
T ss_pred HHHHHHHHHHHHhccCCCeEEEeeeeecc--CCceeeeeecccccHHHHHHHhcccccHHHHHH----------------
Confidence 35678999999999846999999999865 668999999999 69999999888888887777
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
++.||+.||+|||++|||||||||+|||++.+ .++|
T Consensus 134 -------------------------------------------~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 134 -------------------------------------------YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred -------------------------------------------HHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEE
Confidence 99999999999999999999999999999988 8999
Q ss_pred EecCCcccccC--CCccccccccCcccCchhhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q psy9855 168 GDLGSLQFIKS--KGLHTEYIATRWYRSPECLLTEG-YYSFELDIWAAGCVFYETLTRNPLFPGDSEIDQLDRIHQVLGT 244 (470)
Q Consensus 168 ~DFG~a~~~~~--~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~g~ 244 (470)
+|||++..... ........|++.|+|||.+.+.. .++.++|||||||+||+|++|..||.+.+..+....+.....
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~- 249 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL- 249 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-
Confidence 99999976543 22335568999999999997654 478899999999999999999999988765544444433110
Q ss_pred CchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCc-----CHHHHHhcccCCChhH
Q psy9855 245 PKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRP-----TAQKILSCAYFADLTQ 316 (470)
Q Consensus 245 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rp-----t~~elL~hp~f~~~~~ 316 (470)
......+..+++++.+||.+||++||.+|| |++|+++||||+++..
T Consensus 250 --------------------------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 250 --------------------------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp --------------------------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred --------------------------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 001112346899999999999999999999 5899999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=337.16 Aligned_cols=205 Identities=19% Similarity=0.262 Sum_probs=168.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+++|+++|++|+ |||||+++|++.. +..++++|+|. |+|.+++..... +++..+..
T Consensus 55 ~~~~~~E~~~l~~l~-HpnIv~l~g~~~~---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~--------------- 115 (317)
T d1xkka_ 55 NKEILDEAYVMASVD-NPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN--------------- 115 (317)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEEES---SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEeeEEEEEec---CCeeEEEEeccCCcccccccccccCCCHHHHHH---------------
Confidence 456899999999999 9999999999864 34677888887 799988876544 77777776
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
|+.||+.||+|||++|||||||||+|||++.+ .+|
T Consensus 116 --------------------------------------------i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~k 151 (317)
T d1xkka_ 116 --------------------------------------------WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK 151 (317)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeE
Confidence 99999999999999999999999999999988 899
Q ss_pred EEecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy9855 167 VGDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 167 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 242 (470)
|+|||+++....... .....||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~ 230 (317)
T d1xkka_ 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230 (317)
T ss_dssp ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred eeccccceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987654332 23356899999999998765 8999999999999999998 899998877666555443311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
....++.+++++.+||.+||..||.+|||+.|+++|
T Consensus 231 ------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 231 ------------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 112235688999999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-42 Score=331.20 Aligned_cols=211 Identities=21% Similarity=0.362 Sum_probs=168.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcc--cccHHHHHHHHHHHHhhhccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTD--NISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~--~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+.+|+.+|.+|+ |||||+++|++.+ +.+++|||||+ |+|..++.... .+++..+..
T Consensus 56 ~~~~~~E~~~l~~l~-h~nIv~~~g~~~~---~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~-------------- 117 (285)
T d1fmka3 56 PEAFLQEAQVMKKLR-HEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-------------- 117 (285)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHH--------------
T ss_pred HHHHHHHHHHHHhcc-cCCEeEEEEEEec---CCeEEEEEecCCCchhhhhhhcccccchHHHHHH--------------
Confidence 467899999999999 9999999998743 45799999999 68998886533 367766666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
|+.||+.||+|||++||+||||||+|||++.+ .+
T Consensus 118 ---------------------------------------------i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~ 152 (285)
T d1fmka3 118 ---------------------------------------------MAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 152 (285)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred ---------------------------------------------HHHHHHHHHHHHhhhheecccccceEEEECCCCcE
Confidence 99999999999999999999999999999987 89
Q ss_pred EEEecCCcccccCCC--ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHh
Q psy9855 166 VVGDLGSLQFIKSKG--LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVL 242 (470)
Q Consensus 166 kL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~ 242 (470)
||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+....+.+..+....
T Consensus 153 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~ 231 (285)
T d1fmka3 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 231 (285)
T ss_dssp EECCCCTTC--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred EEcccchhhhccCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 999999998765333 223467899999999998755 89999999999999999995 56666666666665554311
Q ss_pred CCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh--cccCCCh
Q psy9855 243 GTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS--CAYFADL 314 (470)
Q Consensus 243 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~--hp~f~~~ 314 (470)
....++.+++++.+||.+||+.||++|||++++++ ++||...
T Consensus 232 ------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 ------------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------------------------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11234568899999999999999999999999988 8888753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=327.85 Aligned_cols=204 Identities=20% Similarity=0.290 Sum_probs=169.3
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
...+.+|+++|.+|+ |||||+++|++.. +.+++|||||+ |+|.+++..... +++..+..
T Consensus 55 ~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~--------------- 115 (273)
T d1u46a_ 55 MDDFIREVNAMHSLD-HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--------------- 115 (273)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECS---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHH---------------
T ss_pred HHHHHHHHHHHHhCC-CCCEEEEEEEEee---cchheeeeeecCcchhhhhhcccCCCCHHHHHH---------------
Confidence 346899999999998 9999999999853 35789999999 699988766543 77777766
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEE
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVV 166 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ik 166 (470)
++.||+.||+|||++||+||||||+|||++.+ .+|
T Consensus 116 --------------------------------------------~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vk 151 (273)
T d1u46a_ 116 --------------------------------------------YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 151 (273)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred --------------------------------------------HHHHHHHHHHHhhhCCEeeeeecHHHhcccccccee
Confidence 99999999999999999999999999999888 899
Q ss_pred EEecCCcccccCCCc----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 167 VGDLGSLQFIKSKGL----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 167 L~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
|+|||+++....... .....||..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.+.
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred eccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 999999987654332 23346788999999998755 8999999999999999998 89999999888877666431
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
......++.+++++.+||.+||..||++|||+.+++
T Consensus 231 -----------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 231 -----------------------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp -----------------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -----------------------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 111123356889999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=335.11 Aligned_cols=223 Identities=17% Similarity=0.203 Sum_probs=173.5
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|.++.+|||||+++|++.. .+.+++|||||+ |+|.++|.....+.......
T Consensus 54 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~---------------- 115 (309)
T d1fvra_ 54 HRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA---------------- 115 (309)
T ss_dssp -CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHH----------------
T ss_pred HHHHHHHHHHHHhccCCCCEeeEEEEEec--CCeeEEEEEecCCCcHHHHHhhccccccchhhh----------------
Confidence 45689999999999449999999999975 678999999999 69999998764321111111
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
........+....+..++.||+.||.|||++||+||||||+|||++.+ .+||
T Consensus 116 ---------------------------~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 116 ---------------------------IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp ---------------------------HHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred ---------------------------ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence 001112234455666699999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCc
Q psy9855 168 GDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLGTPK 246 (470)
Q Consensus 168 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~g~p~ 246 (470)
+|||+++............||..|+|||.+.+.. |+.++|||||||++|||++| .+||.+.+..+....+...
T Consensus 169 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~----- 242 (309)
T d1fvra_ 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 242 (309)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-----
T ss_pred ccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-----
Confidence 9999998766555555668999999999998755 89999999999999999996 4678888776665544321
Q ss_pred hHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 247 AETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
.....+..+++++.+||.+||+.||++|||++++++|
T Consensus 243 -------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 -------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0112335688999999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-42 Score=327.64 Aligned_cols=209 Identities=20% Similarity=0.283 Sum_probs=164.2
Q ss_pred CchhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc--ccHHHHHHHHHHHHhhhc
Q psy9855 6 PDFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN--ISEKRAKEILYQVKAANE 82 (470)
Q Consensus 6 ~~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~--l~~~~~~~~~~~~~~~~~ 82 (470)
.+.....+.+|+++|++|+ ||||++++|++.+ +.+.+|+|||||+ |+|.++|..... +++..+..
T Consensus 40 ~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~---------- 107 (262)
T d1byga_ 40 NDATAQAFLAEASVMTQLR-HSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK---------- 107 (262)
T ss_dssp CCC--HHHHHTHHHHTTCC-CTTBCCEEEEECC-C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHH----------
T ss_pred cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEe-cCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHH----------
Confidence 3444567899999999998 9999999998864 3456899999998 699999976543 66666665
Q ss_pred cccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC
Q psy9855 83 TAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG 162 (470)
Q Consensus 83 ~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~ 162 (470)
|+.||+.||+|||+++|+||||||+|||++.
T Consensus 108 -------------------------------------------------i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~ 138 (262)
T d1byga_ 108 -------------------------------------------------FSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 138 (262)
T ss_dssp -------------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred -------------------------------------------------HHHHHHhhccccccCceeccccchHhheecC
Confidence 9999999999999999999999999999998
Q ss_pred C-eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy9855 163 D-LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQ 240 (470)
Q Consensus 163 ~-~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 240 (470)
+ .++|+|||+++..... .....+|..|+|||++.+.. ++.++|||||||++|||++ |++||.+.+..+....+..
T Consensus 139 ~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~ 215 (262)
T d1byga_ 139 DNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215 (262)
T ss_dssp TSCEEECCCCC--------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred CCCEeecccccceecCCC--CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 8 8999999999865433 23457899999999998755 8999999999999999998 7899988766665555422
Q ss_pred HhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 241 VLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 241 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
......++.+++++.+||.+||..||.+|||+.+++++
T Consensus 216 ------------------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 ------------------------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ------------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11122345678999999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-41 Score=327.33 Aligned_cols=229 Identities=18% Similarity=0.219 Sum_probs=173.6
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+.+|+++|++|+ ||||+++++++.. .+..++||||++ |+|.+++.............
T Consensus 60 ~~~~~~E~~il~~l~-h~niv~~~~~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~---------------- 120 (301)
T d1lufa_ 60 QADFQREAALMAEFD-NPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH---------------- 120 (301)
T ss_dssp HHHHHHHHHHHHTCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCC------------------------
T ss_pred HHHHHHHHHHHHhcC-CCCcccceeeecc--CCceEEEEEecCCCcHHHHHHhcCccccccccc----------------
Confidence 457899999999999 9999999999864 677999999999 79999998765422111111
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
.+.. ............+....+..|+.||+.||+|||++|||||||||+|||++.+ .+||
T Consensus 121 ------------~~~~-------~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl 181 (301)
T d1lufa_ 121 ------------SDLS-------TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181 (301)
T ss_dssp ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred ------------cccc-------hhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEE
Confidence 0000 0000111223345667788899999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRN-PLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~-~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||+++...... .....+||+.|+|||++.+.. |+.++|||||||++|||++|. +||.+.+..+....+...
T Consensus 182 ~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~-- 258 (301)
T d1lufa_ 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-- 258 (301)
T ss_dssp CCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--
T ss_pred ccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC--
Confidence 9999998664332 234567899999999998755 899999999999999999984 789888877776665431
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++++.+||.+||+.||.+|||+.||++
T Consensus 259 ----------------------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 259 ----------------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112234568899999999999999999999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=324.75 Aligned_cols=224 Identities=19% Similarity=0.298 Sum_probs=174.1
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.....+.+|+.++.++..|||||++++++.. .+.+++|||||+ |+|.++|.............
T Consensus 60 ~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~-------------- 123 (299)
T d1fgka_ 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYN-------------- 123 (299)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC---------------------
T ss_pred HHHHHHHHHHHHHHHhcCCCeEEeccccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccc--------------
Confidence 3446788999999999559999999999965 677999999999 79999997664311100000
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
........++...+..++.||+.||+|||++|||||||||+|||++.+ .+
T Consensus 124 -----------------------------~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 124 -----------------------------PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred -----------------------------cccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCe
Confidence 001122334556666699999999999999999999999999999988 89
Q ss_pred EEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
||+|||++....... .....+||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+.......+...
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~ 253 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998765433 234467899999999998755 8999999999999999998 79999888776655444321
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 254 ------------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 254 ------------------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp ------------------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 111223568899999999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=326.72 Aligned_cols=227 Identities=19% Similarity=0.258 Sum_probs=173.4
Q ss_pred hhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 8 FAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 8 ~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
.+...+++|+.++..|.+|||||+++|++.. .+.+++|||||+ |+|.+++.............
T Consensus 68 ~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~-------------- 131 (311)
T d1t46a_ 68 TEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS-------------- 131 (311)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------------
T ss_pred HHHHHHHHHHHHHHhccCCCCEEEEEEEEee--CCEEEEEEEcCCCCCHHHHHHhccccccccccc--------------
Confidence 3455788999999999669999999999854 667999999999 69999997655311100000
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
..........++...+..|+.||+.||+|||++|||||||||+|||++.+ .+
T Consensus 132 ---------------------------~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 132 ---------------------------PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEE
T ss_pred ---------------------------cccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcc
Confidence 00001122345556677799999999999999999999999999999887 89
Q ss_pred EEEecCCcccccCCC---ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKG---LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLT-RNPLFPGDSEIDQLDRIHQV 241 (470)
Q Consensus 166 kL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 241 (470)
+++|||.++...... .....+||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+.+..+...
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~ 263 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 999999998765432 224468899999999997754 8999999999999999998 77778777666655555431
Q ss_pred hCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 242 LGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 242 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
- .....+..+++.+.+||.+||..||.+|||+.|+++
T Consensus 264 ~-----------------------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 264 G-----------------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp T-----------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-----------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 011122457899999999999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=323.52 Aligned_cols=208 Identities=23% Similarity=0.283 Sum_probs=164.9
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhccc-ccHHHHHHHHHHHHhhhccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
+...+.+|+++|.+|+ ||||++++|++.. ..+..++|||||+ |+|.+++..... ++...+..
T Consensus 71 ~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~-------------- 134 (311)
T d1r0pa_ 71 EVSQFLTEGIIMKDFS-HPNVLSLLGICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-------------- 134 (311)
T ss_dssp HHHHHHHHHHHHHTCC-CTTBCCCCEEEEE-TTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHH--------------
T ss_pred HHHHHHHHHHHHHhCC-CCCEeEEeEEEEe-cCCceEEEEEEeecCchhhhhccccccchHHHHHH--------------
Confidence 3467899999999999 9999999998764 3467999999999 699999876554 55555555
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LV 165 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~i 165 (470)
++.||+.||.|||+.||+||||||+|||++.+ .+
T Consensus 135 ---------------------------------------------i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~ 169 (311)
T d1r0pa_ 135 ---------------------------------------------FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 169 (311)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred ---------------------------------------------HHHHHHHhhhhhcccCcccCCccHHhEeECCCCCE
Confidence 99999999999999999999999999999987 89
Q ss_pred EEEecCCcccccCCCc-----cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHH
Q psy9855 166 VVGDLGSLQFIKSKGL-----HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDS-EIDQLDRIH 239 (470)
Q Consensus 166 kL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~ 239 (470)
||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||.... ..+....+.
T Consensus 170 kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~ 248 (311)
T d1r0pa_ 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248 (311)
T ss_dssp EECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH
T ss_pred EEecccchhhccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 9999999987653322 23357899999999988755 8999999999999999999777665432 222222222
Q ss_pred HHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHhc
Q psy9855 240 QVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILSC 308 (470)
Q Consensus 240 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~h 308 (470)
. +.....++.+++++.+||.+||..||++|||+.|+++|
T Consensus 249 ~------------------------------g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 249 Q------------------------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp T------------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c------------------------------CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1 01112234678999999999999999999999999965
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=322.83 Aligned_cols=215 Identities=22% Similarity=0.308 Sum_probs=172.1
Q ss_pred hhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccccc
Q psy9855 10 EVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAHYR 88 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (470)
...+++|++++.+++ |||||+++|++.. ....++|||||+ |+|.+++...... ...
T Consensus 67 ~~~~~~E~~il~~l~-h~nIv~~~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~----~~~---------------- 123 (308)
T d1p4oa_ 67 RIEFLNEASVMKEFN-CHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPA----MAN---------------- 123 (308)
T ss_dssp HHHHHHHHHHGGGCC-CTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHH----HHH----------------
T ss_pred HHHHHHHHHHHHHcC-CCCEeeeeeEEec--CCceeEEEeecCCCCHHHHHHhcccc----ccc----------------
Confidence 346789999999999 9999999999864 667999999999 7999998654310 000
Q ss_pred cccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC-eEEE
Q psy9855 89 VGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-LVVV 167 (470)
Q Consensus 89 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-~ikL 167 (470)
......+....+..++.||+.||.|||+++|+||||||+|||++.+ .+||
T Consensus 124 -----------------------------~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 124 -----------------------------NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp -----------------------------CTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred -----------------------------ccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 0011123344555599999999999999999999999999999988 8999
Q ss_pred EecCCcccccCCCc---cccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhC
Q psy9855 168 GDLGSLQFIKSKGL---HTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTR-NPLFPGDSEIDQLDRIHQVLG 243 (470)
Q Consensus 168 ~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~g 243 (470)
+|||+++....... ....+||+.|+|||.+.+.. ++.++|||||||++|||++| .+||.+.+..+.+..+.+.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~-- 251 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-- 251 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT--
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC--
Confidence 99999986654322 24457899999999998755 89999999999999999997 5889888877777665431
Q ss_pred CCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 244 TPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
.....++.+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 ----------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 252 ----------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112233567899999999999999999999999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-39 Score=315.71 Aligned_cols=215 Identities=16% Similarity=0.143 Sum_probs=162.0
Q ss_pred chhhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccc
Q psy9855 7 DFAEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAA 85 (470)
Q Consensus 7 ~~~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~ 85 (470)
+.....+.+|+++++.+++|++|+.+.+++.. .+..++|||||+++|...+..... +++..+..
T Consensus 43 ~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~------------- 107 (299)
T d1ckia_ 43 KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL------------- 107 (299)
T ss_dssp CTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHH-------------
T ss_pred hccCHHHHHHHHHHHHccCCCcccEEEEEEec--CCEEEEEEEEcCCchhhhhhhccCCCcHHHHHH-------------
Confidence 34455688999999999944445555554433 678999999999988887765443 77777776
Q ss_pred ccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCC--
Q psy9855 86 HYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGD-- 163 (470)
Q Consensus 86 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~-- 163 (470)
++.||+.||+|||++||+||||||+|||++..
T Consensus 108 ----------------------------------------------~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~ 141 (299)
T d1ckia_ 108 ----------------------------------------------LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 141 (299)
T ss_dssp ----------------------------------------------HHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGG
T ss_pred ----------------------------------------------HHHHHHHHHHHHHHCCeeeccCCHhhccccccCC
Confidence 99999999999999999999999999998643
Q ss_pred --eEEEEecCCcccccCCC--------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChHH
Q psy9855 164 --LVVVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEID 233 (470)
Q Consensus 164 --~ikL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~ 233 (470)
.++|+|||+|+...... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.....
T Consensus 142 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 142 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp TTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 69999999998765432 124568999999999998766 8999999999999999999999998766554
Q ss_pred HHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 234 QLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 234 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
....+....... . ........+.+|+++.+||.+||..||++||++.++.
T Consensus 221 ~~~~~~~~~~~~-------~----------------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 221 KRQKYERISEKK-------M----------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp ----HHHHHHHH-------H----------------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred HHHHHHHhhccc-------C----------------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 443332211000 0 0011222346889999999999999999999998654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.8e-38 Score=304.38 Aligned_cols=210 Identities=20% Similarity=0.186 Sum_probs=167.8
Q ss_pred hhhhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeeccccCHHHHHHhccc-ccHHHHHHHHHHHHhhhcccccc
Q psy9855 9 AEVANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMELNLEEYIRTTDN-ISEKRAKEILYQVKAANETAAHY 87 (470)
Q Consensus 9 ~~~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~gsL~~~l~~~~~-l~~~~~~~~~~~~~~~~~~~~~~ 87 (470)
....+.+|++++..|.+|+||+.+++++.. ....++|||||+++|.+++..... ++...+..
T Consensus 43 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~--------------- 105 (293)
T d1csna_ 43 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--------------- 105 (293)
T ss_dssp TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHH---------------
T ss_pred CcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEEecCCCHHHHHHhhccchhhHHHHH---------------
Confidence 345678999999999967999999998854 778999999999999999977654 77777666
Q ss_pred ccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeC-----
Q psy9855 88 RVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRG----- 162 (470)
Q Consensus 88 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~----- 162 (470)
++.|++.||+|||++||+||||||+|||++.
T Consensus 106 --------------------------------------------i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~ 141 (293)
T d1csna_ 106 --------------------------------------------AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKN 141 (293)
T ss_dssp --------------------------------------------HHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTT
T ss_pred --------------------------------------------HHHHHHHHHHHHHHCCceeccCCccceeecCccccc
Confidence 9999999999999999999999999999974
Q ss_pred -CeEEEEecCCcccccCCC--------ccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCChH-
Q psy9855 163 -DLVVVGDLGSLQFIKSKG--------LHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFPGDSEI- 232 (470)
Q Consensus 163 -~~ikL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~- 232 (470)
+.++|+|||+|+...... .....+||+.|||||++.+.. ++.++|||||||++|||++|..||.+....
T Consensus 142 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 142 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp TTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred CCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 279999999998764321 233568999999999998765 899999999999999999999999865432
Q ss_pred --HHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHH
Q psy9855 233 --DQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKIL 306 (470)
Q Consensus 233 --~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL 306 (470)
.....+..... ......+.+.+++++.+++..|+..+|++||+++.+.
T Consensus 221 ~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 221 NKQKYERIGEKKQ--------------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHHHHHHHH--------------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHHHHHHhccC--------------------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 22222222100 0011122346789999999999999999999987765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-38 Score=305.57 Aligned_cols=227 Identities=23% Similarity=0.228 Sum_probs=155.8
Q ss_pred hhhHH--HHHHhcCCCCCCeeeeceeeecCCC--CeEEEEeeccc-cCHHHHHHhcccccHHHHHHHHHHHHhhhccccc
Q psy9855 12 ANLKE--ISILRKIPDHLNVLCLCETYVNRST--RQVTLVFPLME-LNLEEYIRTTDNISEKRAKEILYQVKAANETAAH 86 (470)
Q Consensus 12 ~~~rE--i~iL~~L~~HpnIv~l~~~~~~~~~--~~~~lV~E~~~-gsL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (470)
...+| +..+..++ |||||++++++...+. ..+|+|||||+ |+|.++|++. .++...+..
T Consensus 41 ~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~-------------- 104 (303)
T d1vjya_ 41 SWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIK-------------- 104 (303)
T ss_dssp HHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHH--------------
T ss_pred HHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHH--------------
Confidence 34444 44556788 9999999999875433 46899999998 6999999765 366666666
Q ss_pred cccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh--------CCCeecCCCCCcE
Q psy9855 87 YRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS--------YKVFHRDIKPENI 158 (470)
Q Consensus 87 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~--------~gIvHrDLKp~NI 158 (470)
++.|++.||+|||+ +|||||||||+||
T Consensus 105 ---------------------------------------------~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NI 139 (303)
T d1vjya_ 105 ---------------------------------------------LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139 (303)
T ss_dssp ---------------------------------------------HHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGE
T ss_pred ---------------------------------------------HHHHHHHHHHHHHHhhhhhccCCCeeccccCccce
Confidence 99999999999996 6999999999999
Q ss_pred EEeCC-eEEEEecCCcccccCCC-----ccccccccCcccCchhhccCC-----CCCCcccHHHHHHHHHHHHhCCCCCC
Q psy9855 159 LIRGD-LVVVGDLGSLQFIKSKG-----LHTEYIATRWYRSPECLLTEG-----YYSFELDIWAAGCVFYETLTRNPLFP 227 (470)
Q Consensus 159 Ll~~~-~ikL~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~-----~~~~~~DIwSlG~il~elltg~~pf~ 227 (470)
|++.+ .+||+|||++....... .....+||+.|+|||++.+.. .++.++|||||||++|||++|.+||.
T Consensus 140 Ll~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred EEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 99888 99999999998765432 223568999999999986542 15678999999999999999998874
Q ss_pred CCChHHHHHHHHHHhCCCchHHHHHHhhhccCccccccccCCCCCcccccccccHHHHHHHHHhcccCCCCCcCHHHHHh
Q psy9855 228 GDSEIDQLDRIHQVLGTPKAETLKKFEKYKSSNFTYQFKQYPGGGIDVLVPQIHEKGKKLMSEMLKYDPKRRPTAQKILS 307 (470)
Q Consensus 228 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~Rpt~~elL~ 307 (470)
......... .......+.......... ...+ .+..............+.+||.+||..||.+|||+.|+++
T Consensus 220 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~------~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 220 IHEDYQLPY-YDLVPSDPSVEEMRKVVC--EQKL------RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp BCCCCCCTT-TTTSCSSCCHHHHHHHHT--TSCC------CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccccccch-hhcccccchHHHHHHHHh--cccc------CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 322110000 000000011111111000 0000 0000011111234567899999999999999999999985
Q ss_pred c
Q psy9855 308 C 308 (470)
Q Consensus 308 h 308 (470)
+
T Consensus 291 ~ 291 (303)
T d1vjya_ 291 T 291 (303)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=303.91 Aligned_cols=244 Identities=25% Similarity=0.394 Sum_probs=176.5
Q ss_pred hhhhhHHHHHHhcCC----------CCCCeeeeceeeecCCCCeEEEEeeccc--cCHHHHHHhcc--cccHHHHHHHHH
Q psy9855 10 EVANLKEISILRKIP----------DHLNVLCLCETYVNRSTRQVTLVFPLME--LNLEEYIRTTD--NISEKRAKEILY 75 (470)
Q Consensus 10 ~~~~~rEi~iL~~L~----------~HpnIv~l~~~~~~~~~~~~~lV~E~~~--gsL~~~l~~~~--~l~~~~~~~~~~ 75 (470)
...+.+|+++|+.+. +|+||+++++++........+++++++. ++......... .+++..++.
T Consensus 53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--- 129 (362)
T d1q8ya_ 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--- 129 (362)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHH---
T ss_pred hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHH---
Confidence 456789999998885 2688999999987655566667776665 34444333322 366666666
Q ss_pred HHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHh-CCCeecCCC
Q psy9855 76 QVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHS-YKVFHRDIK 154 (470)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~-~gIvHrDLK 154 (470)
++.||+.||+|||+ .||+|||||
T Consensus 130 --------------------------------------------------------i~~qil~al~~lh~~~~IvHrDlK 153 (362)
T d1q8ya_ 130 --------------------------------------------------------ISKQLLLGLDYMHRRCGIIHTDIK 153 (362)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHHTTCEECSCCS
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhhhcCcccccCC
Confidence 99999999999998 899999999
Q ss_pred CCcEEEeCC-------eEEEEecCCcccccCCCccccccccCcccCchhhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy9855 155 PENILIRGD-------LVVVGDLGSLQFIKSKGLHTEYIATRWYRSPECLLTEGYYSFELDIWAAGCVFYETLTRNPLFP 227 (470)
Q Consensus 155 p~NILl~~~-------~ikL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlG~il~elltg~~pf~ 227 (470)
|+|||++.+ .++++|||.+...... ....+||+.|+|||++.+.. |+.++||||+||++++|++|+.||.
T Consensus 154 p~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 154 PENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred hhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCC
Confidence 999999754 4899999998765432 35568999999999998765 8999999999999999999999996
Q ss_pred CCC------hHHHHHHHHHHhCCCchHHHHHHhhhc----cCccccccccCCCCC-------cccccccccHHHHHHHHH
Q psy9855 228 GDS------EIDQLDRIHQVLGTPKAETLKKFEKYK----SSNFTYQFKQYPGGG-------IDVLVPQIHEKGKKLMSE 290 (470)
Q Consensus 228 ~~~------~~~~~~~i~~~~g~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~-------~~~~~~~~s~~~~~Li~~ 290 (470)
... ..+.+..+...+|.++.+.+....... ............... ........++++.|||.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 543 345667778888988776654322110 000000000000000 111224567889999999
Q ss_pred hcccCCCCCcCHHHHHhcccCCChh
Q psy9855 291 MLKYDPKRRPTAQKILSCAYFADLT 315 (470)
Q Consensus 291 ~L~~dP~~Rpt~~elL~hp~f~~~~ 315 (470)
||++||.+|||++|+|+||||++..
T Consensus 311 mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp GGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HCCCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.66 E-value=2.3e-17 Score=148.53 Aligned_cols=123 Identities=18% Similarity=0.171 Sum_probs=88.9
Q ss_pred hhhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHHhcccccHHHHHHHHHHHHhhhcccccccc
Q psy9855 11 VANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIRTTDNISEKRAKEILYQVKAANETAAHYRV 89 (470)
Q Consensus 11 ~~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (470)
..+.+|+.+|.++. |++|+..+++. . .++||||+++ .+.+ ++...+..
T Consensus 59 ~~~~~e~~~l~~l~-~~~v~~~~~~~----~--~~lvme~~~~~~~~~-------l~~~~~~~----------------- 107 (191)
T d1zara2 59 RSARNEFRALQKLQ-GLAVPKVYAWE----G--NAVLMELIDAKELYR-------VRVENPDE----------------- 107 (191)
T ss_dssp HHHHHHHHHHHHTT-TSSSCCEEEEE----T--TEEEEECCCCEEGGG-------CCCSCHHH-----------------
T ss_pred HHHHHHHHHHHHcc-CCCcceEEEec----C--CEEEEEeeccccccc-------hhhHHHHH-----------------
Confidence 44568999999998 99999987643 1 3799999996 3221 22222223
Q ss_pred ccCCCccceeeeccCCCCchhhhhcccccCcccchhhhHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEeCCeEEEEe
Q psy9855 90 GWDLKLPFLLLVFGKSRNLGTLIVGLTTFLPQQSKRLYHTTFVLYQIVNGLHHLHSYKVFHRDIKPENILIRGDLVVVGD 169 (470)
Q Consensus 90 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~i~~qIl~aL~yLH~~gIvHrDLKp~NILl~~~~ikL~D 169 (470)
++.||+.||+|||++||+||||||+|||++++.++|+|
T Consensus 108 ------------------------------------------i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liD 145 (191)
T d1zara2 108 ------------------------------------------VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIID 145 (191)
T ss_dssp ------------------------------------------HHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECC
T ss_pred ------------------------------------------HHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEE
Confidence 99999999999999999999999999999998999999
Q ss_pred cCCcccccCCCccccccccCcccC------chhhccCCCCCCcccHHHHHHH
Q psy9855 170 LGSLQFIKSKGLHTEYIATRWYRS------PECLLTEGYYSFELDIWAAGCV 215 (470)
Q Consensus 170 FG~a~~~~~~~~~~~~~gt~~Y~A------PE~l~~~~~~~~~~DIwSlG~i 215 (470)
||.|......... .|.. .+.+ . +.|+.++|+||+.--
T Consensus 146 FG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGWR-------EILERDVRNIITYF-S-RTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTHH-------HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCCcH-------HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHH
Confidence 9998765422110 1111 1111 2 337889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.53 E-value=9.5e-05 Score=67.25 Aligned_cols=47 Identities=11% Similarity=-0.046 Sum_probs=34.0
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc-CHHHHHH
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL-NLEEYIR 60 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g-sL~~~l~ 60 (470)
.+.+|..+|..|.++--+.+++++... .+..++||++.+| ++.+...
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCSSEEHHHHTT
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEEEeccccccccccc
Confidence 457899999888755445666665543 5678999999997 7766543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.38 E-value=0.0019 Score=62.42 Aligned_cols=29 Identities=17% Similarity=0.088 Sum_probs=25.8
Q ss_pred CCCeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
..++|||++|.|||++++.++|+||..+.
T Consensus 223 ~~LiHGDl~~gNIlv~~~~~~vID~E~a~ 251 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHETKVIDPEFAF 251 (392)
T ss_dssp CEEECSCCCGGGEEECSSCEEECCCTTCE
T ss_pred cceeccCCcCCceeEcCCceEEechhhcc
Confidence 36999999999999999989999998664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.38 E-value=0.00083 Score=60.35 Aligned_cols=27 Identities=30% Similarity=0.258 Sum_probs=23.5
Q ss_pred CeecCCCCCcEEEeCCe-EEEEecCCcc
Q psy9855 148 VFHRDIKPENILIRGDL-VVVGDLGSLQ 174 (470)
Q Consensus 148 IvHrDLKp~NILl~~~~-ikL~DFG~a~ 174 (470)
++|+|+.|.|||++++. +-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 79999999999999985 5699999653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.09 E-value=0.026 Score=52.53 Aligned_cols=28 Identities=29% Similarity=0.312 Sum_probs=23.2
Q ss_pred CCCeecCCCCCcEEEeCCeEEEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGDLVVVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~ikL~DFG~a~ 174 (470)
.++||+|+.+.|||++++. .++||+.+.
T Consensus 192 ~~liHgDlh~~NvL~~~~~-~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDGP-MFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSSE-EECCCTTCC
T ss_pred ceeecCCCCcccEEEeCCc-eEEechhcc
Confidence 4689999999999998764 478999664
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.91 E-value=0.017 Score=53.26 Aligned_cols=29 Identities=24% Similarity=0.249 Sum_probs=25.3
Q ss_pred CCCeecCCCCCcEEEeCCeE-EEEecCCcc
Q psy9855 146 YKVFHRDIKPENILIRGDLV-VVGDLGSLQ 174 (470)
Q Consensus 146 ~gIvHrDLKp~NILl~~~~i-kL~DFG~a~ 174 (470)
.|+||+|+.++||+++++.+ -++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 47999999999999999954 699999664
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.47 E-value=0.023 Score=54.33 Aligned_cols=36 Identities=8% Similarity=-0.035 Sum_probs=26.2
Q ss_pred hhhHHHHHHhcCCCCCCeeeeceeeecCCCCeEEEEeecccc
Q psy9855 12 ANLKEISILRKIPDHLNVLCLCETYVNRSTRQVTLVFPLMEL 53 (470)
Q Consensus 12 ~~~rEi~iL~~L~~HpnIv~l~~~~~~~~~~~~~lV~E~~~g 53 (470)
...+|..+++.+..+.-..++++++.+ .+|+||++|
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~efi~g 125 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIFSG------GRLEEYIPS 125 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETT------EEEECCCCE
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEcCC------ceEEEEecc
Confidence 456899999988755445577776621 689999997
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=83.24 E-value=0.41 Score=42.89 Aligned_cols=45 Identities=18% Similarity=0.053 Sum_probs=37.9
Q ss_pred HHHHHHhhhccccccccccCCCccceeeeccCCCCchhhhhcccc
Q psy9855 73 ILYQVKAANETAAHYRVGWDLKLPFLLLVFGKSRNLGTLIVGLTT 117 (470)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~ 117 (470)
+++++..++.+...|....+....|++|||+.||+|.+++.....
T Consensus 62 ~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~ 106 (277)
T d1phka_ 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 106 (277)
T ss_dssp HHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS
T ss_pred HHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCC
Confidence 455666677888889999999999999999999999999976543
|